Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,positive regulation of nervous system development (GO:0051962),-0.6419931162654835,-2.3818233186615125,0.0,0.0008421451914924935,0.001,12/42,6.02%,CX3CR1;NUMB;IL1RAPL1;NRXN1;GRID2;PTPRD;NLGN1;CLSTN2;RGS14;TGM2;CLSTN3;EPHB1
prerank,positive regulation of synapse assembly (GO:0051965),-0.6250996242128425,-2.1689792453673884,0.0,0.021474702383058583,0.046,11/27,15.02%,IL1RAPL1;NRXN1;GRID2;PTPRD;NLGN1;CLSTN2;CLSTN3;EPHB1;NLGN3;SEMA4A;SLITRK2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5577517293455645,-2.0357228341595097,0.0,0.09488169157482094,0.26,17/37,5.28%,GRIA4;GRIK2;GRID2;GRM7;GRIA3;GRM1;GRIN3A;GRIN2B;PLCB1;GRIK3;GRIN2A;GRM5;GRIA2;GRM3;KCNB1;GRIK4;GRIN1
prerank,regulation of synapse assembly (GO:0051963),-0.5136965565886409,-1.9774931907607949,0.0,0.14190146476648516,0.458,14/46,6.61%,IL1RAPL1;NRXN1;GRID2;PTPRD;NLGN1;LRFN5;MEF2C;CLSTN2;ROBO2;CLSTN3;GPC6;PDLIM5;EPHB1;IL1RAPL2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6676803519875234,-1.9739145579793824,0.0,0.1182371848855461,0.475,11/17,21.50%,NLGN1;SYT10;SCAMP5;KCNB1;RAB3A;STX1A;CACNA1I;SYT4;SLC4A8;RAB15;CACNA1H
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.7070542172826505,-1.9501712670168587,0.003816793893129771,0.13319929778772938,0.587,7/13,11.45%,SYT1;SYT10;SCAMP5;KCNB1;STX1A;CACNA1I;SYT4
prerank,reverse cholesterol transport (GO:0043691),0.8818054994004851,1.9472561439833103,0.0,0.05597172145356758,0.046,4/13,2.39%,ABCA1;ABCG1;APOE;APOA2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.633147115471931,-1.935191162789743,0.0,0.13630721456585645,0.646,11/18,14.59%,GRIK2;GRID2;GRIK3;UNC13B;CDH8;GRID1;GRIA2;GRIK4;NAPB;GRIK5;UNC13C
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8469086494192553,1.9245456909087777,0.0,0.04612484453118069,0.075,7/15,8.84%,OSBPL8;PLIN2;LPL;PPARG;APOC4;ABHD5;TREM2
prerank,synaptic membrane adhesion (GO:0099560),-0.6845870886365455,-1.9103283198066028,0.0,0.16095499972400282,0.743,5/14,4.99%,LRRC4C;PTPRD;LRFN5;GPC6;NTNG1
prerank,neuronal action potential (GO:0019228),-0.598939950804066,-1.8891817622627018,0.0,0.17956406916378836,0.814,9/22,14.03%,SCN1A;ANK3;SCN8A;KCNMB2;KCNA1;CACNA1I;SCN2A;MYH14;SCN7A
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.8356311427274434,1.884865033326642,0.0,0.07635648420517552,0.168,6/14,8.84%,IGF1;PTPRC;CD200R1;CST7;TNFRSF1B;TREM2
prerank,cholesterol efflux (GO:0033344),0.7870471061816984,1.881684466225122,0.0,0.06115428825482383,0.176,8/20,9.20%,ABCA1;ABCG1;APOE;APOA2;SOAT1;SOAT2;NPC1;NPC2
prerank,intracellular pH reduction (GO:0051452),0.7179881255878654,1.8724236706856685,0.0,0.059910472222522326,0.214,19/33,14.42%,TCIRG1;ATP6V1C1;ATP6V0D2;DMXL2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V1G1;ATP6V0B;SLC11A1;DMXL1;RAB7A;GPR89A;GPR89B;RAB20;ATP6V0A4;ATP6V1F;ATP6V0C
prerank,response to histamine (GO:0034776),-0.743883488971647,-1.8717327510697161,0.003389830508474576,0.18889316645176632,0.85,3/10,0.97%,GABRB3;GABRB2;GABRB1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6706044284237176,-1.8665138132595571,0.007272727272727273,0.18106121617088614,0.859,5/13,13.39%,CACNB2;KCNJ3;KCNN2;CACNA1C;GJC1
prerank,neurotransmitter transport (GO:0006836),-0.4285059950444785,-1.8565566763657135,0.0,0.1819033613623786,0.882,31/73,16.05%,SNAP25;CASK;NRXN1;PPFIA2;RIMS1;SYN2;LIN7A;PPFIA4;UNC13B;SYT1;CPLX1;GAD2;STXBP3;GABRA2;RAB3A;GAD1;STXBP1;LIN7C;GLUL;STX1A;SNAPIN;SYN1;APBA1;NAAA;SLC1A3;SNPH;TSPOAP1;SLC1A6;BRSK1;SLC32A1;SLC1A1
prerank,proteoglycan metabolic process (GO:0006029),0.7282170137909706,1.8487217469920625,0.0,0.08015703319276343,0.328,4/26,1.35%,XYLT1;IGF1;CHST11;B4GALT7
prerank,"wound healing, spreading of cells (GO:0044319)",0.7235413540436956,1.8267523125899157,0.0012224938875305623,0.10913004950073889,0.46,9/24,6.11%,LCP1;ARHGAP24;MRTFA;ITGA5;MMP12;FLNA;ADAM17;PDPN;CD44
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.7286349047180285,1.82358240286394,0.0,0.10170787347465404,0.484,4/25,2.35%,IGF1;NIBAN2;DOT1L;TRIM6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.748096918086846,1.8168868177509903,0.0,0.10457268123423737,0.526,3/20,2.35%,IGF1;NIBAN2;TRIM6
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8720221182606396,1.8127361230894063,0.0,0.10489515205742662,0.558,4/10,2.64%,ABCA1;APOE;APOA2;BMP1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5091795739349824,-1.8059103226308721,0.0,0.26430402932995184,0.964,13/34,15.24%,GRID2;MEF2C;GRIN2B;GABRG3;GRIN2A;GRIN1;GABRA2;MPP2;LRRK2;GABRG1;NLGN3;GLRA1;DRD2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5447435383325202,-1.7998898657402653,0.006134969325153374,0.25721520277299303,0.971,10/29,10.38%,KCNIP4;DPP10;FGF12;DPP6;KCNN2;KCNIP3;SNTA1;WNK1;KCNAB2;WNK3
prerank,endosome organization (GO:0007032),0.6554960024860794,1.7994424235185797,0.0,0.12645462995065268,0.661,18/41,19.75%,CORO1C;EEA1;ALS2;SQSTM1;WASHC5;VPS18;PI4K2A;ARFGEF2;SNX33;SNX10;HOOK3;PI4K2B;RAB22A;RILP;HOOK1;VPS11;USP8;LAMTOR1
prerank,glycolipid metabolic process (GO:0006664),0.6464139234387022,1.7953259277682851,0.0,0.1267137582907155,0.69,20/47,12.57%,CERK;CTSA;HEXA;ESYT1;PSAP;GALC;GLTP;GLB1;GLA;SMPD4;HEXB;NEU1;ARSA;PGAP1;ASAH1;ST8SIA6;FUCA1;ST3GAL2;GBA2;GBGT1
prerank,negative regulation of blood coagulation (GO:0030195),0.6531873556338874,1.7908526976870829,0.0011750881316098707,0.1292452428436368,0.722,11/38,12.73%,PLAU;APOE;PLAUR;PDGFA;A2M;F11;SERPINE2;TFPI;KLKB1;SERPINF2;APOH
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5407733702931381,-1.7906439581105251,0.0,0.2604474362222452,0.977,13/26,12.60%,NRXN1;NLGN1;RIMS1;SLC8A3;GRIN1;RIMS2;PRKCZ;LRRK2;SHANK3;NLGN3;RELN;TMEM108;SLC8A2
prerank,glycosphingolipid metabolic process (GO:0006687),0.6490245008263263,1.788351003688015,0.0011376564277588168,0.1271949966365464,0.741,16/42,10.95%,LARGE1;CERK;CTSA;HEXA;ESYT1;PSAP;GALC;GLTP;GLB1;GLA;SMPD4;HEXB;NEU1;ARSA;ASAH1;GBA2
prerank,negative regulation of lipid storage (GO:0010888),0.740751918247274,1.7864614980490492,0.0,0.12223947561896423,0.754,10/19,14.62%,OSBPL8;ABCA1;ABCG1;PPARD;PPARG;PTPN2;ABHD5;TREM2;IL6;TNF
prerank,chloride transmembrane transport (GO:1902476),-0.46308368068508216,-1.7864133330180596,0.0,0.25316989819243085,0.982,24/48,21.35%,GABRB3;GABRB2;GABRB1;GLRA3;ANO4;GABRG3;SLC12A2;GABRA2;SLC12A9;SLC6A1;LRRC8A;GLRA2;GABRG1;SLC1A3;CLCN1;SLC12A8;GLRA1;SLC1A1;ANO7;GABRR2;SLC4A8;SLC12A6;GABRE;GABRA1
prerank,ganglion development (GO:0061548),0.8221285123100793,1.7863994317514724,0.001392757660167131,0.1146642904777947,0.754,3/11,1.74%,CTNNB1;NRP2;NRP1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.8382333475028402,1.7852581668345369,0.0028735632183908046,0.11090692954688389,0.761,6/10,8.84%,STAP1;CD300A;NCKAP1L;APPL2;ANO6;TREM2
prerank,tRNA aminoacylation (GO:0043039),0.6667459231681045,1.7773573347186225,0.0,0.12225099243407815,0.813,19/37,17.39%,EPRS1;AARS1;VARS1;CARS1;FARSB;FARSA;NARS1;GARS1;RARS2;RARS1;YARS1;LARS1;GATB;TARS1;AIMP2;FARS2;QARS1;SARS1;SARS2
prerank,fibrinolysis (GO:0042730),0.779725312584371,1.7707544625659226,0.0028530670470756064,0.13196451676040932,0.852,2/13,1.15%,PLAU;PLAUR
prerank,amino acid transmembrane transport (GO:0003333),0.6302045518788575,1.7674369837089103,0.0011467889908256881,0.13267371011216017,0.87,15/45,13.05%,MFSD12;SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC7A1;SFXN1;SLC38A7;SLC7A6;SLC7A8;LRRC8D;SLC25A18;SFXN2;SLC38A10
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.8236588968990513,1.7638738262223832,0.0014814814814814814,0.13361150791429224,0.881,8/10,15.17%,RENBP;NAGK;NPL;GNPDA1;ST6GAL1;AMDHD2;NANP;GNPDA2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.6537659843200133,1.7627883131576305,0.0,0.1302708836861232,0.887,20/42,17.39%,EPRS1;AARS1;VARS1;VARS2;CARS1;FARSB;EARS2;FARSA;NARS1;GARS1;RARS2;RARS1;YARS1;LARS1;TARS1;AIMP2;FARS2;QARS1;SARS1;SARS2
prerank,negative regulation of phagocytosis (GO:0050765),0.7498389160774033,1.7598899217960973,0.007832898172323759,0.1313217361640064,0.902,4/17,3.27%,SIRPA;CD300LF;FER1L5;CD300A
prerank,phagosome acidification (GO:0090383),0.6920943253964286,1.7585465613454443,0.0,0.12900272529460366,0.909,14/26,14.42%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V1G1;ATP6V0B;RAB7A;RAB20;ATP6V0A4;ATP6V1F;ATP6V0C
prerank,positive regulation of lipid transport (GO:0032370),0.8215651130439645,1.7568901815694644,0.0013531799729364006,0.12740822224208384,0.915,5/12,8.17%,SPP1;LRP1;APOE;CYP19A1;TRIAP1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5016248610277377,-1.7522059500218703,0.005988023952095809,0.3190739516707736,0.997,12/32,5.28%,GRIA4;NLGN1;DLG2;MEF2C;GRIA3;GRIN2B;CCR2;LRRC7;NEFL;GRIN2A;GRIA2;GRIN1
prerank,wound healing (GO:0042060),0.6062820742592977,1.750410511337507,0.001081081081081081,0.13622177507609715,0.939,22/62,18.39%,IGF1;MYOF;AHNAK2;MACF1;MMP12;PDGFA;FGF2;FER1L5;HMOX1;DCBLD2;SLC11A1;DST;ARL8B;SRF;RAF1;HPSE;NF1;FUT10;TRIM72;CORO1B;JAML;TGFBR1
prerank,cholesterol transport (GO:0030301),0.6337397877910032,1.749160714611109,0.0011235955056179776,0.13424767484439357,0.942,14/45,14.67%,ABCA1;ABCG1;APOE;APOA2;CEL;SOAT1;SOAT2;NPC1;CAV1;NPC2;OSBPL2;OSBP;MSR1;SERAC1
prerank,amino sugar biosynthetic process (GO:0046349),0.7863361135813057,1.7480963155208147,0.004273504273504274,0.1316371967519089,0.943,9/12,15.17%,RENBP;NAGK;GNPNAT1;GNPDA1;UAP1;UAP1L1;AMDHD2;NANP;GNPDA2
prerank,steroid catabolic process (GO:0006706),0.8344715701432552,1.7464432389386642,0.004231311706629055,0.13042197419161436,0.948,3/10,2.72%,SPP1;CYP19A1;CYP27B1
prerank,transferrin transport (GO:0033572),0.6609402870765132,1.7462733286543743,0.0024183796856106408,0.1266619326227029,0.95,19/33,20.61%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;REP15;ATP6V1G1;ATP6V0B;DNM2;ATP6V0A4;ATP6V1F;ATP6V0C;ATP6AP1;TFRC;ATP6V1D;STEAP3;ATP6V1E1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7480197552086357,1.741183341186957,0.0,0.1331752488348624,0.964,7/16,8.84%,SIRPA;NLRC3;ADCY7;CHID1;ABCD2;APPL2;TREM2
prerank,regulation of vasculature development (GO:1901342),0.687078059097751,1.7410880587037032,0.0037313432835820895,0.1292402596063279,0.964,9/26,14.72%,GPNMB;CTNNB1;FGF2;HMOX1;RNH1;EGLN1;PLXND1;IL6;NF1
prerank,acylglycerol metabolic process (GO:0006639),0.6422108470994707,1.7388326677979007,0.0,0.13085195935777919,0.971,14/37,13.12%,LPL;DGKZ;APOE;ABHD12;MGLL;APOA2;GK;PLAAT3;APOBR;DGKH;CAV1;DGKD;APOH;LYPLA2
prerank,secretory granule organization (GO:0033363),0.8249721093114939,1.7363278565854223,0.0014265335235378032,0.1322469104932332,0.976,4/10,7.18%,LYST;ABCA1;DTNBP1;BLOC1S3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7602053695015513,1.736124613002698,0.0026246719160104987,0.1289126473478199,0.976,3/15,2.39%,ABCG1;APOE;APOA2
prerank,sympathetic nervous system development (GO:0048485),0.7576737839045439,1.7358827365655352,0.0013477088948787063,0.12579241308160324,0.976,3/15,1.74%,CTNNB1;NRP2;NRP1
prerank,intracellular sterol transport (GO:0032366),0.773309586727057,1.7349635840740014,0.001366120218579235,0.1243535893555488,0.978,8/13,14.67%,ABCA1;ABCG1;NPC1;NPC2;OSBPL2;OSBP;ARV1;SERAC1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.7746508681354646,1.7346611742982596,0.0027548209366391185,0.12179031982952204,0.978,4/13,2.23%,PLXNC1;NRP2;NRP1;PLXNA2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7049931031410379,1.7332786891371428,0.0012285012285012285,0.12129864041504389,0.978,7/21,4.20%,PRKCH;STAP1;CD22;RUNX1;CD300A;ELF2;PRKCB
prerank,positive chemotaxis (GO:0050918),0.7479463304558649,1.7325951026029318,0.0025806451612903226,0.11935451343293159,0.978,4/17,3.49%,LGALS3;GPNMB;NRP1;VEGFA
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7161893195343335,1.7296339531000435,0.003787878787878788,0.12112037826740843,0.979,5/20,1.74%,IGF1;PLAU;LRP1;PDGFA;NRP1
prerank,neurotransmitter secretion (GO:0007269),-0.4668717647669618,-1.7283580082885717,0.0,0.3637599368807854,0.999,19/44,10.29%,SNAP25;NRXN1;RIMS1;SYN2;LIN7A;SYT1;SYT10;CPLX1;GAD2;STXBP3;RIMS2;RAB3A;GAD1;STXBP1;LIN7C;STX1A;SNAPIN;SYN1;NAAA
prerank,vesicle transport along actin filament (GO:0030050),0.7077393763449916,1.7277982106667449,0.005161290322580645,0.12198775094576035,0.982,4/19,2.30%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,regulation of T cell proliferation (GO:0042129),0.5921180513868849,1.7263214987775268,0.0010976948408342481,0.12139258795872795,0.983,14/61,12.58%,LGALS3;GPNMB;PTPRC;CD274;SLC7A1;NCKAP1L;TNFRSF1B;IL27;TNFSF8;LILRB1;NCK1;TNFSF9;RIPK3;IL6
prerank,B cell receptor signaling pathway (GO:0050853),0.6622581092189651,1.7257883566817067,0.0,0.11936393628166116,0.983,12/32,12.45%,RFTN1;BCL2;TEC;BLNK;PTPRC;PRKCB;NCKAP1L;BAX;PLEKHA1;SYK;LAT2;BTK
prerank,chemical synaptic transmission (GO:0007268),-0.34715862594858926,-1.7231971379792914,0.0,0.3582219704022281,0.999,92/284,16.05%,CACNB2;GABRB3;FCHSD2;GRIA4;GRIK2;SNAP25;NRXN1;GRID2;SYNJ2BP;NLGN1;GRM7;CHRM2;DLG2;RIMS1;GABRB2;GRIA3;GABRB1;GRM1;RPS6KA1;SYN2;GLRA3;DLGAP1;KCND2;LIN7A;AMPH;GRIN2B;HTR1F;HTR2C;GRIK3;UNC13B;GABRG3;GRIN2A;CDH8;SYT1;GRM5;GRID1;PDE7B;SYT10;GRIA2;GRM3;CPLX1;RIT2;HRH2;GRIK4;GRIN1;GAD2;STXBP3;KCNQ3;CACNA1B;APBA2;GABRA2;RAB3A;PRKAR2A;PLP1;HTR2A;GAD1;STXBP1;LIN7C;SHISA6;PENK;KCNA1;STX1A;CHRM3;SLC6A1;PRKAR2B;SNAPIN;GLRA2;GABRG1;SYN1;APBA1;NAAA;SLC1A3;NAPB;NLGN3;HAP1;PAFAH1B1;SNPH;TSPOAP1;NSG1;GRIK5;CAMK4;KIF5A;SLC1A6;UNC13C;BRSK1;RIC3;GLRA1;DRD2;SLC32A1;SST;CBLN2;SLC1A1
prerank,eosinophil migration (GO:0072677),0.7470881343864048,1.7231488471012686,0.0013717421124828531,0.11951449701679646,0.984,3/14,7.26%,LGALS3;CCL4;CCL13
prerank,eosinophil chemotaxis (GO:0048245),0.7470881343864048,1.7231488471012686,0.0013717421124828531,0.11951449701679646,0.984,3/14,7.26%,LGALS3;CCL4;CCL13
prerank,regulation of fibroblast proliferation (GO:0048145),0.6246154805163523,1.7212630378760951,0.0,0.12089715406164596,0.984,11/45,7.99%,IGF1;CTNNB1;FN1;PDGFA;NLRC3;B4GALT7;CDK6;SPHK1;CD300A;SKI;GAS6
prerank,proteoglycan biosynthetic process (GO:0030166),0.6489937343329647,1.7200739460953434,0.0,0.12084018258262506,0.986,5/31,4.16%,XYLT1;IGF1;CHST11;B4GALT7;HS3ST3B1
prerank,myotube cell development (GO:0014904),0.8280737694823802,1.7199644242926155,0.0,0.11864904974794427,0.986,3/10,7.38%,IGF1;SELENON;SKI
prerank,phagosome maturation (GO:0090382),0.6467531202895042,1.7192490431309404,0.001176470588235294,0.11754061505249193,0.986,16/35,14.46%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V1G1;RAB32;ATP6V0B;RAB7A;RAB20;ATP6V0A4;ATP6V1F;ATP6V0C;MREG
prerank,positive regulation of leukocyte migration (GO:0002687),0.6664963647408926,1.7189113189992202,0.001215066828675577,0.1158862584343654,0.987,6/27,5.80%,LGALS3;CSF1;ADAM8;VEGFA;ADAM17;NCKAP1L
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.48212666728103304,-1.716151718430381,0.006289308176100629,0.35951178224814556,0.999,17/31,21.50%,SYT1;SYT10;SCAMP5;KCNB1;STXBP3;STXBP1;STX1A;CBARP;CACNA1I;SYT4;REST;ADRA2A;SYT7;SYT2;SYT17;SYT9;CACNA1H
prerank,primary alcohol metabolic process (GO:0034308),0.6824085126442806,1.7152585798493816,0.002466091245376079,0.12013588504296714,0.993,10/25,17.23%,IGF1;DHRS3;GPD2;GDPD3;RDH12;ALDH3A2;CYP1B1;NAPEPLD;RBP4;RDH10
prerank,regulation of lipid storage (GO:0010883),0.6802866731079239,1.7150945318387745,0.0025380710659898475,0.11816252306864264,0.993,10/22,19.57%,LPL;IKBKE;FBXW7;PTPN2;ALKBH7;NFKB1;IL6;TNF;FTO;ZC3H12A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7040567731789421,1.7136283701033554,0.002560819462227913,0.11889192135918984,0.995,7/21,8.84%,LRP1;APOE;EEPD1;PON1;PPARG;CAV1;TREM2
prerank,excitatory postsynaptic potential (GO:0060079),-0.5636338586503922,-1.7124957699669714,0.012658227848101266,0.35342026536301646,1.0,7/19,8.51%,GRID2;MEF2C;GRIN2B;GRIN2A;GRIN1;MPP2;LRRK2
prerank,acylglycerol catabolic process (GO:0046464),0.6578607800078002,1.7112774688327677,0.0012091898428053204,0.12100822338496883,0.996,5/30,2.39%,LPL;ABHD12;FABP5;MGLL;APOA2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5225375176496774,-1.7103716026984161,0.004784688995215311,0.34252341697612876,1.0,10/25,15.24%,GRID2;MEF2C;GRIN2B;GRIN2A;GRIN1;MPP2;LRRK2;NLGN3;GLRA1;DRD2
prerank,actin filament-based transport (GO:0099515),0.6852094866959918,1.7092225623617638,0.0050568900126422255,0.1225306865154158,0.996,4/21,2.30%,MYO1E;MYO5A;MYO1F;MYO1A
prerank,cellular response to cAMP (GO:0071320),-0.48408614649670556,-1.7074596216193831,0.0125,0.33495409616405786,1.0,9/30,16.05%,AKAP6;EZR;HCN1;RAPGEF2;RAPGEF3;DMTN;IGFBP5;PDE2A;INPP5K
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5180090443805275,-1.7071525176703946,0.013333333333333334,0.3217345525331114,1.0,11/25,15.31%,DMD;ANK3;CTSS;GLRX;WNK1;STAC;SLC6A9;WNK3;COX17;NDUFA4;TCAF1
prerank,dendritic cell migration (GO:0036336),-0.5869000378513956,-1.7062241369752398,0.02564102564102564,0.31098737631434803,1.0,7/16,16.39%,EPS8;CCR5;ALOX5;CCR2;CCR1;CCL5;CCR6
prerank,dopaminergic neuron differentiation (GO:0071542),0.7042323732873812,1.705511401604656,0.003826530612244898,0.12680013440406976,0.997,3/19,7.57%,CTNNB1;VEGFA;LRP6
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7814405679132368,1.7046526275408653,0.007132667617689016,0.126418888110644,0.997,8/11,15.17%,RENBP;NAGK;GNPNAT1;GNPDA1;UAP1;UAP1L1;AMDHD2;GNPDA2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.681778698204506,1.703986248766969,0.002531645569620253,0.12554109275178715,0.997,8/22,12.87%,RAB7B;MFHAS1;WDFY1;APPL2;NINJ1;TREM2;ACOD1;TNFAIP3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6526491897927192,1.703337522523532,0.002430133657351154,0.1247443829062381,0.997,6/27,4.65%,LPL;ABCA1;ABCG1;PRKCH;CSF1;PPARG
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7590861139925466,1.7018379903944427,0.004155124653739612,0.12563901288029103,0.997,8/13,15.17%,RENBP;NAGK;GNPNAT1;GNPDA1;UAP1;UAP1L1;AMDHD2;GNPDA2
prerank,regulation of neuroinflammatory response (GO:0150077),0.7051702350899728,1.701735310750446,0.00392156862745098,0.12384662859260112,0.997,7/19,14.62%,IGF1;CD200R1;SPHK1;TNFRSF1B;TREM2;IL6;TNF
prerank,negative regulation of cellular metabolic process (GO:0031324),0.6251033354689517,1.6985526215480324,0.002352941176470588,0.1273759751597649,0.998,11/37,10.20%,APOE;SDCBP;OPTN;TRAT1;ANKRD13B;LRPAP1;SIRT5;BRCA1;TRAP1;NFKB1;ATXN2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.44375577161345914,-1.696840380609941,0.0,0.3205010257622394,1.0,19/46,12.36%,OPHN1;NRXN1;NLGN1;GRM7;MEF2C;GRM1;TSHZ3;CCR2;GRIK3;SYT1;GRM5;GRM3;CACNG3;CDH2;GRM8;LRRK2;SHANK3;NLGN3;RELN
prerank,response to iron ion (GO:0010039),0.7645600553291589,1.6964415044005916,0.0014265335235378032,0.12951558346764466,0.998,2/12,0.56%,BCL2;HIF1A
prerank,intracellular cholesterol transport (GO:0032367),0.7276433357873897,1.6956456871708319,0.00801068090787717,0.12889442293709025,0.998,8/15,14.67%,ABCA1;ABCG1;LRP6;NPC1;NPC2;OSBPL2;OSBP;SERAC1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7061884068264399,1.6943914688713928,0.0079155672823219,0.12940712255258047,0.999,8/18,16.89%,GPR137B;FSTL3;FBXW7;TCTA;LILRB3;LILRB1;TMEM178A;MAFB
prerank,signal release from synapse (GO:0099643),-0.45577813129474903,-1.6942262757074962,0.0,0.3144944431784746,1.0,18/43,10.29%,SNAP25;NRXN1;RIMS1;SYN2;LIN7A;SYT1;SYT10;CPLX1;GAD2;STXBP3;RAB3A;GAD1;STXBP1;LIN7C;STX1A;SNAPIN;SYN1;NAAA
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.5005023835803238,-1.6939211680345574,0.009433962264150943,0.30395426090082645,1.0,4/23,1.51%,HPGD;ELOVL6;LTC4S;ALOX5
prerank,phospholipid homeostasis (GO:0055091),0.796688557781956,1.6934760517711949,0.002789400278940028,0.12931664445283894,0.999,4/11,5.99%,ABCA1;ABCG1;TLCD1;TLCD2
prerank,neuron cell-cell adhesion (GO:0007158),-0.6012714919735996,-1.6908472378927866,0.024305555555555556,0.3008200702989911,1.0,9/14,16.95%,NRXN3;NRXN1;ASTN2;NLGN1;CNTN4;NLGN3;RET;NCAM2;ASTN1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.47315231390196305,-1.6896649062315858,0.0072992700729927005,0.29295424061385544,1.0,9/35,4.47%,NLGN1;CDH13;CDH23;CDH9;CDH8;CDH10;CDH12;CDH7;CDH20
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.6349298337664098,-1.6825973903397926,0.02491103202846975,0.2970327588315782,1.0,8/12,27.01%,PAEP;IL18;RASGRP1;IL1B;CD80;TLR9;IL17D;ISL1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.7290138768232755,1.6801942501572165,0.003989361702127659,0.15398320537144328,1.0,5/16,11.02%,PLEKHM2;LYST;ARL8B;VAMP2;CEBPG
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5497700496269008,-1.6776023750765252,0.01195219123505976,0.29861942149579135,1.0,9/18,13.87%,NRXN1;NLGN1;TSHZ3;CCR2;CACNG3;SHANK3;NLGN3;RELN;CCL2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.648103314794822,1.6749146200348,0.002403846153846154,0.16379915478521223,1.0,13/29,20.90%,TENT5C;LARP1;NOCT;SLC11A1;DHX34;TAF15;VIP;EIF4ENIF1;PABPC1;CIRBP;FUS;HNRNPU;GDNF
prerank,acylglycerol homeostasis (GO:0055090),0.6868614772952095,1.6745245722671844,0.011479591836734694,0.16243645088508896,1.0,4/20,5.97%,LPL;APOE;GCKR;APOC4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6512345905013155,1.6726562451623237,0.009913258983890954,0.16429466698968428,1.0,3/27,0.15%,XYLT1;CHST11;CSPG4
prerank,vacuolar acidification (GO:0007035),0.6882711479814431,1.6705036101281172,0.0012547051442910915,0.16697942313269812,1.0,8/21,9.50%,TCIRG1;ATP6V0D2;DMXL2;ATP6V0A1;ATP6V0D1;TMEM199;SLC11A1;DMXL1
prerank,positive regulation of lipid localization (GO:1905954),0.769682677189578,1.6703753289370955,0.011315417256011316,0.16491921478518198,1.0,4/11,9.41%,LPL;LRP1;IKBKE;NFKB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7496811510693863,1.6691224327986574,0.006811989100817439,0.16544994339578084,1.0,3/12,4.65%,ABCA1;ABCG1;PPARG
prerank,regulation of cytoplasmic translation (GO:2000765),0.7305854062823773,1.6646067413002672,0.0027397260273972603,0.17392694185016,1.0,9/14,20.51%,PKM;UNK;CPEB4;CPEB2;DHX9;CPEB1;CPEB3;CNBP;YBX3
prerank,cell differentiation in spinal cord (GO:0021515),-0.6572062352443759,-1.6640786028823884,0.02821316614420063,0.31843296058919196,1.0,6/10,30.85%,MDGA2;SOX13;MDGA1;ISL1;ZC4H2;SOX6
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3876436946720609,-1.663783643290748,0.0,0.3096122027545932,1.0,30/72,16.59%,GRIK2;NRXN1;NLGN1;RIMS1;TSHZ3;SLC8A3;CLSTN2;GRIN2B;CCR2;GRIN2A;SYT1;RGS14;CACNG3;CLSTN3;RIMS2;PRKCZ;MPP2;ZDHHC12;NMU;SHANK3;LGMN;NLGN3;HAP1;RELN;SLC8A2;SLC24A2;CCL2;LGI1;APP;BAIAP3
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7419982163713618,1.6620461839205336,0.006993006993006993,0.17830757463059024,1.0,3/13,4.03%,IGF1;GCK;DYRK2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5746709825227078,-1.6607125864878751,0.0199203187250996,0.3071183206917196,1.0,6/15,8.45%,GRM7;GRM1;GRIK3;GRM5;GRM3;GRM8
prerank,regulation of mast cell degranulation (GO:0043304),0.735927039593819,1.6599085323379912,0.004092769440654843,0.18103984651972832,1.0,6/14,8.63%,CD84;FGR;GAB2;CD300A;SPHK2;SYK
prerank,base conversion or substitution editing (GO:0016553),0.7671527816853265,1.6596341782964459,0.0070126227208976155,0.17968889304253102,1.0,2/11,1.13%,APOBEC1;ADARB1
prerank,neuron projection extension (GO:1990138),0.6306495336774783,1.6595440345977386,0.0011806375442739079,0.1776373972714138,1.0,10/32,7.94%,ALCAM;CTNNB1;NRP2;IQGAP1;NRP1;CDK5;LLPH;SLC9A6;CYFIP1;USP9X
prerank,regulation of mast cell activation (GO:0033003),0.7763184060998528,1.6594959416106323,0.007246376811594203,0.17553353755854942,1.0,3/10,1.84%,CD84;CD300LF;MILR1
prerank,iron ion transport (GO:0006826),0.594565356911889,1.658944766875569,0.006779661016949152,0.17502999680884715,1.0,21/47,20.61%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;REP15;ATP6V1G1;ATP6V0B;SLC11A1;DNM2;MELTF;ATP6V0A4;ATP6V1F;ATP6V0C;ATP6AP1;TFRC;ATP6V1D;STEAP3;ATP6V1E1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6687160249149247,1.657596635375651,0.004968944099378882,0.17577749741041343,1.0,5/22,8.63%,LGALS3;MGAT5;NCKAP1L;PTPA;BOD1L1
prerank,response to exogenous dsRNA (GO:0043330),0.684179044615467,1.6574349988547148,0.002544529262086514,0.17404682773279145,1.0,6/18,12.69%,COLEC12;RFTN1;SLC3A2;CAV1;TICAM1;DHX9
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7045070139658283,1.6564009214437625,0.006906077348066298,0.174516767309922,1.0,6/16,11.18%,LGALS3;CD22;TNFRSF1B;IL27;TNFSF8;TNFSF9
prerank,aminoglycan metabolic process (GO:0006022),0.7765116769199957,1.6559953721595118,0.01466275659824047,0.1732562567347033,1.0,2/10,1.35%,XYLT1;B4GALT7
prerank,positive regulation of glucose import (GO:0046326),0.6736926076592138,1.6536795733529417,0.006188118811881188,0.17683400025123674,1.0,3/21,5.07%,IGF1;OSBPL8;RHOQ
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5571571754470188,1.650875976374425,0.0020920502092050207,0.1813302683106212,1.0,39/88,26.78%,LGALS3;FNIP2;PLEK;SDCBP;CLDN19;ATP13A2;VEGFA;BAX;ERCC1;LIMK1;VCP;SLX4;PDCD6IP;SYK;RAB7A;VPS4B;BCL2L11;BID;BIK;FNIP1;TPR;TNF;PIH1D1;SLF2;TFRC;PFN1;SYNPO;SDC4;TGFB1;SUMO1;TIRAP;STX18;RACK1;GSK3B;EMILIN1;SH3GLB1;FAF1;TRABD2B;ICE1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7586750015498741,1.6481705191452611,0.006963788300835654,0.18577146270321293,1.0,4/12,5.85%,MYO1E;IQGAP1;BASP1;JAG1
prerank,early endosome to late endosome transport (GO:0045022),0.6770496204691729,1.6462999286492908,0.0039164490861618795,0.18845909208523315,1.0,11/20,19.57%,EEA1;WDR91;PTPN23;RAB5A;RAB7A;BECN1;HOOK3;KIF16B;RILP;HOOK1;WDR81
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.6576926522708381,1.643991058098785,0.006157635467980296,0.19227322832660712,1.0,15/23,23.30%,COPS3;COPS2;COPS4;UBA52;COPS8;DDB2;DDB1;XPA;RPS27A;UBC;COPS7A;CETN2;CUL4A;PARP1;COPS6
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6214101720378513,1.6435187548229193,0.00842358604091456,0.19119684906788464,1.0,11/34,12.87%,RAB7B;CD300LF;MFHAS1;CD300A;OTUD4;GRAMD4;SARM1;TREM2;ACOD1;TICAM1;TNFAIP3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5901784625634867,1.6434288279732108,0.0011261261261261261,0.18932141853980464,1.0,15/47,13.32%,SIRPA;PLEK;SLC27A1;GCK;FBXW7;SIK1;GLA;BRCA1;CAV1;PRMT3;NFKB1;ACADL;PTGIS;MPV17L;FYN
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.745111704399888,1.6425373690656393,0.012064343163538873,0.18934758577751085,1.0,4/12,3.66%,PTPRC;RUNX1;CD300A;ELF2
prerank,negative regulation of platelet activation (GO:0010544),0.7019617289465243,1.6409519933550365,0.008,0.19145724972385614,1.0,5/16,7.77%,CD9;APOE;PDGFA;PRKCD;SERPINE2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.6737837703711166,1.6392979525265285,0.009067357512953367,0.1934897676915336,1.0,10/20,14.62%,LCP1;PLEK;FMNL2;STRIP1;FMNL3;RHOQ;NCKAP1L;LLGL2;LLGL1;TNF
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6673981689263485,1.6388799588319194,0.007712082262210797,0.19280228202090205,1.0,5/23,7.57%,PLEK;GCK;HDAC4;SIK1;GIT1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7492172932896393,1.6377789794341564,0.015384615384615385,0.19372114131953544,1.0,3/11,8.49%,CTNNB1;LRP6;FZD1
prerank,cytoplasmic translational initiation (GO:0002183),0.7034535253309533,1.6377300627561522,0.009174311926605505,0.19187131498283622,1.0,8/17,13.14%,EIF4A1;EIF3A;EIF4G1;DENR;EIF4A2;EIF2S2;DHX29;EIF3M
prerank,regulation of microglial cell activation (GO:1903978),0.7087155011997587,1.6364966959995983,0.004054054054054054,0.19308464030054118,1.0,6/15,12.58%,STAP1;PTPRC;SPHK1;CST7;TREM2;IL6
prerank,androgen receptor signaling pathway (GO:0030521),0.7587829427452082,1.636091354842918,0.0071633237822349575,0.19202446512014684,1.0,6/11,10.34%,ZMIZ1;KDM3A;DDX17;TMF1;RNF14;PMEPA1
prerank,positive regulation of bone resorption (GO:0045780),0.774017374966481,1.6351736207310945,0.00872093023255814,0.19250413476824726,1.0,6/11,15.41%,SPP1;ADAM8;PLEKHM1;SYK;DEF8;ATP6AP1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7499266731943359,1.6350934810985125,0.011299435028248588,0.1908099153474289,1.0,3/12,4.03%,IGF1;GCK;DYRK2
prerank,superoxide metabolic process (GO:0006801),0.6289607752876558,1.634608802245088,0.0048134777376654635,0.19026561264340203,1.0,9/29,12.62%,SH3PXD2B;CYBA;NCF4;CYB5R4;NRROS;CYBB;ATP7A;PRDX1;NCF2
prerank,carbohydrate catabolic process (GO:0016052),0.6018887189377925,1.634599593448663,0.004694835680751174,0.18846603502260734,1.0,12/38,11.49%,PKM;GCK;DERA;PFKL;LDHA;ALDOA;NEU1;ENO2;PGK1;MAN2C1;ENO1;HK3
prerank,keratan sulfate catabolic process (GO:0042340),0.7801675347985592,1.6340907628121313,0.008534850640113799,0.18812223910769615,1.0,5/11,6.39%,GALNS;GNS;HEXA;GLB1;HEXB
prerank,positive regulation of DNA binding (GO:0043388),0.6231582945133984,1.6339554505069136,0.0047562425683709865,0.1866017401290059,1.0,7/31,11.02%,IGF1;NIBAN2;PLAUR;TRIM6;PPARG;SKI;CEBPG
prerank,regulation of platelet activation (GO:0010543),0.6622555201898828,1.6319753521996538,0.013157894736842105,0.18969163196672903,1.0,4/21,1.29%,APOE;PLEK;TEC;PDGFA
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6607967972279003,1.6317063426834435,0.0039011703511053317,0.188616639527943,1.0,7/22,6.16%,SASH1;XDH;MFHAS1;GDF6;SPHK1;VEGFA;RELL1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5971330936750066,-1.6281414875235607,0.028112449799196786,0.3724621038595412,1.0,9/13,37.66%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNT2;KCNE2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5514640670432689,1.627493428526766,0.002103049421661409,0.1968709733695565,1.0,60/86,33.60%,HIF1A;ATF3;NFE2L2;PSMD1;MUC1;PSMD8;VEGFA;PSMA1;HMOX1;PSMA8;UBA52;STOX1;DDIT3;PSMD14;EGLN1;BAG3;PSMA5;INO80;CUL2;PSMD12;MAPK7;ELOB;PSMB10;RPS27A;UBC;PSMD2;PSMC4;EPO;PSMD6;EGLN3;PSMD3;PSMD5;PSMC2;HIF1AN;PSME4;CREBBP;PSMB8;PSMA6;PSMB7;PSMD4;EP300;PSMA3;IMPACT;PSMD10;PSMC6;PSME3;PSMC5;BACH1;PSMA4;PSMB6;VHL;TP53;RBX1;PSMA2;PSMC3;EGLN2;PSMD7;PSMD13;ARNT;EPAS1
prerank,negative regulation of immune effector process (GO:0002698),0.7311562312765916,1.6273140754185031,0.008287292817679558,0.1955146882895747,1.0,4/13,10.07%,LGALS3;CD300A;HAVCR2;LILRB1
prerank,regulation of ATP metabolic process (GO:1903578),0.5791523440730514,1.6270933323771093,0.0022026431718061676,0.19436026198441034,1.0,26/54,24.10%,HIF1A;NUP205;EIF6;GCKR;GCK;SPHK2;SLC25A33;AK4;NUP188;RAE1;ATP7A;COX7A2L;OGT;SLC2A6;NUP42;TPR;JMJD8;PRKAG1;NUP54;COX7A2;FIS1;RANBP2;NUP133;NUP93;NUP98;EP300
prerank,positive regulation of cholesterol transport (GO:0032376),0.6395223735589018,1.6263020653096991,0.011990407673860911,0.1946516563050408,1.0,8/27,9.40%,LRP1;APOE;EEPD1;PON1;PPARG;CAV1;TREM2;LPCAT3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6700515548467046,1.626181019234749,0.01008827238335435,0.19315839239089247,1.0,5/21,8.48%,IGF1;FGF2;MEF2D;ERN1;JUN
prerank,negative regulation of translation (GO:0017148),0.5446856757119962,1.6259927337857,0.0,0.1920368305426902,1.0,46/87,29.11%,EPRS1;UNK;AGO2;CPEB4;CPEB2;PATL2;LARP1;NCL;LSM14A;CNOT10;CELF1;ENC1;FXR2;DAPK1;YTHDF2;EIF4ENIF1;RPL13A;CPEB1;TPR;PUM1;RIDA;CPEB3;PAIP2;EIF4E2;CNOT9;CAPRIN1;FTO;PCIF1;ROCK1;CALR;RACK1;METTL3;GIGYF2;EIF2AK4;EIF4EBP1;SAMD4B;SYNCRIP;EIF3E;NANOS1;EIF4A3;ILF3;DHX36;FMR1;SHMT1;EIF4EBP2;TRIM71
prerank,regulation of cation channel activity (GO:2001257),-0.3688880540932522,-1.6219041476623266,0.0,0.37753141327799977,1.0,23/89,8.15%,CACNB2;GRIA4;NLGN1;FGF14;DLG2;MEF2C;GRIA3;FGF12;DMD;GRIN2B;LRRC7;ANK3;NEFL;GRIN2A;AHNAK;GRIA2;CTSS;CACNG3;NETO1;GRIN1;SHISA6;PDE4D;STAC
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4932007926041714,-1.6201500788126508,0.01507537688442211,0.3715633231727144,1.0,13/25,25.07%,NLGN1;MEF2C;CACNG3;SHISA6;SHANK3;NLGN3;RELN;SHISA9;CNIH3;CACNG8;CACNG2;SHISA7;PRRT1
prerank,neutrophil mediated immunity (GO:0002446),0.5064055045704962,1.6186205756431964,0.0,0.2087177381159846,1.0,153/432,19.83%,LGALS3;PLAU;CTSB;GALNS;IQGAP1;TCIRG1;CTSD;SIRPA;ANPEP;ATG7;ITGAX;PKM;ATP6V0A1;FGR;COTL1;PLAUR;IGF2R;SDCBP;CTSZ;PSMD1;DOCK2;GNS;ADAM8;PTPRC;SYNGR1;CTSA;DYNC1H1;PRKCD;FABP5;RETN;TARM1;FTL;CD300A;CYBA;GAA;CRACR2A;PSAP;TOM1;OLR1;DERA;PFKL;CAB39;CAPN1;UBR4;ARPC5;CAP1;ADAM17;GLB1;GLA;DPP7;NCKAP1L;DNAJC5;TNFRSF1B;ANXA3;CD44;CYFIP1;HEXB;ALDOA;C3AR1;NEU1;MOSPD2;VCP;CCT2;ANO6;PDXK;EEF2;SLC11A1;MAGT1;ARSA;ASAH1;GYG1;LPCAT1;ARL8A;GUSB;FUCA1;PPIE;CAT;NPC2;CYBB;DNASE1L1;NFKB1;VAT1;NRAS;QPCT;RAB7A;MVP;LILRB3;EEF1A1;RHOG;COMMD9;ALDH3B1;LAMP2;RAB37;C5AR1;PSMD14;RAB5C;VAMP2;TIMP2;CPNE3;CDK13;PSMA5;HK3;RHOA;JUP;RNASE3;CSTB;SRP14;IL6;OSTF1;HPSE;PSMD12;MGAM;ORMDL3;AP1M1;PLEKHO2;TMBIM1;CAND1;HUWE1;RHOF;ATP6V0C;APRT;S100A11;B4GALT1;BST2;VPS35L;CREG1;PRG2;ARHGAP9;PDAP1;RAP2B;NHLRC3;HRNR;PSMD2;TUBB;IRAK4;HVCN1;ATP6V1D;AGA;TMC6;CKAP4;CD68;ITGB2;PGM1;FRK;LAMTOR3;PTPN6;EPX;CYB5R3;LAMTOR1;PSMD6;DGAT1;STK11IP;LAMP1
prerank,positive regulation of histone methylation (GO:0031062),0.6394537683649579,1.6183647014108888,0.010050251256281407,0.20763328407033044,1.0,12/24,16.52%,CTNNB1;KMT2A;FAM47E;PHF1;MTF2;BRCA1;DNMT3B;CHTOP;OGT;DNMT1;SNW1;WDR5
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.739969825775748,1.6175935584438004,0.009845288326300985,0.207683612857864,1.0,7/13,16.18%,CTNNB1;NRP1;VEGFA;DLL4;TGFBR2;COL4A1;NOTCH4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.6496086375918536,1.6175645955447213,0.007471980074719801,0.2059675022980622,1.0,8/22,11.29%,ERCC6;EAPP;HMGN1;DDX39B;BRD4;THOC1;CCNT2;CDK13
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5930842674116499,1.6157847910924907,0.004592422502870264,0.2090098705259582,1.0,11/38,17.53%,LGALS3;BCL2L1;TRAF2;HMOX1;BRCA1;TNFAIP3;TMBIM1;ARHGEF2;BMP5;SERPINE1;SFRP1
prerank,neutrophil activation involved in immune response (GO:0002283),0.5052759807880709,1.6156474408046948,0.0,0.20767408933767362,1.0,151/428,19.83%,LGALS3;PLAU;CTSB;GALNS;IQGAP1;TCIRG1;CTSD;SIRPA;ANPEP;ATG7;ITGAX;PKM;ATP6V0A1;FGR;COTL1;PLAUR;IGF2R;SDCBP;CTSZ;PSMD1;DOCK2;GNS;ADAM8;PTPRC;SYNGR1;CTSA;DYNC1H1;PRKCD;FABP5;RETN;TARM1;FTL;CD300A;CYBA;GAA;CRACR2A;PSAP;TOM1;OLR1;DERA;PFKL;CAB39;CAPN1;UBR4;ARPC5;CAP1;GLB1;GLA;DPP7;NCKAP1L;DNAJC5;TNFRSF1B;ANXA3;CD44;CYFIP1;HEXB;ALDOA;C3AR1;NEU1;MOSPD2;VCP;CCT2;ANO6;PDXK;EEF2;SLC11A1;MAGT1;ARSA;ASAH1;GYG1;SYK;LPCAT1;ARL8A;GUSB;FUCA1;PPIE;CAT;NPC2;CYBB;DNASE1L1;NFKB1;VAT1;NRAS;QPCT;RAB7A;MVP;LILRB3;EEF1A1;RHOG;COMMD9;ALDH3B1;LAMP2;RAB37;C5AR1;PSMD14;RAB5C;VAMP2;TIMP2;CPNE3;CDK13;PSMA5;HK3;RHOA;JUP;RNASE3;CSTB;SRP14;OSTF1;HPSE;PSMD12;MGAM;ORMDL3;AP1M1;PLEKHO2;TMBIM1;CAND1;HUWE1;RHOF;ATP6V0C;APRT;S100A11;B4GALT1;BST2;VPS35L;CREG1;PRG2;ARHGAP9;PDAP1;RAP2B;NHLRC3;HRNR;PSMD2;TUBB;HVCN1;ATP6V1D;AGA;TMC6;CKAP4;CD68;ITGB2;PGM1;FRK;LAMTOR3;PTPN6;EPX;CYB5R3;LAMTOR1;PSMD6;DGAT1;STK11IP;LAMP1
prerank,carboxylic acid transport (GO:0046942),0.5735916732788131,1.615135492031714,0.005574136008918618,0.20720844356295473,1.0,15/55,10.44%,SLC38A6;SLC38A1;SLC23A2;SLC23A1;SLC36A4;SLC6A6;SLC3A2;SLC6A7;SLC17A5;PSAP;SLC7A1;SLC16A3;SLC7A6;LLGL2;SLC7A8
prerank,integrin-mediated signaling pathway (GO:0007229),0.5513932453961933,1.6149713996999033,0.002157497303128371,0.205883838188267,1.0,27/73,19.90%,FN1;PTPRA;PLEK;ITGA5;FGR;TEC;LAT;NRP1;PTK2B;ADAMTS13;DAB2;PLPP3;NEDD9;ERBIN;ITGB5;DST;SYK;ADAM15;ITGA11;ILK;ITGA2B;FYB1;COL16A1;ITGB6;ITGB2;ITGB1BP1;ITGA2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6417322368158738,1.614437087967507,0.008728179551122194,0.20553301509372376,1.0,9/24,15.49%,HIF1A;ATF3;NFE2L2;MUC1;VEGFA;MBTPS2;DDIT3;MAPK7;SESN2
prerank,leukotriene biosynthetic process (GO:0019370),-0.5858537546810538,-1.6128899180566392,0.02766798418972332,0.37993704216180574,1.0,4/14,7.34%,LTC4S;ALOX5;ALOX5AP;GGT5
prerank,neutrophil degranulation (GO:0043312),0.5045067983499247,1.6128369160799092,0.0,0.2080466211555919,1.0,150/425,19.83%,LGALS3;PLAU;CTSB;GALNS;IQGAP1;TCIRG1;CTSD;SIRPA;ANPEP;ATG7;ITGAX;PKM;ATP6V0A1;FGR;COTL1;PLAUR;IGF2R;SDCBP;CTSZ;PSMD1;DOCK2;GNS;ADAM8;PTPRC;SYNGR1;CTSA;DYNC1H1;PRKCD;FABP5;RETN;TARM1;FTL;CD300A;CYBA;GAA;CRACR2A;PSAP;TOM1;OLR1;DERA;PFKL;CAB39;CAPN1;UBR4;ARPC5;CAP1;GLB1;GLA;DPP7;NCKAP1L;DNAJC5;TNFRSF1B;ANXA3;CD44;CYFIP1;HEXB;ALDOA;C3AR1;NEU1;MOSPD2;VCP;CCT2;ANO6;PDXK;EEF2;SLC11A1;MAGT1;ARSA;ASAH1;GYG1;LPCAT1;ARL8A;GUSB;FUCA1;PPIE;CAT;NPC2;CYBB;DNASE1L1;NFKB1;VAT1;NRAS;QPCT;RAB7A;MVP;LILRB3;EEF1A1;RHOG;COMMD9;ALDH3B1;LAMP2;RAB37;C5AR1;PSMD14;RAB5C;VAMP2;TIMP2;CPNE3;CDK13;PSMA5;HK3;RHOA;JUP;RNASE3;CSTB;SRP14;OSTF1;HPSE;PSMD12;MGAM;ORMDL3;AP1M1;PLEKHO2;TMBIM1;CAND1;HUWE1;RHOF;ATP6V0C;APRT;S100A11;B4GALT1;BST2;VPS35L;CREG1;PRG2;ARHGAP9;PDAP1;RAP2B;NHLRC3;HRNR;PSMD2;TUBB;HVCN1;ATP6V1D;AGA;TMC6;CKAP4;CD68;ITGB2;PGM1;FRK;LAMTOR3;PTPN6;EPX;CYB5R3;LAMTOR1;PSMD6;DGAT1;STK11IP;LAMP1
prerank,positive regulation of calcium ion import (GO:0090280),0.7290397989219621,1.60885732886688,0.0136986301369863,0.21657324754433743,1.0,2/12,5.56%,LGALS3;SPHK2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.6586711773737296,1.6086728813466065,0.007434944237918215,0.21524104818233325,1.0,5/22,6.44%,GPNMB;PDGFA;RAP2A;VEGFA;RAD50
prerank,positive regulation of monooxygenase activity (GO:0032770),0.6351728437060589,1.608419651849975,0.01098901098901099,0.21411754335583918,1.0,10/26,15.80%,HIF1A;APOE;PIK3CB;CYP27B1;VDR;POR;ATP7A;TNF;HTR2B;TERT
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5530748496600328,-1.608002132723295,0.044897959183673466,0.382460238716316,1.0,3/17,5.52%,CACNA2D1;NOS1AP;SNTA1
prerank,sterol transport (GO:0015918),0.6696794596389745,1.6067125069159343,0.011734028683181226,0.21692281167508223,1.0,8/19,14.36%,APOA2;NPC1;CAV1;NPC2;OSBPL2;OSBP;MSR1;ARV1
prerank,positive regulation of transporter activity (GO:0032411),0.7214773214736977,1.6065602153172682,0.016150740242261104,0.2156188838941266,1.0,5/13,7.19%,KMT2A;SGK1;SGK2;PON1;KCTD7
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5397240775783504,1.6059930818521369,0.0031982942430703624,0.21553896667440062,1.0,20/74,18.39%,LGALS3;IGF1;BCL2;BCL2L1;EYA4;TRAF2;MCL1;SIAH2;HMOX1;HTT;BRCA1;TNFAIP3;MAPK7;TMBIM1;TNF;TERT;ARHGEF2;BMP5;SERPINE1;TGFBR1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5933718357604315,1.6055867257312852,0.004576659038901602,0.2148747582010934,1.0,19/41,24.10%,HIF1A;NUP205;EIF6;GCKR;GCK;NUP188;RAE1;OGT;SLC2A6;NUP42;TPR;JMJD8;PRKAG1;NUP54;RANBP2;NUP133;NUP93;NUP98;EP300
prerank,positive regulation of ERAD pathway (GO:1904294),0.7161653943984313,1.6054435342273754,0.013368983957219251,0.21357671882934684,1.0,9/13,24.54%,NFE2L2;ATXN3;CAV1;RNF185;USP13;HERPUD1;RNFT1;UBQLN1;UBQLN2
prerank,positive regulation of transport (GO:0051050),0.5465879097920067,1.6044070170608467,0.0,0.2147530989104021,1.0,21/85,11.16%,LRP1;SIRPA;APOE;KMT2A;SGK1;DOCK2;DYNC1H1;SGK2;APOA2;PON1;CYBA;DAB2;BAX;KCTD7;SLC11A1;GAS6;TREM2;HIP1R;PLAA;NUMA1;LYAR
prerank,myoblast differentiation (GO:0045445),0.7111388814611604,1.604010543491128,0.017496635262449527,0.2142952696447811,1.0,4/14,8.55%,IGF1;PLEKHM3;JAG1;DDX17
prerank,response to cAMP (GO:0051591),-0.45276267342291654,-1.603106095437188,0.014925373134328358,0.38477819200558244,1.0,11/37,16.05%,AKAP6;EZR;HCN1;RAPGEF2;RAPGEF3;NDUFS4;DMTN;IGFBP5;STAT1;PDE2A;INPP5K
prerank,AMP metabolic process (GO:0046033),0.7241560740497264,1.60224353142218,0.012465373961218837,0.21720713304820669,1.0,8/13,23.07%,XDH;AMPD2;AK4;AK3;ADSS1;NUDT2;ADSL;ADSS2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6841788812287004,1.5984810886168803,0.018995929443690638,0.22535019879344853,1.0,2/15,1.09%,IGF1;SLC9A1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.6258912576108204,1.5974667426130573,0.012033694344163659,0.22642899157371862,1.0,9/26,12.92%,B4GALT5;LARGE1;TNIP1;GK;ST8SIA6;ST3GAL2;GCNT1;GBGT1;GOLPH3
prerank,cellular response to ketone (GO:1901655),0.6016920556711937,1.5973331948038079,0.005980861244019139,0.22506610753571554,1.0,14/35,14.03%,SPP1;ADCY8;ADCY3;PTGFR;MSN;SPHK2;LARP1;PCK2;ACOD1;NR3C1;ADAM15;PTGER4;GOLPH3;GNB1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5393700114844404,1.5972632058943916,0.0010649627263045794,0.22361843631089587,1.0,43/88,29.11%,APOE;EPRS1;NELL1;CDK5;RIC1;PATL2;LARP1;NCL;RGP1;LSM14A;CNOT10;ENC1;SERPINE2;NFKB1;FXR2;DAPK1;EIF4ENIF1;CSTB;RPL13A;DNAJC1;RIDA;CPEB3;PAIP2;EIF4E2;CNOT9;CAPRIN1;CLN3;PCIF1;CLN8;CALR;RACK1;GIGYF2;SAMD4B;SYNCRIP;NANOS1;EIF4A3;ATRAID;ILF3;DHX36;CDK5RAP3;FMR1;SHMT1;TRIM71
prerank,regulation of osteoclast differentiation (GO:0045670),0.6014420594856471,1.5969505050991861,0.013268998793727383,0.22286517978773693,1.0,9/33,16.89%,GPR137B;CSF1;FSTL3;TCTA;LILRB3;UBASH3B;TNF;TMEM178A;MAFB
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7650658816872378,1.5966711297584277,0.0188953488372093,0.22204909616843474,1.0,3/10,8.49%,CTNNB1;LRP6;FZD1
prerank,negative regulation of leukocyte activation (GO:0002695),0.6933245807433063,1.5966154135083654,0.012113055181695828,0.2206459567160199,1.0,5/15,8.96%,CD84;CD300LF;MILR1;CD300A;HAVCR2
prerank,regulation of cholesterol storage (GO:0010885),0.7142731470505899,1.5959011260110834,0.01366120218579235,0.22103103781469693,1.0,6/15,8.84%,LPL;ABCA1;ABCG1;PPARD;PPARG;TREM2
prerank,positive regulation of organelle assembly (GO:1902117),0.5818725332596292,1.5955485432571852,0.006825938566552901,0.22043184128009946,1.0,20/44,19.46%,LCP1;ASAP1;SDCBP;DYNC1H1;KCTD17;CAPG;HTT;PDCD6IP;NUMA1;CEP120;MARK4;CNOT6;TNF;RAB3GAP1;CCP110;RAB3GAP2;PIP4K2A;IL5;G3BP1;SDC4
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6262179123252473,1.5953747679090244,0.009900990099009901,0.21927618845315267,1.0,5/27,2.68%,IGF1;FN1;PDGFA;CDK6;SPHK1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6937068281940281,1.5943978816212818,0.022408963585434174,0.22036558015204685,1.0,8/14,16.52%,CTNNB1;KMT2A;BRCA1;DNMT3B;PRDM9;DNMT1;SNW1;WDR5
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7431273731328194,1.5941420879831114,0.01167883211678832,0.2194587879214962,1.0,3/10,4.20%,HIF1A;ITGA5;PRKCB
prerank,positive regulation of phagocytosis (GO:0050766),0.5787973857981418,1.5930207660895566,0.005605381165919282,0.22091041163787312,1.0,14/47,11.16%,SIRPA;CD300LF;STAP1;DOCK2;PTPRC;APOA2;CYBA;NCKAP1L;APPL2;ANO6;SLC11A1;GAS6;TREM2;LYAR
prerank,cellular response to insulin stimulus (GO:0032869),0.5229329090097683,1.5926158514111055,0.0,0.22036691426871907,1.0,36/124,14.42%,BCAR3;MYO5A;TCIRG1;ATP6V1C1;PKM;ATP6V0D2;ATP6V1A;ATP6V0A1;EPRS1;SLC27A1;GRB2;GCK;ATP6V1B2;PDPK1;ATP6V0D1;DENND4C;CPEB2;PPARG;ATP6V1G1;RHOQ;RAB8B;PTPN2;SLC25A33;ATP6V0B;HDAC9;PCK2;PIK3R2;NAMPT;IGF1R;BAIAP2;VAMP2;CPEB1;ATP6V0A4;ATP6V1F;AP3S1;ATP6V0C
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6986559365858789,1.5889891361539097,0.020380434782608696,0.2284613647775125,1.0,6/14,10.41%,AK8;DCTPP1;AK4;AK3;ITPA;AK5
prerank,renal filtration (GO:0097205),0.7645519354430929,1.5874176652469016,0.01023391812865497,0.23118366529736353,1.0,1/10,0.01%,MYO1E
prerank,positive regulation of glycolytic process (GO:0045821),0.648374640670579,1.5862150307261538,0.011450381679389313,0.23154895516357854,1.0,3/20,3.77%,IGF1;HIF1A;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.648374640670579,1.5862150307261538,0.011450381679389313,0.23154895516357854,1.0,3/20,3.77%,IGF1;HIF1A;PFKFB3
prerank,regulation of neuron differentiation (GO:0045664),-0.36501634963642415,-1.5850783235412957,0.0,0.421032493594271,1.0,20/76,14.34%,ZFHX3;NLGN1;MEF2C;BEND6;BIN1;TIAM1;MMD;CNTN4;ZEB1;BRINP1;LRRK2;BRINP3;NREP;NBL1;YWHAH;TCF3;PCP4;DISP3;ECT2;REST
prerank,ceramide catabolic process (GO:0046514),0.7017664508614196,1.584677331442491,0.015214384508990318,0.23422509699184121,1.0,5/14,8.48%,HEXA;GLA;HEXB;NEU1;ASAH1
prerank,fatty acid transport (GO:0015908),0.6826479901459032,1.5845657722636823,0.010767160161507403,0.23302157775042004,1.0,6/17,8.56%,APOE;SLC27A1;FABP5;PPARD;PPARG;ACSL1
prerank,homocysteine metabolic process (GO:0050667),0.7401129943502822,1.584305662369618,0.02912621359223301,0.23231187902451766,1.0,9/11,26.03%,MTRR;MTHFR;TST;MPST;BLMH;MMUT;NOX4;CBS;CTH
prerank,positive regulation of angiogenesis (GO:0045766),0.5178768696039128,1.5837722347050198,0.0,0.23211957473295383,1.0,27/108,15.46%,FLT1;HIF1A;ITGAX;PKM;ITGA5;SASH1;FGF2;SPHK1;RUNX1;AGO2;HSPB1;PDPK1;VEGFA;PRKCB;HMOX1;ANXA3;MYDGF;ECM1;NINJ1;BRCA1;CYP1B1;JUP;JAK1;PTGIS;SP1;JMJD8;FGF18
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5941024612333985,-1.5824658496839723,0.046822742474916385,0.4182328038214465,1.0,7/12,15.52%,DMD;ANK3;GLRX;WNK1;WNK3;FXYD1;NOS1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5798189155601992,1.5821190751795895,0.01070154577883472,0.23498676306455585,1.0,18/40,22.36%,SLC38A6;SLC38A1;SLC23A2;SLC23A1;SLC36A4;SLC27A1;SLC38A7;SLC7A6;SLC7A8;SLC38A10;SLC19A1;SLC25A21;SLC38A2;SLC25A14;SLC5A6;SLC7A7;ABCC5;SLC7A10
prerank,positive regulation of phospholipase activity (GO:0010518),0.6374316482880509,1.5812044670194139,0.017543859649122806,0.23608384491508846,1.0,7/22,10.21%,FLT1;ABL2;FGF2;GNA13;PDPK1;ARL1;PLAA
prerank,monosaccharide transmembrane transport (GO:0015749),0.6761848981018233,1.580554282336225,0.01971090670170828,0.23616956913324763,1.0,6/16,18.83%,SLC23A2;SLC23A1;SLC5A3;SLC2A6;SLC45A3;SLC2A8
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6441614912079275,-1.5805129115536984,0.05970149253731343,0.4138569426282316,1.0,6/10,21.35%,GABRB2;GABRG3;GABRA2;GABRG1;GABRE;GABRA1
prerank,carboxylic acid catabolic process (GO:0046395),0.722120909208204,1.5793203887781855,0.024285714285714285,0.2379731667597966,1.0,7/12,15.17%,RENBP;PON1;NAGK;NPL;GNPDA1;AMDHD2;GNPDA2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6505124438424419,1.5781702911272475,0.021628498727735368,0.23957534729165345,1.0,4/21,6.41%,LGALS3;GPNMB;FOXJ1;SAMSN1
prerank,cellular component disassembly (GO:0022411),0.5547019323531178,1.577488549341571,0.005543237250554324,0.2399687403423403,1.0,14/53,12.30%,SH3PXD2B;LCP1;MMP12;ADAM8;A2M;BMP1;CAPG;CAPN1;CD44;LAMC1;KLKB1;ADAM15;TIMP2;FURIN
prerank,amino acid transport (GO:0006865),0.5560273174834692,1.576260169342046,0.00778642936596218,0.24186786453326306,1.0,19/49,22.36%,SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC7A1;PDPN;SLC16A10;SLC38A7;SLC7A6;SLC7A8;SLC38A10;SLC38A2;SLC1A5;SLC7A3;SLC43A2;SLC7A7;SLC7A2;SLC7A10
prerank,triglyceride metabolic process (GO:0006641),0.5631676126457901,1.5756415010344615,0.00340522133938706,0.24203529246739675,1.0,10/48,8.57%,LPL;APOE;FABP5;APOA2;SLC27A5;GK;PLAAT3;APOBR;CAV1;LPGAT1
prerank,monocyte chemotaxis (GO:0002548),0.5915397046056616,1.57459140572078,0.013414634146341463,0.24320599627582073,1.0,6/32,12.58%,LGALS3;FLT1;CCL4;CCL13;CCL14;IL6
prerank,regulation of cholesterol esterification (GO:0010872),0.7644029806390551,1.573619592749404,0.010248901903367497,0.2444868130159104,1.0,3/10,2.39%,ABCG1;APOE;APOA2
prerank,regulation of dephosphorylation (GO:0035303),-0.545626998792976,-1.5735342554804705,0.04150943396226415,0.42285045781717545,1.0,7/15,20.24%,MTMR9;SMG6;SMG5;SMG7;INPP5K;IGBP1;SRC
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5403430240231546,1.5732704022482105,0.007438894792773645,0.24391997439007868,1.0,53/74,33.60%,HIF1A;NFE2L2;PSMD1;PSMD8;VEGFA;PSMA1;PSMA8;UBA52;STOX1;PSMD14;EGLN1;PSMA5;CUL2;PSMD12;ELOB;PSMB10;RPS27A;UBC;PSMD2;PSMC4;EPO;PSMD6;EGLN3;PSMD3;SIRT2;PSMD5;PSMC2;HIF1AN;PSME4;NOTCH1;CREBBP;PSMB8;PSMA6;PSMB7;PSMD4;EP300;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;BACH1;PSMA4;PSMB6;VHL;RBX1;PSMA2;PSMC3;EGLN2;PSMD7;PSMD13;ARNT;EPAS1
prerank,triglyceride catabolic process (GO:0019433),0.6660544382184713,1.5724785922949003,0.023968042609853527,0.24491154734646728,1.0,2/19,2.10%,LPL;FABP5
prerank,negative regulation of mitochondrion organization (GO:0010823),0.5958352636191074,1.5724056942018148,0.009445100354191263,0.2437086795447222,1.0,13/33,20.19%,IGF1;BCL2L1;SLC35F6;TRIAP1;VAT1;MPV17L;HUWE1;GHITM;FLCN;TFRC;ACAA2;IAPP;NOL3
prerank,extracellular matrix disassembly (GO:0022617),0.5549026405133999,1.5712401308117752,0.002229654403567447,0.24522330118318494,1.0,14/53,12.30%,SH3PXD2B;LCP1;MMP12;ADAM8;A2M;BMP1;CAPG;CAPN1;CD44;LAMC1;KLKB1;ADAM15;TIMP2;FURIN
prerank,natural killer cell mediated immunity (GO:0002228),0.6871932437784433,1.5709122359551033,0.02165087956698241,0.24461112677882874,1.0,4/15,11.02%,PLEKHM2;LYST;ARL8B;CEBPG
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7525791993568377,1.5705679333290472,0.014749262536873156,0.2441318490760563,1.0,4/10,9.71%,NOC2L;BRCA1;THAP7;TAF7
prerank,lipoprotein catabolic process (GO:0042159),0.7265092586563165,1.5697896205664892,0.027220630372492838,0.2448911737926951,1.0,6/11,13.12%,CTSD;APOE;ABHD17C;ABHD17B;ABHD10;LYPLA2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6043565943495844,1.5686466191649913,0.010856453558504222,0.24664871920538778,1.0,11/30,19.27%,CD300LF;TANK;IKBKE;TRAF3;UBA52;TICAM1;RPS27A;UBC;TBK1;TNIP3;BIRC2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5251213737919542,-1.5678389499050664,0.04,0.4280477548323042,1.0,9/18,12.36%,NRXN1;NLGN1;RIMS1;GRIN1;RIMS2;PRKCZ;SHANK3;NLGN3;RELN
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.6459333964479148,1.5677076290778245,0.01437908496732026,0.24762657533229754,1.0,5/21,1.09%,PEAK1;CORO1C;PTPRA;MACF1;SLC9A1
prerank,regulation of T cell activation (GO:0050863),0.5706020915801681,1.5667307464050597,0.011534025374855825,0.24902672680612692,1.0,8/42,8.69%,LGALS3;GPNMB;SIRPA;LAT;TNFRSF1B;IL27;CRTAM;TNFSF8
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3831596444294712,-1.5660237294442283,0.00980392156862745,0.4237065392175106,1.0,14/57,5.28%,GRIA4;NLGN1;DLG2;MEF2C;GRIA3;DLGAP1;GRIN2B;LRRC7;NEFL;GRIN2A;GRIA2;CACNG3;NETO1;GRIN1
prerank,insulin receptor signaling pathway (GO:0008286),0.5357746063646414,1.5655160535177208,0.004319654427645789,0.2507896483106792,1.0,22/69,15.41%,BCAR3;TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;GRB2;ATP6V1B2;ATP6V0D1;ATP6V1G1;RHOQ;PTPN2;ATP6V0B;PIK3R2;NAMPT;IGF1R;BAIAP2;ATP6V0A4;ATP6V1F;AP3S1;ATP6V0C;ATP6AP1
prerank,macrophage chemotaxis (GO:0048246),0.7411290217701352,1.5638650918136658,0.02092675635276532,0.2539863073035776,1.0,1/10,0.01%,LGALS3
prerank,neuron projection fasciculation (GO:0106030),-0.612259115503657,-1.5637240873687792,0.040293040293040296,0.4200023695653917,1.0,3/10,4.56%,EPHA4;CNTN4;SEMA5A
prerank,lipid homeostasis (GO:0055088),0.5479218484998258,1.5632151567551162,0.004347826086956522,0.2544237210887835,1.0,21/57,20.06%,ABCA1;ABCG1;APOE;ATP13A2;ORMDL1;TLCD1;FBXW7;PPARG;CEBPA;TLCD2;ABHD5;TREM2;ABHD4;ORMDL3;ACOX3;TM6SF2;USF2;ABCB11;CLN8;XBP1;RBP1
prerank,negative regulation of neuron death (GO:1901215),0.515740131258657,1.5626908102008337,0.0021164021164021165,0.2544783464245586,1.0,17/93,7.55%,GPNMB;BCL2;CSF1;APOE;ADAM8;CDK5;PTK2B;TRAF2;CD200R1;ATP13A2;EIF4G1;CPEB4;CHMP4B;CHMP4A;RETREG1;TNFRSF1B;FGF20
prerank,positive regulation of vasculature development (GO:1904018),0.5148247888065629,1.5620891237924575,0.0010515247108307045,0.2547829571294518,1.0,22/94,13.80%,FLT1;HIF1A;ITGAX;SASH1;FGF2;SPHK1;RUNX1;AGO2;HSPB1;PDPK1;VEGFA;PRKCB;HMOX1;ANXA3;MYDGF;ECM1;NINJ1;BRCA1;CYP1B1;JUP;PTGIS;SP1
prerank,plasma membrane repair (GO:0001778),0.7081997119401948,1.5614948871001273,0.01634877384196185,0.25498228662180783,1.0,4/13,8.42%,MYOF;AHNAK2;FER1L5;ARL8B
prerank,response to hydrogen peroxide (GO:0042542),0.5710335644639325,1.5609948402220082,0.006779661016949152,0.2550498853192155,1.0,14/45,13.32%,SIRPA;NFE2L2;PRKCD;STK24;HMOX1;PLEKHA1;CAT;CYP1B1;GLRX2;RIPK3;IL6;TNFAIP3;MAPK7;FYN
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5356881964056788,1.5599138338196044,0.005537098560354375,0.2566575163229707,1.0,17/64,11.84%,PLAU;PEAK1;CORO1C;CSF1;PTPRA;MACF1;SLC9A1;CDK6;PIK3CB;PTK2B;JAG1;MYOC;CCL28;RASA1;ADAM15;RHOA;JUP
prerank,glycoprotein biosynthetic process (GO:0009101),0.5324512568029593,1.5595408479064015,0.0031545741324921135,0.25620269751371655,1.0,18/79,13.64%,XYLT1;IGF1;CHST11;B4GALT5;LARGE1;B4GALT7;TNIP1;GCNT2;B3GALNT2;ALG10B;TMEM106A;NPC1;ST8SIA6;ATP7A;ST3GAL2;GCNT1;GOLPH3;CHST12
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6808252253842968,1.5560636162374613,0.0214190093708166,0.2644217639079462,1.0,5/15,3.49%,PKM;ITGA5;FGF2;PDPK1;VEGFA
prerank,positive regulation of lipid storage (GO:0010884),0.6378494023985927,1.5559657005613357,0.025252525252525252,0.2632799068727553,1.0,6/21,13.91%,PLIN2;LPL;IKBKE;APOC4;NFKB1;MSR1
prerank,detection of visible light (GO:0009584),0.6695456024674871,1.5558198492491397,0.02425876010781671,0.2622817537249529,1.0,4/16,14.35%,GNAQ;GNA11;CEP250;CNGB1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6814604272550324,1.5551784884868356,0.024161073825503355,0.2626197534868171,1.0,8/15,14.62%,PRKCD;SPHK1;ORMDL1;SPHK2;SIRT3;SAMD8;ORMDL3;TNF
prerank,regulation of store-operated calcium entry (GO:2001256),0.732129621877087,1.5550371765228537,0.02877697841726619,0.2616029478757687,1.0,3/10,6.68%,CD84;SLC8B1;HOMER2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5771807524610729,1.5544677805214504,0.008064516129032258,0.261779007041372,1.0,19/41,24.10%,HIF1A;NUP205;EIF6;GCKR;GCK;NUP188;RAE1;OGT;SLC2A6;NUP42;TPR;JMJD8;PRKAG1;NUP54;RANBP2;NUP133;NUP93;NUP98;EP300
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.584615957457567,1.5542662739375157,0.0194884287454324,0.2610133980392283,1.0,11/33,17.93%,BCAR3;PLAUR;FBXW7;ADAM17;DGKD;HIP1R;DOK1;CBL;HIP1;CNOT9;PDE6G
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7089944460766591,1.5536758769478562,0.027510316368638238,0.26123876674992236,1.0,5/12,9.40%,SOAT1;APOC4;SOAT2;P4HB;LPCAT3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6559559767828039,1.552572861125942,0.021108179419525065,0.2628810499722353,1.0,5/18,5.17%,FLT1;FGF2;PDPK1;PPARG;ADAM17
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6293175939836677,1.5525166373737471,0.01568627450980392,0.26168789346261695,1.0,4/22,4.92%,IGF1;P2RX4;SLC9A1;LMCD1
prerank,regulation of calcium ion import (GO:0090279),0.6308559024149772,1.550916775853269,0.021850899742930592,0.2647476104625506,1.0,4/21,6.34%,LGALS3;CTNNB1;SPHK2;PSEN2
prerank,regulation of hemopoiesis (GO:1903706),0.744127961444569,1.5505806376487536,0.027220630372492838,0.2643737258555995,1.0,3/10,4.20%,LGALS3;RUNX1;PRKCB
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5144819145216537,-1.550515402321495,0.044,0.4450479537489413,1.0,6/16,13.83%,MAPK14;MEF2C;PLCB1;LRRC8A;RIPOR2;IGFBP3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6081227406629248,1.5491658103295691,0.016928657799274487,0.266941254838576,1.0,3/26,5.07%,IGF1;OSBPL8;RHOQ
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6130168562708304,1.5489553872143926,0.024111675126903553,0.26620254374652763,1.0,9/25,17.93%,BCAR3;PLAUR;DGKD;HIP1R;DOK1;CBL;HIP1;CNOT9;PDE6G
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.33722510892235796,-1.5483853053087946,0.0,0.441014593880789,1.0,29/107,5.72%,CX3CR1;OPHN1;SNCAIP;LRRC4C;GRIK2;GRID2;NLGN1;GRM7;NRG3;MEF2C;RIMS1;GRM1;DLGAP1;SLC8A3;CLSTN2;GRIK3;MCTP2;SYT1;GRM5;GRID1;GRM3;CPLX1;CLSTN3;SLC12A2;GRIK4;RIMS2;CNTNAP4;CACNA1B;CDH2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5546914701305071,1.5483314989418275,0.010033444816053512,0.2665850481171577,1.0,19/52,19.95%,CXXC1;TLN1;GOSR2;ATP6V0D1;ERN2;TATDN2;EDEM1;ERN1;MYDGF;DCTN1;TPP1;VAPB;EXTL2;CTDSP2;ZBTB17;EXTL3;WFS1;FKBP14;XBP1
prerank,neutral amino acid transport (GO:0015804),0.6019109695871971,1.547213387991266,0.019777503090234856,0.26865194796690356,1.0,13/28,22.36%,SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC6A7;LLGL2;SLC7A8;SLC38A2;CTNS;SLC1A5;SLC43A2;SLC7A10
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5136005323004633,1.5466492879502853,0.004136504653567736,0.26896755801948363,1.0,37/113,21.44%,LGALS3;FNIP2;LCP1;ABCA1;ASAP1;PLEK;PIEZO1;EIF4G1;VEGFA;CAPG;BAX;ERCC1;VCP;DHX33;SYK;BCL2L11;DDB2;DDB1;ERCC4;XPA;BID;BIK;FNIP1;TNF;PIH1D1;SLF2;TFRC;GTF2H1;PSMC4;ERCC2;IL5;TERF1;CUL4A;TGFB1;PSMC2;SUMO1;TIRAP
prerank,cellular response to increased oxygen levels (GO:0036295),0.723133352559551,1.5464166136741295,0.023088023088023088,0.26828928902620996,1.0,6/11,8.56%,ATG7;ATP6V1A;ATP6V0D1;ATP6V1G1;TMEM199;CAV1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5960525164774771,1.5463124219934754,0.021739130434782608,0.26723842508643725,1.0,13/29,26.60%,CD300LF;TANK;IKBKE;TRAF3;UBA52;TICAM1;RPS27A;UBC;TBK1;BIRC2;CHUK;TLR3;IRF3
prerank,regulation of glucose import (GO:0046324),0.5994529505651779,1.544619995924097,0.013301088270858524,0.27082685250254174,1.0,4/30,5.91%,IGF1;OSBPL8;RHOQ;APPL2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7271839883428921,1.5445547586532313,0.03202328966521106,0.26844201059314743,1.0,2/10,14.35%,CEP250;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7271839883428921,1.5445547586532313,0.03202328966521106,0.26844201059314743,1.0,2/10,14.35%,CEP250;CNGB1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3632610809080697,-1.5444458857358943,0.0,0.44239042794657635,1.0,56/224,9.62%,CACNB2;GABRB3;GRIA4;GRIK2;SNAP25;NRXN1;SYNJ2BP;NLGN1;GRM7;CHRM2;DLG2;GABRB2;GRIA3;GABRB1;GRM1;RPS6KA1;SYN2;GLRA3;DLGAP1;KCND2;AMPH;GRIN2B;HTR1F;HTR2C;UNC13B;GABRG3;GRIN2A;SYT1;GRM5;PDE7B;SYT10;GRIA2;GRM3;CPLX1;RIT2;HRH2;GRIK4;GRIN1;GAD2;KCNQ3;CACNA1B;APBA2;GABRA2;PRKAR2A;PLP1;HTR2A;GAD1;PENK;KCNA1;CHRM3;SLC6A1;PRKAR2B;GLRA2;GABRG1;SYN1;APBA1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.664067907240651,1.542570697504198,0.03274215552523874,0.2729104961783067,1.0,9/15,15.17%,LARGE1;RENBP;NAGK;GNPDA1;OGA;AMDHD2;EXTL2;CHST3;GNPDA2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.582114409194127,-1.5414315812573713,0.05387205387205387,0.44121929994272113,1.0,7/12,18.74%,RIMS1;UNC13B;SYT1;RIMS2;UNC13C;SYT7;SYT2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.5570914650487012,1.5408387923726792,0.007865168539325843,0.27648253518016236,1.0,20/48,24.10%,HIF1A;NUP205;EIF6;GCKR;GCK;NUP188;RAE1;OGT;SLC2A6;NUP42;TPR;JMJD8;PRKAG1;NUP54;NOA1;RANBP2;NUP133;NUP93;NUP98;EP300
prerank,negative regulation of endocytosis (GO:0045806),0.6074971114790613,1.539721899208167,0.0225,0.2783210305770386,1.0,6/24,10.07%,LGALS3;MCTP1;CD300A;SNX33;CAV1;LILRB1
prerank,natural killer cell activation (GO:0030101),0.6137981951845197,1.5391603566531622,0.02357320099255583,0.2784749597161817,1.0,9/23,16.63%,PTPRC;ELF4;AXL;NFIL3;PRDX1;SNX27;IL2;RABL3;KAT7
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5328333334741876,-1.5384127807535477,0.04946996466431095,0.4408073943846181,1.0,5/15,7.88%,WHRN;SCN1A;COL11A1;KIT;KCNA1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7146166505823621,1.5376436845393828,0.029871977240398292,0.28156179823538685,1.0,4/11,8.17%,BCL2;MUC1;CD44;TRIAP1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5454262857699799,1.5373046641610704,0.011363636363636364,0.28131166338033964,1.0,25/48,28.40%,FNIP2;BCL2;BCL2L1;MCL1;IKBKE;DYRK2;TNFRSF1B;BAX;BRCA1;BCL2L11;CDIP1;CASP9;CHEK2;SNW1;BCL2L2;HIPK1;EP300;ABL1;AEN;TMEM109;PHLDA3;PRKDC;USP28;HIPK2;HTRA2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6514373487345964,1.5366231501123497,0.030585106382978722,0.28192681299596717,1.0,8/16,16.52%,CTNNB1;KMT2A;BRCA1;DNMT3B;PIH1D1;DNMT1;SNW1;WDR5
prerank,synapse organization (GO:0050808),-0.3302168068478007,-1.5357885410562406,0.0,0.4386172872356737,1.0,40/125,15.90%,CACNB2;CX3CR1;LRRC4C;CTNND2;NRXN1;PTPRD;NLGN1;PPFIA2;LRFN5;ADGRL3;SLC8A3;PPFIA4;ANK3;UNC13B;GRM5;GPC6;NTNG1;CDH2;C1QC;SLC6A1;DNER;LRRK2;PSEN1;FLRT3;SHANK3;NLGN3;GPHN;F2R;SLC8A2;MAPT;ELFN1;KIRREL3;REST;UNC13C;GPM6A;SLITRK2;SPOCK2;DRD2;APP;CBLN2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.7246843537103407,1.5352173165659844,0.03142857142857143,0.28439815189190126,1.0,4/11,12.70%,COLEC12;RFTN1;TICAM1;TNIP2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6715407659218307,1.5350979631503214,0.014416775884665793,0.2833359424119066,1.0,7/15,17.21%,APOE;ADAM8;SNX33;TNFRSF1B;FURIN;TNF;SH3D19
prerank,regulation of mRNA stability (GO:0043488),0.5030093607071224,1.5332712264552868,0.0,0.28740898899297085,1.0,71/145,29.12%,TENT5C;PSMD1;PRKCD;EIF4G1;HSPB1;PSMD8;PSMA1;VIM;LARP1;PSMA8;NOCT;UBA52;CELF1;SLC11A1;TAF15;FXR2;YTHDF2;VIP;TNPO1;PSMD14;EIF4ENIF1;PSMA5;EXOSC9;MAPKAPK2;PSMD12;PSMB10;RPS27A;UBC;PUM1;RIDA;DCP2;EXOSC5;PABPC1;CIRBP;PSMD2;PSMC4;FTO;FUS;HNRNPU;PSMD6;PSMD3;EXOSC4;PSMD5;GDNF;PSMC2;XPO1;ROCK1;PSME4;PUM2;PCBP4;PSMB8;SET;PSMA6;METTL3;GIGYF2;XRN1;PSMB7;PSMD4;SAMD4B;PSMA3;PSMD10;DHX36;PSMC6;FASTKD3;FMR1;PSME3;PSMC5;YWHAZ;DCP1A;PSMA4;RC3H1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5974119937833792,1.5316017170681286,0.025220680958385876,0.29093368152805676,1.0,7/25,8.84%,P2RX4;PLEK;CCL4;CD22;TRAT1;HTT;TREM2
prerank,pre-replicative complex assembly (GO:0036388),0.534214080194408,1.5305761092507544,0.01079913606911447,0.2924616674436201,1.0,36/64,28.92%,PSMD1;ORC3;MCM2;PSMD8;PSMA1;MCM7;GMNN;PSMA8;UBA52;PSMD14;PSMA5;PSMD12;MCM8;PSMB10;RPS27A;UBC;PSMD2;PSMC4;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;MCM6;MCM3;PSMA3;MCM5;PSMD10;PSMC6;PSME3;PSMC5;PSMA4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6175800841626062,1.5305575525278876,0.03117206982543641,0.2911758323279567,1.0,5/21,4.20%,PRKCH;STAP1;PTPRC;TRAT1;PRKCB
prerank,regulation of phagocytosis (GO:0050764),0.5505988414010132,1.5303618943041764,0.008869179600886918,0.2903544722851568,1.0,13/53,11.16%,SIRPA;FGR;DOCK2;PTPRC;FER1L5;APOA2;SPHK1;CYBA;SLC11A1;GAS6;SYK;TREM2;LYAR
prerank,cellular response to oxygen levels (GO:0071453),0.7260822750212615,1.530274236886432,0.03692762186115214,0.2893592050631453,1.0,5/10,5.83%,ATP6V1A;CPEB4;ATP6V0D1;ATP6V1G1;TMEM199
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6675191703989254,1.5299283503889507,0.03225806451612903,0.28906691792364136,1.0,4/15,3.49%,P2RX4;FGF2;HSPB1;VEGFA
prerank,retinol metabolic process (GO:0042572),0.6788407271672989,1.5298388976907762,0.027888446215139442,0.2880539729028911,1.0,8/14,29.69%,DHRS3;RDH12;CYP1B1;RBP4;RDH10;DHRS9;RETSAT;CYP1A1
prerank,P-body assembly (GO:0033962),0.6971320596707581,1.5292957531685092,0.033707865168539325,0.2884763444532896,1.0,6/12,11.01%,DYNC1H1;PATL2;PATL1;LSM14A;ATXN2;EIF4ENIF1
prerank,toll-like receptor signaling pathway (GO:0002224),0.514238696519378,1.5268873431928494,0.007383966244725738,0.29405929691709504,1.0,25/84,19.27%,COLEC12;RFTN1;CTSB;IRAK2;TNIP1;SFTPA1;SFTPA2;TRAF3;UBA52;TAB1;TICAM1;BTK;MAPKAPK3;TNIP2;MAPKAPK2;HSPD1;MAP3K1;RPS27A;UBC;TNIP3;IRAK4;ITGB2;TLR7;CTSL;BIRC2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.589085511125161,1.5261259589701288,0.030450669914738125,0.29509717210802294,1.0,10/27,19.57%,SIRPA;NLRC3;CD200R1;FOXJ1;NCKAP1L;GAS6;TNFAIP3;TNF;PTPN6;ZC3H12A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6247750384586163,1.5259326298416398,0.026525198938992044,0.29440600438507597,1.0,11/19,27.80%,ZMIZ1;AXL;NCKAP1L;GAS6;SYK;BTK;XBP1;IL7;PRKDC;ZBTB1;PPP2R3C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6208935543205333,1.5251429566716446,0.02295918367346939,0.2942621046115891,1.0,13/23,24.10%,SDCBP;DAB2;ADAM17;GIPC1;ZEB2;FLCN;SNW1;STK11;TGFB1I1;RNF111;CREBBP;HSP90AB1;EP300
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6208935543205333,1.5251429566716446,0.02295918367346939,0.2942621046115891,1.0,13/23,24.10%,SDCBP;DAB2;ADAM17;GIPC1;ZEB2;FLCN;SNW1;STK11;TGFB1I1;RNF111;CREBBP;HSP90AB1;EP300
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5826393932093175,1.5246174031870652,0.02874251497005988,0.2944725521013803,1.0,9/30,17.51%,BCL2L1;TRAF2;HMOX1;BRCA1;TNFAIP3;TMBIM1;ARHGEF2;BMP5;SERPINE1
prerank,Rac protein signal transduction (GO:0016601),-0.5122467257717723,-1.5244531831494381,0.05,0.46016344436225287,1.0,5/18,1.92%,ELMO1;NCKAP1;CDH13;EPS8;TIAM1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.709545059686715,1.524173101210366,0.027220630372492838,0.2944409711944628,1.0,5/11,12.87%,MFHAS1;CYBA;TREM2;ACOD1;TNFAIP3
prerank,glycolytic process (GO:0006096),0.5935147892354031,1.5236694588690987,0.021144278606965175,0.2947773123846166,1.0,9/28,11.49%,PKM;GCK;PFKL;LDHA;ALDOA;ENO2;PGK1;ENO1;HK3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6272680414019636,1.5235613399845722,0.01486988847583643,0.2938405108933547,1.0,5/22,5.38%,LGALS3;DGKZ;CD22;CD300A;PTPN2
prerank,negative regulation of cell death (GO:0060548),0.5077808230067561,1.5231071384304422,0.009615384615384616,0.29397890579837926,1.0,19/88,13.32%,GPNMB;CSF1;FGF2;CDK5;TRAF2;CD200R1;ATP13A2;EIF4G1;CHMP4B;CHMP4A;LRPAP1;TNFRSF1B;VPS4B;NCK1;CCN6;BECN1;INPP5A;VPS35;FYN
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5851421644914954,1.522911029811992,0.014580801944106925,0.29338576264023075,1.0,4/27,1.59%,NIBAN2;PDGFA;FGF2;PARP4
prerank,epithelial cell differentiation (GO:0030855),0.5146942335899014,1.5228423435405654,0.004197271773347324,0.2923620940631376,1.0,18/88,12.20%,LGALS3;CTSB;ANXA4;GSTA2;VEGFA;DAB2;BASP1;PPARG;JAG1;PCK2;ANXA7;TPP1;PGK1;CBR1;TST;PTER;CPT1A;TAGLN
prerank,respiratory system development (GO:0060541),0.5886833758959343,1.522709744224823,0.026128266033254157,0.29155516179753505,1.0,14/32,20.04%,FGF2;VEGFA;BASP1;PDPN;CEBPA;NKX2-1;CHD7;ITGA3;FGF7;RBP4;DISP1;CCDC40;LOXL3;FGFR2
prerank,regulation of hippo signaling (GO:0035330),-0.524122129754829,-1.5226922853954044,0.06086956521739131,0.45683368977069594,1.0,11/17,25.51%,MAPK14;MOB3B;SCHIP1;CIT;WWC1;VGLL4;LIMD1;AJUBA;NEK8;SHANK2;DLG5
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5983146256415748,1.5220038901161828,0.035487959442332066,0.2924090565382134,1.0,9/24,14.72%,CTNNB1;CDK5;MCL1;FBXW7;BAX;DDIT3;SRPK2;TNF;NF1
prerank,action potential (GO:0001508),-0.39475451436250114,-1.5212924890044652,0.008928571428571428,0.45257178080347477,1.0,14/44,11.77%,DMD;AKAP6;KCND2;GNA15;SCN1A;ANK3;SCN8A;KCNB1;KCNMB2;KCNA1;CACNA1I;SCN2A;MYH14;YWHAH
prerank,triglyceride homeostasis (GO:0070328),0.5996570644222585,1.5204646515973232,0.027261462205700124,0.2955955466253455,1.0,4/26,5.97%,LPL;APOE;GCKR;APOC4
prerank,lipid catabolic process (GO:0016042),0.6392244267885717,1.5203407095641464,0.03896103896103896,0.29467817845159544,1.0,4/18,9.96%,LPL;CEL;PLAAT3;ACADL
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6602406878692951,1.520064811118749,0.03942181340341656,0.29417358190571113,1.0,3/15,8.17%,IGF1;BCL2L1;TRIAP1
prerank,camera-type eye morphogenesis (GO:0048593),0.7283427597573958,1.5197587454797608,0.039589442815249266,0.29380905757548176,1.0,6/10,14.72%,TH;VEGFA;SKI;LRP6;IFT122;NF1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.6320875181209371,1.5195832143571948,0.03054448871181939,0.2931132862787243,1.0,8/19,15.17%,RENBP;NAGK;GNPNAT1;GNPDA1;UAP1;UAP1L1;AMDHD2;GNPDA2
prerank,positive regulation of immune system process (GO:0002684),0.6597039173275243,1.5188290692358244,0.03674540682414698,0.29407906495421177,1.0,4/16,5.80%,PIK3CB;GPR151;VEGFA;NCKAP1L
prerank,regulation of B cell activation (GO:0050864),0.5997850884848243,1.5185150497789872,0.021518987341772152,0.2936731901907007,1.0,8/25,12.87%,CD22;FOXJ1;SH3KBP1;SAMSN1;THEMIS2;IL6;TNIP2;TNFAIP3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6824575032018093,1.517616148276804,0.03773584905660377,0.2949256663956837,1.0,5/13,17.82%,FGF2;PDPK1;ADAM17;SP1;ITGA4
prerank,regulation of plasminogen activation (GO:0010755),0.695151968319182,1.5171856669657509,0.027210884353741496,0.2950191761756092,1.0,7/12,17.51%,CTSZ;RUNX1;SERPINE2;ENO1;SERPINF2;MELTF;SERPINE1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5451369774324515,1.5169891300061407,0.00813953488372093,0.29435321009759136,1.0,21/48,20.98%,ZMIZ1;ERCC6;TAF1D;CDCA4;ZMIZ2;DDX21;POLR2H;SPHK2;ELOF1;BAZ1B;POLR1A;MYBBP1A;SERTAD1;TAF1A;POLR1G;TAF1C;ARID1B;DEK;PHF2;ASF1A;TBP
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.719847434808574,1.5143831199994522,0.036671368124118475,0.30070450146125743,1.0,3/11,8.20%,IL12RB1;MALT1;NFKBIZ
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6861731268777491,1.514306644029622,0.030344827586206897,0.29972922648757516,1.0,5/12,14.07%,TH;VEGFA;MYO7A;AGTPBP1;PROM1
prerank,regulation of translational initiation (GO:0006446),0.5242600782514352,1.51388520416916,0.014084507042253521,0.2998473372467543,1.0,30/63,25.46%,ATF3;EIF1;AGO2;EIF4G1;HSPB1;EIF4G2;LARP1;EIF4G3;MIF4GD;YTHDF2;ALKBH1;NCK1;EIF4A2;TPR;POLR2D;DDX1;PAIP2;EIF5B;EIF2B2;EIF3B;NCK2;CSDE1;EIF2AK4;EIF4EBP1;KLHL25;EIF5;EIF4B;PPP1R15B;EIF3E;IMPACT
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4538191595668195,-1.5138009011188416,0.024271844660194174,0.46376064510810766,1.0,9/24,15.31%,ITGAM;ANK3;C2CD5;KCNB1;CEMIP;HRAS;CHP1;MTCL1;TCAF1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6560601224378271,1.513744046040407,0.030789825970548863,0.299083073567616,1.0,7/15,17.87%,PRKCH;CYP27B1;VDR;NUMA1;SULT2B1;ETV4;MED1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.69706573545455,1.5123696607934578,0.03367496339677892,0.3018652085713684,1.0,2/11,2.39%,ABCG1;APOA2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5750510022047988,1.512253160724531,0.026004728132387706,0.30101400690577845,1.0,9/33,13.24%,SIRPA;NFE2L2;PRKCD;PLEKHA1;CYP1B1;RIPK3;IL6;TNFAIP3;MAPK7
prerank,positive regulation of protein import (GO:1904591),0.582005151642996,1.5115011125314641,0.030624263839811542,0.3020125679209901,1.0,15/30,21.07%,PRKCD;IPO5;FLNA;TRIM28;PIK3R2;BAG3;JUP;TPR;ARHGEF5;RBM22;HDAC3;CDH1;ZC3H12A;TGFB1;DMAP1
prerank,regulation of anoikis (GO:2000209),0.6183455230034018,1.5107117459578074,0.037760416666666664,0.30315605291162473,1.0,7/19,13.88%,BCL2;ITGA5;MCL1;SIK1;CAV1;TLE5;MYBBP1A
prerank,negative regulation of T cell activation (GO:0050868),0.5746378933679543,1.5104694163401675,0.011890606420927468,0.3027339368709118,1.0,6/35,10.07%,LGALS3;GPNMB;CD274;NCKAP1L;HAVCR2;LILRB1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5915260738627506,1.5099445508311764,0.019393939393939394,0.303012721099912,1.0,6/28,5.90%,MFSD12;MITF;SIRPA;EIF6;SIRT5;TNFRSF1B
prerank,endomembrane system organization (GO:0010256),0.48389184633144455,1.5095532135977425,0.0,0.30287238091786084,1.0,59/178,21.03%,MYOF;PLEKHM2;ARHGAP21;SYNGR1;OPTN;FER1L5;ALS2;GOLGB1;SQSTM1;TLCD1;WASHC5;VPS18;PI4K2A;TRAPPC8;TOR1AIP2;SYNE1;ARFGEF2;SNX33;SNX10;SMPD4;DOP1B;TLCD2;COG4;ARL1;HTT;REEP3;OSBPL2;AP3D1;VAPB;CSNK1D;RAB1A;HOOK3;GOLPH3;GAK;HUWE1;CTDNEP1;PI4K2B;RAB22A;ARFGEF1;TRAPPC11;TRAPPC12;DYM;SUN1;TMED3;TRIP11;MAPK15;TOR1B;HOOK1;GOLGA2;TBC1D20;VPS11;SEC61A1;USP8;LAMTOR1;SEC16A;LMAN2L;LEMD2;GOLPH3L;DNAJC28
prerank,cellular potassium ion homeostasis (GO:0030007),0.678031267370053,1.5087781495790558,0.029535864978902954,0.30388831013106726,1.0,6/13,13.63%,KCNMA1;KCNJ2;ATP1A1;ATP1A3;ATP1A4;ATP1B3
prerank,JNK cascade (GO:0007254),0.5494355915979634,1.5083989492220307,0.02288329519450801,0.30381664801676317,1.0,12/40,14.97%,IRAK2;DUSP9;MAP4K3;UBA52;MAP3K12;TAB1;CRKL;PTGER4;SH2D3C;MINK1;RPS27A;UBC
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6557782779110234,1.508187890976652,0.03416557161629435,0.30329794348261047,1.0,9/16,21.64%,LRP1;APOE;LRPAP1;TREM2;SRF;TNF;HDAC1;ABCA7;ROCK1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6745389120137167,1.5076545162951625,0.025139664804469275,0.3037883760905441,1.0,7/13,17.83%,ZMIZ1;CDCA4;ZMIZ2;FAM47E;ELOF1;SERTAD1;ARID1B
prerank,positive regulation of calcium ion transport (GO:0051928),0.5588103950208436,1.5076375265485753,0.028402366863905324,0.30266969452690107,1.0,8/36,8.56%,LGALS3;P2RX4;CCL4;ATP2B1;CACNA1D;CRACR2A;SPHK2;CAV1
prerank,fatty acid transmembrane transport (GO:1902001),0.6212292193951319,1.5074234991814228,0.029525032092426188,0.3021145289694125,1.0,8/19,12.26%,SLC27A1;SLC27A5;ABCD4;ACACA;ABCD2;SLC2A1;CPT1A;ACACB
prerank,regulation of glycolytic process (GO:0006110),0.5230486837478167,1.5071447529931858,0.010834236186348862,0.30180329684270946,1.0,24/68,24.10%,IGF1;HIF1A;NUP205;EIF6;GCKR;GCK;PFKFB3;HDAC4;GIT1;NUP188;RAE1;OGT;SLC2A6;NUP42;TPR;JMJD8;PRKAG1;NUP54;SLC4A4;RANBP2;NUP133;NUP93;NUP98;EP300
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.37347108277288293,-1.506394645915701,0.02912621359223301,0.4750983508275873,1.0,18/53,24.30%,CHRM2;HTR1F;HTR2C;HRH2;HTR2A;CALCRL;CHRM3;CCR1;AGT;CCL2;VIPR1;TSHR;HTR7;OPRD1;MC5R;SSTR2;HTR6;NPY
prerank,RNA stabilization (GO:0043489),0.5691861356938993,1.5059640938445735,0.013095238095238096,0.3041607996957362,1.0,15/33,24.42%,TENT5C;LARP1;NOCT;SLC11A1;TAF15;VIP;EIF4ENIF1;DKC1;PABPC1;CIRBP;FUS;HNRNPU;GDNF;NSUN2;PHAX
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5720437347287984,1.5044902594122185,0.030915576694411414,0.30729933874589693,1.0,7/32,13.55%,CDK14;CDK18;CDK5;ID2;BRD4;CDK16;NPAT
prerank,anterior/posterior axis specification (GO:0009948),0.6545633560474472,1.504197233265869,0.048,0.3071866071165286,1.0,3/15,9.15%,WLS;SKI;DDIT3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6262250096383715,1.5040185266465205,0.031413612565445025,0.30648785492017516,1.0,9/20,15.41%,SLC9A1;KCNMA1;KCNJ2;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP1B3;ATP6AP1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6299064899508376,1.503987494002288,0.03939008894536213,0.3054866848564677,1.0,11/19,28.54%,SLC46A1;FPGS;MTHFS;MTRR;MTHFR;MTHFD2;SLC19A1;SLC25A32;MTHFD1;ALDH1L2;SHMT1
prerank,secondary alcohol metabolic process (GO:1902652),0.54831815029336,1.5035507990313464,0.020809248554913295,0.30564282282795663,1.0,8/42,6.88%,ABCA1;ABCG1;APOE;APOA2;SOAT1;PPARD;SOAT2;CH25H
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5838374281443515,-1.5030352875301036,0.06188925081433225,0.47599449798474885,1.0,4/11,20.45%,PTS;QDPR;HSP90AA1;PRKG2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5141645149222798,1.5001681380093936,0.012903225806451613,0.3146703796143126,1.0,24/65,20.66%,SNX25;PDPK1;VEPH1;WFIKKN1;ADAM17;SMAD7;BAMBI;UBA52;NKX2-1;SKI;NRROS;SPRED2;CAV1;PMEPA1;TGFBR2;DAND5;RPS27A;UBC;SPRED3;PIN1;LDLRAD4;TGFBR1;TGFB1I1;TGFB1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4310519247167009,-1.4994837846388511,0.049689440993788817,0.4774411009407362,1.0,13/31,12.55%,TANC2;NLGN1;PPFIA2;EPHA4;SIPA1L1;ARHGAP44;SRCIN1;ABI3;PDLIM5;LRRK2;SHANK3;RELN;DBN1
prerank,positive regulation of viral process (GO:0048524),0.5244424274533214,1.498571109935187,0.018743109151047408,0.31822837901308076,1.0,20/60,19.82%,MDFIC;ADARB1;AXL;POLR2H;LARP1;SRPK1;PPIE;GTF2F1;RAB7A;PKN2;DDB1;VAPB;SRPK2;KPNA6;DHX9;POLR2D;PABPC1;ADAR;TBC1D20;TMEM39A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6174894658181805,1.498360539571791,0.0456989247311828,0.3177568286130533,1.0,10/18,20.43%,RAD51B;CCNB1;BRD4;STOX1;VPS4B;CDC25B;CDC25A;CDK4;CCND1;FBXO5
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5296828076772863,1.4981568335601563,0.014238773274917854,0.3172215582861033,1.0,16/54,15.46%,HIF1A;P2RX4;APOE;FGF2;HSPB1;PDPK1;VEGFA;PPARG;ADAM17;JUP;ANGPT2;MAP2K3;SP1;TNF;NF1;FGF18
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.598628204490084,1.4972948032847933,0.033582089552238806,0.3186962799132378,1.0,8/24,18.04%,NFE2L2;PDPK1;GAS6;TNIP2;TNFAIP3;MAPK7;SERPINE1;KRIT1
prerank,regulation of integrin activation (GO:0033623),0.6606350438292786,1.4961360947555111,0.04336043360433604,0.3209378528346526,1.0,3/15,2.93%,FBLIM1;PLEK;PIEZO1
prerank,positive regulation of cellular component organization (GO:0051130),0.4977152501351114,1.4947298382430207,0.001034126163391934,0.3240893250712996,1.0,25/107,15.22%,LGALS3;FNIP2;PLEKHM2;LRP1;ASAP1;APOE;CLDN19;RUNX1;VEGFA;DAB2;PTPN23;LRP4;BAX;VCP;DCTN1;SYK;TREM2;IGF1R;BCL2L11;BID;BIK;FNIP1;TNF;PIH1D1;SLF2
prerank,Golgi ribbon formation (GO:0090161),0.678065317056235,1.4946395541557642,0.034578146611341634,0.3232267673302652,1.0,10/13,24.64%,OPTN;VTI1A;GCC2;STX6;GOLPH3;VAMP4;TRIP11;GOLGA2;PRMT5;MYO18A
prerank,protein import (GO:0017038),0.5046035680668663,1.4945440404627113,0.005285412262156448,0.32238129317779207,1.0,31/84,22.40%,APOE;MMP12;PRICKLE1;IPO5;GCKR;E2F3;ABCD2;HSPA4;SAMM50;RAB8B;SNX33;APPL2;NUP188;SYK;TOMM22;ALDH3A2;LAMP2;TNPO1;EIF4ENIF1;TNPO2;PEX14;TPR;PTTG1IP;NXT2;ACBD5;PPP1R10;PXMP2;IPO13;FIS1;NUP133;NUP93
prerank,regulation of translation (GO:0006417),0.4820918250044645,1.4940230282501261,0.0010121457489878543,0.32276442087035095,1.0,83/173,27.68%,EPRS1;SHFL;EIF6;EIF1;EIF4G1;HSPB1;PIWIL2;EIF4G2;NOLC1;VIM;PATL2;LARP4;LARP1;NCL;LSM14A;CYFIP1;OGFOD1;CNOT10;EEF2;ENC1;EIF4G3;MIF4GD;TRAP1;ETF1;YBX2;FXR2;DAPK1;ATXN2;NSUN3;ALKBH1;UPF3A;EIF4ENIF1;EIF4A2;RBM4B;TCOF1;GEMIN5;IL6;DHX9;EIF4E;RPL13A;UPF3B;NAT10;RIDA;CPEB3;DDX1;PAIP2;EIF5B;EIF4E2;CNOT9;CAPRIN1;MTRF1;CIRBP;EIF2B2;PYM1;PUM3;MTG1;EIF3B;PCIF1;EIF2A;CALR;TSFM;RACK1;METTL3;GIGYF2;CSDE1;EIF2AK4;KLHL25;EIF5;SAMD4B;SYNCRIP;EIF4B;EIF3E;IMPACT;GSPT1;NANOS1;LARP4B;ZCCHC4;EIF4A3;PRKDC;ILF3;DHX36;MTG2;MTPN
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5050590247095855,1.4938191961187868,0.01822079314040729,0.322213816367789,1.0,21/73,17.43%,BCAR3;FNIP2;TRIM6;EIF4G1;VEGFA;CD44;GAS6;CAV1;STOX1;DOCK7;RAF1;IL6;FNIP1;SH2D3C;HAX1;TNF;TBK1;CNOT9;TFRC;LATS1;IRGM
prerank,RNA catabolic process (GO:0006401),0.5336856250853791,1.493597769785048,0.02508551881413911,0.3217322973529531,1.0,21/46,23.09%,RNASEH2A;DXO;ERN1;CNOT10;SND1;RNASEH1;RNH1;RNASEH2B;YTHDF2;RNASE3;AGO3;AGO4;PABPC4;SUPV3L1;RIDA;DCP2;LSM6;PPP1R8;XRN2;ZC3H12D;METTL3
prerank,mononuclear cell differentiation (GO:1903131),0.5862426004216087,1.4935331161349452,0.04092071611253197,0.3207629637772653,1.0,9/24,12.08%,PDE1B;VEGFA;AXL;IRF8;PPARG;GAS6;TREM2;LILRB1;PIR
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.5021390583887493,1.492668586819,0.008501594048884165,0.32217210579726135,1.0,20/77,18.88%,LGALS3;IGF1;BCL2;BCL2L1;PLAUR;NOC2L;MCL1;SIAH2;SLC35F6;HTT;TRIAP1;CSNK2A2;MPV17L;TNF;PIH1D1;GHITM;QARS1;ACAA2;TGFBR1;BCL2L2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5659699956070574,1.492360574291027,0.029691211401425176,0.3220543847188966,1.0,10/33,18.04%,NFE2L2;PDPK1;GAS6;TNIP2;TNFAIP3;MAPK7;CAST;SERPINE1;WFS1;KRIT1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5638919261572508,1.4917774814328848,0.029832935560859187,0.32267733159821715,1.0,4/32,3.54%,OSBPL8;ABHD12;SLC27A1;PLAAT3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5859137245967987,1.4916985023534248,0.032569360675512665,0.3218320555056411,1.0,14/28,21.07%,PRKCD;IPO5;FLNA;TRIM28;PIK3R2;BAG3;JUP;TPR;RBM22;HDAC3;CDH1;ZC3H12A;TGFB1;DMAP1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.6027575949456998,1.4916403991799043,0.04086845466155811,0.3208931772832641,1.0,9/22,14.86%,UBTF;SMARCB1;NCL;PWP1;DHX33;WDR43;LYAR;RASL11A;PIH1D1
prerank,epiboly involved in wound healing (GO:0090505),0.6374951265082983,1.4902898824904334,0.03911342894393742,0.323604423694005,1.0,6/16,11.62%,LCP1;MRTFA;FLNA;PDPN;CD44;RHOA
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5777319210166086,-1.4900496658126299,0.07621951219512195,0.49478746597575907,1.0,4/11,1.79%,CACNB2;CACNA2D1;NOS1AP;BIN1
prerank,tRNA methylation (GO:0030488),0.5625812853363326,1.4896268657691432,0.030229746070133012,0.32437227286828785,1.0,18/34,24.78%,METTL1;TRMT10C;PRORP;METTL2A;METTL2B;GTPBP3;TRMT13;TRMT5;ALKBH8;TRMT12;LCMT2;TRMT10A;TRMT1L;MTO1;THUMPD2;METTL6;NSUN2;NSUN6
prerank,neutrophil chemotaxis (GO:0030593),0.5214857813971993,1.489188285824617,0.022857142857142857,0.32456219873386044,1.0,7/53,9.76%,LGALS3;CCL4;NCKAP1L;PIP5K1C;CCL13;SYK;CCL14
prerank,"phototransduction, visible light (GO:0007603)",0.650199726028487,1.4886668809278498,0.04514363885088919,0.3250519904685225,1.0,6/14,20.74%,GNAQ;GNA11;GNB1;CNGB1;PDE6G;SAG
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6090713318355774,1.4884192498700861,0.029262086513994912,0.3247532465482153,1.0,10/22,21.64%,APOE;ADAM8;SNX33;TNFRSF1B;TIMP2;FURIN;TNF;SH3D19;TIMP1;ROCK1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.7118371831396495,1.4873873377986855,0.043227665706051875,0.32675909770283074,1.0,6/10,17.87%,PRKCH;CYP27B1;VDR;NUMA1;ETV4;MED1
prerank,regulation of phospholipase C activity (GO:1900274),0.640972543224165,1.4866539512847468,0.047182175622542594,0.3277531510311532,1.0,3/15,1.55%,FLT1;ABL2;FGF2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6050964662372671,1.4857490964793627,0.041666666666666664,0.329348665175301,1.0,5/21,3.76%,ADCY8;ADCY3;NPPA;ADCY7;AMPD2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6008756248521769,1.4854668764933452,0.043092522179974654,0.3290912700967819,1.0,2/21,0.15%,CHST11;CSPG4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5953165622971667,1.4850951001511974,0.0493046776232617,0.329110152696995,1.0,4/23,3.85%,ITGAX;FGF2;VEGFA;SOX9
prerank,negative regulation of receptor internalization (GO:0002091),0.6695306998388596,1.4848742513067699,0.04293628808864266,0.32868420195716497,1.0,6/12,18.67%,SDCBP;ANKRD13B;LRPAP1;ATXN2;DLG4;ANKRD13A
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5851286988155405,1.4846560574692398,0.03383458646616541,0.3282917397756307,1.0,8/28,11.64%,BCL2;TRAF2;ERN2;BAX;ERN1;ERO1A;DDIT3;DNAJC10
prerank,axon development (GO:0061564),-0.3570654946068836,-1.483243303476762,0.0,0.50531384966348,1.0,33/78,21.26%,GRM7;CTNNA2;GAP43;ANK3;CNTN4;MAP1B;SEMA5A;NTNG1;RAB3A;PLP1;PARD3;SLITRK4;NEFH;NREP;DSCAML1;DCC;PLPPR4;MAPT;S100A6;BRSK1;SPTBN4;SLITRK2;DRD2;APP;APBB1;PAX2;ZDHHC17;RAB10;RTN4RL1;CCK;ARHGAP35;ATL1;SLITRK5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.6130831049876597,1.4804319095984482,0.051248357424441525,0.3399899757802498,1.0,4/18,10.19%,BCL2;BCL2L1;ALKBH7;SLC25A31
prerank,platelet degranulation (GO:0002576),0.48427596826867214,1.480091227312159,0.002070393374741201,0.3398070172342648,1.0,37/118,20.97%,IGF1;CD9;FN1;TLN1;PLEK;ANXA5;PDGFA;LHFPL2;A2M;CHID1;VEGFA;PSAP;FLNA;TOR4A;APLP2;GTPBP2;CYB5R1;PROS1;ECM1;ALDOA;GAS6;LAMP2;SERPINF2;LY6G6F;APOH;FAM3C;ITGA2B;ACTN1;LGALS3BP;SERPINE1;CDC37L1;TAGLN2;TIMP1;OLA1;TGFB1;ACTN2;PDGFB
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5233602815910806,1.4800726502223973,0.027303754266211604,0.3387879368763895,1.0,13/47,13.27%,CSF1;APOE;WDR91;EIF4G1;NOLC1;CYFIP1;NFKB1;ATXN2;RBM4B;TCOF1;GEMIN5;EIF4E;VPS35
prerank,UV-damage excision repair (GO:0070914),0.6722804195653176,1.4797354306680974,0.06392045454545454,0.33868410576521407,1.0,5/12,12.03%,ERCC1;DDB2;DDB1;XPA;INO80
prerank,folic acid metabolic process (GO:0046655),0.6221951918861052,1.4785551311618406,0.043202033036848796,0.3413349190908951,1.0,11/18,28.54%,SLC46A1;FPGS;MTHFS;MTRR;MTHFR;MTHFD2;SLC19A1;SLC25A32;MTHFD1;ALDH1L2;SHMT1
prerank,actomyosin structure organization (GO:0031032),-0.3526017954397703,-1.4785298147121388,0.0,0.51106370456839,1.0,27/75,25.49%,CAPN3;F11R;EPB41L5;FRMD5;EPB41L4B;CIT;TMOD2;MYH10;FRMD6;EPB41L4A;PDCD10;TJP1;EPB41L3;ROCK2;MYH14;PGM5;PHACTR1;FRMD3;CDC42BPA;SRC;EPB41L1;SORBS1;FHOD3;ITGB1;PDLIM1;TNNT3;CDC42BPG
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5069107036339451,1.478372477326723,0.01406926406926407,0.34071865947200974,1.0,23/67,13.32%,FLT1;NRP2;PIK3CB;NRP1;PTK2B;HSPB1;CYBA;VEGFA;AXL;NCF4;NCKAP1L;CYFIP1;PIK3R2;CYBB;BAIAP2;PAK2;AAMP;NCK1;RHOA;MAPKAPK3;NCF2;MAPKAPK2;FYN
prerank,negative regulation of complement activation (GO:0045916),0.7066712720645787,1.478362972661032,0.058011049723756904,0.33967642652761104,1.0,3/10,2.49%,A2M;C4BPA;C4BPB
prerank,granulocyte chemotaxis (GO:0071621),0.5158615116473624,1.4781698918383683,0.027303754266211604,0.3391026545542499,1.0,7/55,9.76%,LGALS3;CCL4;NCKAP1L;PIP5K1C;CCL13;SYK;CCL14
prerank,regulation of postsynapse organization (GO:0099175),-0.4378261780255526,-1.477914546289311,0.03482587064676617,0.5047429595409932,1.0,12/28,9.75%,TANC2;IL1RAPL1;PPFIA2;CDKL5;EPHA4;SIPA1L1;ARHGAP44;SRCIN1;ABI3;PDLIM5;LRRK2;SHANK3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5807405965399225,1.4773653826489008,0.038130381303813035,0.34052609851321464,1.0,16/26,24.91%,SPHK1;CCNB1;PKN2;MDM2;USP2;EIF4E;CDC25B;KLHL18;CCDC57;DUSP3;PPP1R10;HSF1;ASNS;EIF4EBP1;CUL3;SMOC2
prerank,relaxation of cardiac muscle (GO:0055119),0.6642938581356653,1.4770947560708763,0.05394190871369295,0.34025036499330485,1.0,9/13,28.24%,P2RX4;KCNJ2;SLC8A1;ATP1A1;PIK3CA;GSN;ATP1A2;CAMK2D;RGS2
prerank,axon extension (GO:0048675),0.5951730874810651,1.4770778983777941,0.028606965174129355,0.33923601547651666,1.0,7/23,7.94%,ALCAM;NRP2;NRP1;CDK5;SLC9A6;CYFIP1;USP9X
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7012083872379893,1.4769902324165547,0.04950495049504951,0.33840521159418147,1.0,5/10,14.86%,KMT2A;SPHK2;SMARCB1;BRCA1;PIH1D1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4621172876689992,-1.4764133878827987,0.04040404040404041,0.5017781765976108,1.0,6/22,12.68%,SH3GL2;NTRK3;RAPGEF2;NTRK2;TMEM108;MAPT
prerank,long-chain fatty acid transport (GO:0015909),0.5665953945387924,1.475391794679099,0.028014616321559074,0.34199055323469674,1.0,10/30,12.26%,APOE;SLC27A1;FABP5;ABCD4;ACACA;ABCD2;PPARG;ACSL1;CPT1A;ACACB
prerank,cochlea morphogenesis (GO:0090103),0.704872364863059,1.4750546289457156,0.04172461752433936,0.34191577036791204,1.0,3/10,11.41%,TBX18;SOX9;MYO3B
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5599753704224314,1.4749808897386603,0.03305785123966942,0.34103888958812256,1.0,7/32,12.60%,IGF1;HIF1A;PFKFB3;VCP;TREM2;ENO1;PID1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5673859092171001,1.474846314202701,0.04784688995215311,0.34042985675752035,1.0,12/27,21.69%,IRAK2;TNIP1;UBA52;TAB1;BTK;HSPD1;MAP3K1;RPS27A;UBC;IRAK4;TIRAP;IRAK1
prerank,negative regulation of transport (GO:0051051),0.5254078503708733,1.4743179502095964,0.02144469525959368,0.3410484146720784,1.0,10/51,10.53%,LGALS3;SIRPA;MCTP1;FER1L5;TRAT1;SNX33;YRDC;RAB7A;LILRB1;WWP2
prerank,regulation of protein modification process (GO:0031399),0.5246269129066812,1.4741645597038473,0.023127753303964757,0.3405203907272628,1.0,16/50,16.76%,FNIP2;FN1;CORO1C;ATG7;HSPB1;SPRED2;ATG10;KDM4D;ASPSCR1;FNIP1;HPF1;SPRED3;SESN2;FLCN;RABL3;PIN1
prerank,phagolysosome assembly (GO:0001845),0.680100722917971,1.4739142895175936,0.04874651810584958,0.3402684029543079,1.0,8/12,22.19%,RAB7B;ARL8B;RAB7A;RAB20;PIKFYVE;PLA2G5;CLN3;RAB34
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5918659178087546,1.4738740325949606,0.0491183879093199,0.33935895290769286,1.0,3/23,2.93%,IGF1;NIBAN2;PIEZO1
prerank,cellular response to alcohol (GO:0097306),0.5357161733451367,1.4738290421644453,0.0246189917936694,0.33842001748609474,1.0,17/42,19.61%,CTNNB1;ADCY8;ADCY3;PTGFR;ADCY7;SPHK2;LARP1;LRP6;BRCA1;ADAM15;JUP;PTGER4;GOLPH3;GNB1;SFRP1;CDH1;BLM
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6329168753887034,1.4737994275395416,0.05053191489361702,0.337477303938001,1.0,6/16,15.80%,HIF1A;APOE;PIK3CB;TNF;HTR2B;TERT
prerank,regulation of acute inflammatory response (GO:0002673),0.6155454098154883,1.4735792303482733,0.04342105263157895,0.3370380094255514,1.0,4/18,12.58%,ADAM8;PTGES;KLKB1;IL6
prerank,response to laminar fluid shear stress (GO:0034616),0.7084377144562999,1.473378199019362,0.06609195402298851,0.33656663241938883,1.0,4/10,13.24%,ABCA1;NFE2L2;SMAD7;MAPK7
prerank,negative regulation of anoikis (GO:2000811),0.6430087715905665,1.47252867626934,0.059379217273954114,0.33802937530333665,1.0,4/14,8.56%,BCL2;ITGA5;MCL1;CAV1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4794935689044706,-1.4723543260027878,0.036036036036036036,0.505815026806581,1.0,4/20,3.97%,ST3GAL6;FUT9;B3GALT5;B3GALT1
prerank,glycoprotein metabolic process (GO:0009100),0.5244648166143951,1.4722007204525465,0.020022246941045607,0.33808238956776954,1.0,14/53,13.02%,B4GALT5;MAN1C1;HIF1A;LARGE1;B4GALT7;TNIP1;ADAMTS13;STT3B;ST8SIA6;OGA;ST3GAL2;GCNT1;GOLPH3;HPSE
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6551448344896704,1.471617074988703,0.05420054200542006,0.33882087331065,1.0,3/13,6.60%,IGF1;SOAT1;ALG10B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.671351781025764,1.4714735949391948,0.05439330543933055,0.33824053448680896,1.0,4/12,8.17%,BCL2;MUC1;CD44;TRIAP1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5574371493138712,1.4712371927928285,0.0509478672985782,0.3379375946219763,1.0,5/29,1.94%,FLT1;DGKZ;FGR;FGF2;PTK2B
prerank,negative regulation of histone acetylation (GO:0035067),0.6898531672665704,1.4707967340360835,0.05286343612334802,0.3383471321200993,1.0,4/11,9.71%,NOC2L;BRCA1;THAP7;TAF7
prerank,phospholipid transport (GO:0015914),0.5211713016822932,1.4706726454399854,0.02783964365256125,0.33765892393307256,1.0,11/52,10.16%,OSBPL8;ABCA1;ABCG1;APOE;APOA2;ATP9B;PRELID2;TRIAP1;NPC2;PITPNC1;OSBPL2
prerank,regulation of autophagy (GO:0010506),0.46763854784522524,1.4700743900217283,0.0,0.3384031029548862,1.0,88/216,25.63%,GPR137B;BCL2;RRAGD;ATP6V1C1;ATP6V0D2;ABL2;ATP6V1A;ATP6V0A1;PIK3CB;CDK5;CTSA;OPTN;TRIM6;TFEB;ATP13A2;EIF4G1;ATP6V1B2;MCL1;HSPB1;ATP6V0D1;PSAP;SMCR8;FBXW7;EIF4G2;PLK2;CAPN1;ATP6V1G1;TPCN2;VPS26A;ERN1;ATP6V0B;EIF4G3;PIK3R2;TREM2;DDIT3;DAPK1;DRAM1;EEF1A1;CSNK2A2;ZKSCAN3;TICAM1;ORMDL3;EIF4E;VPS35;USP36;HAX1;ATP6V0C;RUBCN;HTR2B;FLCN;EXOC4;UFL1;USP13;IRGM;PRKAG1;PIP4K2A;PIK3C2A;MAPK15;ATP6V1D;GOLGA2;GFAP;LAMTOR3;ZC3H12A;LAMTOR1;STK11;DAP;RMC1;USP33;NEDD4;ATP6V1E1;ATG13;SIRT2;MTDH;ROCK1;EEF1A2;UBQLN1;RRAGC;NPRL2;CAPNS1;FOXO1;GSK3B;EP300;UBQLN2;ABL1;TPCN1;SH3GLB1;KAT8;SNX5
prerank,sphingolipid metabolic process (GO:0006665),0.48694265395385244,1.4699666629673935,0.008342022940563087,0.3377587971987868,1.0,40/108,20.71%,CERK;CTSA;SPHK1;HEXA;ESYT1;ORMDL1;PSAP;SGMS1;HACD2;TEX2;GALC;GLTP;PLPP3;CERS6;GLB1;GLA;SMPD4;SPHK2;HEXB;NEU1;ARSA;ASAH1;ALDH3A2;PPP2R1A;ALDH3B1;VAPB;GBA2;SAMD8;ORMDL3;KDSR;ARV1;PDXDC1;SGPL1;HACD1;ELOVL2;CLN8;SPTSSA;SGMS2;UGCG;TECR
prerank,inorganic anion transmembrane transport (GO:0098661),-0.36364542766170643,-1.4699615616489663,0.017543859649122806,0.5045068921445546,1.0,28/63,21.35%,GABRB3;GABRB2;GABRB1;GLRA3;ANO4;GABRG3;SLC12A2;SLC37A1;GABRA2;SLC12A9;SLC6A1;SLC25A11;LRRC8A;GLRA2;GABRG1;SLC1A3;SLC25A10;CLCN1;SLC12A8;GLRA1;SLC1A1;ANO7;GABRR2;SLC4A8;SLC12A6;GABRE;SLC37A4;GABRA1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6050296198849874,1.4691859342772955,0.054637865311308764,0.33924959616720474,1.0,2/19,1.57%,APOE;CHRNB2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.5091796551654552,1.4690365903899472,0.021505376344086023,0.3387258394947327,1.0,43/67,33.05%,PSMD1;PSMD8;CYBA;PSMA1;NCF4;PSMA8;SEC22B;ITGB5;TAPBP;CYBB;PSMD14;PSMA5;NCF2;PSMD12;PSMB10;PSMD2;PSMC4;VAMP3;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;CALR;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;PSMA3;B2M;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;ITGAV;PDIA3;PSMA2;PSMC3;PSMD7;PSMD13
prerank,regulation of protein import into nucleus (GO:0042306),0.5516415512048798,1.4683205742378458,0.03344867358708189,0.3400007707120634,1.0,17/36,22.20%,MDFIC;PRKCD;IPO5;FLNA;TRIM28;PIK3R2;BAG3;JUP;TPR;SUFU;RBM22;HDAC3;CDH1;ZC3H12A;TGFB1;DMAP1;UFM1
prerank,lipoprotein localization (GO:0044872),0.6941609143925037,1.4681226927499582,0.043154761904761904,0.3395538737838916,1.0,3/11,4.65%,LRP1;PRKCB;PPARG
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5761154201094479,1.4674854411432745,0.046798029556650245,0.3405643458813834,1.0,5/24,8.17%,BCL2;BCL2L1;MUC1;CD44;TRIAP1
prerank,lipid droplet formation (GO:0140042),-0.5852843343020813,-1.4674631850636406,0.07717041800643087,0.5038713345735667,1.0,4/10,18.64%,CDS1;SQLE;PLA2G4C;CDS2
prerank,negative regulation of histone modification (GO:0031057),0.6521441813475388,1.467042355087995,0.05089408528198074,0.3409705888548964,1.0,6/14,10.67%,NOC2L;SPHK2;BRCA1;THAP7;TAF7;PRMT6
prerank,axonal fasciculation (GO:0007413),-0.5452702830103194,-1.4668129736781421,0.044444444444444446,0.4984055856164432,1.0,3/12,4.56%,EPHA4;CNTN4;SEMA5A
prerank,sensory perception of pain (GO:0019233),0.5951080562575303,1.4649892998951783,0.05443037974683544,0.3460538456729534,1.0,4/21,5.78%,P2RX4;CHRNB2;PTGES;RETREG1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5068582962112813,1.464679596848016,0.018085106382978722,0.3460602649291025,1.0,40/72,29.87%,PSMD1;TRAF2;TNFSF15;PSMD8;MALT1;PSMA1;PSMA8;CARD10;COPS8;PSMD14;PSMA5;PSMD12;FBXW11;PSMB10;PSMD2;PSMC4;REL;CUL1;BIRC2;PSMD6;PSMD3;PSMD5;PSMC2;TIRAP;PSME4;IRAK1;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;PSMA3;TLR3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;BTRC;PSMB6
prerank,sulfur compound catabolic process (GO:0044273),0.5482622631905033,1.4642365242914142,0.033760186263096625,0.34633026897481767,1.0,9/38,12.89%,CSPG4;GALNS;GNS;HEXA;GLB1;HEXB;TST;IDUA;MPST
prerank,protein deacylation (GO:0035601),0.5887505983110399,1.4641552645286215,0.0491183879093199,0.34564584140666654,1.0,11/23,20.75%,HDAC4;SIRT5;HDAC7;ABHD17C;ABHD17B;ABHD10;SIRT3;LYPLA2;HDAC1;HDAC3;SIRT2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6793763976442613,1.4640483227503058,0.06358381502890173,0.34497130430362116,1.0,3/11,9.15%,ATF3;MBTPS2;DDIT3
prerank,regulation of endocytosis (GO:0030100),0.5115624820104012,1.463930492266551,0.015283842794759825,0.34430954259967855,1.0,15/61,11.20%,LGALS3;LRP1;APOE;MCTP1;ABL2;CD22;SPHK1;DAB2;SNX33;LRPAP1;RAB5A;HIP1R;LILRB1;RAB5C;RUFY1
prerank,cholesterol homeostasis (GO:0042632),0.5071684583868988,1.4630325486380102,0.021621621621621623,0.3460918109878928,1.0,12/64,9.20%,LPL;ABCA1;ABCG1;APOE;APOA2;MALL;SOAT1;SOAT2;HDAC9;NPC1;CAV1;NPC2
prerank,regulation of DNA binding (GO:0051101),0.5261956612565277,1.4628479652723398,0.03068181818181818,0.3456639170109686,1.0,9/44,11.02%,IGF1;PLAUR;DOT1L;PPARG;MDFI;SKI;ILRUN;JUN;CEBPG
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6837130155780233,1.4626329039466122,0.04694167852062589,0.345320904176206,1.0,6/11,17.83%,ZMIZ1;CDCA4;ZMIZ2;ELOF1;SERTAD1;ARID1B
prerank,protein import into nucleus (GO:0006606),0.5069033873812573,1.4619682654887876,0.009868421052631578,0.34628355127804694,1.0,24/66,22.40%,MMP12;PRICKLE1;IPO5;GCKR;KPNA4;E2F3;APPL2;RGPD1;NUP188;SYK;TNPO1;EIF4ENIF1;TNPO2;KPNA6;TPR;PTTG1IP;NXT2;NUP54;KPNA3;PPP1R10;IPO13;RANBP2;NUP133;NUP93
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4854597489950778,1.4610734130472751,0.01861427094105481,0.34814844088687724,1.0,58/109,29.87%,TEC;PSMD1;LAT;PIK3CB;GRB2;GAB2;PSMD8;PDPK1;MALT1;PSMA1;PSMA8;TAB1;JUN;SYK;PIK3R2;PPP3R1;NFKB1;PAK2;PSMD14;LAT2;PSMA5;BTK;PSMD12;FBXW11;MAP3K1;PSMB10;NFATC3;VAV1;PSMD2;PSMC4;MAPK3;CUL1;PSMD6;PIK3CA;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;LYN;MAPK1;PSMA3;VAV3;PRKCQ;PSMD10;RAC1;PSMC6;PSME3;PSMC5;PSMA4;BTRC;MAP2K7;PSMB6
prerank,androgen metabolic process (GO:0008209),0.6113184115113154,1.4604676040445335,0.05844155844155844,0.3491122985123433,1.0,3/18,6.64%,SPP1;CYP19A1;SRD5A3
prerank,regulation of phosphorylation (GO:0042325),0.4800409151935124,1.4592266901237947,0.008247422680412371,0.3519079320228307,1.0,43/120,24.10%,FNIP2;HIF1A;FN1;CORO1C;SDCBP;STAP1;NUP205;NRP1;EIF6;GCKR;GCK;HSPB1;MCM7;NCKAP1L;NUP188;RAE1;TESK1;KDM4D;OGT;SLC2A6;FNIP1;NUP42;ILK;TPR;JMJD8;SESN2;FLCN;ANKLE2;PIN1;PRKAG1;NUP54;LDB2;LDB1;SIRT2;ROCK1;CADM4;RANBP2;NUP133;NUP93;PTGES3;NLRC5;NUP98;EP300
prerank,sodium ion export across plasma membrane (GO:0036376),0.6640956521424015,1.4591300079512877,0.037142857142857144,0.35119801840154513,1.0,7/13,23.67%,SLC9A1;ATP1A1;ATP1A3;ATP1A4;ATP1B3;SLC4A4;ATP1A2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.49600724812607816,1.4589250994636065,0.011566771819137749,0.35090030648706955,1.0,15/84,6.02%,NRP2;HIF1A;P2RX4;SASH1;FGF2;PIK3CB;NRP1;PTK2B;HSPB1;RIN2;PDPK1;VEGFA;PLPP3;ADAM17;ANXA3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.488969047669517,1.4582863920165137,0.014893617021276596,0.35180822547803614,1.0,24/94,14.20%,FNIP2;BCL2;BCL2L1;PRKCD;TRAF2;MCL1;ERN2;IKBKE;DIABLO;STK24;TNFRSF1B;BAX;ERN1;ERO1A;BRCA1;DDIT3;CYP1B1;BCL2L11;DNAJC10;C1QBP;CUL2;CASP9;MYBBP1A;CHEK2
prerank,lymphocyte migration (GO:0072676),0.542684512539212,1.4569539240862204,0.045454545454545456,0.35494536260670556,1.0,6/32,9.76%,ADAM8;CCL4;MSN;CRTAM;CCL13;CCL14
prerank,sterol homeostasis (GO:0055092),0.504143414391155,1.4566272411232817,0.02159827213822894,0.354840730267731,1.0,12/65,9.20%,LPL;ABCA1;ABCG1;APOE;APOA2;MALL;SOAT1;SOAT2;HDAC9;NPC1;CAV1;NPC2
prerank,melanosome organization (GO:0032438),0.5741625089044652,1.456528959262802,0.0480295566502463,0.3541353837271686,1.0,9/26,15.66%,LYST;TYRP1;DTNBP1;RAB32;HPS1;BLOC1S3;AP3D1;AP1M1;AP1G1
prerank,atrial septum morphogenesis (GO:0060413),-0.5749359856288001,-1.4564551824567298,0.096875,0.5181921003651275,1.0,5/10,27.01%,NOTCH2;ZFPM1;TGFB2;HEY2;ISL1
prerank,telomere maintenance via recombination (GO:0000722),0.6686701643067607,1.4560932035099137,0.06419400855920114,0.354484713797222,1.0,5/11,11.79%,NSMCE2;ERCC1;RAD50;ERCC4;TPRKB
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5211065008055801,1.4560744560788959,0.02883506343713956,0.3535763486694433,1.0,9/43,10.07%,IGF1;SIRPA;NLRC3;POMC;CD274;GAS6;ILRUN;HAVCR2;LILRB1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.628320555281495,1.4557388576479464,0.05327868852459016,0.3536555187550962,1.0,3/15,0.73%,LPL;PRKCH;CSF1
prerank,regulation of protein autophosphorylation (GO:0031952),0.5457073026106561,1.4553617779800023,0.038777908343125736,0.3538532003734245,1.0,8/36,11.40%,GPNMB;PDGFA;RAP2A;VEGFA;PPP2R5C;RAD50;MVP;TESK1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4927751995616691,1.4548372438954282,0.013641133263378805,0.3545355820863756,1.0,39/84,29.11%,IGF1;APOE;EPRS1;SPHK1;ORMDL1;PATL2;LARP1;NCL;LSM14A;CNOT10;ENC1;FXR2;DAPK1;EIF4ENIF1;ORMDL3;RPL13A;RIDA;CPEB3;PAIP2;EIF4E2;CNOT9;CAPRIN1;PIN1;PCIF1;ABCA7;ROCK1;CALR;RACK1;GIGYF2;SAMD4B;SYNCRIP;NANOS1;GGA3;EIF4A3;ILF3;DHX36;FMR1;SHMT1;TRIM71
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4816849488378294,1.4546947476864005,0.013265306122448979,0.354039727835602,1.0,47/110,26.78%,LGALS3;FNIP2;FBLIM1;ABCA1;APOE;TRAF2;NAPA;VEGFA;BAX;VCP;SYK;BCL2L11;BBS10;RAF1;SAR1A;BID;BIK;FNIP1;RIOK3;HCFC1;TNF;PIH1D1;SLF2;TFRC;LATS1;IRGM;MAPK15;TRAF3IP1;HSF1;GFAP;NCLN;IAPP;TGFB1;SUMO1;TIRAP;CDC42;GSN;RACK1;PTPN11;GSK3B;EP300;RALB;SH3GLB1;IMPACT;FAF1;TRABD2B;ICE1
prerank,T cell mediated immunity (GO:0002456),0.6659641957686043,1.4542599203386757,0.05255878284923928,0.35442577166141437,1.0,4/13,9.93%,CADM1;JAG1;CRTAM;BTN3A3
prerank,organophosphate ester transport (GO:0015748),0.5829435946514778,1.454087523821692,0.0491183879093199,0.35394690142612123,1.0,7/24,14.88%,OSBPL8;PRELID2;TRIAP1;NPC2;PITPNC1;OSBPL2;SCP2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6507324034149571,1.453788812738345,0.06573426573426573,0.3539148327130668,1.0,5/13,8.63%,LPL;CD9;ABCA1;PPARG;SYK
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4927377941180126,-1.4537408465821708,0.05090909090909091,0.5184573299735593,1.0,7/15,16.59%,NLGN1;CNTNAP4;STXBP1;ZDHHC12;HAP1;DRD2;BAIAP3
prerank,regulation of biomineral tissue development (GO:0070167),0.566143669360277,1.4537368501706665,0.05048076923076923,0.35309997873978516,1.0,10/26,21.65%,ANKH;CYP27B1;SOX9;ECM1;GAS6;SGMS2;FBXO5;TGFB1;ROCK1;NOTCH1
prerank,cellular response to hypoxia (GO:0071456),0.4756778093245331,1.453645584721191,0.01017293997965412,0.352400648204457,1.0,63/126,28.92%,HIF1A;PSMD1;ADAM8;MGARP;PSMD8;VEGFA;PSMA1;CPEB2;HMOX1;PSMA8;AK4;UBA52;NDRG1;STOX1;P4HB;PGK1;PSMD14;EGLN1;MDM2;PSMA5;PLK3;CUL2;PTGIS;PSMD12;ELOB;CPEB1;PSMB10;RPS27A;UBC;TERT;PSMD2;ACAA2;SFRP1;PSMC4;HP1BP3;EPO;PSMD6;EGLN3;PSMD3;SIRT2;PSMD5;PSMC2;HIF1AN;PSME4;CREBBP;PSMB8;UBQLN1;LMNA;PSMA6;PSMB7;PSMD4;EP300;PSMA3;NPEPPS;PSMD10;BNIP3;HIPK2;PSMC6;BNIP3L;PSME3;PSMC5;BACH1;PSMA4
prerank,positive regulation of neuron differentiation (GO:0045666),-0.39144824530465505,-1.4529892672759768,0.030534351145038167,0.513604740690922,1.0,11/40,14.34%,MEF2C;BEND6;MMD;ZEB1;BRINP1;BRINP3;NBL1;TCF3;PCP4;ECT2;REST
prerank,cellular component maintenance (GO:0043954),0.652517462475754,1.4522971982196515,0.0673352435530086,0.3554132255223021,1.0,6/12,21.28%,TREM2;IGF1R;ITGA3;FYN;SUPV3L1;CLDN1
prerank,muscle cell development (GO:0055001),0.5542595068019178,1.4521388529651555,0.05084745762711865,0.35492152279941985,1.0,4/30,3.49%,IGF1;MYOF;FER1L5;VEGFA
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6852925409606588,1.4520199552856303,0.06017191977077364,0.3543359515601465,1.0,4/10,16.31%,DNMT3A;PRMT7;ZFP57;PCGF3
prerank,keratan sulfate metabolic process (GO:0042339),0.5543795751413548,1.451047813478183,0.04156769596199525,0.35621692438788566,1.0,7/31,6.39%,B4GALT5;GALNS;GNS;B4GAT1;HEXA;GLB1;HEXB
prerank,regulation of exocytosis (GO:0017157),-0.37852547633029565,-1.4504432184484253,0.028846153846153848,0.5136858061295699,1.0,20/46,22.36%,IL1RAPL1;CADPS;STXBP5L;SYT1;CPLX1;CLASP2;RIMS2;RAB3A;RAB27B;STXBP6;HAP1;NSF;RAB2B;LGI3;RAB10;RAB26;RAB15;RAB13;CHMP6;CPLANE2
prerank,organic acid transport (GO:0015849),0.483126619829177,1.4497347903251554,0.008501594048884165,0.35912720043752877,1.0,32/94,22.36%,SLC38A1;SLC26A1;SLC23A2;SLC23A1;SLC6A6;SLC27A1;SLC27A5;PPARD;SLC3A2;SLC46A1;SLC7A1;PDPN;SLC16A10;ACSL1;SLC7A6;SLC7A8;LRRC8D;SLC13A5;SFXN5;SLC19A1;SLC38A2;ABCB11;SLC25A14;SLC5A6;SLC25A32;SLC1A5;SLC7A3;SLC43A2;RXRA;SLC7A7;SLC7A2;SLC7A10
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6136703584845632,1.4496256753455758,0.0650730411686587,0.3584996143233121,1.0,2/16,1.09%,IGF1;SLC9A1
prerank,modified amino acid transport (GO:0072337),0.6344553945067156,1.4494691341654464,0.06775067750677506,0.3580062592973072,1.0,7/15,20.39%,SLC46A1;PDPN;SLC19A1;CTNS;SLC5A6;SLC25A32;SLC6A8
prerank,negative regulation of inflammatory response (GO:0050728),0.4652809585036972,1.4493192674324524,0.00101010101010101,0.3575399786290301,1.0,40/182,14.03%,IGF1;SIRPA;APOE;FGR;NLRC3;MFHAS1;ADCY8;ADCY3;PRKCD;RHBDF2;CD200R1;POMC;ADCY7;OTULIN;PPARD;PTGIR;PLK2;PPARG;ADAM17;PTPN2;SCTR;CRH;TNFRSF1B;GIT1;SYK;TREM2;LPCAT3;ACOD1;YES1;GLP1R;VIP;FURIN;PTGER4;IL6;PTGIS;TNFAIP3;MAPK7;VPS35;FYN;GNB1
prerank,regulation of neuron projection development (GO:0010975),-0.30170003504959775,-1.4492287017436298,0.0,0.5098234703270024,1.0,48/163,15.17%,CSMD3;TANC2;IL1RAPL1;LRRC4C;PPFIA2;ARSB;TWF2;CTNNA2;FUT9;CDKL5;EPHA4;SIPA1L1;ARHGAP44;LRRC7;SRCIN1;SERPINI1;NTRK3;RAPGEF2;NCS1;RIT2;NTRK2;ABI3;NTNG1;CDH2;KANK1;PDLIM5;CRMP1;LRRK2;NDRG4;PSEN1;SHANK3;TENM3;CAMK1D;DCC;PLPPR5;RELN;PRKCI;DBN1;PTK7;ADCY6;PAK1;PLA2G3;WNT5A;CHN1;RET;NDNF;BRSK1;PTPRO
prerank,anion transmembrane transport (GO:0098656),0.4996761686547375,1.4490925607616527,0.029157667386609073,0.3572932100815819,1.0,27/67,23.93%,MFSD12;SLC23A2;SLC23A1;SLC36A4;SLC27A1;SLC3A2;SLC7A1;SFXN1;SLC25A1;SLC7A8;LRRC8D;SLC25A18;SFXN2;SLC13A5;SLC19A1;SLC35B1;SLC25A21;SLC25A14;SLC5A6;SLC25A13;SLC6A8;SLC7A3;SLC7A2;ABCC5;SLC35B4;LRRC8C;ARL6IP5
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5491842241989187,1.4487818935433976,0.030915576694411414,0.35728047204608276,1.0,16/33,25.24%,HIF1A;FGF2;PPARG;JUN;GNL3;SRF;NR3C1;TNF;TERT;TGFB1;PDGFB;SMARCA4;KLF5;TEAD1;EGR1;SPI1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.41497881119556446,-1.4481240136214686,0.03954802259887006,0.506051694082509,1.0,11/28,16.05%,ITGAM;ANK3;C2CD5;KCNB1;DMTN;CEMIP;HRAS;CHP1;MTCL1;TCAF1;INPP5K
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.533400353413902,1.4477847831292818,0.041031652989449004,0.3594299024419177,1.0,14/37,20.87%,NUDT5;RNASEH2A;NUDT9;SND1;RNASEH1;DNASE1L1;DFFB;RNASEH2B;RNASE3;ENTPD6;PABPC4;SUPV3L1;PPP1R8;XRN2
prerank,response to amino acid starvation (GO:1990928),0.4917071252566143,1.4475562136449815,0.016251354279523293,0.35915591769079985,1.0,30/72,25.46%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;TFEB;ATP6V1B2;ATP6V0D1;ATP6V1G1;LARP1;ATP6V0B;NPRL3;ATP6V1F;LARS1;ATP6V0C;SESN2;FLCN;MAPK3;ATP6V1D;LAMTOR3;LAMTOR1;DAP;ATP6V1E1;EIF2S1;RRAGC;NPRL2;EIF2AK4;SH3GLB1;MAPK1;IMPACT
prerank,lipoxygenase pathway (GO:0019372),-0.5225254159482684,-1.4474977966091112,0.07203389830508475,0.5011420106412668,1.0,5/14,9.19%,HPGD;LTC4S;ALOX5;ALOX5AP;PON3
prerank,proton transmembrane transport (GO:1902600),0.5392303049842483,1.4474264891860706,0.04156769596199525,0.35858797309479756,1.0,13/36,19.16%,ATP6V1A;SLC9A1;ATP6V0D1;SLC46A1;UCP2;ATP1A1;ATP1A3;ATP1A4;ATP6V0A4;ATP6V1F;ATP6V0C;HVCN1;SLC25A14
prerank,negative regulation of interferon-beta production (GO:0032688),0.6816296008904501,1.4474139161767872,0.07103064066852367,0.35770692077962823,1.0,5/10,18.73%,SIRPA;NLRC3;LILRB1;YY1;REL
prerank,regulation of cholesterol efflux (GO:0010874),0.5611640241931358,1.4469536616936547,0.04399524375743163,0.3581474230810419,1.0,7/30,8.84%,LRP1;APOE;EEPD1;PON1;PPARG;CAV1;TREM2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5738922960456857,1.4467681482379247,0.05947955390334572,0.3577063561961169,1.0,6/26,7.31%,IGF1;SLC9A1;DYRK2;LMCD1;HOMER2;RCAN1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5345263317329,1.4463067092458592,0.03431952662721893,0.35819509776374975,1.0,12/37,14.62%,HIF1A;SIRPA;PLD3;NLRC3;ADCY7;CHID1;ABCD2;APPL2;TREM2;TICAM1;IL6;TNF
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4621069624002271,1.4460392986479271,0.004048582995951417,0.35809018213836136,1.0,57/175,23.79%,NFE2L2;PSMD1;CCL4;PTK2B;TRAF2;TANK;TNFSF15;PSMD8;PSMA1;TRAF3;ADAM17;SMPD4;TNFRSF1B;PSMA8;ERBIN;CCL13;BRCA1;TNFRSF9;ASAH1;TNFSF8;ACOD1;CCL14;CDIP1;PSMD14;TNFSF9;LIMS1;PSMA5;AIM2;PID1;DHX9;PSMD12;ILK;TNF;PSMB10;EIF5A;ARHGEF2;PSMD2;SFRP1;PSMC4;PYDC1;TNFRSF21;BIRC2;ZC3H12A;PSMD6;YBX3;PSMD3;PSMD5;PSMC2;PSME4;TNFRSF8;PSMB8;CCL3;PSMA6;CHUK;ACTN4;PSMB7;PSMD4
prerank,negative regulation of cell activation (GO:0050866),0.6212866176133687,1.445777974373588,0.07972972972972973,0.35802546429780596,1.0,3/14,8.84%,APOE;PDGFA;TREM2
prerank,phagosome-lysosome fusion (GO:0090385),0.6943972780042411,1.4449390074405377,0.06349206349206349,0.35970969758581983,1.0,8/10,22.19%,RAB7B;ARL8B;RAB7A;RAB20;PIKFYVE;PLA2G5;CLN3;RAB34
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6212672538710865,1.44456743680978,0.06257982120051085,0.3598595496161641,1.0,4/17,10.28%,LGALS3;DGKZ;PTPN2;PHPT1
prerank,activation of protein kinase B activity (GO:0032148),0.5575145063996035,1.4442963755407925,0.04791154791154791,0.35980921248336983,1.0,4/29,7.99%,IGF1;OSBPL8;PDPK1;GAS6
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4976781756614511,1.4433609580504467,0.016375545851528384,0.3616751088201955,1.0,27/67,24.61%,FN1;CSF1;CDK6;NRP1;PTK2B;FLNA;NEDD9;MYOC;CCL28;CRKL;P4HB;MYADM;LIMS1;TESK1;C1QBP;JUP;ILK;CRK;SFRP1;TRIOBP;PDGFB;CALR;CDC42;PLEKHA2;OLFM4;GSK3B;ABL1
prerank,skeletal system development (GO:0001501),0.4708197712909187,1.4432994665069945,0.007164790174002047,0.3609311837477418,1.0,31/148,17.61%,XYLT1;IGF1;SH3PXD2B;ANKH;BMP8B;COL10A1;MATN3;BMP1;KIAA1217;SHOX2;SOX9;AKAP13;CD44;MYOC;CREB3L2;CHD7;ATP7A;EVC;ANKRD11;PKDCC;PRDX1;TCOF1;PTGER4;RBP4;SUFU;BMP5;DYM;GNAS;WWOX;BPNT2;TRIP11
prerank,activation of protein kinase activity (GO:0032147),0.47685747927046856,1.4423380240422436,0.01026694045174538,0.3629046827243501,1.0,21/106,10.71%,IGF1;OSBPL8;ADCY8;ADCY3;PTK2B;PRKCD;TRAF2;TNFSF15;ADCY7;PAK6;PDPK1;VEGFA;MALT1;STK3;CARD10;TAOK3;SLC11A1;COPS8;GAS6;PAK2;TGFBR2
prerank,protein deacetylation (GO:0006476),0.5280560419309125,1.442049060870847,0.040369088811995385,0.362919956091581,1.0,18/41,21.58%,RCOR1;FLNA;HDAC4;SIRT5;HDAC9;HDAC7;SUDS3;RCOR3;MIER2;SIRT3;MSL3;MIDEAS;MORF4L2;HDAC1;SIRT4;HDAC3;SIRT2;MTA3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5451922236187632,1.4416727803674412,0.03614457831325301,0.3630543521284046,1.0,20/34,28.34%,NRP1;FLNA;NEDD9;MYOC;CRKL;P4HB;MYADM;LIMS1;TESK1;C1QBP;ILK;CRK;TRIOBP;CALR;CDC42;OLFM4;ABL1;RAC1;ARHGEF7;CIB1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5191005382088028,1.4410166936865754,0.0400890868596882,0.36407208676156794,1.0,19/48,22.52%,HIF1A;P2RX4;FGF2;HSPB1;PDPK1;VEGFA;HMOX1;ADAM17;HDAC9;HDAC7;MAP2K3;SP1;FGF18;PIK3C2A;TGFB1;PDGFB;JCAD;ATP5F1B;NUS1
prerank,relaxation of muscle (GO:0090075),0.6453117951379785,1.4404907417133563,0.06043956043956044,0.3648578595913273,1.0,9/13,28.24%,P2RX4;KCNJ2;SLC8A1;ATP1A1;PIK3CA;GSN;ATP1A2;CAMK2D;RGS2
prerank,canonical glycolysis (GO:0061621),0.572284818258229,1.4404811026349167,0.052763819095477386,0.36308755134345816,1.0,10/24,18.20%,PKM;GCK;PFKL;ALDOA;ENO2;PGK1;ENO1;HK3;PFKP;HK1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.572284818258229,1.4404811026349167,0.052763819095477386,0.36308755134345816,1.0,10/24,18.20%,PKM;GCK;PFKL;ALDOA;ENO2;PGK1;ENO1;HK3;PFKP;HK1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.5852363396494107,-1.4404505911590675,0.08741258741258741,0.5128664216189286,1.0,6/10,17.50%,HECW1;PRKCE;COMMD1;HECW2;NEDD4L;OSR1
prerank,mRNA stabilization (GO:0048255),0.5343150411960403,1.4404220899610858,0.03508771929824561,0.3623855450818177,1.0,17/40,21.44%,TENT5C;LARP1;NOCT;HNRNPC;SLC11A1;TAF15;VIP;EIF4ENIF1;DHX9;MAPKAPK2;PABPC1;CIRBP;FUS;HNRNPU;YBX3;GDNF;TIRAP
prerank,lipoprotein transport (GO:0042953),0.700081652484057,1.4398763697587968,0.05007587253414264,0.36309624667087187,1.0,3/10,4.65%,LRP1;PRKCB;PPARG
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6365899748398451,1.4398135922500084,0.07397622192866579,0.36237984169590004,1.0,5/14,7.67%,TRAF2;TNFSF15;MALT1;CARD10;COPS8
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.443149219362384,-1.4395445691851534,0.08717948717948718,0.5087303161214718,1.0,3/25,1.41%,CACNB2;CAPN3;AKAP6
prerank,regulation of pH (GO:0006885),0.6751474561126862,1.4395249338440117,0.07960893854748603,0.3622537979860458,1.0,6/11,15.41%,SLC9A1;SLC9A7;SLC26A4;ATP1A4;ATP6V0A4;ATP6AP1
prerank,icosanoid biosynthetic process (GO:0046456),-0.5808169771466071,-1.4392200015875098,0.08737864077669903,0.5032343859912333,1.0,3/10,6.96%,LTC4S;ALOX5;ALOX5AP
prerank,carbohydrate transport (GO:0008643),0.6692003918355468,1.4381728714736897,0.06276150627615062,0.36527085612003324,1.0,2/11,1.49%,SLC23A2;SLC23A1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6622127644578968,1.4380240977603704,0.06296851574212893,0.3648274219947758,1.0,4/11,8.84%,P2RX4;CCL4;TRAT1;TREM2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6342121836204251,1.4378766153549265,0.06620689655172414,0.3643962334210792,1.0,3/13,1.67%,MGAT5;PTPRC;DOT1L
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5231838762971049,1.4376254518602034,0.041666666666666664,0.36426903509101743,1.0,19/43,25.24%,HIF1A;FGF2;PPARD;SOX9;PPARG;JUN;GNL3;SRF;NR3C1;TNF;NFATC3;TERT;TGFB1;PDGFB;SMARCA4;KLF5;TEAD1;EGR1;SPI1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5592652675570152,1.4373653851584909,0.05425400739827373,0.3642077053905602,1.0,8/26,16.89%,GPR137B;CDK6;FSTL3;PTPN2;TCTA;LILRB3;TMEM178A;MAFB
prerank,lung development (GO:0030324),0.5577097356282535,1.4371174489259202,0.045023696682464455,0.36406905864960315,1.0,13/33,20.04%,FGF2;FOXJ1;VEGFA;PDPN;CEBPA;NKX2-1;ITGA3;FGF7;RBP4;CCDC40;LOXL3;ERRFI1;FGFR2
prerank,homotypic cell-cell adhesion (GO:0034109),0.5369129991396833,1.4370668658476298,0.04074505238649592,0.3633291530499989,1.0,13/39,16.79%,FN1;TLN1;PLEK;PIK3CB;HSPB1;TJP2;FLNA;PLPP3;UBASH3B;ILK;ACTN1;RAP2B;GNAS
prerank,positive regulation of viral genome replication (GO:0045070),0.5545531919037063,1.4369685714492033,0.06031363088057901,0.3627423018081212,1.0,11/29,19.82%,ADARB1;LARP1;SRPK1;PPIE;PKN2;DDB1;VAPB;SRPK2;PABPC1;ADAR;TMEM39A
prerank,positive regulation of type 2 immune response (GO:0002830),-0.5099108629626595,-1.4351043728646453,0.08759124087591241,0.5081670435133162,1.0,6/14,10.82%,IL18;CD86;CD74;RARA;PRKCZ;CD81
prerank,response to glucose (GO:0009749),0.5193664247960295,1.4349109939026083,0.02727272727272727,0.36806415427473455,1.0,15/46,19.95%,LPL;ADCY8;APOA2;GCK;PFKL;ERN1;PCK2;GAS6;IGF1R;VAMP2;ZBED3;TRA2B;EIF2B2;PDK3;XBP1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6851596868764022,1.4342735534103856,0.06725146198830409,0.369117781707082,1.0,4/10,15.68%,CD9;PRKCD;SERPINE2;PRKG1
prerank,organelle fusion (GO:0048284),0.5833517807714305,1.4331975371140502,0.06674907292954264,0.37138595289059695,1.0,12/22,27.04%,EEA1;VPS18;BAX;AFG3L2;MIGA2;VPS11;FIS1;USP30;SPG7;STX4;OPA1;MFN1
prerank,cAMP-mediated signaling (GO:0019933),-0.4332754428910467,-1.4330110927969189,0.07804878048780488,0.506889244771994,1.0,10/24,7.90%,AKAP6;EPHA5;PDE7B;RAPGEF2;ADGRG6;ADCY2;CAP2;RIMS2;RAPGEF3;PDE4D
prerank,Fc receptor signaling pathway (GO:0038093),0.47739907679019516,1.4330000078353407,0.018691588785046728,0.37115569119434927,1.0,58/110,29.87%,TEC;PSMD1;LAT;PIK3CB;GRB2;GAB2;PSMD8;PDPK1;MALT1;PSMA1;PSMA8;TAB1;JUN;SYK;PIK3R2;PPP3R1;NFKB1;PAK2;PSMD14;LAT2;PSMA5;BTK;PSMD12;FBXW11;MAP3K1;PSMB10;NFATC3;VAV1;PSMD2;PSMC4;MAPK3;CUL1;PSMD6;PIK3CA;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;LYN;MAPK1;PSMA3;VAV3;PRKCQ;PSMD10;RAC1;PSMC6;PSME3;PSMC5;PSMA4;BTRC;MAP2K7;PSMB6
prerank,regulation of presynapse organization (GO:0099174),-0.4839786666889953,-1.4326022506186982,0.059574468085106386,0.4958931857951573,1.0,8/18,15.80%,IL1RAPL1;PTPRD;LRFN5;GPC6;IL1RAPL2;SLITRK2;MDGA1;APP
prerank,regulation of presynapse assembly (GO:1905606),-0.4839786666889953,-1.4326022506186982,0.059574468085106386,0.4958931857951573,1.0,8/18,15.80%,IL1RAPL1;PTPRD;LRFN5;GPC6;IL1RAPL2;SLITRK2;MDGA1;APP
prerank,negative regulation of protein polymerization (GO:0032272),-0.41882677727526796,-1.4321228621087907,0.046632124352331605,0.49140658062160225,1.0,7/27,8.24%,SSH2;CYRIB;TWF2;TUBB4A;MAP2;KANK1;STMN1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6030887661305694,1.431920272644991,0.06976744186046512,0.3735855125205811,1.0,13/18,31.54%,KMT2A;SMYD2;EHMT1;PRDM9;SETMAR;ASH1L;KMT2B;KMT2D;SETD3;SETD4;EHMT2;SETD2;SETD1A
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5022486087121395,1.4316168454916194,0.045454545454545456,0.3736090301290464,1.0,13/49,13.00%,BCL2;BCL2L1;PLAUR;NOC2L;MCL1;SGMS1;BAX;CAV1;P4HB;DDIT3;BCL2L11;BECN1;BID
prerank,neutrophil migration (GO:1990266),0.49480777036253115,1.4305193729981072,0.03712035995500562,0.37599460883459285,1.0,14/58,23.19%,LGALS3;CCL4;NCKAP1L;PIP5K1C;CCL13;SYK;CCL14;JAML;IRAK4;PIKFYVE;ITGB2;FCER1G;CCL3;CKLF
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5281930521876784,1.4298488645557623,0.05238649592549476,0.3771661881753875,1.0,9/40,15.47%,IGF1;BCL2L1;PLAUR;BAX;TRIAP1;BCL2L11;BID;BIK;GHITM
prerank,cellular response to zinc ion (GO:0071294),0.6208946760585438,1.4284772908624297,0.06573426573426573,0.38048088542606406,1.0,2/15,3.01%,P2RX4;ATP13A2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5471273587528865,1.4284417770513813,0.043478260869565216,0.3796947955256532,1.0,8/31,7.38%,CDK6;SOX9;PPARG;BAMBI;NOCT;HDAC7;RIOX1;SKI
prerank,engulfment of apoptotic cell (GO:0043652),-0.4993232718724652,-1.4280233636661026,0.08016877637130802,0.49655230663024835,1.0,7/15,19.23%,XKR4;RHOBTB1;XKR6;MEGF10;THBS1;XKR8;RHOBTB2
prerank,response to amyloid-beta (GO:1904645),0.5187238511289343,1.4275216736480898,0.0338389731621937,0.3816335385447798,1.0,10/44,13.32%,CACNA1A;IGF1;LRP1;MMP12;CDK5;TREM2;IGF1R;ATP1A3;CACNB1;FYN
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6603312819838434,1.427106069184143,0.06944444444444445,0.38202056077764873,1.0,2/11,5.25%,GCK;SIK1
prerank,calcium ion import (GO:0070509),0.5496755785002019,1.4269852770655418,0.054678007290400975,0.38153356117481496,1.0,6/28,12.30%,CACNA1A;TRPC4;CACNA1D;AFG3L2;SLC8A1;ATP2A2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5787862970430215,1.4266008271914208,0.059343434343434344,0.3808573348559395,1.0,7/21,15.80%,BCL2;BCL2L1;EYA4;MCL1;MAPK7;TNF;TERT
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5787862970430215,1.4266008271914208,0.059343434343434344,0.3808573348559395,1.0,7/21,15.80%,BCL2;BCL2L1;EYA4;MCL1;MAPK7;TNF;TERT
prerank,cellular response to amino acid starvation (GO:0034198),0.484195003416207,1.4264847866317945,0.017316017316017316,0.38031402709885503,1.0,29/71,25.46%,TCIRG1;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;TFEB;ATP6V1B2;ATP6V0D1;ATP6V1G1;ATP6V0B;NPRL3;ATP6V1F;LARS1;ATP6V0C;SESN2;FLCN;MAPK3;ATP6V1D;LAMTOR3;LAMTOR1;DAP;ATP6V1E1;EIF2S1;RRAGC;NPRL2;EIF2AK4;SH3GLB1;MAPK1;IMPACT
prerank,lipoprotein biosynthetic process (GO:0042158),0.6668969806880349,1.4258705870051898,0.06896551724137931,0.38153266838403105,1.0,4/11,11.22%,ATG7;APOE;WDR45;ATG10
prerank,regulation of activated T cell proliferation (GO:0046006),0.5494262163444974,1.425552216029807,0.06699147381242387,0.3815467774355286,1.0,7/30,13.83%,IGF1;CD274;IL12RB1;CRTAM;TNFSF9;RIPK3;IL2
prerank,regulation of cellular catabolic process (GO:0031329),0.49134083766342024,1.424788897192314,0.02693965517241379,0.3829094803808174,1.0,12/62,10.05%,GPR137B;RRAGD;ABL2;WDR91;HSPB1;PSAP;SMCR8;TPCN2;PIK3R2;DDIT3;DAPK1;DRAM1
prerank,dendritic cell differentiation (GO:0097028),0.5676927798309337,1.4247241168833975,0.07493540051679587,0.38219052835044137,1.0,6/22,10.71%,AXL;IRF8;GAS6;TREM2;LILRB1;TGFBR2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6146517629771594,1.424653444198995,0.06763925729442971,0.38153653570548235,1.0,5/17,10.76%,EIF6;PPARD;PPARG;CAV1;ADIPOR1
prerank,positive regulation of exosomal secretion (GO:1903543),0.6224915934722984,1.4246491544424285,0.07755102040816327,0.3806749135998557,1.0,5/15,10.12%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,protein-containing complex subunit organization (GO:0043933),0.4729196242785613,1.424172196648849,0.008394543546694649,0.3813283069720697,1.0,36/109,18.24%,MITF;KMT2A;EPRS1;NUP205;PTK2B;TRAF2;TUBGCP4;WIPF1;CAPG;SOX9;SKAP2;SLC2A1;NCKAP1L;CARD10;MAGI1;LAMC1;AFG3L2;NDUFAF1;TAPBP;MDN1;PPP2R1A;VAMP2;RANBP9;MDM2;GEMIN5;PEX14;LLGL1;ELOB;TPR;MNAT1;DLG4;LPXN;NUP54;TSPAN4;KPNA3;VAMP3
prerank,positive regulation of cell junction assembly (GO:1901890),-0.35104217485027084,-1.4240191141409622,0.01904761904761905,0.5009989502997355,1.0,10/56,6.02%,IL1RAPL1;NRXN1;GRID2;PTPRD;NLGN1;CNTNAP2;CLSTN2;PTPRJ;CLSTN3;EPHB1
prerank,oligosaccharide metabolic process (GO:0009311),-0.3715950818736296,-1.4232005615109615,0.02608695652173913,0.49732501490320347,1.0,10/46,6.72%,ST3GAL6;FUT9;AMY1A;AMY1C;AMY1B;ST8SIA4;ST6GAL2;B3GALT5;B3GALT1;GAL3ST4
prerank,vitamin transport (GO:0051180),0.5448348601853782,1.4224478816205919,0.06658595641646489,0.38562066140838375,1.0,10/29,19.64%,SLC23A1;SLC27A1;SLC46A1;PDPN;SLC52A2;SLC2A6;SLC19A1;SLC2A8;SLC5A6;SLC25A32
prerank,histone H3-K4 methylation (GO:0051568),0.5640502246617561,1.4222998003781364,0.05256723716381418,0.3852186625965972,1.0,11/26,23.86%,CXXC1;KMT2A;RBBP5;TET3;OGT;PRDM9;SETMAR;WDR5;KMT2B;KMT2D;SETD4
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5667689540603336,1.4219808407562617,0.06289308176100629,0.38535080978119207,1.0,3/24,4.03%,IGF1;GCK;DYRK2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4715194520483581,1.4219416061062555,0.015495867768595042,0.38456517472744006,1.0,21/102,9.41%,MYO5A;PKM;EPRS1;ADCY8;ADCY3;PRKCD;MGARP;ADCY7;GCK;PDPK1;DENND4C;CPEB2;PPARG;RHOQ;RAB8B;SLC25A33;HDAC9;PCK2;CAV1;PIK3R2;NFKB1
prerank,zymogen activation (GO:0031638),0.5244219117052967,1.4216256707687271,0.05985915492957746,0.3847005329635219,1.0,10/39,12.73%,PLAU;ASPH;KLK1;F11;KLKB1;PGK1;TBC1D10A;KLK3;FURIN;APOH
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.48544579879281974,1.421149261844446,0.02685284640171858,0.38523125424403193,1.0,24/72,17.70%,ERCC6;COPS3;POLR2H;HMGN1;ERCC1;COPS2;COPS4;UBA52;COPS8;PPIE;DDB1;ERCC4;XPA;RFC2;LIG3;RPS27A;UBC;MNAT1;POLR2D;LIG1;RFC1;GTF2H1;COPS7A;ERCC2
prerank,cellular sodium ion homeostasis (GO:0006883),0.6188862833946135,1.4210644041268887,0.05970149253731343,0.38461385326184044,1.0,6/15,13.63%,SLC9A1;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP1B3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4914849728424052,1.4200697717254285,0.031016042780748664,0.3867748444366627,1.0,44/70,33.05%,PSMD1;PSMD8;CYBA;PSMA1;NCF4;PSMA8;SEC22B;ITGB5;TAPBP;CYBB;PSMD14;PSMA5;NCF2;PSMD12;PSMB10;PSMD2;PSMC4;VAMP3;PSMD6;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;CALR;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;PSMA3;B2M;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;ITGAV;PDIA3;PSMA2;PSMC3;PSMD7;PSMD13
prerank,negative regulation of axonogenesis (GO:0050771),0.5516871055334056,1.4192979592839194,0.07393939393939394,0.3881788807058804,1.0,5/27,5.71%,FGF13;GDI1;RNF6;RUFY3;LRP4
prerank,cytosolic transport (GO:0016482),0.4705863507244006,1.4185683621133214,0.017507723995880537,0.3894889401817175,1.0,41/108,19.83%,EEA1;VPS13C;WDR91;GOSR2;TMEM87B;PTPN23;CORO7;VTI1A;BET1L;RIC1;DOP1B;RGP1;VPS26A;ARL1;RAB5A;GCC2;DCTN1;VPS50;SPAG9;STX6;RAB7A;TBC1D10A;RAB9A;BECN1;HOOK3;STX5;GAK;VPS35;AP1G1;TBC1D23;YKT6;KIF16B;RILP;HOOK1;VAMP3;PIKFYVE;VPS54;ARFRP1;CLN3;WDR81;LAMP1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6123303882206501,1.4174183263594367,0.06191117092866756,0.39221895888209624,1.0,4/16,7.58%,FGF2;VEGFA;HMOX1;DLL4
prerank,axonal transport of mitochondrion (GO:0019896),0.6628109293648182,1.4174033845763094,0.08345120226308345,0.3913883641331876,1.0,3/11,3.78%,HIF1A;MGARP;TRAK1
prerank,cellular response to amyloid-beta (GO:1904646),0.5310225347915852,1.417256463312323,0.0510688836104513,0.3910797012624085,1.0,9/35,13.32%,CACNA1A;IGF1;LRP1;CDK5;TREM2;IGF1R;ATP1A3;CACNB1;FYN
prerank,protein-DNA complex assembly (GO:0065004),0.4674183853576763,1.4170904759530674,0.012332990750256937,0.3906923173279049,1.0,57/116,28.92%,PSMD1;ORC3;GRWD1;MCM2;PSMD8;SOX9;PSMA1;MCM7;GMNN;PSMA8;UBA52;CHAF1B;DDB2;DDB1;PSMD14;PSMA5;XPA;PSMD12;MCM8;PSMB10;RPS27A;UBC;MNAT1;GTF2H1;PSMD2;PSMC4;ERCC2;CETN2;SART3;PSMD6;CUL4A;PSMD3;ASF1A;PSMD5;PSMC2;PSME4;PARP1;PSMB8;CCNH;PSMA6;DAXX;NAP1L3;PSMB7;PSMD4;MCM6;RAD51;NAP1L2;MCM3;PSMA3;H3-3A;MCM5;RSF1;PSMD10;PSMC6;PSME3;PSMC5;PSMA4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.601206901457739,1.4170018656520758,0.08160621761658031,0.3901057298519186,1.0,10/17,24.61%,STAP1;NRP1;CDK5;BAIAP2;HAX1;BAIAP2L1;BAIAP2L2;FES;CDC42;ABL1
prerank,B cell activation (GO:0042113),0.4850794367535681,1.4168131835988624,0.03707742639040349,0.38977230642995353,1.0,17/68,13.73%,BCL2;BLNK;CHRNB2;PTPRC;CD22;TPD52;MALT1;PRKCB;ADAM17;HDAC4;PTPN2;KLF6;HDAC9;CEBPG;LAT2;BTK;HSPD1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5483205923237457,1.416545736033273,0.06408706166868199,0.389715385120783,1.0,13/28,27.84%,BCL2;DIABLO;BAX;BAG3;CRADD;BID;TNF;DAXX;CASP8AP2;GABARAP;SPI1;DEDD2;TRADD
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.47295500301791316,1.4164015652184243,0.022035676810073453,0.38926860285899784,1.0,33/95,20.66%,SDCBP;SNX25;PDPK1;VEPH1;DAB2;WFIKKN1;ADAM17;SMAD7;BAMBI;UBA52;NKX2-1;SKI;SPRED2;CAV1;PMEPA1;TGFBR2;ITGA3;DAND5;GIPC1;RPS27A;UBC;SPRED3;ZEB2;FLCN;SNW1;PIN1;LATS1;LDLRAD4;TGFBR1;STK11;TGFB1I1;RNF111;TGFB1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5718718195747141,1.4162122170179974,0.06117353308364544,0.38906366334985515,1.0,3/23,3.77%,IGF1;HIF1A;PFKFB3
prerank,regulation of protein kinase A signaling (GO:0010738),-0.4588642332063933,-1.4159420607277975,0.0794392523364486,0.5104251467941526,1.0,5/20,8.51%,AKAP6;AKAP12;PRKAR2A;PRKAR2B;LRRK2
prerank,RNA metabolic process (GO:0016070),0.46656297076452713,1.415468083463325,0.007209062821833162,0.39059843008561806,1.0,47/127,19.68%,APOBEC1;ADARB1;HNRNPA3;AGO2;RNASEH2A;HNRNPUL1;POLR2H;HNRNPM;DDX39B;RBM39;SND1;HNRNPC;RNASEH1;PAPOLA;PABPN1;THOC1;DDX17;RBPMS;GTF2F1;HNRNPK;RNASEL;RNASEH2B;ATXN2;ALKBH1;TP53RK;ATXN1;RNASE3;DHX9;HNRNPL;AGO3;HNRNPA2B1;FASTKD2;DUSP11;DKC1;LAGE3;POLR2D;AGO4;PABPC4;SUPV3L1;PCBP1;RBFOX2;FTO;ADAR;HNRNPU;ZC3H12A;PPP1R8;SNRNP40
prerank,tRNA modification (GO:0006400),0.49988920112605817,1.4152091977520287,0.03425414364640884,0.39045007622681926,1.0,27/62,25.74%,PUS1;AARS1;METTL1;QTRT1;ANKRD16;ALKBH1;TPRKB;METTL2A;METTL2B;WDR4;GTPBP3;TRMT13;TRMT5;ALKBH8;CDKAL1;ELP5;MOCS3;TRMT12;LCMT2;TRMT10A;PUSL1;MTO1;THUMPD2;METTL6;NSUN2;NSUN6;TRUB1
prerank,negative regulation of autophagy (GO:0010507),0.500695417018157,1.4148614217898894,0.03583426651735722,0.3906441231022411,1.0,19/54,20.75%,BCL2;ATG7;CTSA;EIF4G1;MCL1;SMCR8;EIF4G2;EIF4G3;TREM2;ZKSCAN3;EIF4E;USP36;RUBCN;HTR2B;GOLGA2;DAP;SMG1;PIK3CA;SIRT2
prerank,T cell activation (GO:0042110),0.48076540643728133,1.4147881016674542,0.027233115468409588,0.3900341442704752,1.0,16/69,13.83%,LCP1;KIF13B;NLRC3;LAT;PTPRC;MSN;PTPN2;CD44;CRTAM;DLL4;CHD7;GPR89A;GPR89B;NCK1;HSPD1;IL2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4754496599469758,1.4147749868203392,0.026427061310782242,0.38922755694756705,1.0,43/84,29.87%,PSMD1;ANAPC15;PSMD8;PSMA1;FZR1;PSMA8;CCNB1;ANAPC1;UBA52;PSMD14;PSMA5;PSMD12;PSMB10;RPS27A;UBC;PSMD2;CDC26;PSMC4;UBE2C;PSMD6;FBXO5;FBXO31;PSMD3;PSMD5;PSMC2;PSME4;CDK2;PSMB8;PSMA6;ANAPC7;PSMB7;PSMD4;CUL3;PSMA3;PSMD10;ANAPC11;PSMC6;PSME3;PSMC5;PSMA4;CDC16;SKP2;PSMB6
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6410521355334521,1.414491391405539,0.08066759388038942,0.38920406517934325,1.0,5/12,20.66%,PPARG;TNF;TERT;ZC3H12A;TGFB1
prerank,vesicle organization (GO:0016050),0.5057146241583548,1.4144573207625841,0.052941176470588235,0.38848743648315875,1.0,17/46,19.75%,ALS2;SQSTM1;WASHC5;VPS18;PI4K2A;ARFGEF2;SNX33;SNX10;CAV1;HOOK3;SAR1A;PI4K2B;RAB22A;HOOK1;VPS11;USP8;LAMTOR1
prerank,regulation of mRNA catabolic process (GO:0061013),0.46865860121050357,1.4141787776850276,0.011305241521068859,0.38845896094652316,1.0,67/121,33.38%,PSMD1;PRKCD;EIF4G1;HSPB1;PSMD8;PSMA1;VIM;PSMA8;UBA52;FXR2;YTHDF2;TNPO1;PSMD14;PSMA5;EXOSC9;MAPKAPK2;PSMD12;PSMB10;RPS27A;UBC;PUM1;DCP2;EXOSC5;PABPC1;PSMD2;PSMC4;ZC3H12A;PSMD6;ZC3HAV1;PSMD3;EXOSC4;PSMD5;PSMC2;XPO1;PSME4;PUM2;PCBP4;PSMB8;SET;PSMA6;XRN1;PSMB7;PSMD4;SAMD4B;PSMA3;PSMD10;DHX36;PRR5L;PSMC6;FMR1;PSME3;PSMC5;YWHAZ;DCP1A;PSMA4;RC3H1;PSMB6;FXR1;SAMD4A;EXOSC3;PCID2;PSMA2;PSMC3;PSMD7;CNOT7;PSMD13;HNRNPD
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4699147631733141,1.414007730534097,0.03400637619553666,0.38806882646631646,1.0,38/78,28.32%,NFE2L2;PRICKLE1;DAB2;RNF180;CEBPA;SMAD7;USP5;FZR1;VCP;CAV1;SOCS5;RNF14;CSNK1D;MDM2;PLK3;ELOB;TRIB2;HECTD1;RNF19A;RCHY1;SIRT2;SUMO1;HERPUD1;CSNK1E;SUMO2;NUB1;RNF19B;RACK1;UBQLN1;GABARAP;GSK3B;PIAS1;UBQLN2;BBS7;PSMD10;RAD23A;BAG2;HSPBP1
prerank,regulation of RNA metabolic process (GO:0051252),0.4927700941090558,1.4139403376389739,0.028888888888888888,0.3874323047481018,1.0,22/59,20.13%,AHNAK2;MITF;SON;ZNF326;TNFRSF1B;CELF1;HNRNPLL;GRSF1;RASA1;YTHDF2;NOVA2;CLK4;PTBP3;HNRNPL;USP36;TRA2B;RRP1B;FASTK;PCBP1;MED1;FUS;MBNL2
prerank,regulation of macroautophagy (GO:0016241),0.46604796274678173,1.413647260712903,0.02494802494802495,0.38742836160367833,1.0,33/105,20.65%,RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;CDK5;RUFY4;ATP13A2;ATP6V1B2;ATP6V0D1;SMCR8;CAPN1;ATP6V1G1;LARP1;VPS26A;ERN1;ATP6V0B;VPS35;USP36;ATP6V0C;SESN2;TBK1;EXOC4;PRKAG1;ATP6V1D;LAMTOR3;CLN3;LAMTOR1;SMG1;NEDD4;PIK3CA;ATP6V1E1;ATG13
prerank,negative regulation of cytokine production (GO:0001818),0.45404416289294586,1.4134215543471442,0.009127789046653144,0.38727006090834254,1.0,36/163,12.87%,GPNMB;CD84;FN1;SIRPA;NLRC3;PTPRC;ANXA4;ATP2B1;CD200R1;APOA2;ADCY7;CHID1;FOXJ1;CD274;AXL;IKBKE;ABCD2;NPTN;NCKAP1L;APPL2;HOMER2;HDAC9;HDAC7;SLC11A1;UBE2L6;GAS6;ILRUN;TREM2;HAVCR2;DDIT3;ACOD1;LILRB1;C1QBP;PTGER4;IL6;TNFAIP3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.49130018160713723,1.4132859799879285,0.029605263157894735,0.38683074724332217,1.0,24/66,21.07%,PRKCD;IPO5;FLNA;CARD10;TRIM28;CCT2;PIK3R2;BAG3;TESK1;JUP;ORMDL3;TPR;CCT5;DKC1;SESN2;TERT;TFRC;KAT7;RBM22;HDAC3;CDH1;ZC3H12A;TGFB1;DMAP1
prerank,lytic vacuole organization (GO:0080171),0.5467489792935434,1.4125409692323174,0.06287787182587666,0.3882467215091959,1.0,11/32,11.49%,ABCA1;GNPTAB;TFEB;GAA;VPS18;TPCN2;HPS1;TPP1;MYO7A;ZKSCAN3;HOOK3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3731897977748078,-1.4124890352370094,0.028985507246376812,0.5133904230714128,1.0,15/39,14.76%,FGF14;FGF12;DMD;HECW1;ANK3;PRKCE;HECW2;NETO1;GLRX;WNK1;WNK3;YWHAH;FXYD1;NEDD4L;FGF11
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6296480837859268,1.41223054190245,0.07945205479452055,0.38834408382724267,1.0,4/13,11.62%,CSPG4;HEXA;HEXB;IDUA
prerank,global genome nucleotide-excision repair (GO:0070911),0.5539376719722221,1.4120711561476151,0.07635467980295567,0.38793808581302375,1.0,14/26,22.59%,ERCC1;UBA52;DDB2;DDB1;ERCC4;XPA;RPS27A;UBC;GTF2H1;ERCC2;CETN2;CUL4A;RNF111;PARP1
prerank,lamellipodium organization (GO:0097581),-0.4099235273503432,-1.4120170098463132,0.05263157894736842,0.5089333259443757,1.0,8/29,8.04%,P2RY12;CDH13;SNX2;CARMIL1;ABLIM1;KIT;ABLIM3;DMTN
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5842852972698973,1.411764260023444,0.060991105463786534,0.38802477727687845,1.0,3/21,9.40%,OSBPL8;PLAAT3;LPCAT3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5524679242787415,1.41175761263649,0.06186868686868687,0.387229197115041,1.0,6/25,10.12%,LYST;CHMP4B;CHMP4A;VCP;VTA1;VPS4B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5523156055497765,1.4115632404939429,0.054086538461538464,0.38702800436266277,1.0,15/27,29.43%,UBA52;NFKB1;MAP3K8;TNIP2;FBXW11;RPS27A;UBC;KAT7;MAP3K20;MAPK3;CUL1;CHUK;MAPK1;BTRC;MAP2K7
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4991822318691075,1.4098869780987384,0.043333333333333335,0.39126861442890226,1.0,11/52,11.94%,LGALS3;LRP1;PRKCH;PDPK1;SQSTM1;STAC2;TREM2;RHOG;NUMA1;ITGA3;STX3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5389574580988037,1.409766738027695,0.056976744186046514,0.39078068419159395,1.0,5/33,5.38%,LGALS3;DGKZ;CD300A;TRAT1;PTPN2
prerank,histone lysine methylation (GO:0034968),0.5271009751405735,1.4097645056342238,0.06294536817102138,0.38997519537753017,1.0,13/33,24.44%,CXXC1;KMT2A;DOT1L;RBBP5;SMYD3;SMYD2;PRDM9;SETMAR;WDR5;KMT2B;KMT2D;SETD3;SMYD1
prerank,Golgi organization (GO:0007030),0.46447732126525865,1.4094583035661434,0.011351909184726523,0.3900867390839959,1.0,52/112,29.39%,PLEKHM2;ARHGAP21;GOSR2;OPTN;GOLGB1;VTI1A;PI4K2A;TRAPPC8;SYNE1;COG4;ARL1;GCC2;HTT;SEC22B;STX6;CSNK1D;RAB1A;PLK3;STX5;GOLPH3;GAK;VAMP4;HUWE1;PI4K2B;ARFGEF1;TRAPPC11;TRAPPC12;DYM;TMED3;TRIP11;GOLGA2;TBC1D20;SEC16A;LMAN2L;GOLPH3L;DNAJC28;PRMT5;CDC42;LMAN1;VPS51;MYO18A;GOLGA8B;GOLGA5;SURF4;RAB43;BAG5;ARHGEF7;VMP1;SEC23IP;YWHAZ;COG3;GORASP1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5018063432340437,1.4093076026386655,0.052571428571428575,0.3897763331929052,1.0,23/47,24.61%,CORO1C;NRP1;FLNA;NEDD9;PDPN;MYOC;CRKL;P4HB;MYADM;SPRY4;LIMS1;TESK1;C1QBP;ILK;MELTF;CRK;ITGB1BP1;TRIOBP;CALR;CDC42;OLFM4;ACTN4;ABL1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.43712877525102983,-1.4087815031940707,0.08602150537634409,0.5119144314024588,1.0,7/26,8.32%,CCND3;RPTOR;PLCB1;FGF10;CCND2;EGFR;AIF1
prerank,regulation of protein sumoylation (GO:0033233),0.60069159191104,1.4087776691837641,0.08900523560209424,0.39051445593863604,1.0,7/17,17.48%,CTNNB1;ZMIZ1;HDAC4;GNL3;RWDD3;SAE1;PIAS4
prerank,negative regulation of leukocyte migration (GO:0002686),0.6604750694681709,1.4087426493309978,0.09502262443438914,0.38981682727217776,1.0,3/10,4.84%,CD200R1;CD300A;HMOX1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5371473485306061,1.4080780235102546,0.06779661016949153,0.3910754222523226,1.0,14/31,24.03%,OPTN;DNAJB14;BAX;ERN1;ATXN3;HSPA9;BAG3;DNAJB12;PACRG;PTPN1;HSF1;HSPA2;DAXX;HSPA13
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5584635621792498,1.4078652522935677,0.0606826801517067,0.39094255452850957,1.0,4/24,4.20%,HIF1A;NIBAN2;ITGA5;PRKCB
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5257676078780237,1.4078008840529939,0.04513064133016627,0.39035050579778335,1.0,7/36,7.99%,HIF1A;CSF1;CD300LF;TRIM6;AXL;ADAM17;GAS6
prerank,regulation of protein metabolic process (GO:0051246),0.507963495753758,1.4069780014767703,0.06321839080459771,0.39202294646486263,1.0,15/44,21.18%,APOE;PLAUR;GSAP;TRAF3;PARL;MDM2;FURIN;FAM83D;MAPK7;VPS35;CHEK2;ODC1;WFS1;ABCA7;CENATAC
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.48380052791855743,1.406963504475375,0.02577873254564984,0.39124881911766096,1.0,45/73,33.05%,KMT2A;PSMD1;RUNX1;PSMD8;PSMA1;PSMA8;YTHDF2;PSMD14;KITLG;PSMA5;PSMD12;PSMB10;LMO2;PSMD2;PSMC4;LDB1;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;METTL3;PSMB7;PSMD4;ABL1;PSMA3;SPI1;PRKDC;PSMD10;DHX36;PSMC6;PSME3;PSMC5;PSMA4;FOXC1;PSMB6;CBFB;SETD1A;TCF12;PSMA2;PSMC3;PSMD7;PSMD13
prerank,receptor clustering (GO:0043113),-0.4107559491105036,-1.4066698329100418,0.047872340425531915,0.5117435613636053,1.0,5/27,2.54%,NRXN1;SYNJ2BP;NLGN1;DLG2;LRRC7
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.48550133092813397,1.4065687576186687,0.03397027600849257,0.39155878683532225,1.0,17/72,14.62%,IGF1;FLT1;FN1;FGR;PDGFA;FGF2;PIK3CB;SOX9;MYDGF;MYOC;PIK3R5;TREM2;IGF1R;BECN1;CBL;HAX1;TNF
prerank,response to unfolded protein (GO:0006986),0.5053113600977758,1.4065324223692168,0.04426787741203178,0.3908647549978822,1.0,23/48,24.85%,OPTN;HSPB1;HSPA4;STT3B;BAX;ERN1;DNAJC4;DDIT3;HSPA9;BAG3;HSPD1;TOR1B;PACRG;PTPN1;DERL1;HSPE1;HSF1;HSPA2;HERPUD1;DAXX;HSP90AB1;HSPA13;DNAJA1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4865819576088108,1.4065297633485225,0.02918918918918919,0.39007663464235964,1.0,43/70,33.05%,KMT2A;PSMD1;RUNX1;PSMD8;PSMA1;PSMA8;YTHDF2;PSMD14;PSMA5;PSMD12;PSMB10;LMO2;PSMD2;PSMC4;LDB1;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;METTL3;PSMB7;PSMD4;ABL1;N4BP2L2;PSMA3;PRKDC;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;FOXC1;PSMB6;CBFB;SETD1A;TCF12;PSMA2;PSMC3;PSMD7;PSMD13
prerank,cellular response to lectin (GO:1990858),0.46780598726066014,1.4063654916913761,0.01646090534979424,0.38900514266644076,1.0,40/104,25.22%,PSMD1;MUC1;PRKCD;MUC16;PSMD8;PDPK1;MALT1;PSMA1;PSMA8;TAB1;SYK;NFKB1;NRAS;KRAS;PAK2;PSMD14;PSMA5;RAF1;PSMD12;FYN;FBXW11;PSMB10;PSMD2;PSMC4;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;CREBBP;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;EP300;LYN;PSMA3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.46780598726066014,1.4063654916913761,0.01646090534979424,0.38900514266644076,1.0,40/104,25.22%,PSMD1;MUC1;PRKCD;MUC16;PSMD8;PDPK1;MALT1;PSMA1;PSMA8;TAB1;SYK;NFKB1;NRAS;KRAS;PAK2;PSMD14;PSMA5;RAF1;PSMD12;FYN;FBXW11;PSMB10;PSMD2;PSMC4;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;CREBBP;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;EP300;LYN;PSMA3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5246122086426943,1.405699464934957,0.0448642266824085,0.39018341415987357,1.0,6/37,8.48%,IGF1;FGF2;MEF2D;PPARG;ERN1;JUN
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.46779011372149826,1.405221049998347,0.014418125643666324,0.3908449471124829,1.0,40/105,25.22%,PSMD1;MUC1;PRKCD;MUC16;PSMD8;PDPK1;MALT1;PSMA1;PSMA8;TAB1;SYK;NFKB1;NRAS;KRAS;PAK2;PSMD14;PSMA5;RAF1;PSMD12;FYN;FBXW11;PSMB10;PSMD2;PSMC4;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;FCER1G;PSME4;CREBBP;PSMB8;PSMA6;CHUK;PSMB7;PSMD4;EP300;LYN;PSMA3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5549920389952876,1.4046730500676334,0.08478802992518704,0.391643549137993,1.0,10/25,18.20%,PKM;GCK;PFKL;ALDOA;ENO2;PGK1;ENO1;HK3;PFKP;HK1
prerank,regulation of cellular metabolic process (GO:0031323),0.5082358135937508,1.4042300321283685,0.046538024971623154,0.3921038462336807,1.0,18/45,23.33%,ABCG1;EIF6;ACACA;NPC2;CYP1B1;RNF41;PARL;ACACB;TBC1D16;PID1;VPS35;KIF16B;AGPAT1;ABCB11;PDK3;LAMTOR1;RNF34;RSPO1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5912130295436608,1.4040754482065365,0.08235294117647059,0.3917625837344023,1.0,5/18,6.90%,FGF2;VEGFA;HMOX1;HDAC9;HDAC7
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.477229202339734,1.4039738215815587,0.030949839914621132,0.3912879395482884,1.0,13/75,10.61%,NRP2;HIF1A;FGF2;NRP1;PDPK1;VEGFA;HMOX1;ADAM17;MYDGF;ECM1;EGFL7;NRAS;VIP
prerank,DNA replication initiation (GO:0006270),0.5150408569069461,1.4034668915331048,0.06904761904761905,0.391969630179325,1.0,19/37,26.22%,ORC3;MCM2;MCM7;GMNN;DBF4;POLA2;MCM8;POLE;NOC3L;PURA;TOPBP1;POLE4;CDK2;MCM6;MCM3;CDC34;POLA1;CDC7;MCM5
prerank,DNA duplex unwinding (GO:0032508),0.49824719717395527,1.4029952759932836,0.04157303370786517,0.3925288483877388,1.0,24/50,23.94%,MCM2;ASCC3;MCM7;RAD50;UBA52;TWNK;DDB2;DDB1;XPA;DHX9;RPS27A;UBC;SUPV3L1;DDX1;GTF2H1;PURA;RECQL5;ERCC2;CETN2;BLM;CUL4A;PARP1;MCM6;RAD51
prerank,negative regulation of immune system process (GO:0002683),0.6092883221654694,1.402837754823444,0.07936507936507936,0.39222654670024487,1.0,4/16,6.79%,PDCD1;SOX9;HMOX1;FCRLB
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5258869659272003,-1.4023929701493345,0.08813559322033898,0.5172921633699636,1.0,9/12,28.94%,DOCK8;AIF1;JAM2;TNFRSF14;CCL5;APP;SPN;CXCL12;CXCL10
prerank,macrophage migration (GO:1905517),0.6227002425997137,1.40229158939343,0.075177304964539,0.3929331659450884,1.0,2/13,0.66%,LGALS3;P2RX4
prerank,positive regulation of telomere maintenance (GO:0032206),0.5353502408708077,1.4019274227345737,0.07134071340713408,0.3932141713469589,1.0,16/31,30.09%,TNKS2;ERCC1;RAD50;SLX4;GNL3;PKIB;HNRNPA2B1;PNKP;MAPK3;MAPK15;PPP1R10;MAPK1;PRKCQ;DHX36;MAP2K7;MRE11
prerank,regulation of mitochondrial translation (GO:0070129),0.5678816114747016,1.401845853931317,0.070242656449553,0.39270336614040885,1.0,14/21,28.48%,TRMT10C;TRUB2;RCC1L;NSUN3;ALKBH1;C1QBP;FASTKD2;MTG1;NGRN;TSFM;RMND1;MTG2;MRPS27;FASTKD3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5171309805309068,1.4017461786019427,0.05420991926182238,0.39220888677988425,1.0,11/39,18.04%,NFE2L2;PDPK1;ANO6;GAS6;TNIP2;TNFAIP3;MAPK7;TNF;SERPINE1;ITGA4;KRIT1
prerank,sterol metabolic process (GO:0016125),0.48962103971952126,1.4015858620719517,0.03169398907103825,0.3919163114902763,1.0,14/60,14.36%,ABCA1;ABCG1;APOE;APOA2;CYP19A1;LIPA;SOAT1;PPARD;SOAT2;CH25H;CYP1B1;GBA2;SULT2B1;ARV1
prerank,platelet aggregation (GO:0070527),0.5335614905025197,1.4007520666254425,0.06432748538011696,0.39363885774068347,1.0,11/33,16.79%,FN1;TLN1;PLEK;PIK3CB;HSPB1;FLNA;UBASH3B;ILK;ACTN1;RAP2B;GNAS
prerank,positive regulation of response to wounding (GO:1903036),-0.43192530237141696,-1.4006663945129718,0.05581395348837209,0.5160665733466001,1.0,8/24,14.37%,PRKCE;PTK2;KANK1;DMTN;VTN;HRAS;HBEGF;ADRA2A
prerank,histone H3-K4 trimethylation (GO:0080182),0.655203856675896,1.4004455031174654,0.09392265193370165,0.3937531341472107,1.0,4/11,12.31%,KMT2A;TET3;OGT;PRDM9
prerank,regulation of protein kinase C signaling (GO:0090036),0.610897431650602,1.4000356119549249,0.09016393442622951,0.39405966146647914,1.0,4/14,9.54%,VEGFA;SPHK2;DGKD;MYADM
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5068802495549313,1.3997603205473779,0.06380510440835267,0.39409776531271706,1.0,18/42,24.61%,CSF1;CDK6;NRP1;PTK2B;RIN2;VEGFA;MYOC;CCL28;LIMS1;JUP;GFUS;SFRP1;COL16A1;EFEMP2;ROCK1;PLEKHA2;GSK3B;ABL1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6372180955199087,1.3993357537212745,0.08664772727272728,0.39456810629618927,1.0,4/11,13.32%,ABCD2;TRAP1;MPV17L;FYN
prerank,regulation of embryonic development (GO:0045995),0.5305289814876359,1.3987336650506517,0.06965761511216056,0.39558310572063665,1.0,8/34,14.06%,B4GALT5;NIBAN2;DAG1;TRIP12;EHMT1;RBM19;PHLDB1;ZBED3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.5057316265601648,1.3976004645684348,0.059509918319719954,0.3981116994650461,1.0,9/41,12.87%,IGF1;SIRPA;NLRC3;POMC;GAS6;ILRUN;HAVCR2;LILRB1;TNFAIP3
prerank,cardiac cell development (GO:0055006),0.6466885121275432,1.3968718743748554,0.10249307479224377,0.39948952426350315,1.0,4/11,12.09%,VEGFA;JAG1;ALPK3;SLC8A1
prerank,positive regulation of hormone secretion (GO:0046887),0.5873107273308297,1.3964598510260058,0.10174029451137885,0.39996384106391464,1.0,2/17,2.52%,SPP1;CYP19A1
prerank,nuclear membrane disassembly (GO:0051081),0.6125457840436392,1.3946118448157359,0.09308510638297872,0.40465041366179405,1.0,5/14,14.18%,PRKCB;NEK6;CCNB1;DCTN1;CTDNEP1
prerank,regulation of stem cell differentiation (GO:2000736),0.4694050637993269,1.393773330703962,0.02301255230125523,0.40636116847214376,1.0,49/89,33.05%,KMT2A;PSMD1;RUNX1;PSMD8;PSMA1;JAG1;PSMA8;YTHDF2;SP7;PSMD14;PSMA5;PSMD12;PSMB10;LMO2;PSMD2;PSMC4;LDB1;HNRNPU;PSMD6;PSMD3;PSMD5;GDNF;PSMC2;PSME4;NOTCH1;PSMB8;PSMA6;METTL3;PSMB7;PSMD4;NSUN2;ABL1;PDGFRA;PSMA3;PRKDC;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;CBFB;SETD1A;TCF12;SMYD5;PSMA2;PSMC3;PSMD7;PSMD13
prerank,melanocyte differentiation (GO:0030318),0.640563440386784,1.393724377496179,0.1017191977077364,0.40570528226680475,1.0,6/11,16.99%,MITF;LRMDA;TYRP1;HPS6;MREG;USP13
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6542787465230427,1.3937213199470422,0.10869565217391304,0.4049444825316328,1.0,4/10,20.74%,GNB1;CNGB1;PDE6G;SAG
prerank,cellular response to peptide (GO:1901653),0.48847369781971683,1.3934332224593826,0.04013377926421405,0.40500270308483954,1.0,12/56,13.32%,CACNA1A;IGF1;LRP1;CDK5;VIM;CAV1;TREM2;IGF1R;MDM2;ATP1A3;CACNB1;FYN
prerank,lysosome localization (GO:0032418),0.5211296519708838,1.3932623386123033,0.056338028169014086,0.4047931497475293,1.0,11/37,15.91%,PLEKHM2;MILR1;TFEB;PLEKHM1;SPAG9;ARL8B;BORCS5;HPS6;KXD1;DEF8;FLCN
prerank,response to muscle stretch (GO:0035994),0.601583764527518,1.3924378063348841,0.0856353591160221,0.40652291358525894,1.0,3/15,2.42%,CTNNB1;SLC9A1;NPPA
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5687427032602812,1.3922192761959753,0.08997429305912596,0.4064277472659088,1.0,8/20,20.26%,SDCBP;PDCD6IP;ASAH1;OGT;RIPK3;MLKL;BIRC2;FLOT2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.5247364636640567,-1.3916982293028433,0.13013698630136986,0.5342358558530506,1.0,7/12,27.55%,FDXR;TSPOAP1;STAR;CACNA1H;STARD3NL;STARD3;AKR1B1
prerank,maturation of 5.8S rRNA (GO:0000460),0.6007433812867622,1.391671405723926,0.08689839572192513,0.4073063983089214,1.0,12/17,27.63%,C1D;EIF6;MAK16;WDR12;NSA2;EXOSC10;RPF1;EXOSC4;FTSJ3;URB1;PRKDC;MPHOSPH6
prerank,brain development (GO:0007420),-0.2893582144768359,-1.3916153729959584,0.0,0.5289019078940486,1.0,45/136,17.19%,ZFHX3;CX3CR1;PBX3;CNTNAP2;CTNNA2;ADGRL3;ROBO2;GRIN2B;CNTN4;APOD;GRIN2A;PAFAH1B2;ROGDI;EML1;RAPGEF2;GRIN1;NFIB;SLC6A17;CDH2;PHF8;NDUFS4;AFF2;NDRG4;UTP3;DSCAML1;SHANK3;CENPF;UGP2;MEIS2;PBX1;NNAT;HAP1;PAFAH1B1;MEIS1;RELN;UBE3A;PAFAH1B3;DDIT4;MDGA1;EPHA7;ADGRG1;BBS4;DNAJC30;SMARCA1;PAX2
prerank,regulation of extracellular matrix organization (GO:1903053),0.6169754279100436,1.3915783563556425,0.09918478260869565,0.4068364109449172,1.0,3/15,4.86%,LRP1;RUNX1;RIC1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.582039365817719,1.391412833920344,0.109375,0.4066332214565984,1.0,4/18,13.83%,IGF1;IL12RB1;TNFSF9;IL2
prerank,regulation of p38MAPK cascade (GO:1900744),0.5153428963828809,1.3911708673092233,0.07910271546635184,0.40657187571292,1.0,8/35,8.84%,SASH1;XDH;MFHAS1;GDF6;SPHK1;VEGFA;RELL1;TREM2
prerank,cellular response to interleukin-12 (GO:0071349),0.49892816864649864,1.3907228950676636,0.05436013590033975,0.4071659161337161,1.0,10/48,13.62%,LCP1;SIRPA;GSTA2;IL12RB1;MSN;P4HB;HSPA9;PAK2;JAK1;HNRNPA2B1
prerank,peptidyl-asparagine modification (GO:0018196),0.5321879367294964,1.3890827886944808,0.07765830346475508,0.41140601190190956,1.0,12/31,23.17%,MGAT5;DERL3;STT3B;MCFD2;MAGT1;ST6GAL1;DAD1;HIF1AN;UBE2J1;TUSC3;LMAN1;ASGR2
prerank,connective tissue development (GO:0061448),0.5183830660139633,1.3890698279258504,0.06900584795321638,0.4106891939987994,1.0,12/35,21.82%,SH3PXD2B;ARID5B;SOX9;CD44;CREB3L2;NAMPT;ATP7A;TRIP11;DYRK1B;XBP1;SLC39A13;ZBTB16
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6187756860670628,1.3884850202636545,0.09556786703601108,0.4116999952070383,1.0,7/15,23.83%,SAT1;TH;SMOX;PAOX;MOXD1;AANAT;DDC
prerank,positive regulation of macroautophagy (GO:0016239),0.5043755880994665,1.3883726008407369,0.05756207674943566,0.41128229003168,1.0,14/48,17.65%,OPTN;RUFY4;SMCR8;FYCO1;LARP1;VPS13D;HTT;BAG3;SESN2;TBK1;RAB3GAP1;RAB3GAP2;IRGM;PIP4K2A
prerank,cellular response to unfolded protein (GO:0034620),0.5444707871557062,1.3883238735822254,0.07151664611590629,0.4106646559233958,1.0,12/26,24.03%,OPTN;BAX;ERN1;HSPA9;BAG3;HSPD1;PACRG;PTPN1;HSF1;HSPA2;DAXX;HSPA13
prerank,positive regulation of TOR signaling (GO:0032008),0.5099299102967422,1.388073431008027,0.07308584686774942,0.4106662065728292,1.0,16/40,20.58%,GPR137B;RRAGD;SMCR8;NCKAP1L;GAS6;TREM2;GOLPH3;FNIP1;LARS1;PIH1D1;FLCN;HDAC3;LAMTOR3;LAMTOR1;RICTOR;PIK3CA
prerank,neuropeptide signaling pathway (GO:0007218),-0.3552369989131603,-1.3875995838912485,0.03571428571428571,0.5335333520836169,1.0,14/58,9.74%,SORL1;CPE;GLRA3;CYSLTR1;SORCS1;PPY;RAPGEF2;GPR149;NXPH2;GPR37;PENK;SORCS2;GLRA2;NMU
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5883025394827457,1.3870577251492242,0.09296148738379814,0.41304767877140786,1.0,5/18,13.24%,HIF1A;NFE2L2;HSPB1;TRAP1;MAPK7
prerank,regulation of proteolysis (GO:0030162),0.49335446706369035,1.3870521004570213,0.05444444444444444,0.4122876385756265,1.0,13/48,14.33%,ASPH;PLAUR;GSAP;CDK5;TRAF3;SERPINE2;CAV1;TBC1D10A;PARL;OGT;CSTB;FBXW11;DNAJC1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4675492001013885,-1.3865937471989962,0.08949416342412451,0.530551470640271,1.0,4/17,1.90%,FCHSD2;CTNNA2;NCKAP1;WASF2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5119429937297589,1.386425748413987,0.07268464243845252,0.41350729376895423,1.0,10/36,15.80%,HIF1A;APOE;PIK3CB;GLA;NOSTRIN;DNM2;CAV1;TNF;HTR2B;TERT
prerank,actin crosslink formation (GO:0051764),0.6284930821590684,1.3860427241343856,0.11473087818696884,0.41389322103262427,1.0,6/12,17.64%,GAS2L3;LCP1;FLNA;BAIAP2;BAIAP2L1;BAIAP2L2
prerank,regulation of autophagosome maturation (GO:1901096),0.63724103785775,1.3856416515116443,0.09833795013850416,0.4142758056569456,1.0,6/13,19.82%,SMCR8;FYCO1;RUBCN;IRGM;CLN3;TMEM39A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.5016435563092334,1.3852346866762473,0.05102040816326531,0.41475259784356205,1.0,32/50,33.05%,PSMD1;PSMD8;PSMA1;AZIN1;PSMA8;PSMD14;PSMA5;PSMD12;PSMB10;PSMD2;ODC1;PSMC4;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;PSMA2;PSMC3;PSMD7;PSMD13
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4269151298450589,-1.3851931065732,0.07352941176470588,0.528749279930477,1.0,12/24,23.49%,PDE3B;RAPGEF2;PRKAR2A;PDE4D;PRKAR2B;GNAI1;PDE2A;UBE2B;GPR61;PDE3A;PRKAR1B;PEX5L
prerank,cAMP biosynthetic process (GO:0006171),0.6613602998607562,1.3851250818717378,0.10709117221418235,0.41431328784982197,1.0,3/10,2.77%,ADCY8;ADCY3;ADCY7
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6246940246611427,1.3850192572156679,0.1031636863823934,0.41388511974356124,1.0,9/13,28.03%,IPO5;KPNA4;RGPD1;KPNA6;NUP54;KPNA3;RANBP2;NUP35;KPNA2
prerank,negative regulation of cell development (GO:0010721),0.5468142206296084,1.3839854002520457,0.08998732572877059,0.41630941010194106,1.0,7/25,14.62%,IGF1;FBXW7;APPL2;LILRB1;HOOK3;IL6;TNF
prerank,defense response to bacterium (GO:0042742),0.4572466129254821,1.3831381494025192,0.024922118380062305,0.4180907626525542,1.0,26/105,21.85%,COLEC12;LYST;FGR;PRKCD;OPTN;ADAM17;DEFB130A;ANXA3;SLC11A1;MPEG1;SYK;TREM2;RNASE7;RAB1A;RNASE3;IL6;MBL2;LYZL4;IRGM;SERPINE1;EPX;DMBT1;FCER1G;STAB2;TIRAP;RPS19
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5497652625220167,-1.3830614151310434,0.12333333333333334,0.5289672371117208,1.0,3/10,1.30%,CACNB2;CACNA2D1;NOS1AP
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4713680729040368,1.3828600189407236,0.043010752688172046,0.4182056647302581,1.0,31/73,25.77%,DNMT3A;ERCC6;TAF1D;DDX21;POLR2H;HDAC4;SPHK2;PHF1;MTF2;DNMT3B;EED;PRMT7;BAZ1B;CREBZF;POLR1A;MYBBP1A;DNMT1;ZFP57;TAF1A;POLR1G;TAF1C;DEK;MPHOSPH8;PHF2;TBP;BMI1;WBP2;EP300;SPI1;POLR1H;H3-3A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.48478066799052427,1.3827206447040163,0.044642857142857144,0.41787944013443284,1.0,20/59,20.41%,MITF;CTNNB1;CDK8;SOX9;MED15;CCNC;BAX;CCNB1;TRIM28;JUN;MED17;NFKB1;IL6;AGO3;AGO4;CDK4;MED1;MED6;MED27;CCND1
prerank,T cell activation involved in immune response (GO:0002286),0.6312402141710453,1.3827065412119495,0.10644257703081232,0.4171635874577691,1.0,3/12,10.07%,LCP1;SLC11A1;LILRB1
prerank,regulation of T cell cytokine production (GO:0002724),0.6090198149389255,1.3824646606943354,0.08426966292134831,0.41712501385078404,1.0,4/15,5.90%,TRAF2;MALT1;SMAD7;TNFRSF1B
prerank,membrane fusion (GO:0061025),0.514856702313272,1.3820907104041562,0.06990521327014218,0.4174797404969868,1.0,8/33,13.98%,MYOF;RABEP1;FER1L5;NAPA;DNM2;VAMP2;USO1;HUWE1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5769123065883599,1.382089007373062,0.08375634517766498,0.4167253143608695,1.0,4/19,6.67%,PRKCD;APOA2;ABCD2;ABHD5
prerank,positive regulation of protein sumoylation (GO:0033235),0.6599188825510568,1.3814757459150957,0.11673699015471167,0.417767365870381,1.0,7/10,27.12%,HDAC4;GNL3;RWDD3;SAE1;PIAS4;PIAS1;UBA2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5809711641300348,1.3810250526524603,0.09746328437917223,0.4184632692789086,1.0,7/16,19.18%,SHFL;OGFOD1;ETF1;IGF1R;TNF;MTRF1;CLN3
prerank,lysosome organization (GO:0007040),0.5245466277936802,1.3808921057174413,0.06962785114045618,0.4181294895253548,1.0,11/36,11.49%,ABCA1;GNPTAB;TFEB;GAA;VPS18;TPCN2;HPS1;TPP1;MYO7A;ZKSCAN3;HOOK3
prerank,regulation of cell communication (GO:0010646),0.518761348119283,1.3807222050072663,0.06805074971164937,0.4178658870269024,1.0,14/35,20.49%,MGLL;TBX18;VEPH1;MTCH1;IGFBP7;GLRX2;SLC8A1;YWHAG;SOCS2;SRI;CRK;PTPN1;NCLN;UGCG
prerank,diterpenoid metabolic process (GO:0016101),0.4886402798590124,1.3806020551608469,0.05066079295154185,0.4175157694064844,1.0,9/55,11.42%,LPL;LRP1;APOE;DHRS3;APOA2;RDH12;AKR1B10;ALDH3A2;NAPEPLD
prerank,calcium ion transmembrane transport (GO:0070588),0.4590437942631314,1.3804040547188934,0.0362087326943557,0.41738238258361093,1.0,18/86,12.30%,CACNA1A;TRPC4;P2RX4;MCOLN2;ATP2B1;CACNA1D;SLC24A4;SLC8B1;TRPM7;PMPCA;ANO6;AFG3L2;MCOLN3;GAS6;PARL;CACNB3;SLC8A1;ATP2A2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5768739856504587,1.3802150048226476,0.09772423025435073,0.4172383476274358,1.0,4/18,11.97%,HIF1A;FN1;LILRB1;SERPINF2
prerank,regulation of protein transport (GO:0051223),0.540790368797713,1.380009740175994,0.08626974483596597,0.4171040816653919,1.0,11/27,19.60%,LCP1;RHBDF2;ATP13A2;LLGL2;WWP2;LLGL1;DNAJC1;TNF;DISP1;PTPN1;GAPVD1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6496406221809489,1.3793459072753003,0.10775862068965517,0.4176097573813711,1.0,7/10,22.12%,ASCC3;MGMT;ALKBH1;ASCC2;ASCC1;FTO;ALKBH3
prerank,DNA dealkylation (GO:0035510),0.6496406221809489,1.3793459072753003,0.10775862068965517,0.4176097573813711,1.0,7/10,22.12%,ASCC3;MGMT;ALKBH1;ASCC2;ASCC1;FTO;ALKBH3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6302332779682619,1.3791606328279886,0.09894459102902374,0.41741663344526725,1.0,6/13,22.40%,DAB2;RBPMS;SH2B1;TGFBR1;TGFB1;NUP93
prerank,regulation of cellular component movement (GO:0051270),0.4904335847468447,1.3782637603225047,0.0592841163310962,0.41933949022817285,1.0,21/49,24.85%,CD9;ABL2;CDK6;VEGFA;ADAM17;PDPN;ZSWIM8;PKN2;RHOA;RAF1;MEMO1;ACTN1;PRAG1;TGFBR1;FES;ROCK1;RPS19;CADM4;ACTN4;ABL1;LYN
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5580509105509851,1.3777521694328076,0.09192546583850932,0.4201364729167086,1.0,4/22,4.65%,APOE;APOA2;PPARD;PPARG
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5864113415824468,1.3773410358318217,0.10340314136125654,0.42065960764995397,1.0,1/18,0.02%,GPNMB
prerank,regulation of spindle organization (GO:0090224),0.5798304249035822,1.3773034324141347,0.09736842105263158,0.4200310436652725,1.0,5/18,10.36%,DYNC1H1;DCTN1;TACC3;RAE1;NUMA1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.578197767451377,1.3770754049254754,0.09911054637865312,0.42001784168237594,1.0,5/18,6.34%,ABCG1;APOE;KLK6;ADAM17;PSEN2
prerank,regulation of calcium ion transport (GO:0051924),0.48159695671604136,1.3769929137785135,0.06108597285067873,0.4195674924191726,1.0,10/54,6.68%,CD84;CTNNB1;BCL2;P2RX4;CCL4;ATP2B1;CACNA1D;CRACR2A;SLC8B1;HOMER2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5836823323659435,1.3766736861890612,0.0926892950391645,0.41982427979159015,1.0,4/17,9.40%,ABCG1;APOE;MBTPS2;LPCAT3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.51243010381023,1.3762617380529127,0.07261904761904762,0.42029073787336724,1.0,10/37,15.41%,BCL2;BCL2L1;BAX;CAV1;DDIT3;BCL2L11;NCK1;BECN1;BID;EIF5A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4168159919851341,-1.376203327857499,0.07954545454545454,0.5414911018042666,1.0,14/27,21.46%,TMEFF2;F11R;WASF2;PIK3R1;CLASP2;STMN1;TJP1;SHANK3;PRKN;INPP5K;PHLDB2;ARHGAP28;WAS;CGNL1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4843412414641179,1.3756524699615427,0.05518763796909492,0.42133543259695716,1.0,10/52,11.94%,LGALS3;LRP1;PRKCH;PDPK1;SQSTM1;STAC2;TREM2;RHOG;ITGA3;STX3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.47799336153324057,-1.3754596365363558,0.13135593220338984,0.5383433577033034,1.0,7/16,27.82%,DPYD;CRMP1;DPYSL2;NT5M;DPYS;NT5C3A;UPB1
prerank,hyaluronan catabolic process (GO:0030214),0.5863071886179854,1.3752511722203076,0.08366013071895424,0.42177410927794506,1.0,6/18,8.85%,SLC9A1;FGF2;HEXA;CD44;HEXB;GUSB
prerank,regulation of mononuclear cell migration (GO:0071675),0.5400485293110011,1.3751317041719784,0.08856088560885608,0.421369767528203,1.0,3/23,3.89%,LGALS3;CSF1;MSN
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5007228083047575,1.3747536381737386,0.06697459584295612,0.421794240240817,1.0,12/41,14.62%,PLAUR;FSTL3;PIEZO1;PTPN23;GCNT2;PLPP3;SMAD7;CD44;MAGI1;SERPINF2;JAK1;TNF
prerank,positive regulation of macrophage activation (GO:0043032),0.579304451759624,1.3741461694482862,0.11548556430446194,0.4229568345604416,1.0,5/17,13.73%,STAP1;CEBPA;TREM2;TNIP2;HSPD1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5501745693534219,1.3735293970665945,0.08984375,0.4240597111975583,1.0,10/21,20.43%,RAD51B;CCNB1;BRD4;STOX1;VPS4B;CDC25B;CDC25A;CDK4;CCND1;FBXO5
prerank,negative regulation of hippo signaling (GO:0035331),-0.5167417710479982,-1.3732004531025495,0.15699658703071673,0.5389648250052778,1.0,8/12,25.51%,MAPK14;CIT;WWC1;VGLL4;LIMD1;AJUBA;SHANK2;DLG5
prerank,membrane raft organization (GO:0031579),0.6041160081276847,1.3727722412789718,0.11201079622132254,0.42561964350995246,1.0,6/15,20.26%,RFTN1;NPC1;MYADM;CLN3;ABCA7;FLOT2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6098188122363524,1.3723484290658745,0.08458390177353342,0.4261340937378375,1.0,8/13,22.56%,LARGE1;RENBP;NAGK;OGA;EXTL2;CHST3;CHST1;CHST2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.46195601979231715,1.3718949578739612,0.04878048780487805,0.4268111824634592,1.0,34/83,26.30%,CDK14;CDK18;CDK6;CDK5;E2F3;PLK2;BRD4;CDK16;DBF4;CDKN3;PLK3;CUL2;EIF4E;NPAT;POLE;MNAT1;CDC25A;PPP6C;LATS1;CDK4;CUL1;CUL4A;CCND1;FBXO5;CDK2;CCNH;EIF4EBP1;SPDYA;CUL3;CDC34;GSPT1;POLA1;CDC7;KLF11
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6456394804910787,1.3715660401868284,0.09210526315789473,0.4270363683590732,1.0,2/10,6.57%,BCL2;MYOC
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4562828590728244,-1.3712329870400877,0.11162790697674418,0.5338088246828362,1.0,11/20,24.70%,MCCC2;BCKDHB;IVD;ALDH6A1;BCKDHA;AUH;DBT;HIBCH;MCCC1;DLD;ACADSB
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4562828590728244,-1.3712329870400877,0.11162790697674418,0.5338088246828362,1.0,11/20,24.70%,MCCC2;BCKDHB;IVD;ALDH6A1;BCKDHA;AUH;DBT;HIBCH;MCCC1;DLD;ACADSB
prerank,manganese ion transport (GO:0006828),0.6069822352090468,1.3711448010328384,0.09568733153638814,0.4276062848734114,1.0,2/14,7.56%,TRPC4;SLC11A1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6187257210083758,1.370872717867334,0.10178817056396149,0.4277742196740529,1.0,3/12,12.69%,COLEC12;CAV1;DHX9
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5754986520269253,1.3706515028859918,0.09580052493438321,0.4277001995318939,1.0,9/18,19.25%,WDR91;NELL1;MSN;RIC1;RGP1;VPS35;PTTG1IP;DACT1;VPS11
prerank,limb development (GO:0060173),-0.4046093852187558,-1.3704136370872553,0.09467455621301775,0.5308190681777546,1.0,6/28,5.31%,SALL1;KAT2B;FGF10;PCSK5;BMPR1B;COMP
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6238727836099274,1.37037969290302,0.09620596205962059,0.4278798023825559,1.0,3/13,7.22%,ADAM8;FOXJ1;CLPTM1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5583623276441196,1.37021558394453,0.09284818067754078,0.4276537383984075,1.0,11/22,25.22%,NFE2L2;PSMA1;PSMA8;ENC1;PSMA5;PSMB10;PSME4;PSMB8;PSMA6;PSMB7;PSMA3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.569640051006576,1.3701847587678109,0.10918774966711052,0.4270081888064712,1.0,7/18,15.35%,FLNA;UBTF;DHX33;WDR43;LYAR;RASL11A;MAF1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.5207068127929882,1.3700625138622495,0.073512252042007,0.42665921885798025,1.0,20/36,26.18%,MACF1;GOLGA4;OPTN;NECTIN3;GCC2;RILPL2;RILPL1;RAB7A;VAMP2;GOLPH3;GGA2;VAMP4;BBS2;ARFRP1;AFDN;GOLPH3L;RAB34;RAB31;GOLGA7;GGA3
prerank,protein polymerization (GO:0051258),0.48145799750235396,1.369748011938085,0.06919642857142858,0.4268534476443863,1.0,8/56,4.33%,FGF13;GAS7;TRIM6;MSRB1;CHMP4B;CHMP4A;CORO7;WASHC5
prerank,response to insulin (GO:0032868),0.4651142679293142,1.369428413813742,0.049473684210526316,0.4270768836673202,1.0,21/80,14.47%,MYO5A;PKM;EPRS1;EIF6;SLC27A1;GCK;PDPK1;DENND4C;CPEB2;PPARG;RHOQ;RAB8B;SLC25A33;HDAC9;PCK2;PIK3R2;VAMP2;OGT;CPEB1;ZBED3;ZBTB7B
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5564025157437241,1.3692368831252293,0.09894459102902374,0.42693827464074896,1.0,4/20,6.15%,BCL2;BCL2L1;MCL1;BAX
prerank,stress-activated MAPK cascade (GO:0051403),0.4751849089476168,1.369224902367143,0.04580152671755725,0.4262696211376523,1.0,20/61,19.16%,IRAK2;DUSP9;MAP4K3;UBA52;MAP3K12;TAB1;CRKL;NFKB1;MAP3K8;PTGER4;TNIP2;MAP2K3;FBXW11;SH2D3C;MINK1;RPS27A;UBC;MAP3K20;MAPK3;CUL1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5242493725649121,1.368075615992791,0.07508939213349225,0.4290413708160403,1.0,8/30,16.17%,CHST11;CSPG4;HEXA;HEXB;IDUA;CHST12;CHST3;DSEL
prerank,response to interleukin-1 (GO:0070555),0.46417878035165105,1.3679653222462185,0.05331882480957562,0.42860525435184027,1.0,12/73,10.24%,HIF1A;SIRPA;IRAK2;CCL4;TANK;SOX9;HDAC4;CCL13;NFKB1;ACOD1;CCL14;TLE5
prerank,regulation of histone deacetylation (GO:0031063),0.6207282847391743,1.3679134018800128,0.09340659340659341,0.42803646680224366,1.0,6/13,25.37%,SPHK2;SAP30BP;PRMT6;ZBTB7B;APLNR;CAMK2D
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5135359924559677,-1.3671405406626485,0.11538461538461539,0.5340214207348465,1.0,3/13,1.38%,P2RY12;NLGN1;EPS8
prerank,stress granule assembly (GO:0034063),0.554200864314907,1.366287870889293,0.1011378002528445,0.4322730273669309,1.0,11/20,23.71%,DYNC1H1;LSM14A;OGFOD1;YTHDF2;ATXN2;UBAP2L;CIRBP;G3BP1;PRRC2C;EIF2S1;CSDE1
prerank,lymphocyte differentiation (GO:0030098),0.4671042735196474,1.3661143703031935,0.05585980284775466,0.4320628681161225,1.0,19/68,17.82%,BLNK;PTPRC;TPD52;AXL;NFIL3;ADAM17;HDAC4;PTPN2;KLF6;HDAC9;DLL4;CHD7;GPR89A;GPR89B;CEBPG;IL2;RABL3;KAT7;ITGA4
prerank,regulation of B cell apoptotic process (GO:0002902),0.6110353304717573,1.3653217024455564,0.1260387811634349,0.43378257456508224,1.0,6/12,13.83%,NOC2L;BCL6;BTK;ORMDL3;FNIP1;IL2
prerank,regulation of protein kinase activity (GO:0045859),0.4509515857797162,1.3648189075807209,0.03537981269510926,0.43465902245100424,1.0,29/106,18.41%,IQGAP1;CSF1;FGR;LAT;PTPRC;GNAQ;PTK2B;ALS2;DTNBP1;HSPB1;PDPK1;SMCR8;LRP6;GAS6;TAB1;TAF7;PAK2;JTB;C5AR1;YWHAG;UBASH3B;MAP2K3;TRIB2;TNF;NF1;RAP2B;QARS1;PRKAG1;PYDC1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4873975253808676,-1.3645811986188585,0.11065573770491803,0.535542532967832,1.0,6/15,18.46%,PNP;CCR2;HSPH1;NKAP;EBI3;CD55
prerank,positive regulation of embryonic development (GO:0040019),0.5585167122171055,1.364579896253695,0.10796915167095116,0.43463250974282186,1.0,2/19,0.78%,B4GALT5;NIBAN2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5807694096799334,1.364088643103713,0.09630606860158311,0.4353925246847074,1.0,8/17,17.87%,MGARP;TFPI;ACOD1;NR3C1;ATP1A1;ATP1A3;UBE2L3;MED1
prerank,mitochondrial gene expression (GO:0140053),0.4976097089273345,1.3640848213187509,0.07514450867052024,0.4346796119861639,1.0,16/42,20.07%,MRPL47;MRPL23;SLC25A33;MRPS15;TWNK;MRPS16;MRPS28;GFM2;RARS2;FASTKD2;MRPS12;GATB;FASTKD5;MRPS7;NOA1;POLRMT
prerank,positive regulation of proteolysis (GO:0045862),0.47932776502802854,1.3640013357351157,0.06512141280353201,0.4342079947809404,1.0,14/55,17.45%,ASPH;APOE;ADAM8;TNIP1;TANK;SNX33;TNFRSF1B;TBC1D10A;OGT;FURIN;FBXW11;TNF;SH3D19;MAPK12
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6146639125254296,1.3639209856636056,0.12198581560283688,0.43377397693825964,1.0,4/12,14.85%,CCT2;GNL3;CCT5;DKC1
prerank,regulation of lipase activity (GO:0060191),0.6218098211260223,1.3637507999122118,0.10533515731874145,0.43356240249914535,1.0,4/13,12.30%,LPL;APOA2;RHOA;FURIN
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4635528520850798,1.3633735358034835,0.05698924731182796,0.4339416205652537,1.0,33/71,25.68%,MYO10;FGR;PIK3CB;PRKCD;GRB2;ARPC3;WIPF1;ARPC2;ARPC5;NCKAP1L;CYFIP1;LIMK1;SYK;PIK3R2;YES1;BAIAP2;ARPC1B;NCK1;FYN;VAV1;CRK;ELMO2;MAPK3;ACTR3;PIK3CA;FCER1G;CYFIP2;CDC42;HSP90AB1;ABL1;LYN;MAPK1;VAV3
prerank,regulation of DNA repair (GO:0006282),0.5009904163339401,1.3632347794406017,0.07630979498861047,0.4335989818370321,1.0,15/44,19.88%,ERCC6;EYA4;TRIP12;TRIM28;BRCA1;ABRAXAS1;CEBPG;DHX9;UIMC1;BABAM2;UBE2V2;KAT7;TMEM161A;DEK;BRCC3
prerank,neuromuscular process controlling balance (GO:0050885),-0.5126955043178603,-1.363125485937395,0.11347517730496454,0.5345554882325488,1.0,3/12,2.03%,NRXN1;PCDH15;CDH23
prerank,long-chain fatty acid import into cell (GO:0044539),0.6563649628034264,1.3626314639498855,0.10829817158931083,0.43472359108129827,1.0,4/10,8.56%,SLC27A1;SLC27A5;SLC2A1;ACSL1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5242183419917769,1.3625789220161109,0.09134615384615384,0.43419357441762974,1.0,11/30,23.17%,MGAT5;DERL3;STT3B;MCFD2;MAGT1;ST6GAL1;DAD1;UBE2J1;TUSC3;LMAN1;ASGR2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5534696880803024,1.3624221401540157,0.0946969696969697,0.4339762495215895,1.0,10/24,21.64%,PRKCH;CYP27B1;VDR;RUNX1;NUMA1;ETV4;MED1;ERRFI1;CTSL;ROCK1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5128497622269996,1.3620342731812567,0.08939213349225268,0.43439579395433214,1.0,11/34,22.35%,P2RX4;SLC9A1;NPPA;SMAD7;SLC8A1;ATP2A2;SRI;CALM2;ZC3H12A;SCN10A;HCN4
prerank,lamellipodium assembly (GO:0030032),-0.4027310932771389,-1.3619141096255423,0.10880829015544041,0.5329034076615563,1.0,7/26,8.04%,P2RY12;CDH13;CARMIL1;ABLIM1;KIT;ABLIM3;DMTN
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6594004742661661,1.3618708857848376,0.09985734664764621,0.4341839297941353,1.0,6/10,19.17%,MFSD12;TYRP1;ATP7A;GIPC1;ZEB2;CTNS
prerank,O-glycan processing (GO:0016266),0.4841167011196925,1.3617844615903791,0.07198228128460686,0.4337241965709098,1.0,10/54,17.03%,B4GALT5;GALNT7;GALNT15;MUC1;MUC16;ST6GAL1;ST3GAL2;GCNT1;GALNT3;POFUT1
prerank,regulation of gluconeogenesis (GO:0006111),0.5278819156462252,1.361247300656278,0.09735576923076923,0.4346485413745447,1.0,6/27,12.06%,GCK;GNMT;SIK1;PTPN2;DDB1;OGT
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5905615726331874,1.3610987401652879,0.11436170212765957,0.4344153896881318,1.0,3/15,3.34%,P2RX4;FGF2;HSPB1
prerank,bone development (GO:0060348),0.49336351960382724,1.3599473796145731,0.07657142857142857,0.43716970150467144,1.0,10/39,16.79%,SH3PXD2B;PTPRC;AKAP13;MYOC;MBTPS2;SKI;LRP6;PTGER4;DYM;GNAS
prerank,regulation of platelet aggregation (GO:0090330),0.5781430503083981,1.3598986339697354,0.1096433289299868,0.43659051483892536,1.0,5/17,8.63%,CD9;PRKCD;PDPN;SERPINE2;SYK
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5351617903617668,1.3592220155783705,0.10224438902743142,0.437869869699279,1.0,8/25,11.09%,ERCC6;ZNF326;HMGN1;DDX39B;THOC1;WDR43;CCNT2;EAF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.47998978203220133,1.3589483453874904,0.07776560788608981,0.4379695943680057,1.0,35/55,33.05%,PSMD1;PSMD8;PSMA1;PSMA8;ATF5;PSMD14;PSMA5;USP47;PSMD12;PSMB10;PSMD2;PSMC4;AVEN;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;RBX1;PSMA2;PSMC3;PSMD7;PSMD13
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.45874902709808174,1.3587333453970587,0.0455026455026455,0.43792856650189604,1.0,28/86,20.97%,IGF1;CSPG4;ITGA5;TEC;PDGFA;PTPRC;NRP1;PTK2B;PRKCD;VEGFA;CD44;SAMSN1;TREM2;PAK2;IL6;FYN;FGF7;HAX1;EFNA1;ARHGEF2;RAP2B;SFRP1;ITGB2;IL5;PTPN6;DGKQ;TGFB1;PDGFB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5177213238933928,1.3579011390918978,0.09658421672555949,0.4390483954962648,1.0,14/32,27.50%,NUP205;XPOT;NUP188;NOL6;RAE1;NUP42;TPR;NUP54;RANBP2;NUP133;NUP93;NUP98;NUP35;AAAS
prerank,tRNA export from nucleus (GO:0006409),0.5177213238933928,1.3579011390918978,0.09658421672555949,0.4390483954962648,1.0,14/32,27.50%,NUP205;XPOT;NUP188;NOL6;RAE1;NUP42;TPR;NUP54;RANBP2;NUP133;NUP93;NUP98;NUP35;AAAS
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6246621692292045,1.3574625213481049,0.11976911976911978,0.43897835777833166,1.0,5/11,16.18%,EIF6;AGO2;AGO3;AGO4;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6246621692292045,1.3574625213481049,0.11976911976911978,0.43897835777833166,1.0,5/11,16.18%,EIF6;AGO2;AGO3;AGO4;NOTCH4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4644940321454916,1.3572681398551045,0.055135135135135134,0.43883819725248663,1.0,30/72,24.08%,IRAK2;PTPRC;TRAF2;SPHK1;OTULIN;RUNX1;AXL;PTPN2;GAS6;SYK;RNASEL;IFNGR2;JAK1;TNFAIP3;TNF;SHARPIN;PTPN1;AGPAT1;PTPN6;BIRC2;IFNAR2;SUMO1;HIPK1;IRAK1;RACK1;PTPN11;CHUK;HSP90AB1;IL7;PIAS1
prerank,negative regulation of hemostasis (GO:1900047),0.6073580023017233,1.356621630145752,0.12834978843441466,0.44009761198297387,1.0,5/12,17.51%,APOE;SERPINE2;TFPI;APOH;SERPINE1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4344222834694016,1.356402926301037,0.011088709677419355,0.44002719809403124,1.0,46/182,16.22%,IGF1;APOBEC1;HIF1A;APOE;SDCBP;XDH;FGF2;OPTN;TRIM6;VDR;CLDN19;RUNX1;AGO2;VEGFA;SMCR8;FBXW7;TRAT1;ANKRD13B;LRPAP1;ID2;NOCT;CELF1;DLL4;ANXA7;CRKL;STOX1;HAVCR2;DIP2A;NFKB1;MYADM;ATXN2;TLE5;WWP2;ZNF148;TIPARP;AGO3;MSR1;TNF;DNMT1;DLG4;AGO4;YY1;TERT;FLCN;HDAC1;OLFM1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.29363591978523407,-1.356139301719991,0.0,0.5430031888287671,1.0,35/159,10.44%,IL1RAPL1;ROBO1;LRRC4C;TENM2;ITGAM;GRID2;PTPRD;NLGN1;UNC5D;LRFN5;CDH13;ADGRL3;ROBO2;CDH23;CNTN4;CNTN6;CDH9;CDH8;CADM3;CDH10;CDH12;CDH7;CDH20;GPC6;TENM4;NTNG1;CDH2;CEACAM1;HMCN1;FLRT3;DSCAML1;PECAM1;CDH6;TENM3;VCAM1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4946071459857804,1.354726695249632,0.07226107226107226,0.44448927865576987,1.0,15/40,21.65%,CTNNB1;SDCBP;DAB2;GCNT2;PDPN;BAMBI;JAG1;TGFBR2;IL6;OLFM1;TGFBR1;TGFB1I1;TGFB1;GLIPR2;NOTCH1
prerank,actin filament organization (GO:0007015),0.4383034773418334,1.354278293280428,0.02040816326530612,0.44515200254084625,1.0,38/151,19.42%,MYO1E;GAS2L3;ARHGAP25;MYO5A;LCP1;CORO1C;MYO1F;MYO1A;CAPG;CORO7;INPPL1;FLNA;NEDD9;RUFY3;ARHGAP12;ALDOA;RHOD;HIP1R;BAIAP2;MYO7A;RHOG;ARHGAP17;EVL;RHOA;TPM4;ZBED3;RHOF;FLII;ACTN1;HIP1;BAIAP2L1;ARHGEF2;ELMO2;CORO1B;BAIAP2L2;MYO19;ABI2;SVIL
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4618395128639093,1.3540905850240847,0.05279831045406547,0.44497189503725826,1.0,17/78,14.62%,LGALS3;LRP1;BCL2L1;PRKCH;CDK5;PDPK1;DAB2;SQSTM1;RHOQ;STAC2;TREM2;RHOG;ITGA3;STX3;PID1;TMBIM1;TNF
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.45837990631239883,1.3538625522495396,0.0641025641025641,0.4449073440316492,1.0,33/73,25.68%,MYO10;FGR;PIK3CB;PRKCD;GRB2;ARPC3;WIPF1;ARPC2;ARPC5;NCKAP1L;CYFIP1;LIMK1;SYK;PIK3R2;YES1;BAIAP2;ARPC1B;NCK1;FYN;VAV1;CRK;ELMO2;MAPK3;ACTR3;PIK3CA;FCER1G;CYFIP2;CDC42;HSP90AB1;ABL1;LYN;MAPK1;VAV3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5958769954534273,1.3534766554722317,0.12687585266030013,0.44535305371757405,1.0,10/14,36.11%,SEC24A;RAB1A;SAR1A;TBC1D20;SEC24D;SEC24B;SEC23A;MIA3;SEC23B;SEC13
prerank,regulation of dendritic spine development (GO:0060998),-0.42153645922879923,-1.353305938922467,0.08264462809917356,0.5453374534714313,1.0,5/19,1.99%,TANC2;NLGN1;PPFIA2;MEF2C;GRIN3A
prerank,cellular response to starvation (GO:0009267),0.4379360940671683,1.353238246746164,0.01641025641025641,0.445333953450382,1.0,53/147,25.46%,TCIRG1;ATG7;RRAGD;ATP6V1C1;ATP6V0D2;ATP6V1A;TFEB;ATP6V1B2;CPEB4;ATP6V0D1;STK24;ATP6V1G1;SIK1;WDR45;ATP6V0B;NUPR2;LAMP2;NPRL3;BECN1;MAP1LC3B;FNIP1;ATP6V1F;MYBBP1A;LARS1;ATP6V0C;SESN2;FLCN;KLF10;PRKAG1;SFRP1;MAPK3;ATP6V1D;ASNS;LAMTOR3;ZC3H12A;LAMTOR1;DAP;XBP1;USP33;ATP6V1E1;EIF2S1;BRSK2;RRAGC;NPRL2;FOXO1;GABARAP;EIF2AK4;RALB;GAS2L1;SH3GLB1;MAPK1;XPR1;IMPACT
prerank,nucleotide-excision repair (GO:0006289),0.4494160022845232,1.3530758923729973,0.03814432989690722,0.44512690233793056,1.0,40/101,24.41%,ERCC6;COPS3;POLR2H;HMGN1;ERCC1;COPS2;ATXN3;COPS4;UBA52;COPS8;SLX4;PPIE;DDB2;DDB1;ERCC4;XPA;RFC2;POLE;LIG3;RPS27A;UBC;MNAT1;POLR2D;LIG1;RFC1;PNKP;GTF2H1;COPS7A;MMS19;ERCC2;CETN2;HUS1;CUL4A;RNF111;SLC30A9;PARP1;CCNH;COPS6;EP300;UVSSA
prerank,protein deneddylation (GO:0000338),0.6414000233033492,1.3525322691528818,0.14468085106382977,0.44604352885394793,1.0,4/10,7.67%,COPS3;COPS2;COPS4;COPS8
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5815163272229744,1.3518319919972444,0.11375661375661375,0.4474494537689651,1.0,5/16,15.91%,GPR137B;RRAGD;LARS1;PIH1D1;FLCN
prerank,nucleus organization (GO:0006997),0.48235392928693993,1.3512647281652146,0.0782312925170068,0.44856295370031746,1.0,21/47,24.47%,NUP205;CHMP4B;CHMP4A;SYNE1;PDCD6IP;REEP3;VPS4B;NUMA1;USP36;TPR;CTDNEP1;SUN1;NUP54;IRAG2;LEMD2;RPS19;NUP133;NUP93;WDR73;NUP98;CHMP7
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4606748387556193,1.3511521003310298,0.05837837837837838,0.44816855649772713,1.0,32/70,25.68%,MYO10;FGR;PIK3CB;PRKCD;GRB2;ARPC3;WIPF1;ARPC2;ARPC5;NCKAP1L;CYFIP1;LIMK1;SYK;PIK3R2;YES1;BAIAP2;ARPC1B;NCK1;FYN;VAV1;CRK;ELMO2;MAPK3;ACTR3;PIK3CA;CYFIP2;CDC42;HSP90AB1;ABL1;LYN;MAPK1;VAV3
prerank,positive regulation of protein catabolic process (GO:0045732),0.4564299802335214,1.3509742074336943,0.04777070063694268,0.44799113123773254,1.0,30/84,19.25%,ATG7;APOE;ADAM8;C4BPA;C4BPB;MSN;PLK2;SNX33;TNFRSF1B;FZR1;VCP;SEC22B;RAB7A;RNF41;WWP2;DDB1;VIP;TIPARP;PLK3;FURIN;STX5;TNFAIP3;VPS35;HUWE1;TNF;PTTG1IP;SH3D19;RILP;DACT1;VPS11
prerank,mitochondrion transport along microtubule (GO:0047497),0.6105228304622587,1.3503391871490513,0.1337126600284495,0.44922327078076696,1.0,3/13,2.46%,HIF1A;UXT;MGARP
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.530185567287315,1.349738593833848,0.1227390180878553,0.4503238208783319,1.0,16/24,31.49%,TNKS2;HNRNPC;SLX4;ACD;ERCC4;EXOSC10;NAT10;DCP2;TERF1;HNRNPU;PARP1;XRN1;TENT4B;TERF2;GNL3L;TEN1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6263077845121481,1.3496427095898678,0.14609929078014183,0.4492374639008705,1.0,5/11,25.27%,SRI;CALM2;FKBP1B;GSTO1;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6263077845121481,1.3496427095898678,0.14609929078014183,0.4492374639008705,1.0,5/11,25.27%,SRI;CALM2;FKBP1B;GSTO1;CALM3
prerank,regulation of cell cycle phase transition (GO:1901987),0.45095450449301566,1.349433016329695,0.04712041884816754,0.44921426768044254,1.0,43/91,29.21%,PSMD1;ANAPC15;PSMD8;FBXW7;PSMA1;FZR1;PSMA8;CCNB1;ANAPC1;DDB1;DBF4;PSMD14;PSMA5;PSMD12;PSMB10;PSMD2;CDC26;PSMC4;ERCC2;UBE2C;CUL1;PSMD6;FBXO5;PSMD3;PSMD5;PSMC2;PSME4;TCIM;PSMB8;PSMA6;ANAPC7;PSMB7;PSMD4;PSMA3;NEK10;PSMD10;ANAPC11;PSMC6;PSME3;PSMC5;PSMA4;BTRC;CDC16
prerank,calcium ion import across plasma membrane (GO:0098703),-0.48912167542051543,-1.3493897809903868,0.13503649635036497,0.5506595338967847,1.0,4/14,13.02%,CACNA2D1;SLC8A3;SLC8A2;SLC24A2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.47322252366058865,1.349035055068813,0.0624315443592552,0.44971341756004957,1.0,26/62,25.77%,LGALS3;KMT2A;CDK6;CNOT4;EIF6;PTK2B;RUNX1;PRKCB;RBBP5;HSPA9;PRMT6;AGO3;ITGA2B;AGO4;HDAC1;WDR5;MAFB;FES;KMT2B;ZBTB16;CREBBP;KMT2D;EP300;LYN;SPI1;H3-3A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4626821972784666,1.348396159108759,0.06182212581344902,0.4509811868098753,1.0,23/65,23.00%,HIF1A;ADAM8;MGARP;CPEB4;VEGFA;CPEB2;HMOX1;AK4;NDRG1;P4HB;PGK1;EGLN1;MDM2;PTGIS;CPEB1;TERT;ACAA2;SFRP1;HP1BP3;EGLN3;SIRT2;UBQLN1;LMNA
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5810807851068872,1.348184477369302,0.1041388518024032,0.45096982132514224,1.0,8/16,23.07%,AMPD2;ATIC;ADSS1;GART;PPAT;NUDT2;ADSL;ADSS2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6298217152341294,1.347569173440101,0.12806539509536785,0.45210697331514654,1.0,5/11,23.98%,CSF1;ID2;HSF1;TGFB1;IL34
prerank,autophagosome maturation (GO:0097352),0.5111897414816972,1.3469618723184105,0.1073170731707317,0.4533332523789791,1.0,17/32,31.40%,TECPR1;LIX1L;VCP;LAMP2;ATP2A2;LIX1;MAP1LC3B;CLN3;VIPAS39;UBQLN1;GABARAP;VMP1;VPS16;VPS33A;SNAP29;CHMP3;GABARAPL2
prerank,pseudouridine synthesis (GO:0001522),0.6122559547296726,1.3461440299672514,0.12722298221614228,0.45511388085505833,1.0,6/13,25.74%,PUS1;TRUB2;GAR1;DKC1;PUSL1;TRUB1
prerank,respiratory tube development (GO:0030323),0.5365502600815399,1.3459680258153108,0.10196560196560196,0.45495294020207805,1.0,11/28,20.04%,FGF2;VEGFA;PDPN;CEBPA;NKX2-1;ITGA3;FGF7;RBP4;CCDC40;LOXL3;FGFR2
prerank,cholesterol biosynthetic process (GO:0006695),-0.3872838693017211,-1.3458360339810604,0.07228915662650602,0.5552373092534988,1.0,15/31,23.54%,HMGCS1;NSDHL;IDI1;INSIG1;DHCR7;HSD17B7;MVK;SC5D;INSIG2;FDPS;SQLE;LBR;LSS;HMGCR;GGPS1
prerank,negative regulation of defense response (GO:0031348),0.45904426090720446,1.3457031847658107,0.050213675213675216,0.45502618566146424,1.0,19/77,13.27%,SIRPA;APOE;NLRC3;MFHAS1;PRKCD;OTULIN;PPARD;PPARG;PTPN2;ILRUN;LPCAT3;ACOD1;LYAR;C1QBP;PTGER4;PTGIS;TNFAIP3;MAPK7;VPS35
prerank,negative regulation of DNA replication (GO:0008156),0.6071697175423105,1.3456997487902103,0.13545816733067728,0.4543372980368697,1.0,7/13,25.22%,GMNN;GTPBP4;WAPL;S100A11;TERF1;CDAN1;PDS5A
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4745462189483066,1.345401975649173,0.06476399560922064,0.4545459758920782,1.0,37/61,33.91%,PSMD1;PSMD8;PSMA1;AZIN1;SIRT5;PSMA8;CAV1;PSMD14;PSMA5;PSMD12;PSMB10;PSMD2;ODC1;PSMC4;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;FGFR4;PSMB6;PSMA2;PSMC3;PSMD7;PSMD13;PANK2;NCOR2
prerank,regulation of mRNA metabolic process (GO:1903311),0.6228196608067834,1.344168483632353,0.15351506456241032,0.45750433750973896,1.0,6/11,18.83%,SAFB2;SRPK1;SRPK2;CDK11B;DHX9;SAFB
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5770069418069065,1.3438717317402193,0.11292517006802721,0.45772809200900233,1.0,5/15,11.38%,BCL2;MUC1;CD44;TRIAP1;MDM2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5836194480502537,1.34362441252658,0.1202113606340819,0.45780759959079015,1.0,1/16,0.06%,IGF1
prerank,response to hexose (GO:0009746),0.5352392481630298,1.3435554563324827,0.10074626865671642,0.4573544315936593,1.0,7/25,17.18%,LPL;APOA2;GCKR;PFKL;VAMP2;ZBED3;EIF2B2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.47589664858517106,1.3435295602363801,0.0703125,0.4567673731367601,1.0,13/55,13.02%,CSPG4;GALNS;SLC9A1;GNS;FGF2;HEXA;GLB1;CD44;HEXB;GUSB;FUCA1;IDUA;HPSE
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.44305164646173684,1.343518915049914,0.037075180226570546,0.45610356990546885,1.0,48/114,28.92%,PSMD1;PTK2B;TRAF2;TNFSF15;PSMD8;PSMA1;TRAF3;ADAM17;TNFRSF1B;PSMA8;TNFRSF9;TNFSF8;CDIP1;PSMD14;TNFSF9;LIMS1;PSMA5;AIM2;PSMD12;ILK;TNF;PSMB10;EIF5A;PSMD2;PSMC4;PYDC1;BIRC2;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;TNFRSF8;PSMB8;PSMA6;CHUK;ACTN4;PSMB7;PSMD4;TNFRSF11A;PSMA3;TNFRSF25;PSMD10;TRADD;PSMC6;PSME3;PSMC5;PSMA4
prerank,carboxylic acid metabolic process (GO:0019752),0.5145002905955454,1.3433627636314598,0.09703196347031963,0.4558761385459661,1.0,12/33,19.74%,SLC23A2;SLC23A1;PON1;GNMT;SLC2A1;TBXAS1;GLYAT;ST6GAL1;PTGIS;SIRT4;GSTO1;CYB5R3
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5232292828803045,1.3424416906290593,0.10552147239263804,0.4579729378350008,1.0,4/26,3.33%,BCL2;BCL2L1;EYA4;MCL1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.43068565732273273,1.3420430626005355,0.02129817444219067,0.4584828463159027,1.0,48/170,24.51%,IGF1;C1D;HIF1A;SIRPA;APOE;CDK6;PTPRC;NELL1;UBAP2;TRIM6;TRIM43;TFEB;AFF1;NFKBIZ;STOX1;TREM2;TAPBP;YBX2;HNRNPK;ZFP64;RASA1;HMG20B;NOVA2;SLC8A1;PRDM9;TBC1D16;NPAT;FUBP1;PIN1;PCBP1;KIF16B;CDK4;SART3;CDH1;ZC3H12A;LAMTOR1;UNCX;YBX3;GDNF;BMI1;ATXN7L3B;PCBP4;CDK2;RSPO1;RO60;RFXANK;PRDM6;APLNR
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.43608548948661546,-1.3418249025427846,0.0970873786407767,0.5612026516616615,1.0,7/20,18.32%,SEMA6D;SEMA6A;SEMA5A;SEMA4B;SEMA4A;SEMA6C;SEMA3B
prerank,morphogenesis of an epithelium (GO:0002009),0.530953732933905,1.3418063920646395,0.10259579728059333,0.458549451938502,1.0,9/25,22.46%,TBX18;DAG1;SOX9;ARHGAP12;LRP6;RIPK4;TRAF3IP1;FGFR2;LAMA3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5805946975630737,1.341806350766892,0.14016172506738545,0.4578599038904742,1.0,4/15,14.18%,SLC27A1;FBXW7;SIK1;CTDNEP1
prerank,microglial cell activation (GO:0001774),-0.43085068233722323,-1.3415911909722327,0.0963302752293578,0.5568954997074721,1.0,3/21,1.35%,CX3CR1;ITGAM;IFNGR1
prerank,photoreceptor cell development (GO:0042461),0.6077333994569027,1.3412851128814554,0.12634408602150538,0.45878011169415145,1.0,3/14,10.22%,TH;VEGFA;MYO7A
prerank,protein polyglutamylation (GO:0018095),-0.5015603373694933,-1.340859906098894,0.15824915824915825,0.55402448364721,1.0,8/11,27.81%,TTLL7;TTLL11;CFAP20;TTLL5;TPGS1;TTLL9;TTLL4;TTLL6
prerank,blood vessel morphogenesis (GO:0048514),0.4724091258344928,1.3406323267116647,0.0795964125560538,0.46010315243848576,1.0,13/54,14.72%,FLT1;NRP1;VEGFA;SMAD7;EGFL7;CAV1;SYK;CYP1B1;RASA1;TGFBR2;SERPINF2;COL4A1;NF1
prerank,adipose tissue development (GO:0060612),0.6116634381249646,1.340243974173101,0.13892709766162312,0.4605688152941571,1.0,3/11,9.46%,SH3PXD2B;ARID5B;NAMPT
prerank,positive regulation of cell communication (GO:0010647),-0.3895872238911057,-1.33990459005773,0.0847457627118644,0.5519094049925763,1.0,7/28,5.48%,GRIK2;RIMS1;CLSTN2;ANK3;SYT1;CLSTN3;RIMS2
prerank,positive regulation of protein processing (GO:0010954),0.5555423263362598,1.3397151568237335,0.11979166666666667,0.46148084741051787,1.0,5/19,13.42%,ADAM8;KLKB1;LPCAT3;ENO1;MELTF
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4335660767386843,1.3389716854704774,0.029804727646454265,0.4630708523840098,1.0,40/132,20.93%,IGF1;HIF1A;APOE;ADAM8;PIK3CB;PRKCD;OPTN;TRIM6;TFEB;PFKFB3;MSN;PLK2;ABCD2;DXO;SNX33;TNFRSF1B;ABHD5;ZSWIM8;GRSF1;DAPK1;TICAM1;FURIN;ORMDL3;VPS35;TNF;SUPV3L1;FLCN;UFL1;PTTG1IP;SH3D19;IRGM;PIK3C2A;PTPN1;DACT1;SLC4A4;VPS11;ZC3H12A;STK11;ZC3HAV1;MTDH
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5769274046591901,1.3389072796028703,0.10594315245478036,0.4625660994046449,1.0,10/18,21.42%,BAX;ERN1;ATXN3;DDIT3;BCL2L11;NCK1;RNF185;USP13;XBP1;RNFT1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6275833401779468,1.3387557497210227,0.14798850574712644,0.46232660429813965,1.0,1/10,0.04%,XYLT1
prerank,DNA alkylation (GO:0006305),0.5617201828217433,1.3385519267861319,0.134640522875817,0.46158831096850644,1.0,7/19,21.65%,DNMT3A;MTRR;DNMT3B;EHMT1;DNMT1;DMAP1;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),0.5617201828217433,1.3385519267861319,0.134640522875817,0.46158831096850644,1.0,7/19,21.65%,DNMT3A;MTRR;DNMT3B;EHMT1;DNMT1;DMAP1;GATAD2A
prerank,ncRNA export from nucleus (GO:0097064),0.49971599248991655,1.337650557424174,0.1073512252042007,0.46365315630758974,1.0,15/36,27.50%,NUP205;XPOT;NUP188;NOL6;RAE1;NUP42;TPR;NUP54;RANBP2;NUP133;NUP93;NUP98;PHAX;NUP35;AAAS
prerank,organelle organization (GO:0006996),0.4203265939069904,1.337641617612263,0.002002002002002002,0.4629902784142409,1.0,137/388,24.64%,PLEKHM2;ARHGAP21;ARHGAP10;ANK1;MICAL2;VPS13C;APOE;OPTN;ODF2;ABCD4;PAK6;FGD6;MICAL1;FMNL2;GOLGB1;PLAAT3;CHMP4B;CHMP4A;STRIP1;FMNL3;VPS18;PI4K2A;TRAPPC8;ABCD2;TOR1AIP2;SYNE1;NEDD9;SH3KBP1;RAB32;LARP4;SMPD4;GEM;SIRT5;VPS13D;DOP1B;SLC25A33;COG4;ARL1;HTT;ALAS1;CCL13;LONP1;TWNK;DST;PDCD6IP;ATAD3A;CAV1;NRF1;ATP7A;RAB7A;HPS6;VPS4B;YTHDF2;NUMA1;VAPB;CSNK1D;AGTPBP1;RANBP9;RAB1A;GABPB1;AFG1L;CENPT;RANBP10;SLC25A36;TMEM11;SAR1A;PYROXD2;PEX14;PALLD;SIRT3;MARK4;TNFAIP3;GOLPH3;GAK;HUWE1;HAX1;HCFC1;MREG;PI4K2B;FGD5;ARFGEF1;ZMYM4;TRAPPC11;TERT;TRAPPC12;RHOU;RAB3GAP1;DYM;SIRT4;TMED3;PRPF40A;SH3D19;NDP;TRIP11;MTX3;MAPK15;TOR1B;GOLGA2;RHOT2;PIKFYVE;TBC1D20;STX7;VPS11;ABI2;SEC61A1;STOML2;WDR81;BCS1L;POLRMT;SEC16A;ARC;IQCG;LMAN2L;IRAG2;CAPZB;GOLPH3L;DNAJC28;RAB34;ATP5F1B;CDC42;CAMSAP1;PARP1;LMAN1;WDR73;CCL3;ZMYM6;KIF3A;WTIP;STX4;RAB31;ZMYM3;VPS51;CHMP7;ZFYVE16;PPRC1;CENPW;MYO18A
prerank,regulation of response to oxidative stress (GO:1902882),0.6213969427243943,1.3375210390086834,0.12309820193637622,0.4626937460681985,1.0,4/11,11.42%,MCTP1;SELENON;STOX1;AIFM2
prerank,regulation of interleukin-17 production (GO:0032660),0.506885240442679,1.3373321521976143,0.11018957345971564,0.4626060026331979,1.0,8/31,14.47%,RFTN1;SPHK1;LY9;NCKAP1L;DDIT3;IL6;IL2;ZBTB7B
prerank,mRNA modification (GO:0016556),0.547125105941641,1.3372539119152413,0.1092964824120603,0.46218268121235734,1.0,10/22,25.93%,PUS1;TRMT10C;TRUB2;METTL8;DKC1;PCIF1;METTL3;NSUN2;TRUB1;CBLL1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4797082198633662,-1.3369407923094887,0.1213235294117647,0.5549456096871702,1.0,5/13,10.82%,TMEM30A;SORL1;SAR1B;INSIG1;CD81
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5048412756256466,-1.3365947534622162,0.15161290322580645,0.55124318679157,1.0,4/11,19.79%,MEF2C;FRS2;GREM1;BMP2
prerank,epithelium development (GO:0060429),0.4429143328755371,1.3364911554956524,0.044284243048403706,0.4639799628729396,1.0,27/107,20.73%,LGALS3;CTSB;ANXA4;GSTA2;DAG1;FOXJ1;VEGFA;SOX9;PPARG;ANXA7;TPP1;PGK1;CBR1;TST;PTER;CPT1A;TAGLN;RIPK4;IFT122;PIH1D1;LOXL3;ERRFI1;DACT1;TAGLN2;FGFR2;TGFB1;DMBT1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5505804490673963,1.3351572550405932,0.11771995043370508,0.46742795227600664,1.0,7/21,22.40%,VEPH1;DAB2;RBPMS;SH2B1;TGFBR1;TGFB1;NUP93
prerank,innate immune response (GO:0045087),0.42621741334110796,1.3348938980483922,0.009036144578313253,0.46758607098958943,1.0,51/217,19.00%,COLEC12;FGR;CD300LB;SHFL;MFHAS1;PTK2B;TRIM6;TRIM43;CYP27B1;MSRB1;OTULIN;CYBA;AKAP1;MALT1;PPP1R14B;PPARG;TRIM28;SLC11A1;NRROS;ATAD3A;SYK;IRF5;SRPK1;TREM2;CYBB;RNASE7;MASP1;YES1;CYBC1;ADAM15;SRPK2;ZDHHC1;RNASE3;BTK;NCF2;FYN;MASP2;BST2;TBK1;KYNU;TREML1;MBL2;S100B;IRGM;IRAK4;TTC4;FES;PYDC1;ADAR;REL;FRK
prerank,response to interferon-gamma (GO:0034341),0.45951010973171325,1.3348860965875686,0.06352683461117196,0.4669302989293481,1.0,12/67,9.76%,SIRPA;EPRS1;SHFL;CCL4;CYP27B1;IL12RB1;IRF8;CCL13;SLC11A1;ACOD1;DAPK1;CCL14
prerank,cellular glucose homeostasis (GO:0001678),0.4850347901344167,1.3346306616301125,0.09930715935334873,0.4670386756473625,1.0,16/41,23.30%,HIF1A;ADCY8;GCK;ERN1;PCK2;GAS6;PIK3R2;IGF1R;HK3;LRRC8D;TRA2B;HK1;PDK3;XBP1;RACK1;FOXO1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5283901645179915,1.3345110029171696,0.115995115995116,0.46668068321443745,1.0,9/27,13.03%,VPS13C;OPTN;ZDHHC15;VPS13D;ARL1;GCC2;CSNK1D;GOLPH3;GAK
prerank,regulation of viral genome replication (GO:0045069),0.4733668480954807,1.3345001838279622,0.08435072142064373,0.4660396754362336,1.0,19/56,20.35%,ADARB1;SHFL;TNIP1;TRIM6;LARP1;SRPK1;PPIE;RNASEL;PKN2;DDB1;VAPB;SRPK2;TNF;BST2;PABPC1;ADAR;RSAD2;TMEM39A;ZC3HAV1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.44413306602099045,1.333997241350277,0.05268703898840885,0.4668760942692117,1.0,19/98,12.60%,CSF1;APOE;XDH;GRB2;APOA2;PPARD;EIF4G1;VEGFA;ACACA;PPARG;CCNB1;ACOD1;SCYL2;RNF41;CBR1;TGFBR2;RAB1A;ACACB;PID1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5226485042362443,1.3339443743393806,0.13493975903614458,0.46636924314828065,1.0,10/26,23.86%,KMT2A;ETFBKMT;KMT5B;TET3;OGT;PRDM9;KMT2D;EEF2KMT;SETD3;SETD4
prerank,lymphocyte proliferation (GO:0046651),0.5315162455375746,1.3339190341381055,0.11673151750972763,0.4657690877610885,1.0,4/22,3.89%,BCL2;PTPRC;ELF4;MSN
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4238665143069616,-1.3331646840965619,0.10648148148148148,0.5553326283243534,1.0,4/21,3.97%,ST3GAL6;FUT9;B3GALT5;B3GALT1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5631121729351101,1.3328858491358548,0.12236842105263158,0.4681254861280826,1.0,6/18,17.40%,SLC35F6;BAX;HIP1R;MPV17L;BID;ACAA2
prerank,positive regulation of growth (GO:0045927),0.46130626207366704,1.332571571842158,0.07982261640798226,0.4684440380601792,1.0,18/64,18.39%,RFTN1;BCL2;SDCBP;SPHK1;EIF4G1;EIF4G2;DDX49;ADAM17;SLC25A33;INO80;EXOSC9;USP47;IL2;SUPV3L1;CDKN2AIP;SFRP1;WFS1;TGFBR1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.42141879096286505,1.332463812966359,0.004004004004004004,0.46815204368954966,1.0,87/308,21.85%,B4GALT5;CTNNB1;LRP1;ABCA1;PRKCH;ITGAX;NIBAN2;APOE;FGR;SDCBP;FGF2;PEMT;SLC27A1;DYNC1H1;FABP5;BMP1;CYP27B1;VDR;AGO2;FOXJ1;VEGFA;DAB2;SOX9;KDM3A;GCNT2;CADM1;PDPN;KMT5B;UCP2;LRPAP1;BAMBI;CRH;APPL2;CRTAM;SLC11A1;GAS6;ACSL1;CAV1;SYK;TREM2;YBX2;IGF1R;ACADL;EHMT1;NUMA1;VIP;TGFBR2;ADIPOR1;ENO1;C1QBP;RBM19;OGT;PTGER4;IL6;SNX4;ETV4;IL2;ZBED3;ZBTB7B;TNF;HTR2B;TERT;PPARGC1B;OLFM1;TFRC;GNAS;SERPINE1;MED1;DECR1;TGFBR1;AGPAT1;HSF1;HDAC3;FST;ABCA7;XBP1;TGFB1I1;FBXO5;ALMS1;TGFB1;GDNF;PDGFB;NPR1;GLIPR2;ROCK1;ZBTB16;RPS19
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5399693555225166,1.3321530990724215,0.11794871794871795,0.46843523708093715,1.0,7/20,14.32%,AMPD2;AK4;AK3;ATIC;ADSS1;GART;PPAT
prerank,B cell differentiation (GO:0030183),0.47771412392388357,1.331943669623257,0.096,0.46836065946384786,1.0,13/46,17.82%,BLNK;PTPRC;TPD52;ADAM17;HDAC4;PTPN2;KLF6;HDAC9;CEBPG;FNIP1;IRF2BP2;RABL3;ITGA4
prerank,liver development (GO:0001889),0.5028885001078267,1.3318933657238472,0.11189634864546526,0.46783738923351914,1.0,10/32,20.22%,ARID5B;CEBPA;PCK2;CEBPG;IL6;NF1;GFER;CCDC40;XBP1;PHF2
prerank,regulation of feeding behavior (GO:0060259),-0.5209064820281084,-1.3318167699686319,0.1624203821656051,0.5543095504327828,1.0,4/11,11.33%,SGIP1;LEPR;STAT3;CFAP20
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6004881612368219,1.331211016514663,0.13472222222222222,0.4692441927704117,1.0,8/13,25.06%,NCK1;BFAR;UFL1;WFS1;PTPN1;ABCA7;RACK1;PPP1R15B
prerank,regulation of cell-substrate adhesion (GO:0010810),0.48485950702255926,1.3312022387188525,0.1038374717832957,0.4685947523414212,1.0,11/42,14.74%,CORO1C;PIK3CB;GCNT2;PDPN;ATXN3;FZD4;MYADM;LIMS1;RHOA;NF1;MINK1
prerank,positive regulation of protein maturation (GO:1903319),0.6048612727669489,1.3311585644726276,0.13439306358381503,0.4680540910568376,1.0,1/11,1.54%,ADAM8
prerank,pyruvate metabolic process (GO:0006090),0.4718309317034741,1.3310967222126742,0.09070548712206047,0.46756242798412423,1.0,13/52,11.49%,PKM;GCK;PFKL;LDHA;ALDOA;PCK2;ENO2;SLC16A3;PGK1;PDHB;DLAT;ENO1;HK3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.441671675643692,-1.3310923698034813,0.10822510822510822,0.5517680962710979,1.0,6/18,11.96%,SELPLG;CX3CR1;ADD2;VCAM1;ITGB7;JAM2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.463822367969453,1.331070378661167,0.09788654060066741,0.46696407612690655,1.0,13/54,13.02%,XYLT1;B4GALT7;GNS;HEXA;HS3ST3B1;GCNT2;GLB1;NDST1;HS6ST1;GUSB;FUCA1;IDUA;HPSE
prerank,sulfur compound transport (GO:0072348),0.5185486742046942,1.330568243974855,0.1324422843256379,0.46774550623184113,1.0,6/27,11.60%,SLC26A1;SLC6A6;SLC27A1;SLC26A11;SLC26A4;LRRC8D
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6075762530109453,1.3304902524770488,0.12622720897615708,0.4666433277942526,1.0,3/12,7.31%,DYRK2;HOMER2;RCAN1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6075762530109453,1.3304902524770488,0.12622720897615708,0.4666433277942526,1.0,3/12,7.31%,DYRK2;HOMER2;RCAN1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3859141230240678,-1.3298698996759588,0.09497206703910614,0.5505338917440049,1.0,7/26,7.75%,FCHSD2;SNAP91;DNAJC6;SGIP1;PICALM;FNBP1L;AP2S1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5751803879413,1.3298084416906142,0.14325068870523416,0.46816687752746117,1.0,5/15,9.77%,PIK3CB;DAB2;DGKD;HIP1R;SCYL2
prerank,positive regulation of axon extension (GO:0045773),0.542164760183633,1.329609306293691,0.12015018773466833,0.4681423618312652,1.0,6/22,7.07%,MACF1;GOLGA4;NRP1;VEGFA;RUFY3;LIMK1
prerank,dendritic cell chemotaxis (GO:0002407),-0.4849910777617436,-1.3295263407075524,0.1566265060240964,0.5469799855663706,1.0,6/14,22.09%,CCR5;CCR2;CCR1;CCL5;CCR6;TRPM4
prerank,positive regulation of protein depolymerization (GO:1901881),0.6289794204896213,1.329312124978456,0.13019390581717452,0.4683719054023721,1.0,2/11,1.84%,PLEK;NES
prerank,positive regulation of interleukin-17 production (GO:0032740),0.53841520994654,1.3292465540947402,0.1111111111111111,0.46791027941220525,1.0,6/22,14.47%,RFTN1;SPHK1;LY9;IL6;IL2;ZBTB7B
prerank,negative regulation of immune response (GO:0050777),0.42862294130647277,1.3290506808280353,0.015212981744421906,0.4678188859344165,1.0,34/154,14.03%,LGALS3;FGR;NLRC3;ADCY8;ADCY3;RHBDF2;POMC;ADCY7;CD300A;PDCD1;PTGIR;PLK2;ADAM17;SCTR;CRH;SAMSN1;FCRLB;ILRUN;SYK;TREM2;HAVCR2;ACOD1;YES1;LILRB1;GLP1R;VIP;LYAR;C1QBP;FURIN;PTGER4;IL6;TNFAIP3;FYN;GNB1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5052670507058086,1.3288161774850848,0.12232779097387174,0.4678388574810771,1.0,12/30,24.03%,DNAJB14;CCT2;DNAJB13;ERO1A;HSPA9;GAK;SDF2L1;DNAJB12;HSPE1;HSPA2;PTGES3;HSPA13
prerank,DNA-dependent DNA replication (GO:0006261),0.4375423356361735,1.3284829280424797,0.037871033776867964,0.4682485601884333,1.0,60/128,28.92%,PSMD1;ORC3;MCM2;PSMD8;DDX21;PSMA1;MCM7;GMNN;PSMA8;UBA52;TWNK;DBF4;PSMD14;SRPK2;PSMA5;POLA2;PSMD12;MCM8;RFC2;POLE;PSMB10;RPS27A;UBC;NOC3L;RFC1;PNKP;PURA;PSMD2;RECQL5;PSMC4;BLM;PSMD6;PSMD3;PSMD5;TOPBP1;PSMC2;GINS1;PSME4;POLE4;CDK2;PSMB8;PSMA6;PSMB7;PSMD4;MCM6;RAD51;MCM3;PSMA3;CDC34;POLA1;CDC7;MCM5;PSMD10;DDX23;WDHD1;POLG;PSMC6;PSME3;PSMC5;PSMA4
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4913324443924684,1.3284613184250154,0.10635838150289018,0.46766141615814333,1.0,9/39,11.17%,MYO1E;MYO5A;MYO1F;MYO1A;TRAK1;KIF1A;HTT;MYO7A;RAB1A
prerank,import into nucleus (GO:0051170),0.452734214381315,1.328132125010088,0.07717041800643087,0.46797122438152633,1.0,24/73,22.41%,MMP12;PRICKLE1;IPO5;GCKR;E2F3;APPL2;NUP188;SYK;TNPO1;EIF4ENIF1;TNPO2;GEMIN5;TPR;PTTG1IP;NXT2;SNRPF;PPP1R10;GEMIN2;IPO13;NUP133;SNRPD3;NUP93;SNRPD2;SNRPD1
prerank,cardiac conduction system development (GO:0003161),0.5357355567924416,1.3279342127024285,0.1375796178343949,0.4679312670748854,1.0,3/24,3.68%,NPPA;TBX18;SHOX2
prerank,positive regulation of cell development (GO:0010720),-0.38204875136275773,-1.3275471014869091,0.08917197452229299,0.5478983353721164,1.0,6/31,9.77%,CX3CR1;NUMB;RGS14;TGM2;BAD;MME
prerank,leukocyte tethering or rolling (GO:0050901),-0.4430538191081434,-1.3273557393409945,0.13306451612903225,0.5440850070379276,1.0,6/17,11.96%,SELPLG;CX3CR1;ADD2;VCAM1;ITGB7;JAM2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6058438192085909,1.3272470558501452,0.11740890688259109,0.46946216042707517,1.0,4/13,9.41%,APOE;PLEK;CYP27B1;NFKB1
prerank,positive regulation of behavior (GO:0048520),-0.528906845683673,-1.3270379612411494,0.13486842105263158,0.5406115151370922,1.0,5/10,12.95%,NLGN1;MEF2C;SGIP1;CFAP20;NPAS2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.5703243178785511,1.326974000017251,0.15114709851551958,0.4696072369694414,1.0,5/15,19.43%,PPARD;PPARG;LPGAT1;SLC45A3;MID1IP1
prerank,hyaluronan metabolic process (GO:0030212),0.5311500201348758,1.3263000026568823,0.12109862671660425,0.4710591311252464,1.0,6/23,8.85%,SLC9A1;FGF2;HEXA;CD44;HEXB;GUSB
prerank,negative regulation of protein phosphorylation (GO:0001933),0.42924321112338454,1.3261371986805457,0.0274949083503055,0.47088932062493877,1.0,50/150,21.06%,SIRPA;CORO1C;XDH;PTPRC;GNAQ;PRKCD;SNX25;EIF4G1;DTNBP1;HSPB1;PDPK1;SMCR8;PLPP3;SMAD7;SAMSN1;LRP6;TAB1;SPRED2;CAV1;CRKL;CNKSR3;MYADM;TAF7;PAK2;MVP;PMEPA1;NCK1;TESK1;DNAJC10;YWHAG;PID1;UBASH3B;TRIB2;ZBED3;NF1;SPRED3;QARS1;CALM2;SFRP1;LDLRAD4;PYDC1;ERRFI1;TRAF3IP1;PTPN6;ZC3H12A;ITGB1BP1;DGKQ;TGFB1;SIRT2;NCK2
prerank,phosphorylation (GO:0016310),0.4154718647806757,1.3260033088460326,0.006,0.47064635892634116,1.0,111/385,22.54%,FNIP2;FAM20C;CDK14;DGKZ;CDK18;PEAK1;PRKCH;CERK;FGR;GNPTAB;TEC;SGK1;CDK6;PIK3CB;CDK5;PTK2B;PRKCD;CDK8;SGK3;SGK2;SPHK1;MAP4K5;GK;PAK6;PDPK1;MAP4K3;ERN2;IKBKE;DYRK2;PRKCB;PLK2;STK24;STK3;NEK6;SIK1;SPHK2;ERN1;COPS2;TLK1;TAOK3;LIMK1;MAP3K12;COPS8;PI4KA;GAS6;DGKH;SYK;DGKD;SRPK1;PGK1;DAPK1;CDK16;RNASEL;PKN2;PAK2;TGFBR2;CSNK1D;SRPK2;CDK11B;CDK13;MAK;TP53RK;JAK1;BTK;MARK4;MAPKAPK2;FYN;ILK;COQ8B;MAP3K1;TRIB2;CHEK2;STK38L;MINK1;CDC25B;FASTK;PRKG1;HTR2B;TBK1;PNKP;STK38;MAP3K9;LATS1;CDK4;MAP3K20;PRKAG1;MAPK3;HK1;PRAG1;TGFBR1;MARK2;MKNK1;DYRK1B;FRK;TAOK1;PDK3;STK11;DGKQ;NADK;MAPK6;PIK3CA;TGFB1;PDGFB;HIPK1;ROCK1;IRAK1;CSNK1E;BRSK2;GNPTG;BIRC6;CDK2
prerank,sodium ion homeostasis (GO:0055078),0.5450713699022579,1.3250012864323817,0.12372448979591837,0.4730998727591303,1.0,6/21,13.63%,SLC9A1;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP1B3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.50620845458039,-1.3249814778895994,0.10752688172043011,0.5418945185656814,1.0,3/12,6.43%,FUT9;SKAP1;WNK1
prerank,regulation of T cell migration (GO:2000404),-0.4266488507059289,-1.3249620707050243,0.13636363636363635,0.5378029193120537,1.0,9/18,16.39%,DOCK8;APOD;AIF1;LRCH1;RIPOR2;TNFRSF14;CCL5;APP;CCR6
prerank,regulation of angiogenesis (GO:0045765),0.42413178855049716,1.3243294487875956,0.017189079878665317,0.47442656100589015,1.0,35/192,12.87%,GPNMB;FLT1;CTNNB1;HIF1A;ITGAX;NIBAN2;SASH1;FGF2;SPHK1;RUNX1;AGO2;HSPB1;PDPK1;VEGFA;PTPRM;PRKCB;PPARG;HMOX1;ANXA3;MYDGF;ECM1;RNH1;NINJ1;BRCA1;PGK1;CYP1B1;EGLN1;PLXND1;CCN6;KLK3;JUP;IL6;PTGIS;APOH;TNFAIP3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.48200696498057316,-1.324067155619587,0.1423841059602649,0.5360062747215292,1.0,5/12,20.76%,TUBB4A;MAP2;STMN1;CLIP3;DYRK1A
prerank,endodermal cell fate commitment (GO:0001711),-0.5208734451411539,-1.323723232706233,0.15306122448979592,0.5328246294654274,1.0,6/10,40.56%,CDC73;RTF1;LEO1;SOX2;EOMES;SOX17
prerank,retinoid metabolic process (GO:0001523),0.4540258438385325,1.3223382944783058,0.061505832449628844,0.47985393200857757,1.0,15/71,20.06%,LPL;LRP1;APOE;DHRS3;APOA2;RDH12;AKR1B10;RDH13;CYP1B1;NAPEPLD;SCPEP1;RBP4;RDH10;SDC4;RBP1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.44727948800897005,1.3222274107867842,0.06396588486140725,0.4795582671908158,1.0,27/76,19.82%,TNIP1;PRICKLE1;TANK;SPHK1;FBXW7;MALT1;HDAC4;SMAD7;BRCA1;CAV1;GNL3;RWDD3;DCUN1D4;HUWE1;SAE1;CENPX;UBE2L3;PTTG1IP;DCUN1D2;PIAS4;WFS1;DERL1;HDAC3;CENPS;BIRC2;ZC3H12A;RCHY1
prerank,regulation of leukocyte migration (GO:0002685),0.5745353140156162,1.3221917135252224,0.14174252275682706,0.4790096680229448,1.0,4/16,10.24%,VEGFA;HMOX1;NCKAP1L;RHOG
prerank,sphingosine biosynthetic process (GO:0046512),0.605708763902503,1.3220246993409124,0.12912087912087913,0.4782015148647163,1.0,3/11,8.48%,SPHK1;SPHK2;ASAH1
prerank,sphingoid biosynthetic process (GO:0046520),0.605708763902503,1.3220246993409124,0.12912087912087913,0.4782015148647163,1.0,3/11,8.48%,SPHK1;SPHK2;ASAH1
prerank,autophagosome organization (GO:1905037),0.4684316172726486,1.3220005894317564,0.09131403118040089,0.4776070817880587,1.0,22/50,27.88%,ATG7;RUFY4;ATP13A2;TMEM41B;PACS2;WDR45;RAB7A;RAB1A;BECN1;ATG2B;ATP2A2;MAP1LC3B;ATG16L1;IRGM;ATG13;UBQLN1;GABARAP;AMBRA1;UBQLN2;ATG2A;RAB43;VMP1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5741456577252649,1.3219364896622319,0.14647137150466044,0.47714687788424387,1.0,7/16,15.91%,SPHK2;AK4;VCP;TREM2;ENO1;PID1;FLCN
prerank,negative regulation of gene expression (GO:0010629),0.4181953656791849,1.3217720350251057,0.004,0.4770168319392555,1.0,74/302,16.50%,GPNMB;IGF1;DNMT3A;HIF1A;APOE;EPRS1;XDH;FGF2;ATP2B1;TRIM6;VDR;CLDN19;RUNX1;AGO2;VEGFA;SMCR8;FBXW7;DXO;PATL2;NPTN;LARP1;NCL;ID2;NOCT;LSM14A;ERN1;CNOT10;PHF1;HDAC9;CELF1;SLC11A1;DLL4;ENC1;ANXA7;RNH1;MTF2;CRKL;STOX1;HAVCR2;DIP2A;NFKB1;MYADM;FXR2;DAPK1;DNMT3B;EED;YTHDF2;TLE5;WWP2;EIF4ENIF1;ZNF148;TIPARP;PTBP3;CREBZF;PTGER4;RPL13A;AGO3;MSR1;RPS26;TNF;DNMT1;AGO4;YY1;RIDA;CPEB3;TERT;FLCN;HDAC1;PAIP2;OLFM1;DCP2;EIF4E2;CNOT9;CAPRIN1
prerank,regulation of protein localization (GO:0032880),0.4514295080635125,1.3213225282594536,0.09748083242059145,0.47768621068610684,1.0,21/58,23.50%,PLEKHM2;CTSD;TRIM6;FBXW7;DNAJB6;STX6;SLC26A4;VIP;RAB9A;TESK1;TRIM67;TPR;UFL1;USP8;AFDN;SUMO1;CSNK1E;PARP1;KDM1A;RACK1;HSP90AB1
prerank,gliogenesis (GO:0042063),0.5758357229115232,1.321121170954467,0.14189189189189189,0.4776722124871853,1.0,2/15,1.41%,CD9;CDK6
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.519141426919165,1.320799802120504,0.12484548825710753,0.4779857964806246,1.0,6/25,12.30%,FGF13;TBX18;CAV1;PKP2;JUP;ATP2A2
prerank,mitochondrion organization (GO:0007005),0.42447546488919013,1.3207365859734888,0.022267206477732792,0.4775296346781578,1.0,67/165,26.43%,BCL2L1;VPS13C;MGARP;TRAK1;SAMM50;TIMM44;RAB32;SIRT5;VPS13D;SLC25A33;BAX;ALAS1;AFG3L2;LONP1;TWNK;DNM2;ATAD3A;TOMM5;MTFP1;TOMM22;PITRM1;NRF1;ATP7A;TOMM40;COX7A2L;AGTPBP1;GABPB1;AFG1L;AIFM2;SLC25A36;TMEM11;PYROXD2;PID1;SIRT3;BID;BIK;TIMM23;HSPD1;HAX1;HCFC1;SUPV3L1;TERT;SIRT4;FBXO7;MIGA2;MTX3;COX7A2;RHOT2;FMC1;STOML2;WDR81;BCS1L;POLRMT;HIGD2A;FIS1;ATP5F1B;PARP1;TIMM9;USP30;SPG7;PPRC1;PRDX3;CYCS;TIMM17A;OMA1;OPA1;MTFR1L
prerank,T cell differentiation in thymus (GO:0033077),0.5805411124160755,1.3206754621533168,0.15512465373961218,0.4770747175190811,1.0,4/14,16.35%,PTPRC;ADAM17;RIPK3;RABL3
prerank,calcium ion import into cytosol (GO:1902656),-0.46902279496141985,-1.32064526101095,0.14122137404580154,0.5363836403246369,1.0,4/15,13.02%,CACNA2D1;SLC8A3;SLC8A2;SLC24A2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3267347133013656,-1.3205552110605074,0.0625,0.5326474764502078,1.0,34/75,21.26%,OPHN1;MEF2C;CTNNA2;BTBD3;MAP2;ANK3;CNTN4;MAP1B;NTNG1;RAB3A;PARD3;SLITRK4;NEFH;DSCAML1;DCC;PLPPR4;MAP6;S100A6;DCDC2;BRSK1;SPTBN4;SLITRK2;DRD2;APP;MEF2A;APBB1;PAX2;SDC2;ZDHHC17;RAB10;CCK;ABITRAM;ATL1;SLITRK5
prerank,positive regulation of T cell differentiation (GO:0045582),0.4884626627344914,1.320134675403107,0.09608540925266904,0.478019062023447,1.0,7/36,11.18%,ZMIZ1;ADAM8;IL12RB1;NCKAP1L;BCL6;SART1;TNFSF9
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4454226388214362,1.3194545534819937,0.06645569620253164,0.4794558248957577,1.0,12/92,6.02%,NRP2;HIF1A;IQSEC1;SASH1;FGF2;PIK3CB;NRP1;PTK2B;RIN2;VEGFA;SOX9;ANXA3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.48795810075672574,1.319288736249477,0.11214953271028037,0.479335321786952,1.0,10/40,12.60%,BCL2;BCL2L1;SLC25A33;BAX;VCP;STOX1;TUSC2;CCN6;SLC25A36;PID1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.45804112241398803,1.3191501650353976,0.08172043010752689,0.4791363875493044,1.0,20/68,19.74%,FLAD1;SLC23A2;SLC23A1;ABCD4;SLC46A1;SLC2A1;SLC52A2;PDXK;FPGS;MTHFS;MTRR;MTHFR;MTHFD2;SLC19A1;AASDHPPT;GSTO1;SLC5A6;MMUT;SLC25A32;CYB5R3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4269132622770744,1.3189661446242644,0.029322548028311426,0.4790672054764513,1.0,55/163,23.79%,RFTN1;BCL2;TEC;PSMD1;LAT;BLNK;PIK3CB;PTPRC;PSMD8;PDPK1;MALT1;TRAT1;PRKCB;PSMA1;SPG21;NCKAP1L;PSMA8;PLEKHA1;NFKBIZ;SYK;PIK3R2;NFKB1;BTN3A3;PAK2;PSMD14;NCK1;LAT2;PSMA5;THEMIS2;BTK;PSMD12;FYN;FBXW11;PSMB10;FYB1;EIF2B2;PSMD2;SPPL3;PSMC4;DENND1B;TNFRSF21;CUL1;STOML2;ZC3H12A;PSMD6;PIK3CA;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;CHUK;PSMB7;PSMD4
prerank,cellular response to interleukin-1 (GO:0071347),0.43093763822398845,1.3186741972953966,0.04892966360856269,0.47928994917231,1.0,50/143,25.22%,HIF1A;SIRPA;IRAK2;PSMD1;CCL4;TANK;PSMD8;SQSTM1;SOX9;PSMA1;PSMA8;UBA52;CCL13;TAB1;NFKB1;ACOD1;CCL14;MAP3K8;PSMD14;PSMA5;PTGIS;TNIP2;PSMD12;FBXW11;PSMB10;RPS27A;UBC;PSMD2;SFRP1;PSMC4;MAPK3;IRAK4;CUL1;ZC3H12A;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;IRAK1;PSMB8;CCL3;PSMA6;CHUK;PSMB7;IL1R1;PSMD4;PELI2;EGR1;PSMA3
prerank,Golgi to plasma membrane transport (GO:0006893),0.47478926786394177,1.3174183965553528,0.09777777777777778,0.48252218168409877,1.0,20/47,22.19%,RABEP1;MACF1;GOLGA4;OPTN;ARFGEF2;GCC2;VAMP2;EXOC2;LLGL1;GOLPH3;GGA2;VAMP4;CCDC93;CCDC22;VPS35L;EXOC4;BBS2;ARFRP1;GOLPH3L;RAB34
prerank,macroautophagy (GO:0016236),0.4351326723716524,1.3173115193541125,0.043478260869565216,0.48216475337636416,1.0,40/118,24.01%,TCIRG1;ATG7;TECPR1;ATP13A2;PLEKHM1;SQSTM1;CHMP4B;CHMP4A;STAM2;LIX1L;VCP;VTA1;ILRUN;ARL8B;TOMM5;TOMM22;TOMM40;VPS4B;PLAA;LAMP2;CSNK2A2;ATG10;BECN1;LIX1;MAP1LC3B;MTMR14;MVB12A;ATG16L1;PRKAG1;PIP4K2A;ACBD5;CLN3;VIPAS39;ATG13;VPS39;MTERF3;UBQLN1;GABARAP;YOD1;AMBRA1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.49725958851485985,1.3172279080694347,0.1364190012180268,0.4817901285496703,1.0,16/30,27.75%,TAF1D;POLR2H;UBTF;TTF1;POLR1A;MNAT1;TAF1A;GTF2H1;POLR1G;TAF1C;ERCC2;TBP;CCNH;POLR1H;POLR1F;POLR1C
prerank,regulation of sequestering of calcium ion (GO:0051282),0.606259468604803,1.3165038373215925,0.1383737517831669,0.48336119534322347,1.0,4/12,22.09%,PTK2B;UBASH3B;FKBP1B;ANXA6
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.532555538431612,1.315850488683986,0.12337662337662338,0.48470931222932173,1.0,5/21,8.56%,CTNNB1;LRP6;FZD1;FRAT1;CAV1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6255543593062853,1.3153248685069872,0.1598240469208211,0.48573103001025153,1.0,2/10,1.59%,XDH;PIK3CB
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4427294699165399,1.3153045976018554,0.061780104712041886,0.48513271429668486,1.0,29/100,20.97%,IGF1;FLT1;FN1;FGR;PDGFA;NLRC3;FGF2;PIK3CB;PPP2R5C;SOX9;MYDGF;MYOC;PIP5K1C;PIK3R5;TREM2;IGF1R;BECN1;CBL;HAX1;TNF;PIP5K1A;PIP4K2A;MAPK3;STAMBP;PTPN6;EPO;NEDD4;PIK3CA;PDGFB
prerank,cellular response to chemical stress (GO:0062197),0.43133434844461316,1.3152702688852644,0.05981112277019937,0.4845776275419331,1.0,41/96,27.70%,ATG7;NFE2L2;MSRA;ATP13A2;CYBA;CPEB2;SRXN1;NCF4;LONP1;ERO1A;CAV1;STOX1;CAT;CYBB;ALDH3B1;PRDX1;LRRC8D;NCF2;SESN2;TMEM161A;GSR;ZC3H12A;PIK3CA;SIRT2;EIF2S1;ERMP1;NUDT2;NOX4;PARP1;TXNRD2;FOXO1;STX4;ABL1;PRDX3;CYCS;TXNRD1;PRDX5;PRDX6;SOD2;GPX3;PRR5L
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.47198965015744326,-1.3144607907523769,0.12367491166077739,0.5441620230733629,1.0,5/13,16.18%,CCR2;GRM3;EDNRB;DRD2;ADGRV1
prerank,tRNA transport (GO:0051031),0.49397334045775676,1.3140880574117002,0.1260115606936416,0.4875118647193496,1.0,14/35,27.50%,NUP205;XPOT;NUP188;NOL6;RAE1;NUP42;TPR;NUP54;RANBP2;NUP133;NUP93;NUP98;NUP35;AAAS
prerank,regulation of leukocyte activation (GO:0002694),0.5744562655731378,1.314032381024452,0.1523545706371191,0.4870145898438737,1.0,2/14,1.78%,GPR137B;MFHAS1
prerank,cellular response to dsRNA (GO:0071359),0.5701908969592352,1.3140049964911977,0.15220293724966621,0.48646750637562663,1.0,4/15,13.95%,COLEC12;CAV1;DHX9;RIOK3
prerank,calcium ion transport into cytosol (GO:0060402),-0.41858843460275164,-1.3134543399010405,0.1013215859030837,0.5425627969481275,1.0,5/21,8.84%,CACNA2D1;GRIN2B;GRIN2A;GRIN1;CACNA1C
prerank,detection of mechanical stimulus (GO:0050982),0.5391199985979555,1.313339041224974,0.13157894736842105,0.48784998792896084,1.0,4/19,13.37%,CTNNB1;PIEZO1;JUP;PKD1L2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4641380925144061,1.313302368157528,0.10022271714922049,0.4873115186216352,1.0,20/55,20.97%,XDH;EIF6;GRB2;SPHK2;SIRT5;SLC25A33;BRCA1;ACOD1;CYP1B1;RNF41;CBR1;TGFBR2;CCN6;PARL;PID1;PIKFYVE;ZC3H12A;PDK3;SIRT2;PDGFB
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.45339289480111383,1.312823566052029,0.0889132821075741,0.48819366314303964,1.0,21/62,22.04%,BCL2;BCL2L1;NFE2L2;PLAUR;NOC2L;MCL1;HSPB1;ENO1;MDM2;MAPK7;ARHGEF2;PTTG1IP;TMEM161A;TXNDC12;BCL2L2;EPO;XBP1;NOL3;YBX3;HERPUD1;SYVN1
prerank,male meiosis I (GO:0007141),0.5731336492470976,1.3124901249928598,0.13941018766756033,0.48855658576458016,1.0,4/16,17.04%,SLC25A31;HSF2BP;FOXJ3;SYCP3
prerank,hexose metabolic process (GO:0019318),0.4878942112821824,1.3122924707890498,0.12514484356894554,0.4885410090227934,1.0,17/39,26.64%,SORD;PPARD;GAA;GALK2;AKR1A1;ALDOA;FUOM;FUCA1;HECTD4;HK1;FPGT;PGM1;CHST1;ALDOC;ADPGK;OMA1;GALT
prerank,protein stabilization (GO:0050821),0.4202833097093315,1.3119750669517192,0.032388663967611336,0.48887372004157204,1.0,60/168,24.98%,IGF1;GNAQ;PRKCD;HYPK;CSN3;APOA2;FBXW7;FLNA;STK3;PLPP3;SMAD7;CCT2;GTPBP4;USP9X;HIP1R;LAMP2;BAG3;USP2;TNIP2;USP36;ATP1B3;MCM8;NAA16;HSPD1;ZBED3;EFNA1;CHEK2;HCFC1;CCT5;HIP1;RABL3;PIN1;USP13;IRGM;PFN1;NAA15;WFS1;CDC37L1;TBRG1;WDR81;NCLN;LAMP1;SEC16A;USP33;FLOT2;MFSD1;SUMO1;CRTAP;SYVN1;CALR;PARVA;RPS7;PTGES3;PER3;CCNH;HSP90AB1;EP300;USP19;RPL23;PTEN
prerank,positive regulation of acute inflammatory response (GO:0002675),0.571415872638473,1.3119217695742593,0.12985274431057564,0.48837716288995486,1.0,4/14,18.78%,ADAM8;IL6;TNF;PTGER3
prerank,plasma membrane organization (GO:0007009),0.4583483516045641,1.3117747844467003,0.08791208791208792,0.48817591376836045,1.0,11/61,10.16%,MYOF;AHNAK2;FER1L5;TLCD1;CHMP4A;ABCD2;SNX33;TLCD2;ANO6;ARL8B;OSBPL2
prerank,regulation of centrosome cycle (GO:0046605),0.5230312257488661,1.3116519692956008,0.1484771573604061,0.48793422603996195,1.0,8/21,15.70%,CHMP4B;PDCD6IP;ATF5;VPS4B;MARK4;NAT10;GEN1;FBXW5
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4963815110898312,1.3116079567365564,0.11421911421911422,0.4874122246579385,1.0,12/33,21.65%,APOE;FGF2;PPARG;CARD10;DLL4;RHOA;JUP;ANGPT2;TNF;ITGB1BP1;TGFB1;NOTCH1
prerank,inorganic anion transport (GO:0015698),0.46699292747310783,1.3115507201777519,0.10414333706606943,0.4869447147658149,1.0,13/53,19.16%,PACC1;SLC26A1;ANO9;CLIC4;SLC26A11;ANO8;ANO6;SLC11A1;SLC26A4;CLIC5;CLCN4;TTYH3;SLC25A14
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.604910379956804,1.311483642902587,0.14905149051490515,0.48586529800002826,1.0,6/12,17.65%,IGF1;SLC9A1;LMCD1;TNF;CHERP;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.604910379956804,1.311483642902587,0.14905149051490515,0.48586529800002826,1.0,6/12,17.65%,IGF1;SLC9A1;LMCD1;TNF;CHERP;SPPL3
prerank,positive regulation of myelination (GO:0031643),0.6043393688565977,1.3110501627366982,0.15543328748280605,0.4865955383871657,1.0,5/11,14.30%,ITGAX;CST7;TNFRSF1B;EGR2;NCMAP
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4986375435759674,1.3110453314362254,0.12454212454212454,0.4859757248210687,1.0,7/32,10.73%,PEMT;SLC27A1;APOA2;CHKB;LPCAT1;LPCAT3;CSNK2A2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5532395227667051,1.3109356790520283,0.1456953642384106,0.4856768731089555,1.0,7/18,20.66%,RUNX1;COLGALT1;PDPN;IL6;MELTF;EFEMP2;TGFB1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5096831304113781,1.3106437077419804,0.14004914004914004,0.4859369232497861,1.0,5/26,8.56%,MFHAS1;CYBA;WDFY1;NINJ1;CAV1
prerank,cardiac muscle cell differentiation (GO:0055007),0.5309381360453967,1.3101637607308274,0.15286624203821655,0.48672130099068983,1.0,6/21,12.09%,VEGFA;SHOX2;AKAP13;SIK1;ALPK3;SLC8A1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.45091819230800706,1.3101420392563206,0.088139281828074,0.48616924572492176,1.0,7/63,9.97%,LGALS3;IGF1;TRAF2;SIAH2;HTT;CAV1;PAK2
prerank,aggrephagy (GO:0035973),0.5111194654024336,1.3101282955089948,0.14234016887816647,0.4855715101252872,1.0,11/27,19.57%,DYNC1H1;SQSTM1;VIM;UBA52;IFT88;DYNC1LI2;WDFY3;RPS27A;UBC;ACBD5;WDR81
prerank,regulation of protein catabolic process (GO:0042176),0.43429068829685946,1.3099641203475036,0.06360792492179354,0.48542703517447716,1.0,37/99,21.89%,ATG7;WDR91;CTSA;C4BPA;C4BPB;ATP13A2;FLNA;PLK2;SF3B3;AZIN1;FZR1;VCP;SEC22B;RAB7A;EEF1A1;RNF41;WWP2;DDB1;VIP;MDM2;TIPARP;FURIN;STX5;TNFAIP3;FAM83D;HUWE1;CHEK2;TNF;PIN1;ODC1;RILP;DACT1;GFAP;NEDD4;SIRT2;CENATAC;EEF1A2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6101675806222675,1.3097706825532116,0.14206128133704735,0.48542525370305595,1.0,5/12,21.61%,APOBEC1;TRIM28;DNMT1;MPHOSPH8;RESF1
prerank,cellular component assembly (GO:0022607),0.41557210249946347,1.3095414129188374,0.01,0.4854838172046673,1.0,71/253,18.24%,MITF;FBLIM1;LCP1;KMT2A;EPRS1;PDGFA;PTK2B;TRAF2;NOC2L;TUBGCP4;WIPF1;MICAL1;FOXJ1;CAPG;TLCD1;SOX9;SKAP2;FLNA;NEDD9;RHOQ;SLC2A1;NCKAP1L;TLCD2;CYFIP1;CARD10;MAGI1;LAMC1;RHOD;AFG3L2;DNAJB13;GAS6;NDUFAF1;FZD1;ACD;TAPBP;SPAG16;PKP2;CHAF1B;MDN1;PARVB;PPP2R1A;BAIAP2;YTHDF2;RHOG;VAMP2;RANBP9;LIMS1;MDM2;RHOA;GEMIN5;MYO9A;PEX14;LLGL1;TRIP13;ELOB;ILK;ESPN;SYCP2;MNAT1;DLG4;BAIAP2L1;LPXN;RHOU;CORO1B;VASP;BAIAP2L2;CCDC40;TSPAN4;SYCE2;KPNA3;VAMP3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5582329610551527,1.3094340670992104,0.1495956873315364,0.48517663745776207,1.0,6/18,21.51%,DOCK2;FER1L5;SYK;SBNO2;FCER1G;IFI35
prerank,establishment of protein localization to organelle (GO:0072594),0.4477919718643349,1.3092376551569296,0.07841031149301826,0.4851537869906854,1.0,23/72,22.40%,MMP12;PRICKLE1;IPO5;GCKR;E2F3;ZDHHC15;APPL2;NUP188;SYK;LAMP2;TNPO1;EIF4ENIF1;TNPO2;TPR;PTTG1IP;NXT2;HK1;PPP1R10;CD68;LAMP1;IPO13;NUP133;NUP93
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5598745965464671,1.3091538267608651,0.1419098143236074,0.4847917242909158,1.0,6/18,17.53%,NLRC3;B4GALT7;CD300A;SKI;NF1;SFRP1
prerank,heart process (GO:0003015),-0.471819996765451,-1.3084373497121586,0.11244979919678715,0.5510497728013093,1.0,3/14,8.11%,SGCZ;SGCD;SOD1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.46819726648406895,1.308217404407706,0.0883668903803132,0.4869985320465944,1.0,32/53,33.05%,PSMD1;PSMD8;PSMA1;AZIN1;PSMA8;PSMD14;PSMA5;PSMD12;PSMB10;PSMD2;ODC1;PSMC4;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;PSMA2;PSMC3;PSMD7;PSMD13
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5332074220962916,1.3082021214390938,0.1692111959287532,0.4864191997015586,1.0,10/20,23.50%,HSPA4;CCT2;LONP1;NDUFAF1;BBS10;HSPD1;PSMG3;PTGES3;PFDN6;HSP90AB1
prerank,mucosal immune response (GO:0002385),-0.46082276134230094,-1.3077661836285588,0.12260536398467432,0.5487393833371088,1.0,5/15,25.57%,OTUD7B;RPL39;CAMP;IFNLR1;LTF
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.31140738034000276,-1.3073709140338552,0.045454545454545456,0.5458544518342489,1.0,8/76,4.23%,P2RY12;CX3CR1;CHRM2;GRM1;GNA15;HTR2C;GRM5;TGM2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4577603160029075,1.3073167732213251,0.09257265877287406,0.4884945095966141,1.0,18/61,20.97%,ERCC6;EYA4;FGF2;OTUD4;TRIM28;RAD50;USP9X;BRCA1;ABRAXAS1;GNL3;CEBPG;DHX9;UIMC1;BABAM2;TMEM161A;PPP1R10;BRCC3;PDGFB
prerank,cellular response to nutrient levels (GO:0031669),0.4513778326975996,1.307090346815563,0.08568329718004339,0.48856057235442735,1.0,21/62,24.63%,LPL;ATG7;RRAGD;TFEB;EIF4G1;STK24;WDR45;NUPR2;LAMP2;MAP1LC3B;FNIP1;FLCN;KLF10;SFRP1;CD68;XBP1;USP33;RRAGC;FOXO1;RALB;GAS2L1
prerank,negative regulation of telomere maintenance (GO:0032205),0.562262630365073,1.3069701190710188,0.14829931972789115,0.48834112615197206,1.0,9/15,27.92%,TNKS2;ERCC1;RAD50;SLX4;ERCC4;TERF1;PARP1;TERF2IP;TERF2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6234629643976671,1.306373202226512,0.18023255813953487,0.48951530454546177,1.0,5/10,14.12%,NELL1;RIC1;RGP1;FURIN;EFNA1
prerank,glycerolipid catabolic process (GO:0046503),0.5372404508674187,1.306099568935457,0.14456233421750664,0.48971748276463367,1.0,6/19,15.18%,ABHD12;MGLL;GDPD3;SMPD4;LYPLA2;PNPLA6
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.43339267416410476,1.3057049200720694,0.06309148264984227,0.4903025493996659,1.0,24/93,17.43%,BCAR3;FNIP2;TRIM6;EIF4G1;VEGFA;SMAD7;CD44;GAS6;CAV1;STOX1;CNKSR3;NCK1;DOCK7;RAF1;IL6;FNIP1;SH2D3C;HAX1;TNF;TBK1;CNOT9;TFRC;LATS1;IRGM
prerank,smooth muscle cell differentiation (GO:0051145),0.5955810651624474,1.3056837569229518,0.17275280898876405,0.48976114531341897,1.0,3/12,4.69%,MRTFA;TBX18;MRTFB
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5723902629099612,1.3054496018815807,0.1553133514986376,0.48984619178815375,1.0,3/14,15.41%,CSF1;TNF;ATP6AP1
prerank,positive regulation of actin nucleation (GO:0051127),-0.5129351831988603,-1.3053073528609778,0.1575091575091575,0.5472629759296043,1.0,3/11,1.90%,FCHSD2;NCKAP1;WASF2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4537806419900335,1.3053032067787411,0.12104689203925845,0.4896452236604437,1.0,22/58,22.33%,ERCC6;NSMCE2;CYREN;ERCC1;RAD50;BRCA1;ABRAXAS1;PSMD14;DCLRE1A;ERCC4;SETMAR;LIG3;UIMC1;BABAM2;UBE2V2;KDM2A;PIAS4;DCLRE1C;POLM;BRCC3;SUMO1;XRCC5
prerank,transcription by RNA polymerase I (GO:0006360),0.48577654890662664,1.3050746249374718,0.11913357400722022,0.4896881094767717,1.0,18/34,27.75%,TAF1D;POLR2H;UBTF;TTF1;TCOF1;POLR1A;MNAT1;TAF1A;GTF2H1;POLR1G;TAF1C;ERCC2;MAPK3;TBP;CCNH;POLR1H;POLR1F;POLR1C
prerank,regulation of mitotic cell cycle (GO:0007346),0.4195632955879725,1.3046110684427092,0.03423967774420947,0.4904665614656067,1.0,74/171,30.08%,IQGAP1;SDCBP;PSMD1;ANAPC15;SPHK1;PSMD8;PSMA1;NEK6;SIK1;FZR1;PSMA8;CCNB1;ANAPC1;DYNLT3;TTLL12;PKN2;DDB1;PSMD14;CDK11B;CDK13;MDM2;PSMA5;USP2;PSMD12;EIF4E;PSMB10;CDC25B;CCDC57;PIN1;PSMD2;CDC26;PSMC4;ERCC2;DUSP3;UBE2C;HSF1;ASNS;CUL1;HNRNPU;PSMD6;CUL9;FBXO5;PSMD3;TGFB1;PSMD5;RNF20;PSMC2;THAP1;PSME4;PRMT5;PSMB8;PSMA6;SCRIB;ANAPC7;PSMB7;PSMD4;EIF4EBP1;SMOC2;PSMA3;PSMD10;ANAPC11;CKS2;CDK5RAP3;PSMC6;PSME3;PSMC5;PSMA4;FOXC1;BTRC;CDC16;BORA;PSMB6;PKMYT1;TRIM35
prerank,positive regulation of T cell proliferation (GO:0042102),0.45688214740005023,1.3045646230750296,0.11,0.48999266644647066,1.0,11/55,13.83%,IGF1;PTPRC;CD274;IL12RB1;SLC7A1;NCKAP1L;SYK;NCK1;TNFSF9;IL6;IL2
prerank,regulation of tissue remodeling (GO:0034103),0.5455003846642691,1.3042555757079641,0.14624505928853754,0.49024592211205964,1.0,3/18,8.74%,GPNMB;RUNX1;SUCO
prerank,negative regulation of reproductive process (GO:2000242),0.5478779145929366,1.3040557527094356,0.15038560411311053,0.49019883930437996,1.0,1/17,0.06%,IGF1
prerank,alcohol catabolic process (GO:0046164),0.6147004007397245,1.3039998142470424,0.17543859649122806,0.48974275962892827,1.0,5/10,19.38%,APOE;CEL;SRD5A3;SNX17;SCARF1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5312146269285039,1.3038675437354244,0.13227513227513227,0.4895228066086354,1.0,6/20,9.96%,SLC27A1;FBXW7;SIK1;BRCA1;PRMT3;ACADL
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5099700853012974,1.3037698749139481,0.13944723618090452,0.4891860657941513,1.0,8/25,18.79%,ITGAX;ITGA5;CD200R1;NINJ1;PKP2;JUP;ITGA4;ITGB2
prerank,embryonic skeletal system development (GO:0048706),0.4856764059469606,1.3037226259928627,0.13058823529411764,0.4887069342912266,1.0,3/35,2.74%,XYLT1;HOXA4;KIAA1217
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5308783166553012,1.303439196223945,0.1471698113207547,0.48896249764173677,1.0,6/21,18.09%,IGF1;SOX9;PTGER4;HTR2B;MAPK3;MAP2K2
prerank,cholesterol metabolic process (GO:0008203),0.44895034152809155,1.303239198239005,0.09570957095709572,0.48892646936392953,1.0,10/68,6.88%,ABCA1;ABCG1;APOE;PLPP6;APOA2;CEL;SOAT1;PPARD;SOAT2;CH25H
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4342493319067169,1.3032213190934867,0.08054393305439331,0.48837551774761906,1.0,41/85,28.69%,PRICKLE1;DAB2;FBXW7;RNF180;CEBPA;SMAD7;USP5;ATXN3;VCP;TREM2;SOCS5;RNF14;CSNK1D;MDM2;ELOB;TRIB2;RNF185;USP13;HECTD1;RNF19A;RCHY1;SIRT2;PSMC2;SUMO1;RNFT1;CSNK1E;SUMO2;NUB1;RNF19B;RACK1;GABARAP;GSK3B;PIAS1;BBS7;PSMD10;RAD23A;BAG2;HSPBP1;PSMC6;FMR1;PSMC5
prerank,positive regulation of endocytosis (GO:0045807),0.4666273232122717,1.3027928917668063,0.11422172452407615,0.4890969680183574,1.0,10/45,9.47%,LRP1;APOE;STAP1;DAB2;AXL;NCKAP1L;APPL2;ANO6;TREM2;HNRNPK
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5943854578072219,1.3026439770425293,0.16570605187319884,0.48897679522874044,1.0,2/12,1.57%,B4GALT5;CHRNB2
prerank,hepaticobiliary system development (GO:0061008),0.5326739584371382,1.3024101374386678,0.15077319587628865,0.4890624154189978,1.0,7/20,20.22%,ARID5B;CEBPA;CEBPG;NF1;GFER;XBP1;PHF2
prerank,tRNA wobble uridine modification (GO:0002098),0.5772861266354279,1.3021914635237075,0.1680327868852459,0.48912716953933677,1.0,8/14,25.19%,GTPBP3;TRMU;ALKBH8;MOCS3;KTI12;ELP1;MTO1;ELP3
prerank,regulated exocytosis (GO:0045055),0.4198291668705395,1.3021305989824252,0.022267206477732792,0.4886863978568658,1.0,34/173,12.79%,IGF1;CD9;FN1;TLN1;PLEK;ANXA5;PDGFA;LHFPL2;SYNGR1;CDK5;A2M;CPLX4;CHID1;VEGFA;PSAP;FLNA;TOR4A;APLP2;DNAJC5;GTPBP2;CYB5R1;PROS1;ECM1;ALDOA;PIP5K1C;GAS6;LAMP2;ARHGAP17;VAMP2;SYT8;SERPINF2;LY6G6F;APOH;FAM3C
prerank,sulfur amino acid metabolic process (GO:0000096),0.5240729648906497,1.3019112960992025,0.1475826972010178,0.4887450202287826,1.0,12/24,26.03%,MSRA;MTRR;AHCY;MTHFR;TST;MPST;CDO1;MMUT;NOX4;MTHFD1;CBS;CTH
prerank,regulation of macrophage differentiation (GO:0045649),0.5739668609704295,1.3016550708239532,0.1553133514986376,0.4888819429359742,1.0,3/15,5.88%,CSF1;PTPN2;ID2
prerank,tRNA wobble base modification (GO:0002097),0.5710062816338174,1.3012440586254959,0.14572192513368984,0.48948219585089364,1.0,7/14,25.19%,ALKBH1;GTPBP3;ALKBH8;MOCS3;KTI12;MTO1;ELP3
prerank,superoxide anion generation (GO:0042554),0.5877992011991252,1.301243387653863,0.1634349030470914,0.48887768386761316,1.0,4/13,12.62%,CYBA;NCF4;CYBB;NCF2
prerank,membrane depolarization (GO:0051899),0.4953447516547686,1.3011995832049537,0.13205282112845138,0.4884220075584926,1.0,3/32,1.57%,CACNA1A;P2RX4;CHRNB2
prerank,mitochondrial membrane organization (GO:0007006),0.4910948797371203,1.3010397386751311,0.13341493268053856,0.48828992719925063,1.0,10/32,17.84%,BCL2;BCL2L1;SAMM50;IMMT;RCC1L;HSPA9;SLC25A31;TMEM11;GHITM;MTX3
prerank,regulation of peptidase activity (GO:0052547),0.5438826039123972,1.300917045024831,0.13350449293966624,0.4880584832378124,1.0,8/19,17.45%,ATP13A2;CST7;ECM1;CAV1;FURIN;CSTB;HDAC1;MAPK12
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4910189335661986,1.3008784955072277,0.11970979443772672,0.4876003933524803,1.0,8/33,12.73%,CORO1C;APOE;PTPN23;PTPRM;DLL4;ADIPOR1;EVL;APOH
prerank,mitochondrial transport (GO:0006839),0.45492793019948685,1.30047018457742,0.10857142857142857,0.4881722941946924,1.0,19/53,25.73%,BCL2;BCL2L1;MGARP;TIMM44;TOMM5;TOMM22;PITRM1;TOMM40;SLC25A31;TIMM23;FLVCR1;FBXO7;SLC25A13;BCS1L;FIS1;TIMM9;SPG7;TMEM14C;TIMM17A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5572866888963446,1.30002998787728,0.1436241610738255,0.488880312532264,1.0,10/17,28.40%,NFE2L2;HSPB1;TREM2;P4HB;MAPK7;NOL3;UBQLN1;SOD2;BAG5;HTRA2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.47383309387891037,-1.2993969309954565,0.17883211678832117,0.557725479565754,1.0,7/14,18.46%,IL18;CCR2;CD81;LGALS9;EBI3;PTPN22;CD55
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.43785912236129954,1.2984502433131249,0.07931404072883172,0.49304079007200413,1.0,25/74,21.50%,CTNNB1;SDCBP;DAG1;DAB2;GCNT2;PDPN;SMAD7;BAMBI;NKX2-1;SPRED2;TGFBR2;ADIPOR1;PHLDB1;IL6;EFNA1;SPRED3;OLFM1;BMP5;SFRP1;LDLRAD4;TGFBR1;MCRIP1;TGFB1I1;TGFB1;GLIPR2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.484643045242214,1.298438448306288,0.13302217036172695,0.49248357218506456,1.0,8/33,18.78%,CSF1;RUNX1;ID2;ACIN1;HAX1;TNF;FES;HSF1
prerank,negative regulation of translational initiation (GO:0045947),0.5883744675927558,1.2983663699256691,0.15214384508990317,0.49211421464051275,1.0,9/13,28.84%,AGO2;LARP1;TPR;PAIP2;EIF2AK4;EIF4EBP1;EIF3E;FMR1;EIF4EBP2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5344522477899917,-1.2980625322429333,0.16825396825396827,0.5571349908808102,1.0,5/10,11.20%,IL18;RARA;PRKCZ;IRF4;LGALS9
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5216946922075997,1.2978220270462484,0.15471698113207547,0.49314847446134874,1.0,4/21,8.28%,ABCD2;SIRT5;BRCA1;TRAP1
prerank,RNA transport (GO:0050658),0.446925211958968,1.2976613597873112,0.07319698600645856,0.4930918063097088,1.0,23/71,21.12%,RFTN1;DDX39B;SRSF11;NUP188;THOC1;RAE1;ATXN2;TST;TGFBR2;THOC2;CHTOP;EIF4E;SRSF2;HNRNPA2B1;TPR;UPF3B;SRSF7;THOC6;SRRM1;SIDT1;ARC;NXF1;SRSF1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5951482110501334,1.2975222154009047,0.16269284712482468,0.49291392846748255,1.0,3/11,6.11%,CORO1C;PDPN;CD44
prerank,response to lipid (GO:0033993),0.4292624736585361,1.2973073819244403,0.07120743034055728,0.4929157590940019,1.0,18/105,13.71%,SPP1;CTNNB1;ABCG1;TRIM6;CYP19A1;CYP27B1;PPARD;SOX9;PPARG;ADAM17;NOCT;ERBIN;PCK2;SLC11A1;VPS4B;MAPKAPK3;MAPKAPK2;SOCS2
prerank,post-translational protein modification (GO:0043687),0.4097204341855375,1.2965768547281322,0.009009009009009009,0.494442092143016,1.0,113/332,25.81%,FAM20C;SPP1;HIF1A;FN1;CSF1;APOE;PSMD1;WSB2;NEURL2;SERPINA10;COPS3;APOA2;MATN3;ENAM;FSTL3;FBXO32;PSMD8;FBXW4;FBXW7;RBBP5;PSMA1;SPSB2;APLP2;STT3B;IGFBP7;PSMA8;WSB1;RABGGTB;COPS2;LAMC1;RAB5A;COPS4;ANO8;LGALS1;KCTD7;KLHL13;COPS8;FBXL19;GAS6;P4HB;DCAF17;SOCS5;DDB2;DDB1;PSMD14;RAB1A;PSMA5;TULP4;CUL2;IL6;PSMD12;ELOB;MELTF;FBXW11;SOCS2;CAND1;SPSB3;PSMB10;CCDC22;UBE2F;CALU;FBXW5;KLHL11;WDR5;FBXO7;COPS7A;PSMD2;GAN;PSMC4;WFS1;CKAP4;ASB18;CUL1;TIMP1;PSMD6;KLHL41;WDTC1;PTP4A2;CUL9;CUL4A;FBXO31;SERPIND1;PSMD3;RNF7;PSMD5;PSMC2;PSME4;FBXW2;DCAF7;ZBTB16;SPSB1;FBXO30;SUMF2;NUB1;PSMB8;HSP90B1;PSMA6;SHISA5;COPS6;FSTL1;PSMB7;SOCS6;PSMD4;SPARCL1;KLHL25;CUL3;ASB10;FBXL3;PSMA3;DCUN1D3;FBXL8;DCAF6;RCN1
prerank,organophosphate catabolic process (GO:0046434),0.6106562144722063,1.2963210624233787,0.176056338028169,0.4945969717590643,1.0,3/11,2.47%,ABHD12;APOA2;PON1
prerank,endocytic recycling (GO:0032456),0.4528000012864418,1.2959469122861684,0.11764705882352941,0.49509614130408924,1.0,23/50,25.64%,PTPN23;VPS26A;VPS50;STX6;RAB7A;VPS26C;EHD4;SNX4;SNX27;VPS35;CCDC93;SNX31;CCDC22;VPS35L;SNX17;DENND1B;ARF6;VPS39;VPS51;ANKRD27;EHD1;SNX12;RAB11FIP4
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4984462505808686,1.2953031407452913,0.14285714285714285,0.49634164674033776,1.0,4/27,1.94%,FLT1;FGR;FGF2;PTK2B
prerank,cellular response to glucagon stimulus (GO:0071377),0.5416849952808082,1.2952201785026363,0.15708812260536398,0.49600552406754445,1.0,3/17,2.77%,ADCY8;ADCY3;ADCY7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6001924834878803,1.2947427645304943,0.16981132075471697,0.4967681413571762,1.0,4/11,18.81%,CCT2;CCT5;DKC1;TERF1
prerank,DNA methylation (GO:0006306),0.521948935613066,1.2946756752391173,0.1585677749360614,0.49639476065288674,1.0,8/23,21.65%,DNMT3A;MTRR;DNMT3B;EHMT1;DNMT1;ZFP57;DMAP1;GATAD2A
prerank,regulation of MAPK cascade (GO:0043408),0.41778007211704016,1.2945557840841222,0.040526849037487336,0.4962010761752854,1.0,38/157,20.04%,BCAR3;IGF1;FLT1;IQGAP1;FN1;PDGFA;FGF2;PTPRC;DAG1;PAK6;STK3;MYDGF;MYOC;TAOK3;PRDM15;TMEM106A;DHX33;CAV1;SYK;PIK3R2;IGF1R;PAK2;RNF41;IL6;APIP;FAM83D;NF1;MINK1;ARHGEF5;MAPK3;DUSP3;MAP2K2;PTPN6;TAOK1;ABCA7;LAMTOR1;IAPP;FGFR2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.586236037434355,1.2941348967827042,0.15244755244755245,0.4968745334337921,1.0,7/13,19.83%,FGR;GAB2;SPHK2;SYK;AP1G1;ITGB2;LAMP1
prerank,regulation of exosomal secretion (GO:1903541),0.5398635308221631,1.2939322933473887,0.14901960784313725,0.4968902855875944,1.0,5/19,10.12%,SDCBP;ATP13A2;PDCD6IP;RAB7A;VPS4B
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5012950808926918,1.2938936044429068,0.16321559074299635,0.4964026929074437,1.0,7/26,11.29%,CYBA;ABCD2;SPHK2;SLC25A33;TRAP1;SLC5A3;CCN6
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4336355478708788,1.293859925338634,0.07692307692307693,0.49589885052539223,1.0,18/88,15.74%,NRP2;HIF1A;APOE;XDH;FGF2;NRP1;VEGFA;PTPRM;MYDGF;ECM1;EGFL7;CAV1;NRAS;VIP;APOH;NF1;FGF18;HTR2B
prerank,negative regulation of chemotaxis (GO:0050922),-0.376430125561656,-1.2937397650263522,0.13245033112582782,0.5639682596971328,1.0,12/31,18.32%,ROBO1;SEMA6D;ROBO2;SEMA6A;SEMA5A;AIF1;SEMA4B;SEMA4A;THBS1;SEMA6C;SLIT2;SEMA3B
prerank,translation (GO:0006412),0.4114805601826519,1.293714527666187,0.034170854271356785,0.4957504206042949,1.0,62/208,18.57%,EPRS1;AARS1;TNIP1;MRPL47;VARS1;CARS1;IGHMBP2;AGO2;EIF4G1;MRPL23;RRBP1;GTPBP2;UBA52;EEF2;MRPS15;FARSB;FARSA;MRPL52;DRG1;MRPS16;ETF1;NARS1;RPL10A;MRPS28;EEF1A1;RPL12;GARS1;GFM2;RARS2;EEF1D;RPL36;MRPS33;RPS6;RARS1;MRPL24;RPS28;RPL13A;MRPL37;YARS1;FASTKD2;RWDD1;LARS1;RPS26;MRPL18;MRPL11;RPS27A;MRPS12;RPS12;GATB;PABPC4;TARS1;AIMP2;MRPS7;FARS2;QARS1;TMA7;SARS1;SARS2;RPL18;RPS13;ZC3H15;NOA1
prerank,positive regulation of T cell migration (GO:2000406),-0.4130993552587531,-1.2936107066262936,0.11618257261410789,0.5604040657042118,1.0,8/20,15.80%,DOCK8;CCR2;WNK1;AIF1;TNFRSF14;WNT5A;CCL5;APP
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5877164799277357,1.2933205652828788,0.18907563025210083,0.4963198368892662,1.0,2/12,1.59%,XDH;PIK3CB
prerank,cortical cytoskeleton organization (GO:0030865),0.4772709499316204,1.2926725067368243,0.13018433179723501,0.49771982928926,1.0,14/41,14.62%,LCP1;PLEK;FMNL2;STRIP1;FMNL3;RHOQ;NCKAP1L;RHOD;LLGL2;RHOG;RHOA;LLGL1;RHOF;TNF
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.43327993517682317,1.2925821323408873,0.09119496855345911,0.4974100064022451,1.0,41/87,28.92%,GPNMB;PSMD1;CDK6;PSMD8;PSMA1;PSMA8;WEE1;PSMD14;PSMA5;PRMT2;USP47;PSMD12;PSMB10;CDK4;PSMD2;PSMC4;CDK2AP2;AVEN;DACT1;CUL1;PSMD6;FBXO5;PSMD3;PSMD5;PSMC2;PSME4;KANK2;PSMB8;PSMA6;PSMB7;PSMD4;PTEN;PSMA3;RBL1;DCUN1D3;BRD7;PSMD10;PSMC6;PSME3;PSMC5;PSMA4
prerank,alanine transport (GO:0032328),0.615595636343037,1.292562167377465,0.17113095238095238,0.49687457217972664,1.0,2/10,1.61%,SLC36A4;SLC6A6
prerank,protein-containing complex assembly (GO:0065003),0.40875547006739915,1.2924826740275142,0.012048192771084338,0.4965368453382868,1.0,76/259,20.19%,SH3PXD2B;MITF;CTNNB1;FN1;KMT2A;SLC9A1;EPRS1;CTSZ;GOSR2;ADCY8;PTK2B;TRAF2;TUBGCP4;WIPF1;NAPA;CAPG;SOX9;SKAP2;RBBP5;SAMM50;SEC24A;SLC2A1;DNAJB14;NCKAP1L;CARD10;MAGI1;LAMC1;ANO6;AFG3L2;MCFD2;SEC22B;ANKRD28;NDUFAF1;TAPBP;MDN1;PPP2R1A;VAMP2;CSNK1D;RANBP9;RAB1A;MDM2;USO1;AIM2;STX5;GEMIN5;PEX14;DHX9;LLGL1;ZNHIT6;ELOB;CAND1;TNF;MNAT1;DLG4;TERT;HDAC1;LPXN;PPP6C;COL16A1;DNAJB12;TSPAN4;KPNA3;VAMP3;GOLGA2;HSF1;TBC1D20;CUL1;STOML2;ZC3H12A;BLM;SEC24D;ITGB1BP1;FANCA;AFDN;SEC16A;NOL3
prerank,lipid transport (GO:0006869),0.4293790704135079,1.2923676674628568,0.07892004153686397,0.4963159133891643,1.0,17/97,10.39%,OSBPL8;ABCA1;ABCG1;APOE;SLC27A1;FABP5;SLC27A5;PPARD;ABCD2;GLTP;PRELID2;TRIAP1;ACSL1;NPC2;PITPNC1;OSBPL2;OSBP
prerank,proteasomal protein catabolic process (GO:0010498),0.41635357740773404,1.292225760331276,0.03714859437751004,0.49618671015889654,1.0,91/201,30.38%,CTNNB1;NFE2L2;PSMD1;KCTD17;ZFAND2A;FBXL17;NHLRC1;PSMD8;PPP2R5C;FBXW7;SIAH2;PSMA1;SPSB2;DDI2;PSMA8;ATXN3;AGAP3;ZSWIM8;VCP;ENC1;FBXL19;RMND5B;DDIT3;RNF41;PLAA;WWP2;DDB1;PSMD14;MDM2;PSMA5;BFAR;PSMD12;FBXW11;HUWE1;SPSB3;KCTD10;PSMB10;RNF185;FBXW5;ATE1;UBE4B;SHARPIN;TRIM72;NHLRC3;PSMD2;DNAJB12;PSMC4;DERL1;BIRC2;PSMD6;CUL4A;NEDD4;PSMD3;SIRT2;PSMD5;PSMC2;PSME4;SPSB1;BRSK2;SYVN1;PSMB8;PSMA6;RNF34;PSMB7;SOCS6;PSMD4;KCTD2;CUL3;UBXN6;PSMA3;CDC34;FAF1;PCBP2;FEM1B;PSMD10;RAD23A;APPBP2;PSMC6;TNFAIP1;PSME3;RNF216;PSMC5;PSMA4;TRIM71;BTRC;SKP2;TRIM3;PSMB6;UBE2K;TOPORS;KLHL22
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.45329321814696566,1.2921488102101104,0.10543478260869565,0.49584607950404136,1.0,14/56,18.94%,CTSB;IRAK2;SFTPA1;SFTPA2;TRAF3;UBA52;TAB1;MAPKAPK3;MAPKAPK2;RPS27A;UBC;IRAK4;TLR7;CTSL
prerank,regulation of autophagosome assembly (GO:2000785),0.4913641856222874,1.2920886271387455,0.15898058252427186,0.49546937039189326,1.0,17/33,25.17%,SMCR8;CHMP4B;CHMP4A;RAB5A;SEC22B;IFT88;NPRL3;TBC1D12;RAB3GAP1;RAB3GAP2;PIP4K2A;PIKFYVE;TMEM39A;NPRL2;UBQLN2;RALB;SH3GLB1
prerank,negative regulation of T cell proliferation (GO:0042130),0.5058001465091234,1.2918599036820362,0.1404561824729892,0.49553689675518947,1.0,4/28,10.07%,GPNMB;CD274;CRTAM;LILRB1
prerank,error-free translesion synthesis (GO:0070987),0.523581888587539,1.2917930781957274,0.13909774436090225,0.49516757837413533,1.0,8/22,19.82%,UBA52;VCP;REV1;RFC2;RPS27A;UBC;RFC1;RCHY1
prerank,RNA methylation (GO:0001510),0.4529632157820748,1.2916983134284976,0.10405257393209201,0.494855491968653,1.0,28/60,25.93%,METTL1;TRMT10C;NSUN3;RBM15B;METTL2A;METTL2B;METTL8;NSUN4;GTPBP3;TRMT13;DIMT1;MRM2;TRMT5;ALKBH8;TGS1;PCIF1;TRMT12;LCMT2;TRMT10A;FTSJ3;METTL3;MTO1;THUMPD2;METTL6;NSUN2;NSUN6;ZCCHC4;CBLL1
prerank,positive regulation of ion transport (GO:0043270),0.4648567174991172,1.2913978201114829,0.11697247706422019,0.4951719244847998,1.0,18/48,20.90%,P2RX4;CHRNB2;CCL4;ATP2B1;CACNA1D;CRACR2A;PRSS8;ANO6;PKP2;CNKSR3;SNX4;SCN1B;ORAI1;WFS1;AHCYL1;SCN3B;ACTN2;GDNF
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4443661096578384,-1.290789248296622,0.13865546218487396,0.5639084955882238,1.0,9/17,26.61%,ROBO1;ROBO2;NOTCH2;TGFB2;SLIT2;HEY1;HEY2;NFATC1;HEYL
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.47928396570959264,-1.290728539013278,0.17216117216117216,0.5602385208600948,1.0,3/13,1.62%,TMEM30A;SORL1;SAR1B
prerank,ether lipid biosynthetic process (GO:0008611),-0.5145879927171185,-1.2904738521363954,0.1676470588235294,0.5570790441722845,1.0,4/10,10.67%,LPCAT2;PEX7;FAR1;AGPS
prerank,regulation of macrophage activation (GO:0043030),0.49541367558290056,1.2904702375445334,0.12879708383961117,0.49732717745159005,1.0,7/30,13.73%,GPR137B;MFHAS1;SPHK1;CEBPA;IL6;TNIP2;HSPD1
prerank,striated muscle tissue development (GO:0014706),-0.37886122911432935,-1.2902390451861527,0.10650887573964497,0.5539280646806263,1.0,3/29,0.82%,SGCZ;SGCD;MEF2C
prerank,peptidyl-lysine methylation (GO:0018022),0.5035779419305416,1.2901789756730206,0.14549938347718866,0.4976265237516261,1.0,13/26,30.27%,KMT5A;ETFBKMT;SMYD3;SMYD2;EEF1AKMT3;EHMT1;EEF2KMT;SETD3;SETD4;SMYD1;TRMT112;EHMT2;SETD2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3759972813736169,-1.2901672628191787,0.09868421052631579,0.5503924113518341,1.0,8/33,8.32%,CCND3;RPTOR;PLCB1;FGF10;EZH2;CCND2;EGFR;AIF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.45197562978450845,1.2899042414863893,0.10491803278688525,0.49783492807371077,1.0,17/59,21.64%,IRAK2;NLRC3;TRAF2;TANK;UBA52;TAB1;TICAM1;TNF;RPS27A;UBC;TBK1;SHARPIN;REL;TLR7;BIRC2;NKIRAS2;ROCK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4148965134065473,1.2894529043909604,0.045408678102926335,0.4985714522426872,1.0,40/166,19.95%,BCAR3;IGF1;HIF1A;P2RX4;FGF2;EIF6;SLC27A1;TYRP1;GCK;PIWIL2;DYRK2;VIM;PTPN2;LARP4;EEF2;LPGAT1;ATP7A;FXR2;PAOX;DDB1;UPF3A;IL6;DHX9;SP1;SLC45A3;CTDNEP1;UPF3B;NAT10;TNF;GIPC1;ZEB2;CPEB3;KAT7;CIRBP;PYM1;SLC25A37;MID1IP1;LDB1;PCIF1;DDAH1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5661172873404424,1.2890712807597238,0.1791044776119403,0.499159043119494,1.0,11/15,32.88%,ATF3;CPEB2;VCP;GSTO1;HSF1;ZC3H12A;DAXX;DHX36;ZFAND1;MKNK2;DDX3X
prerank,glucan biosynthetic process (GO:0009250),0.5956168049600891,1.2890214884753186,0.1815680880330124,0.4981502628821571,1.0,5/12,18.97%,GYS1;NHLRC1;GYG1;GBE1;PGM1
prerank,glycogen biosynthetic process (GO:0005978),0.5956168049600891,1.2890214884753186,0.1815680880330124,0.4981502628821571,1.0,5/12,18.97%,GYS1;NHLRC1;GYG1;GBE1;PGM1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5153303503821314,1.2890123633740291,0.15841584158415842,0.4975967261076119,1.0,10/24,21.64%,IQSEC1;NRP1;VEGFA;MYOC;LIMS1;SFRP1;COL16A1;DUSP3;ARF6;ROCK1
prerank,regulation of interleukin-13 production (GO:0032656),-0.4735335944186907,-1.2886726305363883,0.1760797342192691,0.5504673678509975,1.0,7/13,16.79%,IL18;RARA;PRKCZ;LILRA5;IRF4;LGALS9;LEF1
prerank,mesonephros development (GO:0001823),-0.4912239170542405,-1.2885565535828423,0.18081180811808117,0.5470730295944198,1.0,6/11,25.39%,FGF10;PAX8;PAX2;OSR1;GATA3;BMP7
prerank,artery morphogenesis (GO:0048844),0.5011957083270072,1.2885450503919844,0.16209773539928488,0.4983437569838829,1.0,5/30,5.85%,LRP1;NRP1;VEGFA;SMAD7;JAG1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.44102846650155253,1.2884710510525652,0.10042735042735043,0.49796303056710084,1.0,22/71,16.00%,CTSB;CTSZ;FBXL17;CHMP4B;MALT1;DDI2;PSMA8;ATXN3;UBA52;VCP;LONP1;USP9X;PDCD6IP;VPS4B;RNF41;DDB1;MDM2;CLPP;TNFAIP3;RPS27A;UBC;ATE1
prerank,RNA modification (GO:0009451),0.4587606294942824,1.2877736147862942,0.1184939091915836,0.49941943906921804,1.0,21/54,25.74%,ADARB1;AARS1;METTL1;QTRT1;NSUN3;ANKRD16;ALKBH1;RBM15B;NSUN4;NAT10;WDR4;MRM2;CDKAL1;ELP5;ADAR;LCMT2;FTSJ3;METTL3;NSUN2;NSUN6;TRUB1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6172060581685019,1.2876773412273816,0.16810344827586207,0.49913970554301734,1.0,3/10,12.30%,FN1;LILRB1;FURIN
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.602651052850901,1.2871803978741048,0.18786127167630057,0.49998391378287077,1.0,5/11,22.34%,SMARCB1;NCL;PWP1;PIH1D1;SMARCA4
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4771626795502631,-1.286630226409548,0.15,0.5480658889365397,1.0,7/13,23.10%,PSEN1;PER2;TAF1;TMSB4X;MAD2L2;HEY1;HEY2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4410624215202798,1.2856347124009977,0.10893246187363835,0.504153597645552,1.0,19/65,18.45%,BCAR3;PLAUR;RHBDF2;GRB2;SH3KBP1;PTPN2;STAM2;DGKD;HIP1R;MVP;DOK1;CBL;MVB12B;HIP1;MVB12A;CNOT9;DUSP3;PDE6G;ERRFI1
prerank,negative regulation of programmed cell death (GO:0043069),0.4044491664952375,1.285453410450467,0.011,0.5041326825275848,1.0,103/355,23.79%,IGF1;CTNNB1;BCL2;ARHGAP10;BCL2L1;NIBAN2;ANXA5;PLAUR;ANXA4;PTK2B;HYPK;SPHK1;MCL1;HSPB1;VEGFA;DAB2;AXL;SQSTM1;SON;SOX9;MALT1;FLNA;SIAH2;PLK2;PDPN;NAT8;NCKAP1L;MGMT;CD44;MYDGF;PSEN2;UBA52;GAS6;TRIAP1;ATAD3A;TREM2;ATF5;CAT;HSPA9;NFKB1;HNRNPK;IGF1R;RAB7A;PAK2;RASA1;VIP;BAG3;AIFM2;PLK3;RAF1;RIPK3;BFAR;PRDM9;IL6;APIP;GOLPH3;USP47;CIAPIN1;BID;CBL;NAA16;SOCS2;HSPD1;IL2;BNIP2;HAX1;RPS27A;UBC;BABAM2;SUPV3L1;HTR2B;HDAC1;ANKLE2;TFRC;FIGNL1;THOC6;SFRP1;NAA15;AVEN;WFS1;MED1;BCL2L2;ASNS;HDAC3;CLN3;BIRC2;XBP1;NOL3;GDNF;MTDH;HIGD2A;IRAK1;KANK2;UFM1;BIRC6;TCIM;WDR73;TMBIM4;HSP90B1;FOXO1;FSTL1;IL7;GSK3B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.556630921889185,1.2853617721193633,0.16688918558077437,0.5038079481165614,1.0,5/16,9.78%,SLC25A33;AK4;VCP;ATP7A;COX7A2L
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4023849089355563,-1.2851350584756338,0.13366336633663367,0.5482201142358051,1.0,6/22,7.61%,CASK;PTPRK;FGF10;EPB41L4B;NOTCH2;KLF9
prerank,histone H4 deacetylation (GO:0070933),0.6188470050157671,1.285014722421855,0.18063583815028902,0.5042637497622339,1.0,6/10,20.75%,RCOR1;HDAC4;HDAC9;HDAC1;HDAC3;SIRT2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6169123548650145,1.2847766686945423,0.15173410404624277,0.5044333065720321,1.0,3/10,5.38%,LRP1;PTGIR;PTPN2
prerank,Golgi to endosome transport (GO:0006895),0.5585627730147975,1.2846663106960732,0.1652892561983471,0.5041512413836384,1.0,3/16,5.86%,VPS13C;CORO7;DOP1B
prerank,negative regulation of cyclase activity (GO:0031280),-0.4529795225842734,-1.2845593363255168,0.1811320754716981,0.5460741081376519,1.0,5/14,16.18%,CCR2;GRM3;EDNRB;DRD2;ADGRV1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4609683665367233,1.283998298832596,0.13014460511679643,0.5055327912061861,1.0,17/46,21.07%,PRKCD;IPO5;FLNA;TRIM28;GAS6;PIK3R2;BAG3;JUP;DHX9;TPR;RBM22;HDAC3;CDH1;ZC3H12A;NEDD4;TGFB1;DMAP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6186059717289589,1.2835843784183716,0.1966053748231966,0.5061982562640852,1.0,3/10,13.24%,PTPRC;TLE5;MAPK7
prerank,response to peptide (GO:1901652),0.48192475358745784,1.2834838006276292,0.13746958637469586,0.5059210976495401,1.0,7/33,17.18%,CACNA1A;MMP12;ERBIN;IRF5;FYN;KAT7;EIF2B2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5937988277621705,1.2833773641261752,0.1863013698630137,0.5056767438372429,1.0,5/12,17.43%,SMCR8;FYCO1;IGF1R;TNF;IRGM
prerank,cAMP metabolic process (GO:0046058),0.5735124056542629,1.2830944465394805,0.19262295081967212,0.5059541828600947,1.0,3/13,2.77%,ADCY8;ADCY3;ADCY7
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.499846871037625,1.2830697483496754,0.14850299401197606,0.5054547891968345,1.0,16/30,26.18%,MACF1;GOLGA4;OPTN;GCC2;VAMP2;GOLPH3;GGA2;VAMP4;BBS2;ARFRP1;SEC16A;GOLPH3L;RAB34;RAB31;GOLGA7;GGA3
prerank,negative regulation of catalytic activity (GO:0043086),0.5144476587771315,1.2827840727161315,0.17228464419475656,0.5057330341646519,1.0,11/24,26.36%,NES;PHPT1;TMBIM1;CAND1;PPP1R12A;CLN3;TIMP1;NOTCH1;APBA3;PARP9;ATP5IF1
prerank,regulation of receptor recycling (GO:0001919),0.5551490228312299,1.2826240352558302,0.18073878627968337,0.5056394425515832,1.0,7/16,23.08%,OPTN;TRAT1;TBC1D16;KIF16B;VAMP3;LAMTOR1;SCRIB
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3703015608088398,-1.2822431418687392,0.13414634146341464,0.548344486993856,1.0,14/30,23.54%,HMGCS1;NSDHL;IDI1;INSIG1;DHCR7;HSD17B7;MVK;INSIG2;FDPS;SQLE;LBR;LSS;HMGCR;GGPS1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.476277625972902,1.282148635960234,0.14788732394366197,0.5065043955004227,1.0,9/34,13.20%,FLT1;NRP1;SPHK1;HSPB1;VEGFA;ERN1;DLL4;MAPKAPK2;MAP2K3
prerank,positive regulation of binding (GO:0051099),0.4296752331068387,1.2817453507088843,0.10348468848996832,0.5071070620963477,1.0,20/84,18.46%,IGF1;LRP1;APOE;PLAUR;PON1;STK3;PPARG;GMNN;BAMBI;SKI;CAV1;HIP1R;CEBPG;KDM4D;DHX9;TERT;PIN1;SPPL3;DERL1;DACT1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5994291967871437,1.28172437256742,0.16759776536312848,0.5065808357859197,1.0,8/11,34.64%,TRIM28;TPR;DNMT1;MPHOSPH8;RESF1;SETDB1;PPHLN1;TASOR
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.511657404177477,-1.2813972933970859,0.2,0.546959891919096,1.0,4/10,16.11%,PDE3B;PDE4D;PDE2A;UBE2B
prerank,cellular response to fatty acid (GO:0071398),0.5824534944660327,1.28089507224495,0.1790633608815427,0.5084865382469931,1.0,4/12,19.62%,LPL;PID1;ZC3H12A;PDK3
prerank,lymphocyte chemotaxis (GO:0048247),0.47505394311407945,1.280071706910298,0.15990453460620524,0.5103171528735533,1.0,6/34,9.76%,ADAM8;CCL4;CH25H;CCL13;GAS6;CCL14
prerank,regulation of inflammatory response (GO:0050727),0.4103413064363415,1.2800147169748106,0.03323262839879154,0.5099257039926063,1.0,46/190,19.69%,LPL;SIRPA;APOE;NLRC3;MFHAS1;TNIP1;PRKCD;CD200R1;MGLL;SPHK1;OTULIN;PPARD;PTGES;PPARG;CEBPA;PTPN2;TNFRSF1B;BRD4;CELF1;BCL6;NFKBIZ;NINJ1;LPCAT3;ACOD1;VAMP2;NAPEPLD;GPRC5B;PTGER4;IL6;DHX9;PTGIS;TNFAIP3;MAPK7;VPS35;IL2;TNF;SBNO2;SHARPIN;UFL1;SERPINE1;NLRP6;VAMP3;METRNL;TLR7;BIRC2;CCN4
prerank,nuclear migration (GO:0007097),0.5691115092494943,1.2798631462330514,0.18698060941828254,0.5097728006241822,1.0,7/13,13.60%,DYNC1H1;DCTN1;DOCK7;HOOK3;CEP120;TMEM201;FBXW11
prerank,response to steroid hormone (GO:0048545),0.4886544041574314,1.2798399276994923,0.14475271411338964,0.5092653380402716,1.0,15/31,26.24%,MGARP;SOX30;CAV1;TFPI;NR3C1;ATP1A1;ATP1A3;UBE2L3;MED1;TGFB1;CATSPER2;WBP2;ATP1A2;ADTRP;CATSPERD
prerank,estrogen metabolic process (GO:0008210),0.5408313141958554,1.2797564718155603,0.18337730870712401,0.5089515369696668,1.0,3/15,10.33%,CYP19A1;CYP1B1;HSD17B8
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6044278341020791,1.279656767819111,0.1884272997032641,0.5086736216490041,1.0,3/10,14.85%,CCT2;CCT5;DKC1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5236565990737738,1.2792714501774214,0.16602316602316602,0.5092501403060414,1.0,2/20,5.25%,GCK;SIK1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.41664877794955923,-1.2792625518725964,0.14356435643564355,0.5489081038016643,1.0,6/20,8.24%,BICD1;GRK3;RGS14;APLP1;MRAP2;STMN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.443062776703271,1.2790793250885226,0.11194833153928956,0.5092603057008717,1.0,38/65,33.05%,PSMD1;PSMD8;PSMA1;PSMA8;PSMD14;PSMA5;ZFYVE19;USP47;PSMD12;PSMB10;PSMD2;PSMC4;AVEN;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;INTS3;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;PSMA3;PSMD10;CDK5RAP3;PSMC6;PSME3;PSMC5;PSMA4;PSMB6;RBX1;PSMA2;PSMC3;NABP2;PSMD7;PSMD13
prerank,protein kinase A signaling (GO:0010737),0.5775137013001387,1.2782705587034173,0.17857142857142858,0.5111868877586357,1.0,1/12,0.32%,LCP1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.45768155635085356,1.2778834304281532,0.1361079865016873,0.5117971475404564,1.0,13/50,14.86%,PLAUR;VEGFA;SIAH2;CD44;GAS6;DNAJB6;TRIAP1;PAK2;RAF1;USP47;FNIP1;TNF;PIH1D1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4521307940026355,1.2776714892925547,0.11025358324145534,0.5118580464686415,1.0,12/56,18.39%,SDCBP;BMP8B;GDF6;SNX25;DAB2;SMAD7;RBPMS;PMEPA1;BMP5;PIN1;LDLRAD4;TGFBR1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.449141692482291,-1.2775695363717092,0.16194331983805668,0.549565943831831,1.0,7/15,16.05%,CD33;TRIM27;SLC30A1;CBARP;ADRA2A;NOS1;INPP5K
prerank,negative regulation of bone remodeling (GO:0046851),0.6002463072799449,1.277533550880482,0.17236467236467237,0.5117138351167588,1.0,5/11,17.53%,GPR137B;IL6;TNFAIP3;UBASH3B;SFRP1
prerank,ion transport (GO:0006811),0.41833156821279166,1.2774365496728204,0.07849133537206932,0.5114477994325273,1.0,24/111,14.35%,SLC26A1;SLC9A1;SLC15A3;CHRNB2;PIEZO1;VDAC2;SLC17A5;SLC9A8;SLC24A4;LASP1;SLC26A11;SLC9A7;SLC9A6;PANX1;SLC8B1;ANO6;SLC26A4;SLC4A2;SLC8A1;ATP1A4;KCNN4;SLC25A18;SLC12A4;CNGB1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4674128189278907,1.277368921448806,0.1397228637413395,0.5110789413069351,1.0,11/43,15.11%,IGF1;FGF2;MEF2D;HMOX1;ID2;ERN1;JUN;SERPINF2;IL6;TNF;DNMT1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5977380320599948,1.277321314202181,0.1669024045261669,0.5106459095733665,1.0,5/11,20.66%,GDF6;SMAD7;TGFBR2;TGFBR1;TGFB1
prerank,negative regulation of binding (GO:0051100),0.43144894412683454,1.27672587422336,0.09237379162191192,0.5118544130391521,1.0,30/81,24.57%,CTSZ;NES;PRKCD;DAB2;MDFI;LRPAP1;BAX;GTPBP4;ILRUN;JUN;CAV1;GTF2F1;SYMPK;TLE5;PEX14;WAPL;PSME3IP1;PIN1;DACT1;GOLGA2;ITGB1BP1;USP33;PDGFB;SUMO1;ROCK1;CSNK1E;KDM1A;RACK1;GSK3B;RALB
prerank,regulation of mitotic spindle organization (GO:0060236),0.47784565559579706,1.2765826892158418,0.16216216216216217,0.5117399642841355,1.0,10/35,13.67%,DYNC1H1;CHMP4B;DCTN1;DRG1;PDCD6IP;TACC3;RAE1;VPS4B;NUMA1;TPR
prerank,cation transmembrane transport (GO:0098655),0.46115375081237053,1.2760399595547836,0.14482758620689656,0.5127802802959053,1.0,9/44,12.64%,MFSD12;SLC36A4;ATP13A2;SLC3A2;SLC7A1;SFXN1;TRPM7;SLC7A8;SFXN2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6176949618424729,1.2759220778705198,0.17094017094017094,0.5125714563436455,1.0,4/11,9.73%,PRKCD;DIABLO;STK24;CYP1B1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.41677566505051933,1.275737015460846,0.06109979633401222,0.5125454684257112,1.0,29/136,12.87%,IRAK2;NLRC3;ANXA4;OTULIN;FOXJ1;FLNA;TRAF3;MDFI;HDAC4;SIK1;BHLHE40;SMAD7;ID2;ERBIN;RNF2;GAS6;HAVCR2;DDIT3;ACOD1;CYP1B1;WWP2;EGLN1;CEBPG;AIM2;PRMT2;RWDD3;PEX14;PTGIS;TNFAIP3
prerank,response to interferon-beta (GO:0035456),0.5147206811280113,1.2753235490042494,0.16518424396442186,0.5131813388443954,1.0,8/22,17.43%,SHFL;TRIM6;IKBKE;IRGC;ACOD1;AIM2;BST2;IRGM
prerank,regulation of mitochondrial fusion (GO:0010635),0.5862914413711598,1.2751885428399112,0.17548746518105848,0.5130061641151974,1.0,7/11,27.72%,VAT1;PID1;HUWE1;ZDHHC6;TFRC;OMA1;BNIP3
prerank,positive regulation of DNA replication (GO:0045740),0.5414261978793364,1.275086311306218,0.17567567567567569,0.5127209395157156,1.0,1/16,0.03%,BCAR3
prerank,maturation of LSU-rRNA (GO:0000470),0.5124054671817054,1.2747987839150627,0.14037267080745341,0.5130327447201909,1.0,9/26,14.99%,EIF6;MAK16;DDX18;WDR12;NSA2;RPL10A;ZNHIT6;MRPL1;SNU13
prerank,nuclear pore organization (GO:0006999),0.5647482021375307,1.2746106463494553,0.19298245614035087,0.5130477126518492,1.0,8/14,26.96%,NUP205;AHCTF1;TPR;NUP54;NUP133;NUP93;NUP98;NUP35
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.61654599659523,1.2741376781170937,0.19313304721030042,0.5138606710291618,1.0,3/10,8.20%,MALT1;SMAD7;NFKBIZ
prerank,selective autophagy (GO:0061912),0.4491761334824503,1.2737840796736961,0.11946902654867257,0.5143362544547527,1.0,24/56,25.31%,DYNC1H1;SQSTM1;VIM;RETREG1;UBA52;IFT88;DYNC1LI2;WDFY3;RAB7A;BECN1;ATG2B;MAP1LC3B;RPS27A;UBC;LGALS8;UFL1;ACBD5;WDR81;ATG13;UFM1;USP30;UBQLN1;AMBRA1;DYNC1I2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4920105841766442,1.2734628910584562,0.16140776699029127,0.5147158315053413,1.0,7/29,17.51%,LGALS3;MOSPD2;ANO6;GAS6;C1QBP;TNF;SERPINE1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.37203370392034274,-1.2734527208236952,0.11052631578947368,0.5559421481637697,1.0,9/26,14.00%,VSIR;EPHA4;GRIN2B;PICALM;GRIN1;APH1B;STAT3;ROCK2;PSME1
prerank,negative regulation of MAPK cascade (GO:0043409),0.42595626020453303,1.2730871747786596,0.1069182389937107,0.5152499914257127,1.0,27/87,19.72%,SIRPA;APOE;PIK3CB;PTPRC;TNIP1;PRKCD;DUSP9;DAG1;CD300A;PTPN2;PRDM15;SPRED2;CAV1;PIK3R2;CNKSR3;SPRY4;RANBP9;NF1;SPRED3;FLCN;STK38;PIN1;QARS1;DUSP3;PTPN1;ABCA7;ITGB1BP1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5577255581741166,1.2727688123534973,0.178335535006605,0.5156106030671869,1.0,5/15,19.21%,FSTL3;SMAD7;SKI;DACT1;FST
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4737168106829366,1.2727566056567363,0.14149821640903687,0.5150844247150437,1.0,15/33,25.77%,RUNX1;SAFB2;RNF6;CARM1;RNF14;KLK3;PRMT2;UFL1;LATS1;UFM1;CALR;KDM1A;UFSP2;EP300;H3-3A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.48489051064281724,1.2722082251545275,0.14676616915422885,0.5161483436093344,1.0,9/32,18.08%,CTNNB1;TNKS2;CCT2;ACD;PKIB;CCT5;PNKP;MAPK3;MAPK15
prerank,snRNA transcription (GO:0009301),0.43356064793418975,1.272042645889388,0.10954446854663774,0.516126764636723,1.0,26/70,28.15%,SNAPC1;POLR2H;ELL2;SNAPC2;GTF2A2;GTF2F1;CCNT2;SNAPC4;INTS6;SP1;RPRD1A;INTS14;POLR2D;GTF2E2;INTS2;USPL1;POU2F1;TBP;INTS3;PHAX;TAF6;GTF2A1;INTS12;ICE1;INTS1;INTS8
prerank,regulation of monocyte differentiation (GO:0045655),0.5612188207424578,1.2719815302964304,0.21331521739130435,0.5157313153378206,1.0,3/14,10.26%,CSF1;CDK6;ACIN1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3694094054892116,-1.271839642113816,0.14444444444444443,0.5560250550040501,1.0,11/27,23.68%,FGF12;COMMD1;SNTA1;YWHAH;FXYD1;NEDD4L;NOS1;FXYD2;FXYD6;PTPN3;SCN2B
prerank,hexose transmembrane transport (GO:0008645),0.5243088238805738,1.2716081592645958,0.16412213740458015,0.5163051286839259,1.0,6/21,18.83%,PPARD;SLC2A1;SLC5A3;SLC2A6;SLC45A3;SLC2A8
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5150592238085256,1.2714890993019894,0.17146433041301626,0.5161008684212082,1.0,11/22,22.59%,UBA52;DDB2;DDB1;XPA;RPS27A;UBC;GTF2H1;ERCC2;CETN2;CUL4A;PARP1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5876434128103443,1.271217579174184,0.19744318181818182,0.5158181579735063,1.0,3/11,14.85%,CCT2;CCT5;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5876434128103443,1.271217579174184,0.19744318181818182,0.5158181579735063,1.0,3/11,14.85%,CCT2;CCT5;DKC1
prerank,lipid phosphorylation (GO:0046834),0.6078461296800668,1.2712124414609938,0.18823529411764706,0.5152782584197783,1.0,3/10,8.80%,DGKZ;DGKH;DGKD
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5820166413802123,1.271118976604274,0.201949860724234,0.5149811624152892,1.0,3/12,9.49%,UMPS;UCKL1;CAD
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.490870490879,1.271078450613656,0.16545893719806765,0.5145437291115375,1.0,7/28,10.53%,NIBAN2;FBXW7;EGFL7;DLK2;DLL4;YTHDF2;WWP2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.4507050211041776,1.270937968078018,0.12806236080178174,0.5138427763265969,1.0,21/50,29.11%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;RAE1;NUP42;TPR;POLR2D;PUM1;NUP54;RANBP2;PUM2;NUP133;NUP93;NUP98;H3-3A;NUP35;AAAS;FMR1;TRIM71
prerank,regulation of gene silencing by RNA (GO:0060966),0.4507050211041776,1.270937968078018,0.12806236080178174,0.5138427763265969,1.0,21/50,29.11%,NUP205;AGO2;EIF4G1;POLR2H;NUP188;RAE1;NUP42;TPR;POLR2D;PUM1;NUP54;RANBP2;PUM2;NUP133;NUP93;NUP98;H3-3A;NUP35;AAAS;FMR1;TRIM71
prerank,organonitrogen compound catabolic process (GO:1901565),0.44910564768433947,1.2703993105264184,0.1197339246119734,0.5148289911501309,1.0,16/57,19.65%,ANPEP;RENBP;ADAMTS13;NAGK;NPL;GNPDA1;TPP1;TST;AMDHD2;MPST;GNPDA2;RIDA;PDXDC1;SGPL1;PLA2G5;CLN8
prerank,autophagosome assembly (GO:0000045),0.44957744004582245,1.2703521977177468,0.12151616499442586,0.51439698736378,1.0,22/52,27.88%,ATG7;RUFY4;TRAPPC8;TMEM41B;PACS2;WDR45;RAB7A;RAB1A;BECN1;ATG2B;ATP2A2;MAP1LC3B;ATG16L1;IRGM;ATG13;UBQLN1;GABARAP;AMBRA1;UBQLN2;ATG2A;RAB43;VMP1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5980784373356152,1.2702885702916642,0.19681620839363242,0.5140197635004429,1.0,5/11,26.40%,RASA1;NOVA2;PCBP1;PCBP4;PCBP2
prerank,axonogenesis (GO:0007409),-0.2603349405713626,-1.2700645651913565,0.0,0.5568970992235054,1.0,93/237,20.53%,ROBO1;OPHN1;NRXN3;NRXN1;RPS6KA5;UNC5D;CTNNA2;GAB1;SEMA6D;EPHA4;EPHA5;ROBO2;EPHA6;PIK3R1;SEMA6A;FEZ2;ANK3;CNTN4;MAP1B;CNTN6;VLDLR;NCAM1;EZR;PPP3CB;DOK6;EFNA5;SEMA5A;SPTBN1;UNC5C;NTNG1;NOTCH2;GFRA1;PTK2;RAB3A;EPHB1;DAB1;AUTS2;DOK5;PARD3;SLITRK4;NEFH;IRS2;SEMA4B;FEZ1;DSCAML1;SHANK3;DCC;B4GALT6;NLGN3;RAP1GAP;PLPPR4;FRS2;RELN;GPC1;SEMA4A;SPTBN2;WNT5A;TNR;KIF5A;RET;S100A6;BRSK1;SPTBN4;SLITRK2;PTPRO;DRD2;LGI1;EPHA7;HSP90AA1;APP;NTN4;VSTM2L;LAMA1;SEMA6C;SLIT2;APBB1;PAX2;ULK2;UNC5A;EMB;SEMA3B;EFNA3;ZDHHC17;RAB10;NOTCH3;CCK;ARHGAP35;UNC5B;EFNA2;SRC;SHC1;SLIT3;SLIT1
prerank,erythrocyte differentiation (GO:0030218),0.46390139532380736,1.2699416443814997,0.12585034013605442,0.5145207498087849,1.0,21/44,28.22%,MFHAS1;VEGFA;PTPN2;NCKAP1L;ID2;ALAS1;HSPA9;ACIN1;CEBPG;LYAR;FLVCR1;UFL1;MED1;EPO;RPS19;LYN;SH2B3;ATP5IF1;JAK3;HIPK2;CDK5RAP3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4649533857115176,1.2697780399300278,0.15375722543352602,0.5144654590120501,1.0,10/39,16.18%,CTNNB1;FGF2;NRP1;VEGFA;NKX2-1;LRP6;DLL4;TGFBR2;COL4A1;NOTCH4
prerank,regulation of neurotransmitter transport (GO:0051588),-0.42772110729603435,-1.2693423453586592,0.15833333333333333,0.5553405051726696,1.0,5/16,4.00%,SNCAIP;MEF2C;RIMS1;MCTP2;CPLX1
prerank,mitotic recombination (GO:0006312),0.5475038441540715,1.2693185211504443,0.18598382749326145,0.5152231733873714,1.0,5/15,15.08%,NSMCE2;ERCC1;RAD50;TPRKB;GEN1
prerank,cellular protein metabolic process (GO:0044267),0.3983894608147262,1.2691607992096479,0.005,0.5151236844623662,1.0,82/396,15.59%,IGF1;FAM20C;SPP1;FN1;CSF1;APOE;ABL2;UBL4A;B4GALT7;MSRA;PARP4;TNIP1;CSF2RA;SERPINA10;APOA2;MATN3;ENAM;FSTL3;MSRB1;IGHMBP2;AGO2;EIF4G1;NAPSA;SFTPA1;SFTPA2;MRPL23;SIAH2;GNMT;LMCD1;APLP2;RRBP1;ADAM17;IGFBP7;RABGGTB;PSEN2;BAP1;LAMC1;UBA52;TTF1;ANO8;LGALS1;SPCS3;AFG3L2;MRPS15;ERO1A;UBE2L6;FARSB;GAS6;MRPL52;TGM5;MRPS16;RPL10A;P4HB;YES1;QPCT;EEF1A1;RPL12;WWP2;PARL;KLK3;RPL36;MRPS33;RIPK3;FURIN;IL6;RPS6;DUSP12;MRPL24;RPS28;MELTF;RPL13A;MRPL37;CHEK2;RPS26;MRPL18;MRPL11;UBE2L3;RPS27A;MRPS12;RPS12;PABPC4;CALU
prerank,nucleic acid metabolic process (GO:0090304),0.4321674176827297,1.2691509718062282,0.12055974165769645,0.5145881592122714,1.0,26/69,23.09%,HNRNPA3;POLR2H;DXO;HNRNPM;RAD50;DNASE2;HNRNPC;GTF2F1;DNASE1L1;HNRNPK;ATXN2;HNRNPL;SETMAR;HNRNPA2B1;DUSP11;POLR2D;DDX1;PCBP1;RECQL5;MMS19;RBFOX2;HNRNPU;XRN2;TOPBP1;LSM8;METTL3
prerank,mRNA catabolic process (GO:0006402),0.4561736320099992,1.2691132123152395,0.1534154535274356,0.5141407190079827,1.0,19/44,23.59%,DXO;ERN1;CNOT10;DHX34;RNH1;YTHDF2;EXOSC9;AGO3;EXOSC10;AGO4;SUPV3L1;RIDA;DCP2;LSM6;EXOSC4;XRN2;ZC3H12D;METTL3;XRN1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4454242936904894,1.269018200431521,0.12362030905077263,0.5138734866784622,1.0,14/55,18.39%,BCL2;BCL2L1;TRAF2;BAX;CAV1;DDIT3;PAK2;BCL2L11;BECN1;CRADD;BID;TNF;WWOX;TGFBR1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5399641344605661,1.2684565112015802,0.191958495460441,0.5150770753005631,1.0,2/16,1.55%,IGF1;FGF2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4902393889347557,1.268189912383991,0.1466030989272944,0.5153426666808893,1.0,3/31,3.56%,GPNMB;CD300A;CD274
prerank,regulation of cellular amide metabolic process (GO:0034248),0.48058472534779995,1.2681896919599962,0.17328519855595667,0.5147920176944646,1.0,13/32,21.64%,PRKCD;NOLC1;CYFIP1;ATXN2;RBM4B;TCOF1;GEMIN5;SAMD8;EIF4E;PUM3;PCIF1;EIF2A;ROCK1
prerank,negative regulation of protein transport (GO:0051224),0.5017771669310924,1.2670867190423716,0.1791044776119403,0.5175638236013935,1.0,5/25,11.32%,APOE;RHBDF2;SERGEF;WWP2;PKDCC
prerank,positive regulation of cell migration (GO:0030335),0.4008038212083215,1.267058524931822,0.02208835341365462,0.5170917099814116,1.0,38/253,11.75%,GPNMB;IGF1;PLAU;FLT1;HIF1A;FN1;ITGAX;CSF1;MGAT5;FGR;SDCBP;PDGFA;PTPRC;NRP1;PTK2B;SPHK1;AGO2;VEGFA;DAB2;SOX9;GCNT2;NEDD9;ADAM17;PDPN;RUFY3;NCKAP1L;MYOC;RHOD;CCAR1;SPAG9;CAV1;CRKL;MYADM;IGF1R;PLAA;CPNE3;CAPN7;C1QBP
prerank,neurotrophin signaling pathway (GO:0038179),-0.3980537449291878,-1.2666973129454056,0.13679245283018868,0.5586041485739507,1.0,9/21,14.89%,RAPGEF2;NTRK2;ZFYVE27;HAP1;CASP3;FRS2;SORT1;DDIT4;BCAR1
prerank,cell projection assembly (GO:0030031),0.5195550401656756,1.2666967348583804,0.17160493827160495,0.5175564528502372,1.0,11/22,22.48%,PDGFA;CAPG;RHOQ;NCKAP1L;CYFIP1;PARVB;RHOG;RHOU;PARVA;CDC42;GSN
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4835643615274246,1.266323128043062,0.15739644970414202,0.5180920314148822,1.0,12/32,21.94%,FGF2;VEGFA;HMOX1;CARD10;HDAC9;HDAC7;DLL4;RHOA;PIK3C2A;ITGB1BP1;NOTCH1;JCAD
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4525845869308027,1.2654358931949488,0.14009111617312073,0.5201784796572524,1.0,21/45,29.12%,GCNT2;ZC3H7B;NOLC1;LARP4;LARP1;CYFIP1;ATXN2;RBM4B;TCOF1;GEMIN5;EIF4E;PUM1;PUM3;PCIF1;EIF2A;PUM2;NANOS1;PARP9;MTPN;TRIM71;RC3H1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6018247848730416,1.2646639959358061,0.17888563049853373,0.5219892308963177,1.0,4/10,19.43%,ABCD2;LPGAT1;SLC45A3;MID1IP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5740601767591526,1.2644187406268854,0.21486486486486486,0.5221570986257847,1.0,4/12,14.18%,PRKCB;NEK6;CCNB1;CTDNEP1
prerank,potassium ion homeostasis (GO:0055075),0.5077023287881606,1.2642020359278372,0.19183168316831684,0.522246486329735,1.0,7/23,13.89%,KCNMA1;KCNJ2;ATP1A1;ATP1A3;ATP1A4;ATP1B3;SLC12A4
prerank,protein-containing complex disassembly (GO:0032984),0.44322481103766503,1.2641683461032653,0.14189189189189189,0.5217882998779981,1.0,18/54,24.94%,CTNNB1;TECPR1;LIX1L;VCP;LRP6;FZD1;FRAT1;CAV1;LAMP2;LIX1;MAP1LC3B;PYM1;CLN3;VIPAS39;UBQLN1;GABARAP;GSK3B;RPL23
prerank,dermatan sulfate metabolic process (GO:0030205),0.5674416593292768,1.2641342904335904,0.19166666666666668,0.5213475541818834,1.0,4/13,16.17%,CSPG4;IDUA;CHST12;DSEL
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4704072571143092,1.2635394662557402,0.16626506024096385,0.5226615876968098,1.0,12/33,20.75%,IGF1;PIK3CB;PLEKHA1;PIK3R5;PIK3R2;IGF1R;C1QBP;NF1;HTR2B;PIK3C2A;PIK3CA;SIRT2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.49338142606975804,1.263192149091253,0.17208182912154033,0.5231642312255891,1.0,8/27,13.66%,FBXL17;CRTC1;SIK1;BHLHE40;ID2;RBM4B;USP2;FBXL6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.47541087896176687,1.2631892126705828,0.15853658536585366,0.522621638183368,1.0,10/35,18.08%,CTNNB1;TNKS2;CCT2;ACD;PKIB;HNRNPA2B1;CCT5;PNKP;MAPK3;MAPK15
prerank,regulation of cell morphogenesis (GO:0022604),0.483283189699,1.263061364222438,0.1652593486127865,0.5224770826262267,1.0,15/30,24.37%,MACF1;FMNL2;STRIP1;PDPN;LARP4;CD44;MYO9A;ZMYM4;SH3D19;ARC;CAPZB;CAMSAP1;ZMYM6;WTIP;ZMYM3
prerank,negative regulation of type I interferon production (GO:0032480),0.46810400420695053,1.2629512224404262,0.16102683780630106,0.5222716675990541,1.0,14/40,18.73%,SIRPA;NLRC3;IKBKE;UBE2L6;ILRUN;HAVCR2;ACOD1;LILRB1;TNFAIP3;YY1;TBK1;PIN1;TRAF3IP1;REL
prerank,negative regulation of protein binding (GO:0032091),0.43485855554466507,1.262204034586504,0.13290460878885316,0.5239924177412476,1.0,32/71,28.25%,CTSZ;NES;PRKCD;DAB2;LRPAP1;BAX;CAV1;GTF2F1;SYMPK;ADAM15;TLE5;ATP2A2;PEX14;PSME3IP1;PIN1;ITGA4;DACT1;GOLGA2;ITGB1BP1;USP33;PDGFB;ROCK1;CSNK1E;KDM1A;RACK1;GSK3B;RALB;TTBK2;B2M;CFHR2;STYX;BAG2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.39800987970096735,1.2615098171606443,0.021,0.5254959248562133,1.0,111/341,23.15%,CTNNB1;MYLIP;NFE2L2;PSMD1;WDR91;CNOT4;ANAPC15;KCTD17;ZFAND2A;COPS3;FBXL17;NHLRC1;PSMD8;PPP2R5C;SQSTM1;PTPN23;FBXW4;FBXW7;SIAH2;RNF128;PSMA1;SPSB2;TRIP12;UBR4;RNF6;FZR1;PSMA8;ATXN3;ANAPC1;AGAP3;ZSWIM8;UBAP1;UBE3C;VCP;TTC3;FBXL19;USP9X;UBE2L6;RNF149;RMND5B;DDIT3;RNF14;UBE2R2;UBE3B;VPS4B;PLAA;WWP2;DDB1;RNF167;PSMD14;MDM2;PSMA5;BFAR;ZNRF3;UBE4A;TNFAIP3;PSMD12;CBL;FBXW11;KCTD21;HUWE1;SPSB3;KCTD10;MVB12B;PSMB10;UBE2L3;RNF185;FBXW5;ATE1;UBE4B;MVB12A;UBAP1L;SHARPIN;FBXO7;TRIM72;NHLRC3;PSMD2;CDC26;UBE2H;PSMC4;UBE2C;RNF19A;BIRC2;WDR81;PSMD6;RCHY1;XBP1;USP33;CUL4A;TGFB1I1;RNF111;NEDD4;PSMD3;RNF7;SIRT2;UBA6;PSMD5;RNF20;PSMC2;HERPUD1;PSME4;SPSB1;SYVN1;BIRC6;NUB1;RNF19B;PSMB8;UBQLN1;PSMA6;RNF34;ANAPC7
prerank,response to muramyl dipeptide (GO:0032495),0.5726173062664064,1.2614764370897629,0.19525801952580196,0.5250647873122339,1.0,4/12,15.83%,VIM;ERBIN;IRF5;ARHGEF2
prerank,protein catabolic process (GO:0030163),0.4424717722409427,1.261435310979187,0.12458286985539488,0.524628028776572,1.0,12/59,10.55%,CTSD;APOE;SIAH2;STT3B;DDI2;PSMA8;VCP;TPP1;OGA;RNF41;LAMP2;DDB1
prerank,sphingolipid catabolic process (GO:0030149),0.5551032349877274,1.261255878790713,0.17671232876712328,0.5245963608982316,1.0,6/15,16.14%,SPHK1;GLA;SMPD4;ASAH1;PDXDC1;SGPL1
prerank,modification-dependent protein catabolic process (GO:0019941),0.40337192231889707,1.260913414782842,0.049494949494949494,0.5250770465715093,1.0,65/193,23.15%,MYLIP;WDR91;CNOT4;ANAPC15;COPS3;SQSTM1;FBXW4;SIAH2;RNF128;SPSB2;TRIP12;UBR4;RNF6;FZR1;ATXN3;ANAPC1;UBA52;UBE3C;TTC3;LONP1;UBE2L6;RNF149;RNF14;UBE2R2;UBE3B;DDB1;RNF167;PSMD14;MDM2;BFAR;ZNRF3;UBE4A;CBL;KCTD21;KCTD10;UBE2L3;RPS27A;UBC;RNF185;UBE4B;FBXO7;CDC26;UBE2H;UBE2C;RNF19A;WDR81;RCHY1;XBP1;USP33;RNF111;NEDD4;PSMD3;RNF7;UBA6;RNF20;PSMC2;HERPUD1;SPSB1;SYVN1;BIRC6;NUB1;RNF19B;UBQLN1;RNF34;ANAPC7
prerank,aminoglycan biosynthetic process (GO:0006023),0.4440398523163365,1.2607625482618885,0.1383219954648526,0.5249875116532823,1.0,8/49,7.35%,XYLT1;B4GALT7;B4GAT1;HEXA;HS3ST3B1;GCNT2;NDST1;HS6ST1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.37127542278175574,-1.2607596890356885,0.17204301075268819,0.5697137739997976,1.0,10/29,17.35%,CCR2;STAT5A;STAT4;FER;STAT3;CLCF1;CCL2;STAT1;IL31RA;GHR
prerank,positive regulation of cell growth (GO:0030307),0.4203393225127466,1.260650977222101,0.10864978902953587,0.5247811905562981,1.0,25/96,18.39%,IGF1;BCL2;MACF1;SDCBP;GOLGA4;SPHK1;EIF4G1;EIF4G2;ITSN2;DDX49;ADAM17;RUFY3;SLC25A33;LIMK1;PLAA;INO80;NTN1;EXOSC9;USP47;IL2;CPNE6;SUPV3L1;CDKN2AIP;SFRP1;TGFBR1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.45087985924564833,1.2603836736561682,0.132821075740944,0.5249983447892224,1.0,14/53,17.26%,ERCC6;EYA4;PRKCD;TRIM28;BRCA1;SPRED2;ABRAXAS1;FXR2;CEBPG;DHX9;UIMC1;BABAM2;SPRED3;TMEM161A
prerank,receptor metabolic process (GO:0043112),0.4471717093595597,1.2602536854982413,0.14732142857142858,0.5248464840437195,1.0,19/53,21.52%,CD9;LRP1;GRB2;SNX25;REP15;ARFGEF2;DNM2;CAV1;SYK;LILRB1;BECN1;MVB12A;TFRC;KIF16B;ITGB2;NEDD4;TGFB1;FCER1G;SNX1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3948058203532724,-1.25953701431998,0.17010309278350516,0.5691683935176255,1.0,12/24,21.46%,TMEFF2;F11R;WASF2;PIK3R1;CLASP2;STMN1;TJP1;INPP5K;PHLDB2;ARHGAP28;WAS;CGNL1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.538337895147268,1.2594994847080871,0.18880208333333334,0.5266761917748332,1.0,2/17,0.87%,IGF1;APOE
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5195692413937668,1.259359788929009,0.195,0.5265423155402459,1.0,3/20,3.49%,HIF1A;NFE2L2;VEGFA
prerank,protein methylation (GO:0006479),0.4637661721197735,1.2591357073175151,0.1511627906976744,0.5266349835448708,1.0,24/40,31.25%,ETFBKMT;ETF1;PRMT3;CARM1;EEF1AKMT3;EHMT1;PRMT6;PRMT7;PRMT2;METTL22;NTMT1;NSD1;PRMT5;SNRPD3;EEF2KMT;SETD3;GSPT1;FAM98B;NSD3;RAB6A;TRMT112;EHMT2;PRMT1;FAM98A
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3401523017003456,-1.258079388173277,0.11688311688311688,0.5694969036576154,1.0,9/41,6.41%,CACNA2D1;SLC8A3;RYR3;GRIN2B;HTR2C;GRIN2A;ITPR2;GRIN1;HTR2A
prerank,ketone body metabolic process (GO:1902224),0.5950851086145842,1.2579904709075762,0.1954674220963173,0.5296002048438895,1.0,4/10,15.21%,SLC27A5;OXCT1;HMGCL;AACS
prerank,negative regulation of protein kinase activity (GO:0006469),0.4211552186330447,1.2575068753259,0.11332633788037776,0.53047334485506,1.0,25/88,18.46%,CORO1C;ADARB1;PTPRC;GNAQ;DTNBP1;HSPB1;PDPK1;SMCR8;LRP6;TAB1;CAV1;TAF7;PAK2;MVP;TESK1;SLC8A1;YWHAG;UBASH3B;TRIB2;NF1;QARS1;DUSP3;PTPN1;PYDC1;ADAR
prerank,axonal transport (GO:0098930),0.4648538829639062,1.2571270466846185,0.16549295774647887,0.5310245913311248,1.0,11/36,14.04%,HIF1A;DYNC1H1;MGARP;DTNBP1;KIF1A;BLOC1S3;DCTN1;DST;AP3D1;FBXW11;AP3S1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4104143415157327,1.2570874803031298,0.0889348500517063,0.5305778839721734,1.0,42/119,24.29%,ITPKB;FGF2;PIK3CB;SLC27A1;ARF3;EFR3B;PIGQ;INPPL1;PI4K2A;TTC7B;PIGZ;RAB5A;PIP5K1C;PLEKHA1;PIK3R5;PI4KA;VAC14;PIGN;PIK3R2;SOCS5;PIGL;RUFY1;MTMR12;MTMR14;SOCS2;PI4K2B;PIP5K1A;MTMR6;INPP4A;PIP4K2A;PIK3C2A;PGAP2;PIKFYVE;SMG1;SYNJ1;PIK3CA;PIGA;PLEKHA2;ITPKC;SOCS6;SYNJ2;PGAP3
prerank,smooth muscle contraction (GO:0006939),0.5571763277128443,1.2568602258562631,0.1814569536423841,0.5307355721008533,1.0,7/14,22.78%,CHRNB2;TPCN2;SLC8A1;EDNRA;PIK3C2A;ROCK1;SMTN
prerank,regulation of response to stress (GO:0080134),0.6020729192846027,1.2566579578503503,0.20090634441087613,0.5307933520489952,1.0,6/10,24.82%,ADCY8;EIF4G1;STOX1;SLC38A2;OPRM1;MLC1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3951813362562466,1.2565932460223583,0.0160481444332999,0.5304520246253414,1.0,71/348,17.75%,GPNMB;BCAR3;IGF1;FNIP2;CSPG4;IQGAP1;CSF1;ITGA5;PLAUR;SDCBP;TEC;PDGFA;RAP2A;LAT;FGF2;PTPRC;NRP1;PTK2B;BMP8B;TRIM6;GDF6;SPHK1;CLDN19;ALS2;EIF4G1;VEGFA;DAB2;SOX9;CAB39;ADAM17;NPTN;CD44;MYDGF;RAD50;FGF20;GAS6;CAV1;CRKL;STOX1;RBPMS;TREM2;KRAS;FXR2;PAK2;JTB;CSNK1D;DOCK7;TESK1;RAF1;IL6;FNIP1;MAP2K3;ILK;FGF7;SH2D3C;HAX1;EFNA1;TNF;FGF18;TBK1;ARHGEF2;FLCN;BMP5;CNOT9;TFRC;PIN1;LATS1;CALM2;IRGM;PRKAG1;MAPK3
prerank,mitochondrial fusion (GO:0008053),0.5358533207599087,1.2565512932363565,0.1713917525773196,0.5300408753182554,1.0,12/18,34.51%,BAX;AFG3L2;MIGA2;STOML2;FIS1;USP30;SPG7;OPA1;MFN1;MIGA1;THG1L;MFF
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.46579564062116513,-1.256515883086783,0.19471947194719472,0.5698265157316025,1.0,6/12,20.04%,PLCB1;NBL1;SLIT2;CCN3;GREM1;DUSP1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5354034234424054,1.2562694952699474,0.19079837618403248,0.5303190910121748,1.0,5/16,12.06%,ARHGAP24;PIK3CB;ALS2;ARHGAP17;OGT
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5903934253301831,1.2559992544428782,0.18461538461538463,0.5305871368998903,1.0,7/11,29.29%,CAT;PRDX1;PRDX3;PXDNL;PRDX5;GPX3;PXDN
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.49197738285662773,-1.2556895578757978,0.20394736842105263,0.5683433589969519,1.0,4/11,2.23%,SYNJ2BP;EPN2;ALOX5;SEMA6A
prerank,calcium ion transport (GO:0006816),0.40927695842147604,1.2555025507001314,0.10227272727272728,0.5314618390297104,1.0,23/113,13.32%,CACNA1A;TRPC4;P2RX4;CHRNB2;MCOLN2;CYP27B1;CACNA1D;SLC3A2;CRACR2A;SLC24A4;PANX1;PSEN2;TRPM7;ANO6;MCOLN3;GAS6;CAV1;CACNB3;SLC8A1;ATP2A2;KCNN4;ORAI3;FYN
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.4282563050984336,1.2554701544549696,0.1259500542888165,0.5310077099844865,1.0,35/69,35.44%,SNAPC1;POLR2H;ELL2;SNAPC2;GTF2A2;GTF2F1;CCNT2;SNAPC4;INTS6;SP1;RPRD1A;INTS14;POLR2D;GTF2E2;INTS2;POU2F1;TBP;INTS3;PHAX;TAF6;GTF2A1;INTS12;ICE1;INTS1;INTS8;TAF13;TAF9;NABP2;POLR2B;CDK9;POLR2K;GTF2F2;POLR2F;ELL;INTS10
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4293140576192739,1.2551964683740784,0.1180931744312026,0.5312614677522447,1.0,22/70,23.79%,BCL2;BCL2L1;TRAF2;MCL1;PDPK1;DIABLO;TNFRSF1B;BAX;RNF41;BAG3;CRADD;CASP9;BID;TNF;BCL2L2;TGFB1;HIPK1;DAXX;CASP8AP2;FGFR3;GABARAP;GSK3B
prerank,positive regulation of DNA recombination (GO:0045911),0.4847239460563001,1.2549067759760837,0.17058096415327564,0.5315539995761441,1.0,10/27,22.59%,ERCC6;KMT5B;ARID2;RAD51AP1;PRDM9;TFRC;MMS19;ERCC2;FUS;PARP1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5849330255260051,1.25487355065119,0.20868347338935575,0.5311064752324457,1.0,2/11,1.55%,ITPKB;FGF2
prerank,carbohydrate derivative transport (GO:1901264),0.5222436119459082,1.2548708333335412,0.18758256274768825,0.5305708403840708,1.0,3/18,9.20%,ABCG1;SLC15A3;NPC2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.44976053233898017,1.2548668985814817,0.14722536806342015,0.5300415935198614,1.0,9/46,13.62%,LCP1;GSTA2;IL12RB1;MSN;P4HB;HSPA9;PAK2;JAK1;HNRNPA2B1
prerank,regulation of interleukin-6 production (GO:0032675),0.41622807501814774,1.2543942368010552,0.10114702815432743,0.530918008121103,1.0,27/96,21.44%,RAB7B;LPL;SIRPA;NLRC3;CD200R1;CYBA;FOXJ1;SPHK2;NCKAP1L;TMEM106A;GAS6;SYK;TREM2;IL6;DHX9;TNFAIP3;MAPKAPK2;HSPD1;TNF;ARHGEF2;MBP;TLR7;PTPN6;ZC3H12A;XBP1;IL17RA;TIRAP
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5134519312416822,1.2541535965421087,0.17519181585677748,0.531087891386473,1.0,9/21,24.50%,GCK;DERA;RPIA;HK3;PGLS;HK1;RBKS;PGD;H6PD
prerank,epidermal cell differentiation (GO:0009913),0.4654639299577194,1.253968232992912,0.14631336405529954,0.531101212794564,1.0,10/41,20.49%,CTNNB1;ST14;CLIC4;JAG1;ASAH1;PIP5K1A;HDAC1;ERCC2;MED1;UGCG
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.41594240210156574,1.2538544958147018,0.11052631578947368,0.5309331436220046,1.0,11/95,7.35%,XYLT1;CHST11;CSPG4;B4GALT5;B4GALT7;B4GAT1;HEXA;HS3ST3B1;GCNT2;NDST1;HS6ST1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.4128179051664649,-1.2535651544371624,0.14798206278026907,0.5700926642784656,1.0,11/20,39.24%,FDXR;TSPOAP1;STAR;CYP46A1;STARD3NL;STARD3;AKR1B1;HSD3B2;FDX2;AKR1C1;AKR1D1
prerank,regulation of synapse maturation (GO:0090128),-0.504510791918125,-1.253343267543499,0.2120253164556962,0.5673399184791537,1.0,5/10,26.91%,NRXN1;RELN;ADGRL1;CAMK2B;ARHGEF15
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4017406867768251,1.253337692916377,0.04513540621865597,0.5319378137871533,1.0,50/208,17.92%,LITAF;NLRC3;TNIP1;OPTN;TRAF2;TANK;TRIM6;HSPB1;PDPK1;SQSTM1;IKBKE;MALT1;PRKCB;FLNA;DDX21;AKAP13;PLK2;TRAF3;NEK6;HMOX1;SPHK2;WLS;ECM1;BRD4;CC2D1A;LGALS1;TMEM106A;TREM2;GPR89A;EEF1D;RHOA;GPRC5B;TICAM1;TNIP2;TNFAIP3;RIOK3;JMJD8;TNF;CCDC22;CARD19;BST2;HTR2B;TBK1;DDX1;TNIP3;TFRC;SHARPIN;UFL1;S100B;IRAK4
prerank,regulation of necroptotic process (GO:0060544),0.501408837068295,1.2532403498603824,0.1821656050955414,0.5316692682370597,1.0,9/23,20.51%,SDCBP;PDCD6IP;OGT;RIPK3;MLKL;ARHGEF2;BIRC2;FLOT2;YBX3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.47793076518145083,1.2531470706245182,0.18536585365853658,0.5314191383241104,1.0,13/29,23.44%,RUNX1;VPS18;BRCA1;CARM1;CNOT9;UFL1;LATS1;VPS11;KANK2;UFM1;KMT2D;UFSP2;WBP2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.40408226106457446,1.2531100769627013,0.07106598984771574,0.5309836359644149,1.0,42/151,20.38%,B4GALT5;LARGE1;APOE;PEMT;TNIP1;SLC27A1;APOA2;GSTA2;SPHK1;SGMS1;HACD2;CHKB;PLPP3;CERS6;SPHK2;AKR1A1;ALAS1;LPCAT1;ALDH3A2;LPCAT3;ALDH3B1;ST3GAL2;VAPB;CSNK2A2;NANP;GCNT1;MOCOS;FURIN;SAMD8;GOLPH3;CDO1;KDSR;SGPL1;LPIN3;STARD10;GSTO1;HACD1;MOCS3;ELOVL2;SPTSSA;LCMT2;SGMS2
prerank,methylguanosine-cap decapping (GO:0110156),0.5928515167654521,1.25298329677273,0.20494186046511628,0.5307987016051842,1.0,7/10,28.82%,PATL2;PATL1;EDC4;DCP2;EDC3;PNRC2;DCP1A
prerank,cellular response to acid chemical (GO:0071229),0.4904598457336017,1.2519327697525706,0.18081180811808117,0.5333683951321604,1.0,12/27,19.95%,RRAGD;IPO5;CPEB4;VEGFA;CPEB1;LARS1;SESN2;CPEB3;NSMF;LAMTOR3;LAMTOR1;XBP1
prerank,positive regulation of telomerase activity (GO:0051973),0.47028165236209973,1.251509967685049,0.17070217917675545,0.5340902069408576,1.0,14/33,26.66%,CTNNB1;CCT2;ACD;PKIB;DKC1;PNKP;MAPK3;MAPK15;NVL;XRCC5;PTGES3;HSP90AB1;MAPK1;PRKCQ
prerank,regulation of neuron death (GO:1901214),0.42184816818280363,1.251458177118491,0.11758474576271187,0.5337018797127399,1.0,16/82,13.32%,GPNMB;CSF1;CTSZ;CDK5;TRAF2;CD200R1;ATP13A2;EIF4G1;CHMP4B;CHMP4A;TNFRSF1B;SARM1;RILPL1;INPP5A;VPS35;FYN
prerank,cellular copper ion homeostasis (GO:0006878),0.5515225882751,1.2513112549606458,0.21448087431693988,0.5336089894020084,1.0,6/14,22.24%,SLC31A2;ATP7A;CCDC22;ATOX1;ATP7B;MT2A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4683907026137436,1.2505893801388042,0.16292798110979928,0.5352260635068992,1.0,14/35,23.44%,ZMIZ1;KDM3A;DDX17;TMF1;RNF14;NR3C1;PMEPA1;PPARGC1B;RBFOX2;MED1;SAFB;NEDD4;DAXX;WBP2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4943145159057476,1.2504424763874762,0.18247298919567828,0.5351151423944205,1.0,12/26,28.61%,PLEK;SLC9A1;LIMK1;PTGER4;PFN1;SYNPO;ALMS1;ROCK1;CDC42;RAC1;PFN2;CX3CL1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5422077890492489,1.2503752814740083,0.18915343915343916,0.5347648481858283,1.0,3/17,3.85%,FGF2;FOXJ1;SOX9
prerank,autophagy of peroxisome (GO:0030242),0.5737425178629175,1.2496798085719651,0.19858156028368795,0.5362853522671845,1.0,5/12,22.97%,SQSTM1;TRAPPC8;MAP1LC3B;ACBD5;USP30
prerank,receptor internalization (GO:0031623),0.45385966087557217,1.2496132110627185,0.1541135573580533,0.535926269965977,1.0,16/44,21.52%,CD9;LRP1;GRB2;RAB5A;DNM2;CAV1;SYK;SCYL2;LILRB1;TFRC;ITGB2;NEDD4;SAG;DRD3;FCER1G;SNX1
prerank,regulation of type I interferon production (GO:0032479),0.42138572054819423,1.2492541295031663,0.12341772151898735,0.536462133724668,1.0,42/84,28.63%,CTNNB1;LRRFIP1;IKBKE;IRF8;POLR2H;TRAF3;POLR3D;POLR3E;DHX33;UBE2L6;ILRUN;DTX4;IRF5;NFKB1;ACOD1;DHX9;TNFAIP3;TBK1;PIN1;TRAF3IP1;G3BP1;POLR3GL;NLRP4;TIRAP;IRAK1;POLR3B;CREBBP;XRCC5;NLRC5;EP300;OTUD5;STAT6;GPATCH3;POLA1;CRCP;PCBP2;IRF3;PRKDC;DHX36;POLR1C;POLR3A;RNF216
prerank,regulation of axon guidance (GO:1902667),0.5960637140128776,1.2491302806604603,0.22142857142857142,0.5362810145543391,1.0,3/10,6.98%,NRP1;VEGFA;ZSWIM8
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.49471617179268285,1.2491004021950596,0.17224287484510534,0.5358255815818844,1.0,11/25,24.03%,DNAJB14;DNAJB13;ERO1A;HSPA9;GAK;SDF2L1;DNAJB12;HSPE1;HSPA2;PTGES3;HSPA13
prerank,chromatin assembly or disassembly (GO:0006333),0.5939994889429222,1.2487415418087169,0.21469740634005763,0.5363278401287275,1.0,3/11,9.26%,NOC2L;HIRIP3;CHAF1B
prerank,gastrulation (GO:0007369),-0.435512735127014,-1.2485518815658796,0.1652542372881356,0.5759489718932849,1.0,5/15,21.60%,SMAD2;LRP5;GPC3;UGDH;LMBRD1
prerank,glycine metabolic process (GO:0006544),0.5785439621393772,1.2482288729871271,0.2185792349726776,0.537244942840967,1.0,5/12,15.98%,GLYAT;AMT;GCSH;RIDA;GCAT
prerank,myotube differentiation (GO:0014902),0.5308933994359966,1.2481234053768442,0.21610738255033557,0.5370244958140833,1.0,3/17,7.38%,IGF1;PLD3;SKI
prerank,regulation of vacuole organization (GO:0044088),0.5163095295963251,1.2479829919391396,0.20332480818414322,0.536897402468949,1.0,10/20,25.91%,RAB5A;ENO2;IFT88;ENO1;NPRL3;TBC1D12;PIKFYVE;NPRL2;UBQLN2;ENO3
prerank,positive regulation of MAPK cascade (GO:0043410),0.3956470795832908,1.247890080943018,0.041082164328657314,0.5366344229776825,1.0,31/245,9.76%,GPNMB;BCAR3;IGF1;FLT1;IQGAP1;APOE;PDGFA;ADAM8;FGF2;PTPRC;CCL4;NRP1;MFHAS1;PTK2B;ALKAL2;VEGFA;FBXW7;GCNT2;CD44;MYDGF;TAOK3;MAP3K12;CCL13;TMEM106A;PIK3R5;DHX33;GAS6;CRKL;TREM2;IGF1R;CCL14
prerank,protein localization to nucleus (GO:0034504),0.41188092450772223,1.2476325099580694,0.10384215991692627,0.5368768286807555,1.0,31/102,23.00%,MMP12;PRICKLE1;IPO5;GCKR;E2F3;TOR1AIP2;APPL2;NUP188;SYK;TNPO1;EIF4ENIF1;MDM2;TNPO2;XPA;NOL8;TPR;CTDNEP1;PTTG1IP;NXT2;TOR1B;PPP1R10;PIKFYVE;TBRG1;ARL2BP;HNRNPU;ABCA7;IPO13;CALR;NUP133;NUP93;LMNA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4489244914552804,1.2472398773411841,0.15497737556561086,0.5375181245252103,1.0,12/48,15.95%,SLC26A1;ADCY8;ADCY3;NPPA;ADCY7;AMPD2;ADSS1;AK5;PPCS;COASY;SLC35B3;NPPC
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.44268460189504044,-1.2472380513364465,0.14516129032258066,0.5759153494814186,1.0,8/15,14.89%,NTRK2;ZFYVE27;HAP1;CASP3;FRS2;SORT1;DDIT4;BCAR1
prerank,DNA metabolic process (GO:0006259),0.3915149650505135,1.2470388400006853,0.03406813627254509,0.5375709960438789,1.0,102/270,28.03%,DCTPP1;ORC3;PARP4;DOT1L;RAD51B;IGHMBP2;MCM2;DDX21;RNASEH2A;MCM7;ZRANB3;KMT5B;GMNN;SMARCB1;MGMT;ERCC1;TRIM28;RAD50;UBA52;VCP;DNASE2;LONP1;SLX4;RNASEH1;BRCA1;ACD;DNASE1L1;DFFB;MBD4;DDB2;ALKBH1;DDB1;GLRX2;DBF4;SRPK2;ERCC4;XPA;POLA2;INO80;RAD51AP1;PARP2;ADPRS;SETMAR;MCM8;RFC2;POLE;LIG3;RPS27A;UBC;MNAT1;GEN1;DNMT1;LIG1;SUPV3L1;NOC3L;RFC1;UBE2V2;TERT;PNKP;GTF2H1;PURA;RECQL5;MMS19;CNBP;RAD9A;TERF1;CENPS;BLM;FANCA;HUS1;ASF1A;TOPBP1;SUMO1;INTS3;PSME4;CSNK1E;ALKBH3;POLE4;XRCC5;CDK2;PARP1;PTGES3;MCM6;RAD51;TOP1;MCM3;PDS5A;CBS;CDC34;POLA1;CDC7;MCM5;TERF2IP;PRKDC;DDX23;ZBTB1;SMARCAL1;WDHD1;REXO4;POLG;TERF2;KPNA2
prerank,regulation of aerobic respiration (GO:1903715),0.5443598910471309,1.2464297580027586,0.20162381596752368,0.5388636751768052,1.0,5/15,9.78%,SLC25A33;AK4;VCP;ATP7A;COX7A2L
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4251653823562081,1.245913647313833,0.13290460878885316,0.5398726018156971,1.0,27/76,22.40%,PLEK;STAP1;NRP1;CDK5;NES;PTK2B;DYNC1H1;NCKAP1L;LIMK1;BAIAP2;NUMA1;NCK1;EVL;HAX1;SORBS3;BAIAP2L1;PFDN2;VASP;BAIAP2L2;PFN1;FES;SYNPO;CDC42EP1;ARF6;NCK2;WDR1;CDC42
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5146662631571305,1.2456665428209557,0.20606826801517067,0.5400439654062383,1.0,6/19,17.14%,SLC26A1;SULT6B1;TPST1;SULT2B1;SLC35B3;BPNT2
prerank,regulation of cytokine production (GO:0001817),0.4113708159201668,1.2451309567200846,0.08682328907048008,0.541098894513297,1.0,25/126,15.78%,GPNMB;SIRPA;FGR;PLD3;PTPRC;ATP2B1;IRF8;CADM1;TRAF3;NPTN;TNFRSF1B;HDAC9;CRTAM;SLC11A1;BCL6;DTX4;TREM2;BTN3A3;RIPK3;PTGER4;IL6;MAPKAPK2;TNF;HTR2B;TBK1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.41032428287479633,1.244958703059151,0.1154639175257732,0.5410548579931065,1.0,25/113,21.28%,IGF1;NRP2;HIF1A;MMP12;FGF2;NRP1;VEGFA;SOX9;MYDGF;LAMC1;ECM1;EGFL7;NRAS;VIP;C5AR1;FGF7;HTR2B;BMP5;SFRP1;JAML;TGFBR1;XBP1;FGFR2;PDGFB;CLDN1
prerank,protein transport (GO:0015031),0.393995301627422,1.2446221529019972,0.025025025025025027,0.541483165896463,1.0,121/332,26.20%,LRP1;ABCA1;ABCG1;TCIRG1;TBC1D22A;APOE;ATP6V1C1;ATP6V0D2;MACF1;ATP6V1A;ATP6V0A1;GOLGA4;SNX8;CTSA;ARF3;OPTN;ATP6V1B2;TBC1D2;NAPA;ATP6V0D1;TOM1;PRKCB;PPARG;REP15;RIC1;ATP6V1G1;RAB32;RAB8B;ARL11;SNX33;VPS26A;TLK1;WLS;ARL1;RAB5A;ATP6V0B;GCC2;DNM2;ACD;STX6;RAB7A;LAMP2;AP3D1;TBC1D10A;RAB5C;VAMP2;SIL1;RAB1A;RUFY1;VPS26C;TBC1D12;ARRDC4;STX3;USO1;RAB20;STX5;SAR1A;TBC1D16;SNX4;GOLPH3;SNX27;GGA2;VPS35;VAMP4;ATP6V0A4;ATP6V1F;ARFGAP3;ATP6V0C;RAB22A;SNX31;ARRDC2;ATP6AP1;ARHGEF2;RABL3;SNX17;TFRC;COPA;RAB3GAP2;TMED3;COPG2;RILP;ATP6V1D;UNC119B;BBS2;ARFRP1;STX7;VIPAS39;STEAP3;ARF6;LMAN2L;ATP6V1E1;RUNDC1;GOLPH3L;AP3B1;SNX1;COPG1;RAB34;SNX15;HSP90B1;SGSM1;DNAJC27;SCAMP1;ARL6IP5;TBC1D1;KIF3A;TBC1D15;STX4;RAB31;TBC1D10C;SCAMP3;ARF5;EHD1;ARHGAP1;COPZ2;ARF4;PDCD6;VPS26B;CANX;GOLGA7;GGA3;STX11
prerank,regulation of gene silencing by miRNA (GO:0060964),0.43188656141795406,1.2444940856802895,0.14709110867178923,0.5413275272535039,1.0,25/62,29.11%,NUP205;AGO2;EIF4G1;PPARG;POLR2H;NUP188;RAE1;DHX9;NUP42;TPR;POLR2D;PUM1;NUP54;TGFB1;RANBP2;PUM2;NUP133;NUP93;NUP98;WTIP;H3-3A;NUP35;AAAS;FMR1;TRIM71
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.49288336074562394,1.2444844401805204,0.19225967540574282,0.540828390849601,1.0,8/26,23.37%,IQGAP1;PDPK1;SOX9;EEF1A1;DUSP3;MED1;PTPN12;PTPN11
prerank,cellular protein catabolic process (GO:0044257),0.43427957123896965,1.2437798840662153,0.1343784994400896,0.5423635144520985,1.0,12/59,14.20%,CTSB;TCIRG1;MYLIP;CTSZ;MALT1;SIAH2;LONP1;RAB7A;AFG1L;MDM2;CLPP;CHEK2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.40132863930678087,-1.2435517457509706,0.16666666666666666,0.5821014041723775,1.0,6/18,10.77%,CHRM2;GNA15;PLCB1;RGS10;CHRM3;RGS8
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.537512408023155,1.243289458035155,0.20242914979757085,0.5432877650454849,1.0,4/16,11.97%,RUNX1;VIM;SUCO;SERPINF2
prerank,regulation of phospholipase activity (GO:0010517),0.5926883065098423,1.2431771617586556,0.20260492040520983,0.5430790898706809,1.0,2/10,3.48%,LRP1;PDPK1
prerank,regulation of potassium ion transport (GO:0043266),-0.35724995982305396,-1.2430810783947774,0.15757575757575756,0.5799733627352875,1.0,6/31,4.74%,KCNIP4;DPP10;DPP6;ANK3;KCNN2;KCNIP3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4139073074163309,1.2428823793029824,0.11320754716981132,0.543340303443706,1.0,38/107,25.07%,BCL2;ATF3;TRAF2;ERN2;BAX;TMX1;ERN1;MBTPS2;VCP;CREB3L2;ERO1A;JUN;PIK3R2;P4HB;DDIT3;BCL2L11;NCK1;ATG10;DNAJC10;ATP2A2;RNF185;UFL1;DNAJB12;WFS1;DERL1;SEC16A;EIF2S1;HERPUD1;TMCO1;BRSK2;SYVN1;UFM1;HSP90B1;UBQLN1;GSK3B;USP19;PPP1R15B;UBXN6
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4937165795723545,1.2426137115137552,0.16449086161879894,0.543599990140623,1.0,7/23,11.75%,CD274;AXL;GAS6;HAVCR2;DDIT3;LILRB1;C1QBP
prerank,mesonephric tubule development (GO:0072164),-0.4476016822313964,-1.2424318750065746,0.20080321285140562,0.5783336404257484,1.0,2/15,2.01%,SALL1;ROBO2
prerank,regulation of cell cycle process (GO:0010564),0.41005217407014427,1.242346931408232,0.11487179487179487,0.5438682964528515,1.0,37/104,25.64%,CTNNB1;BCL2L1;DYNC1H1;SOX9;PLK2;SND1;KLHL13;GIT1;ATF5;AHCTF1;YTHDF2;NUMA1;CSNK2A2;DBF4;CDK13;BECN1;PLK3;MARK4;CEP250;FLCN;PIN1;CCP110;PRPF40A;CALM2;SFRP1;MYO19;CETN2;CUL9;FBXO5;PRMT5;CDC42;BIRC6;USP19;SH3GLB1;CALM3;DCUN1D3;RAB11FIP4
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4528974879954775,-1.2422311663955714,0.20357142857142857,0.5755182175600199,1.0,4/12,15.90%,DOCK4;MEF2C;IGFBP5;FGF9
prerank,nucleosome organization (GO:0034728),0.43552238622165856,1.2422279028894765,0.15027624309392265,0.5436862131809393,1.0,30/55,32.06%,GRWD1;SOX9;SMARCB1;BPTF;ARID2;CHAF1B;SRCAP;INO80;PRDM9;ACTR6;SMARCD2;ANP32E;MCM3AP;SART3;ASF1A;DMAP1;SMARCA4;SET;DAXX;VPS72;NAP1L3;NAP1L2;H3-3A;RSF1;SMARCC1;SMARCC2;SETD2;NPM1;SMARCE1;BRD2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5364078663162187,1.2421993964302422,0.20027434842249658,0.5432342227794928,1.0,9/14,28.48%,TRMT10C;TRUB2;RCC1L;C1QBP;FASTKD2;NGRN;RMND1;MRPS27;FASTKD3
prerank,negative regulation of DNA metabolic process (GO:0051053),0.49397600939690656,1.2412533080369403,0.18309859154929578,0.5454750153495502,1.0,5/24,11.54%,NIBAN2;KMT2A;ZRANB3;ERCC1;ERCC4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5131302639918237,1.241119975623607,0.19518377693282637,0.545355544039251,1.0,4/21,7.58%,CTNNB1;NES;VEGFA;DLL4
prerank,positive regulation of B cell activation (GO:0050871),0.43640955387872804,1.2410891618995203,0.1670428893905192,0.5449062763061849,1.0,11/50,13.83%,BCL2;CHRNB2;PTPRC;SH3KBP1;KMT5B;NCKAP1L;SYK;BTK;IL6;TNIP2;IL2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5216962833674285,1.2410352250826777,0.21322537112010798,0.5445193878050657,1.0,3/17,6.15%,BCL2;BCL2L1;BAX
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5280964531926451,1.2407974388776732,0.21808510638297873,0.5447134570031759,1.0,4/17,8.56%,MAFF;SOX9;MAFG;CAV1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5714618970726693,1.2405523137213308,0.22836879432624113,0.5449071493678915,1.0,3/11,10.07%,AXL;GAS6;LILRB1
prerank,regulation of interferon-alpha production (GO:0032647),0.4946413762274183,1.2403730069050634,0.20270270270270271,0.5448802948745817,1.0,14/23,32.88%,NLRC3;IRF5;HAVCR2;DHX9;HSPD1;TBK1;TLR7;CHUK;TLR3;IRF3;DHX36;SETD2;MAVS;DDX3X
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4451844422164898,1.2399895325316452,0.15856481481481483,0.5453858103327445,1.0,11/46,14.62%,IGF1;CTNNB1;PTGIR;PPARG;HMOX1;ID2;VIP;SERPINF2;IL6;TNFAIP3;TNF
prerank,positive regulation of translation (GO:0045727),0.409680343298651,1.239843497871214,0.11703239289446186,0.5453304492314334,1.0,43/94,28.50%,PKM;EIF6;AGO2;PIWIL2;TRMT10C;VIM;LARP4;LARP1;TRUB2;RCC1L;EEF2;FXR2;YTHDF2;UPF3A;C1QBP;IL6;DHX9;FASTKD2;UPF3B;NAT10;POLR2D;EIF5AL1;EIF5A;CPEB3;CIRBP;PYM1;CNBP;USP16;PCIF1;YBX3;NGRN;METTL3;RMND1;EIF3E;LARP4B;ZCCHC4;EIF4A3;CDC123;PRKDC;DHX36;MRPS27;FASTKD3;FMR1
prerank,protein modification by small protein removal (GO:0070646),0.39679658021298775,1.239695062530033,0.041082164328657314,0.5452340955522037,1.0,95/252,25.25%,HIF1A;PSMD1;TNIP1;TRAF2;COPS3;PSMD8;USP12;JOSD1;OTUD4;SIAH2;RNF128;PSMA1;TRAF3;SMAD7;USP5;STAM2;PSMA8;COPS2;ATXN3;BAP1;COPS4;SENP5;UBA52;VCP;COPS8;USP9X;SUDS3;TAB1;BRCA1;ABRAXAS1;DDB2;PSMD14;ASXL2;MDM2;PSMA5;BECN1;RHOA;USP2;INO80;OGT;TNIP2;TNFAIP3;USP47;PSMD12;USP36;USP35;USP40;MYSM1;HCFC1;PSMB10;UIMC1;RPS27A;UBC;BABAM2;YY1;TNIP3;USP14;CDC25A;CCP110;USP13;USPL1;STAMBPL1;COPS7A;PSMD2;PSMC4;TGFBR1;STAMBP;BIRC2;USP21;USP16;ZC3H12A;USP8;PSMD6;BRCC3;USP33;PSMD3;PSMD5;SMAD1;PSMC2;PSME4;PSMB8;USP30;PSMA6;ASXL1;COPS6;PSMB7;PSMD4;YOD1;EP300;USP48;USP19;SENP1;PTEN;PSMA3;OTUD5
prerank,positive regulation of chromatin organization (GO:1905269),0.5741300898798307,1.2388254417854792,0.21914008321775313,0.5472359913387566,1.0,9/12,37.19%,ACD;TERF1;DAXX;H3-3A;TERF2IP;TERF2;TINF2;UBE2N;TAL1
prerank,negative regulation of histone methylation (GO:0031061),0.597495870066945,1.2387875132184594,0.22028985507246376,0.5468168252817379,1.0,6/10,16.52%,PHF1;MTF2;BRCA1;DNMT3B;DNMT1;WDR5
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4200680352454514,1.2379823057856845,0.14225941422594143,0.5485884394604227,1.0,26/80,19.10%,RAB7B;SNX8;GOSR2;TMEM87B;VTI1A;BET1L;RIC1;RGP1;VPS26A;ARL1;GCC2;DCTN1;VPS50;SPAG9;STX6;RAB7A;TBC1D10A;RAB9A;STX5;VPS35;TBC1D23;YKT6;VAMP3;PIKFYVE;VPS54;ARFRP1
prerank,regulation of steroid metabolic process (GO:0019218),0.4964633045554014,1.2377408960690581,0.20051413881748073,0.548782897296031,1.0,8/23,20.09%,ABCG1;APOE;ASAH1;ACADL;ARV1;ABCB11;LAMTOR1;DGKQ
prerank,T cell receptor signaling pathway (GO:0050852),0.4049902014034317,1.2376120533017043,0.08841463414634146,0.5485869165950373,1.0,46/138,23.79%,RFTN1;TEC;PSMD1;LAT;PIK3CB;PTPRC;PSMD8;PDPK1;MALT1;TRAT1;PSMA1;PSMA8;NFKBIZ;PIK3R2;NFKB1;BTN3A3;PAK2;PSMD14;NCK1;PSMA5;THEMIS2;PSMD12;FYN;FBXW11;PSMB10;FYB1;EIF2B2;PSMD2;SPPL3;PSMC4;DENND1B;TNFRSF21;CUL1;STOML2;ZC3H12A;PSMD6;PIK3CA;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;CHUK;PSMB7;PSMD4
prerank,regulation of immune response (GO:0050776),0.40153451692520664,1.2375925785749113,0.10780287474332649,0.5481281978500974,1.0,32/135,21.44%,COLEC12;CD300LF;FGR;CD300LB;CD22;CD200R1;GPR151;ADCY7;CD300A;PDCD1;TRAF3;APPL2;FCRLB;CRTAM;BCL6;SYK;TREM2;LILRB1;PIANP;RIPK3;ELMOD2;TREML1;JAML;ITGA4;DENND1B;ITGB2;RSAD2;PVR;BIRC2;TREML2;LAG3;TIRAP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.46917648719419586,1.237552526830351,0.18007202881152462,0.5477281104330962,1.0,4/30,2.60%,FLT1;PLEK;PTPRC;FSTL3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.33963716941216304,-1.2372837806359969,0.11258278145695365,0.584358870993328,1.0,16/37,22.64%,BICD1;CYLD;CLASP2;EFNA5;STMN3;STMN1;TRIM36;SKA2;MAP6;TPPP;MAPT;MAP6D1;PHLDB2;CAMSAP3;SKA3;FAM107A
prerank,regulation of actomyosin structure organization (GO:0110020),0.5623100328818939,1.2370999047246518,0.213986013986014,0.5485085460680067,1.0,6/13,22.40%,SLC9A1;AKAP13;PTGER4;ALMS1;ROCK1;CDC42
prerank,regulation of telomerase activity (GO:0051972),0.4444269897230151,1.237044641900382,0.18023255813953487,0.5481386745929265,1.0,17/45,26.66%,CTNNB1;PARP4;CCT2;ACD;PKIB;ERCC4;DKC1;PNKP;MAPK3;MAPK15;TERF1;NVL;XRCC5;PTGES3;HSP90AB1;MAPK1;PRKCQ
prerank,regulation of DNA replication (GO:0006275),0.44284935842147843,1.237005194072325,0.17732884399551066,0.5477198702394342,1.0,14/49,21.10%,BCAR3;ORC3;GMNN;GTPBP4;PPP2R1A;DHX9;WAPL;S100A11;KAT7;OBI1;TERF1;BLM;FBXO5;CDAN1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.580471176603027,1.2369428750613183,0.23323615160349853,0.5473891527609746,1.0,3/11,10.07%,PTPRC;SMAD7;LILRB1
prerank,defense response to protozoan (GO:0042832),0.5571135638312027,1.2366139747063278,0.21763085399449036,0.5478409118371946,1.0,2/12,7.56%,LYST;SLC11A1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4548123986314452,1.2356977693916442,0.17447306791569087,0.5501183286321455,1.0,16/39,23.75%,ITPKB;PIK3CB;EFR3B;PI4K2A;TTC7B;PI4KA;PIK3R2;SOCS5;SOCS2;PI4K2B;PIP4K2A;PIK3C2A;SMG1;PIK3CA;ITPKC;SOCS6
prerank,apoptotic mitochondrial changes (GO:0008637),0.4645269276781686,1.2354303103404947,0.1903030303030303,0.5503974956486074,1.0,8/32,13.73%,BCL2;BCL2L1;BAX;AIFM2;BID;BIK;VPS35;HSPD1
prerank,positive regulation of cell motility (GO:2000147),0.39379206223130264,1.2353480465264184,0.0634441087613293,0.5501129153348729,1.0,27/205,10.28%,GPNMB;IGF1;PLAU;FLT1;ITGAX;CSF1;MGAT5;FGR;SDCBP;PDGFA;PTK2B;SPHK1;VEGFA;DAB2;GCNT2;NEDD9;ADAM17;PDPN;RUFY3;MYOC;RHOD;CCAR1;SPAG9;CAV1;MYADM;IGF1R;PHPT1
prerank,glial cell differentiation (GO:0010001),-0.36215290167518327,-1.2348691624457397,0.15897435897435896,0.5868011237658813,1.0,11/28,12.97%,SLC8A3;FGF10;ADGRG6;SOX8;NFIB;CDH2;STAT3;TPPP;RELN;ERBB3;GPC1
prerank,negative regulation of response to stimulus (GO:0048585),0.42984811746626944,1.2348256375704698,0.16375545851528384,0.5511042820897785,1.0,18/60,20.43%,VPS13C;MCTP1;CDK6;PDCD1;APPL2;FCRLB;LPCAT3;SOCS5;TLE5;BRAP;ZKSCAN3;UBASH3B;MAPK7;TERT;WFS1;PTPN1;DDAH1;FBXO5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.553693730905666,1.2347473818051222,0.21067415730337077,0.5508471848857235,1.0,6/14,22.59%,ERCC6;ARID2;RAD51AP1;MMS19;FUS;PARP1
prerank,cellular amide metabolic process (GO:0043603),0.41048250493045985,1.2346879421853338,0.11610878661087866,0.5505048571988419,1.0,28/102,19.84%,CERK;ORMDL1;PLAAT3;SLC46A1;ACOT9;PLPP3;CPD;FPGS;MTHFS;MTRR;GLYAT;ST6GAL1;PPP2R1A;MTHFR;NAPEPLD;ABHD4;MTHFD2;ORMDL3;ACOT6;SLC19A1;SGPL1;AASDHPPT;ACOT1;SLC5A6;NLN;SLC25A32;CLN8;DNPEP
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3911454933579907,1.2341341936917258,0.050200803212851405,0.5516042581109931,1.0,47/234,15.97%,RAB7B;CTNNB1;PRKCH;IRAK2;ADAM8;ARID5B;ADCY8;TRAF2;TRIM6;SPHK1;VEGFA;IKBKE;MALT1;PRKCB;STK3;PPARG;PLPP3;CRTC1;HDAC4;SMARCB1;ANXA3;UBA52;MBTPS2;LRP6;DHX33;TAB1;FZD4;FZD1;CAV1;DDIT3;NFKB1;SRF;CEBPG;JUP;TICAM1;RIPK3;AIM2;BTK;IL6;DHX9;RIPK4;TNF;RPS27A;UBC;ARHGEF5;ARHGEF2;PPARGC1B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5067284906150448,1.233757889781952,0.20050761421319796,0.5520977595876428,1.0,8/22,22.04%,MAN1C1;EDEM1;UBA52;RPS27A;UBC;RNF185;MAN1A2;SYVN1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.39756809975113216,-1.233612677294266,0.15021459227467812,0.5868254837695583,1.0,5/19,14.30%,ITGAM;PRKCE;SCIMP;LGALS9;TRIL
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.46671422143353664,1.2335358808454837,0.2026378896882494,0.5522199316427114,1.0,7/35,8.56%,FLT1;APOE;XDH;PTPRM;PPARG;DLL4;CAV1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5294513557814807,1.233488316794267,0.2064935064935065,0.5518510989399811,1.0,11/16,36.65%,PLEKHN1;CPEB3;ZC3H12A;ZC3H12D;TARDBP;DHX36;TRIM71;RC3H1;KHSRP;UPF1;ZFP36L2
prerank,phospholipid biosynthetic process (GO:0008654),0.4662839311497276,1.2331673160045398,0.1700356718192628,0.552286090369182,1.0,15/36,22.52%,SGMS1;SPHK2;SRD5A3;DPAGT1;LPCAT1;CPNE3;SAMD8;CPNE6;PIP5K1A;HDHD5;CLN3;SGMS2;AGPAT5;AGPAT3;NUS1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5065823064177671,1.233038256225064,0.19367088607594937,0.5521108915404104,1.0,6/21,23.79%,MFHAS1;PTPA;BOD1L1;FKBP1B;PPP1R8;GSK3B
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.469392414356008,1.232746749729951,0.19951923076923078,0.5523735320597879,1.0,17/31,30.24%,FBXW7;FZR1;RAB1A;ARRDC4;DCUN1D4;UBE2L3;PIN1;DCUN1D2;UBE2C;GOLGA2;RPS2;BMI1;PTEN;DCUN1D3;BTRC;GORASP1;TOPORS
prerank,cellular transition metal ion homeostasis (GO:0046916),0.4102557933133452,1.232361811097148,0.1446673706441394,0.5530453931611529,1.0,26/91,22.25%,ATP6V1A;SLC31A2;ATP13A2;FTL;ATP6V0D1;FRRS1;SLC46A1;HMOX1;ATP6V1G1;TMEM199;SLC11A1;SLC39A7;ATP7A;CAND1;CCDC22;FLVCR1;ATP6AP1;TFRC;ATOX1;SLC39A6;CUL1;SLC39A13;ATP7B;SLC30A9;MT2A;TMPRSS6
prerank,photoperiodism (GO:0009648),0.480657679017922,1.2321839949278541,0.2007168458781362,0.5530438660306085,1.0,8/28,13.66%,FBXL17;CRTC1;SIK1;BHLHE40;ID2;RBM4B;USP2;FBXL6
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.5562294632806212,1.2318857254047397,0.22523744911804613,0.5534132222627353,1.0,5/13,21.69%,IRAK2;TNIP2;IRAK4;TLR7;IRAK1
prerank,cellular iron ion homeostasis (GO:0006879),0.4285264326729255,1.2315413821815941,0.1534216335540839,0.5539456975278422,1.0,10/55,7.56%,ATP6V1A;ATP13A2;FTL;ATP6V0D1;FRRS1;SLC46A1;HMOX1;ATP6V1G1;TMEM199;SLC11A1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5518613436777939,1.2312156133010637,0.2211267605633803,0.5543534527297138,1.0,4/13,7.51%,SMCR8;CHMP4B;CHMP4A;SEC22B
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4307095209806502,1.2312062468691019,0.17721518987341772,0.5538611573632515,1.0,29/51,34.82%,CTNNB1;TNKS2;CCT2;HNRNPC;ACD;PKIB;EXOSC10;CCT5;NAT10;DCP2;PNKP;MAPK3;MAPK15;TERF1;HNRNPU;XRCC5;XRN1;MAPK1;PRKCQ;TENT4B;TERF2;MAP2K7;GNL3L;TEN1;ATR;CCT7;TINF2;PINX1;MAPKAPK5
prerank,regulation of focal adhesion assembly (GO:0051893),0.4351684675095255,1.2306620578293939,0.16111111111111112,0.5549731726176027,1.0,11/54,12.03%,PEAK1;CORO1C;PTPRA;MACF1;SLC9A1;NRP1;VEGFA;MYOC;LIMS1;RHOA;ARHGAP6
prerank,regulation of transferase activity (GO:0051338),0.5132056614141262,1.230250946258827,0.21693121693121692,0.5556449896001807,1.0,12/17,34.86%,PARP4;PPP1R3F;JMJD8;LDB2;LDB1;NLRC5;FEM1B;BAG5;SPTSSB;NABP2;PINX1;EMP2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5821466274035078,1.2302097431846422,0.2309899569583931,0.5552266271593812,1.0,4/10,18.20%,PFKL;HK3;PFKP;HK1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5400405457332567,1.2301736131087826,0.2160737812911726,0.5548022601641944,1.0,6/15,21.88%,RNASEH1;ZC3H12B;POP1;ZC3H12C;ZC3H12A;ZC3H12D
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4098816860270104,1.2299163051290491,0.10961737331954498,0.5550529044145451,1.0,13/108,7.38%,MDFIC;CDK14;CTNNB1;LRP1;MACF1;CCNY;GNAQ;SOX30;OTULIN;RUNX1;MDFI;WLS;SKI
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5043579272477469,1.2298433336004475,0.2130718954248366,0.5547533704416246,1.0,7/20,15.80%,AGO2;SNIP1;ZC3H7B;AGO3;AGO4;PUM1;TERT
prerank,peptidyl-lysine monomethylation (GO:0018026),0.584050926231001,1.2297112786949533,0.21714285714285714,0.5546216684456345,1.0,5/10,23.86%,KMT5A;SMYD2;EHMT1;SETD3;SETD4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4138846669053988,1.2294886354100087,0.12381951731374606,0.554765520700962,1.0,40/85,29.87%,PSMD1;PRICKLE1;PSMD8;DAAM1;PSMA1;PSMA8;FZD4;FZD1;CELSR1;PSMD14;PSMA5;RHOA;PSMD12;PSMB10;PSMD2;PSMC4;PFN1;PSMD6;PARD6A;PSMD3;PSMD5;PSMC2;PSME4;CDC42;PSMB8;CELSR3;PSMA6;PSMB7;PSMD4;CELSR2;PSMA3;PSMD10;AP2B1;RAC1;PSMC6;PSME3;PSMC5;PSMA4;WNT7A;PSMB6
prerank,positive regulation of fat cell differentiation (GO:0045600),0.43914242276260107,1.2293530364831247,0.1864594894561598,0.5546388781281878,1.0,16/47,21.82%,LPL;PPARD;PPARG;ID2;NOCT;CARM1;ASXL2;NAPEPLD;ZBTB7B;SFRP1;METRNL;HNRNPU;ZC3H12A;XBP1;FRZB;ZBTB16
prerank,copper ion transport (GO:0006825),0.5787472539814251,1.2290026275646968,0.22033898305084745,0.555173911323114,1.0,5/11,20.52%,SLC31A2;ATP7A;ATOX1;STEAP3;ATP7B
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4542724039740502,-1.2288211787623933,0.20588235294117646,0.5954990105742142,1.0,3/12,10.23%,HAGH;GGCT;CHAC2
prerank,regulation of cell junction assembly (GO:1901888),0.4844156580475074,1.2285568632616504,0.22126081582200247,0.5559776746987842,1.0,4/27,3.00%,PRKCH;CHRNB2;CLDN19;RUNX1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4587609379947926,1.2277460612349274,0.1853146853146853,0.5579165492645243,1.0,5/34,1.94%,FLT1;FGR;FGF2;WDR91;PTK2B
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.41443728816758846,1.227320207406424,0.13912133891213388,0.5586383945076592,1.0,44/94,29.20%,IRAK2;PSMD1;PSMD8;SQSTM1;PSMA1;PSMA8;UBA52;TAB1;NFKB1;MAP3K8;PSMD14;PSMA5;TNIP2;PSMD12;FBXW11;PSMB10;RPS27A;UBC;PSMD2;PSMC4;MAPK3;IRAK4;CUL1;PSMD6;PSMD3;PSMD5;PSMC2;PSME4;IRAK1;PSMB8;PSMA6;CHUK;PSMB7;IL1R1;PSMD4;PELI2;EGR1;PSMA3;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;BTRC
prerank,mesenchymal cell differentiation (GO:0048762),0.43720716993467457,1.2271243275777826,0.16983240223463686,0.5586960711603772,1.0,17/51,21.65%,CTNNB1;HIF1A;FBXL17;SOX9;TRIM28;LRP6;DDX17;LIMS1;FAM83D;HTR2B;NOTCH4;LOXL3;TGFBR1;FGFR2;TGFB1;ROCK1;NOTCH1
prerank,regulation of establishment of planar polarity (GO:0090175),0.4141123307712123,1.2269500017986157,0.12025316455696203,0.5587008556018739,1.0,41/88,29.87%,PSMD1;PRICKLE1;PSMD8;DAAM1;PSMA1;PSMA8;FZD4;FZD1;CELSR1;PSMD14;PSMA5;RHOA;PSMD12;PSMB10;PSMD2;PSMC4;PFN1;DACT1;PSMD6;PARD6A;PSMD3;PSMD5;PSMC2;PSME4;CDC42;PSMB8;CELSR3;PSMA6;PSMB7;PSMD4;CELSR2;PSMA3;PSMD10;AP2B1;RAC1;PSMC6;PSME3;PSMC5;PSMA4;WNT7A;PSMB6
prerank,histone methylation (GO:0016571),0.48529988306486427,1.2267217456101323,0.2094175960346964,0.558874388223316,1.0,16/26,31.17%,SMYD3;SMYD2;CARM1;EHMT1;PRMT6;PRMT7;PRMT2;NTMT1;NSD1;PRMT5;CREBBP;SMYD1;NSD3;TRMT112;EHMT2;PRMT1
prerank,defense response to fungus (GO:0050832),-0.40757229046516075,-1.2265454429434113,0.17355371900826447,0.597960103330725,1.0,2/17,6.82%,CX3CR1;GAPDH
prerank,regulation of protein localization to nucleus (GO:1900180),0.4435792319394065,1.2265055513151966,0.1836027713625866,0.5590073657372042,1.0,17/43,23.79%,MFHAS1;ATP13A2;CARD10;ILRUN;TESK1;ORMDL3;TPR;SESN2;FLCN;TFRC;KAT7;PIN1;LATS1;BYSL;TGFB1;NVL;GSK3B
prerank,regulation of blood circulation (GO:1903522),-0.3488450550130331,-1.2253218520172353,0.16352201257861634,0.5977896312571934,1.0,19/34,32.02%,CELF2;ADORA3;KCNMB2;PER2;AGT;FXYD1;TMIGD3;KCNJ12;CACNA1H;KCNG2;BDKRB2;KCNQ1;PLN;KCNIP2;TBX2;DES;ACE;ACE2;S100A1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5148090725932501,1.2252996528945463,0.22296395193591456,0.5620859777550865,1.0,6/18,18.23%,CCT2;EXOSC10;CCT5;DKC1;DCP2;RUVBL2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5404707866893242,1.2250937696166881,0.2336065573770492,0.5621602880001056,1.0,3/14,5.17%,CCL4;PTK2B;ADAM17
prerank,snRNA 3'-end processing (GO:0034472),0.5082001151859421,1.2244725855836724,0.2064516129032258,0.5634639476222244,1.0,11/19,28.15%,INTS6;USB1;EXOSC9;INTS14;EXOSC5;INTS2;EXOSC4;TOE1;INTS12;INTS1;INTS8
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.40004179780202986,-1.2239820390736764,0.19831223628691982,0.59766678090139,1.0,5/21,5.76%,SLC8A3;PDZD8;TGM2;RAP1GDS1;MICU3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5231423352070647,1.223971900409085,0.2046936114732725,0.5643977500040663,1.0,5/16,15.06%,PIGQ;PIGZ;PIGN;PIGL;PIGX
prerank,positive regulation of nuclear division (GO:0051785),0.48254155251946,1.223935414412499,0.22704081632653061,0.563975787366294,1.0,1/25,0.06%,IGF1
prerank,positive regulation of organelle organization (GO:0010638),0.47276242632344834,1.2238862754980115,0.18681318681318682,0.563593660181689,1.0,18/32,30.98%,MGARP;SMCR8;FYCO1;TREM2;SORBS3;PFDN2;RAB3GAP1;RAB3GAP2;IRGM;PLA2G5;SYNJ1;STX18;LMAN1;GSK3B;SURF4;HTRA2;LIG4;ATL3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5451274546101753,1.223672818174144,0.2446236559139785,0.5636881362427173,1.0,10/13,33.55%,ATG7;ATG10;SAE1;UBA6;UBA2;DESI1;DESI2;UBA5;SENP6;UBA3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.47026325641734845,1.223525981826404,0.18704156479217604,0.5636302902030463,1.0,8/30,10.02%,PTPRC;PRKCD;CD300A;PTPN2;SAMSN1;CAV1;PPP2R1A;MVP
prerank,positive regulation by host of viral transcription (GO:0043923),0.529460078076802,1.2234702636357742,0.22298221614227087,0.563282782492617,1.0,8/15,24.10%,SMARCB1;JUN;SP1;RRP1B;SNW1;CHD1;SMARCA4;EP300
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.45896456598869306,1.2233952250670566,0.18967587034813926,0.5629928625267262,1.0,2/34,1.83%,IGF1;NSMCE2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.4971598460134469,1.2233434246755746,0.21419185282522996,0.562649418844822,1.0,14/19,34.45%,HNRNPC;ACD;EXOSC10;NAT10;DCP2;TERF1;HNRNPU;XRN1;TENT4B;TERF2;GNL3L;TEN1;TINF2;PINX1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5078545152770703,1.2230624098210947,0.23673997412677877,0.5629432913104979,1.0,9/19,27.41%,NRP1;VEGFA;MYOC;LIMS1;SFRP1;COL16A1;ROCK1;ABL1;RAC1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4012383626566049,1.2227495486360602,0.12410986775178026,0.5633691492789171,1.0,33/112,20.95%,ZMIZ1;ZMIZ2;SOX9;GCNT2;SMAD7;BAMBI;APPL2;UBA52;SKI;ITGB5;USP9X;NRROS;TGFBRAP1;JUN;CRKL;NR3C1;TGFBR2;LIMS1;RHOA;DUSP15;FURIN;MAPK7;CBL;RPS27A;UBC;LPXN;WWOX;SFRP1;TGFBR1;ID1;PARD6A;TGFB1;SMAD1
prerank,regulation of immunoglobulin production (GO:0002637),0.4832625963136419,1.2220794667756225,0.22069825436408977,0.5648837040311617,1.0,7/23,19.95%,PTPRC;CD22;IL6;IL2;RBP4;VAMP3;XBP1
prerank,protein O-linked glycosylation (GO:0006493),0.4091039132383316,1.2219777006862762,0.14225941422594143,0.5646956911948953,1.0,21/96,17.17%,B4GALT5;LARGE1;GALNT7;GALNT15;MUC1;MUC16;B4GAT1;TRAK1;B3GALNT2;TET3;ST8SIA6;ST6GAL1;OGA;ST3GAL2;OGT;GCNT1;SDF2L1;GALNT3;B3GLCT;POFUT1;PLOD3
prerank,negative regulation of endothelial cell migration (GO:0010596),0.45178091238661183,1.2219057250392975,0.19839449541284404,0.5643768046506121,1.0,12/36,21.65%,APOE;FGF2;PTPRM;PPARG;DLL4;JUP;APOH;ANGPT2;TNF;KRIT1;TGFB1;NOTCH1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.33193527474901996,-1.2215298049367869,0.12408759124087591,0.6004449693979778,1.0,10/37,10.44%,IL1RAPL1;TENM2;GRID2;PTPRD;NLGN1;CADM3;TENM4;HMCN1;TENM3;VCAM1
prerank,organelle transport along microtubule (GO:0072384),0.4717007442519352,1.2214397294274235,0.20983213429256595,0.5652242222795402,1.0,14/31,22.40%,ARHGAP21;UXT;TRAK1;HTT;BORCS5;RAB1A;TMEM201;PEX14;FBXW11;COPG2;RHOT2;CLN3;COPG1;CDC42
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.42205166173881303,1.2214142569841282,0.16184351554126475,0.5647753997337018,1.0,25/72,25.17%,FGF2;GRB2;POLR2H;HNRNPM;FGF20;SPRED2;GTF2F1;FLRT2;CBL;FGF7;GALNT3;POLR2D;FGF18;FGFRL1;KIF16B;RBFOX2;MAPK3;FGFR2;SHOC2;CEP57;PTPN11;FGFR3;HNRNPF;FGF1;MAPK1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4329878583284555,1.2211081618316382,0.17845117845117844,0.5651313728779146,1.0,17/48,23.50%,CD84;APOE;FLNA;SF3B3;AZIN1;TREM2;NFKB1;PFDN2;PIN1;RILP;IAPP;FLOT2;SIRT2;ROCK1;PFDN1;PFDN6;HSP90AB1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.48425740278430696,1.2210877546410623,0.21588089330024815,0.5646919143200395,1.0,5/24,13.02%,HIF1A;BRCA1;CYP1B1;IL6;HPSE
prerank,protein targeting to mitochondrion (GO:0006626),0.42526213760371806,1.2209702106513627,0.18701870187018702,0.5645257719830064,1.0,21/52,26.27%,MGARP;HSPA4;SAMM50;TIMM44;PMPCA;TOMM5;TOMM22;PITRM1;TOMM40;TIMM23;HSPD1;TIMM21;FBXO7;DNAJC15;PAM16;FIS1;TIMM9;GRPEL2;IMMP1L;TIMM17A;AGK
prerank,intestinal lipid absorption (GO:0098856),0.5689591914091315,1.2206850309814,0.24225352112676057,0.5647946278076311,1.0,2/11,6.14%,CEL;SOAT2
prerank,fatty acid beta-oxidation (GO:0006635),0.4325011403982493,1.220440996192411,0.18365061590145576,0.5649682568801884,1.0,19/51,28.67%,ACAD11;PPARD;ABCD4;ABCD2;CRAT;ACADL;ACAD10;ACOX3;ECI2;SCP2;ACAA2;DECR1;MCAT;GCDH;CPT2;ACADM;PEX2;ECI1;ACADS
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4707304879655935,1.2203911900871265,0.2077764277035237,0.5646036346625746,1.0,15/29,27.64%,FBXW7;SMAD7;LIMK1;ARRDC4;DCUN1D4;UBE2L3;PIN1;DCUN1D2;FBXO5;RPS2;BMI1;ABL1;DCUN1D3;FEM1B;BAG5
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3825256635362854,1.2203686972166412,0.013,0.5641563381499044,1.0,96/509,16.03%,BCAR3;IGF1;OSBPL8;LITAF;FLT1;BCL2;IQGAP1;FN1;BCL2L1;P2RX4;RRAGD;FGR;SASH1;PDGFA;ADAM8;FGF2;PIK3CB;PTPRC;CCL4;MFHAS1;GRB2;TRAF2;TRIM6;SPHK1;GAB2;PDPK1;VEGFA;AXL;SOX9;SMCR8;IKBKE;MALT1;TRAT1;PRKCB;FLNA;DDX21;AKAP13;PLK2;GCNT2;NEK6;HMOX1;SPHK2;SCTR;BAX;MYDGF;WLS;ECM1;MYOC;BRD4;CC2D1A;LGALS1;TMEM106A;PIK3R5;FGF20;DHX33;GAS6;CAV1;PIK3R2;TREM2;DDIT3;IGF1R;BCL2L11;RHOG;GPR89A;KITLG;LIMS1;EEF1D;BECN1;RHOA;GPRC5B;C1QBP;TICAM1;IL6;TNIP2;GOLPH3;BID;HPSE;FNIP1;FYN;ILK;CBL;FGF7;HAX1;LARS1;JMJD8;TNF;CCDC22;FGF18;HIP1;PUM1;BST2;HTR2B;TBK1;FLCN;VAV1;DDX1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.53595624020647,1.2201980892471096,0.23577235772357724,0.5641747832735794,1.0,7/15,19.52%,ZFAND2A;EDEM1;SPCS3;SRP14;RAB3GAP1;RAB3GAP2;SEC61A1
prerank,histone H4-K16 acetylation (GO:0043984),0.51071087813082,1.2200716470161876,0.21128608923884515,0.5640333720628536,1.0,11/19,25.53%,KMT2A;ING4;OGT;MSL3;HCFC1;MSL1;WDR5;KAT7;JADE3;KANSL1;KAT8
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.46495942646247124,1.2198900212101358,0.19058823529411764,0.5640761734236512,1.0,13/32,25.27%,PRKCD;CD300A;PTPA;SYMPK;ANKLE2;PIN1;CALM2;SPPL3;NSMF;TGFB1;HSP90AB1;PPP1R15B;CALM3
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5404707303893204,1.2197237899152369,0.23129251700680273,0.5640722499683065,1.0,4/13,16.84%,FLNA;MDFI;SUFU;LATS1
prerank,glucose homeostasis (GO:0042593),0.40761923646980924,1.2195143113045075,0.15578947368421053,0.5641811196456067,1.0,21/83,18.20%,HIF1A;ADCY8;GCKR;GCK;PPARG;CEBPA;PTPN2;APPL2;SLC8B1;CYB5R4;PIK3R2;IGF1R;ADIPOR1;HK3;LRRC8D;IL6;RPS6;RBP4;HECTD4;WFS1;HK1
prerank,RNA processing (GO:0006396),0.39585864383155345,1.2193058433616875,0.07381193124368049,0.5642739619496104,1.0,68/176,27.21%,APOBEC1;ADARB1;SNRNP35;SON;PIWIL2;HNRNPUL1;SF3B3;DDX39B;ZRSR2;RBM39;CELF1;HNRNPC;SRSF11;PABPN1;THOC1;DDX17;SRPK1;RBPMS;HNRNPK;PPP2R1A;RNASEL;SRPK2;ZMAT5;KIN;USB1;ATXN1;PPIG;HNRNPL;SRSF2;HNRNPA2B1;FASTKD2;DUSP11;DKC1;PABPC4;ZCCHC8;SMU1;FASTKD5;SRSF7;LSM6;SRRM1;SNRPF;ADAR;PRPF6;GEMIN2;FUS;HNRNPU;SNRNP40;NOL3;XRN2;SRSF1;PPP1R9B;SNRPD3;SNRPD2;SNRPD1;TSEN2;MTPAP;RRAGC;METTL3;SCNM1;HNRNPF;SYNCRIP;LSM4;SUPT4H1;SF3B4;DEDD2;TENT4B;TARDBP;DDX23
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4580156224271349,1.2186346304454767,0.19644970414201182,0.5657325277080495,1.0,12/30,25.77%,DAB2;SAFB2;RNF6;RNF14;KLK3;PRMT2;HDAC1;SFRP1;SMARCA4;KDM1A;EP300;H3-3A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.49971434594561126,1.2184029058174288,0.2126081582200247,0.565913984095707,1.0,4/21,9.91%,MITF;JUN;MED17;SRF
prerank,regulation of interleukin-1 beta production (GO:0032651),0.41816708665322655,1.218063152063197,0.16866158868335146,0.5664108989329255,1.0,12/66,14.62%,IGF1;LPL;SIRPA;HSPB1;MALT1;PANX1;TMEM106A;GIT1;AIM2;IL6;TNFAIP3;TNF
prerank,transepithelial transport (GO:0070633),0.539804208333867,1.2176403039765564,0.2267037552155772,0.5671370541315298,1.0,2/15,1.49%,SLC23A2;SLC23A1
prerank,chromosome organization (GO:0051276),0.40531516174672505,1.2174552610005944,0.13874614594039056,0.5671535952714318,1.0,39/99,25.77%,DOT1L;COPS3;HMGN1;GEM;COPS2;COPS4;PHF1;UBA52;COPS8;MTF2;RAE1;EHMT1;DDB2;DDB1;MTHFR;CENPT;XPA;RPS27A;UBC;HDAC1;LATS1;COPS7A;BAHD1;CETN2;SAFB;HDAC3;LDB1;CUL4A;CDAN1;GATAD1;HMGN2;NUP133;SMARCA4;PARP1;COPS6;ABL1;CENPW;SUPT4H1;H3-3A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5150729035563327,1.2168410440405546,0.21870882740447958,0.5684372652715161,1.0,7/18,16.84%,MDFIC;MFHAS1;ILRUN;POLR1A;SUFU;FLCN;LATS1
prerank,cellular response to oxidative stress (GO:0034599),0.3962106732571519,1.2167067324775964,0.14256198347107438,0.5683110208421874,1.0,57/118,32.29%,HIF1A;NFE2L2;MSRA;PRKCD;ATP13A2;CYBA;CPEB2;SRXN1;HMOX1;NCF4;AGAP3;LONP1;ERO1A;JUN;CAT;CYBB;DAPK1;ALDH3B1;PRDX1;NCF2;SESN2;TMEM161A;MAPK3;GSR;ZC3H12A;SIRT2;EIF2S1;ERMP1;NUDT2;NOX4;PARP1;TXNRD2;FOXO1;CHUK;STX4;ABL1;PDGFRA;PRDX3;CYCS;MAPK1;TXNRD1;PRDX5;PRDX6;SOD2;GPX3;PRR5L;HTRA2;PXN;ZFAND1;ADNP2;GSTP1;FOXO3;CHCHD2;ROMO1;MAPK9;TP53;STX2
prerank,protein N-linked glycosylation (GO:0006487),0.41900248270693635,1.2162091451107904,0.18211206896551724,0.5692298367036195,1.0,11/66,9.18%,MAN1C1;MGAT5;B4GALT7;DERL3;STT3B;ALG10B;SRD5A3;MCFD2;DPAGT1;MAGT1;ST6GAL1
prerank,vitamin D metabolic process (GO:0042359),0.5455350109864513,1.216148798286915,0.24360699865410498,0.5688887872991111,1.0,2/13,2.72%,CYP27B1;VDR
prerank,pinocytosis (GO:0006907),0.5853314933053322,1.2160562778984794,0.2511144130757801,0.5686581806271752,1.0,4/10,12.90%,DOCK2;SNX33;MAPKAPK3;MAPKAPK2
prerank,response to tumor necrosis factor (GO:0034612),0.4006698927343946,1.215469228258983,0.16170212765957448,0.5698554955700194,1.0,22/91,23.49%,NFE2L2;CCL4;TANK;SPHK1;MAP4K3;SMPD4;ERBIN;CCL13;BRCA1;ASAH1;ACOD1;CCL14;PID1;DHX9;ARHGEF2;SFRP1;TNFRSF21;ZC3H12A;YBX3;NUB1;CCL3;CHUK
prerank,cellular lipid catabolic process (GO:0044242),0.47785367134797313,1.2153816691171238,0.22276029055690072,0.5695995632486135,1.0,9/27,17.71%,ABHD12;APOA2;CEL;PPARD;CYP1B1;ACADL;PLBD2;LPIN3;ACBD5
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4588985523827038,1.2144565635721913,0.2096177558569667,0.5717936077622621,1.0,19/30,34.45%,NIBAN2;HNRNPC;ACD;ERCC4;EXOSC10;NAT10;DCP2;TERF1;HNRNPU;XRN1;TENT4B;TERF2;GNL3L;TEN1;TP53;BMPR2;ACVRL1;TINF2;PINX1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5744710228181791,1.2143817572248057,0.2460881934566145,0.5709938918025226,1.0,3/10,16.11%,MYADM;MAPK7;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5744710228181791,1.2143817572248057,0.2460881934566145,0.5709938918025226,1.0,3/10,16.11%,MYADM;MAPK7;MBP
prerank,regulation of mitochondrion organization (GO:0010821),0.4344220941220095,1.213194963536251,0.19473081328751432,0.5739410422507977,1.0,22/47,24.10%,MGARP;ATP13A2;SQSTM1;FBXW7;INF2;STOX1;TREM2;PRMT6;CSNK2A2;PARL;PID1;GOLPH3;VPS35;USP36;HAX1;FLCN;MYO19;RHOT2;IAPP;FIS1;GSK3B;EP300
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5056729856389385,1.213100428199918,0.21108179419525067,0.5736973031406221,1.0,8/19,25.49%,RUNX1;VIM;SUCO;SERPINF2;IL6;TGFB1;EMILIN1;SCX
prerank,regulation of ossification (GO:0030278),0.447656151330814,1.2129619088226278,0.21205098493626884,0.5735896307462179,1.0,6/36,7.57%,ANKH;CYP27B1;SOX9;LRP4;ECM1;LRP6
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4872033463801765,1.212936161933795,0.24231242312423124,0.5731451901788601,1.0,8/24,15.77%,UBA52;RFC2;POLE;LIG3;RPS27A;UBC;LIG1;RFC1
prerank,presynapse assembly (GO:0099054),-0.42012886356751167,-1.2127946312348357,0.19784172661870503,0.619918469509512,1.0,4/16,3.27%,IL1RAPL1;PTPRD;NLGN1;LRRTM3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4404802679238216,1.2127158419044464,0.19839449541284404,0.5732687347522704,1.0,15/42,23.51%,ERCC6;CHD3;SMARCB1;HNRNPC;SRCAP;INO80;ACTR6;SMARCD2;GATAD2B;ANP32E;HDAC1;ARID1B;DMAP1;SMARCA4;VPS72
prerank,regulation of B cell proliferation (GO:0030888),0.4351829699759372,1.2125528580921348,0.20598388952819333,0.5732805494146601,1.0,6/44,5.80%,BCL2;CHRNB2;PTPRC;CD22;CD300A;NCKAP1L
prerank,positive regulation of JUN kinase activity (GO:0043507),0.48412618854874245,1.2125090198847914,0.22042341220423411,0.5729179199298888,1.0,5/23,15.28%,SASH1;TRAF2;TAOK3;TNF;ARHGEF5
prerank,B cell proliferation (GO:0042100),0.5054742067112312,1.212376065316893,0.24214659685863874,0.5727876845053933,1.0,4/17,13.73%,BCL2;PTPRC;CD180;HSPD1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4132233081086506,-1.2120232721188449,0.2149122807017544,0.6187065087336696,1.0,9/17,23.08%,CD33;OTUD7B;CACTIN;BCL3;PTPN22;TMSB4X;TLR9;MAPKBP1;TLR6
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4567726526590198,1.2116807013121094,0.21575757575757576,0.574302242900372,1.0,16/32,27.75%,TAF1D;POLR2H;UBTF;POLR1A;MNAT1;TAF1A;GTF2H1;POLR1G;TAF1C;ERCC2;MAPK3;TBP;CCNH;POLR1H;POLR1F;POLR1C
prerank,eye photoreceptor cell development (GO:0042462),0.5430928907947137,1.2116448536629236,0.2483574244415243,0.5738841115526774,1.0,3/15,10.22%,TH;VEGFA;MYO7A
prerank,regulation of protein processing (GO:0070613),0.48706578224363145,1.2115988728240008,0.2455012853470437,0.5735176755613213,1.0,3/21,7.77%,ADAM8;RUNX1;SERPINE2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49950765674299696,1.2113446865555417,0.25945241199478486,0.5737937933456845,1.0,4/19,7.35%,XYLT1;HS3ST3B1;NDST1;HS6ST1
prerank,regulation of dendrite development (GO:0050773),-0.33736140248904795,-1.2111990593597255,0.14666666666666667,0.6174850436790732,1.0,7/37,4.15%,CSMD3;CDKL5;HECW1;ADGRB3;VLDLR;HECW2;BCL11A
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3780186811163412,1.2105819368478161,0.04704704704704705,0.5755574279122762,1.0,100/336,22.59%,FNIP2;BCL2;BCL2L1;PARP4;DOT1L;RAD51B;GRB2;TANK;IGHMBP2;MCL1;IKBKE;DYRK2;RBBP5;TRIP12;MCM7;ZRANB3;KMT5B;ALKBH7;TNFRSF1B;MGMT;BAX;ERCC1;TRIM28;RAD50;FANCF;PHF1;TAOK3;VCP;SLX4;BCL6;NUPR2;BRCA1;SUSD6;BOD1L1;CBX3;DDIT3;MBD4;BCL2L11;DDB2;ALKBH1;DDB1;KIN;ERCC4;XPA;PLK3;INO80;RAD51AP1;BAZ1B;PARP2;ADPRS;MAPKAPK2;CASP9;USP47;BID;MCM8;SHPRH;CHEK2;RFC2;HPF1;ZBTB40;MNAT1;BABAM2;SLF2;LIG1;YY1;ZBTB4;PNKP;SIRT4;GTF2H1;CDKN2AIP;UFL1;RECQL5;MAPK12;MMS19;MAPK3;ALKBH8;RAD9A;MAPK15;BCL2L2;CENPS;TAOK1;USP16;ZC3H12A;BLM;STK11;FANCA;HUS1;CUL4A;CCND1;FBXO31;UBA6;ASF1A;TOPBP1;SUMO1;INTS3;PSME4;CSNK1E;ALKBH3;XRCC5;PARP1
prerank,L-amino acid transport (GO:0015807),0.4687967116026145,1.2105199919955907,0.22934648581997533,0.5752449470813661,1.0,12/28,23.93%,SLC36A4;SLC3A2;SLC7A1;SFXN1;SLC7A8;SLC25A18;SLC38A2;CTNS;SLC25A13;SLC7A3;SLC7A2;ARL6IP5
prerank,protein deubiquitination (GO:0016579),0.3881683300416649,1.210490131391581,0.06012024048096192,0.5748377952608108,1.0,89/242,25.55%,HIF1A;PSMD1;TNIP1;TRAF2;OTULIN;PSMD8;USP12;JOSD1;OTUD4;SIAH2;RNF128;PSMA1;TRAF3;SMAD7;USP5;STAM2;PSMA8;ATXN3;BAP1;UBA52;VCP;USP9X;SUDS3;TAB1;BRCA1;ABRAXAS1;DDB2;PSMD14;ASXL2;MDM2;PSMA5;BECN1;RHOA;USP2;INO80;OGT;TNIP2;TNFAIP3;USP47;PSMD12;USP36;USP35;USP40;MYSM1;HCFC1;PSMB10;UIMC1;RPS27A;UBC;BABAM2;YY1;TNIP3;USP14;CDC25A;MINDY2;CCP110;USP13;STAMBPL1;PSMD2;PSMC4;TGFBR1;STAMBP;BIRC2;USP21;USP16;ZC3H12A;USP8;PSMD6;BRCC3;USP33;PSMD3;PSMD5;SMAD1;PSMC2;PSME4;PSMB8;USP30;PSMA6;ASXL1;PSMB7;PSMD4;YOD1;EP300;USP48;USP19;PTEN;PSMA3;OTUD5;ABRAXAS2
prerank,neuron remodeling (GO:0016322),-0.4878225844388566,-1.210476247555118,0.21671826625386997,0.6159512311701395,1.0,4/10,16.41%,ADGRB3;ANKS1A;APP;FARP2
prerank,activation of protein kinase A activity (GO:0034199),0.5129097429412356,1.2103058888028861,0.24187256176853056,0.5748744103430562,1.0,3/16,2.77%,ADCY8;ADCY3;ADCY7
prerank,muscle contraction (GO:0006936),0.3991673071708157,1.2098190491581764,0.13604060913705585,0.5757628034531024,1.0,25/126,22.78%,MYOF;ASPH;TLN1;MYOM3;CHRNB2;SGCA;VIM;TPCN2;ARHGEF11;ALDOA;ITGB5;PABPN1;SLC8A1;TPM4;SORBS3;EDNRA;MYL4;TRIM72;SSPN;KLHL41;SLC6A8;ACTN2;ROCK1;HCN4;SMTN
prerank,regulation of tumor necrosis factor production (GO:0032680),0.39391403851844126,1.2091411515525645,0.13917525773195877,0.5772384508487536,1.0,20/112,12.90%,IGF1;LPL;SIRPA;NLRC3;PTPRC;POMC;HSPB1;CYBA;ARFGEF2;SPHK2;TMEM106A;GAS6;ILRUN;SYK;HAVCR2;LILRB1;IL6;DHX9;TNFAIP3;MAPKAPK2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.44017681607414366,-1.209121528692288,0.22297297297297297,0.6161488808408133,1.0,5/13,13.45%,ASPA;GLUD1;GAD1;GLUL;DDO
prerank,positive regulation of viral transcription (GO:0050434),0.47637827518391224,1.2088027356991353,0.23558282208588957,0.5777201954972497,1.0,5/25,15.24%,MDFIC;POLR2H;GTF2F1;DHX9;POLR2D
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4231959599556605,1.2086750634504007,0.18763796909492272,0.5776079046344376,1.0,19/60,20.41%,CTNNB1;CDK8;SOX9;MED15;CCNC;BAX;CCNB1;TRIM28;MED17;NFKB1;SRF;IL6;AGO3;AGO4;CDK4;MED1;MED6;MED27;CCND1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.48726989971165857,1.2086257532601408,0.21820448877805487,0.5772603610254983,1.0,7/22,14.62%,TRIM6;APOA2;SPHK2;TNFRSF1B;LILRB1;BTK;TNF
prerank,mitochondrial translation (GO:0032543),0.3986310011947148,1.2085668527356546,0.1424083769633508,0.5769368560553281,1.0,35/104,22.88%,MRPL47;MRPL23;DAP3;MRPL4;MRPS15;EARS2;MRPL52;MRPS16;MRPS28;MRPS35;CHCHD1;MRPL53;MTRF1L;GFM2;RARS2;MRPS33;MRPL24;MRPL37;FASTKD2;MRPS30;MRPL17;MRPL18;MRPL11;MRPL1;MRPS12;GATB;MRPS7;MTRF1;MRPS22;NOA1;MRPL42;MRPS9;TSFM;MRPL39;MRPS10
prerank,striated muscle cell differentiation (GO:0051146),0.5158011958586095,1.2085662374892812,0.23809523809523808,0.576436508233699,1.0,4/16,7.38%,PLD3;AKAP13;SIK1;SKI
prerank,negative regulation of signaling (GO:0023057),0.4785792354722672,1.2082517790129625,0.21662468513853905,0.5768637727876793,1.0,6/25,18.30%,OPTN;TRAT1;SOCS5;BRAP;UBASH3B;PTPN1
prerank,activation of phospholipase C activity (GO:0007202),-0.35547724757749694,-1.2080542697716021,0.13513513513513514,0.6155596344726022,1.0,7/29,7.72%,P2RY12;GNA15;CD86;NTRK2;HTR2A;EGFR;RASGRP4
prerank,positive regulation of cell cycle (GO:0045787),0.42039444208288945,1.2078777876960312,0.19633225458468176,0.5774278387423626,1.0,25/62,24.91%,CCNY;SPHK1;ADAM17;CCNB1;LRP6;PKN2;SRPK2;MDM2;USP2;EIF4E;HCFC1;CDC25B;CCDC57;CDK4;DUSP3;HSF1;ASNS;FGFR2;CCND1;PDGFB;CALR;EIF4EBP1;SPDYA;USP19;SMOC2
prerank,regulation of axon extension (GO:0030516),0.4494091762263313,1.2073740151248722,0.20578034682080926,0.5783996043911575,1.0,7/37,8.29%,APOE;MACF1;GOLGA4;RNF6;RUFY3;LIMK1;DNM2
prerank,metal ion export (GO:0070839),0.46067387823451833,1.2070509612092917,0.20833333333333334,0.5788348284866994,1.0,10/31,23.67%,SLC9A1;SLC11A1;ATP7A;ATP1A1;ATP1A3;ATP1A4;ATP1B3;SLC4A4;ATP7B;ATP1A2
prerank,regulation of histone methylation (GO:0031060),0.5438797888514096,1.206961944507132,0.25338753387533874,0.5785995111217753,1.0,6/13,21.32%,FAM47E;TTLL12;MTHFR;CHTOP;PIH1D1;NSD1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.47795944632274473,1.2063689477331958,0.21601941747572814,0.5798158984053705,1.0,17/25,36.02%,SF3B3;SMNDC1;TRA2B;SRRM1;PRPF6;GEMIN2;SNRNP40;WDR83;SRSF10;SF3B4;DDX23;PRPF4;SF3A3;PRPF8;KHSRP;SF3B1;SCAF11
prerank,dendrite morphogenesis (GO:0048813),-0.33608026174458366,-1.206334849116021,0.17575757575757575,0.6166652026432508,1.0,12/35,17.24%,CTNND2;CTNNA2;BTBD3;MAP2;DOCK10;EPHB1;SHANK3;MAP6;PHACTR1;DCDC2;MEF2A;SDC2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5514858891565328,1.2060258000583695,0.2517385257301808,0.5803069527272644,1.0,3/12,14.47%,VEGFA;SAP30BP;ZBTB7B
prerank,embryonic appendage morphogenesis (GO:0035113),0.5740039868720326,1.2057832809532807,0.25426136363636365,0.5805279702673811,1.0,3/12,7.57%,FBXW4;SKI;LRP6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4034138603677123,1.2057205294542048,0.18230277185501065,0.5802410726146507,1.0,35/76,28.32%,PRICKLE1;DAB2;FBXW7;RNF180;CEBPA;SMAD7;USP5;VCP;SOCS5;RNF14;CSNK1D;MDM2;ELOB;TRIB2;CCDC22;HECTD1;RNF19A;RCHY1;SIRT2;SUMO1;CSNK1E;SUMO2;NUB1;RNF19B;RACK1;GABARAP;GSK3B;PIAS1;PTEN;BBS7;PSMD10;RAD23A;CDK5RAP3;BAG2;HSPBP1
prerank,Golgi localization (GO:0051645),0.5632056799683374,1.2048305175172738,0.24687933425797504,0.5823901631118521,1.0,9/11,34.26%,ARHGAP21;HOOK3;TBCCD1;COPG1;CDC42;YWHAZ;ARCN1;RIPOR1;STK25
prerank,maintenance of blood-brain barrier (GO:0035633),-0.34620097065089317,-1.2043900504086653,0.17679558011049723,0.6187323627380523,1.0,16/30,25.02%,DMD;F11R;SLC12A2;TJP1;PECAM1;WNK3;JAM2;CLDN12;SLC1A1;ESAM;JAM3;OCLN;TJP3;MFSD2A;CLDN5;ITGB1
prerank,protein sumoylation (GO:0016925),0.43549966365548254,1.20415996394735,0.2011173184357542,0.5838326523105403,1.0,21/49,27.50%,NUP205;NSMCE2;TRIM28;NUP188;EGR2;RAE1;NUP42;TPR;SAE1;PIAS4;NUP54;SUMO1;SUMO2;RANBP2;NUP133;NUP93;NUP98;PIAS1;NUP35;UBA2;AAAS
prerank,import into cell (GO:0098657),0.4402750878207591,1.204129268515732,0.22525597269624573,0.5834099670454945,1.0,11/41,15.76%,SLC38A1;SLC6A6;SLC27A1;SLC46A1;SLC7A1;TREM2;SLC7A8;SLC5A3;LRRC8D;SLC12A4;SLC19A1
prerank,cell differentiation in hindbrain (GO:0021533),-0.47759579879546477,-1.2040861684639843,0.25249169435215946,0.6163547791714082,1.0,2/11,0.48%,OPHN1;GRID2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5340324670516238,1.2039457492195436,0.2637215528781794,0.5834474933478198,1.0,4/14,14.88%,CRAT;ACOX3;ECI2;SCP2
prerank,regulation of nervous system development (GO:0051960),0.44796198572550633,1.2037105869410734,0.21169590643274855,0.5836166324610569,1.0,8/37,11.13%,CTNNB1;BHLHE41;HES7;BHLHE40;TNFRSF1B;GBX1;YTHDF2;DOCK7
prerank,tetrahydrofolate metabolic process (GO:0046653),0.5807333769600629,1.2034869499584713,0.2524964336661912,0.5838281509594276,1.0,6/10,32.27%,MTHFS;MTHFR;MTHFD2;MTHFD1;SHMT1;SHMT2
prerank,regulation of endothelial cell migration (GO:0010594),0.407159171309991,1.2031657582215805,0.17391304347826086,0.5842604653358666,1.0,12/85,7.58%,NRP2;APOE;SASH1;FGF2;PIK3CB;NRP1;PTK2B;RIN2;VEGFA;PTPRM;ANXA3;DLL4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5497215540374131,1.2027054110147728,0.26164383561643834,0.585049672054282,1.0,5/13,15.14%,PPARD;SOX9;PPARG;SRF;NFATC3
prerank,nucleotide catabolic process (GO:0009166),0.5212907966038072,1.2022768701021043,0.25132978723404253,0.5858100418799648,1.0,4/16,9.05%,XDH;DERA;VCP;ITPA
prerank,central nervous system development (GO:0007417),-0.2630638082198756,-1.202075585587843,0.0,0.6186312202838063,1.0,62/250,14.25%,ZFHX3;CX3CR1;ITGAM;PBX3;CNTNAP2;NCKAP1;ADGRL3;COX7B;SLC8A3;SH3GL2;ROBO2;GRIN2B;CNTN4;APOD;GRIN2A;CNTN6;MARCKS;PAFAH1B2;SERPINI1;ROGDI;EML1;VCAN;JARID2;GRIN1;SOX8;ADAM22;RNF103;NFIB;SLC6A17;CDH2;PHF8;PTS;TBX6;IL1RAPL2;DHX30;NDUFS4;STAT3;AFF2;MARCKSL1;DNER;NDRG4;UTP3;DCLK1;DSCAML1;PAX8;UGP2;MEIS2;PBX1;NNAT;HAP1;MEIS1;TPPP;RELN;ZIC4;PRKN;NPAS2;UBE3A;ACAN;PAFAH1B3;DDIT4;RPS6KA6;ATP6AP2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.565207371975653,1.202022068842868,0.25677603423680456,0.5860632579720108,1.0,4/10,21.51%,WDFY1;NINJ1;TIRAP;IFI35
prerank,negative regulation of macroautophagy (GO:0016242),0.47208032487333074,1.2019750249869645,0.2456575682382134,0.5856990904224862,1.0,9/26,20.58%,SMCR8;CHMP4B;CHMP4A;SEC22B;USP36;RUBCN;TMEM39A;SMG1;PIK3CA
prerank,mitochondrion distribution (GO:0048311),-0.45647466408951476,-1.2019693144238708,0.22875816993464052,0.615741331414361,1.0,8/12,20.09%,ATCAY;DNM1L;LRRK2;HAP1;MSTO1;MAPT;MEF2A;ARMC1
prerank,cellular macromolecule catabolic process (GO:0044265),0.4258899753457526,1.2019220300644597,0.2080989876265467,0.5853567698488532,1.0,13/49,15.50%,SIAH2;RNASEH2A;STT3B;SND1;RNASEH1;DNASE1L1;DFFB;OGA;RNASEH2B;RNASE3;CHEK2;PABPC4;SUPV3L1
prerank,positive regulation of cellular protein localization (GO:1903829),0.4079965784027399,1.2017959232782087,0.1961206896551724,0.5852350600747513,1.0,23/69,24.21%,GPR137B;SNX33;CARD10;GNL3;NUMA1;SLC5A3;TESK1;STX3;MARK4;CEP250;ORMDL3;FYN;TNF;SESN2;TRAPPC12;TFRC;KAT7;ABCA7;PARD6A;TGFB1;HSP90AB1;GSK3B;STX4
prerank,nuclear export (GO:0051168),0.4093332169842547,1.201778439573539,0.1740041928721174,0.5847842395137453,1.0,32/80,27.61%,MALT1;DDX39B;SRSF11;NUP188;EGR2;THOC1;XPO7;RAE1;THOC2;CHTOP;ATXN1;CCHCR1;EIF4E;NUP42;SRSF2;TPR;UPF3B;SRSF7;THOC6;SRRM1;XPO6;TGFB1;NXF1;SRSF1;XPO1;CALR;PHAX;NUTF2;EIF4A3;DESI1;SRSF3;DDX39A
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49049243014505617,1.2013157841719697,0.22397891963109354,0.5856468091835271,1.0,9/20,21.77%,BCL2;KCTD17;PACS2;BAX;ATP2A2;WFS1;HERPUD1;TMCO1;FIS1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3858792414604551,1.2012559203354576,0.10808080808080808,0.5853330204786877,1.0,67/185,25.31%,PSMD1;ANAPC15;DYNC1H1;ODF2;PSMD8;HAUS8;PSMA1;NEK6;ID2;FZR1;APPL2;PSMA8;CCNB1;NINL;ANAPC1;UBA52;DCTN1;PPP2R1A;DDB1;PSMD14;CSNK1D;RIOK2;PSMA5;INO80;YWHAG;CEP250;PSMD12;CEP41;PSMB10;RPS27A;UBC;KLHL18;CCP110;PSMD2;MAPRE1;CDC26;TUBB;PSMC4;ERCC2;UBE2C;CETN2;CUL1;PTPN6;PSMD6;FBXO5;ALMS1;PSMD3;SIRT2;PSMD5;PSMC2;PSME4;CSNK1E;HAUS2;PPP1R9B;CDK2;CEP57;PSMB8;PSMA6;ANAPC7;PSMB7;PSMD4;CDK5RAP2;NPM2;SSNA1;CUL3;PSMA3;DYNC1I2
prerank,defense response to virus (GO:0051607),0.3919491062117159,1.2011892771782409,0.1755485893416928,0.5850259294551835,1.0,17/100,12.58%,LYST;BCL2;BCL2L1;ATG7;SHFL;PTPRC;AKAP1;FLNA;AGBL5;ATAD3A;ACOD1;RNASEL;LILRB1;ZDHHC1;RIPK3;MLKL;IL6
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5140037273341321,1.2011629291448453,0.24420190995907232,0.5846023341066655,1.0,8/17,25.27%,PTPRC;CD300A;PTPA;CALM2;PPP1R12A;HSP90AB1;PPP1R15B;CALM3
prerank,protein modification process (GO:0036211),0.40947302681809933,1.201011895179929,0.18985976267529667,0.5845504570183027,1.0,17/76,12.94%,ABL2;UBL4A;B4GALT7;MSRA;PARP4;GNMT;RABGGTB;BAP1;UBA52;ERO1A;UBE2L6;TGM5;YES1;QPCT;WWP2;RIPK3;DUSP12
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5625702395236856,1.2008698510603861,0.276657060518732,0.5844723158226255,1.0,2/10,2.97%,MUC1;ING4
prerank,regulation of defense response to virus (GO:0050688),0.5292371157081719,1.2001003871696299,0.24351585014409222,0.5861013505525031,1.0,11/14,31.01%,TRAF3;ILRUN;C1QBP;ELMOD2;DHX9;TNFAIP3;TRAF3IP1;PCBP2;RNF216;PPM1B;ZMPSTE24
prerank,cellular response to lipid (GO:0071396),0.3844056188763289,1.1998780368150075,0.09797979797979799,0.5862763347911154,1.0,49/191,19.95%,LPL;SPP1;SIRPA;ABL2;STAP1;ADCY8;ADCY3;PTK2B;MGARP;CD274;AXL;SOX9;MSN;VIM;SPHK2;TNFRSF1B;GIT1;PABPN1;FZD4;TFPI;NFKB1;ACOD1;NR3C1;LILRB1;ADAM15;PLAA;RHOA;TICAM1;ATP1A1;ATP1A3;CD180;IL6;PID1;TNIP2;TNFAIP3;UBE2L3;SBNO2;SNW1;TNIP3;IRGM;SERPINE1;SFRP1;MED1;RUVBL2;FES;CD68;ZC3H12A;PDK3;XBP1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4832339295194725,1.1998415898249104,0.26496815286624203,0.5858622345440421,1.0,3/21,1.94%,CSF1;STAP1;PTK2B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3889399061620104,1.1997876028665644,0.11830131445904954,0.5855101141413198,1.0,37/158,19.27%,LITAF;TRAF2;TRIM6;IKBKE;MALT1;PRKCB;FLNA;DDX21;AKAP13;PLK2;NEK6;HMOX1;WLS;ECM1;BRD4;CC2D1A;LGALS1;TMEM106A;GPR89A;EEF1D;RHOA;GPRC5B;TICAM1;TNIP2;JMJD8;TNF;CCDC22;BST2;HTR2B;TBK1;DDX1;TFRC;SHARPIN;S100B;IRAK4;REL;BIRC2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4714200874247714,1.1995215024558792,0.23863636363636365,0.5857944911678872,1.0,9/26,23.89%,CACNA1D;CAB39;WWP2;VAMP2;ATP1B3;NEDD4;ACTN2;STK39;KCNAB1
prerank,nuclear membrane organization (GO:0071763),0.49194017362588194,1.1993489530082964,0.25132978723404253,0.5858022181304642,1.0,8/19,27.33%,CHMP4B;DCTN1;TOR1B;TMEM43;NEMP1;CHMP7;TARDBP;TOR1AIP1
prerank,body fluid secretion (GO:0007589),0.5223659181694152,1.1990132443402999,0.2562747688243065,0.5862596409031543,1.0,4/15,14.47%,CSN3;VEGFA;VIP;ZBTB7B
prerank,regulation of multicellular organism growth (GO:0040014),0.533594104236923,1.1989964698358804,0.2631578947368421,0.5858080356846265,1.0,1/15,0.06%,IGF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.38993422648824455,1.1989370655172567,0.13422131147540983,0.5854896964385083,1.0,55/146,25.31%,PSMD1;DYNC1H1;RAD51B;ODF2;PSMD8;HAUS8;PSMA1;PSMA8;CCNB1;NINL;BRD4;DCTN1;STOX1;PPP2R1A;VPS4B;PSMD14;CSNK1D;PSMA5;YWHAG;USP47;CEP250;PSMD12;CEP41;PSMB10;CDC25B;CDC25A;CCP110;CDK4;PSMD2;MAPRE1;TUBB;PSMC4;AVEN;CETN2;CUL1;PSMD6;CCND1;FBXO5;ALMS1;PSMD3;PSMD5;PSMC2;PSME4;CSNK1E;HAUS2;CDK2;CEP57;PSMB8;PSMA6;PSMB7;PSMD4;CDK5RAP2;SSNA1;PSMA3;DYNC1I2
prerank,regulation of oxidoreductase activity (GO:0051341),0.5382813056116961,1.1988092479542707,0.25426136363636365,0.5853356439068604,1.0,3/13,16.66%,ABL2;ATP7A;SIRT4
prerank,protein kinase B signaling (GO:0043491),0.4824680630667887,1.1985806279960673,0.24189526184538654,0.5854899321263395,1.0,9/23,25.82%,IGF1;GAS6;PLK3;TNF;TGFB1;SIRT2;CCL3;PTEN;ADTRP
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5631065392765114,1.1983851901259395,0.2816691505216095,0.585569179468788,1.0,3/11,3.56%,TARM1;RUNX1;CD274
prerank,rRNA processing (GO:0006364),0.3844540364327196,1.1982777152607258,0.10316649642492338,0.5853780880436562,1.0,55/172,22.13%,C1D;EIF6;RRP7A;DDX49;NOLC1;ESF1;MAK16;UBA52;WDR12;DDX52;NOL6;NSA2;RRP12;SART1;RPL10A;MDN1;WDR43;RPL12;UTP14A;LYAR;RIOK2;UTP20;RPL36;NOL8;EXOSC9;RPS6;KRR1;RPS28;RPL13A;EXOSC10;RRP9;RIOK3;MRPL1;NAT10;RRP1B;RRP1;DKC1;PIH1D1;SNU13;WDR3;EXOSC5;UTP11;LSM6;MRM2;UTP4;RPL18;BYSL;SRFBP1;RPF1;EXOSC4;RPS2;XRN2;PDCD11;RPS19;NVL
prerank,negative regulation of proteolysis (GO:0045861),0.44810694762685344,1.198070824542919,0.2236842105263158,0.5854920203809185,1.0,12/34,21.64%,CDK5;CST7;ECM1;SERPINE2;TIMP2;CSTB;EFNA1;DNAJC1;CLN3;TIMP1;CLN8;ROCK1
prerank,negative regulation of apoptotic process (GO:0043066),0.37531912574733983,1.1980193495936822,0.033,0.5851477879325012,1.0,94/444,17.87%,IGF1;CTNNB1;BCL2;ARHGAP10;BCL2L1;PRKCH;NIBAN2;APOE;ANXA5;ITGA5;PLAUR;ADAM8;ANXA4;PTK2B;PRKCD;HYPK;SPHK1;MCL1;HSPB1;CPEB4;VEGFA;DAB2;AXL;SQSTM1;SON;SOX9;MALT1;FLNA;SIAH2;PLK2;PDPN;NAT8;RETREG1;NCKAP1L;MGMT;CD44;MYDGF;PSEN2;UBA52;FGF20;GAS6;DNAJB6;TRIAP1;ATAD3A;CAV1;TREM2;ATF5;CAT;HSPA9;NFKB1;HNRNPK;IGF1R;PAK2;RASA1;VIP;CSNK2A2;BAG3;PLK3;RAF1;BFAR;PRDM9;IL6;APIP;APOH;GOLPH3;USP47;CIAPIN1;BID;FNIP1;CBL;NAA16;SOCS2;HSPD1;IL2;BNIP2;HAX1;TNF;RPS27A;UBC;BABAM2;SUPV3L1;HTR2B;HDAC1;ANKLE2;TFRC;FIGNL1;QARS1;THOC6;SFRP1;MAPK3;NAA15;AVEN;WFS1;MED1
prerank,regulation of myoblast differentiation (GO:0045661),-0.3342300083097983,-1.19768834765191,0.15441176470588236,0.6237132480930421,1.0,9/32,15.33%,MAPK14;MEF2C;PLCB1;SOX8;LRRC8A;SRA1;RIPOR2;IGFBP3;EID2B
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4052163263841643,1.1975730434673557,0.16754478398314016,0.5859333760303249,1.0,30/87,25.52%,FGF2;GRB2;POLR2H;HNRNPM;CD44;FGF20;DLL4;SPRED2;GTF2F1;FLRT2;CBL;FGF7;GALNT3;POLR2D;FGF18;FGFRL1;KIF16B;SFRP1;RBFOX2;MAPK3;ITGB1BP1;FGFR2;SHOC2;CEP57;PTPN11;FGFR3;HNRNPF;FGF1;MAPK1;DSTYK
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5422872858722046,1.1970753144630646,0.2595108695652174,0.586894300426641,1.0,5/14,18.30%,BAX;BCL2L11;BFAR;UFL1;PTPN1
prerank,negative regulation of insulin secretion (GO:0046676),-0.3919806386432195,-1.1969743559770054,0.23430962343096234,0.622417601908182,1.0,8/17,25.97%,KCNB1;PRKN;REST;ADRA2A;IRS1;CCN3;KLF7;MIDN
prerank,"phagocytosis, engulfment (GO:0006911)",-0.33082721196598314,-1.1969360693574804,0.17333333333333334,0.6194422231392651,1.0,15/36,19.23%,ITGAM;XKR4;ELMO1;RHOBTB1;BIN2;XKR6;MEGF10;AIF1;GULP1;FCGR1A;THBS1;FCGR2B;CD36;XKR8;RHOBTB2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5071874647178858,1.1959045012926994,0.2519893899204244,0.5897518762950763,1.0,9/16,29.79%,SOX9;APPL2;BRCA1;ACADL;SIRT4;WDTC1;ERLIN2;ERLIN1;APOC1
prerank,regulation of stem cell proliferation (GO:0072091),0.5019327835335295,1.1958798928618426,0.2503382949932341,0.5893343519186681,1.0,5/17,22.80%,PTPRC;AGO3;TERT;HNRNPU;KDM1A
prerank,positive regulation of secretion (GO:0051047),0.549545557020983,1.1955291069705944,0.2813793103448276,0.589857295529515,1.0,4/11,21.49%,TRH;ABCB11;XBP1;NPR1
prerank,nuclear pore complex assembly (GO:0051292),0.5715627458076694,1.1954255798809719,0.2579250720461095,0.5896337000641931,1.0,5/10,24.02%,NUP205;AHCTF1;TPR;NUP93;NUP98
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3689993500438381,-1.1952915451623154,0.19117647058823528,0.6206104774184782,1.0,4/25,4.78%,ACVR2B;RBPJ;BMPR1B;SMAD2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4242749863072054,1.1951348850373675,0.21579532814238042,0.5900235889500104,1.0,25/52,32.68%,MDH1B;SLC46A1;FPGS;MTHFS;MTRR;DLST;MTHFR;MTHFD2;SLC19A1;HOGA1;SLC25A32;PHYH;IDH2;MTHFD1;ALDH1L2;SDHAF3;ME2;ACOT4;SHMT1;OGDH;GOT1;ACLY;ALDH18A1;SHMT2;ACOT8
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3994215021549704,1.1949550750846365,0.1705020920502092,0.5900432001888456,1.0,26/87,20.95%,ZMIZ1;ZMIZ2;GCNT2;SMAD7;BAMBI;APPL2;UBA52;SKI;ITGB5;USP9X;NRROS;TGFBRAP1;JUN;TGFBR2;RHOA;DUSP15;FURIN;CBL;RPS27A;UBC;LPXN;TGFBR1;ID1;PARD6A;TGFB1;SMAD1
prerank,actin polymerization or depolymerization (GO:0008154),0.4265638597073268,1.1947232235939385,0.21700223713646533,0.590253896762812,1.0,7/50,4.33%,MICAL2;GAS7;MSRB1;MICAL1;CAPG;CORO7;WASHC5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5272829307858566,1.1945434863471602,0.27553763440860213,0.5902775852103699,1.0,5/15,20.66%,APOA2;SMAD7;LILRB1;TNF;TGFB1
prerank,protein polyubiquitination (GO:0000209),0.3780989650435256,1.1944445543934172,0.074,0.5901138712620488,1.0,120/297,30.24%,CTNNB1;BCL2;MYLIP;SASH1;PSMD1;TRAF2;TRIM6;FBXL17;FBXO32;NHLRC1;PSMD8;TNKS2;FBXW4;FBXW7;SIAH2;PSMA1;TRIP12;TRAF3;RNF6;FZR1;PSMA8;WSB1;ANAPC1;UBA52;HECTD2;UBE2Q1;UBE3C;TTC3;FBXL19;UBE2L6;BRCA1;RNF14;TPP2;UBE2R2;UBE3B;RNF41;DDB2;WWP2;RNF167;PSMD14;MDM2;PSMA5;UBR2;BFAR;UBE4A;TNFAIP3;PSMD12;FBXW11;BLMH;SHPRH;HUWE1;PSMB10;UBE2L3;RPS27A;UBC;FBXW5;UBE2V2;UBE4B;SHARPIN;FBXO7;NHLRC3;PSMD2;HECTD1;CDC26;UBE2H;PSMC4;UBE2C;RNF19A;CUL1;BIRC2;PSMD6;FBXO31;NEDD4;PSMD3;PSMD5;RNF20;PSMC2;PSME4;FBXW2;SPSB1;SYVN1;UBE2J1;FBXO30;RNF19B;PSMB8;PSMA6;RNF34;ANAPC7;PSMB7;PSMD4;CUL3;PELI2;FBXL3;PSMA3;FBXL8;NPEPPS;CDC34;FBXO11;ZNRF2;PSMD10;ANAPC11;RNF213;PSMC6;PSME3;RNF216;PSMC5;LRSAM1;PSMA4;TRIM71;RC3H1;BTRC;CDC16;UBOX5;SKP2;TRIM3;ARIH2;PSMB6;CBFB;UBE2K;TOPORS
prerank,peptidyl-lysine acetylation (GO:0018394),-0.46910711658466553,-1.1943795074155796,0.24149659863945577,0.6197937222760427,1.0,3/10,7.78%,KAT2B;KAT5;ESCO1
prerank,positive regulation of autophagy (GO:0010508),0.4030668388489614,1.1941743526230881,0.18008474576271186,0.5904433520914253,1.0,29/81,25.17%,PIK3CB;OPTN;TRIM6;RUFY4;TFEB;PLK2;LARP1;HTT;DAPK1;PLK3;TICAM1;ORMDL3;SESN2;TBK1;FLCN;UFL1;FBXO7;IRGM;PIK3C2A;ZC3H12A;STK11;MTDH;ROCK1;NPRL2;FOXO1;GSK3B;EIF2AK4;TPCN1;SH3GLB1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.4211276954745802,-1.194088573633485,0.2548262548262548,0.6175509055712876,1.0,6/15,17.96%,CDH13;NTRK3;IL16;F3;VEGFD;F7
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.41419095257708594,1.1935597201368333,0.20044052863436124,0.5918002203743798,1.0,19/60,25.17%,CTNNB1;FGF2;TNKS2;CCT2;ACD;PKIB;RFC2;CCT5;DKC1;PNKP;MAPK3;MAPK15;PDGFB;NVL;XRCC5;PTGES3;HSP90AB1;SMOC2;MAPK1
prerank,activation of GTPase activity (GO:0090630),0.4024816920679065,1.193333505019169,0.18514644351464435,0.5919622964152538,1.0,18/89,15.76%,ARHGAP25;ABR;ARHGAP24;CORO1C;TBC1D22A;SIPA1L2;TBC1D2;RALGAPA2;FOXJ1;GMIP;RHOG;TBC1D10A;DOCK7;TBC1D12;TBC1D16;GPR65;ARHGEF5;PIP5K1A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.43626772333188724,1.193249889020227,0.21923937360178972,0.591719778689086,1.0,15/45,21.06%,IQGAP1;PTK2B;GRB2;PDPK1;SOX9;ADAM17;ERBIN;DGKD;AAMP;CBL;KIF16B;PIK3C2A;PIK3CA;TGFB1;NCK2
prerank,synapse assembly (GO:0007416),-0.2867913876510709,-1.1927856527994878,0.14285714285714285,0.6177777996861881,1.0,19/67,15.39%,GABRB3;NRXN1;GRID2;NLGN1;GABRB2;ADGRL3;LRRTM3;CDH2;GABRA2;DNER;FLRT3;SHANK3;NLGN3;KIRREL3;WNT5A;GPM6A;SPOCK2;DRD2;PLXNB1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5255072183974431,1.1927713143775014,0.25203252032520324,0.5926143169314287,1.0,11/14,34.45%,TNKS2;ACD;TPP1;TERT;XRCC5;TERF2IP;TERF2;ATR;NABP2;TINF2;PINX1
prerank,dicarboxylic acid transport (GO:0006835),0.45603365328169143,1.1927365331065731,0.25644171779141106,0.5922553529989425,1.0,9/28,19.91%,SLC26A1;SLC46A1;PDPN;SLC25A18;SLC13A5;GIPC1;SLC19A1;SLC25A32;SLC25A13
prerank,cellular response to light stimulus (GO:0071482),0.41414716431398313,1.1926267805504027,0.21120689655172414,0.5920960803614305,1.0,29/66,28.50%,PRKCD;NOC2L;TRIAP1;RRH;ERCC4;INO80;CASP9;USP47;GNB1;CNGB1;YY1;CDC25A;TMEM161A;PDE6G;RUVBL2;NEDD4;SAG;EIF2S1;CREBBP;PARP1;KDM1A;METTL3;EIF2AK4;EP300;USP28;ZBTB1;DHX36;SDE2;FMR1
prerank,diol biosynthetic process (GO:0034312),0.5195478637183291,1.192522837454001,0.256,0.5918901111098007,1.0,3/15,8.48%,SPHK1;SPHK2;ASAH1
prerank,RNA splicing (GO:0008380),0.402535250035593,1.1924540635115697,0.17789473684210527,0.5916111145244438,1.0,38/95,27.21%,SNRNP35;SF3B3;DDX39B;ZRSR2;SMNDC1;HNRNPC;SRSF11;SRPK1;PPP2R1A;SRPK2;ZMAT5;USB1;PPIG;SRSF2;TRA2B;SMU1;SRSF7;LSM6;SRRM1;SNRPF;PRPF6;GEMIN2;FUS;SNRNP40;NOL3;WDR83;SRSF10;PPP1R9B;SNRPD3;SNRPD2;SNRPD1;RRAGC;SCNM1;SYNCRIP;LSM4;SF3B4;TARDBP;DDX23
prerank,regulation of intracellular protein transport (GO:0033157),0.45609311486152243,1.1922070298379188,0.22422062350119903,0.591792018181148,1.0,16/32,31.64%,LCP1;ATP13A2;RUFY3;GCC2;VAMP2;PLK3;TPR;PTPN1;TGFB1;B3GAT3;ICE1;PRR5L;ZFAND1;PCM1;TENM1;IFI27
prerank,positive regulation of mitochondrion organization (GO:0010822),0.42128604572053663,1.1921143798630252,0.20902090209020902,0.5915314463013498,1.0,13/57,16.82%,DDHD1;PLAUR;MGARP;BAX;HTT;TREM2;HIP1R;BCL2L11;BID;BIK;VPS35;ZDHHC6;FBXO7
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4613847691178678,1.1916491409932413,0.23002421307506055,0.5922839877569034,1.0,13/29,23.05%,UBA52;DDB2;DDB1;XPA;RPS27A;UBC;MNAT1;GTF2H1;ERCC2;CETN2;CUL4A;PARP1;CCNH
prerank,tyrosine metabolic process (GO:0006570),0.5531490626202188,1.1913315167800973,0.24927953890489912,0.5926424568126641,1.0,1/11,2.52%,TH
prerank,cellular response to leucine starvation (GO:1990253),0.5610100128077834,1.1910232576730333,0.2725925925925926,0.5930937943368809,1.0,5/10,25.46%,RRAGD;LARS1;SESN2;EIF2AK4;IMPACT
prerank,regulation of nervous system process (GO:0031644),-0.393389279248115,-1.1908855671365197,0.21224489795918366,0.6199344494941703,1.0,8/18,15.80%,DLGAP1;SLC8A3;HTR2C;BEGAIN;ROCK2;TMEM108;SLC8A2;APP
prerank,regulation of cytokinesis (GO:0032465),0.4009628395810967,1.190550855602325,0.20106382978723406,0.5939841255102065,1.0,29/78,25.64%,BCL2L1;MAP10;PLK2;KLHL13;GIT1;AHCTF1;PKN2;BECN1;ZFYVE19;RHOA;PLK3;PKP4;GIPC1;CDC25B;FLCN;PIN1;CCP110;PRPF40A;CALM2;MYO19;CETN2;SVIL;DRD3;CDC42;BIRC6;CUL3;SH3GLB1;CALM3;RAB11FIP4
prerank,oligodendrocyte development (GO:0014003),0.5152384326339944,1.1904513599181568,0.2557510148849797,0.5937720221467457,1.0,1/15,0.23%,B4GALT5
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5648228469802858,1.1899665747085302,0.2656675749318801,0.5946578002291167,1.0,3/10,14.97%,UBA52;RPS27A;UBC
prerank,peptidyl-methionine modification (GO:0018206),0.5500150298469473,1.1898270718379802,0.2552891396332863,0.5945530397813095,1.0,5/12,18.31%,APOA2;NAA20;NAA16;NAA15;METAP1D
prerank,cellular calcium ion homeostasis (GO:0006874),0.38589036126282145,1.1896028077468117,0.15734989648033126,0.594665906643282,1.0,35/133,23.04%,TRPC4;BCL2;ADCY8;ATP2B1;KCTD17;HCRTR1;ATP13A2;SLC24A4;NPTN;PACS2;TPCN2;BAX;SLC8B1;CCL13;AFG3L2;CAV1;CCL14;VAPB;SLC8A1;ATP2A2;HTR2B;TMEM178A;CHERP;FKBP1B;WFS1;CLN3;STOML2;TMEM165;HERPUD1;DRD3;TMCO1;ANXA6;CALR;ATP13A3;CCL3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5407316193283809,1.1891462729156377,0.24645892351274787,0.5955597788977083,1.0,3/12,16.17%,CSPG4;CHST12;DSEL
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4955196974207232,1.189007312684492,0.23863636363636365,0.5955288778454813,1.0,7/19,16.82%,ATP13A2;FBXW7;HTT;CSNK2A2;USP36;HAX1;FBXO7
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.37402782385175287,1.1889205265764429,0.046,0.5952861664908775,1.0,89/390,18.40%,BCAR3;IGF1;FLT1;NRP2;TCIRG1;CSF1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;FGR;SDCBP;PDGFA;STAP1;FGF2;BLNK;PIK3CB;NRP1;PTK2B;GRB2;ARPC3;ATP6V1B2;CYBA;ARPC2;VEGFA;ATP6V0D1;AXL;MTSS1;POLR2H;ARPC5;NEDD9;ATP6V1G1;HNRNPM;RHOQ;PTPN2;NCF4;NCKAP1L;CYFIP1;PSEN2;ATP6V0B;FGF20;GIT1;SPRED2;SYK;PIK3R2;CYBB;GTF2F1;NAMPT;YES1;IGF1R;BAIAP2;ARPC1B;PAK2;MVP;RASA1;AAMP;NCK1;FLRT2;RHOA;MAPKAPK3;NCF2;ANGPT2;MAPKAPK2;UBASH3B;FYN;CBL;FGF7;ATP6V0A4;SOCS2;ATP6V1F;AP3S1;EFNA1;ATP6V0C;GALNT3;POLR2D;ATP6AP1;FGF18;VAV1;CRK;FGFRL1;POLR1G;KIF16B;ELMO2;RBFOX2;MAPK3;PIK3C2A;APH1A;ATP6V1D;FES
prerank,sulfate transport (GO:0008272),0.5329709222085601,1.1887661697826697,0.2697986577181208,0.5952369840070685,1.0,3/14,10.16%,SLC26A1;SLC26A11;SLC26A4
prerank,supramolecular fiber organization (GO:0097435),0.3769906783609774,1.1886339970684188,0.06906906906906907,0.5951322637047157,1.0,83/334,18.52%,MYO1E;FGF13;ARHGAP25;MYO5A;CORO1C;MYO1F;MAP10;B4GALT7;DYNC1H1;MYO1A;COL10A1;NPPA;BMP1;CLIP2;TUBGCP4;COLGALT1;CORO7;INPPL1;SIAH2;COL20A1;VIM;NAT8;RUFY3;ARHGAP12;ALDOA;P4HA1;TSPAN5;UBA52;RHOD;DCTN1;DST;USP9X;UBE2L6;COL12A1;DNAJB6;CRIPT;P4HB;KLHL24;ATP7A;HIP1R;CYP1B1;COL9A3;VPS4B;P4HA3;MYO7A;RHOG;ARHGAP17;MDM2;HOOK3;EVL;RHOA;PLK3;SERPINF2;RIPK3;FURIN;GGA2;COL8A2;SLAIN2;TPM4;COL4A1;ZBED3;RHOF;FLII;NF1;ACTN1;RPS27A;UBC;CLIP1;HIP1;ARHGEF2;FIGNL1;PIN1;PLOD3;ELMO2;CORO1B;COL16A1;APH1A;LOXL3;HOOK1;EFEMP2;ADAMTS2;TGFBR1;MYO19
prerank,sphingosine metabolic process (GO:0006670),0.5008558049586052,1.188588055298654,0.2437417654808959,0.5947818468462388,1.0,4/17,8.48%,SPHK1;PLPP3;SPHK2;ASAH1
prerank,receptor catabolic process (GO:0032801),0.4747636795595327,1.1881245337948527,0.23223350253807107,0.5955997590281399,1.0,11/24,27.27%,MYLIP;SNX25;BECN1;ZNRF3;MVB12A;KIF16B;NEDD4;TGFB1;SH3GLB1;CLTA;AP2B1
prerank,establishment of spindle localization (GO:0051293),0.5315384274412196,1.18791352449224,0.24664879356568364,0.5957286981743157,1.0,4/14,14.06%,DYNC1H1;LLGL2;LLGL1;ZBED3
prerank,regulation of humoral immune response (GO:0002920),0.4282556302031827,1.1875431704008501,0.22972972972972974,0.5962807692939716,1.0,7/44,11.75%,C4BPA;C4BPB;PROS1;C3AR1;C8G;C5AR1;C1QBP
prerank,positive regulation of cartilage development (GO:0061036),0.5005855850138526,1.1873979065846356,0.27906976744186046,0.596184020610912,1.0,4/17,11.32%,GDF6;BMP1;SOX9;PKDCC
prerank,sterol biosynthetic process (GO:0016126),-0.3276224857481015,-1.1872837899991584,0.18072289156626506,0.625845334089302,1.0,15/33,23.54%,HMGCS1;NSDHL;IDI1;INSIG1;DHCR7;HSD17B7;MVK;SC5D;INSIG2;FDPS;SQLE;LBR;LSS;HMGCR;GGPS1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.48503929325668776,1.1872448995546427,0.2538659793814433,0.5961880608441926,1.0,9/20,25.37%,SLC9A1;SLC8A1;ATP2A2;CALM2;FKBP1B;GSTO1;ATP1A2;CALM3;CAMK2D
prerank,regulation of cell division (GO:0051302),0.40551679327583534,1.1871138391487626,0.19441460794844254,0.5960923814571527,1.0,30/72,28.34%,BCL2L1;PLK2;PRDM15;KLHL13;GIT1;AHCTF1;BECN1;PLK3;EFHC1;HTR2B;FLCN;PIN1;CCP110;PRPF40A;CALM2;CDK2AP2;MYO19;CETN2;BLM;FGFR2;SIRT2;BIRC6;RACK1;FGF1;SH3GLB1;CALM3;RAB11FIP4;KIF20A;ZFYVE26;CIB1
prerank,amide transport (GO:0042886),0.46439094907447004,1.1867112475672907,0.2655860349127182,0.5967880562576827,1.0,8/26,19.64%,SLC27A1;SLC46A1;GLTP;PDPN;DISP1;SLC19A1;SLC5A6;SLC25A32
prerank,glutathione biosynthetic process (GO:0006750),-0.45427881188183417,-1.1866608387449207,0.24315068493150685,0.6245038045765839,1.0,3/11,10.23%,HAGH;GGCT;CHAC2
prerank,regulation of epithelial cell migration (GO:0010632),0.422566599344478,1.1860033652155844,0.2101123595505618,0.5982614571185781,1.0,9/51,11.57%,HIF1A;CORO1C;MACF1;SASH1;PTPN23;SOX9;ADIPOR1;CAPN7;EVL
prerank,regulation of blood coagulation (GO:0030193),0.4581519853704889,1.1859196701548584,0.23893805309734514,0.5980314293586406,1.0,7/27,17.51%,APOE;SERPINE2;CAV1;TFPI;APOH;HPSE;SERPINE1
prerank,microtubule polymerization (GO:0046785),0.461523082166528,1.185652587495507,0.2632850241545894,0.5983379863149004,1.0,8/29,18.47%,FGF13;TUBGCP4;CSNK1D;RANBP9;SLAIN2;CCDC57;PIN1;GOLGA2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.515701673759117,1.1854675577170495,0.242503259452412,0.5983369345509632,1.0,5/16,11.51%,ACACA;SLC25A1;DIP2A;HSD17B8;PPCS
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4997458127113394,1.1851501145567667,0.2718954248366013,0.5987344793193894,1.0,10/18,30.63%,DAB2;PTPN23;MSN;MAPK3;MAP2K2;VPS11;MAPK1;SNX12;MAP2K1;CHMP3
prerank,chordate embryonic development (GO:0043009),0.4213067506551058,1.1839335167048208,0.2152317880794702,0.6016926727854648,1.0,14/55,22.38%,XYLT1;KIAA1217;VEGFA;CHD7;BRCA1;RBP4;FLCN;BMP5;TGFBR1;DACT1;ZNF568;FGFR2;TGFB1;EGFL8
prerank,cellular response to amino acid stimulus (GO:0071230),0.4407509188669748,1.1831836262536697,0.2398568019093079,0.6033973028561112,1.0,13/33,19.95%,RRAGD;IPO5;CPEB4;UBR2;FYN;CPEB1;LARS1;SESN2;CPEB3;NSMF;LAMTOR3;LAMTOR1;XBP1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4235395158327706,1.1831459485747415,0.2345679012345679,0.6030195150609716,1.0,26/49,31.54%,RAB7B;KMT2A;CNOT4;EIF6;RUNX1;RBBP5;PRMT6;AGO3;ITGA2B;AGO4;HDAC1;WDR5;KMT2B;PITHD1;KMT2D;EP300;H3-3A;PRKCQ;CIB1;THPO;RBM15;MYL9;CBFB;TNRC6C;PRMT1;SETD1A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.43530709198237516,1.183011132734998,0.22863741339491916,0.6028925260605601,1.0,18/39,25.88%,RRP7A;METTL17;DDX52;RIOK2;RPS6;RPS28;RIOK3;SNU13;WDR3;MRPS7;LSM6;UTP4;SRFBP1;RPS19;RPS7;SURF6;NOP14;LTV1
prerank,neuron projection regeneration (GO:0031102),-0.4685556196990772,-1.182984417429586,0.2626582278481013,0.6306202883945746,1.0,6/10,33.39%,GAP43;NREP;RTN4RL1;MTR;PTN;FOLR1
prerank,muscle cell differentiation (GO:0042692),0.44280933249796284,1.182933656488787,0.25058823529411767,0.6026569398869177,1.0,6/32,8.26%,MRTFA;SPEG;TBX18;MRTFB;SYNE1;NINJ1
prerank,skeletal muscle organ development (GO:0060538),0.46151617677768475,1.1828170991304259,0.24474660074165636,0.6025179964051379,1.0,6/26,19.42%,LARGE1;BASP1;IGSF8;CAV1;DISP1;SVIL
prerank,regulation of complement activation (GO:0030449),0.4320387046404263,1.182777907395401,0.22554660529344073,0.6021694849288142,1.0,7/40,11.75%,C4BPA;C4BPB;PROS1;C3AR1;C8G;C5AR1;C1QBP
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3999368055280061,1.1825764097328788,0.20358649789029537,0.6022639751769723,1.0,40/88,29.87%,PSMD1;FBXL17;PSMD8;FBXW4;FBXW7;PSMA1;PSMA8;PSMD14;PSMA5;CUL2;PSMD12;FBXW11;FBXL6;PSMB10;FBXW5;PSMD2;PSMC4;CUL1;PSMD6;CUL4A;FBXO31;PSMD3;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;PSMD4;FBXL3;PSMA3;FBXL8;PSMD10;PSMC6;PSME3;PSMC5;PSMA4;BTRC;SKP2;PSMB6
prerank,endochondral bone morphogenesis (GO:0060350),-0.46558935758106823,-1.182488320637653,0.22742474916387959,0.6288435803223059,1.0,3/11,4.16%,TMEM119;MEF2C;BMPR1B
prerank,response to glucagon (GO:0033762),0.4833622979524344,1.1822642993112797,0.26376440460947503,0.6027085102900586,1.0,3/19,2.77%,ADCY8;ADCY3;ADCY7
prerank,retinoic acid metabolic process (GO:0042573),-0.4302770244454547,-1.1819987051294158,0.2767527675276753,0.6272853443826648,1.0,10/14,35.14%,BCO2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A1;UGT1A8;UGT1A7;ALDH1A2
prerank,muscle organ development (GO:0007517),0.41549071754379413,1.181967914706378,0.22580645161290322,0.6030861578221023,1.0,12/54,17.45%,IGF1;LARGE1;SPEG;MEF2D;SGCA;MEF2B;EVC;ITGA11;TAGLN;SRI;TRIM72;MAPK12
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.43288428153414216,-1.1818042777203166,0.2491103202846975,0.6219661316163092,1.0,4/14,13.24%,SLCO2B1;SLCO1B1;HMOX2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.43288428153414216,-1.1818042777203166,0.2491103202846975,0.6219661316163092,1.0,4/14,13.24%,SLCO2B1;SLCO1B1;HMOX2;BLVRB
prerank,sensory perception of taste (GO:0050909),0.5449091730813137,1.1817877227313613,0.2640449438202247,0.6031193517234213,1.0,4/10,28.91%,ASIC3;ASIC1;PKD2L1;PKD1L3
prerank,positive regulation of neurogenesis (GO:0050769),-0.2878519579211197,-1.1813786365787384,0.16666666666666666,0.6201128172789019,1.0,13/68,5.43%,CX3CR1;NUMB;IL1RAPL1;ROBO1;PTPRD;CDKL5;TIAM1;ROBO2;RGS14;TGM2;NTRK2;SOX8;TIAM2
prerank,regulation of amyloid-beta formation (GO:1902003),0.44714678305245414,1.1810261586151307,0.2535377358490566,0.6048001773107154,1.0,4/34,1.42%,IGF1;ABCG1;APOE;GSAP
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.4599817908569217,1.1810257876316597,0.2451219512195122,0.6043202990061054,1.0,6/27,16.44%,FGF13;CAV1;PKP2;JUP;ATP2A2;SRI
prerank,regulation of protein dephosphorylation (GO:0035304),0.43765750968350114,1.1810233296787476,0.24659090909090908,0.6038428334169527,1.0,13/37,22.93%,MFHAS1;PRKCD;PTPA;HTT;SYMPK;ANKLE2;PIN1;CALM2;SPPL3;NSMF;PPP1R8;TGFB1;HSP90B1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5310608529426508,1.1807799955144267,0.27906976744186046,0.6040953115917113,1.0,4/13,17.14%,SULT6B1;TPST1;SULT2B1;BPNT2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.42439463792615634,1.1807567827682783,0.23103448275862068,0.6036961717964077,1.0,18/46,24.98%,SIRPA;PTPRC;TNIP1;DUSP9;PTPN2;SPRED2;CNKSR3;RANBP9;SPRED3;FLCN;PIN1;DUSP3;PTPN1;ITGB1BP1;DUSP6;EMILIN1;LYN;PTEN
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3187244034098527,-1.1804841664812025,0.14782608695652175,0.6193602278764418,1.0,9/35,10.21%,HPGD;LTC4S;HMGCLL1;ALOX5;ALOX5AP;GGT5;PAM;FAR1;SCD
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5552262467259687,1.1804125742728633,0.2949852507374631,0.6042042034317292,1.0,4/11,8.84%,NPPA;LRRC52;ALG10B;TREM2
prerank,regulation of spindle assembly (GO:0090169),0.4694548886222865,1.1803164303964877,0.25,0.6039724717251503,1.0,7/25,13.67%,DYNC1H1;CHMP4B;DRG1;PDCD6IP;VPS4B;NUMA1;TPR
prerank,aorta morphogenesis (GO:0035909),0.5092214969563637,1.1801850104891312,0.2667525773195876,0.6038601995278023,1.0,3/17,7.58%,LRP1;JAG1;DLL4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3772936824303919,1.1801790632781497,0.1346153846153846,0.6033935732312985,1.0,58/173,25.94%,ANK1;CTSZ;GOSR2;DYNC1H1;NAPA;GOLGB1;VTI1A;BET1L;TRAPPC8;SEC24A;COG4;PROS1;MCFD2;SEC22B;DCTN1;GAS6;PGAP1;DYNC1LI2;YIF1B;VAPB;RAB1A;USO1;STX5;SAR1A;VAMP4;ARFGAP3;DCTN6;TRAPPC11;TRAPPC12;YKT6;F9;COPA;TMED3;COPG2;TRIP11;GOLGA2;TBC1D20;SEC24D;SEC16A;TEX261;LMAN2L;CAPZB;COPB1;COPG1;KDELR1;LMAN1;KDELR2;DCTN5;CNIH4;SEC24B;ARFGAP1;CUL3;ERGIC1;DYNC1I2;COPZ2;SPTAN1;ARF4;PDCD6
prerank,gene silencing by miRNA (GO:0035195),0.4433978273219898,1.1801393577684913,0.2582216808769793,0.6030269084610475,1.0,10/32,18.46%,EIF6;AGO2;SNIP1;ZC3H7B;CNOT6;AGO3;AGO4;PUM1;NOTCH4;ADAR
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4564271529728877,1.1799523586183691,0.23579201934703747,0.6030549442882837,1.0,12/29,22.29%,ACSBG2;ACACA;HACD2;SLC25A1;ACSL1;HSD17B8;HSD17B12;ACSBG1;HACD1;ELOVL2;TECR;GCDH
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.42090188414728036,1.1795855291763986,0.22533632286995517,0.6036241169713424,1.0,24/51,29.30%,PLEK;NRP1;MYOC;LIMK1;TESK1;EVL;RHOA;SERPINF2;SORBS3;GPR65;ARHGEF5;SFRP1;PFN1;TGFBR1;SYNPO;ITGB1BP1;NF2;CDC42;ABL1;RAC1;PFN2;CX3CL1;CCDC88A;PXN
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4829226364737711,-1.1794472768202389,0.2391304347826087,0.6192088959633288,1.0,5/10,17.50%,HECW1;PRKCE;HECW2;NEDD4L;OSR1
prerank,macrophage differentiation (GO:0030225),0.5348995630983535,1.1792928391543538,0.26713286713286716,0.6040377731820623,1.0,2/13,3.49%,CSF1;VEGFA
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.43977708087829465,-1.179147067810842,0.26199261992619927,0.6171514150063526,1.0,6/12,29.36%,CENPE;CHAMP1;CDT1;KIF2C;NUF2;MIS12
prerank,RNA destabilization (GO:0050779),0.4889651166095694,1.1789244191635395,0.26666666666666666,0.6046633112234161,1.0,9/18,23.34%,DXO;CELF1;YTHDF2;PUM1;RIDA;FTO;ROCK1;METTL3;GIGYF2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3883334343586164,1.1788089775844066,0.1847599164926931,0.6045453963722947,1.0,32/109,20.58%,PLEK;FGF2;PIK3CB;SLC27A1;ARF3;PLAAT3;INPPL1;PI4K2A;PLCB2;RAB5A;PIP5K1C;PLEKHA1;PIK3R5;PI4KA;PGAP1;VAC14;LPGAT1;PIK3R2;RUFY1;MTMR12;MTMR14;PI4K2B;PIP5K1A;MTMR6;INPP4A;PIP4K2A;PIK3C2A;PIKFYVE;PLA2G5;MTMR10;SYNJ1;PIK3CA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5047956900253192,1.1787800322262185,0.24633821571238348,0.6041509916003678,1.0,2/17,1.74%,IGF1;NRP1
prerank,proteolysis (GO:0006508),0.3736641000727639,1.178756891210455,0.10932798395185557,0.6037351886764479,1.0,53/252,19.89%,PLAU;ADAM33;CTSB;CAPN15;CTSD;ANPEP;MMP12;CTSZ;ST14;CTSA;ADAMTS13;BMP1;NAPSA;OLR1;MALT1;CAPN1;ADAM17;DPP7;ATG4D;DDI2;PSEN2;CPD;SPCS3;AFG3L2;LONP1;TPP1;KLKB1;PITRM1;PGPEP1L;ATG4A;PARL;MDM2;KLK3;CAPN7;OGT;FURIN;CLPP;FBXL6;MMP19;MMP17;SUFU;CASP7;TASP1;F9;XPNPEP1;SPPL3;PSMC4;APH1A;CTSL;CLN3;NLN;PSMD6;RNPEPL1
prerank,regulation of B cell differentiation (GO:0045577),0.4936395837006582,1.1783163416381344,0.2700534759358289,0.6045293051176702,1.0,6/17,19.95%,NCKAP1L;ID2;SYK;BTK;SFRP1;XBP1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4699899917411961,1.1782641848508415,0.26474278544542035,0.6042026092232855,1.0,11/24,25.77%,DNMT3A;PHF1;MTF2;DNMT3B;EED;CREBZF;DNMT1;MPHOSPH8;BMI1;SPI1;H3-3A
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.42927336134986593,1.1776882718759145,0.23917995444191345,0.6054328234152031,1.0,12/44,17.01%,VEGFA;SIAH2;CST7;CD44;GAS6;DNAJB6;TRIAP1;RAF1;USP47;FNIP1;TNF;CAST
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.41444393594730944,-1.1774432159455988,0.241635687732342,0.6185673396122295,1.0,6/16,22.43%,HELB;KLHL15;RMI2;SHLD3;POLQ;MAD2L2
prerank,regulation of neuron migration (GO:2001222),-0.3594771661161526,-1.1773322267065076,0.22099447513812154,0.6159651734953784,1.0,5/26,5.71%,CTNNA2;SEMA6A;RAPGEF2;NTNG1;NEXMIF
prerank,mitochondrial translational termination (GO:0070126),0.3937621155058034,1.1770458903044096,0.20190274841437633,0.6068326406585945,1.0,43/88,32.19%,MRPL47;MRPL23;DAP3;MRPL4;MRPS15;MRPL52;MRPS16;MRPS28;MRPS35;CHCHD1;MRPL53;MTRF1L;GFM2;MRPS33;MRPL24;MRPL37;MRPS30;MRPL17;MRPL18;MRPL11;MRPL1;MRPS12;MRPS7;MTRF1;MRPS22;MRPL42;MRPS9;MRPL39;MRPS10;MRPS31;MRPS34;MRPS27;MRPL21;MRPS17;MRPS26;MRPL43;MRPL51;MRPL41;MRPL27;MRRF;MRPS18B;MRPL38;MRPL57
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3944704273232482,1.1765441253347981,0.2135306553911205,0.6078273558164285,1.0,25/88,17.21%,MYO5A;VPS13C;RABEP1;FTL;DTNBP1;NAPA;GOLGB1;CORO7;ARFGEF2;DOP1B;BLOC1S3;DNM2;AP4E1;VAMP2;EXOC2;LLGL1;AP1M1;CCDC93;CCDC22;PUM1;AP1G1;VPS35L;EXOC4;KIF16B;SH3D19
prerank,intermediate filament organization (GO:0045109),0.5009320488790604,1.1762849928586967,0.26162018592297476,0.6080948725604957,1.0,4/17,9.21%,VIM;DNAJB6;PKP2;KLHL24
prerank,regulation of cell migration (GO:0030334),0.37030445276164026,1.1761941660755066,0.063,0.6078939986610941,1.0,54/382,10.19%,GPNMB;IGF1;PLAU;PLXNC1;FLT1;MITF;CORO1C;ITGAX;CSF1;MCTP1;MACF1;MGAT5;FGR;ADARB1;SDCBP;SASH1;PDGFA;RAP2A;SGK1;FGF2;PTK2B;SGK3;PLXNA2;SPHK1;CLDN19;DAG1;VEGFA;DAB2;FLNA;STK24;GCNT2;CLIC4;NEDD9;ADAM17;PDPN;SMAD7;RUFY3;JAG1;APPL2;MYOC;NKX2-1;RHOD;ARID2;GTPBP4;FGF20;CCAR1;SERPINE2;SPAG9;CAV1;MYADM;IGF1R;CYP1B1;RNF41;ADAM15
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5397589131774349,1.1759722018383179,0.2733612273361227,0.6080597438286449,1.0,6/12,23.12%,APOE;TREM2;PFDN2;IAPP;PFDN1;PFDN6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.5311118815666271,1.1758560835392504,0.2764227642276423,0.6079110369070454,1.0,9/13,33.29%,TSR1;KRI1;UTP20;NOP14;BMS1;RCL1;ABT1;TBL3;NOP9
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.529557539602698,1.1751886384846022,0.2698191933240612,0.6093573848229935,1.0,6/12,23.07%,ATIC;ADSS1;GART;PPAT;ADSL;ADSS2
prerank,cellular response to interferon-gamma (GO:0071346),0.3916784667646071,1.175077445013384,0.19853709508881923,0.6091787912335935,1.0,15/88,13.46%,SIRPA;EPRS1;CCL4;PRKCD;IL12RB1;IRF8;CD44;CCL13;IRF5;ACOD1;DAPK1;CCL14;IFNGR2;JAK1;RPL13A
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5603976607923875,1.1746054946124476,0.28654970760233917,0.6095643044750484,1.0,2/10,7.57%,HDAC4;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.5603976607923875,1.1746054946124476,0.28654970760233917,0.6095643044750484,1.0,2/10,7.57%,HDAC4;GIT1
prerank,positive regulation of catabolic process (GO:0009896),0.40699856682499114,1.1743869424237108,0.23793859649122806,0.6097053903811936,1.0,18/65,14.62%,ATG7;APOA2;C4BPA;C4BPB;PLK2;FZR1;VCP;SEC22B;RAB7A;RNF41;WWP2;DDB1;VIP;TIPARP;STX5;TNFAIP3;HUWE1;TNF
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.454497396913361,-1.1742431269773224,0.26217228464419473,0.621205696368502,1.0,5/11,14.74%,GPM6B;COMMD1;PICALM;TAX1BP3;NEDD4L
prerank,myeloid dendritic cell activation (GO:0001773),0.5249691432273617,1.1741311492657063,0.28851540616246496,0.6100106804503863,1.0,2/12,10.71%,DOCK2;TGFBR2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4481654983566944,1.1739809294810508,0.2731535756154748,0.6099877098220183,1.0,9/28,17.43%,IRAK2;OTULIN;UBA52;TAB1;AAMP;TNFAIP3;RPS27A;UBC;IRGM
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3028341381674254,-1.1737344983819162,0.20253164556962025,0.619557372933811,1.0,10/54,4.74%,KCNIP4;DPP10;NOS1AP;AKAP6;GABBR1;DPP6;BIN1;KCNJ3;KCNN2;KCNIP3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.49674749859229983,1.1735242737136613,0.258148631029987,0.6108387294502415,1.0,2/19,0.87%,IGF1;APOE
prerank,nucleosome assembly (GO:0006334),0.4423791448582055,1.1732709708513336,0.2647412755716005,0.6111086566254023,1.0,14/31,26.93%,GRWD1;SOX9;CABIN1;CHAF1B;UBN1;SART3;HAT1;ASF1A;DAXX;NAP1L3;NAP1L2;H3-3A;IPO4;RSF1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5162587442665997,1.1729742096064424,0.2870493991989319,0.6115043146092523,1.0,6/14,19.55%,ABCG1;ADAM17;PSEN2;APH1A;CLN3;ABCA7
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5650804061955168,1.1729631801578262,0.2720797720797721,0.6110619596181139,1.0,3/10,11.32%,GDF6;SOX9;PKDCC
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4806345964448561,1.1724423315650925,0.27352572145545795,0.6121413647206434,1.0,10/22,25.97%,KRI1;WDR12;ERI3;UTP20;EXOSC9;EXOSC10;ERI2;FTSJ3;NOP14;URB1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3374349605315508,-1.1724059425377147,0.19047619047619047,0.6203930508417655,1.0,9/28,15.78%,MAP2;MAP1B;CLASP2;ARL2;STMN3;STMN1;SKA2;MAPT;FKBP4
prerank,cytoplasmic microtubule organization (GO:0031122),0.41502934681770776,1.1720786945693238,0.24141749723145073,0.6127036492502056,1.0,16/54,18.19%,MAP10;DYNC1H1;CLIP2;TUBGCP4;DCTN1;DST;CRIPT;VPS4B;NUMA1;HOOK3;RHOA;PLK3;SLAIN2;CLIP1;FIGNL1;HOOK1
prerank,response to interleukin-6 (GO:0070741),-0.4827087535363839,-1.1718396311073744,0.24414715719063546,0.6190757916518642,1.0,3/10,5.50%,SELPLG;ST3GAL6;RELA
prerank,regulation of trans-synaptic signaling (GO:0099177),0.444007849108093,1.1715647347206808,0.2647754137115839,0.613700015839704,1.0,5/33,3.39%,CACNA1A;ABR;FABP5;CEL;BTBD9
prerank,leukotriene metabolic process (GO:0006691),-0.38811068297275164,-1.1714291671704702,0.23333333333333334,0.617250697449104,1.0,4/19,7.34%,LTC4S;ALOX5;ALOX5AP;GGT5
prerank,cellular metal ion homeostasis (GO:0006875),0.3858346217631807,1.171383661893698,0.20276008492569003,0.6137279647671463,1.0,29/102,23.67%,SLC9A1;KCNMA1;ATP2B1;ATP13A2;KCNJ2;SLC24A4;NPTN;TPCN2;SLC8B1;CCL13;CAV1;CCL14;VAPB;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP2A2;ATP1B3;HTR2B;CHERP;STOML2;TMEM165;DRD3;TMCO1;CALR;ATP13A3;CCL3;ATP1A2
prerank,membrane organization (GO:0061024),0.3713340800352217,1.171256230657169,0.12224448897795591,0.613631904845288,1.0,62/227,20.55%,MYOF;CORO1C;RABEP1;IGF2R;SYNGR1;GRB2;FER1L5;ARPC3;NAPA;ARPC2;DAB2;MTCH1;TLCD1;CHMP4B;CHMP4A;TOR1AIP2;ARPC5;GLTP;SH3KBP1;STAM2;TLCD2;RAB5A;UBA52;PIP5K1C;NPC1;DNM2;FZD4;PDCD6IP;REEP3;LPCAT3;MYADM;HIP1R;VPS4B;OSBPL2;AP3D1;VAPB;VAMP2;USO1;SAR1A;GAK;VAMP4;CBL;HUWE1;CTDNEP1;GRIN3B;RPS27A;UBC;HIP1;TFRC;SUN1;BAIAP2L2;PIK3C2A;TOR1B;VAMP3;SLC2A8;TMEM43;CLN3;GAPVD1;SYNJ1;ACTR3;GCA;REPS1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5619099866538529,1.1709855610072875,0.28820960698689957,0.6134593941542499,1.0,4/10,14.62%,PRKCD;SPHK2;SIRT3;TNF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5619099866538529,1.1709855610072875,0.28820960698689957,0.6134593941542499,1.0,4/10,14.62%,PRKCD;SPHK2;SIRT3;TNF
prerank,iron ion homeostasis (GO:0055072),0.40765581812174206,1.1706066341511319,0.2328159645232816,0.6140890828042519,1.0,10/58,7.56%,ATP6V1A;ATP13A2;FTL;ATP6V0D1;FRRS1;SLC46A1;HMOX1;ATP6V1G1;TMEM199;SLC11A1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.396924776380442,1.1705659721753818,0.2301845819761129,0.6137490613696347,1.0,26/68,27.75%,TAF1D;POLR2H;UBTF;TTF1;PAPOLA;PABPN1;SYMPK;POLR1A;CPSF7;MNAT1;TAF1A;GTF2H1;POLR1G;TAF1C;SSU72;ERCC2;SNRPF;TBP;PRMT5;SNRPD3;WDR33;CCNH;MAZ;POLR1H;POLR1F;POLR1C
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3810786879570084,1.170460174447752,0.17563451776649747,0.613619096089218,1.0,52/152,23.79%,DKK2;MACF1;PSMD1;PSMD8;TNKS2;PSMA1;BAMBI;PSMA8;WLS;PRDM15;VCP;SKI;FRAT1;CAV1;JRK;NFKB1;PSMD14;CSNK1D;PSMA5;GPRC5B;JUP;TNFAIP3;USP47;PSMD12;ILK;ZBED3;ATP6V0C;PSMB10;ZEB2;TERT;CSNK1G1;PIN1;PSMD2;SFRP1;PSMC4;DACT1;USP8;PSMD6;DEPDC1B;FGFR2;PSMD3;TGFB1;PSMD5;PSMC2;PSME4;CSNK1E;SMARCA4;PSMB8;PSMA6;RSPO1;PSMB7;PSMD4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3851459321356644,1.1701638639900822,0.20976116303219106,0.6139829082388452,1.0,28/101,19.49%,ASPH;ATG7;CSF1;EIF6;EIF4G1;PIWIL2;MSN;VIM;LARP4;EEF2;FXR2;TBC1D10A;UPF3A;ATG10;ASPSCR1;OGT;IL6;VPS35;FBXW11;UPF3B;NAT10;CPEB3;PTTG1IP;CIRBP;PYM1;DACT1;VPS11;PCIF1
prerank,error-prone translesion synthesis (GO:0042276),0.4805392712624727,1.169562184784704,0.2786259541984733,0.6152124421267794,1.0,6/21,15.77%,UBA52;REV1;RFC2;RPS27A;UBC;RFC1
prerank,protein localization to chromosome (GO:0034502),0.4377067911463294,1.1692486041128394,0.2526817640047676,0.6156372692956725,1.0,19/34,34.45%,FAM47E;TNKS2;ACD;TPP1;WAPL;MCM8;CENPA;SLF2;LEMD2;XRCC5;CHMP7;TERF2IP;TERF2;ATR;MCM9;TINF2;PARP3;MRNIP;PINX1
prerank,translational elongation (GO:0006414),0.388564899583034,1.1691748992264477,0.2,0.615387116006948,1.0,34/101,22.98%,MRPL47;MRPL23;GTPBP2;DAP3;MRPL4;EEF2;MRPS15;MRPL52;MRPS16;MRPS28;MRPS35;CHCHD1;MRPL53;EEF1A1;GFM2;EEF1D;MRPS33;MRPL24;MRPL37;MRPS30;MRPL17;MRPL18;MRPL11;MRPL1;MRPS12;MRPS7;MRPS22;MRPL42;EEF1A2;MRPS9;TSFM;MRPL39;MRPS10;RACK1
prerank,DNA geometric change (GO:0032392),0.4651581703042139,1.1690019192871361,0.2723833543505675,0.615414331377722,1.0,9/24,19.61%,ASCC3;ZRANB3;RAD50;DHX9;HNRNPA2B1;SUPV3L1;DDX1;RECQL5;BLM
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.491795607048656,1.168800030094307,0.285140562248996,0.615554910925829,1.0,3/16,8.19%,CHMP4B;CHMP4A;VTA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5172654858947532,1.1681612100439505,0.28512960436562074,0.6170028038419166,1.0,3/15,9.72%,TEC;PTK2B;IGF1R
prerank,autonomic nervous system development (GO:0048483),0.503055898327092,1.1680974054378177,0.2696476964769648,0.6167127799730514,1.0,2/17,1.74%,FN1;NRP1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3762858313878659,-1.1679554537923424,0.2537313432835821,0.6231685595252638,1.0,3/22,0.90%,SSH2;CYRIB;TWF2
prerank,inflammatory response (GO:0006954),0.37093174690032116,1.1675685848938402,0.14729458917835672,0.6177936119726543,1.0,40/195,18.79%,LAT;ADAM8;BLNK;PARP4;CCL4;MFHAS1;ADCY8;MGLL;PTGFR;CYBA;PTGIR;OLR1;NFX1;HDAC4;CRH;SIGLEC1;CD44;C3AR1;HDAC9;CCL13;SLC11A1;NRROS;CYBB;TUSC2;NFKB1;CCL14;TPST1;C5AR1;PTGER4;IL6;MAPKAPK2;CDO1;TNF;NFATC3;TBK1;LOXL3;TAC4;REL;PTGER3;ITGB2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.44971232724160054,1.1675494626046592,0.26618705035971224,0.6173792987384554,1.0,7/31,15.09%,BCL2;BAX;PPP3R1;HIP1R;YWHAG;BID;PPP3CC
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3732056492232277,-1.167489748188656,0.23636363636363636,0.6216610535448651,1.0,10/22,17.14%,CACNB2;DMD;NOS1AP;AHNAK;STAC;CBARP;PDE4B;GNB5;DRD2;CRHR1
prerank,RNA interference (GO:0016246),0.4877363473052879,1.1672988954425056,0.285336856010568,0.6176331885651414,1.0,6/17,15.80%,AGO2;CELF1;DHX9;AGO3;AGO4;TERT
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.37052275454391326,1.1672378450566554,0.12337011033099297,0.6173459364029276,1.0,104/264,28.60%,SNRNP35;HNRNPA3;SNIP1;HNRNPUL1;POLR2H;HNRNPM;SF3B3;DDX39B;ZRSR2;PNN;DNAJC8;SMNDC1;HNRNPC;SRSF11;CCAR1;PAPOLA;PABPN1;CD2BP2;SART1;PUF60;DDX17;SRPK1;PPIE;GTF2F1;SYMPK;HNRNPK;RBM15B;SRPK2;CDK13;ZMAT5;NOVA2;RBM4B;RBM19;PRMT7;GEMIN5;DHX9;HNRNPL;SRSF2;CTNNBL1;HNRNPA2B1;CPSF7;PRCC;UPF3B;TRA2B;SNU13;ZMAT2;IK;POLR2D;ZCCHC8;SMU1;SNW1;DDX1;SRSF7;PABPC1;SNRPB2;PCBP1;CHERP;LSM6;PRPF40A;SF3B5;GCFC2;SRRM1;RBM22;SNRPF;PRPF6;SART3;GEMIN2;TGS1;FUS;HNRNPU;SNRNP40;DDX42;RALY;SRSF1;WBP11;WDR83;PRMT5;SRSF10;SNRPD3;SNRPD2;SNRPD1;LSM8;WDR33;METTL3;SCNM1;PPIL3;HNRNPF;SYNCRIP;LSM4;SF3B4;SUGP1;SRRM2;SF1;EIF4A3;PCBP2;EFTUD2;DDX23;WDR77;SRSF3;DDX39A;GEMIN8;PTBP1;RBM6;CWC22
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5407341875292917,1.1667980770484412,0.2815533980582524,0.6181658400616854,1.0,5/11,29.12%,SMAD7;SOCS5;ZC3H12A;JAK3;RC3H1
prerank,positive regulation of sodium ion transport (GO:0010765),0.5337385191224209,1.1666598342896224,0.30303030303030304,0.6180882870680302,1.0,6/12,18.59%,PRSS8;PKP2;CNKSR3;SCN1B;AHCYL1;SCN3B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.38298901937016944,1.1661948957878647,0.20777891504605936,0.618956788520917,1.0,45/129,23.79%,DKK2;PSMD1;PSMD8;TNKS2;PSMA1;BAMBI;PSMA8;WLS;PRDM15;VCP;FRAT1;CAV1;JRK;NFKB1;PSMD14;CSNK1D;PSMA5;GPRC5B;JUP;USP47;PSMD12;ILK;ZBED3;PSMB10;ZEB2;CSNK1G1;PIN1;PSMD2;SFRP1;PSMC4;DACT1;USP8;PSMD6;FGFR2;PSMD3;TGFB1;PSMD5;PSMC2;PSME4;CSNK1E;PSMB8;PSMA6;RSPO1;PSMB7;PSMD4
prerank,peptidyl-lysine modification (GO:0018205),0.388284897894473,1.1658023810966232,0.20725388601036268,0.6196445291165196,1.0,40/99,27.50%,NUP205;NSMCE2;ETFBKMT;HDAC4;SIRT5;TRIM28;SENP5;HDAC9;NUP188;EGR2;RAE1;ATP7A;EEF1AKMT3;SIRT3;GCSH;NUP42;TPR;SAE1;SIRT4;USPL1;PLOD3;PIAS4;NUP54;LOXL3;VIPAS39;SIRT2;SUMO1;SUMO2;RANBP2;NUP133;NUP93;P3H3;NUP98;PIAS1;EP300;SENP1;CTH;NUP35;UBA2;AAAS
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4598079818972577,1.1655552036893302,0.2825278810408922,0.6198790294516247,1.0,7/24,14.97%,IRAK2;UBA52;TAB1;AAMP;TNFAIP3;RPS27A;UBC
prerank,response to fatty acid (GO:0070542),0.4942830521875531,1.165316424175853,0.26193548387096777,0.6200534509269502,1.0,2/17,3.85%,LPL;SOX9
prerank,transcription by RNA polymerase II (GO:0006366),0.3697372623918005,1.1652222949845836,0.1,0.6198718955877723,1.0,94/305,24.52%,ERCC6;NFYA;NFIC;SNAPC1;NPPA;VDR;PPARD;NFX1;E2F3;DDX21;PPARG;POLR2H;TAF4B;ELL2;SNAPC2;NOCT;COPS2;HDAC9;HDAC7;GTF2A2;MNT;PAPOLA;TAF15;PABPN1;MED17;GTF2F1;SYMPK;ELOF1;YBX2;NFKB1;TAF7;BTF3;NR3C1;CCNT2;NRBF2;SNAPC4;HSF2BP;C5AR1;MAML2;EAF1;CDK13;INTS6;GMEB2;PIR;TRIP13;ELOB;SP1;TBPL1;RPRD1A;CPSF7;ZBTB7B;INTS14;MNAT1;POLR2D;GTF2E2;HDAC1;SNW1;NOTCH4;TAF1A;INTS2;KLF13;GTF2H1;TAF5L;PRRX1;TAF1C;SSU72;TRIP11;ERCC2;MED1;SNRPF;RNMT;RXRB;DEK;HDAC3;MED27;XBP1;POU2F1;TBP;INTS3;RXRA;NOTCH1;CREBBP;SNRPD3;PARP1;MLLT1;WDR33;TFCP2;CCNH;NR2C2AP;NELFA;TSC22D1;TEAD1;PHAX;MAZ
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4164248137965718,1.165175792164307,0.25,0.6195415329603513,1.0,25/48,28.34%,NRP1;CUX1;FLNA;NEDD9;MYOC;SS18L2;CRKL;P4HB;MYADM;LIMS1;TESK1;C1QBP;ILK;CAPRIN1;CRK;SS18L1;TRIOBP;CALR;CDC42;OLFM4;ABL1;PRKDC;RAC1;ARHGEF7;CIB1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4183809149831996,1.1651149270075605,0.24886363636363637,0.6192547928443286,1.0,13/46,22.30%,DGKZ;DDHD1;SLC27A1;ABHD5;DGKH;LPCAT1;DGKD;ABHD4;AGPAT1;PLA2G5;DGKQ;AGPAT5;AGPAT3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4877194089953308,1.1643406779862302,0.291497975708502,0.6209796198303443,1.0,5/18,14.62%,ABL2;POR;ATP7A;SIRT3;TNF
prerank,cell cycle G1/S phase transition (GO:0044843),0.40232428730469655,1.164312088595078,0.2251655629139073,0.6205967171489224,1.0,25/61,26.14%,CDK6;E2F3;PLK2;DBF4;CDKN3;PLK3;CUL2;EIF4E;POLE;MNAT1;CDC25A;PPP6C;LATS1;CDK4;CUL1;CUL4A;CCND1;CDK2;CCNH;EIF4EBP1;SPDYA;CUL3;CDC34;GSPT1;CDC7
prerank,cellular protein modification process (GO:0006464),0.36192070220242967,1.1641085982743697,0.015,0.6207275643314156,1.0,266/983,22.59%,FNIP2;FAM20C;B4GALT5;CDK14;SPP1;CDK18;PEAK1;HIF1A;FN1;PRKCH;ATG7;CSF1;PTPRA;LARGE1;APOE;ABL2;FGR;UBL4A;TEC;PSMD1;B4GALT7;SGK1;CDK6;MSRA;WSB2;PARP4;PTPRC;CDK5;PTK2B;PRKCD;PPM1H;NEURL2;CDK8;SGK3;SGK2;SERPINA10;COPS3;APOA2;MATN3;ENAM;FSTL3;DUSP9;MAP4K5;CEL;PPM1J;PAK6;FBXO32;PSMD8;PDPK1;PPP2R5C;MAP4K3;TNKS2;ERN2;IKBKE;PTPRM;DYRK2;FBXW4;FBXW7;PRKCB;RBBP5;GNMT;PSMA1;SPSB2;PLK2;STK24;STK3;GCNT2;NEK6;APLP2;STT3B;SIK1;SIRT5;B3GALNT2;IGFBP7;PSMA8;WSB1;ERN1;RABGGTB;COPS2;OGFOD1;TLK1;BAP1;LAMC1;RAB5A;COPS4;ALG10B;WDR45;TAOK3;UBA52;ANO8;LGALS1;LIMK1;MAP3K12;KCTD7;KLHL13;COPS8;ERO1A;NPC1;FBXL19;UBE2L6;GAS6;PGAP1;TAB1;TGM5;SYK;SRPK1;ST8SIA6;P4HB;DCAF17;SOCS5;YES1;DAPK1;OGA;QPCT;CDK16;PPP2R1A;RNASEL;PKN2;PAK2;DDB2;PHPT1;ST3GAL2;WWP2;DDB1;TGFBR2;PSMD14;CSNK1D;SRPK2;CDK11B;RAB1A;ATG10;CDK13;PTPN21;PSMA5;MAK;TIPARP;TULP4;TP53RK;ART4;JAK1;RIPK3;BTK;PARP2;CUL2;IL6;SIRT3;PTPN18;MARK4;MAPKAPK2;DUSP12;PSMD12;FYN;ELOB;ILK;MELTF;COQ8B;FBXW11;SOCS2;CAND1;MAP3K1;TRIB2;DUSP11;CTDNEP1;CHEK2;SPSB3;STK38L;MINK1;PSMB10;CTDSP2;ZDHHC6;UBE2L3;PPP3CC;CDC25B;CCDC22;NAA80;FUT10;UBE2F;FASTK;CALU;PRKG1;FBXW5;KLHL11;TBK1;ATE1;STK38;WDR5;SIRT4;MAP3K9;PPP6C;UFL1;FBXO7;LATS1;CDK4;COPS7A;PSMD2;GAN;MAP3K20;MTMR6;PRKAG1;PTAR1;PSMC4;MAPK3;WFS1;AGA;PTPN1;METAP1D;PPP1R12A;PRAG1;CKAP4;TGFBR1;GOLGA2;MARK2;MKNK1;DYRK1B;B3GALT4;ASB18;FRK;CUL1;PTPN6;TAOK1;TIMP1;ABCA7;PDK3;PSMD6;STK11;KLHL41;TRIOBP;WDTC1;PTP4A2;MAPK6;CUL9;CUL4A;ZC3HAV1;FBXO31;EGLN3;UGCG;SERPIND1;DAD1;PSMD3;TGFB1;GPAA1;RNF7;SIRT2;PSMD5;PDGFB;PSMC2;PPP4R2;DUSP6;HIPK1;ROCK1;PSME4;IRAK1;FBXW2;DCAF7;ZBTB16;CSNK1E;SPSB1;BRSK2;FBXO30;SUMF2;BIRC6;PTPN12;NUS1;CDK2;NUB1;PARP1
prerank,negative regulation of kinase activity (GO:0033673),0.40609500392342457,1.163881089049299,0.24917309812568908,0.6208933899504445,1.0,18/62,19.72%,PTPRC;GNAQ;DTNBP1;HSPB1;PDPK1;SMCR8;LRP6;TAB1;TAF7;PAK2;YWHAG;UBASH3B;TRIB2;NF1;QARS1;PYDC1;HNRNPU;ITGB1BP1
prerank,actin filament polymerization (GO:0030041),0.45164082799676264,1.1637847334270564,0.2658536585365854,0.620705129508108,1.0,4/29,4.33%,GAS7;MSRB1;CORO7;WASHC5
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3214954710515617,-1.1637021143121309,0.18181818181818182,0.6284648849044648,1.0,12/35,7.90%,AKAP6;EPHA5;HTR2C;PDE7B;RAPGEF2;ADGRG6;ADCY2;CAP2;RIMS2;NUDT4;RAPGEF3;PDE4D
prerank,sphingoid metabolic process (GO:0046519),0.5256166536526894,1.163421464661577,0.2959326788218794,0.6213070257234967,1.0,4/12,13.52%,SPHK1;PLPP3;SPHK2;KDSR
prerank,neuron maturation (GO:0042551),0.48970336369135686,1.1631980856462592,0.25935828877005346,0.6214697012459643,1.0,2/18,3.64%,B4GALT5;MTCH1
prerank,positive regulation of apoptotic process (GO:0043065),0.366572856676856,1.1631612713586603,0.11811811811811812,0.6211076407966319,1.0,68/293,17.53%,ABR;CTNNB1;CTSD;ATG7;KCNMA1;CDK5;DUSP9;ING4;GNA13;SQSTM1;MTCH1;DIABLO;AKAP13;STK3;SIK1;SPHK2;PTPA;BAX;PSEN2;ARHGEF11;UBA52;HTT;ANO6;CCAR1;BCL6;SUDS3;DNM2;JUN;IRF5;DDIT3;ARHGEF1;HIP1R;DAPK1;CYP1B1;LILRB1;BCL2L11;TLE5;SRPK2;AIFM2;TCTN3;C1QBP;PRMT2;IL6;RPS6;PTGIS;CRADD;CASP9;BID;RPS6KA2;CTNNBL1;HSPD1;MYBBP1A;TNF;NF1;RRP1B;RPS27A;UBC;MTCH2;ARHGEF5;PLEKHN1;ARHGEF2;FLCN;VAV1;OLFM1;UTP11;LATS1;MAP3K20;SFRP1
prerank,cell-cell junction organization (GO:0045216),-0.2688303660510227,-1.1630514074951879,0.1206896551724138,0.6272751995587252,1.0,20/79,13.39%,CADM2;CTNND2;CSF1R;CDH13;TLN2;CDH9;CDH8;CADM3;CDH10;CDH12;CDH7;CDH20;CDH2;CTNND1;TJP1;CDH6;NECTIN2;F2R;PRKCI;GJC1
prerank,neutrophil activation (GO:0042119),0.5277596961328836,1.162912458788186,0.3006993006993007,0.6213480964617797,1.0,2/12,8.63%,PRKCD;SYK
prerank,regulation of interleukin-1 production (GO:0032652),0.5091841016843375,1.1628158503382693,0.29863013698630136,0.6211602013315305,1.0,2/15,7.99%,SIRPA;GAS6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.47386810133678725,1.1628151367538035,0.2883895131086142,0.6206965474221151,1.0,11/21,29.39%,FZR1;RAB1A;UBE2C;GOLGA2;FBXO5;RPS7;RPL23;PTEN;BAG2;BTRC;GORASP1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4219676320489155,1.1627913370399712,0.24743443557582667,0.6202980793573171,1.0,14/47,21.65%,CTNNB1;HIF1A;SOX9;TRIM28;DDX17;LIMS1;FAM83D;NOTCH4;OLFM1;LOXL3;TGFBR1;TGFB1;ROCK1;NOTCH1
prerank,positive regulation of programmed cell death (GO:0043068),0.3672136059588749,1.162773477730652,0.12024048096192384,0.6198846799583803,1.0,63/272,17.53%,ABR;CTNNB1;CTSD;ATG7;KCNMA1;DUSP9;ING4;GNA13;SQSTM1;MTCH1;DIABLO;AKAP13;STK3;SPHK2;PTPA;BAX;PSEN2;ARHGEF11;UBA52;HTT;ANO6;CCAR1;BCL6;SUDS3;DNM2;JUN;SYK;IRF5;ARHGEF1;HIP1R;DAPK1;CYP1B1;LILRB1;BCL2L11;AIFM2;TCTN3;C1QBP;PRMT2;IL6;RPS6;MARK4;CRADD;CASP9;BID;RPS6KA2;CTNNBL1;HSPD1;TNF;NF1;RRP1B;RPS27A;UBC;MTCH2;ARHGEF5;PLEKHN1;ARHGEF2;FLCN;VAV1;OLFM1;UTP11;LATS1;MAP3K20;SFRP1
prerank,striated muscle cell development (GO:0055002),-0.40880360169048735,-1.1626613715020813,0.26459143968871596,0.6254838640548147,1.0,3/14,12.21%,CAPN3;TMOD2;PGM5
prerank,response to axon injury (GO:0048678),-0.3843544543539118,-1.1625826745891927,0.2145748987854251,0.6229842926450939,1.0,7/18,11.42%,P2RY12;GAP43;APOD;SOD1;NREP;FLRT3;MORN4
prerank,regulation of TORC1 signaling (GO:1903432),0.43996286924963074,1.1625744380798564,0.26139088729016785,0.6199723119338145,1.0,9/33,20.09%,GPR137B;RRAGD;SMCR8;LARS1;PIH1D1;SESN2;FLCN;STK11;DGKQ
prerank,regulation of developmental growth (GO:0048638),0.45210338745115086,1.1625341036379375,0.275,0.6196124917979431,1.0,2/29,0.87%,IGF1;APOE
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5054639558378323,1.1623746912618234,0.26764314247669774,0.6196111087418233,1.0,4/17,12.73%,LPL;HDAC9;FURIN;APOH
prerank,regulation of transmembrane transport (GO:0034762),0.4482263376005848,1.1622256140577245,0.2603550295857988,0.619556315188508,1.0,5/31,10.53%,BCL2;KCNJ2;PRKCB;SLC2A1;WWP2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4590644801479602,1.1618134706459728,0.2844611528822055,0.6202619710532772,1.0,16/27,32.24%,AGO2;EIF4G1;EIF4ENIF1;IL6;DHX9;PUM1;EIF4E2;MAP2K2;TGFB1;PUM2;WTIP;FMR1;MAP2K1;FXR1;DDX5;TP53
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4967094673504448,1.161474312878568,0.2786666666666667,0.6207725663922056,1.0,2/16,6.95%,CLDN19;CLDN18
prerank,regulation of cell cycle (GO:0051726),0.3691159769168249,1.1608377206146403,0.12437311935807423,0.6220887494788423,1.0,83/271,25.46%,APBB2;IQGAP1;ADARB1;SDCBP;CDK6;PTPRC;CDK5;FBXL17;ING4;NUDT6;SON;SOX9;EIF4G2;NEK6;SIK1;GMNN;ID2;ERN1;CCNB1;BAP1;SND1;LRP6;WDR12;NUPR2;DYNLT3;BRCA1;JUN;TTLL12;LILRB1;MYBL2;CSNK2A2;RNF167;SRPK2;CDK11B;CDKN3;MDM2;RPS6KA2;SETMAR;FBXL6;MYBBP1A;HCFC1;PRCC;PUM1;ZBTB17;CDC25A;FIGNL1;CDK4;MAP3K20;MAPK12;SFRP1;CDC26;RASSF1;JUNB;TGFBR1;TBRG1;LIN9;BIRC2;HNRNPU;STK11;FGFR2;CCND1;FBXO5;TGFB1;BEX2;SIRT2;RNF20;THAP1;NOTCH1;CALR;NF2;PPP1R9B;RACK1;METTL3;HSP90AB1;GADD45G;EP300;ABL1;GAS2L1;PCLAF;RPL23;FBXL3;DCUN1D3;FBXL8
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5353202399913106,1.1607914116260307,0.296875,0.6217760401383882,1.0,2/11,2.97%,MUC1;ING4
prerank,regulation of DNA recombination (GO:0000018),0.44159483221450485,1.1607783729598231,0.24849939975990396,0.6213527411363304,1.0,17/32,32.21%,PPP4C;ZRANB3;RAD50;THOC1;RAD51AP1;FIGNL1;BLM;PPP4R2;KDM1A;RAD51;TERF2IP;KPNA2;MRE11;SETD2;SPIDR;MSH3;SMARCAD1
prerank,peripheral nervous system development (GO:0007422),-0.3575719450946767,-1.1605978687938294,0.25125628140703515,0.6254895503938527,1.0,8/23,14.11%,SCN8A;SERPINI1;ADGRG6;SOX8;NFASC;ERBB3;GPC1;ADGRB2
prerank,camera-type eye development (GO:0043010),0.46172942392128774,1.1603758000805315,0.2894088669950739,0.6220236124362807,1.0,7/25,16.57%,NES;VEGFA;SKI;CYP1B1;IFT122;NF1;RAB3GAP1
prerank,lipid modification (GO:0030258),0.4302398238452845,1.1603226997036875,0.2752941176470588,0.6217101083249079,1.0,6/37,9.40%,DGKZ;PLPP6;PLPP3;DGKH;DGKD;LPCAT3
prerank,polyol biosynthetic process (GO:0046173),0.5095159017392167,1.160262508662544,0.2925170068027211,0.6214293886005828,1.0,3/16,2.72%,ITPKB;FGF2;CYP27B1
prerank,mesoderm development (GO:0007498),0.48589273060461613,1.160147061710364,0.2918287937743191,0.6212890300565355,1.0,3/18,12.45%,VEGFA;HES7;BTK
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.47177763630403313,-1.1599746549890304,0.2761904761904762,0.6243371529658741,1.0,5/10,20.39%,PRKCE;IRS2;GPLD1;IRS1;PMAIP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4054074249201726,1.1598576880138554,0.24070021881838075,0.6216759723888562,1.0,19/63,21.64%,BCL2;NELL1;EIF4G1;MCL1;EIF4G2;RIC1;RGP1;EIF4G3;TREM2;ZKSCAN3;TIMP2;EIF4E;RUBCN;HTR2B;GOLGA2;TIMP1;DAP;SIRT2;ROCK1
prerank,modulation by symbiont of host process (GO:0044003),0.5520276637979813,1.1593007499367587,0.29362880886426596,0.6227794551610362,1.0,5/10,14.97%,UBA52;PGK1;ENO1;RPS27A;UBC
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4684987124432911,-1.1592449669592444,0.2705479452054795,0.6234098263654022,1.0,5/10,27.82%,DPYD;NT5M;DPYS;NT5C3A;UPB1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3783131419840796,1.1591210697003742,0.18896833503575078,0.6228056628061868,1.0,49/124,29.21%,CTNNB1;PSMD1;PRICKLE1;AGO2;PSMD8;DAAM1;PSMA1;PLCB2;PSMA8;FZD4;FZD1;CELSR1;PPP3R1;PSMD14;PSMA5;RHOA;PSMD12;AGO3;GNB1;PSMB10;AGO4;PSMD2;SFRP1;PSMC4;PFN1;PDE6G;PSMD6;PARD6A;PSMD3;FRZB;PSMD5;PSMC2;PSME4;CDC42;PSMB8;CELSR3;PSMA6;PSMB7;PSMD4;CELSR2;PSMA3;PSMD10;AP2B1;RAC1;PSMC6;PSME3;PSMC5;PSMA4;WNT7A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.37340524609729986,1.1589814848928655,0.19250253292806485,0.6227597664046259,1.0,34/140,16.52%,ARHGAP25;ABR;MYO9B;ARHGAP24;ARHGAP21;ARHGAP10;A2M;GNA13;ARAP2;SQSTM1;AKAP13;RHOQ;ARHGAP12;FAM13B;ARHGEF11;RHOD;ARHGAP19;PIK3R2;ARHGEF1;GMIP;RHOG;ARHGAP17;RHOA;ARHGAP6;MYO9A;RHOF;ARHGEF5;ARHGEF2;FLCN;VAV1;CHN2;ARHGAP9;RABL3;RHOU
prerank,positive regulation of signal transduction (GO:0009967),0.36637726486834,1.158843197549038,0.13326653306613226,0.6227062769943441,1.0,64/238,20.17%,IGF1;ZMIZ1;HIF1A;MACF1;MGAT5;ITGA5;SASH1;PTPRC;NRP1;PTK2B;CYP27B1;AXL;TEDC2;KLK6;PRKCB;FLNA;NPTN;SMARCB1;JAG1;BAX;ERN1;WLS;TSPAN5;ARMC9;HTT;SKI;DLL4;GAS6;TREM2;NEPRO;EVC;ASXL2;MAML2;LIMS1;RWDD3;CD180;IL6;PTGIS;TNFAIP3;CRADD;VPS35;ILK;ATP6V0C;ZBTB7B;PIH1D1;DLG4;TERT;SNW1;NOTCH4;CDKN2AIP;SFRP1;PDE6G;LOXL3;FGFBP3;TGFBR1;DACT1;AGPAT1;HOMER1;ITGB1BP1;PDCL;DEPDC1B;XBP1;FGFR2;TEDC1
prerank,regulation of protein phosphorylation (GO:0001932),0.36854465485224147,1.1587848148308513,0.13627254509018036,0.6224216797140658,1.0,48/256,16.76%,GPNMB;FNIP2;FN1;SIRPA;CORO1C;ATF3;FGR;PLAUR;XDH;PDGFA;RAP2A;FGF2;CLDN19;HSPB1;VEGFA;DAB2;PPP2R5C;SOX9;PLPP3;ADAM17;NPTN;MYDGF;BRD4;FGF20;LRP6;GAS6;CRKL;TREM2;KRAS;MYADM;FXR2;CSNK1D;TESK1;DNAJC10;KDM4D;PID1;FNIP1;FYN;ILK;FGF7;ZBED3;EFNA1;TNF;FGF18;SESN2;FLCN;TFRC;PIN1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.47225977329947133,1.1587298747405173,0.2781289506953224,0.6221222034133859,1.0,4/22,7.58%,NES;ID2;APPL2;DLL4
prerank,regulation of apoptotic process (GO:0042981),0.3608023649310729,1.1585322512678864,0.052,0.6222519918234006,1.0,188/676,24.03%,IGF1;ABR;CTSB;CTNNB1;BCL2;ARHGAP10;CTSD;BCL2L1;ATG7;NIBAN2;ANXA5;PLAUR;SGK1;KCNMA1;CDK5;ANXA4;PTK2B;TRAF2;HYPK;DUSP9;SPHK1;ING4;GNA13;MCL1;HSPB1;VEGFA;DAB2;AXL;SQSTM1;MTCH1;SON;SOX9;RBM25;MALT1;FLNA;SIAH2;DIABLO;AKAP13;PLK2;STK3;PDPN;NAT8;SPHK2;NCKAP1L;MGMT;PTPA;GLS2;CD44;BAX;MYDGF;RABGGTB;PSEN2;HS1BP3;ARHGEF11;UBA52;LGALS1;HTT;VCP;ANO6;CCAR1;BCL6;GAS6;SUDS3;TRIAP1;NDRG1;DNM2;ATAD3A;JUN;IRF5;ATF5;CAT;ARHGEF1;HSPA9;NFKB1;HNRNPK;HIP1R;DAPK1;IGF1R;CYP1B1;PAK2;LILRB1;RASA1;BCL2L11;VIP;BAG3;TNFSF9;AIFM2;TCTN3;PLK3;C1QBP;RAF1;RIPK3;BFAR;PRDM9;PRMT2;IL6;RPS6;APIP;CRADD;GOLPH3;CASP9;USP47;CIAPIN1;BID;USP36;RPS6KA2;CTNNBL1;CBL;NAA16;SOCS2;HSPD1;IL2;BNIP2;HAX1;TNF;NF1;RRP1B;ACTN1;RPS27A;UBC;MTCH2;BABAM2;ARHGEF5;SUPV3L1;PLEKHN1;HIP1;ANP32E;HTR2B;ARHGEF2;FLCN;VAV1;HDAC1;ANKLE2;OLFM1;UTP11;TFRC;FIGNL1;LATS1;THOC6;MAP3K20;SFRP1;NAA15;AVEN;WFS1;MED1;APH1A;BCL2L2;NSMF;ASNS;HDAC3;CLN3;PTPN6;BIRC2;IAPP;XBP1;STEAP3;NOL3;EGLN3;BEX2;FRZB;DDX42;ACTN2;GDNF;MTDH;HIGD2A;DUSP6;IRAK1;TNFRSF8;CREBBP;UFM1;CALR;NF2;BIRC6;TCIM;WDR73;TMBIM4;HSP90B1;RACK1;SCRIB;DAXX;FOXO1;OLFM4;ACTN4;FSTL1;IL7;GSK3B;ARL6IP5;GADD45G
prerank,embryonic axis specification (GO:0000578),-0.4130701760567481,-1.1584808693879098,0.2530612244897959,0.6225050137044427,1.0,4/15,24.73%,SMAD2;STIL;FZD5;HOXD8
prerank,water transport (GO:0006833),0.5334065976088995,1.1581036303648256,0.2930298719772404,0.6229918867905418,1.0,1/12,5.18%,PDPN
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.47171666293479064,1.1576801252698528,0.29109159347553326,0.6237421410437433,1.0,6/22,21.69%,CYP27B1;VDR;CBR1;PIAS4;RBP1;CYP2R1
prerank,regulation of receptor internalization (GO:0002090),0.432874424324465,1.157341618551726,0.26421800947867297,0.6242159553914575,1.0,6/35,10.20%,SDCBP;VEGFA;ANKRD13B;LRPAP1;SCYL2;ATXN2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5216775476311399,1.157215384796177,0.30307262569832405,0.6240984127664583,1.0,9/12,29.40%,BRCA1;RBM15B;PCGF3;HNRNPU;METTL3;SMCHD1;CDYL;LRIF1;RBM15
prerank,DNA catabolic process (GO:0006308),0.5400688914455881,1.157069750985643,0.30962962962962964,0.6240267378026383,1.0,5/11,27.60%,DNASE1L1;DFFB;SETMAR;XRN2;REXO4
prerank,histone H2A acetylation (GO:0043968),0.49374331964189727,1.1563804880664852,0.2874331550802139,0.6255183093820518,1.0,10/16,30.43%,SPHK2;EP400;MSL3;MORF4L2;RUVBL2;BRD8;DMAP1;NAA40;TRRAP;EPC1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3776639955148003,-1.1561326960847162,0.2345679012345679,0.6261403714102366,1.0,6/19,16.64%,MORC3;ARL2;TAPT1;SUPT7L;BCL3;BBS4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.45155233537049416,1.155804136472115,0.28182941903584674,0.6267217575817049,1.0,10/27,23.93%,SLC38A1;SLC36A4;SLC3A2;SLC7A1;SLC7A8;SLC25A18;SLC25A13;SLC7A3;SLC7A2;ARL6IP5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4563519247944518,1.1555448443223713,0.2725060827250608,0.6269887553931555,1.0,5/25,11.57%,ARHGAP24;STAP1;PRKCD;TESK1;EVL
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5418626859130838,1.155497433755187,0.29338842975206614,0.6266600312485182,1.0,5/11,26.25%,BCL2L1;PTGIS;ZC3H12A;SIRT2;DFFA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3903786057945535,1.155496714534998,0.2390608324439701,0.6262058285024807,1.0,15/80,14.62%,CTSD;VEGFA;MALT1;SIAH2;GRAMD4;CD44;GAS6;DNAJB6;TRIAP1;SYK;DAPK1;RAF1;USP47;FNIP1;TNF
prerank,cellular response to interleukin-6 (GO:0071354),-0.34948795669559407,-1.1554779219578644,0.1951219512195122,0.6250156885304204,1.0,7/26,9.82%,SELPLG;ST3GAL6;IL6R;RELA;FER;STAT3;ST18
prerank,translational termination (GO:0006415),0.3844005651249098,1.1554761068543369,0.23516949152542374,0.6258046088049799,1.0,46/95,32.19%,MRPL47;MRPL23;DAP3;MRPL4;MRPS15;MRPL52;MRPS16;ETF1;MRPS28;MRPS35;CHCHD1;MRPL53;MTRF1L;GFM2;MRPS33;MRPL24;MRPL37;MRPS30;MRPL17;MRPL18;MRPL11;MRPL1;MRPS12;MRPS7;MTRF1;MRPS22;MRPL42;MRPS9;MRPL39;MRPS10;MRPS31;GSPT1;MRPS34;MRPS27;MRPL21;MRPS17;MRPS26;TRMT112;MRPL43;MRPL51;MRPL41;MRPL27;MRRF;MRPS18B;MRPL38;MRPL57
prerank,protein-DNA complex disassembly (GO:0032986),0.4998564610790135,1.1553980105457125,0.3012987012987013,0.625559301152981,1.0,10/16,31.32%,GRWD1;SMARCB1;ARID2;SMARCD2;SMARCA4;SET;RPL23;SMARCC1;SMARCC2;SMARCE1
prerank,inner ear morphogenesis (GO:0042472),0.4724992759085634,1.1552811539345385,0.29129886506935687,0.6254529069854451,1.0,4/22,11.41%,TBX18;SOX9;CHD7;MYO3B
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4376360820516494,1.155026396550386,0.28250591016548465,0.6256810760978844,1.0,6/33,3.49%,PKM;ITGA5;FGF2;PIK3CB;PDPK1;VEGFA
prerank,regulation of centrosome duplication (GO:0010824),0.43668975443502567,1.1546820452247104,0.2619617224880383,0.6262007388783267,1.0,11/30,21.18%,CHMP4B;PLK2;PDCD6IP;VPS4B;CEP120;NAT10;GEN1;FBXW5;CEP295NL;ALMS1;CENATAC
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4201783589620589,1.154634172048083,0.2647058823529412,0.6258599122057613,1.0,5/45,8.83%,SDCBP;BMP8B;GDF6;DAB2;RBPMS
prerank,digestive tract development (GO:0048565),-0.3170287873724721,-1.153914247264875,0.21333333333333335,0.6261654104454252,1.0,5/33,6.92%,SALL1;PCSK5;KIT;RARB;CLMP
prerank,myeloid cell differentiation (GO:0030099),0.4171334419167655,1.1538292557669145,0.2737556561085973,0.6276869744702871,1.0,19/47,27.85%,MFHAS1;RUNX1;CEBPA;PTPN2;HSPA9;ACIN1;FLVCR1;UFL1;EPO;TIRAP;ZBTB16;RPS19;LYN;PRDX3;SPI1;KAT8;ATP5IF1;JAK3;HIPK2
prerank,regulation of cell development (GO:0060284),0.4317622056773811,1.1533615460407383,0.26210153482880755,0.6285751959745502,1.0,7/36,11.13%,CTNNB1;BHLHE41;HES7;BHLHE40;HDAC9;YTHDF2;DOCK7
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.41734706061670246,-1.1533213887792613,0.2653061224489796,0.6248967109702288,1.0,5/14,9.27%,PIK3R1;PTK2;STAT5A;STAT3;PRLR
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5268915182317981,1.1533026809799398,0.30428769017980634,0.6282891693104067,1.0,7/12,24.28%,AMPD2;PRPSAP1;GART;PPAT;PRPS2;ADSL;MTHFD1
prerank,positive regulation of cell cycle process (GO:0090068),0.3832785803008231,1.1530656029418713,0.22962962962962963,0.6285112691420025,1.0,30/91,27.36%,IGF1;MAP10;DYNC1H1;RANBP1;CCNB1;PKN2;NUMA1;DBF4;RHOA;CEP120;INO80;TPR;PKP4;GIPC1;GEN1;CDC25B;MAP3K20;SVIL;SIRT2;PDGFB;DRD3;CDC42;CEP295;USP19;NPM2;CUL3;CDC7;PHIP;PLSCR1;TGFA
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3368544843552738,-1.1529886402700673,0.22099447513812154,0.6230808410472943,1.0,11/27,21.02%,RIMS1;SYT1;SYT10;PPP3CB;RIMS2;SDF4;SYT4;SYT7;SYT2;SYT17;SYT9
prerank,regulation of lamellipodium assembly (GO:0010591),-0.33146580851970764,-1.1529303003591382,0.2153846153846154,0.620590237626481,1.0,8/34,8.04%,TWF2;NCKAP1;WASF2;PIK3R1;ABI3;AUTS2;FER;DMTN
prerank,GPI anchor biosynthetic process (GO:0006506),0.4443837639477047,1.152664668970052,0.27450980392156865,0.6291929662600548,1.0,14/30,30.83%,PIGQ;PIGZ;PGAP1;PIGN;PIGL;PIGX;PGAP2;GPAA1;PIGA;PGAP3;PIGT;DPM1;PIGU;PIGB
prerank,membrane lipid biosynthetic process (GO:0046467),0.4014828521113532,1.1526491570190027,0.2554347826086957,0.6287837553568877,1.0,19/58,20.38%,SPHK1;SGMS1;HACD2;PLPP3;CERS6;SPHK2;ST8SIA6;ALDH3A2;ALDH3B1;ST3GAL2;VAPB;GBGT1;SAMD8;KDSR;SGPL1;HACD1;ELOVL2;SPTSSA;SGMS2
prerank,cellular response to hexose stimulus (GO:0071331),0.45604021646451737,1.1525990119476617,0.29679802955665024,0.6284668381823334,1.0,9/23,22.98%,ADCY8;ERN1;PCK2;GAS6;IGF1R;TRA2B;PDK3;XBP1;RACK1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.39661971381278566,1.1524395019416396,0.26537216828478966,0.6284703474757618,1.0,9/66,7.54%,FLT1;SASH1;PDGFA;ADAM8;FGF2;TRAF2;VEGFA;TAOK3;PIK3R5
prerank,amino acid import (GO:0043090),0.47520697304670145,1.1524353304816182,0.2937420178799489,0.6280272727953043,1.0,5/21,12.64%,SLC6A6;SLC7A1;SFXN1;SLC7A8;SFXN2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3889540446179728,1.1517074883451799,0.2418848167539267,0.6296263656372527,1.0,14/85,17.53%,IGF1;NLRC3;CDK6;FGF2;VEGFA;SOX9;MTSS1;LAMC1;C5AR1;LIMS1;FGF7;FGF18;BMP5;SFRP1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36806747351584573,1.1512550384213462,0.16800804828973842,0.6304219653716143,1.0,53/214,21.65%,GPNMB;FN1;SIRPA;APOE;PDGFA;FGF2;PTPRC;CCL4;NRP1;MFHAS1;TNIP1;PTK2B;ALKAL2;DUSP9;FBXW7;GCNT2;PTPN2;CD44;MAP3K12;CCL13;GAS6;SPRED2;SYK;CRKL;TREM2;CNKSR3;CCL14;C5AR1;RANBP9;SERPINF2;APIP;FAM83D;TNF;SPRED3;ARHGEF5;ATP6AP1;HTR2B;FLCN;PIN1;MAPK3;DUSP3;PTPN1;PLA2G5;PTPN6;ABCA7;ITGB1BP1;FGFR2;TGFB1;PDGFB;TIRAP;GLIPR2;DUSP6;NOTCH1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.49846852025615074,1.1505612382343025,0.30266666666666664,0.631947367013589,1.0,4/15,13.10%,AK8;AK4;AK5;ENTPD6
prerank,ceramide metabolic process (GO:0006672),0.4097852770189888,1.1502601675884017,0.2593010146561443,0.6323180528591227,1.0,14/49,20.38%,CERK;ORMDL1;SGMS1;PLPP3;CERS6;SMPD4;ASAH1;PPP2R1A;SAMD8;ORMDL3;SGPL1;CLN8;SPTSSA;SGMS2
prerank,glucose import (GO:0046323),0.5128419778516365,1.1501105757985726,0.2843915343915344,0.6322851152754596,1.0,2/13,5.31%,SLC27A1;SLC2A1
prerank,response to organic cyclic compound (GO:0014070),0.4090902193688904,1.149968196942292,0.2688888888888889,0.6322387736793111,1.0,11/52,17.53%,SPP1;CTNNB1;CHRNB2;CYP19A1;CYP27B1;CYP1B1;TIPARP;SOCS2;TNF;KYNU;SFRP1
prerank,histone H3 acetylation (GO:0043966),-0.30316475421934475,-1.1498384044239602,0.2127659574468085,0.6257033064187785,1.0,8/40,7.31%,MEAF6;JADE1;KAT2B;SGF29;PHF14;NAA60;MBIP;BRCA2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3661534188530247,-1.1495072101179222,0.2398190045248869,0.6239944975129589,1.0,12/23,25.10%,GRIK3;SLC30A1;STXBP1;LRRK2;ARF1;SLC24A2;IL1B;DRD2;ACHE;TMEM25;PRRT1;SHANK2
prerank,histone H4 acetylation (GO:0043967),0.4063887243189616,1.1493582853188657,0.2842465753424658,0.6335068097468765,1.0,20/47,25.53%,KMT2A;ING4;ZZZ3;OGT;EP400;MSL3;HCFC1;MORF4L2;MSL1;WDR5;KAT7;RUVBL2;BRD8;HAT1;DMAP1;JADE3;KANSL1;NAA40;EP300;KAT8
prerank,peptidyl-tyrosine modification (GO:0018212),0.4064773303075352,1.149289403443457,0.27815315315315314,0.6332387712710208,1.0,19/56,25.05%,FLT1;ABL2;FGR;TEC;PTK2B;SYK;TPST1;PKDCC;BTK;FYN;FES;PTPN6;ABI2;FGFR2;PDGFB;FGFR3;ABL1;LYN;PDGFRA
prerank,protein phosphorylation (GO:0006468),0.35857835631932977,1.1491819628092597,0.087,0.6330844638079061,1.0,112/479,20.24%,FNIP2;FAM20C;FLT1;CDK14;CDK18;PEAK1;PRKCH;ABL2;FGR;TEC;SGK1;CDK6;CDK5;PTK2B;PRKCD;CDK8;SGK3;SGK2;GDF6;MAP4K5;ATP13A2;PAK6;PDPK1;MAP4K3;ERN2;IKBKE;DYRK2;PRKCB;CAB39;PLK2;STK24;STK3;NEK6;SIK1;SMAD7;ERN1;COPS2;TLK1;TAOK3;LIMK1;MAP3K12;COPS8;GAS6;SYK;SRPK1;CAD;DAPK1;IGF1R;CDK16;RNASEL;STK32A;PKN2;PAK2;TGFBR2;CSNK2A2;CSNK1D;SRPK2;CDK11B;RIOK2;CDK13;PKDCC;MAK;TP53RK;JAK1;RIPK3;BAZ1B;BTK;MAPKAPK3;MARK4;MAPKAPK2;RPS6KA2;FYN;ILK;COQ8B;MAP3K1;TRIB2;CHEK2;STK38L;MINK1;CDC25B;FASTK;PRKG1;TBK1;CSNK1G1;STK38;GTF2H1;MAP3K9;LATS1;CDK4;MAP3K20;MAPK12;PRKAG1;MAPK3;MAPK15;PRAG1;TGFBR1;FES;MARK2;MKNK1;TLR7;DYRK1B;FRK;PTPN6;ABI2;TAOK1;PDK3;STK11;SMG1;RICTOR;FGFR2;DGKQ;MAPK6
prerank,regulation of myotube differentiation (GO:0010830),0.4638135001076473,1.1490774732060753,0.27728983688833125,0.6329124944427642,1.0,10/24,24.44%,PIEZO1;BHLHE41;HDAC4;SIK1;HDAC9;HDAC1;HDAC3;XBP1;NOTCH1;SMYD1
prerank,monoacylglycerol metabolic process (GO:0046462),0.5149476627260509,1.1488413201898287,0.329608938547486,0.6331279754268039,1.0,2/13,2.14%,ABHD12;MGLL
prerank,fatty acid catabolic process (GO:0009062),0.3906046308186751,1.148665965379319,0.24086021505376345,0.6331965618710464,1.0,18/67,22.17%,AIG1;ACAD11;CEL;PPARD;ABCD4;ABCD2;ALDH3A2;ACADL;ACAD10;ECI2;SCP2;LPIN3;ACAA2;ACBD5;DECR1;MMUT;PHYH;MCAT
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3920517258218363,1.1485568130627015,0.27415966386554624,0.633029343503174,1.0,21/76,19.85%,IRAK2;NLRC3;ANXA4;OTULIN;FOXJ1;TRAF3;ERBIN;HAVCR2;DDIT3;ACOD1;CYP1B1;AIM2;PRMT2;RWDD3;PTGIS;TNFAIP3;CCDC22;UFL1;PYDC1;ZC3H12A;DAP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3781405447718265,1.1484731640224708,0.21443298969072164,0.6327984651265233,1.0,40/118,20.91%,GPNMB;CTNNB1;KIF13B;RAP2A;FGF2;CHRNB2;CDK5;DAG1;FMNL2;STRIP1;HMOX1;LARP4;RUFY3;ZDHHC15;KIF1A;INF2;RNH1;BCL6;SARM1;PAK2;EGLN1;PLXND1;PHLDB1;IL6;PID1;TNFAIP3;NF1;ZMYM4;SH3D19;SFRP1;MYO19;MARK2;NSMF;ABI2;FGFR2;ARC;NEDD4;TGFB1;GDNF;CAPZB
prerank,skeletal muscle tissue development (GO:0007519),0.43655471255870254,1.1484592014644546,0.28019323671497587,0.6323867504295659,1.0,8/32,20.96%,SELENON;SKI;EGR2;IGSF8;CAV1;SVIL;KLHL41;LEMD2
prerank,acyl-CoA metabolic process (GO:0006637),0.4287561621960066,1.1480439640941844,0.28941176470588237,0.6330959796147656,1.0,8/35,16.91%,ACACA;ACOT9;GLYAT;DLST;SUCLG2;ACACB;ACOT6;ACOT1
prerank,integrated stress response signaling (GO:0140467),0.5068850659112383,1.1480215849864235,0.3231197771587744,0.6327076253105647,1.0,7/14,25.98%,NFE2L2;DDIT3;EIF2S1;HERPUD1;EIF2AK4;IMPACT;OMA1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5239217251595892,1.1479546761481514,0.313969571230982,0.6324561510398838,1.0,4/12,14.62%,STAP1;TREM2;IL6;TNF
prerank,ribosome biogenesis (GO:0042254),0.36704509572495425,1.1478838753051952,0.1752786220871327,0.6322050360181611,1.0,54/187,22.13%,DDX31;C1D;EIF6;NOC2L;RRP7A;DDX49;NOLC1;ESF1;METTL17;UBA52;WDR12;DDX52;NOL6;RRP12;RPL10A;MDN1;WDR43;RPL12;UTP14A;LYAR;RIOK2;UTP20;DHX29;RPL36;NOL8;EXOSC9;RPS6;KRR1;RPS28;RPL13A;EXOSC10;RRP9;RRP1B;RRP1;DKC1;PIH1D1;SNU13;WDR3;EXOSC5;UTP11;MRM2;UTP4;RPL18;BYSL;CUL4A;RPF1;EXOSC4;RPS2;XRN2;EIF2A;PDCD11;XPO1;RPS19;NVL
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3653520088768712,1.1478341731058865,0.14056224899598393,0.6318876940354254,1.0,89/241,27.61%,SNRNP35;HNRNPA3;SNIP1;HNRNPUL1;POLR2H;HNRNPM;SF3B3;DDX39B;ZRSR2;PNN;DNAJC8;SMNDC1;HNRNPC;SRSF11;CCAR1;PAPOLA;PABPN1;CD2BP2;SART1;PUF60;PPIE;GTF2F1;SYMPK;HNRNPK;RBM15B;ZMAT5;NOVA2;RBM4B;RBM19;GEMIN5;DHX9;HNRNPL;SRSF2;CTNNBL1;HNRNPA2B1;CPSF7;PRCC;UPF3B;TRA2B;SNU13;ZMAT2;IK;POLR2D;ZCCHC8;SMU1;SNW1;SRSF7;PABPC1;SNRPB2;PCBP1;CHERP;LSM6;PRPF40A;SF3B5;GCFC2;SRRM1;RBM22;SNRPF;PRPF6;SART3;FUS;HNRNPU;SNRNP40;DDX42;RALY;SRSF1;WBP11;WDR83;SRSF10;SNRPD3;SNRPD2;SNRPD1;LSM8;WDR33;METTL3;PPIL3;HNRNPF;SYNCRIP;LSM4;SF3B4;SUGP1;SRRM2;SF1;EIF4A3;PCBP2;EFTUD2;DDX23;SRSF3;DDX39A
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.40648431367208937,1.147479170576311,0.2677966101694915,0.6324476270378706,1.0,11/47,12.60%,XDH;PRKCD;GRB2;CYBA;SYK;ACOD1;RNF41;SLC5A3;CBR1;TGFBR2;PID1
prerank,intracellular lipid transport (GO:0032365),0.46434305599532,1.1474209568464087,0.2950191570881226,0.6321556831643255,1.0,7/21,14.36%,ABCD4;ACACA;ABCD2;NPC2;CPT1A;ACACB;ARV1
prerank,cytoskeleton organization (GO:0007010),0.3817897572404207,1.1471033129613168,0.22291021671826625,0.6326422784428114,1.0,28/114,17.21%,ARHGAP10;ANK1;MICAL2;APOE;PAK6;FGD6;MICAL1;FMNL2;STRIP1;FMNL3;NEDD9;SH3KBP1;LARP4;RHOD;CCL13;DST;RHOG;RANBP9;RANBP10;RHOA;PALLD;TNFAIP3;RHOF;FGD5;ZMYM4;RHOU;PRPF40A;SH3D19
prerank,vesicle transport along microtubule (GO:0047496),0.4644728192899546,1.1469153102643077,0.3068181818181818,0.632716526642595,1.0,7/23,13.60%,DYNC1H1;TRAK1;FYCO1;KIF1A;HTT;RAB1A;FBXW11
prerank,regulation of TOR signaling (GO:0032006),0.3980597961207185,1.1468817784909136,0.26973684210526316,0.6323557169626147,1.0,26/67,26.81%,RRAGD;SMCR8;GAS6;TREM2;NPRL3;UBR2;GOLPH3;FAM83D;FNIP1;GNA12;LARS1;PIH1D1;FLCN;HDAC3;LAMTOR3;LAMTOR1;RICTOR;DGKQ;PIK3CA;RRAGC;NPRL2;AKT1S1;TMEM127;PDCD6;MINAR1;TTI1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4287845117838807,1.1467737824273647,0.26218097447795824,0.6322171618247778,1.0,15/36,26.14%,UXT;RNF2;BRCA1;CBX3;EED;EHMT1;MGA;L3MBTL2;PCGF6;YAF2;BMI1;RAD51;PCGF2;APAF1;CDC7
prerank,positive regulation of B cell proliferation (GO:0030890),0.43586612141115216,1.1466214446494938,0.28292682926829266,0.6321987975875067,1.0,4/29,5.80%,BCL2;CHRNB2;PTPRC;NCKAP1L
prerank,cytokine-mediated signaling pathway (GO:0019221),0.35891191039132336,1.1465924425786307,0.068,0.6318104337109652,1.0,147/532,23.98%,LCP1;BCL2;HIF1A;FN1;BCL2L1;ITGAX;CSF1;CD300LF;ABL2;IRAK2;TEC;PSMD1;FGF2;PIK3CB;CCL4;MUC1;SLC27A1;CSF2RA;PTK2B;PRKCD;GRB2;TRAF2;TNFSF15;POMC;GSTA2;GAB2;MCL1;PSMD8;VEGFA;SQSTM1;IL12RB1;MSN;INPPL1;PSMA1;IRF8;VIM;TRAF3;HMOX1;ADAM17;CEBPA;TNFRSF1B;APPL2;PSMA8;CD44;IL27;UBA52;CCL13;BCL6;IL3RA;TAB1;TNFRSF9;SYK;CRKL;IRF5;TNFSF8;P4HB;HSPA9;NFKB1;SOCS5;CCL14;RNASEL;IFNGR2;PAK2;BCL2L11;MAP3K8;CDIP1;ADIPOR1;PSMD14;TNFSF9;CNTFR;LIMS1;PSMA5;STX3;JAK1;AIM2;IL6;TNIP2;PSMD12;FYN;ILK;CBL;FBXW11;HNRNPA2B1;SOCS2;IL2;TNF;PSMB10;RPS27A;UBC;EIF5A;BST2;VAV1;RHOU;CRK;PSMD2;PSMC4;MAPK3;IRAK4;JUNB;PYDC1;ADAR;GSTO1;ITGB2;IL5;RSAD2;CUL1;PTPN6;BIRC2;EPO;TIMP1;PSMD6;POU2F1;CCND1;UGCG;PIK3CA;PSMD3;TGFB1;PSMD5;PDGFB;PSMC2;IFNAR2;FCER1G;IL21R;IL17RA;CSF2RB;IFI35;PSME4;IRAK1;TNFRSF8;MT2A;SMARCA4;CDC42;PSMB8;HSP90B1;CCL3;PSMA6;FOXO1;PTPN11;CHUK;ACTN4;PSMB7;IL1R1;SOCS6;IL7;PSMD4;OPRM1;IL34
prerank,bile acid and bile salt transport (GO:0015721),-0.35460372949527463,-1.146547841460672,0.2598870056497175,0.6285897506921938,1.0,5/24,6.67%,SLCO2B1;SLCO1B1;NCOA1;CEACAM1;NCOA2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3719317350479863,1.1461161118048333,0.21703853955375255,0.6326906955607972,1.0,40/150,20.97%,OSBPL8;P2RX4;PDGFA;ADAM8;FGF2;PIK3CB;MFHAS1;GRB2;GAB2;PDPK1;AXL;TRAT1;GCNT2;MYDGF;MYOC;PIK3R5;FGF20;GAS6;PIK3R2;IGF1R;RHOG;KITLG;C1QBP;HPSE;FYN;FGF7;HAX1;TNF;FGF18;HIP1;VAV1;TGFBR1;ITGB1BP1;IAPP;RICTOR;FGFR2;PIK3CA;TGFB1;MTDH;PDGFB
prerank,nucleosome disassembly (GO:0006337),0.5058962960438856,1.1460626263948979,0.3125827814569536,0.6319237302352183,1.0,9/14,31.32%,GRWD1;SMARCB1;ARID2;SMARCD2;SMARCA4;SET;SMARCC1;SMARCC2;SMARCE1
prerank,chromatin disassembly (GO:0031498),0.5058962960438856,1.1460626263948979,0.3125827814569536,0.6319237302352183,1.0,9/14,31.32%,GRWD1;SMARCB1;ARID2;SMARCD2;SMARCA4;SET;SMARCC1;SMARCC2;SMARCE1
prerank,spindle assembly (GO:0051225),0.39433750107217214,1.1459325911932332,0.2571428571428571,0.6318520891242583,1.0,20/67,22.18%,TUBGCP4;HAUS8;FLNA;NEK6;LSM14A;STARD9;BCCIP;ABRAXAS1;NUMA1;CSNK1D;RHOA;INO80;CHEK2;MAPRE1;GOLGA2;HDAC3;STAG1;TOGARAM2;KIFC1;HAUS2
prerank,negative regulation of cell migration (GO:0030336),0.37567401892533747,1.145849149162575,0.20020429009193055,0.6316266117166709,1.0,41/137,22.31%,MITF;LRP1;CORO1C;MCTP1;ADARB1;RAP2A;FGF2;CLDN19;DAG1;PTPN23;STK24;HMOX1;CLIC4;SMAD7;JAG1;NKX2-1;ARID2;GTPBP4;CYP1B1;RNF41;ADAM15;ADIPOR1;EVL;NF1;BST2;FLCN;RAP2B;DNAI3;SERPINE1;SFRP1;DUSP3;LDLRAD4;MAPK15;TIMP1;CDH1;ITGB1BP1;AFDN;RNF20;SINHCAF;CALR;NF2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4322909203330615,-1.145841840785277,0.2755417956656347,0.6277078822158036,1.0,3/11,19.75%,MEF2C;TGFB2;GREM1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.519015021235715,1.145838906328384,0.3315143246930423,0.6312088006985318,1.0,4/13,12.60%,VCP;TREM2;ENO1;PID1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5367062716419266,1.1457886579246928,0.2972972972972973,0.6308947919443981,1.0,3/11,3.89%,DAB2;PTPN23;MSN
prerank,regulation of RNA splicing (GO:0043484),0.39143533890434373,1.145233217309591,0.2707659115426106,0.6320493155343241,1.0,23/69,20.13%,AHNAK2;SON;ZNF326;ERN1;RBM39;CELF1;HNRNPLL;GRSF1;SRPK1;HNRNPK;SRPK2;CLK4;PTBP3;HNRNPL;RPS26;TRA2B;RRP1B;FASTK;RBM22;RPS13;SLC38A2;FUS;MBNL2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3738888012962237,1.1448667706785902,0.22142121524201855,0.6325757707202196,1.0,38/122,26.40%,BCAR3;IGF1;FGF2;EIF6;GCK;PIWIL2;DYRK2;VIM;LARP4;EEF2;TMEM106A;NFKB1;NAMPT;FXR2;UPF3A;IL6;DHX9;UPF3B;NAT10;CPEB3;KAT7;CIRBP;PYM1;SLC25A37;LDB1;PCIF1;XBP1;PDGFB;METTL3;NLRC5;EPM2AIP1;NPM2;SMOC2;EIF3E;LARP4B;ZCCHC4;FAF1;EIF4A3
prerank,midbody abscission (GO:0061952),0.4779722697680271,1.1447698249241787,0.29986431478968795,0.6323914832024252,1.0,4/17,10.12%,CHMP4B;CHMP4A;PDCD6IP;VPS4B
prerank,regulation of defense response to virus by host (GO:0050691),0.4340665416623715,1.1444381354785818,0.2883435582822086,0.6328344728335684,1.0,7/30,12.87%,TRIM6;IL12RB1;LILRB1;ZDHHC1;AIM2;DHX9;TNFAIP3
prerank,angiogenesis involved in wound healing (GO:0060055),0.5406751488413808,1.1444205656943587,0.3219858156028369,0.6324336233206492,1.0,3/11,13.02%,VEGFA;SRF;HPSE
prerank,positive regulation of cellular process (GO:0048522),0.3577906100691729,1.144411736911317,0.064,0.6320158436940729,1.0,156/565,25.21%,IGF1;COLEC12;FLT1;BCL2;LRP1;FN1;TCIRG1;SIRPA;P2RX4;ITGAX;CSF1;SDCBP;PDGFA;DOCK2;ADAM8;FGF2;SLC6A6;DOT1L;PTK2B;DYNC1H1;PRKCD;APOA2;SPHK1;PTGFR;GAB2;EIF4G1;CYBA;VEGFA;ACACA;SOX9;ECHDC3;EIF4G2;EAPP;CAPN1;GCNT2;DDX49;SLC35F6;ADAM17;PDPN;HDAC4;CST7;BAMBI;TNFRSF1B;SLC25A33;CELF1;RHOD;CDCA7L;FGF20;SLC11A1;LRP6;CCAR1;EGR2;GAS6;CAV1;CRKL;STOX1;TREM2;P4HB;KRAS;NAMPT;FXR2;IGF1R;CCL14;SRF;RHOG;NUMA1;VIP;TGFBR2;SRPK2;KITLG;LYAR;CDK13;MDM2;C1QBP;CHTOP;STX3;SERPINF2;INO80;ACACB;EXOSC9;IL6;RPS6;USP47;CNOT6;FGF7;IL2;HCFC1;NCMAP;TNF;SERTAD1;CDC25B;MEIS3;FGF18;SUPV3L1;HTR2B;FLCN;HDAC1;BMP5;CDKN2AIP;UFL1;CDK4;S100B;SFRP1;CNBP;FKBP1B;MAPK15;TGFBR1;AGPAT1;HSF1;PLA2G5;STAMBP;PTPN6;EPO;TIMP1;ABCA7;ZC3H12A;ITGB1BP1;XBP1;FGFR2;CCND1;FBXO5;TGFB1;SIRT2;EXOSC4;GDNF;PDGFB;SINHCAF;FCER1G;NOTCH1;RPS19;CALR;CDC42;KMT2D;CDK2;IER5;LMNA;CAPNS1;ACTN4;HSP90AB1;FGFR3;IL7;IL34;SPDYA;STX4;S1PR3;MAZ;TNFRSF11A;MLC1;LYN;CUL3;RPL23;PTEN;FGF1;PDGFRA;PRDX3;MYRF
prerank,telomere maintenance via telomerase (GO:0007004),0.4463399327387898,1.144176401355562,0.2834158415841584,0.632224346945718,1.0,19/28,34.45%,RAD50;ANKRD28;ACD;GAR1;DKC1;RFC1;TERT;PPP6C;TERF1;CDK2;PTGES3;HSP90AB1;TERF2IP;TERF2;SHQ1;MRE11;TELO2;TINF2;PINX1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.38182392773189583,1.144130953275705,0.23572170301142265,0.6319084775668267,1.0,18/98,15.09%,LGALS3;BCL2;LRP1;PRKCH;PDPK1;SQSTM1;STAC2;TREM2;PPP3R1;RHOG;SLC5A3;ITGA3;STX3;YWHAG;BID;FYN;TNF;PPP3CC
prerank,protein ubiquitination (GO:0016567),0.35810840925268217,1.1437804885210556,0.102,0.6324324454907336,1.0,177/471,30.24%,CTNNB1;BCL2;HIF1A;MYLIP;NFE2L2;SASH1;PSMD1;CNOT4;TRAF2;TRIM6;TRIM43;FBXL17;OTULIN;FBXO32;NHLRC1;PSMD8;TNKS2;FBXW4;FBXW7;NFX1;SIAH2;PSMA1;SPSB2;VPS18;TRIP12;RNF6;USP5;PSMA8;WSB1;KLHL7;UBA52;ZSWIM8;HECTD2;UBE2Q1;UBE3C;VCP;KLHL13;ENC1;FBXL19;USP9X;UBE2L6;DTX3;BRCA1;DTX4;KLHL24;RNF14;TPP2;UBE2R2;UBE3B;RNF41;DDB2;BRAP;WWP2;DDB1;RNF167;PSMD14;MDM2;PSMA5;UBR2;ARRDC4;BFAR;CUL2;PEX14;ZNRF3;UBE4A;PSMD12;ELOB;CBL;FBXW11;BLMH;CAND1;SHPRH;HUWE1;KCTD10;PSMB10;UBE2L3;RPS27A;UBC;RNF185;CCDC22;KLHL18;MKRN2;FBXW5;UBE2V2;UBE4B;OBI1;FBXO7;TRIM72;NHLRC3;PSMD2;GAN;UBE2H;PSMC4;UBE2C;DERL1;RNF19A;ABCB11;CUL1;VPS11;BIRC2;PSMD6;RCHY1;KLHL41;CUL9;CUL4A;FBXO31;RNF111;NEDD4;PSMD3;RNF7;UBA6;PSMD5;RNF20;PSMC2;RNFT1;PSME4;FBXW2;TRIM7;SPSB1;SYVN1;UBE2J1;FBXO30;BIRC6;NUB1;RNF19B;PSMB8;RACK1;PSMA6;RNF34;ANAPC7;PSMB7;PSMD4;KLHL25;UVSSA;DTX2;CUL3;PELI2;FBXL3;PSMA3;FBXL8;NPEPPS;CDC34;RNF25;CBLL1;TSPAN17;PDZRN3;FBXO11;ZNRF2;PRKDC;PEX2;PSMD10;ANAPC11;SDE2;RNF213;PSMC6;TNFAIP1;PSME3;RNF13;PSMC5;RNF182;LRSAM1;PSMA4;TRIM71;RC3H1;BTRC;CDC16;UBOX5;SKP2;TRIM3;ARIH2;PSMB6;RNF43;TRIM35;TRIM37;CBFB;UBE2K;TOPORS
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3565365772982097,1.1437212022322367,0.022,0.6321713882732948,1.0,262/1082,21.18%,IGF1;LITAF;MDFIC;MITF;CXXC1;SPP1;CTNNB1;ZMIZ1;ERCC6;HIF1A;ATF3;MRTFA;NIBAN2;NFE2L2;APOE;NFYA;KMT2A;NFIC;SLC9A1;TOX2;MMP12;FGF2;MAFF;DOT1L;TNIP1;MEF2D;CDCA4;ELF4;CDK8;POU3F1;GDF6;POMC;SOX30;FSTL3;VDR;TFEB;PPARD;RUNX1;AGO2;ZMIZ2;FOXJ1;VEGFA;DAB2;SQSTM1;ELF2;SOX9;KDM3A;E2F3;IRF8;PPARG;MRTFB;UBTF;NFIL3;RAI1;CRTC1;RHOQ;CEBPA;HDAC4;SMAD7;CCNC;PCBD2;HMGN1;KLF6;RNF6;SMARCB1;DDX39B;BAMBI;JAG1;ID2;BPTF;MYDGF;CSRNP1;ARHGEF11;TRIM28;TET3;BRD4;UBA52;NKX2-1;SS18L2;MED21;PRDM15;MAP3K12;SKI;MEF2B;SLC11A1;LRP6;CREB3L2;EGR2;DHX33;TAF15;THOC1;MTF2;TRIAP1;BRCA1;DNM2;FZD4;JUN;FZD1;DDX17;IRF5;PIK3R2;ATF5;TMF1;ECD;PPP3R1;MED17;DDIT3;GTF2F1;ELOF1;NFKB1;NRF1;NAMPT;SERTAD3;ZFP64;RNF14;TAF7;RNASEL;WDR43;SRF;NR3C1;LILRB1;SP7;RHOG;CCNT2;ELK3;MYBL2;ZNF296;ZKSCAN3;NCK1;ASXL2;CEBPG;MAML2;NPAS4;LYAR;GABPB1;GABPB2;ELK4;JUP;SERPINF2;INO80;OGT;PRMT2;RASL11A;IL6;PID1;DHX9;TNIP2;FOXJ3;MAP2K3;MAPK7;SSBP4;ILK;MTF1;ETV4;NPAT;FBXW11;FGF7;NAA16;SMARCD2;SP1;MYSM1;ZBED3;HAX1;CHEK2;HCFC1;TNF;SERTAD1;RRP1B;RPS27A;UBC;NFATC3;LAGE3;DNAJC2;MEIS3;EIF5A;ZEB2;SBNO2;YY1;TBK1;ARHGEF2;AKIRIN1;FLCN;HDAC1;PPARGC1B;SNW1;LMO2;TNIP3;USF2;NOTCH4;BMP5;ZBTB17;DPF3;BCL11B;TASP1;KAT7;GTF2H1;KLF10;PIN1;PCBP1;WWOX;MAFB;YAF2;NDP;LPIN3;UBP1;SERPINE1;SFRP1;MMS19;CNBP;MAPK3;NAA15;ARID1B;MED1;GRHL1;MAP2K2;SS18L1;RUVBL2;JUNB;PPP1R12A;TGFBR1;RXRB;REL;PRPF6;HSF1;ZXDC;DYRK1B;HDAC3;MED6;EPO;USP21;USP16;LDB2;LDB1;CDH1;HNRNPU;ZC3H12A;BRD8;BLM;ITGB1BP1;BARX2;XBP1;FGFR2;POU2F1;GLYR1;SATB2;ACTR3;TGFB1I1;RNF111;TGFB1;CRTC3;BEX1;SIRT2;ASF1A;KMT2B;GDNF;ATF1;RNF20;SMAD1;PDGFB;NCK2;PAXBP1;METTL23
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.40839362030155424,1.1436520536312513,0.2897727272727273,0.6319201395969339,1.0,17/46,25.73%,MGARP;TIMM44;TOMM5;TOMM22;PITRM1;TOMM40;TIMM23;HSPD1;TIMM21;FBXO7;HK1;DNAJC15;PAM16;FIS1;TIMM9;GRPEL2;TIMM17A
prerank,metal ion transport (GO:0030001),0.38440729934467543,1.143510130607602,0.2489406779661017,0.6318746582723264,1.0,16/86,13.32%,CACNA1A;TRPC4;CHRNB2;CYP27B1;CACNA1D;SLC3A2;PANX1;PSEN2;TRPM7;SLC11A1;MAGT1;CAV1;CACNB3;SLC8A1;KCNN4;FYN
prerank,regulation of immune effector process (GO:0002697),0.4162407674095589,1.143322233157964,0.27107061503416857,0.6319685062184099,1.0,7/41,11.75%,C4BPA;C4BPB;PROS1;C3AR1;C8G;C5AR1;C1QBP
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4754645857456492,1.1431183723689877,0.28280254777070063,0.632112961324861,1.0,12/19,32.05%,IRAK2;RUNX1;TLE5;DHX9;MAPK7;IRAK1;SH2B3;PARP9;CBFB;TAF9;MAVS;MAP2K5
prerank,cell projection organization (GO:0030030),0.4409919138608091,1.1431061906782007,0.29239766081871343,0.6316929630296008,1.0,8/30,10.24%,PLEK;PDGFA;CAPG;RHOQ;NCKAP1L;CYFIP1;PARVB;RHOG
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5169679865444563,1.1427400002683614,0.31241473396998637,0.6323223696614316,1.0,4/12,21.44%,LPL;TNF;MBP;TIRAP
prerank,defense response to symbiont (GO:0140546),0.37457158018556835,1.1424808172429777,0.25391849529780564,0.6326434880927251,1.0,20/92,19.09%,LYST;BCL2;BCL2L1;ATG7;SHFL;PTPRC;FLNA;AGBL5;ACOD1;RNASEL;LILRB1;RIPK3;MLKL;IL6;BST2;EXOSC5;TTC4;TLR7;G3BP1;RSAD2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.42625317276223823,1.1423115740583958,0.29674306393244876,0.6326519035892268,1.0,11/32,21.00%,FOXN3;FZR1;TAOK3;BRCA1;ABRAXAS1;UIMC1;BABAM2;TAOK1;BLM;BRCC3;TOPBP1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3610229016896033,1.1422952192039522,0.14014014014014015,0.6322543697202552,1.0,125/314,30.38%,CTNNB1;NFE2L2;PSMD1;ANAPC15;KCTD17;ZFAND2A;DERL3;FBXL17;NHLRC1;PSMD8;PPP2R5C;FBXW4;FBXW7;SIAH2;PSMA1;SPSB2;STT3B;DNAJB14;FZR1;EDEM1;PSMA8;CCNB1;ATXN3;ANAPC1;AGAP3;UBA52;ZSWIM8;VCP;FBXL19;RNF121;RMND5B;DDIT3;UBXN4;PLAA;WWP2;DDB1;PSMD14;MDM2;PSMA5;DNAJC10;UBR2;BFAR;CUL2;UBE4A;PSMD12;FBXW11;FBXL6;HUWE1;SPSB3;KCTD10;PSMB10;RPS27A;UBC;RNF185;FBXW5;UBE4B;SHARPIN;TRIM72;NHLRC3;PSMD2;CDC26;DNAJB12;PSMC4;WFS1;UBE2C;DERL1;CUL1;BIRC2;PSMD6;CUL4A;FBXO5;FBXO31;NEDD4;PSMD3;SIRT2;PSMD5;PSMC2;HERPUD1;PSME4;SPSB1;SYVN1;UBE2J1;CDK2;PSMB8;HSP90B1;UBQLN1;PSMA6;RNF34;ANAPC7;PSMB7;PSMD4;YOD1;ERLIN2;KCTD2;USP19;UBQLN2;CUL3;FBXL3;PSMA3;FBXL8;CDC34;FAF1;PCBP2;FEM1B;ERLIN1;PSMD10;RAD23A;APPBP2;ANAPC11;PSMC6;TNFAIP1;PSME3;RNF216;PSMC5;PSMA4;TRIM71;BTRC;CDC16;SKP2;TRIM3;PSMB6;UBE2K;TOPORS;AUP1;KLHL22
prerank,fluid transport (GO:0042044),0.5167833162177535,1.1420413464793766,0.3238231098430813,0.6324954659893061,1.0,1/12,5.18%,PDPN
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.46424154068154155,1.1420112461608256,0.2991128010139417,0.6321447577016804,1.0,2/20,0.56%,ZMIZ1;HIF1A
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3576658562746638,1.141853596215214,0.072,0.6321635878403578,1.0,140/497,23.34%,MDFIC;CTNNB1;NIBAN2;ZHX2;EPRS1;ARID5B;CDK5;PRICKLE1;FOXN3;VDR;PPARD;ING4;SOX9;KMT5A;ERN2;RCOR1;BASP1;BHLHE41;PPARG;NFIL3;PATL2;CEBPA;HDAC4;BHLHE40;GMNN;CIC;LARP1;NCL;ID2;LSM14A;CNOT10;TRIM28;BAP1;NKX2-1;HDAC9;RIOX1;GTPBP4;ENC1;BCL6;GAS6;SUDS3;BRCA1;THAP7;JUN;ATF5;CBX3;DDIT3;RCOR3;FXR2;DAPK1;TAF7;NR3C1;EED;EHMT1;TLE5;ELK3;WWP2;PRMT6;RBM15B;ENO1;ZKSCAN3;EIF4ENIF1;LIMS1;MDM2;ZNF148;ATXN1;SCML4;CREBZF;PRMT2;PEX14;WAPL;CBFA2T2;USP47;RPL13A;FBXW11;ZGPAT;MYBBP1A;L3MBTL2;MIDEAS;TNF;UIMC1;S100A11;SBNO2;RIDA;CPEB3;HDAC1;SNW1;PAIP2;ZBTB4;PCGF6;YEATS2;EIF4E2;CNOT9;DPF3;CAPRIN1;KAT7;KLF10;YAF2;QARS1;GCFC2;PIAS4;SFRP1;RBFOX2;BAHD1;LOXL3;TERF1;HDAC3;ZNF568;ID1;LDB1;PCIF1;DAP;MPHOSPH8;ARID4A;POU2F1;TGFB1;SIRT2;PDGFB;DMAP1;CDAN1;SUMO1;MTA3;GATAD2A;NOTCH1;GZF1;ZBTB16;TMPRSS6;CALR;PHC2;XRCC5;SMARCA4;MTERF3;PHF10;HIC2;KDM1A;RACK1;SET;DAXX;FOXO1;GIGYF2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3704324987879464,1.141850470138359,0.21356275303643724,0.6317379659960245,1.0,46/161,23.79%,DKK2;APOE;PSMD1;PRICKLE1;TBX18;PSMD8;DAB2;SOX9;SIAH2;PSMA1;STK3;LRP4;PSMA8;LRP6;LZTS2;FZD4;CAV1;DDIT3;SCYL2;TLE5;BICC1;PSMD14;PSMA5;ZNRF3;TPBG;PSMD12;PSMB10;HDAC1;LATS1;PSMD2;SFRP1;PSMC4;RUVBL2;DACT1;PSMD6;STK11;PSMD3;FRZB;PSMD5;PSMC2;PSME4;PSMB8;PSMA6;PSMB7;GSK3B;PSMD4
prerank,mRNA processing (GO:0006397),0.3607929077620309,1.141503836179602,0.152,0.632288985374045,1.0,90/287,23.09%,SNRNP35;HNRNPA3;SNIP1;SON;HNRNPUL1;POLR2H;HNRNPM;SF3B3;DDX39B;ZRSR2;ERN1;PNN;DNAJC8;SMNDC1;CELF1;HNRNPC;SRSF11;CCAR1;PAPOLA;PABPN1;THOC1;CD2BP2;SART1;PUF60;PPIE;GTF2F1;SYMPK;HNRNPK;RBM15B;THOC2;ZMAT5;KIN;NOVA2;RBM4B;RBM19;CHTOP;GEMIN5;DHX9;HNRNPL;SRSF2;CTNNBL1;HNRNPA2B1;RPRD1A;CPSF7;PRCC;UPF3B;TRA2B;SNU13;MNAT1;ZMAT2;IK;POLR2D;ZCCHC8;SMU1;SNW1;SRSF7;PABPC1;SNRPB2;GTF2H1;PCBP1;CHERP;LSM6;PRPF40A;SF3B5;THOC6;GCFC2;SRRM1;RBM22;ERCC2;SNRPF;RNMT;PRPF6;SART3;GEMIN2;FUS;HNRNPU;SNRNP40;DDX42;RALY;SRSF1;WBP11;WDR83;SRSF10;SNRPD3;SNRPD2;SNRPD1;LSM8;WDR33;CCNH;METTL3
prerank,regulation of protein neddylation (GO:2000434),0.5470449420440402,1.1414278955871404,0.31024531024531027,0.6320566400229124,1.0,3/10,17.35%,HIF1A;DCUN1D4;DCUN1D2
prerank,histone H3 deacetylation (GO:0070932),0.501527752237118,1.1410968099928664,0.3042291950886767,0.632549888757214,1.0,6/15,20.75%,HDAC4;HDAC9;ELK4;HDAC1;HDAC3;SIRT2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5436921203199564,1.1404218275614133,0.31563421828908556,0.6335766873309754,1.0,1/10,0.75%,MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5436921203199564,1.1404218275614133,0.31563421828908556,0.6335766873309754,1.0,1/10,0.75%,MYLIP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.532008429238383,1.1402395422557459,0.3021276595744681,0.633628866189855,1.0,4/11,20.51%,RIPK3;ARHGEF2;BIRC2;YBX3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.381761548465554,1.1400656728386096,0.23333333333333334,0.6336465657963072,1.0,29/104,21.65%,FSTL3;SNX25;PDPK1;VEPH1;PPARG;WFIKKN1;ADAM17;SMAD7;BAMBI;UBA52;NKX2-1;SKI;SPRED2;CAV1;PMEPA1;TGFBR2;DAND5;RPS27A;UBC;SPRED3;PIN1;LDLRAD4;TGFBR1;FST;TGFB1I1;TGFB1;SMAD1;LEMD2;NOTCH1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4247689465047009,1.139903554203775,0.2825322391559203,0.6336477656055938,1.0,4/36,5.17%,HIF1A;NRP1;FBXW7;ADAM17
prerank,regulation of mRNA processing (GO:0050684),0.4321683940001733,1.1397907528274691,0.2984165651644336,0.6335215470600852,1.0,10/32,12.69%,SON;SAFB2;RBM39;PAPOLA;PABPN1;SRPK1;HNRNPK;SRPK2;CDK11B;DHX9
prerank,synaptic vesicle transport (GO:0048489),0.535815919970339,1.1396160759507314,0.3319327731092437,0.6335450067267118,1.0,6/11,27.74%,CDK5;DNM2;TMEM230;SYNJ1;KIF5B;SPG11
prerank,sodium-independent organic anion transport (GO:0043252),-0.4626942509716284,-1.139301350751336,0.2786885245901639,0.6418913824389514,1.0,6/10,15.60%,SLCO2B1;SLCO1B1;SLCO3A1;SLCO4C1;SLCO4A1;SLCO1C1
prerank,ERBB signaling pathway (GO:0038127),0.3967057248456224,1.1386867493758648,0.26167209554831705,0.6357050812308953,1.0,20/64,23.37%,IQGAP1;PTK2B;GRB2;PDPK1;SOX9;ADAM17;ERBIN;DGKD;MVP;AAMP;CPNE3;PTPN18;CBL;KIF16B;PIK3C2A;PIK3CA;TGFB1;NCK2;PTPN12;PTPN11
prerank,positive regulation of biosynthetic process (GO:0009891),0.41608042651016075,1.1374503175275508,0.2923433874709977,0.638772967165342,1.0,7/40,11.97%,APOE;RUNX1;CYBA;VIM;SUCO;SLC5A3;SERPINF2
prerank,positive regulation of intracellular transport (GO:0032388),0.4239472578218861,1.137395434677098,0.2939787485242031,0.6384993684365357,1.0,20/38,29.97%,DYNC1H1;RUFY3;PGAP1;NUMA1;VAMP2;PLK3;TPR;TBC1D20;STK11;NEDD4;ACTN2;STX18;MLC1;B3GAT3;EHD1;ICE1;CAPN10;PRR5L;ZFAND1;PCM1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4359597585336784,1.1372346876946295,0.2841463414634146,0.6385214777108963,1.0,13/29,26.04%,TRIM6;PTPN2;TTLL12;RNASEL;YTHDF2;PTPN1;PTPN6;IFNAR2;METTL3;PTPN11;HSP90AB1;NLRC5;USP18
prerank,cellular response to cytokine stimulus (GO:0071345),0.3571834595705792,1.1365953475302395,0.119,0.6398416933198298,1.0,119/416,23.98%,BCL2;HIF1A;FN1;SIRPA;BCL2L1;ITGAX;CSF1;NFE2L2;ABL2;IRAK2;EPRS1;TEC;FGF2;PIK3CB;CCL4;MUC1;CSF2RA;GRB2;TANK;TRIM6;RUFY4;POMC;GAB2;PDE1B;MCL1;VEGFA;AXL;PTPN23;IL12RB1;SOX9;INPPL1;IRF8;VIM;IRGC;HMOX1;CEBPA;PTPN2;SMPD4;TNFRSF1B;ERBIN;UBA52;CCL13;BCL6;GAS6;IL3RA;BRCA1;ASAH1;SYK;CRKL;IRF5;NFKB1;ACOD1;SOCS5;DAPK1;CCL14;IFNGR2;BCL2L11;CNTFR;RHOA;STX3;JAK1;AIM2;IL6;PID1;PTPN18;DHX9;PTGIS;FYN;CBL;RPL13A;TPR;SOCS2;IL2;HAX1;TNF;RPS27A;UBC;SBNO2;TBK1;ARHGEF2;VAV1;RHOU;CRK;IRGM;SFRP1;IRAK4;JUNB;TNFRSF21;ITGB2;IL5;PTPN6;TIMP1;HNRNPU;ZC3H12A;XBP1;POU2F1;CCND1;YBX3;PIK3CA;TGFB1;IFNAR2;CSF2RB;IRAK1;MT2A;PTPN12;HSP90B1;CCL3;FOXO1;PTPN11;STK39;CHUK;RO60;TCF7;IL1R1;SOCS6;IL7;GSK3B;OPRM1;IL34
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5028887959048187,1.1363394193505536,0.316711590296496,0.6401385408257955,1.0,5/14,16.18%,XDH;SPRED2;CAV1;SPRED3;NOTCH4
prerank,carbohydrate homeostasis (GO:0033500),0.3890954938117394,1.1361970743857874,0.2763440860215054,0.640093272873016,1.0,16/67,17.86%,ADCY8;GCKR;GCK;PPARG;CEBPA;PTPN2;APPL2;SLC8B1;CYB5R4;IGF1R;ADIPOR1;IL6;RPS6;RBP4;HECTD4;WFS1
prerank,T cell proliferation (GO:0042098),0.5136979196807693,1.1361394435399454,0.3168044077134986,0.6398026332157886,1.0,5/13,10.07%,MSN;CADM1;CRTAM;SLC11A1;LILRB1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3657223500690715,1.136116143102574,0.2198581560283688,0.6394363243883056,1.0,52/153,24.23%,PRKCH;SGK1;CDK5;PRKCD;SGK3;SGK2;PDPK1;IKBKE;DYRK2;PRKCB;CAB39;PLK2;NEK6;ERN1;TLK1;MAP3K12;GAS6;STK32A;PKN2;PAK2;TGFBR2;CSNK2A2;CSNK1D;SRPK2;MAPKAPK3;MAPKAPK2;RPS6KA2;STK38L;TBK1;CSNK1G1;STK38;LATS1;MAPK12;MAP2K2;TGFBR1;PIKFYVE;MARK2;MKNK1;DYRK1B;PDK3;SMG1;RICTOR;DGKQ;PDGFB;HIPK1;ROCK1;CSNK1E;CDK2;STK39;CHUK;GSK3B;TOP1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.35702661725712553,-1.1360020126577657,0.24285714285714285,0.6479375366560546,1.0,6/22,14.37%,PDE3B;APOD;CEACAM1;CCDC3;IL1B;ADRA2A
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3660641263706051,1.1356502055984161,0.22143579373104147,0.6403237113696905,1.0,21/151,11.97%,GPNMB;APOE;PDGFA;FGF2;PTPRC;CCL4;NRP1;MFHAS1;PTK2B;ALKAL2;FBXW7;GCNT2;CD44;MAP3K12;CCL13;GAS6;CRKL;TREM2;CCL14;C5AR1;SERPINF2
prerank,negative regulation of protein catabolic process (GO:0042177),0.4139275162817976,1.13557334322066,0.2837528604118993,0.640116574139603,1.0,13/40,21.64%,NELL1;CTSA;FLNA;RIC1;SF3B3;AZIN1;RGP1;TIMP2;PIN1;RILP;TIMP1;SIRT2;ROCK1
prerank,protein modification by small protein conjugation (GO:0032446),0.35641328056527005,1.1355267555389867,0.125,0.6398111062574862,1.0,121/361,27.14%,HIF1A;ATG7;MYLIP;NFE2L2;CNOT4;NUP205;NSMCE2;TRIM6;TRIM43;FBXL17;OTULIN;FBXO32;FBXW7;NFX1;SPSB2;VPS18;RNF6;USP5;TRIM28;KLHL7;UBA52;ZSWIM8;VCP;KLHL13;ENC1;NUP188;EGR2;USP9X;DTX3;BRCA1;DTX4;KLHL24;RAE1;RNF14;UBE2R2;RNF41;BRAP;WWP2;DDB1;ATG10;MDM2;UBR2;ARRDC4;CUL2;PEX14;DCUN1D4;ZNRF3;NUP42;ELOB;CBL;FBXW11;TPR;CAND1;SHPRH;HUWE1;SAE1;KCTD10;UBE2L3;RPS27A;UBC;CCDC22;KLHL18;UBE2F;MKRN2;FBXW5;UBE2V2;UFL1;FBXO7;TRIM72;GAN;DCUN1D2;PIAS4;UBE2H;NUP54;UBE2C;DERL1;ABCB11;CUL1;VPS11;MOCS3;RCHY1;KLHL41;CUL9;CUL4A;RNF111;NEDD4;RNF7;UBA6;RNF20;SUMO1;TRIM7;SPSB1;SUMO2;SYVN1;RANBP2;UFM1;NUP133;NUP93;BIRC6;NUB1;RACK1;RNF34;ANAPC7;NUP98;PIAS1;KLHL25;UVSSA;DTX2;CUL3;FBXL3;DCUN1D3;CDC34;RNF25;CBLL1;TSPAN17;PDZRN3;FBXO11;NUP35;UBA2;PRKDC;PEX2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.37749440155949604,1.13518271223203,0.2699579831932773,0.6402993930852773,1.0,12/93,6.73%,SDCBP;SASH1;XDH;MFHAS1;PTK2B;TRAF2;GDF6;SPHK1;VEGFA;TRAF3;RELL1;TAOK3
prerank,entry into host (GO:0044409),0.5164742944718893,1.1347937115180502,0.3259668508287293,0.6409450045239232,1.0,2/13,2.03%,CTNNB1;GRB2
prerank,sodium ion import across plasma membrane (GO:0098719),0.4759095048100723,1.1347769802291936,0.2923076923076923,0.6405518046176198,1.0,4/17,12.09%,SLC9A1;SLC9A7;SLC9A6;SLC8A1
prerank,mammary gland development (GO:0030879),0.47035722807106445,1.1345500789016414,0.3204488778054863,0.6407393059776773,1.0,5/21,16.18%,CSN3;VEGFA;CAV1;ZBTB7B;NOTCH4
prerank,regulation of G0 to G1 transition (GO:0070316),0.4219671467744892,1.1344887684362106,0.2834101382488479,0.6404719280107486,1.0,15/38,26.14%,UXT;RNF2;BRCA1;CBX3;EED;EHMT1;MGA;L3MBTL2;PCGF6;YAF2;BMI1;RAD51;PCGF2;APAF1;CDC7
prerank,monocyte differentiation (GO:0030224),0.5338856562830816,1.1344633770102106,0.30703012912482064,0.6401144757737598,1.0,4/10,12.08%,PDE1B;VEGFA;PPARG;PIR
prerank,T cell differentiation (GO:0030217),0.41165090213309097,1.1339966458173358,0.2988235294117647,0.6409331200281146,1.0,10/40,16.35%,PTPRC;ADAM17;PTPN2;DLL4;CHD7;GPR89A;GPR89B;RIPK3;IL2;RABL3
prerank,regulation of ERAD pathway (GO:1904292),0.5285501995226977,1.133825326198148,0.3328785811732606,0.6409829665803166,1.0,6/11,24.39%,ATXN3;RNF185;USP13;HERPUD1;RNFT1;USP19
prerank,Ras protein signal transduction (GO:0007265),0.37186433183181,1.1337608597077244,0.22842639593908629,0.6407182657503581,1.0,35/137,16.57%,IGF1;MYO9B;RAP2A;LAT;FGF2;RASGRP3;GRB2;GNA13;PLK2;PDPN;GDI1;CYFIP1;ARHGEF11;TRIM28;LIMK1;RHOD;JUN;CRKL;CELSR1;ARHGEF1;NRAS;KRAS;RHOG;BRAP;RAPGEF6;RHOA;ARHGAP6;NTN1;GNA12;GNB1;NF1;DNMT1;RGL2;RIT1;RAP2B
prerank,negative regulation of potassium ion transport (GO:0043267),0.5075977024196581,1.133569931484927,0.31215469613259667,0.6408344259783162,1.0,4/13,10.61%,PTK2B;CAB39;CAV1;VIP
prerank,positive regulation of reproductive process (GO:2000243),0.4284927216903757,1.133529893961773,0.29820359281437125,0.6405131493060217,1.0,6/31,12.31%,LHFPL2;AGO2;VEGFA;VIP;C1QBP;PRDM9
prerank,cellular response to interleukin-2 (GO:0071352),0.5279272996450775,1.1334175452977682,0.3328631875881523,0.6399281595495286,1.0,4/11,13.83%,PTK2B;SYK;JAK1;IL2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5279272996450775,1.1334175452977682,0.3328631875881523,0.6399281595495286,1.0,4/11,13.83%,PTK2B;SYK;JAK1;IL2
prerank,mitochondrial translational elongation (GO:0070125),0.3789105795818481,1.1327998291463799,0.2890295358649789,0.6411576503726916,1.0,41/88,32.19%,MRPL47;MRPL23;DAP3;MRPL4;MRPS15;MRPL52;MRPS16;MRPS28;MRPS35;CHCHD1;MRPL53;GFM2;MRPS33;MRPL24;MRPL37;MRPS30;MRPL17;MRPL18;MRPL11;MRPL1;MRPS12;MRPS7;MRPS22;MRPL42;MRPS9;TSFM;MRPL39;MRPS10;MRPS31;MRPS34;MRPS27;MRPL21;MRPS17;MRPS26;MRPL43;MRPL51;MRPL41;MRPL27;MRPS18B;MRPL38;MRPL57
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4479121939436599,1.1326520427991695,0.3193916349809886,0.641157249021921,1.0,5/23,10.23%,HSPA4;SAMM50;BAX;TOMM22;BCL2L11
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4432298684057408,1.1325403548974313,0.29963459196102316,0.6410101784161801,1.0,7/26,14.97%,IRAK2;UBA52;TAB1;AAMP;TNFAIP3;RPS27A;UBC
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.37387439794778027,1.1325131278215594,0.2523364485981308,0.6406634378737274,1.0,41/100,28.32%,SDCBP;PRICKLE1;DAB2;RNF180;CEBPA;SMAD7;USP5;VCP;SOCS5;RNF14;CSNK1D;MDM2;OGT;ELOB;GNA12;TRIB2;GIPC1;UFL1;HECTD1;RNF19A;RCHY1;SIRT2;SUMO1;HERPUD1;XPO1;CSNK1E;SUMO2;NUB1;RNF19B;RACK1;HSP90AB1;GABARAP;GSK3B;PIAS1;BBS7;PSMD10;DESI1;RAD23A;BAG5;BAG2;HSPBP1
prerank,regulation of cell death (GO:0010941),0.3772831212701605,1.1323359705508629,0.2623294858342078,0.6407292486070778,1.0,22/94,19.69%,LRP1;CTSZ;FGF2;EIF4G1;CHMP4B;LRPAP1;TNFRSF1B;CELF1;SARM1;RILPL1;VPS4B;NCK1;CCN6;BECN1;VPS35;HTR2B;TBK1;PACRG;TXNDC12;NOA1;ZC3H12A;CCN4
prerank,hemopoiesis (GO:0030097),0.3810849750515191,1.1320852631501905,0.2682154171066526,0.6409882661417542,1.0,27/87,21.82%,FLT1;KMT2A;PLEK;PTPRC;FSTL3;RUNX1;CEBPA;ZNF160;JAG1;ETV6;YTHDF2;TGFBR2;KITLG;CDK13;FUT10;FLCN;NOTCH4;SFRP1;FST;FGFR2;PRRC2C;TGFB1;PDGFB;TIRAP;HIPK1;BMI1;ZBTB16
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5089831812388848,1.1317188479357827,0.3236111111111111,0.6415849730200716,1.0,3/13,9.69%,DCTPP1;NEIL2;MBD4
prerank,central nervous system myelination (GO:0022010),0.5186275385433944,1.13164044142277,0.3323943661971831,0.6413506847753287,1.0,1/11,0.23%,B4GALT5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4163350354509463,1.131508544364522,0.29404761904761906,0.6412760685620269,1.0,9/36,17.93%,CTNNB1;AGO2;PLCB2;FZD4;PPP3R1;AGO3;GNB1;AGO4;PDE6G
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.4452904919283847,1.1312558384315516,0.326302729528536,0.6415458932645137,1.0,4/25,5.56%,TRAF2;TRIM6;MALT1;SPHK2
prerank,amino acid import across plasma membrane (GO:0089718),0.4485247961595905,1.1310935897038192,0.30749682337992373,0.6415612866454272,1.0,8/24,21.80%,SLC6A6;SLC3A2;SLC7A1;SLC7A8;SLC1A5;SLC7A3;SLC16A2;SLC7A2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.504385235466277,1.1308513264198703,0.33694181326116374,0.6417859150339542,1.0,4/15,9.89%,ARPC3;ARPC2;ARPC5;ARPC1B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4240849320328346,1.1306406963144282,0.3124274099883856,0.6419544772990129,1.0,9/35,15.91%,ARHGAP24;ABL2;MYOC;SYNGAP1;SPRY4;ITGA3;MAPKAP1;KCTD10;FLCN
prerank,positive regulation of axonogenesis (GO:0050772),0.41383512953245116,1.130621215420336,0.2896551724137931,0.6415759964778301,1.0,9/43,12.33%,PLXNC1;MACF1;GOLGA4;PLXNA2;RUFY3;LIMK1;PLXND1;RHOA;NTN1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.5321313434524035,1.130602340963298,0.33666191155492153,0.6411980240257827,1.0,1/11,0.06%,IGF1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4007735842468943,1.1300145232173298,0.28846153846153844,0.6423614160286751,1.0,8/45,14.62%,LPL;HSPB1;MALT1;PANX1;TMEM106A;AIM2;IL6;TNF
prerank,negative regulation of receptor binding (GO:1900121),0.5258166541108322,1.129752512423636,0.3407079646017699,0.6426584435753917,1.0,2/10,12.30%,ADAM15;ATP2A2
prerank,intraciliary retrograde transport (GO:0035721),0.5213609148349392,1.129685089551247,0.33102493074792244,0.6423993017231174,1.0,6/12,23.11%,IFT43;WDR35;IFT122;DYNLT2B;DYNC2I1;WDR19
prerank,establishment of epithelial cell polarity (GO:0090162),0.4717415059838084,1.1295930754947476,0.3290978398983482,0.6422168743740797,1.0,7/19,16.74%,CYTH1;RAP2A;MSN;RHOA;MYO9A;GOLPH3;SYNE4
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3856265193695249,1.1293490077496577,0.271259418729817,0.6424856508663145,1.0,40/80,32.99%,ARF3;NAPA;PLPP3;ATP9B;COG4;HTT;SCYL1;SEC22B;TAPBP;KLC1;RAB1A;GOLPH3;ARFGAP3;COPA;TMED3;COPG2;GOLPH3L;DNAJC28;COPB1;STX18;COPG1;KDELR1;KDELR2;KIF3A;ARFGAP1;ARF5;ERGIC1;COPZ2;ARF4;SURF4;RAB6A;RER1;COG3;KLC2;ARCN1;TMED2;ATP9A;ARFGAP2;LMAN2;PICK1
prerank,programmed necrotic cell death (GO:0097300),0.4727889325328662,1.1293162661359235,0.32603092783505155,0.6421578126142011,1.0,5/18,12.27%,ALKBH7;TRPM7;TICAM1;RIPK3;MLKL
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35957569584067917,1.1292392771850939,0.20160481444332998,0.6419419625489226,1.0,64/248,21.05%,DKK2;CDK14;CTNNB1;APOE;PSMD1;CCNY;GNAQ;PRICKLE1;OTULIN;PSMD8;DAB2;SOX9;TNKS2;SIAH2;PSMA1;STK3;LRP4;BAMBI;PSMA8;WLS;PRDM15;VCP;LRP6;LZTS2;FZD4;FRAT1;CAV1;JRK;DDIT3;NFKB1;SCYL2;TLE5;BICC1;PSMD14;CSNK1D;PSMA5;GPRC5B;JUP;ZNRF3;TPBG;USP47;PSMD12;ILK;ZBED3;PSMB10;ZEB2;CSNK1G1;HDAC1;PIN1;LATS1;PSMD2;SFRP1;PSMC4;RUVBL2;DACT1;USP8;PSMD6;STK11;FGFR2;PSMD3;TGFB1;FRZB;PSMD5;PSMC2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.438660532852255,1.129131274741222,0.30354957160342716,0.641799102198378,1.0,19/29,34.45%,RAD50;ANKRD28;ACD;GAR1;DKC1;RFC1;TERT;PPP6C;TERF1;CDK2;PTGES3;HSP90AB1;TERF2IP;TERF2;SHQ1;MRE11;TELO2;TINF2;PINX1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.45016563689923644,1.1291092498937472,0.316747572815534,0.6410084888326856,1.0,5/23,15.09%,BCL2;PPP3R1;YWHAG;BID;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.45016563689923644,1.1291092498937472,0.316747572815534,0.6410084888326856,1.0,5/23,15.09%,BCL2;PPP3R1;YWHAG;BID;PPP3CC
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5314613925800137,1.1285532659129172,0.3347517730496454,0.642116571631116,1.0,3/11,10.17%,RUNX1;ETV6;YTHDF2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.35461143802070394,-1.1282771842003398,0.2552083333333333,0.6653015759336944,1.0,9/25,17.35%,CCR2;STAT5A;STAT4;STAT3;CLCF1;CCL2;STAT1;IL31RA;GHR
prerank,cellular response to leucine (GO:0071233),0.5336113830088497,1.128017477188978,0.34,0.6427342056973704,1.0,4/10,15.49%,RRAGD;UBR2;LARS1;SESN2
prerank,response to leucine (GO:0043201),0.5336113830088497,1.128017477188978,0.34,0.6427342056973704,1.0,4/10,15.49%,RRAGD;UBR2;LARS1;SESN2
prerank,MAPK cascade (GO:0000165),0.3589067966501424,1.1279069369127854,0.16332665330661322,0.6426238011331776,1.0,86/295,21.67%,IGF1;FGF13;BCL2L1;PTPRA;PDGFA;PSMD1;LAT;FGF2;PIK3CB;RASGRP3;CSF2RA;GRB2;DUSP9;PSMD8;SOX9;PSMA1;PSMA8;TAOK3;UBA52;ABHD17C;FGF20;PABPN1;IL3RA;PIK3R2;NFKB1;NRAS;KRAS;RASA1;SYNGAP1;BRAP;MAP3K8;PSMD14;KITLG;RANBP9;PSMA5;ABHD17B;JAK1;RAF1;PTGER4;TNIP2;MAPKAPK2;PSMD12;FYN;FBXW11;FGF7;IL2;TNF;NF1;MINK1;PSMB10;RPS27A;UBC;DLG4;FGF18;HTR2B;MBP;RGL2;PSMD2;MAP3K20;MAPK12;PSMC4;MAPK3;MAP2K2;RASA2;HSF1;IL5;LAMTOR3;CUL1;TAOK1;PSMD6;FGFR2;RASAL2;PIK3CA;PSMD3;TGFB1;PSMD5;ACTN2;GDNF;PDGFB;PSMC2;WDR83;SHOC2;CSF2RB;DUSP6;PSME4;RASA3
prerank,negative regulation of coagulation (GO:0050819),0.4889054729541138,1.1277663154003634,0.3360655737704918,0.6425886630353382,1.0,5/14,17.51%,APOE;SERPINE2;TFPI;APOH;SERPINE1
prerank,fatty acid oxidation (GO:0019395),0.39150714674648235,1.1276206915320552,0.300768386388584,0.6425494393534685,1.0,19/57,28.67%,ACAD11;PPARD;ABCD4;ABCD2;ALDH3A2;ACADL;ADIPOR1;ACAD10;ECI2;SCP2;ACAA2;DECR1;PHYH;MCAT;CPT2;ACADM;PEX2;ECI1;ACADS
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.49342048009866346,1.127489471401921,0.32217573221757323,0.6424627781055341,1.0,4/14,10.41%,AK8;AK4;AK3;AK5
prerank,prostanoid metabolic process (GO:0006692),-0.40731902943607945,-1.1270526913201993,0.2949640287769784,0.6657226205836901,1.0,2/13,0.66%,HPGD;PTGS1
prerank,serine family amino acid metabolic process (GO:0009069),0.48891698066050215,1.12694078783831,0.3311772315653299,0.6435723146386034,1.0,11/16,35.87%,GLYAT;CDO1;SARS1;MTHFD1;CBS;CTH;SHMT1;SEPSECS;SHMT2;THNSL2;PSPH
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.469139218082784,1.1268200455656043,0.35046113306982873,0.6435002115744464,1.0,8/18,20.71%,ACSBG2;HACD2;ACSL1;HSD17B12;ACSBG1;HACD1;ELOVL2;TECR
prerank,cell cycle checkpoint signaling (GO:0000075),0.5124246866677347,1.1265035351798642,0.31215469613259667,0.6439838961276328,1.0,3/12,14.43%,PLK2;WEE1;PRCC
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3696772017964356,1.1264675811006482,0.2769070010449321,0.6436514580046042,1.0,34/108,27.02%,CTSD;XDH;TRAF2;TNFSF15;MTCH1;MALT1;DIABLO;GRAMD4;PPARG;BAX;VCP;SYK;HIP1R;DAPK1;CRADD;CASP9;BID;HSPD1;TNF;HIP1;HSPE1;DAP;EGLN3;FIS1;GSN;RACK1;CASP8AP2;ARL6IP5;SENP1;CYCS;APAF1;PDCD6;CASP4;BBC3
prerank,regulation of telomere maintenance (GO:0032204),0.4403683411931566,1.1264543247058345,0.31719745222929935,0.6432618377200833,1.0,17/26,35.76%,ERCC1;RAD50;GNL3;ERCC4;PPP1R10;SMG1;XRCC5;TERF2IP;DHX36;TERF2;HDAC8;MRE11;HNRNPD;TINF2;USP7;UPF1;MYC
prerank,positive regulation of inflammatory response (GO:0050729),0.3751381639364999,1.1262417327810517,0.2802950474183351,0.6433813921405063,1.0,23/86,24.49%,LPL;ADAM8;TNIP1;CEBPA;NFKBIZ;NINJ1;NAPEPLD;GPRC5B;PTGER4;IL6;SNX4;DHX9;IL2;TNF;SERPINE1;TLR7;CCN4;IL17RA;IFI35;RPS19;CCL3;SETD4;GPSM3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5026339133360758,1.1259638024020244,0.32697547683923706,0.643687813076797,1.0,6/13,24.21%,SNX33;STX3;TNF;ABCA7;HSP90AB1;STX4
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41951314635922576,1.1259037409357333,0.31388564760793464,0.6434324415446078,1.0,14/37,22.59%,ERCC1;UBA52;DDB2;DDB1;ERCC4;XPA;RFC2;RPS27A;UBC;RFC1;GTF2H1;ERCC2;CUL4A;PARP1
prerank,membrane protein proteolysis (GO:0033619),0.4140791374217476,1.1253496477705507,0.30113636363636365,0.6445005865680558,1.0,17/37,27.37%,DAG1;NAPSA;ADAM17;PSEN2;MBTPS2;AFG3L2;NFKB1;PARL;CLPP;SPPL3;APH1A;TGFB1;TMPRSS6;HM13;PRKCQ;SPPL2A;MYH9
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35177669942547307,1.1250968026350823,0.057,0.6448022442958783,1.0,200/834,21.18%,IGF1;LITAF;MITF;CTNNB1;ZMIZ1;HIF1A;MICAL2;ATF3;MRTFA;NFE2L2;KMT2A;NFIC;SLC9A1;TOX2;MMP12;FGF2;MAFF;DOT1L;MUC1;TNIP1;MEF2D;ELF4;CDK8;POMC;SOX30;FSTL3;VDR;TFEB;PPARD;RUNX1;AGO2;ZMIZ2;FOXJ1;VEGFA;DAB2;SQSTM1;SOX9;E2F3;EAPP;IRF8;PPARG;MRTFB;CRTC1;RHOQ;CEBPA;HDAC4;SMAD7;CCNC;KLF6;SMARCB1;JAG1;BPTF;MYDGF;CSRNP1;TET3;BRD4;UBA52;NKX2-1;SS18L2;MED21;PRDM15;SKI;MEF2B;SLC11A1;LRP6;EGR2;MTF2;TRIAP1;BRCA1;JUN;DDX17;IRF5;PIK3R2;ATF5;TMF1;ECD;PPP3R1;MED17;DDIT3;GTF2F1;NFKB1;NRF1;NAMPT;ZFP64;TAF7;RNASEL;GNL3;SRF;NR3C1;LILRB1;SP7;CCNT2;ELK3;MYBL2;ZNF296;NCK1;ASXL2;CEBPG;MAML2;NPAS4;PLXND1;GABPB1;GABPB2;CDK13;ELK4;JUP;SERPINF2;INO80;OGT;IL6;PID1;DHX9;TNIP2;FOXJ3;MAPK7;SSBP4;MTF1;ETV4;NPAT;SMARCD2;SP1;MYSM1;ZBED3;HAX1;HCFC1;TNF;RRP1B;RPS27A;UBC;NFATC3;LAGE3;MEIS3;EIF5A;ZEB2;SBNO2;YY1;TBK1;TERT;ARHGEF2;AKIRIN1;FLCN;HDAC1;PPARGC1B;SNW1;LMO2;TNIP3;USF2;NOTCH4;BMP5;ZBTB17;DPF3;BCL11B;KAT7;KLF10;PIN1;PCBP1;WWOX;LPIN3;UBP1;SERPINE1;CNBP;MAPK3;MED1;GRHL1;SS18L1;RUVBL2;JUNB;PPP1R12A;RXRB;REL;PRPF6;HSF1;HDAC3;MED6;USP16;LDB2;LDB1;HNRNPU;ZC3H12A;BRD8;ITGB1BP1;BARX2;XBP1;FGFR2;POU2F1;GLYR1;SATB2;ACTR3;RNF111;TGFB1;CRTC3;BEX1;SIRT2;GDNF;ATF1;SMAD1;PDGFB;NCK2;PAXBP1;METTL23
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3642415208120002,1.1250155457818973,0.2515400410677618,0.6445978880474045,1.0,46/132,24.97%,EIF6;EIF3A;RRP7A;BRIX1;LUC7L2;DDX39B;ZRSR2;DENR;CELF1;SART1;PUF60;SRPK1;MDN1;PPAN;SRPK2;EIF2S2;PRMT7;DHX29;GEMIN5;DHX9;RPS28;CPSF7;POLR2D;DDX1;MRPS7;GCFC2;CELF6;SNRPF;PRPF6;SART3;GEMIN2;TGS1;NOL3;SRSF1;PRMT5;RPS19;SRSF10;XRCC5;SNRPD3;SNRPD2;SNRPD1;PTGES3;HSP90AB1;EIF5;EIF4B;LSM4
prerank,cell cycle G2/M phase transition (GO:0044839),0.365834310428151,1.1247566128591409,0.25770020533880905,0.6449202515046294,1.0,46/130,25.46%,CDK14;CCNY;NES;DYNC1H1;OPTN;ODF2;FBXL17;HAUS8;CCNB1;NINL;PPME1;DCTN1;DNM2;PPP2R1A;WEE1;CSNK1D;PLK3;YWHAG;CEP250;CEP41;FBXW11;FBXL6;CHEK2;MNAT1;CDC25B;CCDC57;CDC25A;CCP110;LATS1;MAPRE1;TUBB;PPP1R12A;CETN2;CUL1;ALMS1;CSNK1E;BRSK2;HAUS2;CDK2;CEP57;CCNH;CDK5RAP2;SSNA1;FBXL3;DYNC1I2;FBXL8
prerank,regulation of telomere capping (GO:1904353),0.4481627962966892,1.1245236413158497,0.327720207253886,0.6451248236354042,1.0,14/23,34.82%,TNKS2;RAD50;PKIB;PNKP;MAPK3;MAPK15;MAPK1;PRKCQ;TERF2;MAP2K7;NABP2;HNRNPD;USP7;MAPKAPK5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5334884920359024,1.124439417934856,0.3424460431654676,0.6449322510820161,1.0,4/11,21.94%,DAB2;CSNK1D;SFRP1;CSNK1E
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.36311412858301817,1.1243948961941366,0.22233400402414488,0.6446199933173871,1.0,50/186,23.79%,DKK2;LRP1;APOE;PSMD1;PRICKLE1;SOX30;PSMD8;DAB2;SOX9;SIAH2;PSMA1;STK3;MDFI;LRP4;PSMA8;LRP6;LZTS2;FZD4;CAV1;DDIT3;SCYL2;TLE5;BICC1;PSMD14;PSMA5;ZNRF3;TPBG;PSMD12;PSMB10;HDAC1;LATS1;WWOX;PSMD2;SFRP1;PSMC4;RUVBL2;DACT1;PSMD6;STK11;PSMD3;FRZB;PSMD5;PSMC2;PSME4;PSMB8;RACK1;PSMA6;PSMB7;GSK3B;PSMD4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5433474966382612,1.1242213139789465,0.34893617021276596,0.6446479751600475,1.0,3/10,10.71%,PDGFA;SOX9;TGFBR2
prerank,phosphatidic acid metabolic process (GO:0046473),0.40152604551270926,1.1239310272959246,0.2973893303064699,0.6450366241840919,1.0,13/48,22.30%,DGKZ;DDHD1;SLC27A1;ABHD5;DGKH;LPCAT1;DGKD;ABHD4;AGPAT1;PLA2G5;DGKQ;AGPAT5;AGPAT3
prerank,peptide hormone secretion (GO:0030072),0.4410641978102128,1.1237694494949075,0.3321123321123321,0.6450330100890073,1.0,6/26,12.58%,SNX19;CYB5R4;CDK16;VIP;RAB1A;IL6
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5145767826801392,1.123710299216066,0.329971181556196,0.6447697626329876,1.0,5/12,19.52%,CHMP4B;CHMP4A;GET3;SEC63;SEC61A1
prerank,keratinocyte differentiation (GO:0030216),0.4375420200206957,1.123572812167967,0.30481927710843376,0.6447310079055361,1.0,7/29,20.49%,ST14;CLIC4;JAG1;ASAH1;PIP5K1A;MED1;UGCG
prerank,telomere capping (GO:0016233),0.4877589721311608,1.1229759973780105,0.32118758434547906,0.6459840425913216,1.0,11/16,33.49%,RAD50;ACD;DCLRE1A;DCLRE1C;TERF1;TERF2IP;PRKDC;TERF2;MRE11;TEN1;TINF2
prerank,negative regulation of double-strand break repair (GO:2000780),0.4292858755408849,1.1228878756765408,0.3395061728395062,0.645803447844606,1.0,3/30,4.67%,ERCC6;CYREN;TRIP12
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.41697242763942993,1.122878388994106,0.3146853146853147,0.645406160432235,1.0,13/33,26.47%,GPNMB;CDK6;WEE1;PLK3;PRMT2;CDK4;CDK2AP2;DACT1;KANK2;PTEN;RBL1;DCUN1D3;BRD7
prerank,ribosomal large subunit biogenesis (GO:0042273),0.39693087775821595,1.12286884909863,0.29711751662971175,0.645003972672114,1.0,11/54,14.99%,EIF6;NOC2L;BRIX1;MAK16;WDR12;NSA2;RPL10A;MDN1;PPAN;MRPL1;SNU13
prerank,cardiocyte differentiation (GO:0035051),0.5307537661708797,1.1226955452474938,0.33284457478005863,0.6450633590294662,1.0,2/10,5.25%,AKAP13;SIK1
prerank,establishment of protein localization to membrane (GO:0090150),0.3893143198820602,1.1225807979898266,0.2962566844919786,0.644962319512736,1.0,18/66,20.77%,RFTN1;SDCBP;NACA;ZDHHC18;ZDHHC15;NECTIN3;NPC1;YIF1B;ZDHHC1;BID;SEC63;GRIN3B;ZDHHC6;RAB3GAP1;RAB3GAP2;PIKFYVE;AFDN;FRMPD1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.44316671963627374,1.1222549952074865,0.3316062176165803,0.6454611426376081,1.0,7/23,18.45%,PTPRC;CAV1;SOCS5;MVP;CBL;ZGPAT;ERRFI1
prerank,ether lipid metabolic process (GO:0046485),0.4933836984631553,1.122125598043768,0.3431372549019608,0.6453755164864002,1.0,3/14,6.26%,NCEH1;PLAAT3;PEDS1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.48588450505377784,1.1219921963582784,0.32138114209827356,0.6453217387913709,1.0,4/17,9.91%,FGF2;NRP1;VEGFA;SRF
prerank,regulation of trophoblast cell migration (GO:1901163),0.4956511222049063,1.1212614938516787,0.34024896265560167,0.6467782634763106,1.0,5/14,22.27%,AGO2;VEGFA;C1QBP;TIMP1;CALR
prerank,base-excision repair (GO:0006284),0.40255860885115036,1.1210805580843346,0.3079545454545455,0.6468328917492454,1.0,14/48,16.29%,ERCC6;NEIL2;MBD4;PRMT6;XPA;ADPRS;USP47;HUWE1;RFC2;POLE;LIG3;LIG1;RFC1;PNKP
prerank,neuron apoptotic process (GO:0051402),0.45987343826481714,1.1209534372939054,0.328125,0.6467688362718876,1.0,6/19,18.62%,BCL2;CDK5;DIABLO;BID;ATN1;TNFRSF21
prerank,heart contraction (GO:0060047),-0.298190658334182,-1.120911888097463,0.22602739726027396,0.6794509232834296,1.0,3/41,1.14%,SGCZ;SGCD;DMD
prerank,lipid droplet organization (GO:0034389),-0.36016468821073455,-1.12061101277261,0.2676056338028169,0.6774888278220116,1.0,5/22,19.06%,CDS1;SQLE;PLA2G4C;CDS2;PNPLA3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.4997599326700941,1.120499557767761,0.3493810178817056,0.6475588594506398,1.0,3/13,15.79%,MDFIC;TPR;SUFU
prerank,cell-substrate junction assembly (GO:0007044),0.415266576642653,1.1200765010989981,0.305458768873403,0.6482852619872745,1.0,5/33,7.90%,PEAK1;FN1;LAMC1;RHOD;DST
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3629948071169202,1.1197584569916361,0.2653061224489796,0.6487457079573861,1.0,27/142,19.84%,CACNA1A;TRPC4;ABL2;ADCY8;ATP2B1;BDKRB1;HCRTR1;PTGFR;PTGIR;NPTN;SLC8B1;C3AR1;CAV1;GLP1R;C5AR1;SLC8A1;PTGER4;EDNRA;DLG4;TMEM178A;SPPL3;FKBP1B;TAC4;PTGER3;CLN3;CD52;IAPP
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.4952600874097527,1.119599727829217,0.33518776077885953,0.6487525022434837,1.0,4/15,18.23%,CCT2;CCT5;DKC1;RUVBL2
prerank,polyamine metabolic process (GO:0006595),0.5049916103395928,1.1194949888527146,0.3489010989010989,0.6486155327916252,1.0,3/13,9.81%,SAT1;SMOX;PAOX
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.37849018436644166,1.119086301076164,0.3067940552016985,0.6492682094865021,1.0,22/72,20.87%,DXO;ERCC1;RAD50;UBA52;DNASE1L1;EDC4;DDB2;DDB1;ERCC4;XPA;SETMAR;RFC2;RPS27A;UBC;RFC1;DDX1;GTF2H1;ERCC2;EDC3;ZC3H12A;CUL4A;XRN2
prerank,negative regulation of developmental growth (GO:0048640),0.42674157901575194,1.1188265386907357,0.3234244946492271,0.6495450180119484,1.0,3/30,6.99%,FGF13;RNF6;SLC6A4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47116635550270486,1.118719047810586,0.33587786259541985,0.6494339492157414,1.0,10/18,33.91%,IL6;TNF;TERT;MAP2K2;ZC3H12A;TGFB1;MAP2K1;DDX5;TP53;NCOR2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38999361042356,1.118695547615979,0.3051224944320713,0.6490751184248992,1.0,10/57,14.62%,ASPH;CTSD;MALT1;GRAMD4;SYK;DAPK1;TBC1D10A;AIM2;FYN;TNF
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3645568290999506,1.1184971983248866,0.2687950566426365,0.6492209466921001,1.0,46/129,25.46%,CDK14;CCNY;NES;DYNC1H1;OPTN;ODF2;FBXL17;HAUS8;CCNB1;NINL;PPME1;DCTN1;DNM2;PPP2R1A;WEE1;CSNK1D;PLK3;YWHAG;CEP250;CEP41;FBXW11;FBXL6;CHEK2;MNAT1;CDC25B;CCDC57;CDC25A;CCP110;LATS1;MAPRE1;TUBB;PPP1R12A;CETN2;CUL1;ALMS1;CSNK1E;BRSK2;HAUS2;CDK2;CEP57;CCNH;CDK5RAP2;SSNA1;FBXL3;DYNC1I2;FBXL8
prerank,lysine catabolic process (GO:0006554),0.5126422197525452,1.1184459091734993,0.34054834054834054,0.6485016053833133,1.0,7/12,29.96%,PIPOX;DLST;SLC25A21;PHYKPL;GCDH;AASS;OGDH
prerank,lysine metabolic process (GO:0006553),0.5126422197525452,1.1184459091734993,0.34054834054834054,0.6485016053833133,1.0,7/12,29.96%,PIPOX;DLST;SLC25A21;PHYKPL;GCDH;AASS;OGDH
prerank,mitochondrial RNA metabolic process (GO:0000959),0.49045187558134284,1.1183936963362662,0.3409395973154362,0.6482398661962826,1.0,5/14,20.07%,SLC25A33;TWNK;EARS2;FASTKD5;POLRMT
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4523184629285697,1.1181797620783147,0.31533742331288345,0.6484159103400113,1.0,7/22,20.26%,GCNT2;CD44;MYADM;MAPK7;TNF;MBP;FLOT2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.48979475605450185,1.1178713177751667,0.3246930422919509,0.6488213224860835,1.0,10/14,34.77%,ATIC;ADSS1;GART;PPAT;ADSL;ADSS2;ADK;IMPDH1;GMPS;IMPDH2
prerank,regulation of cell projection organization (GO:0031344),0.5145135181439897,1.1175069021481372,0.3399715504978663,0.6493696172242802,1.0,3/13,12.54%,MACF1;TREM2;MYO9A
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4795031424110955,1.1174473408674561,0.34358288770053474,0.6491053268420509,1.0,6/17,20.93%,ZC3H3;CPEB1;CPSF7;CPEB3;HSF1;RNF20
prerank,vasculature development (GO:0001944),0.4776927750312621,1.1174184381211734,0.3314917127071823,0.6487541118650731,1.0,7/16,25.05%,FBXW7;NOTCH4;ERRFI1;STK11;PIK3CA;APLNR;PDGFRA
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5163216278638081,1.1170947875393202,0.3406113537117904,0.6491762394964486,1.0,6/11,26.72%,CABIN1;UBN1;HAT1;ASF1A;H3-3A;IPO4
prerank,extracellular matrix organization (GO:0030198),0.3552177917433575,1.1169946140688543,0.20160481444332998,0.6490270110826647,1.0,50/276,14.72%,SH3PXD2B;LCP1;SPP1;FN1;POSTN;ITGAX;ITGA5;MMP12;PDGFA;ADAM8;FGF2;A2M;COL10A1;ADAMTS13;MATN3;BMP1;COLGALT1;DAG1;CAPG;COL20A1;ADAMTS10;CAPN1;CD44;LAMC1;P4HA1;ITGB5;DST;COL12A1;GAS6;P4HB;KLKB1;ATP7A;CYP1B1;ADAMTSL5;COL9A3;P4HA3;ADAM15;TIMP2;FLRT2;ITGA11;ITGA3;SERPINF2;FURIN;COL8A2;MMP28;COL4A1;ITGA2B;MMP19;MMP17;NF1
prerank,negative regulation of wound healing (GO:0061045),0.42793206698553543,1.1169196055923754,0.32929782082324455,0.648797526312394,1.0,9/28,17.51%,APOE;FGF2;CLDN19;SERPINE2;TFPI;APOH;TNF;CRK;SERPINE1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.45213040719212694,1.1167680577286427,0.3374233128834356,0.648774309562135,1.0,10/24,20.66%,BCL2L1;DAB2;RHOQ;GDI1;PID1;TMBIM1;PPFIA1;LZTFL1;ITGB1BP1;TGFB1
prerank,negative regulation of phosphorylation (GO:0042326),0.37562319737714267,1.116739688648791,0.28858350951374206,0.6484390397396035,1.0,33/85,28.34%,SIRPA;CORO1C;XDH;STAP1;PLPP3;HDAC4;GIT1;LRP6;CRKL;MYADM;TESK1;DNAJC10;PID1;ZBED3;ANKLE2;TRAF3IP1;HNRNPU;ZC3H12A;TGFB1;ROCK1;CADM4;NPRL2;LYN;PTEN;PPP1R15B;PRDX3;IMPACT;TERF2IP;TARDBP;PRKDC;PRR5L;CDK5RAP3;CIB1
prerank,pyroptosis (GO:0070269),0.48742613252519695,1.116667503101538,0.3360995850622407,0.6481997548489037,1.0,4/15,12.69%,TREM2;AIM2;APIP;DHX9
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3322935944342982,-1.1166548669230116,0.29069767441860467,0.6853810478343869,1.0,9/29,16.55%,SSH2;CYRIB;TWF2;KANK1;TJP1;SHANK3;PRKN;FKBP4;SLIT2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5331699007982383,1.116572396897668,0.34457478005865105,0.6480516285635373,1.0,4/10,21.23%,NFE2L2;DDIT3;EIF2S1;HERPUD1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5087612222747833,1.116367910863077,0.35704125177809387,0.6481813765432064,1.0,7/12,29.39%,FZR1;RAB1A;UBE2C;GOLGA2;PTEN;BTRC;GORASP1
prerank,organelle fission (GO:0048285),0.4475520025405263,1.1163185212301514,0.3159235668789809,0.6478897302780967,1.0,4/24,8.73%,CORO1C;WASHC5;DNM2;MTFP1
prerank,glycolipid biosynthetic process (GO:0009247),0.4125920294883207,1.1160152896400284,0.31529411764705884,0.6483291785482664,1.0,8/38,12.57%,LARGE1;PIGQ;PIGZ;PIGN;ST8SIA6;PIGL;ST3GAL2;GBGT1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.34954653420862,1.1152380288049728,0.167,0.6500255081211147,1.0,117/417,23.30%,MDFIC;CTNNB1;NIBAN2;ZHX2;ARID5B;CDK5;PRICKLE1;FOXN3;VDR;PPARD;ING4;SOX9;KMT5A;ERN2;RCOR1;BASP1;BHLHE41;PPARG;NFIL3;CEBPA;HDAC4;BHLHE40;GMNN;CIC;ID2;COPS2;TRIM28;BAP1;NKX2-1;HDAC9;RIOX1;BCL6;GAS6;SUDS3;BRCA1;THAP7;JUN;ATF5;CBX3;DDIT3;RCOR3;TAF7;NR3C1;EED;EHMT1;TLE5;ELK3;WWP2;PRMT6;RBM15B;ENO1;ZKSCAN3;EIF4A2;LIMS1;MDM2;ZNF148;ATXN1;SCML4;CREBZF;PRMT2;PEX14;CBFA2T2;USP47;FBXW11;ZGPAT;MYBBP1A;L3MBTL2;MIDEAS;TNF;UIMC1;SBNO2;HDAC1;SNW1;ZBTB4;PCGF6;YEATS2;DPF3;KAT7;KLF10;YAF2;QARS1;GCFC2;PIAS4;SFRP1;RBFOX2;BAHD1;LOXL3;HDAC3;ZNF568;ID1;LDB1;DAP;MPHOSPH8;ARID4A;POU2F1;TGFB1;SIRT2;PDGFB;DMAP1;SUMO1;MTA3;GATAD2A;NOTCH1;GZF1;ZBTB16;TMPRSS6;CALR;PHC2;XRCC5;SMARCA4;MTERF3;PHF10;HIC2;KDM1A;SET;DAXX;FOXO1
prerank,response to UV-B (GO:0010224),-0.41650184628982,-1.11513400948977,0.3234323432343234,0.6865437087508086,1.0,7/12,28.12%,RELA;MME;CRIP1;CDKN1A;MSH2;HYAL2;MFAP4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.449500792234838,1.1149613559183011,0.34191176470588236,0.6503506566810636,1.0,7/25,12.09%,SELENON;CYP27B1;ATP13A2;TRPM7;CNNM2;CAV1;SLC8A1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.36856918681906586,1.1147937919309887,0.274896265560166,0.6504144457289546,1.0,26/117,19.24%,IGF1;LPL;ACSBG2;PPARD;ECHDC3;PPARG;LDHA;ALKBH7;NPC1;MTHFS;SLC16A3;GLYAT;PDHB;DLAT;GBA2;CPT1A;ACOT6;SCPEP1;SCP2;KYNU;SGPL1;AASDHPPT;ACOT1;HOGA1;ABCB11;SLC5A6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4457991466550102,1.114328328938366,0.3249370277078086,0.6512697328283394,1.0,6/23,14.43%,PLK2;WEE1;ZFYVE19;PLK3;SETMAR;PRCC
prerank,inositol lipid-mediated signaling (GO:0048017),0.3990393711769675,1.114221496518494,0.31496062992125984,0.6511243653669481,1.0,10/50,12.06%,IGF1;PLCB4;PIK3CB;GAB2;PLCB2;PI4KA;PIK3R2;IGF1R;RHOA;OGT
prerank,spliceosomal snRNP assembly (GO:0000387),0.4079376663555189,1.1138290944093845,0.31823461091753774,0.6517625021084202,1.0,17/38,28.12%,CD2BP2;SART1;PRMT7;GEMIN5;SNRPF;PRPF6;SART3;GEMIN2;TGS1;PRMT5;SRSF10;SNRPD3;SNRPD2;SNRPD1;LSM4;WDR77;GEMIN8
prerank,regulation of JUN kinase activity (GO:0043506),0.42363015794446085,1.1132527201041982,0.32091346153846156,0.6529302745660519,1.0,6/33,15.28%,SASH1;TRAF2;NPPA;TAOK3;TNF;ARHGEF5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5413730525149478,1.112874418972178,0.3431372549019608,0.6534775526758111,1.0,5/10,21.65%,ARHGAP12;LRP6;DLL4;BMP5;NOTCH1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4557608274337993,1.1127261082448094,0.33026315789473687,0.6534858069856306,1.0,7/21,21.64%,MAFF;RUNX1;MAFG;SULT2B1;ERRFI1;CTSL;ROCK1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3911363381511891,1.1123721077182518,0.3190045248868778,0.6540254612234092,1.0,14/54,16.40%,CNOT4;MUC1;PLK2;BAX;CCNB1;CNOT10;TRIAP1;CARM1;MDM2;PLK3;CRADD;CNOT6;CHEK2;CNOT9
prerank,regulation of cellular response to stress (GO:0080135),0.36488842507358643,1.1123349068234432,0.2822085889570552,0.6537204975391597,1.0,38/115,25.54%,ATF3;NUP205;ADCY8;EIF4G1;MCL1;NEK6;MBTPS2;NUP188;DNAJB6;RAE1;BAG3;AIFM2;MAPKAPK2;CASP9;NUP42;TPR;DNAJC2;NUP54;MAPK3;SLC38A2;HSF1;CLN3;SMG1;CREBBP;RANBP2;NUP133;NUP93;PTGES3;HSP90AB1;GSK3B;OPRM1;NUP98;EP300;USP19;ABL1;MAPK1;CAMK2D;AKT1S1
prerank,positive regulation of double-strand break repair (GO:2000781),0.4127133784539428,1.112321796783004,0.3085234093637455,0.6533469508539863,1.0,18/39,30.11%,ERCC6;KMT5B;MGMT;ARID2;KDM4D;RAD51AP1;SETMAR;SLF2;PNKP;MMS19;FUS;PARP1;SMCHD1;PARP9;PRKDC;WDR48;RIF1;ACTR2
prerank,phospholipid catabolic process (GO:0009395),0.44319249968748603,1.1120881256287545,0.32786885245901637,0.6535416949541123,1.0,6/24,15.18%,ABHD12;APOA2;GDPD3;SMPD4;PLBD2;PNPLA6
prerank,positive regulation of GTPase activity (GO:0043547),0.3558138870991955,1.1120091706085475,0.24012158054711247,0.6533596364232355,1.0,39/188,18.17%,BCAR3;ARHGAP25;ABR;RGS1;ARHGAP24;CORO1C;TBC1D22A;SIPA1L2;CCL4;ALS2;TBC1D2;RALGAPA2;FOXJ1;RIC1;RGP1;CCL13;GMIP;CCL14;RHOG;TBC1D10A;DOCK7;LIMS1;TBC1D12;RAPGEF6;TBC1D16;SNX18;PKP4;LARS1;GPR65;NF1;DOCK11;ARHGEF5;PIP5K1A;FLCN;RAB3GAP1;PIN1;SFRP1;ARHGAP22;ZC3H15
prerank,positive regulation of dephosphorylation (GO:0035306),0.4351582422859024,1.1119455840147998,0.3400713436385256,0.653119459250992,1.0,10/27,20.66%,PRKCD;PTPA;SYMPK;RIPK3;ANKLE2;PIN1;CALM2;SPPL3;NSMF;TGFB1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.37587166169511627,1.1116004275122866,0.2941810344827586,0.6536638502497758,1.0,26/86,22.02%,IGF1;MYO9B;GRB2;SQSTM1;DENND4C;AKAP13;ERBIN;CRKL;SYNGAP1;SPRY4;ARHGAP17;DENND4B;OGT;RAF1;MAPKAP1;ARHGEF2;FLCN;VAV1;RABL3;STAMBP;EPO;ARF6;SHOC2;NOTCH1;KANK2;CADM4
prerank,regulation of protein kinase B signaling (GO:0051896),0.35723442626491164,1.1115622728941628,0.24646464646464647,0.6533504492267237,1.0,38/193,15.94%,OSBPL8;P2RX4;XDH;PDGFA;ADAM8;FGF2;PIK3CB;MFHAS1;GRB2;GAB2;DAG1;PDPK1;AXL;PPP2R5C;TRAT1;GCNT2;MYDGF;MYOC;PLEKHA1;PIK3R5;FGF20;GAS6;PIK3R2;DDIT3;IGF1R;RNF41;RHOG;KITLG;C1QBP;HPSE;FYN;FGF7;HAX1;TNF;FGF18;HIP1;FLCN;VAV1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.45197075354016614,1.111534632843343,0.31909547738693467,0.6530171586126856,1.0,7/24,16.84%,APOE;PTK2B;TMF1;PSMD14;EFNA1;USP14;LATS1
prerank,negative regulation of T cell differentiation (GO:0045581),0.5255461504083205,1.111520820770984,0.3670520231213873,0.6526476672624041,1.0,1/10,3.44%,FOXJ1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5184764895667371,1.1113831532135452,0.34870317002881845,0.6526413561754516,1.0,3/11,12.05%,PLAUR;SYK;JAK1
prerank,erythrocyte development (GO:0048821),0.5327622410464662,1.111337158811405,0.3578363384188627,0.6523483300645695,1.0,4/10,17.87%,NCKAP1L;ALAS1;LYAR;MED1
prerank,cellular response to reactive oxygen species (GO:0034614),0.3889210398852536,1.110809586300122,0.3326063249727372,0.6533526201369624,1.0,11/59,13.24%,SIRPA;NFE2L2;PRKCD;AGAP3;PLEKHA1;JUN;CYP1B1;RIPK3;IL6;TNFAIP3;MAPK7
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4972718487360408,1.1106275406054968,0.3665283540802213,0.6534365477771724,1.0,8/14,23.08%,RAP2A;FOXJ1;MSN;RHOA;MYO9A;SYNE4;CDC42;SCRIB
prerank,regulation of gene expression (GO:0010468),0.3444094259866951,1.1105750924272395,0.081,0.6531559604339481,1.0,219/903,22.54%,APBB2;IGF1;AHNAK2;MITF;CXXC1;C1D;HIF1A;FN1;SIRPA;ITGAX;CSF1;NFE2L2;APOE;NFYA;XDH;CDK6;STAP1;FGF2;PIK3CB;PTPRC;JMJD1C;NELL1;FOXN3;UBAP2;POU3F1;TRIM6;TRIM43;VDR;CLDN19;TFEB;RUNX1;ATP13A2;AGO2;PAK6;DTNBP1;PERM1;VEGFA;AFF1;SON;SOX9;MSN;SMCR8;CHD3;FBXW7;NFX1;GCNT2;ZNF326;ZC3H7B;TRAF3;NFIL3;CEBPA;HDAC4;NAT8;BHLHE40;LARP4;RNF6;LARP1;ID2;NOCT;SBNO1;PHF1;NKX2-1;CELF1;GON4L;HNRNPLL;GRSF1;FGF20;SLC11A1;DLL4;CCAR1;ANXA7;BCL6;CHD7;GAS6;PABPN1;MTF2;NFKBIZ;BRCA1;TGFBRAP1;DNM2;THAP7;CRKL;STOX1;TREM2;ATF5;HAVCR2;TAPBP;PPIE;DIP2A;DDIT3;YBX2;NFKB1;KRAS;HNRNPK;SERTAD3;ZFP64;MYADM;CARM1;RNF14;DNMT3B;PPP2R1A;BTN3A3;NR3C1;LILRB1;YTHDF2;TLE5;WWP2;GLRX2;MYBL2;SRPK2;CDK11B;HMG20B;LIMS1;ZNF148;TIPARP;NOVA2;CLK4;PTBP3;ATXN1;TICAM1;SLC8A1;ASCC2;PRDM9;IL6;PID1;NAB2;HNRNPL;VPS35;USP36;MYT1;AGO3;MSL3;NPAT;FGF7;SP1;MYBBP1A;MSR1;CHEK2;HCFC1;ZBTB7B;TNF;TRA2B;RRP1B;UBE2L3;DNMT1;AGO4;FGF18;SBNO2;PUM1;FASTK;YY1;SUFU;TERT;FLCN;HDAC1;PPARGC1B;ZBTB4;OLFM1;ASCC1;TFRC;KAT7;FUBP1;PIN1;PCBP1;MAFB;TAF5L;USP13;POFUT1;UTP4;YAF2;CDK4;GCFC2;PRKAG1;SFRP1;CNBP;MAPK3;FOXN2;MED1;SLC38A2;MAP2K2;TGFBR1;HP1BP3;REL;SART3;FUS;LDB1;CDH1;ZC3H12A;CCN4;AFDN;DGKQ;MBNL2;FLOT2;UNCX;YBX3;TGFB1;GDNF;RNF20;SMAD1;PDGFB;NSD1;GPBP1L1;CREM;THAP1;ROCK1;NOTCH1;BMI1;GZF1;PRMT5;ZFAT;CREBBP;SRSF10;CALR;PUM2;ATXN7L3B;KMT2D;GSN;PCBP4;CDK2
prerank,DNA replication (GO:0006260),0.36325735331213416,1.1103348709882381,0.29811715481171547,0.6533636884153713,1.0,36/105,26.22%,ORC3;ING4;GRWD1;IGHMBP2;MCM2;RMI1;RNASEH2A;MCM7;PTMS;RAD50;BRCA1;DBF4;KIN;POLA2;REV1;MCM8;RFC2;POLE;RFC1;PNKP;KAT7;RECQL5;RAD9A;TBRG1;BLM;HUS1;TOPBP1;CDK2;SET;MCM6;TOP1;MCM3;PCLAF;POLA1;CDC7;MCM5
prerank,regulation of protein secretion (GO:0050708),0.3633381104740109,1.1102832696220173,0.28556806550665303,0.653079592877352,1.0,21/119,15.39%,CACNA1A;IGF1;ABCG1;APOE;ADAM8;RHBDF2;GCK;CACNA1D;ATP13A2;SERGEF;SLC2A1;SLC8B1;TREM2;LLGL2;GLP1R;IL6;LLGL1;GOLPH3;DNAJC1;TNF;DISP1
prerank,regulation of fibroblast migration (GO:0010762),0.46036979340430334,1.110216942120832,0.3380281690140845,0.6528544140960802,1.0,10/20,27.78%,CORO1C;FGF2;APPL2;GNA12;CLN3;ITGB1BP1;TGFB1;RAC1;PRR5L;ARHGEF7
prerank,positive regulation of telomere capping (GO:1904355),0.4788778484254031,1.1098216784186423,0.34449093444909346,0.6534592487434427,1.0,11/17,34.82%,TNKS2;PKIB;PNKP;MAPK3;MAPK15;MAPK1;PRKCQ;MAP2K7;NABP2;HNRNPD;MAPKAPK5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.4675805660741433,1.1097942844766904,0.34589502018842533,0.6531190905495892,1.0,7/18,19.25%,APOE;MSN;RNF128;VPS35;PTTG1IP;DACT1;VPS11
prerank,"transcription, DNA-templated (GO:0006351)",0.3557962112592204,1.1097896075559956,0.25576730190571717,0.6527235063954636,1.0,83/207,31.05%,ERCC6;NFYA;NFIC;NFX1;DDX21;POLR2H;UBTF;TAF4B;SNAPC2;SLC25A33;NOCT;COPS2;TTF1;GTF2A2;MNT;PWP1;TWNK;TAF15;DRG1;GTF2F1;YBX2;NFKB1;TAF7;BTF3;CCNT2;HSF2BP;EAF1;GMEB2;PIR;TRIP13;ELOB;TBPL1;ZBTB7B;MNAT1;POLR2D;GTF2E2;TAF1A;KLF13;GTF2H1;TAF5L;TAF1C;MMS19;TRIP11;ERCC2;RNMT;DEK;HSF1;POLR3GL;XBP1;POLRMT;GTF3C4;TBP;THAP1;PRMT5;PARP1;MLLT1;RRAGC;CCNH;RO60;NELFA;TSC22D1;SUPT4H1;SCX;CRCP;TAF6;GTF2A1;RSF1;FUBP3;POLR1C;AFF4;POLR3A;TAF4;GTF3A;MBD1;CBFB;TOPORS;ABT1;EPC1;TAF13;TAF9;DDX5;GLIS3;FOXO3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.34902416968000444,1.1094362588378992,0.20040080160320642,0.653234474413673,1.0,94/366,22.42%,APBB2;MITF;CXXC1;HIF1A;NFYA;PDGFA;ORC3;JMJD1C;FOXN3;TFEB;PAK6;PERM1;CHD3;NFX1;NOLC1;NFIL3;CEBPA;BHLHE40;RNF6;GMNN;CYFIP1;SBNO1;PHF1;GON4L;CCAR1;CHD7;MTF2;TGFBRAP1;DNM2;THAP7;ATF5;PPIE;DDIT3;SERTAD3;CARM1;RNF14;PPP2R1A;NR3C1;ATXN2;GLRX2;MYBL2;CDK11B;RBM4B;TCOF1;ATXN1;ASCC2;GEMIN5;NAB2;EIF4E;MYT1;MSL3;SP1;MYBBP1A;CHEK2;HCFC1;UBE2L3;SBNO2;SUFU;PPARGC1B;ZBTB4;ASCC1;RABL3;KAT7;OBI1;MAFB;TAF5L;USP13;POFUT1;UTP4;YAF2;GCFC2;CNBP;FOXN2;TGFBR1;HP1BP3;PUM3;FUS;LDB1;PCIF1;FBXO5;RNF20;EIF2A;NSD1;GPBP1L1;CREM;THAP1;NOTCH1;GZF1;PRMT5;ZFAT;CREBBP;SRSF10;CALR;KMT2D
prerank,intracellular protein transport (GO:0006886),0.3522534719788551,1.1092826328840044,0.20641282565130262,0.6532498969813769,1.0,107/304,26.72%,TBC1D22A;KIF13B;MMP12;SNX8;CTSA;ARF3;PRICKLE1;IPO5;GCKR;TBC1D2;NAPA;TRAK1;E2F3;RIC1;RAB32;ARL11;APPL2;VPS26A;TLK1;WLS;ARL1;RAB5A;NUP188;EGR2;SYK;XPO7;ACD;STX6;RAB7A;AP4E1;LAMP2;AP3D1;TBC1D10A;TNPO1;RAB5C;SIL1;EIF4ENIF1;BAG3;RAB1A;TNPO2;VPS26C;TBC1D12;STX3;USO1;CCHCR1;RAB20;STX5;SAR1A;TBC1D16;SNX27;GGA2;NUP42;VPS35;TPR;ARFGAP3;RAB22A;GIPC1;SNX31;FUT10;ARHGEF2;RABL3;SNX17;COPA;RAB3GAP2;TMED3;PTTG1IP;NXT2;PPP1R10;XPO6;ARFRP1;STX7;VIPAS39;BCS1L;SEC16A;IPO13;ARF6;TGFB1;RUNDC1;AP3B1;SNX1;XPO1;CALR;NUP133;NUP93;SNX15;LMAN1;SGSM1;GABARAP;DNAJC27;TBC1D1;TBC1D15;STX4;RAB31;TBC1D10C;NUTF2;ARF5;EHD1;COPZ2;ARF4;PDCD6;VPS26B;GGA3;STX11;ARL4A;SURF4;WDR11;IPO4
prerank,regulation of secretion (GO:0051046),-0.3964724016901643,-1.109146335461898,0.31086142322097376,0.6997790370486311,1.0,6/13,14.50%,FGF10;OAS2;MYO6;EGF;ERBB3;GPLD1
prerank,positive regulation of bone mineralization (GO:0030501),-0.31011616481379545,-1.1089698853918954,0.296551724137931,0.6974733363936779,1.0,6/35,4.16%,TMEM119;MEF2C;ALOX5;GPM6B;ACVR2B;BMPR1B
prerank,response to lipopolysaccharide (GO:0032496),0.3633747203837133,1.1086037983512564,0.2815040650406504,0.6546337053266635,1.0,26/138,12.90%,SIRPA;STAP1;TRIM6;CYP27B1;CD274;AXL;VIM;ADAM17;TNFRSF1B;NOCT;ERBIN;SLC11A1;GIT1;PABPN1;NFKB1;ACOD1;LILRB1;PLAA;RHOA;TICAM1;MAPKAPK3;CD180;IL6;TNIP2;TNFAIP3;MAPKAPK2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4589903930026442,1.108503362413906,0.3409090909090909,0.6545005309430013,1.0,11/19,30.63%,CHMP4B;DRG1;PDCD6IP;VPS4B;TPR;HNRNPU;EML3;CEP97;CCSAP;CHMP2B;CHMP3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.38947267471486724,1.108500570916762,0.3081201334816463,0.6541001400265367,1.0,22/52,29.50%,BCL2;FBXW7;BAP1;PPP3R1;CSNK2A2;YWHAG;BID;USP36;HUWE1;SAE1;UBE2L3;PPP3CC;RHOU;VPS11;ATG13;SH3GLB1;NPEPPS;BBC3;LEPROT;HTRA2;YWHAZ;ARIH2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5374568122934367,1.1084871307214827,0.3343108504398827,0.6537287175056301,1.0,3/10,11.49%,NINL;DCTN1;HOOK3
prerank,digestive tract morphogenesis (GO:0048546),0.4899514100104333,1.108451866679046,0.33731739707835323,0.653408840462267,1.0,6/14,36.32%,ID2;FGFR2;PDGFRA;BBS7;EPHB3;RBPMS2
prerank,negative regulation of cell cycle process (GO:0010948),0.38765790631946295,1.1082701102059807,0.3053435114503817,0.6534757930595001,1.0,22/61,26.14%,UXT;RNF2;BRCA1;CBX3;EED;EHMT1;ZFYVE19;WAPL;MGA;L3MBTL2;PCGF6;CCP110;YAF2;PPP1R10;TERF1;FBXO5;NME6;BMI1;RAD51;PCGF2;APAF1;CDC7
prerank,regulation of protein binding (GO:0043393),0.3654670701277924,1.1080773546952982,0.31099476439790574,0.653609825709239,1.0,34/114,22.98%,LRP1;CTSZ;NES;PRKCD;DAB2;STK3;HDAC4;LRPAP1;BAMBI;BAX;CAV1;GTF2F1;SYMPK;HIP1R;TLE5;PRMT7;PEX14;PSME3IP1;TERT;CRK;PIN1;SPPL3;DERL1;DACT1;GOLGA2;MARK2;ITGB1BP1;USP33;PDGFB;ROCK1;CSNK1E;NVL;KDM1A;RACK1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3541547956562149,1.1080578053172678,0.27547931382441976,0.6532577047938668,1.0,61/172,27.01%,DGKZ;DDHD1;FGF2;PIK3CB;PEMT;SLC27A1;ARF3;APOA2;INPPL1;PI4K2A;CHKB;RAB5A;ABHD5;PIP5K1C;PLEKHA1;PIK3R5;PI4KA;DGKH;VAC14;LPCAT1;DGKD;PIK3R2;LPCAT3;CSNK2A2;CPNE3;RUFY1;ABHD4;MTMR12;MTMR14;PI4K2B;CPNE6;PIP5K1A;LPIN3;MTMR6;INPP4A;PIP4K2A;PIK3C2A;STARD10;HDHD5;AGPAT1;PIKFYVE;PLA2G5;CLN3;DGKQ;SYNJ1;PIK3CA;CHKA;AGPAT5;AGPAT3;PLEKHA2;TAMM41;SELENOI;SYNJ2;SLC44A2;PTEN;AGPAT2;PIP5K1B;AGK;PLA2G12A;ETNK2;PLSCR1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.42039948079263256,1.1080357523139204,0.33770883054892603,0.6529202120899171,1.0,11/35,18.40%,ABL2;STAP1;NRP1;CDK5;PTK2B;BAIAP2;PHPT1;HAX1;BAIAP2L1;BAIAP2L2;FES
prerank,regulation of ruffle assembly (GO:1900027),0.443974761213064,1.1078912045336975,0.3437892095357591,0.6529041488877171,1.0,7/23,14.27%,ARHGAP24;P2RX4;STAP1;PLEKHM1;CAV1;EVL;DEF8
prerank,renal water homeostasis (GO:0003091),0.4457240583011035,1.1072908291587322,0.33879093198992444,0.654153309032899,1.0,3/23,2.77%,ADCY8;ADCY3;ADCY7
prerank,negative regulation of response to external stimulus (GO:0032102),0.368401246312788,1.107053544144901,0.2897196261682243,0.654358609892033,1.0,27/105,18.53%,SIRPA;APOE;NLRC3;FGF2;MFHAS1;PRKCD;CLDN19;OTULIN;PPARD;PPARG;PTPN2;ILRUN;LPCAT3;ACOD1;LYAR;C1QBP;PTGER4;PTGIS;TNFAIP3;MAPK7;VPS35;CRK;SHARPIN;SERPINE1;DUSP3;METRNL;TRAF3IP1
prerank,glutathione derivative metabolic process (GO:1901685),0.4500150421439382,1.1067625310422562,0.3398184176394293,0.6543363525636239,1.0,10/20,31.11%,GSTA2;AKR1A1;GSTO1;GSTK1;GSTT1;MGST3;HPGDS;ESD;GSTP1;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4500150421439382,1.1067625310422562,0.3398184176394293,0.6543363525636239,1.0,10/20,31.11%,GSTA2;AKR1A1;GSTO1;GSTK1;GSTT1;MGST3;HPGDS;ESD;GSTP1;GSTZ1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3633251577551898,1.1067219581489574,0.30959752321981426,0.6540360747201754,1.0,21/116,14.03%,FGR;ADCY8;ADCY3;RHBDF2;POMC;ADCY7;PTGIR;PLK2;ADAM17;SCTR;CRH;SYK;TREM2;YES1;GLP1R;VIP;FURIN;PTGER4;IL6;FYN;GNB1
prerank,positive regulation of protein secretion (GO:0050714),0.38106989983796186,1.106669111839062,0.32903225806451614,0.6537708478538896,1.0,8/69,6.46%,IGF1;ABCG1;ADAM8;TRH;GCK;ATP13A2;PTPN23;WLS
prerank,negative regulation of myotube differentiation (GO:0010832),0.5133969232011685,1.1065669323488965,0.3352112676056338,0.6536542061516597,1.0,6/12,21.65%,BHLHE41;HDAC4;HDAC1;HDAC3;XBP1;NOTCH1
prerank,regulation of intracellular pH (GO:0051453),0.41493309886882973,1.1064699843124204,0.3489208633093525,0.653523597858761,1.0,8/34,10.74%,SLC9A1;SLC9A8;SLC9A7;SLC9A6;SLC4A9;GPR89A;GPR89B;SLC4A2
prerank,regulation of neuron apoptotic process (GO:0043523),0.3648952974379296,1.1059776258058205,0.3060796645702306,0.6543879988124273,1.0,14/96,11.06%,CTNNB1;BCL2;APOE;ADAM8;CDK5;PTK2B;CPEB4;RETREG1;BAX;FGF20;TREM2;DDIT3;RASA1;SRPK2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.43882402660036357,1.105729846807131,0.3613550815558344,0.6546132797977886,1.0,10/26,22.34%,DAB2;VPS18;BRCA1;HDAC1;CNOT9;SFRP1;VPS11;KANK2;CALR;SMARCA4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.36233116759825257,1.1056681001186588,0.3061855670103093,0.6543497959555759,1.0,21/117,14.03%,FGR;ADCY8;ADCY3;RHBDF2;POMC;ADCY7;PTGIR;PLK2;ADAM17;SCTR;CRH;SYK;TREM2;YES1;GLP1R;VIP;FURIN;PTGER4;IL6;FYN;GNB1
prerank,negative regulation of neurogenesis (GO:0050768),0.41520507059458645,1.105560753754982,0.32231404958677684,0.6542363559985378,1.0,9/34,14.72%,GDI1;RUFY3;LRP4;APPL2;HOOK3;RHOA;IL6;TNF;NF1
prerank,regulation of programmed cell death (GO:0043067),0.35749789253644126,1.1052963114476817,0.2807731434384537,0.6545214198683664,1.0,63/161,29.77%,CTSB;SGK1;CDK5;TRAF2;SOX9;RBM25;MALT1;GLS2;BAX;RABGGTB;HS1BP3;LGALS1;VCP;BCL6;TRIAP1;NDRG1;ASAH1;DAPK1;BCL2L11;TNFSF9;AIFM2;RAF1;RIPK3;MARK4;CRADD;BID;USP36;HAX1;TNF;ACTN1;HIP1;ANP32E;WFS1;PTPN6;BIRC2;STEAP3;BEX2;DDX42;ACTN2;KANK2;CREBBP;CALR;NF2;DAXX;OLFM4;ACTN4;ABL1;APAF1;AKT1S1;OMA1;DFFA;FBXO11;IRF3;JAK3;TNFRSF25;TARDBP;BNIP3;BNIP3L;RABGGTA;PSMC5;SKP2;ALK;PRELID1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4090445913600343,1.1052084774438486,0.32189349112426036,0.6543460276672205,1.0,6/38,9.15%,XDH;PIK3CB;DAG1;PPP2R5C;PLEKHA1;DDIT3
prerank,negative regulation of protein processing (GO:0010955),0.499568401253892,1.1046344604445753,0.3546099290780142,0.6554570733539047,1.0,4/12,17.51%,CTSZ;SERPINE2;SERPINF2;SERPINE1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.47953003302037517,1.1044677120354833,0.3469945355191257,0.6554900278274626,1.0,6/15,26.40%,TGFBR2;TGFBR1;FGFR2;MTHFD1;PDGFRA;EIF4A3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4489995677736423,1.1041783182156077,0.35714285714285715,0.6558316632594293,1.0,6/21,16.69%,XYLT1;HS3ST3B1;HS6ST1;HPSE;XYLT2;EXTL3
prerank,glucose metabolic process (GO:0006006),0.388408264711557,1.1041079804345626,0.31929046563192903,0.6556042622902841,1.0,10/58,10.81%,SORD;PPARD;GAA;SLC25A1;AKR1A1;ALDOA;PCK2;ENO2;PGK1;ENO1
prerank,protein glycosylation (GO:0006486),0.36366977603112915,1.1041037885829363,0.28440366972477066,0.6552134137909322,1.0,19/125,10.45%,B4GALT5;MAN1C1;LARGE1;MGAT5;GALNT7;B4GALT7;B4GAT1;TRAK1;GCNT2;STT3B;B3GALNT2;TET3;ALG10B;DPAGT1;NPC1;MAGT1;ST8SIA6;OGA;ST3GAL2
prerank,mitotic nuclear membrane organization (GO:0101024),0.3871993847500518,1.1039519784563632,0.3363533408833522,0.6548066575125868,1.0,19/51,26.96%,NUP205;CHMP4B;CHMP4A;CCNB1;NUP188;REEP3;AHCTF1;PPP2R1A;ANKLE2;SIRT2;LEMD2;SUMO1;NUP133;NUP93;LMNA;NUP98;CHMP7;IST1;NUP35
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3871993847500518,1.1039519784563632,0.3363533408833522,0.6548066575125868,1.0,19/51,26.96%,NUP205;CHMP4B;CHMP4A;CCNB1;NUP188;REEP3;AHCTF1;PPP2R1A;ANKLE2;SIRT2;LEMD2;SUMO1;NUP133;NUP93;LMNA;NUP98;CHMP7;IST1;NUP35
prerank,regulation of myoblast fusion (GO:1901739),-0.4272432312998041,-1.1038763696002596,0.3238434163701068,0.7089730775745818,1.0,2/11,12.45%,MAPK14;RIPOR2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.40846689573287387,-1.1036121682575697,0.3007518796992481,0.7069344708064489,1.0,6/12,14.95%,EPHA4;NFIB;EPHB1;PAFAH1B1;MYCBP2;SPTBN4
prerank,rRNA metabolic process (GO:0016072),0.35499457947829616,1.1035506858045865,0.2874617737003058,0.6554643413166763,1.0,53/160,25.00%,C1D;RRP7A;ERN2;DDX49;NOLC1;ESF1;UBA52;WDR12;DDX52;NOL6;RRP12;RPL10A;MDN1;WDR43;RPL12;UTP14A;LYAR;UTP20;RPL36;NOL8;EXOSC9;RPS6;KRR1;RPS28;RPL13A;EXOSC10;RRP9;RRP1B;RRP1;DKC1;PIH1D1;SNU13;WDR3;EXOSC5;UTP11;MRM2;UTP4;RPL18;BYSL;TRIR;RPF1;EXOSC4;RPS2;XRN2;PDCD11;RPS19;NVL;RPS7;XRN1;NOP14;RPL17;RPL23;BMS1
prerank,sodium ion transport (GO:0006814),0.37091090892101863,1.1030093357553308,0.3308900523560209,0.6565133270065211,1.0,21/85,22.35%,FGF13;SGK1;SLC23A1;SLC6A6;ASIC3;SLC6A7;SLC24A4;SLC6A4;ANO6;SLC38A7;SLC8A1;ATP1A4;SCN1B;ATP1B3;ASIC1;SCN3B;SLC4A4;SLC5A6;SLC6A8;SCN10A;HCN4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.394957592699124,1.1027080000156566,0.35,0.6569449622485575,1.0,17/52,21.02%,CNOT4;PATL2;PATL1;NT5C3B;CNOT10;EDC4;EXOSC9;CNOT6;POLR2D;DCP2;EXOSC5;CNOT9;LSM6;PAN3;EDC3;EXOSC4;PAN2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4781793701553274,1.1026165812208688,0.3524804177545692,0.6567800577993752,1.0,3/16,14.18%,SLC27A1;ABHD5;CTDNEP1
prerank,negative regulation of innate immune response (GO:0045824),0.4129940828913409,1.102254598835545,0.3361144219308701,0.6573283545899855,1.0,8/34,12.87%,NLRC3;A2M;PTPN2;TTLL12;ACOD1;YTHDF2;LYAR;TNFAIP3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4048390979210052,-1.1022248244844635,0.29545454545454547,0.7078444998954986,1.0,7/13,16.38%,GRIK2;SLC4A10;RAB3A;SHISA6;SLC8A2;SYP;SHISA9
prerank,mitotic cytokinetic process (GO:1902410),0.44551335926023433,1.1015039532838007,0.34889753566796367,0.6589258070570451,1.0,5/20,11.62%,CHMP4B;CHMP4A;PDCD6IP;VPS4B;RHOA
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4925385004637506,1.101381518899164,0.3651685393258427,0.6588252514737826,1.0,5/13,19.83%,AXL;GAS6;TICAM1;AP1G1;LAMP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.33063527143174953,-1.1013209040362844,0.2602040816326531,0.7075039393729768,1.0,5/27,8.63%,IL1RAPL1;CTNNA2;NCS1;NTNG1;PSEN1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.298010364212469,-1.1011778177294356,0.2740740740740741,0.7051212874946332,1.0,6/40,4.16%,TMEM119;MEF2C;ALOX5;GPM6B;ACVR2B;BMPR1B
prerank,cellular response to interferon-beta (GO:0035458),0.4929314236594855,1.1005039633809408,0.3627450980392157,0.660749723891284,1.0,5/14,17.43%,TRIM6;IRGC;ACOD1;AIM2;IRGM
prerank,positive regulation of developmental process (GO:0051094),0.35410221531313135,1.100380031308412,0.28368794326241137,0.6606703253055436,1.0,39/164,21.82%,B4GALT5;CORO1C;NIBAN2;APOE;DDHD1;SLC6A6;LLPH;BMP1;AGO2;DAG1;VEGFA;SOX9;BASP1;KMT5B;ZDHHC15;FZD4;SRF;NUMA1;C1QBP;RBM19;SERPINF2;PHLDB1;VPS35;ZBED3;TNF;ZDHHC6;DLG4;CPEB3;BMP5;TFRC;CORO1B;FST;XBP1;FBXO5;RALBP1;GDNF;PDGFB;FIS1;ZBTB16
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4997721372680707,1.1001793203492956,0.3736559139784946,0.6607756861452854,1.0,2/13,3.85%,PRICKLE1;SOX9
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.42122014327165025,1.0999572426849866,0.3602409638554217,0.6609656092219746,1.0,10/30,20.71%,SLC27A5;ABCD4;HACD2;ABCD2;ACSL1;ACSBG1;ACOT1;HACD1;ELOVL2;TECR
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.39490807037912645,1.099635475750979,0.35266821345707655,0.6614224825151371,1.0,13/43,21.24%,FOXN3;FZR1;TAOK3;BRCA1;ABRAXAS1;UIMC1;BABAM2;TAOK1;BLM;BRCC3;HUS1;TOPBP1;INTS3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.47781368681063985,1.0995267427190913,0.36473755047106327,0.6612986800929179,1.0,4/15,14.62%,HIF1A;TICAM1;IL6;TNF
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.30586352637290715,-1.0992482042921154,0.3005464480874317,0.707842618221336,1.0,7/32,9.81%,NAV3;TUBB4A;MAP2;CLASP2;APC;STMN1;HDGFL3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3827610527834132,-1.0991586124757597,0.30638297872340425,0.7053242358445683,1.0,5/17,14.50%,PDE3B;SORL1;IL1B;ADRA2A;GPLD1
prerank,mRNA export from nucleus (GO:0006406),0.3664630063716111,1.0988871770582804,0.30561330561330563,0.662520666229591,1.0,37/102,27.85%,NUP205;DDX39B;SRSF11;NUP188;PABPN1;THOC1;RAE1;SYMPK;RBM15B;THOC2;CHTOP;EIF4E;NUP42;SRSF2;HNRNPA2B1;TPR;UPF3B;POLR2D;MCM3AP;SRSF7;THOC6;SRRM1;NUP54;SMG1;NXF1;SRSF1;RANBP2;NUP133;NUP93;WDR33;NUP98;EIF4A3;NUP35;AAAS;SRSF3;DDX39A;UPF2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.47176307667208167,1.0985351722502916,0.3452054794520548,0.6630135888686952,1.0,8/16,27.92%,TNKS2;SLX4;ERCC4;HNRNPA2B1;TERF1;PARP1;DHX36;TERF2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.375390812804817,1.0981838057659326,0.31969860064585576,0.6635141035007511,1.0,13/69,12.06%,IGF1;PLCB4;PIK3CB;GAB2;PLCB2;PLEKHA1;PIK3R5;PI4KA;PIK3R2;IGF1R;RHOA;C1QBP;OGT
prerank,regulation of cardiac conduction (GO:1903779),0.3844131836824968,1.0981151658671042,0.3395604395604396,0.6632797605341937,1.0,13/54,18.29%,ASPH;ATP2B1;NPPA;FXYD4;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP2A2;ATP1B3;NPPC;FKBP1B;AHCYL1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3992483308178305,-1.097913940473891,0.34980988593155893,0.7060286163875684,1.0,6/14,12.13%,DMD;ANK3;GLRX;WNK1;WNK3;CHP1
prerank,glycerophospholipid metabolic process (GO:0006650),0.37771816301501077,1.0978948915013167,0.34796573875803,0.6634629506846853,1.0,19/75,20.12%,PLEK;ABHD12;PON1;PIGQ;GDPD3;PLCB2;SMPD4;PIGZ;DGKH;PIGN;PIGL;CPNE3;CPNE6;PIGX;PNPLA6;PIP5K1A;HDHD5;CLN3;SYNJ1
prerank,neuron differentiation (GO:0030182),-0.23337222571995425,-1.0977246587678589,0.11764705882352941,0.7038397834919793,1.0,30/165,15.34%,ATP8A2;IL1RAPL1;OPHN1;TENM2;PTPRD;PBX3;MEF2C;FUT9;MYT1L;EPHA5;ACSL4;NTRK2;RUNX3;TENM4;WNK1;VXN;WNT5B;ERCC3;TENM3;PBX1;NRBP2;CASP3;SNPH;IER2;WNT5A;DDIT4;BRSK1;WNT2B;TGFB2;INHBA
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5198279174594244,1.097579554251208,0.37058823529411766,0.6639075626662228,1.0,5/10,25.46%,CAV1;MVP;TESK1;ERRFI1;IMPACT
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4166197324413904,1.097475148025466,0.36481700118063753,0.663768321632432,1.0,4/35,4.30%,NRP2;NRP1;PLXNA2;FLNA
prerank,organelle assembly (GO:0070925),0.3466039494552902,1.0974045369281307,0.204,0.6635576357253073,1.0,113/385,24.62%,SH3PXD2B;ASAP1;ATG7;DYNC1H1;TEKT2;RUFY4;TUBGCP4;FOXJ1;ATP6V0D1;PTPN23;HAUS8;CHMP4B;CHMP4A;IFT43;FLNA;NEK6;TMEM41B;RAB32;RAB8B;TEKT5;PATL2;PACS2;PATL1;SNX10;STAM2;HPS1;LSM14A;OGFOD1;WDR45;ARMC9;STARD9;RILPL2;VTA1;PDCD6IP;IFT88;RILPL1;SPAG16;RAB7A;VPS4B;YTHDF2;ATXN2;UBAP2L;IFT74;EIF4ENIF1;CSNK1D;RAB1A;EXOC2;BECN1;MAK;CENPT;TCTN3;ATG2B;DHX29;INO80;ATP2A2;MAP1LC3B;EHD4;WDR35;CEP250;CEP41;IFT122;CNGB1;FLII;CENPA;CCDC57;MVB12A;EXOC4;CIRBP;ATG16L1;IRGM;MAPRE1;CEP83;TMEM107;RILP;ATP6V1D;GOLGA2;DNAH5;TRAF3IP1;UNC119B;BBS2;SYNPO;G3BP1;HDAC3;EDC3;STX7;TMEM17;LZTFL1;DYNLT2B;KLHL41;CFAP70;ACTR3;PRRC2C;ATG13;EIF2S1;EIF2A;NOTCH1;CFAP298;DYNC2I1;HAUS2;PARVA;GSN;UBQLN1;WDR19;GABARAP;CPLANE1;CSDE1;AMBRA1;KIF3A;TRAPPC14;CHMP7;TMEM216;UBQLN2;CENPW
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4014825866388465,1.0972848422533301,0.34615384615384615,0.6634683722593351,1.0,9/40,15.74%,FLT1;ABL2;FGF2;GNAQ;PLCB2;C5AR1;ARHGAP6;EDNRA;HTR2B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.44027296556231815,1.097078761138902,0.3553299492385787,0.663598189719307,1.0,6/22,17.57%,HSCB;IBA57;ISCA1;HSPA9;CIAPIN1;MMS19
prerank,ncRNA processing (GO:0034470),0.3498898327628379,1.0970704524151706,0.2786220871327254,0.6632193127025191,1.0,61/200,23.09%,C1D;AARS1;AGO2;RRP7A;DDX49;NOLC1;ESF1;UBA52;WDR12;DDX52;NOL6;RRP12;RPL10A;MDN1;WDR43;RPL12;UTP14A;LYAR;UTP20;INTS6;RPL36;NOL8;EXOSC9;RPS6;KRR1;RPS28;RPL13A;AGO3;HNRNPA2B1;EXOSC10;RRP9;RRP1B;RRP1;DKC1;PIH1D1;SNU13;AGO4;ZCCHC8;WDR3;EXOSC5;UTP11;INTS2;FARS2;MRM2;UTP4;SARS1;RPL18;BYSL;POP1;ADAR;RPF1;EXOSC4;RPS2;XRN2;SMAD1;INTS3;PDCD11;RPS19;NVL;RPS7;METTL3
prerank,diacylglycerol metabolic process (GO:0046339),0.44800723773079665,1.0968050013083546,0.3554987212276215,0.663480097947817,1.0,4/23,8.80%,DGKZ;APOA2;DGKH;DGKD
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4937530628692498,1.0966243102954725,0.35939643347050754,0.6635783584010935,1.0,4/13,14.13%,RHOQ;AK4;AK3;EFL1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.47697757261583246,1.0966227631954477,0.37177747625508817,0.6631814023152,1.0,1/15,0.15%,CSPG4
prerank,regulation of innate immune response (GO:0045088),0.3853664287945648,1.0965488123510676,0.32486187845303865,0.6629825947712564,1.0,21/57,23.50%,FGR;NLRC3;ADAM8;POLR3D;APPL2;TREM2;ACOD1;RNASEL;LYAR;DHX9;TNFAIP3;RIOK3;PTPN1;PTPN6;BIRC2;IFNAR2;TIRAP;IFI35;POLR3B;PTPN11;HSP90AB1
prerank,protein monoubiquitination (GO:0006513),-0.30499206109824967,-1.0964088867112918,0.2695035460992908,0.7046923104856482,1.0,13/36,21.18%,DTX3L;ATXN7L3;UBE3D;UBE2W;KBTBD8;PRKN;PEX12;FANCL;UBE2B;UHRF1;CDC73;UBE2T;UBE2O
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.41341772130956134,1.09601184827635,0.3369434416365824,0.6639730791611405,1.0,12/31,26.47%,GPNMB;CDK6;WEE1;PRMT2;CDK4;CDK2AP2;DACT1;KANK2;PTEN;RBL1;DCUN1D3;BRD7
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4294679253607635,-1.095833415341168,0.33647798742138363,0.7035306546312063,1.0,7/10,25.25%,SORL1;DNAJB1;DNAJA4;SACS;DNAJB2;HSPA1A;HSPA1B
prerank,glucose transmembrane transport (GO:1904659),0.46476045710462777,1.0955747693942817,0.3619791666666667,0.664706208851517,1.0,5/18,18.83%,PPARD;SLC2A1;SLC5A3;SLC2A6;SLC2A8
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4050104769569551,1.095573672586652,0.3653179190751445,0.6643064078301367,1.0,14/39,22.59%,ERCC1;UBA52;DDB2;DDB1;ERCC4;XPA;RFC2;RPS27A;UBC;RFC1;GTF2H1;ERCC2;CUL4A;PARP1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5014594528323102,1.0955695180263636,0.3729050279329609,0.663916448652493,1.0,1/12,0.42%,CTNNB1
prerank,regulation of viral entry into host cell (GO:0046596),-0.3163808401499742,-1.0953683599809376,0.2696629213483146,0.702240631611896,1.0,8/30,12.01%,HS3ST5;CD74;TRIM27;LY6E;IFITM3;CIITA;LGALS9;NECTIN2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3420536150725954,1.094954024995699,0.17,0.6651322447742728,1.0,150/572,22.97%,FNIP2;MITF;DNMT3A;ATF3;NFIC;ZHX2;SDCBP;UXT;ARID5B;TGIF1;CUX1;SOX30;VDR;PPARD;NOC2L;RUNX1;FOXJ1;VEGFA;DAB2;SHOX2;SOX9;KMT5A;LRRFIP1;CHD3;NFX1;IRF8;BHLHE41;PPARG;NFIL3;MDFI;HDAC4;BHLHE40;SMAD7;ID2;BPTF;RNF2;UBA52;CC2D1A;NKX2-1;HDAC9;ETV6;MNT;SKI;DLL4;BCL6;USP9X;NUPR2;MTF2;SUDS3;THAP7;KLF12;JUN;CAV1;SMYD2;ZBTB2;DDIT3;NFKB1;TAF7;DNMT3B;SRF;NR3C1;EED;TLE5;WWP2;MIER2;ENO1;ZKSCAN3;BAG3;LYAR;MDM2;ZNF148;ELK4;PLK3;C1QBP;ATXN1;USP2;CBX2;FNIP1;TPR;ZGPAT;EFNA1;GATAD2B;HCFC1;IRF2BP2;ZBTB7B;TNF;ATN1;RPS27A;UBC;ZNF177;NFATC3;ZEB2;FOXP4;YY1;TCF25;CPEB3;SUFU;ZFP57;FLCN;HDAC1;SNW1;ZBTB4;NOTCH4;YEATS2;PURA;KLF10;WWOX;SARS1;CNBP;WFS1;MED1;DACT1;HSF1;FRK;HDAC3;ZNF568;FST;ID1;EPO;LDB2;LDB1;HNRNPU;FGFR2;CCND1;NEDD4;LCOR;SIRT2;MTDH;PDGFB;DMAP1;SUMO1;NSD1;CREM;THAP1;RXRA;MTA3;GATAD2A;NOTCH1;BMI1;GZF1;ZBTB16;KANK2;CREBBP;TMPRSS6;CALR;SMARCA4;PARP1;KDM1A;MCPH1;PER3
prerank,regulation of osteoblast differentiation (GO:0045667),0.37076008099211416,1.0949492666375098,0.32037815126050423,0.6647459976601126,1.0,11/82,8.74%,IGF1;CDK6;NELL1;SOX9;PPARG;BAMBI;NOCT;HDAC7;RIOX1;SKI;SUCO
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3406130094939358,1.0947703890738967,0.126,0.6648087061430731,1.0,210/807,23.03%,FNIP2;MDFIC;MITF;DNMT3A;CTNNB1;ATF3;NIBAN2;NFIC;ZHX2;SDCBP;UXT;ARID5B;TGIF1;CDK5;MUC1;PRICKLE1;FOXN3;CUX1;SOX30;VDR;PPARD;NOC2L;ING4;RUNX1;FOXJ1;VEGFA;DAB2;SHOX2;SOX9;KMT5A;ERN2;LRRFIP1;CHD3;RCOR1;NFX1;BASP1;FLNA;IRF8;BHLHE41;PPARG;NFIL3;MDFI;CEBPA;HDAC4;BHLHE40;SMAD7;GMNN;CIC;ID2;BPTF;TRIM28;RNF2;BAP1;UBA52;NKX2-1;HDAC9;ETV6;MNT;RIOX1;SKI;DLL4;BCL6;USP9X;GAS6;NUPR2;MTF2;SUDS3;BRCA1;THAP7;KLF12;JUN;CAV1;SMYD2;ZBTB2;ATF5;CBX3;DDIT3;RCOR3;NFKB1;TAF7;DNMT3B;NR3C1;EED;EHMT1;TLE5;ELK3;WWP2;MIER2;PRMT6;RBM15B;ENO1;ZKSCAN3;LYAR;LIMS1;MDM2;ZNF148;ELK4;PLK3;C1QBP;ATXN1;USP2;SCML4;CREBZF;PRMT2;PEX14;NAB2;CBFA2T2;CBX2;USP47;FNIP1;FBXW11;TPR;ZGPAT;MYBBP1A;EFNA1;GATAD2B;HCFC1;L3MBTL2;IRF2BP2;ZBTB7B;MIDEAS;TNF;UIMC1;ATN1;RPS27A;UBC;ZNF177;MAF1;ZEB2;SBNO2;FOXP4;YY1;TCF25;CPEB3;SUFU;ZFP57;FLCN;HDAC1;SNW1;ZBTB4;NOTCH4;PCGF6;YEATS2;DPF3;KAT7;PURA;KLF10;WWOX;KDM2A;YAF2;QARS1;GCFC2;SARS1;PIAS4;SFRP1;RBFOX2;CNBP;WFS1;MED1;BAHD1;LOXL3;DACT1;HSF1;FRK;HDAC3;ZNF568;FST;ID1;EPO;LDB2;LDB1;HNRNPU;DAP;MPHOSPH8;FGFR2;ARID4A;POU2F1;CCND1;TGFB1;LCOR;SIRT2;MTDH;PDGFB;DMAP1;SUMO1;NSD1;CREM;THAP1;RXRA;MTA3;GATAD2A;NOTCH1;BMI1;GZF1;ZBTB16;KANK2;CREBBP;TMPRSS6;CALR;PHC2;XRCC5;SMARCA4;PARP1;MTERF3;PHF10;HIC2;KDM1A;MCPH1;PER3;SET
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5039852823275857,1.0946397371147591,0.38376891334250346,0.6647792047796172,1.0,7/12,36.45%,ACSL1;SCP2;ELOVL2;ACOT8;FADS1;ELOVL1;ACOX1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3975148167220385,1.0943900041168828,0.36470588235294116,0.6650570843301418,1.0,19/38,29.50%,FBXW7;BAP1;CSNK2A2;PARL;USP36;HUWE1;SAE1;HAX1;UBE2L3;RHOU;VPS11;ATG13;LMAN1;SH3GLB1;NPEPPS;ATP5IF1;LEPROT;HTRA2;ARIH2
prerank,regulation of cellular pH (GO:0030641),0.4224844261411381,1.0943546558130939,0.35828220858895704,0.6647482885010514,1.0,10/29,19.18%,SLC9A1;SLC9A8;SLC9A7;SLC9A6;SLC4A9;SLC4A2;ATP1A4;ATP6AP1;SLC4A4;CLN3
prerank,chromatin assembly (GO:0031497),0.4021451367233745,1.0938262491430988,0.35064935064935066,0.6657547683685736,1.0,14/38,26.93%,NOC2L;GRWD1;SOX9;CHAF1B;PRDM9;BAHD1;SART3;ASF1A;CDAN1;DAXX;NAP1L3;NAP1L2;H3-3A;RSF1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4590162184363176,1.0937311109223125,0.36215538847117795,0.665599321076093,1.0,8/20,20.66%,BCL2L1;DAB2;RHOQ;PKDCC;PID1;TMBIM1;PPFIA1;TGFB1
prerank,establishment of vesicle localization (GO:0051650),0.4638685457282625,1.0937134424298156,0.38026315789473686,0.6652386192760326,1.0,4/18,11.40%,CDK5;DNM2;TMEM230;TESK1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.367215803023529,1.0935438926899024,0.30962343096234307,0.6652840222881832,1.0,35/96,27.85%,NUP205;DDX39B;SRSF11;NUP188;THOC1;RAE1;SYMPK;RBM15B;THOC2;CHTOP;EIF4E;NUP42;SRSF2;HNRNPA2B1;TPR;UPF3B;MCM3AP;SRSF7;THOC6;SRRM1;NUP54;SMG1;NXF1;SRSF1;RANBP2;NUP133;NUP93;WDR33;NUP98;EIF4A3;NUP35;AAAS;SRSF3;DDX39A;UPF2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3781376600849892,1.09348661393878,0.32426550598476606,0.6650411062102972,1.0,14/68,17.14%,AMPD2;ACOT9;RHOQ;AK4;AK3;SULT6B1;ADSS1;GLYAT;TPST1;SULT2B1;ACOT6;EFL1;ACOT1;BPNT2
prerank,diol metabolic process (GO:0034311),0.45571240639138344,1.0932804979263573,0.37012113055181695,0.6651336590864171,1.0,3/19,5.56%,SPHK1;PLPP3;SPHK2
prerank,positive regulation of protein kinase activity (GO:0045860),0.35096290463034246,1.0931306960477576,0.2992849846782431,0.6651332238443828,1.0,39/148,19.80%,IQGAP1;CSF1;LAT;PTPRC;SLC27A1;PTK2B;PRKCD;ALS2;PAK6;VEGFA;CAB39;STK3;NEDD9;TAOK3;SLC11A1;GAS6;STOX1;PAK2;JTB;TGFBR2;RHOA;GPRC5B;RIPK3;NAB2;MAP2K3;EFNA1;TNF;MINK1;PIH1D1;DLG4;CALM2;DOK7;IRGM;PRKAG1;MAP2K2;PTPN1;MARK2;TAOK1;STK11
prerank,mRNA transport (GO:0051028),0.3644826781420958,1.0928022866963403,0.31392931392931395,0.6655603895590158,1.0,37/101,28.50%,NUP205;DDX39B;SRSF11;NUP188;THOC1;RAE1;SYMPK;RBM15B;THOC2;CHTOP;EIF4E;NUP42;SRSF2;HNRNPA2B1;TPR;UPF3B;MCM3AP;SRSF7;THOC6;SRRM1;NUP54;SMG1;ARC;NXF1;SRSF1;RANBP2;NUP133;NUP93;WDR33;NUP98;EIF4A3;NUP35;AAAS;SRSF3;DDX39A;UPF2;FMR1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3447224102961257,1.092605938712046,0.264,0.6656506115985856,1.0,42/268,13.78%,CACNA1A;TRPC4;P2RX4;ATP6V1A;SLC9A1;KCNK13;SLC6A6;MCOLN2;ASIC3;LRRC52;CACNA1D;KCNA3;ATP6V0D1;SLC6A7;SLC46A1;KCNJ2;CCDC51;SLC9A8;SLC24A4;UCP2;SLC9A7;SLC9A6;SLC6A4;TRPM7;ANO6;MCOLN3;SLC11A1;GAS6;SLC39A7;KCNH8;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP2A2;KCNN4;SLC39A11;KCNA4;SCN1B;ATP1B3;ATP6V0A4;ATP6V1F
prerank,transition metal ion transport (GO:0000041),0.4130040324795878,1.0922072579987934,0.34624697336561744,0.6663050293768734,1.0,9/35,21.67%,TRPC4;SLC31A2;SLC11A1;ATP7A;MELTF;TFRC;ATOX1;ATP7B;SLC30A9
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.42431124201462017,1.0921900281761368,0.36319612590799033,0.66595303917778,1.0,7/26,20.66%,HIF1A;BRCA1;CYP1B1;IL6;HPSE;SARS1;TGFB1
prerank,protein localization to phagophore assembly site (GO:0034497),0.512595243646061,1.0916317765538874,0.36428571428571427,0.6669725797431397,1.0,3/11,6.66%,TRAPPC8;PACS2;WDR45
prerank,regulation of establishment of protein localization (GO:0070201),0.47878136366317575,1.0912467606601095,0.3825503355704698,0.6675540902250535,1.0,6/14,24.85%,CTSD;TREM2;CEP120;GAPVD1;CEP295;DNAJA1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2539326285422573,-1.0910313056550847,0.27419354838709675,0.7114887484622204,1.0,23/69,18.91%,COX7B;COX6A1;COX8A;NDUFS3;NDUFV3;NDUFB9;UQCRC1;NDUFS4;COX5A;NDUFS5;UQCRFS1;NDUFB7;NDUFA10;NDUFB10;COX15;COX4I1;UQCC3;NDUFA4;COX7C;NDUFS2;COX6B1;COA6;NDUFA5
prerank,nuclear membrane reassembly (GO:0031468),0.3810410077670844,1.090857851217403,0.3483652762119504,0.6681478575538452,1.0,19/54,26.96%,NUP205;CHMP4B;CHMP4A;CCNB1;NUP188;REEP3;AHCTF1;PPP2R1A;ANKLE2;SIRT2;LEMD2;SUMO1;NUP133;NUP93;LMNA;NUP98;CHMP7;IST1;NUP35
prerank,endothelial tube morphogenesis (GO:0061154),0.5167560722330775,1.0907793613533883,0.3870481927710843,0.667939192411564,1.0,2/10,11.62%,CTNNB1;RHOA
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4786240763606725,1.0907230555164495,0.356763925729443,0.6676882800372134,1.0,8/15,28.25%,SMAD7;LIMK1;FBXO5;RPS7;ABL1;RPL23;BAG5;BAG2
prerank,protein localization to synapse (GO:0035418),-0.39356035145725543,-1.0905277154292947,0.3225806451612903,0.7101151880307963,1.0,2/12,0.55%,NRXN1;NLGN1
prerank,aerobic respiration (GO:0009060),0.4431435348271506,1.090323493329717,0.36862244897959184,0.6683289194267539,1.0,11/20,27.50%,NDUFS7;SURF1;SIRT3;SDHB;SLC25A14;UQCRH;UQCR10;NDUFS8;MTFR1L;SDHC;MTFR1
prerank,regulation of synapse organization (GO:0050807),-0.3400826704286639,-1.0901551744816882,0.3191489361702128,0.7086068277568786,1.0,7/26,7.33%,IL1RAPL1;MEF2C;CTNNA2;CDKL5;EPHA4;PDLIM5;SLITRK4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4302567414307791,1.0901088472245801,0.36466165413533835,0.6684982151964893,1.0,8/26,20.21%,EIF6;BRCA1;LPGAT1;ACADL;ADIPOR1;SLC45A3;MID1IP1;WDTC1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.39977148500473547,-1.0900876417525507,0.3230088495575221,0.7061073197384151,1.0,4/14,8.36%,PKIG;RAPGEF2;PRKAR2A;PRKAR2B
prerank,phosphate-containing compound metabolic process (GO:0006796),0.34917829460253663,1.0899421975437786,0.2878787878787879,0.6685461991491971,1.0,46/198,20.66%,LPL;CERK;ITPKB;PLCB4;PIK3CB;PTPRC;CDK5;GPD2;SPHK1;GK;GCK;NUDT5;PLAAT3;PFKFB3;INPPL1;PFKL;PLCB2;PLPP3;SPHK2;ALDOA;PI4KA;ACYP1;PGK1;PAK2;PLAA;HK3;DUSP15;INPP5A;DUSP12;HTR2B;PNKP;ISYNA1;INPP4A;PIP4K2A;MAPK3;DUSP3;PFKP;HK1;AGPAT1;PLA2G5;TAOK1;CLN8;SYNJ1;NADK;PIK3CA;TGFB1
prerank,chromosome condensation (GO:0030261),0.4047103128140503,1.0899410688920506,0.3566350710900474,0.6681523638523932,1.0,8/36,10.73%,NCAPG;KMT5A;ERN2;NCAPG2;CCNB1;DFFB;ACIN1;CSNK2A2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4310897079976436,1.0897555728304704,0.37055214723926383,0.6682747956724165,1.0,4/26,9.73%,SPHK1;SPHK2;ASAH1;CYP1B1
prerank,primary miRNA processing (GO:0031053),-0.43241441588616236,-1.0897423869862706,0.36012861736334406,0.7044654099629141,1.0,4/10,13.01%,DROSHA;SMAD2;MRPL44;DGCR8
prerank,protein homotetramerization (GO:0051289),0.38602723735745437,1.0896849351368323,0.34811529933481156,0.6680595559638564,1.0,23/49,32.61%,ACACA;KCNJ2;GNMT;APPL2;GLS;ALDOA;OSBPL2;ACACB;APIP;GOLGA2;USP16;TK1;ACOT13;CTH;SOD2;B2M;PKD2L1;SHMT1;AQP4;CBR4;HPRT1;SHMT2;THG1L
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.48107658353331273,1.0896088306872838,0.37907608695652173,0.6678586773716881,1.0,1/14,0.18%,CD84
prerank,positive regulation of stem cell proliferation (GO:2000648),0.45831856486059014,1.0890650211320023,0.3724137931034483,0.6688913095057232,1.0,6/17,24.69%,PTPRC;TERT;KAT7;HNRNPU;KDM1A;N4BP2L2
prerank,histone lysine demethylation (GO:0070076),0.43367009362039804,1.089024878147947,0.36159600997506236,0.6685933865239114,1.0,12/25,28.59%,JMJD1C;KDM3A;RIOX1;KDM4D;RIOX2;KDM2A;PHF2;KDM3B;KDM1A;HR;KDM4B;KDM5C
prerank,neurogenesis (GO:0022008),0.3934729927229237,1.0889979012193127,0.36189402480270577,0.6682584691717439,1.0,5/43,10.97%,ERCC6;CDK6;TRAK1;FAT4;THOC2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4823755136315869,1.0887858368987455,0.3748326639892905,0.668425071463467,1.0,6/13,25.94%,NIBAN2;PTPN1;NEDD4;CADM4;EMILIN1;PDCD6
prerank,cognition (GO:0050890),0.39419033693983757,1.0884559666806233,0.338654503990878,0.6688691037616622,1.0,9/42,14.72%,CHRNB2;PTCHD1;DOP1B;CYFIP1;MAGT1;CHD7;C5AR1;TNF;NF1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.39424633466442627,1.0881976938059845,0.35903337169159955,0.669119488485308,1.0,18/42,31.59%,ERCC6;PPP4C;ARID2;RAD51AP1;FIGNL1;MMS19;FUS;PPP4R2;PARP1;KDM1A;RAD51;SMCHD1;TERF2IP;WDR48;RIF1;ACTR2;SETD2;SPIDR
prerank,positive regulation of signaling (GO:0023056),-0.2955259934812987,-1.0879500784218554,0.2978723404255319,0.7066253158437626,1.0,6/37,5.48%,GRIK2;RIMS1;CLSTN2;SYT1;CLSTN3;RIMS2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4400944800866932,1.0872764688952454,0.3745173745173745,0.6711683594060622,1.0,6/23,13.32%,PTK2B;NPPA;PSEN2;CACNB1;UBASH3B;FYN
prerank,mitochondrion disassembly (GO:0061726),0.40889503189746823,1.0871669491789895,0.36018957345971564,0.6710612133204512,1.0,14/34,27.72%,ATG7;SQSTM1;WDR45;BECN1;ATG2B;MAP1LC3B;FBXO7;MARK2;FIS1;USP30;GABARAP;AMBRA1;ATG2A;BNIP3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4183793436459451,1.0871609621210108,0.36633663366336633,0.6706790506172404,1.0,12/28,30.11%,ERCC6;CYREN;KMT5B;KDM4D;SETMAR;PNKP;HSF1;SMCHD1;PARP9;PRKDC;RIF1;ACTR2
prerank,prostaglandin metabolic process (GO:0006693),-0.3247713832635296,-1.087069373809473,0.3016759776536313,0.7064603741635758,1.0,4/26,5.58%,HPGD;PTGS1;PTGDS;CD74
prerank,small GTPase mediated signal transduction (GO:0007264),0.3623071885845139,1.0867915099024836,0.34057971014492755,0.6712442229574864,1.0,35/103,24.57%,IGF1;ABR;LAT;FGF2;RASGRP3;GRB2;RIN2;SIAH2;PLK2;TRIM28;JUN;CRKL;NRAS;KRAS;BRAP;RAPGEF6;NTN1;GNB1;NF1;DNMT1;RGL2;RIT1;RASSF1;KRIT1;G3BP1;USP8;ARHGAP30;RALBP1;RHEBL1;SHOC2;CDK2;RRAGC;RRAD;RGS19;RALB
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.36520835677556635,1.086772738036795,0.3403141361256545,0.6709014007427091,1.0,23/86,24.10%,SDCBP;BMP8B;GDF6;DAB2;ADAM17;RBPMS;NUMA1;SH2B1;GIPC1;ZEB2;FLCN;SNW1;BMP5;TGFBR1;STK11;TGFB1I1;RNF111;TGFB1;NOTCH1;CREBBP;NUP93;HSP90AB1;EP300
prerank,regulation of biosynthetic process (GO:0009889),0.5098251366615778,1.086365758171186,0.37771345875542695,0.6715144980970645,1.0,5/11,19.43%,SPHK2;SLC25A33;CCN6;PIKFYVE;MID1IP1
prerank,glycoprotein catabolic process (GO:0006516),0.4592092195395262,1.0862710910349804,0.37912813738441214,0.6713697276799218,1.0,4/17,9.67%,MMP12;STT3B;EDEM1;OGA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3729316035800179,1.0861247349335352,0.3612004287245445,0.6713321848990692,1.0,20/67,25.05%,FLT1;ABL2;FGR;TEC;PTK2B;SYK;IGF1R;PKDCC;BTK;FYN;MAPK3;FES;PTPN6;ABI2;FGFR2;PDGFB;FGFR3;ABL1;LYN;PDGFRA
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4192340082978906,1.0857947064594589,0.3545232273838631,0.671780418810535,1.0,12/25,31.92%,SDCBP;ANKRD13B;LRPAP1;ATXN2;DLG4;ANKRD13A;ARF6;UBQLN2;RAC1;APOC1;ITGAV;ITGB3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3339252665909453,-1.0856607901948065,0.30939226519337015,0.7077580148868624,1.0,3/25,2.42%,OPHN1;EPHA4;PRKCG
prerank,positive regulation of locomotion (GO:0040017),-0.31301378261827284,-1.0856312031018023,0.29120879120879123,0.705254953332527,1.0,6/27,15.02%,P2RY12;CSF1R;AIF1;CFAP20;THBS1;SPOCK2
prerank,acetyl-CoA metabolic process (GO:0006084),0.4732318602203253,1.0855849066313403,0.3708609271523179,0.6719638345628375,1.0,4/15,12.26%,ACACA;DIP2A;PPCS;ACACB
prerank,vasoconstriction (GO:0042310),0.5009830830046528,1.0855011313919578,0.3806818181818182,0.6717772424253348,1.0,4/11,17.85%,SLC8A1;EDNRA;HTR2B;PIK3C2A
prerank,autophagy of mitochondrion (GO:0000422),0.4020741552301737,1.0853476696847526,0.3700696055684455,0.6717850633203586,1.0,13/38,24.01%,ATG7;SQSTM1;WDR45;BECN1;ATG2B;MAP1LC3B;FBXO7;MARK2;ATG13;FIS1;USP30;GABARAP;AMBRA1
prerank,DNA double-strand break processing (GO:0000729),0.4547870838059373,1.0849155629928509,0.37283621837549935,0.6725024833901653,1.0,6/18,19.61%,RAD50;SLX4;BRCA1;SETMAR;UBE2V2;BLM
prerank,regulation of cell adhesion (GO:0030155),0.352913171374663,1.0848699191318913,0.31584362139917693,0.6722413473838171,1.0,25/129,16.20%,PLAU;PLXNC1;ABL2;CYTH1;ADAM8;PTK2B;PLXNA2;VEGFA;ATXN3;RHOD;P4HB;MYADM;PPP2R1A;RASA1;YTHDF2;PLXND1;C1QBP;STX3;PKP4;EFNA1;TNF;MINK1;PLXNA1;FLCN;LPXN
prerank,protein lipidation (GO:0006497),0.37620410255790904,1.084521785967283,0.35313531353135313,0.6727317010552738,1.0,10/59,11.24%,ATG7;PIGQ;ZDHHC18;ZDHHC15;PIGZ;WDR45;PIGN;PIGL;ATG10;ZDHHC1
prerank,response to acidic pH (GO:0010447),0.48432318381617206,1.0838808998433054,0.3707250341997264,0.6740079485045481,1.0,8/13,28.91%,SLC9A1;GPR151;GPR65;IMPACT;PKD2L1;RAB11B;RAB11FIP5;PKD1L3
prerank,positive regulation of cellular senescence (GO:2000774),-0.4396060903707536,-1.08386128188374,0.35251798561151076,0.707448063692645,1.0,5/10,25.64%,ABI3;HMGA2;EEF1E1;ARG2;HMGA1
prerank,regulation of organelle assembly (GO:1902115),0.37052933050578785,1.0838153568872309,0.34582441113490364,0.6737887470446811,1.0,29/73,24.54%,TBC1D22A;TBC1D2;MSN;PLK2;RAB5A;TBC1D24;PDCD6IP;IFT88;ATXN2;TBC1D10A;NPRL3;TBC1D12;TBC1D16;TRAPPC12;CEP295NL;MAPK15;PIKFYVE;TBC1D20;VPS11;DYNLT2B;ALMS1;STX18;GSN;NPRL2;TBC1D1;CEP295;TBC1D15;TBC1D10C;UBQLN2
prerank,DNA damage checkpoint signaling (GO:0000077),0.42187037846696807,1.0836223247017094,0.36488169364881695,0.6738897054275752,1.0,6/28,20.11%,ERCC6;DOT1L;CHEK2;MAP3K20;RAD9A;HUS1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.417203516016734,1.0834694285330766,0.3614457831325301,0.6738817575004922,1.0,7/29,19.43%,APOE;SLC27A1;LPGAT1;SLC45A3;CTDNEP1;SIRT4;MID1IP1
prerank,regulation of transposition (GO:0010528),0.48754032444470985,1.0834202188911108,0.3829787234042553,0.6736201267555468,1.0,2/13,11.83%,PIWIL2;UBR2
prerank,regulation of lymphocyte activation (GO:0051249),0.4884359808522135,1.083359624103634,0.3901408450704225,0.6733877772585818,1.0,3/12,11.77%,LAT;CRTAM;THEMIS2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4201271125211123,1.0829326790333382,0.3833543505674653,0.6741192092140704,1.0,9/27,25.51%,AK8;AK4;AK5;AK6;GUK1;RRM1;GSR;DTYMK;TXNRD1
prerank,microvillus assembly (GO:0030033),0.47541676965088764,1.0827067567961453,0.38713910761154857,0.6743161576397547,1.0,5/14,16.57%,RAP2A;RAPGEF6;ESPN;MINK1;RAP2B
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3796228326970209,-1.0825305397031086,0.3617886178861789,0.7084921560834085,1.0,6/17,11.44%,CD86;RARA;PRKCZ;IRF4;LGALS9;SLC7A5
prerank,positive regulation of phosphorylation (GO:0042327),0.34392532995993624,1.0819718172060964,0.2961847389558233,0.6757789901776697,1.0,28/240,9.72%,GPNMB;IGF1;FLT1;HIF1A;PLAUR;SDCBP;RAP2A;FGF2;NRP1;CLDN19;VEGFA;DAB2;AXL;PFKFB3;SOX9;ADAM17;NPTN;NCKAP1L;MYDGF;RAD50;FGF20;GAS6;VAC14;CRKL;TREM2;KRAS;FXR2;IGF1R
prerank,actin filament network formation (GO:0051639),0.49951480738548176,1.081961823459729,0.37392550143266473,0.6754122214875552,1.0,1/11,0.32%,LCP1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4893237673981185,1.0819081814299458,0.3789173789173789,0.6751686713008505,1.0,4/13,16.44%,AGO2;EIF4ENIF1;CPEB3;PABPC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4732289573799617,1.0817033872871162,0.3807588075880759,0.6753055990851571,1.0,11/14,36.50%,SLC27A1;CHKB;LPIN3;CHKA;SELENOI;ETNK2;LPIN1;PCYT2;LPIN2;CEPT1;PISD
prerank,long-term synaptic potentiation (GO:0060291),-0.35155431837437573,-1.081576776952819,0.34309623430962344,0.7085431286131808,1.0,9/21,13.02%,TSHZ3;SLC8A3;GRIN2B;GRIN2A;RGS14;PRKCZ;MPP2;SLC8A2;SLC24A2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.28987247050016673,-1.0814869355124048,0.328125,0.706201067891097,1.0,9/41,8.15%,NOS1AP;AKAP6;GABBR1;KCNJ3;ANK3;CTSS;KCNN2;KCNMB2;STAC
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4454458909022617,1.0813126212042088,0.3743654822335025,0.6759095205036552,1.0,13/19,34.80%,IRF5;DHX9;HSPD1;TBK1;TLR7;CHUK;TLR3;IRF3;DHX36;SETD2;MAVS;DDX3X;RIPK2
prerank,hexose biosynthetic process (GO:0019319),0.39431916741587997,1.0812882000198383,0.3681765389082462,0.6755699652235615,1.0,10/42,19.91%,SORD;SLC25A1;ALDOA;PCK2;ENO2;PGK1;ENO1;RBP4;PGM1;SLC25A13
prerank,negative regulation of cellular component organization (GO:0051129),0.3703574509234426,1.0808327519150067,0.3629469122426869,0.6763880231275721,1.0,22/74,24.10%,LGALS3;MCTP1;APOA2;PON1;VEGFA;SNX33;DNAJB6;DNM2;LILRB1;RAF1;RIOK3;TNF;RUBCN;TRAF3IP1;HSF1;ABCA7;IAPP;HSPA2;XRCC5;CDC42;GSK3B;EP300
prerank,nuclear envelope organization (GO:0006998),0.4484488251114318,1.0807337946182556,0.3877551020408163,0.6762454435221156,1.0,13/20,34.98%,REEP3;CTDNEP1;SUN1;TOR1B;TMEM43;LEMD2;NUP93;NEMP1;TOR1AIP1;REEP4;EMD;DMPK;NUP155
prerank,somite development (GO:0061053),-0.40467039336278066,-1.0799550129715254,0.3448275862068966,0.7077018614794419,1.0,5/11,27.34%,PPP2R3A;MEOX2;SMO;SHH;SFRP2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.37944010582094734,1.0799504637068713,0.3559510567296997,0.6778869356137647,1.0,9/51,9.55%,GAS7;SGK1;ALS2;DTNBP1;NCKAP1L;SLC9A6;TAOK3;DNM2;ATP7A
prerank,positive regulation of response to external stimulus (GO:0032103),0.34827944993556903,1.0798688445442048,0.33401015228426395,0.6776980929842165,1.0,38/128,24.49%,LPL;SASH1;ADAM8;TNIP1;OPTN;CYBA;CEBPA;POLR3D;NFKBIZ;NINJ1;TREM2;ACOD1;NAPEPLD;GPRC5B;STX3;SERPINF2;PTGER4;CD180;DHX9;APOH;IL2;RIOK3;TNF;PUM1;SERPINE1;TLR7;SCARF1;CCN4;TGFB1;PDGFB;IL17RA;IFI35;POLR3B;PUM2;CCL3;SETD4;STX4;GPSM3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4705774985912091,1.0795536716577003,0.392235609103079,0.6781187947319138,1.0,8/16,23.94%,MCM2;MCM7;TWNK;PURA;RECQL5;BLM;MCM6;RAD51
prerank,chloride transport (GO:0006821),-0.25871441081963303,-1.0794906953404895,0.20689655172413793,0.7064179489095134,1.0,28/74,21.35%,GABRB3;GABRB2;GABRB1;GLRA3;ANO4;GABRG3;SLC4A10;SLC12A2;GABRA2;SLC12A9;SLC6A1;LRRC8A;GLRA2;GABRG1;SLC1A3;CLCN1;FXYD1;SLC12A8;GLRA1;SLC1A1;ANO7;GABRR2;SLC4A8;SLC12A6;SLC26A7;TTYH1;GABRE;GABRA1
prerank,cellular response to heat (GO:0034605),0.40587953736563775,1.0794528112843,0.3701527614571093,0.6779857242390755,1.0,18/35,29.34%,HMOX1;ATXN3;VCP;BAG3;TPR;POLR2D;HSF1;SUMO1;TCIM;IER5;DAXX;HSP90AB1;FGF1;PDCD6;DHX36;HSBP1L1;HTRA2;ZFAND1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3399099456067635,1.079003996333713,0.2772772772772773,0.678729534932007,1.0,81/327,22.42%,APBB2;MITF;CXXC1;ZMIZ1;HIF1A;NFYA;JMJD1C;FOXN3;TFEB;PAK6;PERM1;CHD3;NFX1;NFIL3;CEBPA;BHLHE40;RNF6;COPS2;SBNO1;PHF1;GON4L;CCAR1;CHD7;MTF2;TGFBRAP1;DNM2;THAP7;ATF5;PPIE;DDIT3;SERTAD3;CARM1;RNF14;PPP2R1A;NR3C1;GLRX2;MYBL2;CDK11B;ATXN1;ASCC2;NAB2;MYT1;MSL3;SP1;MYBBP1A;CHEK2;HCFC1;UBE2L3;SBNO2;SUFU;PPARGC1B;ZBTB4;ASCC1;KAT7;MAFB;TAF5L;USP13;POFUT1;UTP4;YAF2;GCFC2;CNBP;FOXN2;TGFBR1;HP1BP3;FUS;LDB1;RALY;RNF20;NSD1;GPBP1L1;CREM;THAP1;NOTCH1;GZF1;PRMT5;ZFAT;CREBBP;SRSF10;CALR;KMT2D
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34411141989471333,1.078972915323319,0.3208502024291498,0.678429394718035,1.0,38/190,16.07%,ARHGAP25;BCL2;BCL2L1;PLEK;PLAUR;XDH;NLRC3;PIK3CB;TNIP1;CD22;TANK;NOC2L;DAG1;MCL1;PPP2R5C;ARHGAP12;HDAC7;PRDM15;PLEKHA1;CAV1;DGKD;PIK3R2;TREM2;DDIT3;MYADM;ADIPOR1;NPRL3;MDM2;UBR2;TNFAIP3;FNIP1;MAP2K3;RIOK3;NF1;CCDC22;CARD19;FLCN;TNIP3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.45315100153519233,1.0789011247992797,0.37547892720306514,0.6782138846449068,1.0,8/20,20.66%,BCL2L1;DAB2;RHOQ;PID1;TMBIM1;PPFIA1;LZTFL1;TGFB1
prerank,regulation of myelination (GO:0031641),0.42448116946845976,1.078004811582892,0.36633663366336633,0.6801499109581828,1.0,10/25,25.21%,ITGAX;CST7;TNFRSF1B;EGR2;TMEM98;NCMAP;TNFRSF21;SIRT2;KLK8;MYRF
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5113128765666812,1.0779716614683492,0.40029542097488924,0.679838126902489,1.0,6/10,25.46%,JUN;NCK1;BAG3;SIRT2;HIF1AN;IMPACT
prerank,regulation of fatty acid oxidation (GO:0046320),0.46061215936771177,1.0777505521925277,0.3824324324324324,0.6799993089662139,1.0,5/16,19.02%,SOX9;APPL2;ACADL;SIRT4;ABCB11
prerank,positive regulation of kinase activity (GO:0033674),0.3547333671531233,1.077370193717449,0.3645833333333333,0.6805747916175379,1.0,14/107,10.11%,FLT1;IQGAP1;CSF1;LAT;PTPRC;PTK2B;ALS2;AXL;RAD50;GAS6;VAC14;TREM2;IGF1R;JTB
prerank,monocarboxylic acid catabolic process (GO:0072329),0.44515381595758063,1.0772730848065972,0.3905852417302799,0.6804361526716661,1.0,5/21,18.89%,CEL;PPARD;LPIN3;ACBD5;HOGA1
prerank,positive regulation of defense response (GO:0031349),0.35975842136565833,1.0768011381091962,0.34978991596638653,0.6812799779838092,1.0,25/89,24.49%,LPL;ADAM8;TNIP1;OPTN;CYBA;CEBPA;POLR3D;NFKBIZ;NINJ1;NAPEPLD;GPRC5B;PTGER4;DHX9;IL2;RIOK3;TNF;SERPINE1;TLR7;CCN4;IL17RA;IFI35;POLR3B;CCL3;SETD4;GPSM3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.45638259404081455,1.076689493702378,0.39864864864864863,0.6811720517238987,1.0,6/17,22.59%,HDAC4;GIT1;PID1;FLCN;FIS1;PARP1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2941785181985881,-1.07642785752426,0.3108108108108108,0.7122623416731656,1.0,11/40,9.07%,SNAP25;RIMS1;UNC13B;SYT1;SYT10;CPLX1;RIMS2;RAB3A;STX1A;SNAPIN;SNAP23
prerank,cell-cell junction assembly (GO:0007043),0.37203937797565206,1.0763838525911278,0.35357917570498915,0.6815628706123295,1.0,11/63,11.84%,CD9;CTNNB1;TLN1;SMAD7;PIP5K1C;PKP2;GJB2;PKN2;PAK2;RHOA;JUP
prerank,lipid oxidation (GO:0034440),-0.40207062805504556,-1.0763825770723854,0.3448275862068966,0.7098714542266121,1.0,2/12,9.71%,ALOX5;PPARGC1A
prerank,actin filament bundle organization (GO:0061572),0.40958280964613447,1.075985190144924,0.38221153846153844,0.6822303582260041,1.0,9/33,17.64%,LCP1;MICAL1;NEDD9;RHOD;BAIAP2;ESPN;BAIAP2L1;CORO1B;BAIAP2L2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4352975117969561,-1.075925436054018,0.3538961038961039,0.708629342675338,1.0,4/10,11.02%,GALNT13;POGLUT1;POGLUT3;GALNT2
prerank,mitotic cell cycle phase transition (GO:0044772),0.3415552575064277,1.0758074797632922,0.32060301507537686,0.6822985889996556,1.0,70/204,25.69%,CDK14;CCNY;CDK6;NES;DYNC1H1;OPTN;ODF2;FBXL17;HAUS8;CHMP4B;E2F3;PLK2;CCNB1;NINL;ANAPC1;PPME1;DCTN1;DNM2;TACC3;PPP2R1A;WEE1;DBF4;PPP2R2D;CSNK1D;CDKN3;PLK3;YWHAG;CUL2;CEP250;CEP41;EIF4E;FBXW11;FBXL6;CHEK2;POLE;MNAT1;CDC25B;CCDC57;CDC25A;PPP6C;CCP110;LATS1;CDK4;MAPRE1;TUBB;UBE2C;PPP1R12A;CETN2;CUL1;CUL4A;CCND1;ALMS1;CSNK1E;BRSK2;HAUS2;CDK2;CEP57;CCNH;ANAPC7;EIF4EBP1;SPDYA;CHMP7;CDK5RAP2;SSNA1;CUL3;FBXL3;DYNC1I2;FBXL8;CDC34;GSPT1
prerank,Rap protein signal transduction (GO:0032486),0.5138855957479374,1.0757014037342096,0.39914163090128757,0.6821986422704426,1.0,2/10,4.55%,RAP2A;PLK2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.40440124990823567,-1.0751001456270661,0.3662420382165605,0.7082530333793725,1.0,3/12,9.96%,LY6E;IFITM3;CIITA
prerank,fat cell differentiation (GO:0045444),0.38008161057838574,1.0748661979503369,0.35737704918032787,0.6839658401067789,1.0,12/57,18.87%,OSBPL8;GDF6;TMEM120B;PPARG;CEBPA;EGR2;ATF5;PID1;MAFB;MED1;METRNL;BBS2
prerank,anion transport (GO:0006820),0.40271006451020486,1.0748491122687023,0.3803317535545024,0.6836146764367103,1.0,7/33,15.76%,VDAC2;SLC17A5;SLC26A4;SLC4A2;LRRC8D;SLC13A5;SLC19A1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5091693012707014,1.074713642129054,0.41350210970464135,0.6835847118829095,1.0,3/11,10.71%,PDGFA;SOX9;TGFBR2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.41183405054818173,1.0747080413869126,0.3906633906633907,0.6832128329324494,1.0,7/28,13.73%,SIRPA;SH3KBP1;NCKAP1L;TICAM1;IL6;TNIP2;HSPD1
prerank,cGMP-mediated signaling (GO:0019934),0.48291998099695843,1.0746382394258005,0.39640883977900554,0.6830072211241441,1.0,2/13,2.42%,APOE;NPPA
prerank,negative regulation of protein modification process (GO:0031400),0.3658392412348447,1.0741421804378732,0.3833157338965153,0.6839401738020638,1.0,31/79,28.34%,SIRPA;CORO1C;XDH;MFHAS1;PLPP3;PTPA;LRP6;CRKL;MYADM;DNAJC10;PID1;ZBED3;PNKP;TRAF3IP1;ZC3H12A;PPP1R8;TGFB1;CRTAP;CADM4;GSK3B;LYN;PTEN;PPP1R15B;CDYL;IMPACT;TERF2IP;TARDBP;PRKDC;PRR5L;CDK5RAP3;CIB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4434372678366615,1.0738134362934124,0.37823834196891193,0.6844100084207873,1.0,2/19,3.00%,PRKCH;RUNX1
prerank,regulation of urine volume (GO:0035809),-0.4322485639942667,-1.0735879024915418,0.36129032258064514,0.7099521188279324,1.0,5/10,28.83%,ADCY6;INPP5K;TFAP2B;HYAL2;ADM
prerank,histone deacetylation (GO:0016575),0.39253135705035846,1.0733958501215064,0.3751438434982739,0.6851175927342873,1.0,14/43,21.58%,RCOR1;HDAC4;HDAC9;SUDS3;RCOR3;MIER2;ELK4;MSL3;MIDEAS;MORF4L2;HDAC1;HDAC3;SIRT2;MTA3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.26271733427968746,-1.07336545211309,0.3125,0.7080697672160711,1.0,18/80,12.45%,P2RY12;TENM2;NLGN1;TWF2;NCKAP1;EPS8;WASF2;PIK3R1;ANLN;APC;TAPT1;AUTS2;FNBP1L;HRAS;CDC42EP4;FUZ;PLPPR5;RIPOR2
prerank,organelle disassembly (GO:1903008),0.4044595762669908,1.0729693051026092,0.3871359223300971,0.6858426894454733,1.0,10/33,18.47%,RETREG1;DENR;VCP;KLC1;GFM2;PLK3;ATG2B;STX5;UFL1;GOLGA2
prerank,positive regulation of gene expression (GO:0010628),0.33473097434539417,1.0728145726183398,0.259,0.6858251588211047,1.0,90/442,18.55%,IGF1;MITF;ERCC6;HIF1A;FN1;ITGAX;CSF1;NFE2L2;FGR;STAP1;FGF2;PIK3CB;TAF1D;EIF6;POU3F1;VDR;CLDN19;ATP13A2;AGO2;DTNBP1;VEGFA;PIWIL2;SOX9;MSN;DDX21;POLR2H;CADM1;VIM;NAT8;LARP4;SPHK2;ID2;ERN1;NKX2-1;CELF1;HNRNPLL;CRTAM;EEF2;FGF20;SLC11A1;DLL4;GAS6;BRCA1;STOX1;TREM2;KRAS;FXR2;DNMT3B;LILRB1;UPF3A;SRPK2;LIMS1;TICAM1;BAZ1B;PTGER4;IL6;PID1;VPS35;AGO3;POLR1A;FGF7;SP1;MYBBP1A;HCFC1;UPF3B;ZBTB7B;NAT10;TNF;DNMT1;AGO4;FGF18;CPEB3;HTR2B;OLFM1;TAF1A;TFRC;FUBP1;POLR1G;CIRBP;TAF1C;PYM1;PRKAG1;RBM22;MAPK3;MED1;SLC38A2;MAP2K2;TGFBR1;AGPAT1;DEK
prerank,protein localization to vacuole (GO:0072665),0.48744266591002494,1.0722619688855737,0.4172461752433936,0.6868872512019459,1.0,2/13,4.37%,ATP13A2;RNF128
prerank,mRNA destabilization (GO:0061157),0.3928193282590704,1.0721719837826833,0.3904109589041096,0.6867246122828882,1.0,17/38,29.12%,CELF1;YTHDF2;POLR2D;PLEKHN1;PUM1;RIDA;CPEB3;FTO;ZC3H12A;ROCK1;ZC3H12D;METTL3;GIGYF2;TARDBP;DHX36;TRIM71;RC3H1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4379532183513899,1.0720527821926367,0.36795994993742176,0.686603430254078,1.0,5/23,13.89%,SLC9A1;SLC9A7;SLC26A4;ATP6V0A4;SLC12A4
prerank,muscle tissue development (GO:0060537),-0.3900768542496349,-1.0720010134256073,0.37906137184115524,0.7092864815619295,1.0,6/13,27.11%,POGLUT1;SRPK3;PGM5;SMO;ENG;SHH
prerank,regulation of cell growth (GO:0001558),0.3413503620942408,1.0719673134051593,0.3289738430583501,0.6864293523535426,1.0,50/204,22.40%,APBB2;BCL2;SDCBP;SGK1;SGK3;SGK2;SPHK1;CYP27B1;EIF4G1;EIF4G2;DDX49;ADAM17;SPHK2;SLC25A33;DCBLD2;ARHGEF11;BAP1;BCL6;ATAD3A;SERTAD3;PPP2R1A;ADAM15;ENO1;CDK11B;INO80;EXOSC9;USP47;MELTF;SOCS2;TMEM97;IL2;OSGIN2;SESN2;SUPV3L1;BST2;FLCN;TFRC;CDKN2AIP;SFRP1;TGFBR1;LAMTOR1;STK11;TGFB1;FRZB;EXOSC4;NME6;NPR1;SMARCA4;PPP1R9B;CDC42
prerank,negative regulation of cellular process (GO:0048523),0.335372928273541,1.0719385404870478,0.235,0.6861094181134951,1.0,121/521,22.45%,GPNMB;APBB2;PLXNC1;CD9;CTNNB1;BCL2;SIRPA;VPS13C;NIBAN2;SPEG;ADARB1;CDK6;FGF2;PTK2B;PLXNA2;FER1L5;CYP27B1;VDR;CLDN19;ING4;PPP2R5C;NUDT6;PIWIL2;CHMP4B;PDPN;CEBPA;PTPN2;SPHK2;GMNN;LRPAP1;IGFBP7;TNFRSF1B;APPL2;DCBLD2;BAP1;CELF1;MNT;ARID2;GTPBP4;SKI;DLL4;COPS8;BCL6;NUPR2;SMYD2;TREM2;ATF5;LPCAT3;SERTAD3;CYP1B1;PPP2R1A;LILRB1;RASA1;VPS4B;RNF41;ADAM15;ENO1;RNF167;NCK1;PLXND1;CDKN3;CCN6;BECN1;UTP20;UBR2;RAF1;IL6;TMEM98;VPS35;RPS6KA2;SULT2B1;OSGIN2;GNRH1;ACTN1;PLXNA1;S100A11;SESN2;BST2;HTR2B;FLCN;NOTCH4;LPXN;BMP5;ZBTB17;CDKN2AIP;KLF10;CHERP;SFRP1;WFS1;PACRG;VAMP3;TXNDC12;TNFRSF21;FRK;TBRG1;PTPN6;EPO;BLM;CCN4;ITGB1BP1;STK11;DDAH1;TGFB1I1;FBXO5;TGFB1;SIRT2;FRZB;NCK2;SINHCAF;NME6;NPR1;IFI35;NOTCH1;NOX4;KANK2;TNFRSF8;ANXA6;NF2;SMARCA4;PPP1R9B;TES
prerank,positive regulation of cell population proliferation (GO:0008284),0.33634273377990453,1.0717938582563162,0.28,0.6860888527862742,1.0,116/423,25.14%,IGF1;FLT1;BCL2;FN1;TCIRG1;PRKCH;ITGAX;CSF1;SDCBP;PDGFA;CDK6;FGF2;PTPRC;DOT1L;NES;PTK2B;SPHK1;PTGFR;GAB2;VEGFA;SOX9;EAPP;CAPN1;GCNT2;HMOX1;SLC35F6;ADAM17;HDAC4;BAMBI;ID2;SLC25A33;LAMC1;CDCA7L;FGF20;DLL4;CCAR1;GAS6;CRKL;STOX1;KRAS;NAMPT;IGF1R;CCL14;RHOG;VIP;TGFBR2;C5AR1;SRPK2;KITLG;CDK13;MDM2;CHTOP;STX3;SERPINF2;IL6;PID1;RPS6;DHX9;HPSE;CNOT6;FGF7;IL2;TNF;SERTAD1;CDC25B;MEIS3;FGF18;BST2;HTR2B;TERT;HDAC1;BMP5;UFL1;CDK4;S100B;SFRP1;CNBP;MAPK15;TGFBR1;HSF1;STAMBP;PTPN6;EPO;TIMP1;HNRNPU;CCN4;ITGB1BP1;XBP1;FGFR2;FBXO5;TGFB1;GDNF;PDGFB;SINHCAF;NOTCH1;BMI1;CALR;KMT2D;CDK2;KDM1A;CAPNS1;FGFR3;IL7;IL34;SPDYA;STX4;S1PR3;MAZ;TNFRSF11A;LYN;CUL3;RPL23;PTEN;FGF1;PDGFRA;PRDX3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.49019517077619235,1.0714649225292994,0.39415041782729804,0.6865765670696728,1.0,5/12,19.59%,CTSB;LMO2;MED1;CTSL;BRD8
prerank,myeloid leukocyte differentiation (GO:0002573),0.37046255458876787,1.0714605299078344,0.37102085620197583,0.6861983011517914,1.0,22/65,25.24%,CSF1;GAB2;PDE1B;RUNX1;VEGFA;PPARG;CEBPA;SNX10;TREM2;TGFBR2;PIR;SBNO2;CDK4;DEK;RXRA;CDC42;CDK2;PARP1;EP300;OSTM1;TNFRSF11A;SPI1
prerank,protein K63-linked deubiquitination (GO:0070536),0.41496399831552216,1.0714170514141377,0.3962040332147094,0.6859262307762463,1.0,17/31,25.55%,OTUD4;ATXN3;ABRAXAS1;PSMD14;TNFAIP3;UIMC1;BABAM2;USP13;STAMBPL1;STAMBP;USP16;USP8;BRCC3;USP33;YOD1;OTUD5;ABRAXAS2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.507727590397951,1.0708903960162028,0.39290780141843973,0.6868759688596663,1.0,3/10,6.52%,SYNGR1;NPTN;RAB5A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3728253324507254,1.0708120810928172,0.3685968819599109,0.6866924488750843,1.0,15/54,23.49%,TRAF2;SPHK1;OTULIN;ADAM17;PTPN2;GAS6;SYK;TNFAIP3;TNF;SHARPIN;PYDC1;BIRC2;HIPK1;RACK1;CHUK
prerank,signal transduction in response to DNA damage (GO:0042770),0.38172786793347846,1.070763121561939,0.3759820426487093,0.6864240803351729,1.0,12/49,20.11%,ERCC6;DOT1L;GRB2;TRIAP1;NDRG1;CASP9;BID;CHEK2;SESN2;MAP3K20;RAD9A;HUS1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.39120626200732683,1.07063739522336,0.39886363636363636,0.6863547586087256,1.0,12/38,22.28%,SASH1;ADAM8;CYBA;POLR3D;ACOD1;CD180;DHX9;RIOK3;PUM1;IFI35;POLR3B;PUM2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3436881789955682,-1.0706311937611415,0.34579439252336447,0.7104536368089287,1.0,3/19,1.72%,IL1RAPL1;PTPRD;CDKL5
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44131414111767725,1.07042539584982,0.3891687657430731,0.686488833591979,1.0,10/21,27.29%,BCL2L1;DDIT3;BCL2L11;NCK1;TXNDC12;XBP1;HERPUD1;SYVN1;OPA1;CREB3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4425306218181305,1.0703276775140087,0.38910505836575876,0.686356308728407,1.0,8/22,20.54%,PTPN23;UBAP1;VPS4B;PLAA;MVB12B;MVB12A;UBAP1L;NEDD4
prerank,rRNA catabolic process (GO:0016075),0.4708387790934823,1.0702050914558223,0.4061662198391421,0.686261976082872,1.0,8/16,26.37%,ERN2;EXOSC9;EXOSC10;EXOSC5;TRIR;EXOSC4;XRN1;DEDD2
prerank,regulation of inclusion body assembly (GO:0090083),-0.4154557015869721,-1.0698324973204998,0.3344594594594595,0.7101038433430664,1.0,7/11,25.25%,SNCAIP;DNAJB1;DNAJA4;SACS;DNAJB2;HSPA1A;HSPA1B
prerank,regulation of cell population proliferation (GO:0042127),0.3341453605143512,1.0697921698512702,0.223,0.6868983397422156,1.0,186/691,25.21%,GPNMB;IGF1;FLT1;CTNNB1;BCL2;FN1;TCIRG1;ITGAX;CSF1;NIBAN2;SPEG;ADARB1;SDCBP;PDGFA;SGK1;CDK6;FGF2;DOT1L;PTK2B;SGK3;SGK2;CYP27B1;VDR;CLDN19;PTGFR;GAB2;ING4;RUNX1;VEGFA;PPP2R5C;NUDT6;SOX9;EAPP;CAPN1;GCNT2;SLC35F6;ADAM17;PDPN;CEBPA;HDAC4;PTPN2;BAMBI;IGFBP7;JAG1;ID2;SLC25A33;BAP1;CELF1;MNT;CDCA7L;ARID2;GTPBP4;SKI;FGF20;DLL4;COPS8;CCAR1;BCL6;NUPR2;TNFRSF9;JUN;CRKL;SMYD2;STOX1;ATF5;KRAS;NAMPT;IGF1R;CYP1B1;CCL14;GNL3;RNF41;RHOG;VIP;TGFBR2;SRPK2;CDKN3;KITLG;CDK13;CCN6;LIMS1;MDM2;RHOA;UTP20;DUSP15;JUP;CHTOP;STX3;RAF1;IL6;RPS6;CDCA7;RPS6KA2;CNOT6;SULT2B1;MELTF;AGO3;FGF7;IL2;GNRH1;SERTAD1;CDC25B;MEIS3;S100A11;FGF18;HTR2B;ARHGEF2;HDAC1;BMP5;ZBTB17;TFRC;KLF10;UFL1;CHERP;CDK4;S100B;SFRP1;RBFOX2;CNBP;MAPK15;JUNB;TGFBR1;FES;HP1BP3;HSF1;STAMBP;FRK;TBRG1;PTPN6;BIRC2;EPO;TIMP1;ITGB1BP1;STK11;DDAH1;XBP1;FGFR2;KLHL41;TGFB1I1;FBXO5;EGLN3;TGFB1;SIRT2;FRZB;GDNF;PDGFB;NCK2;SINHCAF;IFI35;NOTCH1;NOX4;KANK2;TNFRSF8;CADM4;CALR;NF2;XRCC5;PPP1R9B;KMT2D;TES;BIRC6;CDK2;IER5;LMNA;P3H3;CAPNS1;FGFR3;IL7;SETD4;OPRM1;IL34;PIAS1;SPDYA;STX4;TRAPPC14;S1PR3;MAZ;TNFRSF11A;LYN;CUL3;RPL23;PTEN;FGF1;PDGFRA;PRDX3;INCA1
prerank,nitrogen compound transport (GO:0071705),0.34538479247707277,1.0696470756447591,0.3553299492385787,0.686872791761535,1.0,41/141,25.36%,SLC38A1;SLC15A3;SLC23A1;SLC6A6;SLC3A2;TOM1;SLC7A1;PDPN;SLC16A10;SLC6A4;SLC52A2;SLC11A1;SLC7A6;SLC18A1;RAB7A;SLC7A8;VAMP2;RUFY1;LRRC8D;ARRDC4;SNX4;ARRDC2;FLVCR1;SLC38A2;RILP;SLC1A5;SLC6A8;LMAN2L;RALBP1;SLC7A3;SLC43A2;SLC7A7;SLC7A2;SLC7A10;HSP90B1;SCAMP1;ARL6IP5;KIF3A;SCAMP3;SLC44A2;SLC7A11
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3956985944014876,1.0695588125266218,0.37543053960964407,0.6867292479506348,1.0,10/40,21.44%,FGR;ADAM17;MPEG1;RNASE7;RNASE3;IL6;MBL2;DMBT1;STAB2;TIRAP
prerank,nucleocytoplasmic transport (GO:0006913),0.3929091790894348,1.0694158099101685,0.38657407407407407,0.6866979845075039,1.0,17/40,28.12%,NUP205;MALT1;RBM15B;ATXN1;GEMIN5;NXT2;SNRPF;GEMIN2;XPO1;SNRPD3;SNRPD2;SNRPD1;NUP98;PHAX;NUTF2;AAAS;GEMIN8
prerank,sphingolipid biosynthetic process (GO:0030148),0.3627298168925756,1.0693235097021516,0.37967914438502676,0.6865424447024092,1.0,20/71,20.38%,LARGE1;SPHK1;SGMS1;HACD2;PLPP3;CERS6;SMPD4;SPHK2;ASAH1;ALDH3A2;ALDH3B1;VAPB;SAMD8;KDSR;SGPL1;HACD1;ELOVL2;CLN8;SPTSSA;SGMS2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3764547701206402,1.069310313458533,0.38004484304932734,0.6861934263627096,1.0,10/48,12.58%,STAP1;PTPRC;OTUD4;PPARG;PTPN2;GAS6;TREM2;TTLL12;YTHDF2;IL6
prerank,determination of bilateral symmetry (GO:0009855),0.43164006483929074,1.0690382480569862,0.37220843672456577,0.6865134625004495,1.0,2/25,3.44%,ODAD2;FOXJ1
prerank,DNA repair (GO:0006281),0.3372830535935448,1.068998980774521,0.3196392785571142,0.6862225340098482,1.0,83/284,22.81%,ERCC6;PARP4;DOT1L;RAD51B;IGHMBP2;RNASEH2A;ASCC3;ZRANB3;KMT5B;NEIL2;MGMT;ERCC1;ATXN3;TRIM28;RAD50;BAP1;FANCF;UBA52;VCP;SLX4;BRCA1;ABRAXAS1;MBD4;DDB2;ALKBH1;DDB1;PRMT6;DCLRE1A;ERCC4;XPA;INO80;ASCC2;RAD51AP1;BAZ1B;PARP2;ADPRS;TRIP13;USP47;PMS1;HUWE1;CENPX;CHEK2;RFC2;HPF1;POLE;LIG3;UIMC1;RPS27A;UBC;MNAT1;BABAM2;LIG1;UBE2V2;DDX1;ASCC1;PNKP;GTF2H1;RECQL5;PIAS4;MMS19;ERCC2;FTO;RAD9A;DCLRE1C;CETN2;CENPS;BLM;BRCC3;FANCA;HUS1;FANCE;ASF1A;TOPBP1;SUMO1;INTS3;PSME4;SLC30A9;CSNK1E;PMS2;ALKBH3;XRCC5;PARP1;WDR33
prerank,GPI anchor metabolic process (GO:0006505),0.41947165913391743,1.0688929663979512,0.4005069708491762,0.6861095372225381,1.0,5/26,9.90%,PIGQ;PIGZ;PGAP1;PIGN;PIGL
prerank,positive regulation of interleukin-2 production (GO:0032743),0.41992595446306846,1.068820944507756,0.39097744360902253,0.6859076237869718,1.0,4/25,4.12%,PTPRC;TRAF2;RUNX1;MALT1
prerank,protein ADP-ribosylation (GO:0006471),0.42060200610162335,1.068760779568119,0.39227895392278955,0.6856873239312838,1.0,15/28,26.32%,PARP4;TNKS2;SIRT5;TIPARP;ART4;PARP2;SIRT3;HPF1;SIRT4;ZC3HAV1;SIRT2;PARP1;ARF4;PARP9;PARP16
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.480462626585466,1.068446584948748,0.3914246196403873,0.6860898768005206,1.0,5/12,21.64%,APOE;RANBP9;ABCA7;FLOT2;ROCK1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3627528249999187,1.0682741397742972,0.3684210526315789,0.6861456992502234,1.0,8/69,7.55%,BCL2;HIF1A;APOE;ADAM8;PTK2B;CPEB4;RETREG1;FGF20
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3848651937713275,1.0679004917679373,0.39135514018691586,0.6866834233492872,1.0,19/44,30.53%,AGO2;CELF1;YTHDF2;EIF4ENIF1;PUM1;RIDA;CPEB3;PABPC1;FTO;ZC3H12A;ZC3HAV1;ROCK1;METTL3;GIGYF2;NANOS1;DHX36;PRR5L;RC3H1;TNRC6C
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.44579466092931924,1.0677945581459611,0.3894039735099338,0.6865508160564538,1.0,10/19,27.85%,DYRK2;CDIP1;SNW1;HIPK1;EP300;AEN;TMEM109;PHLDA3;USP28;HIPK2
prerank,positive regulation of response to stimulus (GO:0048584),0.39496143007825807,1.0674061317908743,0.39244851258581237,0.6871381742334904,1.0,10/40,19.35%,SELENON;PRKCD;GPR151;ECHDC3;FXR2;DHX9;ILK;CDKN2AIP;RSAD2;HOMER1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3715325614128062,1.0665174494395329,0.39826839826839827,0.6890471835617458,1.0,9/66,4.05%,APOE;XDH;NLRC3;CDK6;VDR;SOX9;MTSS1;PTPRM;FBXW7
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4077559447681169,1.0664443866102262,0.3905683192261185,0.6888595948933746,1.0,11/29,23.09%,AGO2;SNIP1;ZC3H7B;AGO3;HNRNPA2B1;AGO4;PUM1;ADAR;SMAD1;PUM2;METTL3
prerank,positive regulation of transmembrane transport (GO:0034764),0.46960497116058564,1.0663352277968619,0.3847184986595174,0.6887249100759082,1.0,3/13,8.56%,AZIN1;ANO6;ACSL1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.29008254156925634,-1.0660080881453997,0.362962962962963,0.7181720945137509,1.0,4/38,2.40%,CACNB2;CACNA2D1;BIN1;KCNJ3
prerank,RNA export from nucleus (GO:0006405),0.3572567571191497,1.0659810330320283,0.37801047120418846,0.6892501329079791,1.0,35/100,27.85%,NUP205;DDX39B;SRSF11;NUP188;THOC1;RAE1;SYMPK;RBM15B;THOC2;CHTOP;EIF4E;NUP42;SRSF2;HNRNPA2B1;TPR;UPF3B;MCM3AP;SRSF7;THOC6;SRRM1;NUP54;SMG1;NXF1;SRSF1;RANBP2;NUP133;NUP93;WDR33;NUP98;EIF4A3;NUP35;AAAS;SRSF3;DDX39A;UPF2
prerank,response to light stimulus (GO:0009416),0.37110906817597805,1.0657319280278763,0.39154616240266965,0.6894872990515963,1.0,11/55,17.70%,ERCC6;COPS3;MAP4K3;ZRANB3;RRH;DDB2;ERCC4;REV1;UBE4B;CIRBP;ERCC2
prerank,meiosis I (GO:0007127),0.4341217759169922,1.0657290967250197,0.391358024691358,0.6891062236367107,1.0,5/23,17.04%,SLC25A31;BCL2L11;HSF2BP;FOXJ3;SYCP3
prerank,positive regulation of cellular component movement (GO:0051272),0.4282487270734442,1.0657235196292987,0.4012269938650307,0.6887359728546646,1.0,10/24,24.85%,VEGFA;ADAM17;PDPN;PHPT1;NTN1;TGFBR1;STK11;RPS19;ACTN4;LYN
prerank,embryonic hemopoiesis (GO:0035162),0.4885898243620681,1.0656069590758914,0.40611961057023643,0.688653702103242,1.0,3/12,11.15%,KMT2A;TGFBR2;KITLG
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4025390489775723,1.065160990201611,0.3785103785103785,0.6894083516824804,1.0,8/31,19.95%,PTPRC;KMT5B;IL6;IL2;RBP4;TFRC;VAMP3;XBP1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5021989680217191,1.0651044699441898,0.3942446043165468,0.6891660241485789,1.0,1/11,0.56%,HIF1A
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4634987577587722,1.0651012235569983,0.40716180371352784,0.6887873401011559,1.0,2/15,3.85%,VEGFA;SOX9
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3464461806233108,1.0648879139751548,0.36567926455566907,0.6889610391372324,1.0,32/128,20.95%,ZMIZ1;BMP8B;GDF6;ZMIZ2;GCNT2;SMAD7;BAMBI;APPL2;UBA52;SKI;ITGB5;USP9X;NRROS;TGFBRAP1;JUN;TGFBR2;RHOA;DUSP15;FURIN;CBL;RPS27A;UBC;LPXN;BMP5;MAPK3;TGFBR1;ID1;PARD6A;TGFB1I1;RNF111;TGFB1;SMAD1
prerank,regulation of transport (GO:0051049),0.4011760018817251,1.0647556811943255,0.4,0.6888880853309424,1.0,9/36,19.60%,NRP1;CDK5;CLDN19;TRAT1;YRDC;VAMP2;FES;ICA1L;GAPVD1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4054716968292594,-1.0645654320864049,0.3525423728813559,0.7196101621813996,1.0,3/12,5.92%,GLUD1;IREB2;IDH3B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4492797528428726,1.064480583809451,0.42547770700636944,0.6892244079859247,1.0,5/18,19.52%,PCK2;NR3C1;BCL2L11;UBE2L3;HNRNPU
prerank,regulation of cell differentiation (GO:0045595),0.3451663736020513,1.0640372394148425,0.3525835866261398,0.6899336632299706,1.0,37/148,21.99%,LGALS3;CSF1;CDK6;SLC6A6;RUNX1;DAG1;KLK6;PRKCB;SIK1;SMAD7;ID2;BCL6;DDX17;ZFHX2;PPP2R1A;SRF;SERPINF2;RAF1;YWHAG;PHLDB1;TNF;NF1;CDK5RAP1;NOTCH4;MAFB;TGFBR1;FES;BIRC2;MCRIP1;FGFR2;KLHL41;FLOT2;TGFB1;GDNF;SINHCAF;ROCK1;CREBBP
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3140069631544796,-1.0638900133655413,0.3520408163265306,0.7188562930458846,1.0,10/24,20.04%,CCR2;CCR1;AIF1;LGMN;NBL1;CCL5;SLIT2;CCN3;GREM1;DUSP1
prerank,positive regulation of metabolic process (GO:0009893),0.35326389784451073,1.0638796541120596,0.3724066390041494,0.6899608958215563,1.0,38/103,28.20%,PEMT;DYNC1H1;FABP5;VEGFA;ACACA;KDM3A;UCP2;APPL2;ACSL1;CAV1;SYK;YBX2;IGF1R;ACADL;EHMT1;ADIPOR1;OGT;ACACB;ZBTB7B;TNF;PPARGC1B;GNAS;DECR1;AGPAT1;HSF1;HDAC3;ALMS1;PIGA;KDM1A;CPT2;GADD45G;STAT6;OMA1;LCN2;PTH2R;PDGFC;TRPV2;FABP4
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4963002311201293,1.0638535034009733,0.42857142857142855,0.6896404870339098,1.0,7/11,21.84%,OGFOD1;P4HA1;P4HB;P4HA3;EGLN1;EGLN3;CRTAP
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2977413014998183,-1.0637635184298129,0.31724137931034485,0.7167520797263612,1.0,7/32,4.09%,IL1RAPL1;PTPRD;CDKL5;HECW1;ADGRB3;HECW2;RAPGEF2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4126519518444108,1.063225165338268,0.3939393939393939,0.6908249568176945,1.0,10/29,20.78%,PATL1;NT5C3B;EDC4;EXOSC9;CNOT6;DCP2;EXOSC5;LSM6;EDC3;EXOSC4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.35970904661304387,1.0631937527051314,0.40496760259179265,0.6905170508265622,1.0,17/72,16.40%,CNOT4;MUC1;ING4;PLK2;BAX;CCNB1;CNOT10;TRIAP1;NDRG1;CARM1;MDM2;PLK3;CRADD;CNOT6;CHEK2;SESN2;CNOT9
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3345059077128436,1.0628508983138643,0.312,0.6909626356234719,1.0,68/306,18.06%,B4GALT5;LARGE1;APOE;ORC3;TNIP1;ING4;GRWD1;IGHMBP2;AGO2;EIF4G1;MCM2;RMI1;MRPL23;EIF4G2;RNASEH2A;POLR2H;MCM7;RRBP1;PTMS;GTPBP2;RAD50;ALAS1;EEF2;PWP1;MRPS15;FARSB;MRPL52;DRG1;BRCA1;MRPS16;RPL10A;EEF1A1;RPL12;ST3GAL2;DBF4;EEF1D;KIN;POLA2;RPL36;MRPS33;GCNT1;REV1;RPS6;GOLPH3;MRPL24;RPS28;RPL13A;MRPL37;MCM8;RPS26;MRPL18;RFC2;MRPL11;POLE;RPS27A;MRPS12;RPS12;POLR2D;PABPC4;TERT;KAT7;MRPS7;RECQL5;SARS1;RPL18;MMS19;RPS13;RAD9A
prerank,aerobic electron transport chain (GO:0019646),-0.24684062484981048,-1.0627162337149267,0.3088235294117647,0.7172662690352721,1.0,22/68,18.91%,COX7B;COX6A1;COX8A;NDUFS3;NDUFV3;NDUFB9;UQCRC1;NDUFS4;COX5A;NDUFS5;UQCRFS1;NDUFB7;NDUFA10;NDUFB10;COX15;COX4I1;UQCC3;NDUFA4;COX7C;NDUFS2;COX6B1;NDUFA5
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3589181179536697,-1.0626787450879875,0.35271317829457366,0.7149153854703096,1.0,6/16,14.52%,AOAH;PHKG1;PHKA2;PYGL;AGL;PYGB
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.31089353732133274,-1.0624523851460992,0.3419354838709677,0.7131000008612167,1.0,3/30,2.49%,ROBO1;F11R;ARHGEF3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4242208735873976,1.0621251057515846,0.4017743979721166,0.6924499738049741,1.0,5/25,13.07%,PLAUR;BAX;BCL2L11;BID;BIK
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3050387219661625,-1.0618460805089631,0.31958762886597936,0.7122442957047764,1.0,7/27,15.76%,CACNB2;DMD;AHNAK;PDE4D;ADRA2A;NOS1;JPH3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.39858858243960477,1.0616042454034864,0.40714285714285714,0.6933403456748874,1.0,12/35,25.27%,CD300A;PTPA;HTT;BOD1L1;CALM2;FKBP1B;PPP1R12A;HSP90B1;HSP90AB1;GSK3B;PPP1R15B;CALM3
prerank,recombinational repair (GO:0000725),0.35989216819136555,1.0613056196930306,0.36706135629709363,0.6937149129842453,1.0,20/77,20.11%,NSMCE2;RAD51B;RMI1;AP5Z1;RAD50;SLX4;BRCA1;SEM1;PSMD14;ERCC4;KDM4D;INO80;RAD51AP1;MCM8;LIG3;GEN1;YY1;RECQL5;BLM;HUS1
prerank,response to alcohol (GO:0097305),-0.3156750829344695,-1.0607791883359807,0.35294117647058826,0.7126703304354894,1.0,13/27,20.52%,CCR5;GRIN3A;GRIN2B;GRIN2A;SMAD2;GRIN1;SOD1;SDF4;GLRA1;ABCA2;SLIT2;TGFBR3;SLIT3
prerank,cellular response to misfolded protein (GO:0071218),0.4383123685724893,1.0599771077988265,0.41055341055341055,0.6966457232784863,1.0,6/20,18.30%,DNAJB14;ATXN3;VCP;RNF185;DNAJB12;DERL1
prerank,negative regulation of cell differentiation (GO:0045596),0.3402329058306974,1.059883481733484,0.33434038267875127,0.6964980802364694,1.0,47/181,24.16%,ABCA1;ABCG1;XDH;CDK6;PTK2B;SOX9;PPARG;SMAD7;BAMBI;JAG1;ID2;NOCT;NKX2-1;HDAC7;RIOX1;SKI;SPRED2;CAV1;PKP2;NEPRO;YTHDF2;ADIPOR1;IL6;TRIB2;EFNA1;TNF;SPRED3;SUFU;NOTCH4;BMP5;SFRP1;MED1;LDLRAD4;ANKRD26;TGFBR1;HNRNPU;TGFB1;SIRT2;SINHCAF;NOTCH1;ZBTB16;CALR;ASXL1;FOXO1;PTPN11;EIF2AK4;CCDC85B
prerank,cellular response to growth factor stimulus (GO:0071363),0.34529349338034315,1.059870053450068,0.3580121703853955,0.6961493575382339,1.0,38/151,23.37%,FLT1;CTNNB1;IQGAP1;NRP1;SPHK1;HSPB1;PDPK1;VEGFA;SOX9;SMAD7;APPL2;CD44;ERN1;DLL4;CRKL;NR3C1;EEF1A1;TGFBR2;CPNE3;LIMS1;MAPKAPK2;MAP2K3;MAPK7;KIDINS220;WWOX;SFRP1;CORO1B;DUSP3;MED1;TGFBR1;ITGB1BP1;TGFB1;SIRT2;PDGFB;NOTCH1;PTPN12;RACK1;PTPN11
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.45984574897782726,1.059700984093523,0.41611624834874505,0.6961678559109344,1.0,5/16,12.69%,HNRNPM;PUF60;DDX17;CDK13;DHX9
prerank,peptidyl-serine modification (GO:0018209),0.3405546304265095,1.0596920303354225,0.3661257606490872,0.6958088488688298,1.0,60/166,26.22%,PRKCH;SGK1;CDK5;PRKCD;SGK3;SGK2;PDPK1;IKBKE;DYRK2;PRKCB;CAB39;PLK2;NEK6;TLK1;MAP3K12;GAS6;STK32A;PKN2;PAK2;TGFBR2;CSNK2A2;CSNK1D;SRPK2;PARP2;MAPKAPK3;MAPKAPK2;RPS6KA2;HPF1;STK38L;GALNT3;TBK1;CSNK1G1;STK38;LATS1;MAPK12;TGFBR1;MARK2;MKNK1;DYRK1B;NTMT1;PDK3;SMG1;RICTOR;DGKQ;POGLUT2;PDGFB;HIPK1;ROCK1;CSNK1E;CDK2;PARP1;STK39;CHUK;GSK3B;TOP1;MAPK1;CAMK2D;TTBK2;CDC7;GALNT1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.46332657491235396,1.0596625052452207,0.42140921409214094,0.6954936155213632,1.0,3/15,8.84%,NLRC3;DHX33;TREM2
prerank,Rho protein signal transduction (GO:0007266),0.3736435482791782,1.0596060667778529,0.4145534729878721,0.6952722834715173,1.0,13/53,13.39%,MYO9B;GNA13;PDPN;ARHGEF11;LIMK1;RHOD;CELSR1;ARHGEF1;RHOG;RHOA;ARHGAP6;NTN1;GNA12
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4118178769586655,1.0595499433385855,0.41147741147741146,0.6950392219846714,1.0,7/27,17.06%,KMT5A;CD44;SPRED2;SMYD2;MDM2;SPRED3;PTTG1IP
prerank,T-helper cell differentiation (GO:0042093),0.4658938743808234,1.0583915369023824,0.4092769440654843,0.6975512682379599,1.0,4/14,13.17%,ATP7A;PTGER4;IL6;TMEM98
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.36214078595744664,1.058132698292849,0.38411316648531013,0.6977956014548603,1.0,26/73,27.84%,XDH;TRAF2;TNFSF15;MTCH1;DIABLO;PPARG;BAX;VCP;HIP1R;CRADD;CASP9;BID;HSPD1;TNF;HIP1;HSPE1;DAP;EGLN3;RACK1;CASP8AP2;SENP1;CYCS;APAF1;CASP4;BBC3;TRADD
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41392635962717667,1.0571441790213216,0.4167709637046308,0.6998867206067314,1.0,5/24,12.28%,TRIM6;IL12RB1;LILRB1;ZDHHC1;AIM2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.44321190786343156,1.0569733687614924,0.4157014157014157,0.6999264109101235,1.0,8/21,23.04%,PTK2B;SOX9;ECM1;GAS6;TGFB1;ROCK1;NOTCH1;CCL3
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3589402357452717,1.0567323671391122,0.38782051282051283,0.7001895078893093,1.0,12/73,12.69%,LPL;ADAM8;PTPRC;HSPB1;CYBA;ARFGEF2;SPHK2;TMEM106A;SYK;HAVCR2;IL6;DHX9
prerank,regulation of multicellular organismal development (GO:2000026),0.4197726057178696,1.0564988473059305,0.4127557160048135,0.7003909438833716,1.0,6/25,13.86%,DUSP9;TRIP12;GBX1;EHMT1;HPSE;MYSM1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4804869995857798,1.0564324254543198,0.40446304044630405,0.7001633549684049,1.0,2/13,3.59%,ADCY8;SQSTM1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.40994178672683396,-1.0562060750898228,0.35570469798657717,0.7224305787340874,1.0,4/11,8.81%,PARP8;PARP14;PARP12;PARP11
prerank,sulfur amino acid catabolic process (GO:0000098),0.5093478894720065,1.0560667953248553,0.4073550212164074,0.7006989254915584,1.0,6/10,26.03%,MTRR;TST;MPST;BLMH;CBS;CTH
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.31818011114533096,-1.0560386140216178,0.35436893203883496,0.7204847849823991,1.0,4/23,8.58%,GRK4;METAP2;FNTA;CAMKMT
prerank,positive regulation of protein metabolic process (GO:0051247),0.34828769303171175,1.0559802169157182,0.38381742738589214,0.7005451701469554,1.0,30/110,20.66%,ATG7;CSF1;APOE;C4BPA;C4BPB;EIF4G1;PLK2;FZR1;VCP;SEC22B;RAB7A;RNF41;WWP2;DDB1;VIP;RANBP9;RAB1A;TIPARP;STX5;TNFAIP3;MAPK7;HUWE1;TNF;WFS1;RILP;SLC25A37;DACT1;LDB1;NEDD4;TGFB1
prerank,actin nucleation (GO:0045010),0.43634332343629345,1.055762293294508,0.4191082802547771,0.7007034442656058,1.0,4/21,9.89%,ARPC3;ARPC2;ARPC5;ARPC1B
prerank,telomere maintenance (GO:0000723),0.37510755728596024,1.0556701848665229,0.3799772468714448,0.7005583552371968,1.0,27/50,33.74%,NSMCE2;RAD50;ACD;ERCC4;TPRKB;TERT;TERF1;BLM;HUS1;XRCC5;PARP1;PTGES3;RAD51;TEP1;TERF2IP;PRKDC;TERF2;SMC6;RIF1;MRE11;DNA2;TEN1;ATR;POLD4;TINF2;PARP3;RPA3
prerank,protein export from nucleus (GO:0006611),0.41554029174327883,1.0554896235819617,0.4071340713407134,0.7006229930510555,1.0,12/27,27.83%,EGR2;XPO7;CCHCR1;NUP42;TPR;XPO6;TGFB1;XPO1;CALR;NUTF2;DESI1;STYX
prerank,COPII-coated vesicle budding (GO:0090114),0.36295417013695636,1.0552363196149492,0.39565217391304347,0.7009134307311687,1.0,18/68,20.09%,CTSZ;GOSR2;NAPA;SEC24A;MCFD2;SEC22B;ANKRD28;VAPB;CSNK1D;RAB1A;USO1;STX5;SAR1A;PPP6C;GOLGA2;TBC1D20;SEC24D;SEC16A
prerank,positive regulation of protein modification process (GO:0031401),0.3370830637787864,1.0545814519838437,0.3778894472361809,0.7021568946867535,1.0,49/203,20.66%,GPNMB;ATG7;PLAUR;RAP2A;FGF2;PRKCD;CLDN19;VEGFA;DAB2;SOX9;ADAM17;NPTN;PTPA;MYDGF;ALG10B;FGF20;GAS6;CRKL;TREM2;SYMPK;KRAS;FXR2;CSNK1D;ATG10;TESK1;ASPSCR1;FNIP1;ILK;FGF7;EFNA1;TNF;FGF18;FLCN;ANKLE2;RAB3GAP1;TFRC;PIN1;RAB3GAP2;CALM2;IRGM;SPPL3;MAPK3;GOLGA2;NSMF;HDAC3;TAOK1;CCND1;RALBP1;TGFB1
prerank,multivesicular body organization (GO:0036257),0.3970901279679391,1.0544500378428074,0.4002433090024331,0.7020984122940078,1.0,6/31,10.12%,CHMP4B;CHMP4A;STAM2;VTA1;PDCD6IP;VPS4B
prerank,negative regulation of GTPase activity (GO:0034260),-0.3340474060843551,-1.0543594119729411,0.3627906976744186,0.7225325027941765,1.0,7/22,9.54%,F11R;ARL2;WNK1;RCC2;LRRK2;HRAS;LRCH1
prerank,regulation of fibrinolysis (GO:0051917),0.47243994668634803,1.0541578852768878,0.4079885877318117,0.7024406959520821,1.0,5/13,17.51%,F11;KLKB1;SERPINF2;APOH;SERPINE1
prerank,protein autophosphorylation (GO:0046777),0.3384149690297546,1.053971637838829,0.3815789473684211,0.7025199478500297,1.0,36/157,20.04%,FLT1;PEAK1;FGR;TEC;PTK2B;ATP13A2;PDPK1;STK24;NEK6;SIK1;ERN1;TAOK3;MAP3K12;CAD;DAPK1;IGF1R;PAK2;RIOK2;MAK;RIPK3;MAPKAPK3;MAPKAPK2;CHEK2;MINK1;MAP3K9;MAPK3;MAPK15;MAP2K2;FES;PIKFYVE;MARK2;MKNK1;TAOK1;STK11;SMG1;FGFR2
prerank,regulation of interleukin-12 production (GO:0032655),-0.27166734400515724,-1.0539685358601052,0.34285714285714286,0.7211448750749941,1.0,14/47,19.84%,MAPK14;PLCB1;IL16;CD40;LILRA5;SCIMP;FOXP1;LGALS9;IRAK3;THBS1;LTB;SLAMF1;PLCG2;TLR9
prerank,negative regulation of peptidase activity (GO:0010466),0.3797247581787131,1.0537810766062972,0.40298507462686567,0.7025991134169335,1.0,8/47,12.33%,LRP1;SERPINA10;CST7;ECM1;SERPINE2;TIMP2;SERPINF2;CSTB
prerank,actin cytoskeleton reorganization (GO:0031532),0.36739532822024035,1.0534886924692464,0.4019715224534502,0.7029270237093338,1.0,20/63,22.75%,PLEK;RAP2A;NRP1;GRB2;CLDN19;DTNBP1;FLNA;NEDD9;PARVB;RHOA;FGF7;GPR65;MINK1;PIP5K1A;PTPN1;RICTOR;BRSK2;PARVA;GSN;PDLIM4
prerank,peptide catabolic process (GO:0043171),0.42586975543595956,1.053246034938018,0.42839352428393523,0.7031254359712213,1.0,3/23,8.87%,ANPEP;ADAMTS13;TPP1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.40937381236748427,1.0532336265794808,0.4043583535108959,0.7027746580006955,1.0,4/30,8.65%,IGF1;GRB2;ERBIN;CRKL
prerank,protein targeting (GO:0006605),0.3481769097413866,1.0530952126517936,0.40329218106995884,0.7027515516705213,1.0,25/118,15.37%,KIF13B;SDCBP;NACA;ZFAND2A;MGARP;TRAK1;TIMM44;ZDHHC18;ZDHHC15;EDEM1;SPCS3;TOMM5;TOMM22;PITRM1;YIF1B;TOMM40;AP4E1;LAMP2;ZDHHC1;SRP14;TIMM23;SEC63;GIPC1;ZDHHC6;FUT10
prerank,protein targeting to membrane (GO:0006612),0.35698252232062067,1.053065038028554,0.4004237288135593,0.7024520293451145,1.0,21/83,19.52%,SDCBP;NACA;CHMP4B;CHMP4A;ABCD2;RAB8B;ZDHHC18;ZDHHC15;ALDH3A2;YIF1B;GET3;SIL1;ZDHHC1;SRP14;PEX14;SEC63;ZDHHC6;ACBD5;PXMP2;PIKFYVE;SEC61A1
prerank,response to zinc ion (GO:0010043),0.4172958964327036,1.053048066967183,0.4025157232704403,0.7021168187404432,1.0,2/25,3.01%,P2RX4;ATP13A2
prerank,regulation of hydrolase activity (GO:0051336),0.3578393318192101,1.0530197959895764,0.39572192513368987,0.7018039057170303,1.0,21/71,16.82%,PLXNC1;GPR137B;PLXNA2;FGD6;ARHGAP12;CAV1;PLXND1;RAPGEF6;FBXW11;NF1;FGD5;PLXNA1;ARHGEF5;ADAP1;PRKG1;VAV1;CHN2;ARHGAP9;RAB3GAP1;CRK;RAB3GAP2
prerank,dendritic spine morphogenesis (GO:0060997),-0.3775616934494336,-1.0527907255037205,0.36704119850187267,0.7217909316752221,1.0,4/15,9.75%,CTNND2;DOCK10;EPHB1;SHANK3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.49791489205307343,1.0527607626351754,0.4050073637702504,0.7020556810015018,1.0,2/10,5.17%,FBXW7;ADAM17
prerank,chemical homeostasis (GO:0048878),0.36495087249246194,1.052585430438441,0.39312567132116005,0.7021313412549016,1.0,18/61,20.06%,ATP13A2;TLCD1;FBXW7;PPARG;CEBPA;TLCD2;ABHD5;TREM2;SLC4A9;SLC4A2;ABHD4;ACOX3;TM6SF2;USF2;SLC4A4;ABCB11;CLN8;RBP1
prerank,nuclear transport (GO:0051169),0.45436526923971043,1.0524807344443212,0.4134742404227213,0.7020109589930064,1.0,9/16,31.11%,NUP205;RBM15B;NXT2;XPO1;NUP98;NUTF2;AAAS;PSIP1;NPM1
prerank,multivesicular body assembly (GO:0036258),0.39822144099317325,1.0522849119423832,0.4078144078144078,0.7021157432833497,1.0,6/30,10.12%,CHMP4B;CHMP4A;STAM2;VTA1;PDCD6IP;VPS4B
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4472437926219631,1.0522536407373544,0.42168674698795183,0.701810968958128,1.0,4/17,11.97%,RUNX1;VIM;SUCO;SERPINF2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3951345373725976,-1.0518593455013692,0.3745819397993311,0.7218379414629752,1.0,5/12,22.71%,SORL1;PRKCZ;GKAP1;IRS1;SORBS1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.32230674913260154,-1.0514660142802983,0.35323383084577115,0.7204967645385139,1.0,5/24,6.62%,TWF2;NCKAP1;WASF2;PIK3R1;AUTS2
prerank,positive regulation of secretion by cell (GO:1903532),0.3593850280980424,1.0509991721580534,0.3969957081545064,0.7045919594157475,1.0,6/70,3.19%,IGF1;ABCG1;P2RX4;ADAM8;ATP13A2;DTNBP1
prerank,microtubule nucleation (GO:0007020),0.43571891478360103,1.050827847061232,0.41516709511568123,0.7046363495135934,1.0,6/20,18.47%,TUBGCP4;CSNK1D;RANBP9;SLAIN2;CCDC57;GOLGA2
prerank,regulation of interferon-beta production (GO:0032648),0.3749522833467728,1.0506786593243123,0.40893854748603353,0.704634213739426,1.0,15/46,23.37%,SIRPA;NLRC3;TRAF3;POLR3D;IRF5;LILRB1;DHX9;RIOK3;YY1;TBK1;REL;TLR7;TIRAP;POLR3B;PTPN11
prerank,ganglioside biosynthetic process (GO:0001574),0.455521096938362,1.0506310646898216,0.4024390243902439,0.7043914211221919,1.0,3/15,10.45%,B4GALT5;ST8SIA6;ST3GAL2
prerank,regulation of MAP kinase activity (GO:0043405),0.35151074303490815,1.0505299960556176,0.41605839416058393,0.7042887331597324,1.0,9/92,3.49%,FLT1;APOE;PDGFA;ADAM8;FGF2;PIK3CB;PRKCD;CD300A;VEGFA
prerank,positive regulation of cation channel activity (GO:2001259),-0.28422914341947897,-1.0504034204756523,0.3877551020408163,0.7209563567390608,1.0,10/40,13.87%,AKAP6;CCR2;ANK3;CTSS;STAC;SHANK3;NLGN3;HAP1;RELN;CCL2
prerank,response to thyroid hormone (GO:0097066),0.47378220503920265,1.0502039517595636,0.42954856361149113,0.70468372711019,1.0,5/13,19.59%,CTSB;LMO2;MED1;CTSL;BRD8
prerank,positive regulation of cytokine production (GO:0001819),0.3321881923454433,1.0501726991956342,0.378,0.7043837474246943,1.0,54/292,16.11%,RFTN1;RAB7B;LPL;CTNNB1;HIF1A;FGR;PTPRC;TRAF2;TRIM6;APOA2;SPHK1;RUNX1;CYBA;CD274;IL12RB1;LRRFIP1;MALT1;LY9;POLR2H;CADM1;HMOX1;ADAM17;SPHK2;POLR3D;POLR3E;IL27;CRTAM;TMEM106A;SLC11A1;DHX33;BRCA1;SYK;IRF5;HAVCR2;DDIT3;NFKB1;CYP1B1;LILRB1;CEBPG;RAB1A;SERPINF2;TICAM1;PTGER4;IL6;DHX9;HPSE;HSPD1;IL2;ZBTB7B;TNF;HTR2B;TBK1;ARHGEF2;MBP
prerank,actin filament bundle assembly (GO:0051017),0.40135353599076523,1.0501263643808632,0.4183796856106409,0.7041164820356782,1.0,9/33,17.64%,LCP1;MICAL1;NEDD9;RHOD;BAIAP2;ESPN;BAIAP2L1;CORO1B;BAIAP2L2
prerank,regulation of cellular component size (GO:0032535),-0.3067584784443381,-1.0501074956824779,0.367816091954023,0.7193928974528215,1.0,8/30,9.32%,EPS8;RPTOR;RAP1GAP2;EZR;PICALM;RARG;PPP1CA;LAMTOR4
prerank,regulation of dendrite extension (GO:1903859),-0.35104517854217665,-1.0499419131066254,0.3547008547008547,0.7174418676968949,1.0,9/18,19.26%,RIMS1;SYT1;RIMS2;SYT4;SMURF1;CPNE5;NEDD4L;SYT2;SYT17
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.45491881505737564,1.0498384317525455,0.42201834862385323,0.7044484160900262,1.0,4/15,13.42%,LRP1;PDPN;IL6;MELTF
prerank,female gamete generation (GO:0007292),0.404150235107435,1.049810685659181,0.4050179211469534,0.7041378901089828,1.0,10/29,26.32%,PIWIL2;USP9X;PRDM9;TRIP13;MCM8;DIAPH2;KMT2D;METTL3;NANOS1;MEI4
prerank,blood vessel endothelial cell migration (GO:0043534),0.43190411678650537,1.0496499368358667,0.41935483870967744,0.7041678128647412,1.0,4/22,9.91%,FGF2;NRP1;VEGFA;SRF
prerank,microtubule depolymerization (GO:0007019),-0.354139114329045,-1.0495373350254946,0.38671875,0.716367526057928,1.0,8/17,27.68%,STMN3;STMN1;KIF24;KIF14;KIF2C;KIF18B;KIF19;STMN4
prerank,peptidyl-amino acid modification (GO:0018193),0.4998817130230186,1.0492372803650927,0.42997198879551823,0.7048157106049122,1.0,3/10,18.31%,APOA2;ATP7A;METAP1D
prerank,regulation of chemokine production (GO:0032642),0.3903067358397119,1.0491294270580904,0.4179278230500582,0.7046920713831982,1.0,7/36,14.62%,LPL;HIF1A;HMOX1;ADAM17;TREM2;IL6;TNF
prerank,postreplication repair (GO:0006301),0.3818546897057466,1.049083522800092,0.42290249433106575,0.704431624960529,1.0,10/45,15.80%,UBA52;VCP;UBE2L6;BRCA1;REV1;RFC2;RPS27A;UBC;RFC1;UBE2V2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.39611033272269036,1.0487659795601976,0.4002433090024331,0.7048435505357283,1.0,15/30,29.50%,FBXW7;BAP1;CSNK2A2;USP36;HUWE1;SAE1;UBE2L3;RHOU;VPS11;ATG13;SH3GLB1;NPEPPS;LEPROT;HTRA2;ARIH2
prerank,snRNA processing (GO:0016180),0.4552810309681129,1.0485596024605583,0.4214876033057851,0.7049936815130368,1.0,8/16,28.15%,INTS6;INTS14;INTS2;INTS3;TOE1;INTS12;INTS1;INTS8
prerank,skin development (GO:0043588),0.3620074000642972,1.0482378883135923,0.40560949298813376,0.7053993062617987,1.0,14/65,21.28%,PDGFA;ST14;CLIC4;JAG1;ASCL4;ASAH1;ATP7A;ITGA3;PIP5K1A;HRNR;MED1;ERRFI1;UGCG;CLDN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.349688372923992,-1.0478001326715574,0.3715415019762846,0.7186305634069278,1.0,2/17,0.12%,CACNB2;CACNA2D1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5066311349460924,1.0475337049841311,0.40828402366863903,0.7068276782560514,1.0,2/10,3.49%,CTNNB1;VEGFA
prerank,GTP metabolic process (GO:0046039),0.4593153138836185,1.047533298102068,0.42740841248303935,0.7064513088801462,1.0,4/15,14.13%,RHOQ;AK4;AK3;EFL1
prerank,positive regulation of exocytosis (GO:0045921),0.395942211046514,1.0474287487601102,0.4146919431279621,0.7063183793278714,1.0,7/35,10.85%,SDCBP;ATP13A2;RAB5A;PDCD6IP;RAB7A;VPS4B;RAB9A
prerank,positive regulation of establishment of protein localization (GO:1904951),0.43940170609718704,1.0466729309180052,0.43716577540106955,0.7078204991309339,1.0,6/19,14.85%,CCT2;TREM2;CEP120;CCT5;TNF;DKC1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.34207631800090643,-1.0465244345145517,0.3688888888888889,0.7197027138442688,1.0,6/18,9.58%,NLGN1;RIMS1;RIMS2;LRRK2;SNAPIN;SYN1
prerank,ventricular septum development (GO:0003281),-0.29388308623227677,-1.0463375988154633,0.35443037974683544,0.7178732645691334,1.0,16/37,26.61%,ROBO1;SALL1;ROBO2;ZFPM1;ZFPM2;PDE2A;TGFB2;SLIT2;TGFBR3;SLIT3;HEY1;HEY2;GATA3;MATR3;CITED2;HEYL
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3800668382495247,1.0461552052024852,0.4051918735891648,0.708746772901469,1.0,5/44,3.27%,APOE;PIK3CB;PRKCD;NPPA;CD300A
prerank,membrane assembly (GO:0071709),0.38962841755072475,1.0460860951905393,0.4082125603864734,0.7085363791487246,1.0,6/34,5.99%,RFTN1;CEL;TLCD1;CHMP4B;LRP4;TLCD2
prerank,negative regulation of axon extension (GO:0030517),-0.3100398327071621,-1.0459917825194673,0.3961038961038961,0.7165926800108483,1.0,8/30,18.32%,SEMA6D;SEMA6A;MAP2;SEMA5A;SEMA4B;SEMA4A;SEMA6C;SEMA3B
prerank,regulation of cell motility (GO:2000145),0.34669924548993936,1.045969497836352,0.39979231568016615,0.708421999070568,1.0,29/121,19.48%,PLXNC1;ABL2;MACF1;SGK1;CDK6;FGF2;SGK3;PLXNA2;FLNA;FGF20;SERPINE2;PKN2;PHPT1;PLXND1;RHOA;RAF1;NTN1;MEMO1;FGF7;MINK1;PLXNA1;FGF18;TBCCD1;CRK;PIN1;PRAG1;FES;LDB2;LDB1
prerank,regulation of microtubule nucleation (GO:0010968),0.47817269388611994,1.0459099045349984,0.41935483870967744,0.7081859936965765,1.0,2/10,7.63%,GIT1;DCTN1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3535303131521278,1.0456012119201779,0.4061505832449629,0.7085415063550592,1.0,21/80,17.33%,ABCG1;GSAP;EIF6;PRKCD;PIWIL2;VIM;LARP4;SPHK2;EEF2;FXR2;UPF3A;IL6;SIRT3;SP1;EFNA1;UPF3B;NAT10;TNF;CPEB3;CIRBP;PYM1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38315575659294243,1.045585971053005,0.42,0.7081967859791979,1.0,10/39,13.42%,CORO1C;GCNT2;JAG1;MYOC;FZD4;RASA1;ADAM15;SPRY4;RHOA;MELTF
prerank,double-strand break repair (GO:0006302),0.33693728291359115,1.0454146425101836,0.3957273652085453,0.7082292466014406,1.0,67/158,30.81%,NSMCE2;RAD51B;RMI1;AP5Z1;CYREN;ERCC1;RAD50;BAP1;VCP;SLX4;BRCA1;SEM1;ABRAXAS1;PSMD14;DCLRE1A;ERCC4;KDM4D;INO80;RAD51AP1;BAZ1B;PARP2;TRIP13;SETMAR;MCM8;CHEK2;HPF1;LIG3;UIMC1;GEN1;BABAM2;YY1;UBE2V2;DDX1;KDM2A;RECQL5;PIAS4;DCLRE1C;POLM;BLM;BRCC3;HUS1;SUMO1;XRCC5;PARP1;RAD51;POLA1;PARP9;MDC1;PRKDC;EYA3;SMARCAL1;HELQ;AP5S1;KPNA2;ZFYVE26;TDP2;CIB1;KDM4B;SMC6;BRIP1;RIF1;PAXX;MRE11;MMS22L;EME2;DNA2;LIG4
prerank,negative chemotaxis (GO:0050919),-0.3065925935304151,-1.0453070990961941,0.34306569343065696,0.7161920194498798,1.0,14/33,23.32%,ROBO1;SEMA6D;SEMA6A;UNC5C;SEMA4B;SEMA4A;EPHA7;SEMA6C;SLIT2;SEMA3B;SLIT3;SLIT1;LRTM2;SEMA7A
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.38971960118005833,-1.0451777313857051,0.39361702127659576,0.7142866318936986,1.0,2/12,5.07%,SERINC3;SEPHS1
prerank,regulation of actin filament-based process (GO:0032970),0.3561477851499227,1.0448589068988032,0.42749731471535984,0.7092263976440959,1.0,17/70,16.64%,LRP1;IQGAP1;PDGFA;PRKCD;RHOQ;RHOD;CELSR1;HIP1R;BAIAP2;RHOG;ARHGAP17;TESK1;RHOA;RHOF;ARHGEF5;BST2;CRK
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3433277136979768,1.0445648143984063,0.41867785939139557,0.7095656971421375,1.0,27/107,23.04%,ATP2B1;ATP13A2;SLC24A4;NPTN;TPCN2;SLC8B1;CCL13;SLC11A1;CAV1;SLC39A7;CCL14;VAPB;SLC8A1;ATP2A2;HTR2B;CHERP;SLC39A6;STOML2;SLC39A13;TMEM165;DRD3;TMCO1;SLC30A9;MT2A;CALR;ATP13A3;CCL3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.36851932024775713,1.0443581958779777,0.41935483870967744,0.7096608148923202,1.0,17/57,25.88%,DDX31;NOC2L;METTL17;WDR12;RIOK2;RPS6;RPS28;BYSL;TGS1;CUL4A;XPO1;RPS19;NVL;RPS7;SURF6;NOP14;LTV1
prerank,regulation of intracellular signal transduction (GO:1902531),0.3264824271039388,1.0442462147628433,0.372,0.7095683769095317,1.0,112/420,23.22%,ARHGAP25;ABR;MYO9B;ARHGAP24;ARHGAP21;ARHGAP10;SGK1;CDK5;OPTN;TRAF2;A2M;TRIM6;NOC2L;GNA13;PAK6;ARAP2;RMI1;HSPB1;PDPK1;VEGFA;PPP2R5C;SQSTM1;SGMS1;KMT5A;CHD3;DYRK2;AKAP13;STK3;TRAF3;RHOQ;TAF4B;SPHK2;ARHGAP12;FAM13B;ARHGEF11;RAD50;MYOC;TAOK3;PIP5K1C;RHOD;TAF15;ARHGAP19;BRCA1;SMYD2;PIK3R2;TREM2;ARHGEF1;GMIP;TAF7;PAK2;RNF41;EHMT1;RHOG;ARHGAP17;CSNK2A2;MDM2;RHOA;PLK3;TP53RK;USP2;ARHGAP6;MYO9A;FAM83D;GNA12;CHEK2;MAPKAP1;RHOF;RFC2;TNF;MINK1;ARHGEF5;PIP5K1A;ARHGEF2;FLCN;VAV1;HDAC1;CHN2;ARHGAP9;RHOU;CRK;PIN1;UFL1;PRKAG1;PIP4K2A;MAPK3;ARHGAP22;RAD9A;RHOT2;BIRC2;TAOK1;BLM;STK11;DEPDC1B;RICTOR;HUS1;TAGAP;ARHGAP30;RALBP1;TBP;TOPBP1;PTPMT1;HIPK1;PRMT5;NF2;CDC42;CDK2;TMBIM4;RRAGC;SRGAP1;RNF34;DAXX;ARHGAP36
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.41647119333503185,1.0439956930965204,0.4417721518987342,0.709813827053165,1.0,9/23,20.71%,ACSBG2;HACD2;ACSL1;HSD17B12;ACSBG1;HACD1;ELOVL2;DGAT1;TECR
prerank,negative regulation of transferase activity (GO:0051348),0.40309339787408843,1.0437396409259503,0.4214975845410628,0.71006727762194,1.0,13/28,27.64%,SMAD7;LIMK1;PHPT1;EIF4A2;ERCC4;TERF1;HNRNPU;FBXO5;NPRL2;GSK3B;ABL1;PRDX3;BAG5
prerank,TOR signaling (GO:0031929),0.40998140786717785,1.0437166374142874,0.45037220843672454,0.7097474316908959,1.0,13/26,28.96%,LARP1;NPRL3;RPS6;FNIP1;MAPKAP1;FLCN;SMG1;RICTOR;RHEBL1;EIF4EBP1;PRR5L;EIF4EBP2;CCDC88A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4622672501381051,1.0436862044293034,0.4474053295932679,0.7094444302888699,1.0,6/15,17.94%,NEK6;ANAPC1;TACC3;RIOK2;TPR;UBE2C
prerank,positive regulation of DNA repair (GO:0045739),0.38032641432042136,1.043459932227285,0.4267877412031782,0.7096426860083255,1.0,12/46,17.26%,ERCC6;EYA4;MGMT;TRIM28;BRCA1;ABRAXAS1;CEBPG;DHX9;UIMC1;BABAM2;SLF2;TMEM161A
prerank,endodermal cell differentiation (GO:0035987),0.39501352018786196,1.043455160321785,0.45278450363196127,0.7092774090100203,1.0,4/31,7.97%,FN1;ITGA5;ITGB5;COL12A1
prerank,pentose-phosphate shunt (GO:0006098),0.4856090878724485,1.043054837767192,0.4428969359331476,0.7099001455653605,1.0,7/11,27.98%,DERA;RPIA;PGLS;RBKS;PGD;H6PD;TALDO1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.33853952063526355,-1.0426598021901792,0.37662337662337664,0.7188177067828151,1.0,10/20,26.65%,RBPJ;TGFB2;SPRY1;BMP2;TGFBR3;HEY1;HEY2;ENG;HEYL;SNAI2
prerank,regulation of fat cell differentiation (GO:0045598),0.3528013481964119,1.0426108598027903,0.4057815845824411,0.7106457476042524,1.0,22/74,24.16%,LPL;PPARD;PPARG;ID2;NOCT;CARM1;ASXL2;IL6;TRIB2;TNF;SFRP1;FTO;ANKRD26;ZC3H12A;XBP1;TGFB1;SIRT2;FRZB;ZBTB16;ASXL1;FOXO1;CCDC85B
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3357712197134604,1.0424939464039724,0.3947100712105799,0.7105620079925054,1.0,40/148,23.20%,SGK1;CDK5;NOC2L;RMI1;PDPK1;PPP2R5C;KMT5A;CHD3;DYRK2;TAF4B;RAD50;TAF15;BRCA1;SMYD2;TAF7;EHMT1;CSNK2A2;MDM2;PLK3;TP53RK;USP2;CHEK2;MAPKAP1;RFC2;HDAC1;PIN1;PRKAG1;PIP4K2A;RAD9A;BLM;STK11;RICTOR;HUS1;TBP;TOPBP1;HIPK1;PRMT5;CDK2;RNF34;DAXX
prerank,response to organophosphorus (GO:0046683),0.4463880868113278,1.0424425453699946,0.435656836461126,0.710316573162742,1.0,1/16,0.66%,P2RX4
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.42478744535885493,1.0421812312531913,0.43700787401574803,0.7105625221724522,1.0,6/20,15.39%,EIF6;AGO2;CELF1;CNOT6;AGO3;AGO4
prerank,sarcomere organization (GO:0045214),-0.3047833847197876,-1.0415475251834052,0.3712871287128713,0.719493140391041,1.0,12/27,40.78%,CAPN3;FHOD3;TNNT3;MYPN;CSRP1;TNNT2;MYH6;SIX4;MYOM2;SYNPO2L;MYOZ2;TNNT1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.39707604806498986,1.0411253557908173,0.4447058823529412,0.712772217745842,1.0,3/33,5.80%,RAB7B;HIF1A;NCKAP1L
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.49795686932057515,1.0409935475636936,0.4357142857142857,0.7127209323355108,1.0,3/10,12.60%,PRKCB;APPL2;PID1
prerank,response to purine-containing compound (GO:0014074),0.4396075423813774,1.0407697457411216,0.4270833333333333,0.7128601480974016,1.0,1/17,0.66%,P2RX4
prerank,anterior/posterior pattern specification (GO:0009952),0.3678506525397419,1.0407004112706635,0.4223744292237443,0.7126682984162974,1.0,8/53,9.15%,HOXA4;BASP1;BHLHE41;HES7;BHLHE40;WLS;SKI;DDIT3
prerank,sensory perception (GO:0007600),0.3739174586408892,1.0405006524392928,0.434135166093929,0.7127478065020953,1.0,7/45,10.90%,P2RX4;CHRNB2;ASIC3;PTGES;RETREG1;MYO7A;C5AR1
prerank,protein localization to chromatin (GO:0071168),0.43877409566972975,1.0404629098158944,0.4156706507304117,0.712467155747315,1.0,12/18,34.64%,FAM47E;WAPL;MCM8;PIH1D1;RUVBL2;LEMD2;CHMP7;LRWD1;PPHLN1;MCM9;MRNIP;TASOR
prerank,hydrogen peroxide metabolic process (GO:0042743),0.43828504392599205,1.0404104445787954,0.4173027989821883,0.7122233899749616,1.0,8/19,29.29%,CYBA;CAT;PRDX1;PRDX3;PXDNL;PRDX5;GPX3;PXDN
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4137027606851162,1.0400227370156716,0.43018867924528303,0.7128018867892764,1.0,10/26,24.86%,NSMCE2;ANAPC15;NEK6;CCNB1;RIOK2;UBE2C;FBXO5;ANAPC7;CDK5RAP2;CUL3
prerank,response to cytokine (GO:0034097),0.33824279863537676,1.039864657896669,0.41905737704918034,0.7127862343774956,1.0,26/141,15.81%,BCL2;BCL2L1;IRAK2;SHFL;SPHK1;CYP27B1;MCL1;CD274;PTPN23;MAP4K3;IKBKE;HDAC4;PTPN2;SLC11A1;SRF;TLE5;TIMP2;RHOA;MAPKAPK3;PID1;PTPN18;MAPKAPK2;HAX1;BST2;TBK1;KYNU
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.34814321956586713,1.0398282300339114,0.41041666666666665,0.7125099706656743,1.0,33/90,28.20%,PEMT;DYNC1H1;FABP5;VEGFA;KDM3A;UCP2;APPL2;ACSL1;CAV1;SYK;YBX2;IGF1R;ACADL;EHMT1;ADIPOR1;OGT;ZBTB7B;PPARGC1B;GNAS;DECR1;HSF1;HDAC3;ALMS1;KDM1A;CPT2;GADD45G;STAT6;OMA1;LCN2;PTH2R;PDGFC;TRPV2;FABP4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.44132958906035114,1.0395488370499466,0.45241199478487615,0.712814379538549,1.0,9/17,25.27%,EIF4G1;SMAD7;SPRED2;SPRED3;CALM2;DGKQ;SIRT2;CADM4;CALM3
prerank,telomere organization (GO:0032200),0.3752589100113123,1.0395047657795742,0.42725173210161665,0.7125498295223809,1.0,23/43,33.74%,DOT1L;RAD50;ACD;ERCC4;TERT;TERF1;BLM;HUS1;XRCC5;PARP1;PTGES3;H3-3A;TERF2IP;PRKDC;TERF2;RIF1;MRE11;DNA2;ATR;POLD4;TINF2;PARP3;RPA3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.49752993895846787,1.0394946232971278,0.44377811094452774,0.7121984554318389,1.0,3/10,10.07%,AXL;GAS6;LILRB1
prerank,positive regulation of cell differentiation (GO:0045597),0.3298722701116016,1.0391008835247406,0.41223671013039115,0.7128110539970378,1.0,56/237,21.82%,IGF1;LPL;CTNNB1;PRKCH;CSF1;SDCBP;SLC6A6;NELL1;GDF6;PPARD;RIN2;DAB2;SOX9;GCNT2;PPARG;PDPN;BAMBI;ID2;NOCT;SPAG9;SUCO;NFKB1;CARM1;SRF;SP7;TGFBR2;ASXL2;KITLG;PKDCC;RHOA;GPRC5B;SERPINF2;IL6;MSR1;BNIP2;ATP6AP1;ARHGEF2;AKIRIN1;OLFM1;DNAI3;MAPK12;SFRP1;TGFBR1;FES;PLA2G5;ZC3H12A;CCN4;XBP1;TGFB1I1;FBXO5;TGFB1;FRZB;GDNF;HIF1AN;GLIPR2;ZBTB16
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2731389630871337,-1.03860098116891,0.38461538461538464,0.7249116736522025,1.0,9/44,9.65%,FCHSD2;NCKAP1;BIN1;CARMIL1;PRKCE;SPIRE1;ARPC4;FER;CDC42EP4
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3694407969642063,-1.038267688807264,0.366412213740458,0.7235510217899249,1.0,7/15,12.49%,CDH13;RBPJ;EGFR;CEACAM1;FER;LGMN;EGF
prerank,neuron migration (GO:0001764),0.3741375923716801,1.037296702311081,0.4375,0.7168936436787072,1.0,8/48,8.78%,FGF13;LRP12;NRP1;CDK5;VEGFA;NAV1;USP9X;CELSR1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3892849986008974,-1.0368231390683835,0.38596491228070173,0.7252190075539543,1.0,2/13,4.05%,CPE;RBPJ
prerank,DNA conformation change (GO:0071103),-0.34968100865109397,-1.0365700221295389,0.39094650205761317,0.7236316777159891,1.0,10/17,30.69%,TOP2A;NAA10;ERCC3;HMGB3;TOP1MT;KAT6A;HMGB2;TOP3A;TOP3B;HMGB1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3253649723820738,1.0364580859901782,0.363,0.7185532393213196,1.0,102/476,21.99%,IGF1;MDFIC;MITF;CXXC1;SPP1;CTNNB1;ZMIZ1;HIF1A;NIBAN2;APOE;NFYA;KMT2A;FGF2;ELF4;POU3F1;GDF6;TFEB;PPARD;RUNX1;ELF2;SOX9;KDM3A;PPARG;NFIL3;RAI1;HDAC4;PCBD2;KLF6;RNF6;BAMBI;ID2;ARHGEF11;TRIM28;BRD4;NKX2-1;MAP3K12;LRP6;CREB3L2;EGR2;TAF15;BRCA1;DNM2;FZD4;JUN;FZD1;ATF5;MED17;DDIT3;NFKB1;SERTAD3;RNF14;RHOG;ZKSCAN3;PRMT2;IL6;MAP2K3;ILK;NPAT;FBXW11;FGF7;NAA16;SP1;CHEK2;HCFC1;TNF;DNAJC2;HDAC1;NOTCH4;TASP1;GTF2H1;MAFB;YAF2;NDP;SFRP1;MMS19;CNBP;NAA15;ARID1B;MED1;MAP2K2;SS18L1;TGFBR1;RXRB;ZXDC;DYRK1B;EPO;USP21;USP16;CDH1;BLM;TGFB1I1;RNF111;TGFB1;KMT2B;RNF20;PDGFB;NSD1;RXRA;NOTCH1;ZBTB16;PITHD1;CREBBP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3606854714935701,1.0362925705315345,0.4316469321851453,0.7185992844759079,1.0,7/62,8.65%,IGF1;PIK3CB;GRB2;ALS2;AKAP13;ERBIN;CRKL
prerank,negative regulation of B cell activation (GO:0050869),0.42335226323270536,1.0362065663224063,0.4229299363057325,0.7184302686661331,1.0,7/21,18.62%,CD300A;FOXJ1;ID2;SAMSN1;TNFAIP3;SFRP1;TNFRSF21
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.24503998305545527,-1.036204687482091,0.3880597014925373,0.7223743054264288,1.0,13/72,10.39%,NAV3;SSH2;CYRIB;TWF2;TUBB4A;MAP2;CLASP2;APC;KANK1;STMN1;SHANK3;HDGFL3;PFDN5
prerank,cellular response to UV (GO:0034644),0.35541236591597425,1.0361288844186953,0.4198717948717949,0.7182386373958816,1.0,31/76,28.50%,PRKCD;NOC2L;ERCC1;TRIAP1;DDB2;DDB1;ERCC4;XPA;INO80;CASP9;USP47;YY1;CDC25A;TMEM161A;RUVBL2;TIMP1;STK11;NEDD4;EIF2S1;CREBBP;PARP1;KDM1A;METTL3;EIF2AK4;EP300;IMPACT;USP28;ZBTB1;DHX36;SDE2;FMR1
prerank,regulation of histone modification (GO:0031056),0.46724783421694327,1.0357978784574144,0.4361111111111111,0.7186742131936523,1.0,7/13,36.69%,MTHFR;HPF1;FLCN;PARG;CDK9;AKAP8;UBE2N
prerank,melanosome transport (GO:0032402),0.4351385163408011,1.0356807039182865,0.44416243654822335,0.7182159828232961,1.0,4/18,18.87%,MYO5A;BLOC1S3;MREG;BBS2
prerank,pigment granule transport (GO:0051904),0.4351385163408011,1.0356807039182865,0.44416243654822335,0.7182159828232961,1.0,4/18,18.87%,MYO5A;BLOC1S3;MREG;BBS2
prerank,interstrand cross-link repair (GO:0036297),0.36404584525041367,1.0356594404918475,0.4187568157033806,0.7178992260103827,1.0,17/53,20.75%,ERCC1;FANCF;UBA52;VCP;SLX4;DCLRE1A;ERCC4;XPA;RAD51AP1;MCM8;CENPX;RPS27A;UBC;DCLRE1C;CENPS;FANCA;FANCE
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3487419054766968,1.035644546607422,0.43902439024390244,0.7175579020429286,1.0,31/80,28.32%,PRICKLE1;SPHK1;FBXW7;MALT1;SMAD7;BRCA1;CAV1;ARRDC4;DCUN1D4;HUWE1;CENPX;UBE2L3;PIN1;PTTG1IP;DCUN1D2;WFS1;DERL1;HDAC3;CENPS;BIRC2;RCHY1;RPS2;BMI1;KDM1A;UBQLN1;CUL3;DCUN1D3;PDCD6;PSMD10;CDK5RAP3;HSPBP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.37450130268272697,1.035326303681773,0.4358683314415437,0.7179326479207496,1.0,20/44,29.30%,NRP1;MYOC;LIMK1;TESK1;EVL;RHOA;SERPINF2;SORBS3;GPR65;ARHGEF5;SFRP1;TGFBR1;ITGB1BP1;NF2;CDC42;ABL1;RAC1;PFN2;CCDC88A;PXN
prerank,positive regulation of neuron death (GO:1901216),0.37154680005686436,1.0353138489926803,0.4099099099099099,0.7175808487101131,1.0,15/46,25.09%,CTNNB1;CDK5;BAX;SARM1;DDIT3;SRPK2;FYN;TNF;NF1;ITGB2;EIF2S1;CCL3;DAXX;GSK3B;EGR1
prerank,cell chemotaxis (GO:0060326),-0.25575018321137755,-1.035284826149281,0.39759036144578314,0.7225788818047224,1.0,9/60,6.02%,CX3CR1;DOCK4;CCR5;BIN2;CCR2;KIT;SEMA5A;PLEKHG5;EPHB1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.45416718323676775,1.0346115131296951,0.4657534246575342,0.7189176685484058,1.0,4/15,19.52%,NR3C1;BCL2L11;UBE2L3;HNRNPU
prerank,protein autoprocessing (GO:0016540),0.4404396984563309,1.0345478486600501,0.44919786096256686,0.7187039964862934,1.0,7/17,28.40%,KLK6;AFG3L2;CTSL;MYRF;OMA1;CASP4;HTRA2
prerank,response to chemokine (GO:1990868),-0.3967151394905584,-1.0344165786854476,0.42160278745644597,0.7226909373332984,1.0,5/13,12.45%,DOCK8;SLC12A2;WNK1;LRCH1;RIPOR2
prerank,regulation of lymphocyte migration (GO:2000401),0.5002756319940348,1.0341794660570818,0.4490674318507891,0.7192555154531395,1.0,2/10,6.65%,MSN;SLC8B1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.40493799291191096,1.0341202211708231,0.43625,0.7190375734224367,1.0,6/25,18.45%,PPARG;SOCS5;CBL;ZGPAT;TNF;ERRFI1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.29649269527213584,-1.0339270456446499,0.3687150837988827,0.7218275960783346,1.0,9/31,19.84%,MAPK14;PLCB1;IL16;CD40;SCIMP;LGALS9;LTB;PLCG2;TLR9
prerank,positive regulation of vacuole organization (GO:0044090),0.49304143606980677,1.0335635358375956,0.4437869822485207,0.7200133046228978,1.0,6/10,28.91%,RAB3GAP1;RAB3GAP2;PIP4K2A;RALB;SH3GLB1;LRSAM1
prerank,myelination (GO:0042552),0.37585332335133487,1.0332986614731439,0.4444444444444444,0.7202986291410075,1.0,16/46,21.17%,B4GALT5;MALL;KLK6;ABCD2;MYOC;SKI;NF1;MPZ;MBP;ACSBG1;EIF2B2;AMIGO1;PMP22;TNFRSF21;SIRT2;CMTM8
prerank,negative regulation of cell population proliferation (GO:0008285),0.3256338198776981,1.0325063233198002,0.416,0.7218480525195501,1.0,80/351,22.45%,GPNMB;CTNNB1;NIBAN2;SPEG;ADARB1;NLRC3;B4GALT7;CDK6;NELL1;PTK2B;CYP27B1;VDR;CLDN19;ING4;CD300A;PPP2R5C;NUDT6;PTGIR;SOX9;MTSS1;E2F3;PPARG;HMOX1;PDPN;CEBPA;PTPN2;IGFBP7;APPL2;BAP1;CELF1;MNT;ARID2;GTPBP4;SKI;DLL4;COPS8;NUPR2;SMYD2;TREM2;ATF5;CYP1B1;RNF41;VIP;CDKN3;CCN6;UTP20;RAF1;IL6;TNFAIP3;RPS6KA2;SULT2B1;GNRH1;NF1;RBP4;S100A11;FLCN;BMP5;ZBTB17;KLF10;CHERP;SFRP1;FRK;TBRG1;PTPN6;ITGB1BP1;STK11;DDAH1;TGFB1I1;TGFB1;SIRT2;FRZB;NCK2;SLC16A2;IFI35;NOTCH1;NOX4;KANK2;TNFRSF8;NF2;TES
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4032475266032977,1.0324680159159663,0.4289185905224787,0.7215678334540356,1.0,10/27,23.59%,ERN1;RNASEH1;ZC3H12B;TRIR;POP1;ZC3H12C;ZC3H12A;ZC3H12D;TOE1;XRN1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.41965095809274977,1.0324488608421012,0.4393358876117497,0.721231397636343,1.0,5/22,18.75%,SLC9A1;HTT;STAC2;CALM2;GSTO1
prerank,spliceosomal complex assembly (GO:0000245),0.3714639993709379,1.0323775840936662,0.44279176201373,0.7210357001988583,1.0,16/46,22.41%,LUC7L2;DDX39B;ZRSR2;CELF1;PUF60;SRPK1;SRPK2;DDX1;GCFC2;CELF6;PRPF6;NOL3;SRSF1;SRSF10;SNRPD2;SNRPD1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3202292430280937,1.0321903185039563,0.297,0.7211213761443024,1.0,377/1645,22.64%,APBB2;IGF1;LITAF;MDFIC;MITF;CDK14;CXXC1;SPP1;CTNNB1;ZMIZ1;CDK18;ERCC6;HIF1A;ATF3;NIBAN2;NFE2L2;APOE;NFYA;KMT2A;NFIC;ZHX2;TOX2;UXT;FGF2;ARID5B;MAFF;JMJD1C;TGIF1;CDK5;ANXA4;MEF2D;PRICKLE1;FOXN3;ELF4;CUX1;POU3F1;GDF6;SEBOX;HOXA4;SOX30;FSTL3;TBX18;VDR;TFEB;PPARD;ING4;RUNX1;PAK6;CCNL1;PERM1;ZMIZ2;FOXJ1;VEGFA;ELF2;SHOX2;TRAK1;FAM47E;SOX9;KMT5A;ERN2;LRRFIP1;CHD3;RCOR1;KDM3A;NFX1;PRKCB;BASP1;E2F3;IRF8;ZNF326;BHLHE41;PPARG;SAFB2;NFIL3;RAI1;HES7;CEBPA;HDAC4;BHLHE40;SMAD7;CCNC;ZNF160;PCBD2;KLF6;RNF6;GMNN;SMARCB1;CIC;BAMBI;ID2;MAFG;BPTF;CSRNP1;ARHGEF11;SBNO1;TRIM28;BAP1;BRD4;PHF1;CC2D1A;NKX2-1;HDAC9;MED21;GON4L;VRTN;PRDM15;ETV6;MAP3K12;MNT;RIOX1;MEF2B;LRP6;CREB3L2;CCAR1;EGR2;BCL6;FBXL19;TAF15;GBX1;CHD7;GAS6;ASCL4;NUPR2;THOC1;MTF2;SUDS3;BRCA1;TGFBRAP1;DNM2;THAP7;FZD4;KLF12;JUN;FZD1;DDX17;IRF5;ZBTB2;ATF5;CBX3;PPIE;MED17;DDIT3;CCNL2;RCOR3;ZFHX2;NFKB1;NFE2L1;NRF1;HNRNPK;SERTAD3;CARM1;RNF14;TAF7;CDK16;PPP2R1A;SRF;NR3C1;ZBTB34;EED;EHMT1;SP7;TLE5;RHOG;MED29;CCNT2;ELK3;WWP2;GLRX2;PRMT6;MYBL2;RBM15B;ZNF296;ENO1;ZKSCAN3;CEBPG;NPAS4;CDK11B;SRCAP;ZNF569;GMEB1;LIMS1;MDM2;ZNF148;ELK4;DMRTA2;GMEB2;ATXN1;SCML4;OGT;ASCC2;BAZ1B;CREBZF;PRMT2;ZSCAN12;IL6;PEX14;DHX9;NAB2;CBFA2T2;USP47;FOXJ3;MGA;MAP2K3;ILK;MYT1;MTF1;SP9;MSL3;ETV4;NPAT;FBXW11;FGF7;NAA16;SMARCD2;HSPD1;SP1;ZGPAT;MYBBP1A;CHEK2;HCFC1;L3MBTL2;IRF2BP2;ZBTB7B;ZNF83;TCF24;MIDEAS;TNF;ZBTB40;TOX4;UIMC1;UBE2L3;MNAT1;ZNF177;MRGBP;NFATC3;DNAJC2;MEIS3;ZEB2;SBNO2;FOXP4;YY1;ZFP41;SUFU;ZFP57;HDAC1;PPARGC1B;CREG1;SNW1;USF2;ZBTB4;NOTCH4;PCGF6;YEATS2;ASCC1;ZBTB17;PCGF3;DPF3;BCL11B;PHF20L1;TASP1;KLF13;KAT7;CRK;GTF2H1;PURA;KLF10;ZSCAN20;IFRD1;MAFB;TAF5L;KDM2A;USP13;POFUT1;PRRX1;UTP4;YAF2;QARS1;NDP;UBP1;GCFC2;PIAS4;SFRP1;SP110;MMS19;RBFOX2;CNBP;ZBTB12;FOXN2;NAA15;ARID1B;MED1;GRHL1;BAHD1;MAP2K2;LOXL3;SS18L1;RUVBL2;JUNB;TGFBR1;ZBTB43;RXRB;DEK;ZKSCAN1;HP1BP3;REL;HSF1;SAFB;ZXDC;DYRK1B;HDAC3;ZBTB45;ZNF568;LIN9;ID1;MED6;EPO;USP21;USP16;FUS;LDB1;CDH1;BLM;LCORL;DAP;BARX2;MED27;MPHOSPH8;KTI12;ARID4A;DGKQ;POU2F1;SATB2;PHF2;TGFB1I1;FBXO5;KDM3B;RNF111;TGFB1;LCOR;SIRT2;KMT2B;ZFX;ATF1;MTDH;RNF20;SMAD1;PDGFB;DMAP1;SUMO1;NSD1;GPBP1L1;CREM;THAP1;RXRA;MTA3;GATAD2A;NOTCH1;ARID3A;GZF1;PRMT5;ZBTB16;PITHD1;ZFAT;CREBBP;ZNF250;CHD1;SRSF10;TMPRSS6;CALR;PHC2;XRCC5;SMARCA4;KMT2D;TCIM;MTERF3;PHF10;HIC2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4322514547297469,1.0319200195334415,0.43190661478599224,0.7213891187964514,1.0,8/18,23.98%,TNFRSF1B;TMEM98;SLC45A3;NF1;TNFRSF21;DRD3;NOTCH1;IL34
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2864527694356372,-1.0319059217964182,0.35714285714285715,0.7248641653012883,1.0,14/34,21.07%,RIMS1;SYT1;SYT10;RIMS2;RAB3A;LRRK2;SNAPIN;SYN1;SYT4;SYT7;SYT2;SYT17;SYT9;RAB15
prerank,presynapse organization (GO:0099172),-0.42040933060919894,-1.0314124042671229,0.4041916167664671,0.7239245395186823,1.0,4/10,13.88%,NLGN1;LRRTM3;NLGN3;WNT5A
prerank,actin filament depolymerization (GO:0030042),0.4820901195193902,1.0314016808980697,0.44525547445255476,0.7222886960287619,1.0,2/11,3.21%,MICAL2;MICAL1
prerank,cellular protein localization (GO:0034613),0.3266836149823427,1.0313795622255024,0.4244244244244244,0.7219715451847215,1.0,93/285,26.62%,SH3PXD2B;CTNNB1;RRAGD;TBC1D22A;RAP2A;SNX8;CTSA;ARF3;TBC1D2;NAPA;FOXJ1;FLNA;TRAPPC8;RIC1;RAB32;ARL11;PACS2;ZDHHC15;VPS26A;TLK1;WLS;ARL1;RAB5A;WDR45;CELSR1;ACD;STX6;HPS6;MYO7A;AP3D1;TBC1D10A;RAB5C;SIL1;RAB1A;VPS26C;TBC1D12;STX3;TM9SF2;USO1;RAB20;STX5;SAR1A;TBC1D16;CEP250;SNX27;GGA2;VPS35;FGF7;ARFGAP3;GRIN3B;RAB22A;SNX31;ARHGEF2;RABL3;SNX17;COPA;RAB3GAP2;TMED3;CORO1B;BBS2;ARMCX3;ARFRP1;STX7;LAMTOR3;ID1;VIPAS39;LAMTOR1;TM9SF3;ARF6;ATG13;RUNDC1;AP3B1;SNX1;SNX15;RRAGC;SGSM1;DNAJC27;TBC1D1;TBC1D15;STX4;RAB31;TBC1D10C;ARF5;EHD1;COPZ2;ARF4;PDCD6;REEP1;VPS26B;GGA3;STX11;ARL4A;WDR11
prerank,microtubule anchoring (GO:0034453),0.4744444346462964,1.0313063825186635,0.44285714285714284,0.7217813360874239,1.0,4/12,12.60%,DAG1;GCC2;BCCIP;PEX14
prerank,nucleotide metabolic process (GO:0009117),0.4119487822413941,1.0312087651731874,0.42455242966751916,0.7216631772790391,1.0,5/23,10.41%,AK8;NUDT5;AK4;RNASEH2B;AK5
prerank,nucleoside salvage (GO:0043174),0.4965864082037332,1.0308028771335884,0.44963503649635034,0.7222911730286101,1.0,7/10,38.13%,UCKL1;TK1;TK2;HPRT1;UPP2;UCK2;DCK
prerank,regulation of response to interferon-gamma (GO:0060330),0.46260937990952494,1.0306027208613964,0.4549019607843137,0.722396245513197,1.0,7/14,25.98%,PTPN2;IFNGR2;JAK1;SUMO1;HSP90AB1;PIAS1;PARP9
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.41710663254376873,1.0305325476595157,0.42947903430749684,0.722194431478986,1.0,7/21,22.19%,TEDC2;ARMC9;EVC;SFRP1;PDCL;TEDC1;RAB34
prerank,histone H3-K9 demethylation (GO:0033169),0.4903867192484827,1.0301675823012066,0.45203488372093026,0.7227211142498189,1.0,7/11,28.36%,JMJD1C;KDM3A;KDM4D;KDM3B;KDM1A;HR;KDM4B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31948476075376303,1.0293867892821114,0.319,0.7242131684154258,1.0,378/1667,21.72%,IGF1;FNIP2;LITAF;MITF;DNMT3A;CTNNB1;ZMIZ1;HIF1A;ATF3;MRTFA;NFE2L2;APOE;NFYA;KMT2A;NFIC;ZHX2;SLC9A1;TOX2;MMP12;SDCBP;UXT;FGF2;ARID5B;MAFF;JMJD1C;DOT1L;TGIF1;ANXA4;MUC1;TNIP1;MEF2D;ELF4;CUX1;CDK8;POU3F1;SEBOX;HOXA4;POMC;SOX30;FSTL3;TBX18;VDR;TFEB;PPARD;NOC2L;RUNX1;AGO2;CCNL1;ZMIZ2;FOXJ1;VEGFA;DAB2;SQSTM1;ELF2;SHOX2;TRAK1;SOX9;MED15;KMT5A;LRRFIP1;CHD3;RCOR1;KDM3A;NFX1;PRKCB;E2F3;IRF8;BHLHE41;PPARG;MRTFB;SAFB2;NFIL3;RAI1;HES7;CRTC1;RHOQ;MDFI;CEBPA;HDAC4;BHLHE40;SMAD7;CCNC;ZNF160;KLF6;SMARCB1;CIC;JAG1;ID2;MAFG;BAX;BPTF;CCNB1;MYDGF;CSRNP1;TRIM28;RNF2;TET3;BRD4;UBA52;CC2D1A;NKX2-1;HDAC9;SS18L2;MED21;VRTN;PRDM15;ETV6;MNT;SKI;MEF2B;SLC11A1;LRP6;DLL4;CREB3L2;EGR2;BCL6;FBXL19;GBX1;USP9X;ASCL4;NUPR2;MTF2;SUDS3;TRIAP1;BRCA1;THAP7;KLF12;JUN;DDX17;CAV1;SMYD2;IRF5;ZBTB2;PIK3R2;ATF5;TMF1;ECD;PPP3R1;MED17;DDIT3;GTF2F1;CCNL2;RCOR3;ZFHX2;NFKB1;NFE2L1;NRF1;NAMPT;HNRNPK;ZFP64;RNF14;TAF7;DNMT3B;RNASEL;SRF;NR3C1;LILRB1;ZBTB34;EED;SP7;TLE5;MED29;CCNT2;ELK3;WWP2;MIER2;MYBL2;ZNF296;ENO1;ZKSCAN3;NCK1;ASXL2;CEBPG;MAML2;NPAS4;SRCAP;ZNF569;LYAR;GABPB1;GABPB2;CDK13;GMEB1;MDM2;ZNF148;ELK4;PLK3;C1QBP;JUP;DMRTA2;GMEB2;ATXN1;SERPINF2;USP2;INO80;OGT;BAZ1B;CREBZF;ZSCAN12;IL6;PID1;DHX9;TNIP2;CBX2;FOXJ3;MGA;FNIP1;MAPK7;SSBP4;MYT1;MTF1;SP9;AGO3;ETV4;NPAT;TPR;SMARCD2;HSPD1;SP1;ZGPAT;MYSM1;RPRD1A;ZBED3;HAX1;EFNA1;GATAD2B;HCFC1;IRF2BP2;ZBTB7B;ZNF83;TCF24;MIDEAS;TNF;ZBTB40;TOX4;RRP1B;ATN1;RPS27A;UBC;MNAT1;ZNF177;MRGBP;NFATC3;LAGE3;MEIS3;AGO4;EIF5A;ZEB2;SBNO2;FOXP4;YY1;ZFP41;TCF25;CPEB3;TBK1;SUFU;ARHGEF2;AKIRIN1;ZFP57;FLCN;HDAC1;PPARGC1B;CREG1;SNW1;LMO2;TNIP3;USF2;ZBTB4;NOTCH4;PCGF6;YEATS2;BMP5;ZBTB17;PCGF3;DPF3;BCL11B;PHF20L1;KLF13;KAT7;CRK;GTF2H1;PURA;KLF10;ZSCAN20;PIN1;IFRD1;PCBP1;WWOX;MAFB;KDM2A;PRRX1;CDK4;LPIN3;UBP1;SARS1;PIAS4;SERPINE1;SSU72;SP110;CNBP;ZBTB12;MAPK3;ARID1B;WFS1;MED1;GRHL1;SS18L1;RUVBL2;JUNB;PPP1R12A;ZBTB43;DACT1;RXRB;DEK;ZKSCAN1;REL;PRPF6;HSF1;SAFB;ZXDC;FRK;HDAC3;ZBTB45;ZNF568;FST;LIN9;ID1;MED6;EPO;USP16;FUS;LDB2;LDB1;HNRNPU;ZC3H12A;BRD8;ITGB1BP1;LCORL;BARX2;MED27;XBP1;KTI12;FGFR2;ARID4A;DGKQ;POU2F1;GLYR1;SATB2;PHF2;ACTR3;CCND1;KDM3B;RNF111;TGFB1;LCOR;CRTC3;BEX1;SIRT2;ZFX;GDNF;ATF1;MTDH;SMAD1;NCK2;DMAP1;PAXBP1;SUMO1;METTL23;NSD1;CREM;THAP1;RXRA;MTA3;GATAD2A;NOTCH1;ARID3A;SLC30A9;BMI1;GZF1
prerank,positive regulation of immune response (GO:0050778),0.35631044299555537,1.0293337414764558,0.4485776805251641,0.7239578080668957,1.0,18/64,24.21%,ADAM8;PTPRC;GPR151;CYBA;IL12RB1;SPHK2;POLR3D;LILRB1;DHX9;IL2;RIOK3;ITGB2;RSAD2;XBP1;IFI35;POLR3B;EIF2AK4;STX4
prerank,inner dynein arm assembly (GO:0036159),0.4859474921362218,1.0291258908202041,0.4704225352112676,0.7240900677734579,1.0,5/11,30.22%,DNAAF5;DNAI3;CCDC40;CCDC39;CFAP73
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.31905374702771994,-1.028866305137933,0.40384615384615385,0.7284143847600776,1.0,4/21,8.84%,DMD;AKAP6;PDE4D;CACNA1C
prerank,endothelial cell development (GO:0001885),-0.3104862655818867,-1.0286723145999488,0.3969849246231156,0.7266583295616021,1.0,7/25,16.42%,EZR;RAPGEF2;RAPGEF3;PDE4D;PECAM1;PDE2A;COL22A1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3788069878391649,1.028444347211739,0.4602803738317757,0.7253740507147698,1.0,16/38,28.06%,CABIN1;CENPO;CENPT;CENPX;UBN1;CENPA;CENPK;CENPS;HAT1;ASF1A;CENPW;H3-3A;IPO4;RSF1;CENPU;CENPC
prerank,neuromuscular junction development (GO:0007528),-0.31184272062486673,-1.0281501563937592,0.3942307692307692,0.7257883709159759,1.0,7/24,14.59%,CACNB2;ANK3;UNC13B;LRRK2;GPHN;F2R;UNC13C
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.39065409639853976,-1.0279156104897516,0.39285714285714285,0.7242346568630414,1.0,3/12,9.07%,SNAP25;STX1A;SNAP23
prerank,negative regulation of secretion by cell (GO:1903531),0.3829083408980414,1.0277574569685133,0.4657375145180023,0.7266481715656352,1.0,6/38,10.07%,APOE;RHBDF2;TRH;SERGEF;TNFRSF1B;LILRB1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4669682630901846,1.0276671884583166,0.4392905866302865,0.7264934411587889,1.0,2/12,3.85%,VEGFA;SOX9
prerank,gland development (GO:0048732),0.3605740324692884,1.0276668117316312,0.4517876489707476,0.7261207969126787,1.0,15/59,20.22%,ARID5B;SOX9;MSN;CEBPA;NKX2-1;CAV1;CEBPG;RIPK3;NF1;GFER;NOTCH4;TGFBR1;XBP1;FGFR2;PHF2
prerank,response to UV (GO:0009411),0.3454835402175127,1.0275379568053145,0.44831223628691985,0.7260597563122646,1.0,38/95,28.50%,ERCC6;PRKCD;NOC2L;MAP4K3;ZRANB3;TRIAP1;CAT;DDB2;ERCC4;XPA;INO80;REV1;CASP9;USP47;YY1;UBE4B;CDC25A;CIRBP;TMEM161A;ERCC2;RUVBL2;CCND1;NEDD4;EIF2S1;CREBBP;PARP1;KDM1A;METTL3;EIF2AK4;EP300;UVSSA;PCLAF;DCUN1D3;USP28;ZBTB1;DHX36;SDE2;FMR1
prerank,positive regulation of ossification (GO:0045778),-0.2824731778648347,-1.027461623913667,0.4,0.7231101312835274,1.0,6/39,4.16%,TMEM119;MEF2C;ALOX5;GPM6B;ACVR2B;BMPR1B
prerank,glycogen catabolic process (GO:0005980),-0.3652283902158334,-1.0274300920235855,0.3831417624521073,0.7209955032669725,1.0,6/15,14.52%,PHKG1;PHKA2;PYGL;RB1CC1;AGL;PYGB
prerank,sensory perception of smell (GO:0007608),0.4853818213529104,1.027052671194314,0.449438202247191,0.726849401178203,1.0,2/11,4.87%,ADCY3;SLC24A4
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2695574582574967,-1.026612097608242,0.4117647058823529,0.7208914577048086,1.0,9/47,15.02%,SPOCK3;SORL1;BIN1;SERPINI1;GAPDH;VTN;AGT;SERPING1;SPOCK2
prerank,oogenesis (GO:0048477),0.44492404347105,1.0264780701288276,0.45646437994722955,0.7278394686226947,1.0,6/15,26.32%,PIWIL2;TRIP13;KMT2D;METTL3;NANOS1;MEI4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.41382785211242457,1.0260863519246837,0.4585427135678392,0.7284097639165669,1.0,8/24,21.64%,TNIP1;MSN;OLR1;SYK;GFUS;ITGA4;ITGB2;ROCK1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4998595641104086,1.026081632633994,0.4496240601503759,0.728047196967695,1.0,3/10,14.47%,RUNX1;NCKAP1L;ZBTB7B
prerank,mitotic DNA replication (GO:1902969),0.491310313180496,1.0259933595232895,0.4433139534883721,0.7278816736481517,1.0,6/10,25.96%,MCM2;LIG1;GINS1;MCM6;MCM3;POLA1
prerank,regulation of sensory perception of pain (GO:0051930),0.47310754359063567,1.0259621129958783,0.4629898403483309,0.7275792516098458,1.0,3/11,10.61%,MGLL;ZFHX2;VIP
prerank,positive regulation of neutrophil migration (GO:1902624),0.43129251753827125,1.025687146906772,0.4456094364351245,0.7278814182232012,1.0,4/18,11.75%,ADAM8;NCKAP1L;MOSPD2;C1QBP
prerank,establishment of spindle orientation (GO:0051294),0.40377546813940046,1.0256305305050692,0.45828144458281445,0.727657853879119,1.0,7/28,15.13%,HTT;DCTN1;LLGL2;NUMA1;LLGL1;FBXW11;CENPA
prerank,COPII vesicle coating (GO:0048208),0.3561231124616132,1.0256064250076076,0.45916114790286977,0.7265958655361271,1.0,23/61,28.35%,CTSZ;GOSR2;NAPA;SEC24A;MCFD2;SEC22B;ANKRD28;CSNK1D;RAB1A;USO1;STX5;PPP6C;GOLGA2;TBC1D20;SEC24D;SEC16A;LMAN1;SEC24B;CUL3;PDCD6;TGFA;SEC23A;SEC23IP
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3561231124616132,1.0256064250076076,0.45916114790286977,0.7265958655361271,1.0,23/61,28.35%,CTSZ;GOSR2;NAPA;SEC24A;MCFD2;SEC22B;ANKRD28;CSNK1D;RAB1A;USO1;STX5;PPP6C;GOLGA2;TBC1D20;SEC24D;SEC16A;LMAN1;SEC24B;CUL3;PDCD6;TGFA;SEC23A;SEC23IP
prerank,vesicle coating (GO:0006901),0.3561231124616132,1.0256064250076076,0.45916114790286977,0.7265958655361271,1.0,23/61,28.35%,CTSZ;GOSR2;NAPA;SEC24A;MCFD2;SEC22B;ANKRD28;CSNK1D;RAB1A;USO1;STX5;PPP6C;GOLGA2;TBC1D20;SEC24D;SEC16A;LMAN1;SEC24B;CUL3;PDCD6;TGFA;SEC23A;SEC23IP
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3378357798247145,-1.0254394898003452,0.41975308641975306,0.7217789425360006,1.0,6/18,8.46%,ASPA;NAT8L;NIT2;SLC25A12;ADI1;FOLH1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3883829421754067,1.0252805919612789,0.43942992874109266,0.727002102504606,1.0,9/30,22.80%,BCL2L1;DDX39B;CD44;THOC1;MDM2;PTTG1IP;TMEM161A;FBXO5;KDM1A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.36046696657224625,1.0252368575673085,0.46298342541436466,0.7267308557847809,1.0,6/57,4.30%,RGS1;ADCY8;ADCY3;ADCY7;PSAP;FLNA
prerank,regulation of vasculogenesis (GO:2001212),0.4525212905093854,1.0249717111723524,0.4283783783783784,0.727026026517181,1.0,2/14,3.36%,XDH;RIN2
prerank,protein localization to cell periphery (GO:1990778),0.33652664403048305,1.024802654155079,0.44693877551020406,0.7270575370481167,1.0,27/133,15.76%,FGF13;MYO5A;ANK1;RABEP1;RAB40C;RAP2A;EFR3B;DENND4C;FLNA;RAB8B;TTC7B;PACS2;TSPAN5;LRP6;GAS6;CAV1;PKP2;MYADM;RAPGEF6;CACNB3;JUP;EHD4;GAK;ATP1B3;TNF;FYB1;PIP5K1A
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4358625917693692,1.0245179541085985,0.46625,0.7273543544050515,1.0,6/18,22.40%,PABPN1;THOC2;MCM3AP;NXF1;NUP133;NUP93
prerank,response to reactive oxygen species (GO:0000302),0.36027246240641964,1.0243871032621876,0.44518272425249167,0.7272884593257752,1.0,10/54,13.32%,HIF1A;APOE;STK24;HMOX1;AGAP3;JUN;CAT;GLRX2;PLK3;FYN
prerank,regulation of membrane repolarization (GO:0060306),-0.3767797476115792,-1.024268286873114,0.3862815884476534,0.7226938092114523,1.0,2/13,1.41%,CACNA2D1;AKAP6
prerank,maturation of SSU-rRNA (GO:0030490),0.38495574331021554,1.0241329227929945,0.45077105575326215,0.7275193815152813,1.0,15/34,26.80%,TSR1;DDX52;RIOK2;RPS28;RIOK3;NAT10;SNU13;WDR3;LSM6;UTP4;SRFBP1;RPS19;NOP14;BMS1;DCAF13
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.33412198039901075,1.0241157790609168,0.4375644994840041,0.7271837860469825,1.0,30/121,20.97%,IGF1;CSPG4;ITGA5;TEC;PTPRC;NRP1;PTK2B;VEGFA;NEDD9;CD44;GAS6;TREM2;PAK2;GPRC5B;IL6;FGF7;IL2;HAX1;EFNA1;TNF;DLG4;ARHGEF2;DOK7;PTPN1;IL5;ARL2BP;EPO;DGKQ;TGFB1;PDGFB
prerank,phospholipid metabolic process (GO:0006644),0.3517095613961838,1.0241141128246039,0.45,0.7268168828887711,1.0,16/71,22.30%,LPL;ABHD12;APOA2;PLAAT3;PLCB2;PLPP3;LPCAT1;PLAA;PLBD2;PIP5K1A;PIP4K2A;AGPAT1;PLA2G5;CLN8;AGPAT5;AGPAT3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.44837516984228454,1.0241085496068414,0.466484268125855,0.7264603701477321,1.0,4/15,16.44%,AGO2;EIF4ENIF1;CPEB3;PABPC1
prerank,positive regulation of dendrite extension (GO:1903861),-0.3510572467939616,-1.023840165628295,0.4090909090909091,0.7216432375741123,1.0,9/17,19.26%,RIMS1;SYT1;RIMS2;SYT4;SMURF1;CPNE5;NEDD4L;SYT2;SYT17
prerank,tRNA processing (GO:0008033),0.3637761558020762,1.023836375470043,0.4500548847420417,0.7267629091229089,1.0,21/61,26.20%,AARS1;METTL1;TRMT10C;QTRT1;ANKRD16;WDR4;DDX1;FARS2;SARS1;POP1;CDKAL1;ELP5;LCMT2;TSEN15;TRMT10A;TSEN2;RTCB;NSUN2;NSUN6;TRUB1;FAM98B
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.2725430421261109,-1.0238306200225429,0.3805309734513274,0.7195168566648389,1.0,18/48,20.36%,CYRIB;IL18;CCR2;TRIM27;SLAMF6;PDE4D;CD226;LGALS9;SLC7A5;RASGRP1;EBI3;ZFPM1;IL1B;PDE4B;PTPN22;CD2;TLR9;FZD5
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3584226636476627,1.0236826032694109,0.4451901565995526,0.7267475504181152,1.0,8/51,14.62%,LPL;HSPB1;MALT1;PANX1;TMEM106A;AIM2;IL6;TNF
prerank,defense response to Gram-negative bacterium (GO:0050829),0.37199155062239336,1.0214333774020319,0.44638694638694637,0.7317568492760476,1.0,11/42,21.85%,OPTN;SLC11A1;MPEG1;TREM2;RNASE7;RNASE3;IL6;IRGM;SERPINE1;DMBT1;RPS19
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4432293247194578,1.0214092126308745,0.44369063772048845,0.7310716469714892,1.0,7/15,32.98%,AGO2;CPEB3;PABPC1;NANOS1;DHX36;TNRC6C;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4432293247194578,1.0214092126308745,0.44369063772048845,0.7310716469714892,1.0,7/15,32.98%,AGO2;CPEB3;PABPC1;NANOS1;DHX36;TNRC6C;CNOT7
prerank,macromolecule catabolic process (GO:0009057),0.40818610366958546,1.021238354954152,0.45197044334975367,0.7311003886078072,1.0,9/26,21.59%,SNX25;TPP1;BECN1;MVB12A;KIF16B;CLN8;NEDD4;TGFB1;CLPX
prerank,response to ethanol (GO:0045471),0.45021648303335426,1.0211723883292194,0.4504881450488145,0.7308900673641524,1.0,3/14,2.77%,CHRNB2;TH;ADCY7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.45096285721584917,1.0209704815293936,0.444743935309973,0.7310039352723527,1.0,3/14,13.10%,NUDT5;NUDT9;ENTPD6
prerank,regulation of monooxygenase activity (GO:0032768),0.40874765607973157,1.0206565989441903,0.4524714828897338,0.7313947911898677,1.0,5/23,8.56%,VDR;NOSTRIN;DNM2;POR;CAV1
prerank,activation of adenylate cyclase activity (GO:0007190),0.3826898603356229,1.0203298975687483,0.458628841607565,0.731796791632732,1.0,8/35,17.08%,ADCY8;ADCY3;ADCY7;CAP1;GLP1R;RAF1;EDNRA;GIPR
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3933408907411871,1.0201883289116394,0.44865525672371637,0.7317527423249138,1.0,10/31,20.78%,PATL1;NT5C3B;EDC4;EXOSC9;CNOT6;DCP2;EXOSC5;LSM6;EDC3;EXOSC4
prerank,regulation of GTPase activity (GO:0043087),0.3250651088063795,1.0200917380243013,0.4526958290946083,0.7316222741061627,1.0,39/177,16.82%,BCAR3;PLXNC1;GPR137B;RGS1;CCL4;PLXNA2;ALS2;FGD6;TBC1D2;CPEB2;RIC1;RGP1;ARHGAP12;CCL13;GMIP;CCL14;PLXND1;LIMS1;RAPGEF6;SNX18;PKP4;LARS1;NF1;RRP1B;DOCK11;FGD5;PLXNA1;ARHGEF5;ARFGEF1;ADAP1;PRKG1;FLCN;VAV1;CHN2;ARHGAP9;RAB3GAP1;CRK;PIN1;RAB3GAP2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.41621997406911054,1.020090757839954,0.45268542199488493,0.7308837851996717,1.0,9/21,22.59%,ERCC1;DDB2;DDB1;ERCC4;XPA;GTF2H1;ERCC2;CUL4A;PARP1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.41621997406911054,1.020090757839954,0.45268542199488493,0.7308837851996717,1.0,9/21,22.59%,ERCC1;DDB2;DDB1;ERCC4;XPA;GTF2H1;ERCC2;CUL4A;PARP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.39768336055840736,1.0199431064906372,0.4438964241676942,0.7308580754465799,1.0,8/28,18.30%,PRKCD;PRKCB;PTPN2;APPL2;NCK1;PID1;PIP4K2A;PTPN1
prerank,regulation of organelle organization (GO:0033043),0.33982920412744216,1.0199411838962653,0.44257112750263433,0.7304956032391512,1.0,22/80,19.31%,MYO5A;ATP13A2;SQSTM1;MSN;CLIC4;STOX1;PAK2;PRMT6;PARL;STX5;SAR1A;GOLPH3;VPS35;ARHGEF5;ZEB2;MAPK3;MAPK15;RHOT2;MARK2;CLN3;VPS11;TAOK1
prerank,sulfation (GO:0051923),-0.4040943133505134,-1.0199139381994893,0.4280821917808219,0.7274141211438357,1.0,2/11,3.01%,HS3ST5;UST
prerank,N-glycan processing (GO:0006491),0.4333208041087077,1.019355461975008,0.4542079207920792,0.7315212641209218,1.0,3/18,8.85%,MAN1C1;GNPTAB;ST8SIA6
prerank,negative regulation of viral genome replication (GO:0045071),0.37175114331708914,1.0188967996282465,0.4439359267734554,0.7322428780920525,1.0,12/40,21.61%,SHFL;TNIP1;TRIM6;SRPK1;RNASEL;SRPK2;TNF;BST2;RSAD2;MPHOSPH8;ZC3HAV1;RESF1
prerank,cellular response to superoxide (GO:0071451),0.4844421348495547,1.0188416868675656,0.4833574529667149,0.7319899123932533,1.0,3/10,12.80%,ATP7A;PRDX1;ADPRS
prerank,cellular response to pH (GO:0071467),0.43135253616139246,1.0182473175855273,0.47790055248618785,0.7330764226329247,1.0,8/17,28.91%,SLC9A1;ASIC1;HVCN1;IMPACT;PKD2L1;RAB11B;RAB11FIP5;PKD1L3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3782019049288138,-1.0181705509351116,0.40217391304347827,0.7298467449396376,1.0,6/12,18.88%,PTPRJ;APOD;NDRG4;F3;F7;CBLB
prerank,positive regulation of RNA metabolic process (GO:0051254),0.36548941273747276,1.0181299255669105,0.4518348623853211,0.7330178665316245,1.0,13/45,18.09%,DXO;ERN1;HNRNPLL;GRSF1;NFKB1;WDR43;RIOK2;IL6;SUPV3L1;DIMT1;RBM22;SLC38A2;MAP2K2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4580942612576643,1.0176224943210153,0.467966573816156,0.7338650150676278,1.0,5/13,23.82%,DERL3;EDEM1;BRSK2;UBE2J1;YOD1
prerank,regulation of T cell differentiation (GO:0045580),0.38890205535079003,1.017617723930079,0.46941176470588236,0.7335043912359014,1.0,11/33,24.61%,ZMIZ1;RUNX1;CLPTM1;CRTAM;IL2;XBP1;FANCA;METTL3;TCF7;IL7;ABL1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4611085067037735,1.0175761854436032,0.4682651622002821,0.7332295510417352,1.0,4/13,14.47%,RUNX1;NCKAP1L;TGFBR2;ZBTB7B
prerank,acute-phase response (GO:0006953),-0.3862460529673981,-1.0175727697931896,0.42084942084942084,0.7293026896277436,1.0,1/12,0.40%,IL6R
prerank,mRNA metabolic process (GO:0016071),0.33930204339203746,1.0174389921185718,0.4508975712777191,0.7331778034636293,1.0,24/90,23.09%,SON;DXO;ERN1;CNOT10;CELF1;SRSF11;RNH1;YTHDF2;KIN;SRSF2;AGO3;HNRNPA2B1;AGO4;RIDA;DCP2;SRSF7;LSM6;SNRPF;HSF1;GEMIN2;SRSF1;ZC3H12D;SNRPD3;METTL3
prerank,neural crest cell migration (GO:0001755),0.3843631514308935,1.0173861288904256,0.4702517162471396,0.7329320217548919,1.0,3/36,1.74%,FN1;CORO1C;NRP1
prerank,positive regulation of integrin activation (GO:0033625),0.4717438428637263,1.0172871878519842,0.48409405255878285,0.7327951827735556,1.0,2/11,2.93%,PLEK;PIEZO1
prerank,regulation of macrophage migration (GO:1905521),0.4779342882785903,1.0169966379664737,0.47581903276131043,0.7331003247521874,1.0,3/10,2.06%,CSF1;PTK2B;CD200R1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4223206366909368,1.0169141584232486,0.4473684210526316,0.732947951923311,1.0,5/20,14.36%,APOE;MBTPS2;LPCAT3;ACADL;ARV1
prerank,apoptotic process (GO:0006915),0.32391409913302877,1.0164262092060392,0.46392785571142287,0.7337180001733246,1.0,53/203,21.82%,BCL2;BCL2L1;CDK5;PTK2B;PRKCD;GDF6;PPARD;PDE1B;ING4;PAK6;MCM2;AKAP1;DIABLO;STK3;BAX;CSRNP1;THOC1;DAPK1;PPP2R1A;ADAM15;BCL2L11;GLRX2;CDIP1;TGFBR2;CDK11B;MDM2;AIFM2;PLK3;OGT;RAF1;CASP9;BID;BIK;YARS1;HSPD1;FASTKD2;BNIP2;MRPS30;ATN1;HIP1;CASP7;ERCC2;AHCYL1;TNFRSF21;ITGB2;STK11;IAPP;DAP;EGLN3;PIK3CA;CYFIP2;NUDT2;ZBTB16
prerank,cellular response to lipopolysaccharide (GO:0071222),0.33863978142636014,1.0163921142728058,0.48662551440329216,0.7334227359554486,1.0,29/101,21.69%,SIRPA;STAP1;CD274;AXL;VIM;TNFRSF1B;GIT1;PABPN1;NFKB1;ACOD1;LILRB1;PLAA;RHOA;TICAM1;CD180;IL6;TNIP2;TNFAIP3;TNF;SBNO2;TNIP3;IRGM;SERPINE1;CD68;ZC3H12A;XBP1;TGFB1;MTDH;IRAK1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3401975629204847,1.0163797981388514,0.45531019978969506,0.7330862652609036,1.0,16/87,11.62%,LRP1;IQGAP1;ABL2;PDGFA;PTK2B;PRKCD;RHOQ;RHOD;CELSR1;HIP1R;BAIAP2;RHOG;PHPT1;ARHGAP17;TESK1;RHOA
prerank,protein alkylation (GO:0008213),0.40699898012058827,1.0162881231409935,0.45454545454545453,0.7329336858474584,1.0,11/22,31.25%,ETFBKMT;ETF1;PRMT3;PRMT2;METTL22;SNRPD3;EEF2KMT;GSPT1;FAM98B;PRMT1;FAM98A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.340842591997802,1.0160989184857028,0.46506777893639206,0.7330305404765669,1.0,26/86,22.01%,APOE;PLEK;PTK2B;COLGALT1;NCKAP1L;LIMK1;DCTN1;DRG1;BAIAP2;NUMA1;NCK1;EVL;SLAIN2;CLIP1;BAIAP2L1;MAPRE1;VASP;BAIAP2L2;PFN1;EFEMP2;FES;SYNPO;CDC42EP1;ARF6;NCK2;WDR1
prerank,regulation of amyloid fibril formation (GO:1905906),0.442249807351622,1.0158170424263737,0.48233695652173914,0.7333319073835572,1.0,6/15,23.12%,APOE;TREM2;PFDN2;IAPP;PFDN1;PFDN6
prerank,regulation of bone mineralization (GO:0030500),0.36029548969586705,1.015807191552579,0.4726477024070022,0.7329909769376374,1.0,9/55,12.09%,ANKH;NELL1;PTK2B;ATP2B1;CYP27B1;ECM1;ANO6;PKDCC;SLC8A1
prerank,regulation of actin filament depolymerization (GO:0030834),0.4724326995578062,1.0156955654493407,0.4695035460992908,0.7328977425711445,1.0,7/12,32.02%,PLEK;PLEKHH2;PIK3CA;WDR1;MTPN;CFL2;LIMA1
prerank,chromatin remodeling (GO:0006338),0.33924974414952364,1.0154519541397868,0.48881789137380194,0.7331268307057343,1.0,23/100,18.23%,ERCC6;NUDT5;SOX9;CHD3;NPM3;HDAC4;SMARCB1;BPTF;HNRNPC;CBX3;SRCAP;KDM4D;INO80;BAZ1B;SMARCD2;MYSM1;GATAD2B;HCFC1;PIH1D1;HDAC1;ARID1B;BAHD1;RUVBL2
prerank,regulation of cellular response to heat (GO:1900034),0.34420093102421057,1.0153606285311367,0.471898197242842,0.7329964001562124,1.0,29/77,28.25%,NUP205;NUP188;DNAJB6;RAE1;BAG3;MAPKAPK2;NUP42;TPR;DNAJC2;NUP54;MAPK3;HSF1;CREBBP;RANBP2;NUP133;NUP93;IER5;PTGES3;HSP90AB1;GSK3B;NUP98;EP300;MAPK1;CAMK2D;AKT1S1;NUP35;AAAS;BAG5;BAG2
prerank,regulation of cellular component organization (GO:0051128),0.3308881654398131,1.0152710214292933,0.4780835881753313,0.7328180459369973,1.0,40/135,21.64%,APOE;ABL2;SGK1;CD22;TRAF2;SGK3;SGK2;SPHK1;ARHGEF11;BAP1;RAB5A;ATAD3A;ATF5;HIP1R;RAB5C;CDK11B;RUFY1;BBS10;MARK4;MELTF;SOCS2;TMEM97;HCFC1;STK38L;TNF;HIP1;SNX17;TFRC;LATS1;IRGM;STON1;PTPN1;GFAP;HNRNPU;NCLN;LAMTOR1;STK11;NEDD4;RUFY2;ROCK1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2994355386319142,-1.0152328922231124,0.39487179487179486,0.7332368020507708,1.0,3/27,2.56%,GRM1;GNA15;HTR2C
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4015406123116911,1.0152292624691115,0.46041412911084045,0.7325556882452948,1.0,3/25,5.80%,SDCBP;NRP1;NCKAP1L
prerank,tRNA 5'-end processing (GO:0099116),0.44270039090342145,1.0150801598057646,0.46765498652291104,0.7325413639840226,1.0,4/15,18.42%,TRMT10C;PRORP;RPP38;POP1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.35142422040782106,-1.0150382888292482,0.4049586776859504,0.7315459187559867,1.0,7/16,20.24%,TIPIN;TIMELESS;CLSPN;RAD9B;TICRR;RAD17;CDT1
prerank,membrane lipid metabolic process (GO:0006643),0.410393015388157,1.0148238670187366,0.4659090909090909,0.7327968879735886,1.0,5/22,9.73%,CERK;SPHK1;TEX2;SPHK2;CYP1B1
prerank,endoderm formation (GO:0001706),0.37754541051194745,1.0144643595106306,0.4540023894862604,0.7332450213903957,1.0,4/35,7.97%,FN1;ITGA5;ITGB5;COL12A1
prerank,positive regulation of chemotaxis (GO:0050921),0.3680724479720477,1.0142048921305793,0.44739756367663347,0.7334571613350653,1.0,9/43,12.58%,P2RX4;FGF2;NRP1;HSPB1;VEGFA;ADAM17;TREM2;STX3;IL6
prerank,sulfur compound biosynthetic process (GO:0044272),0.3352174043196567,1.0134769750189512,0.45398138572905894,0.7348055459083758,1.0,6/104,2.60%,CHST11;CSPG4;B4GALT5;SLC26A1;B4GAT1;GSTA2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.34183676124643186,-1.013119556703692,0.42857142857142855,0.7344414506318487,1.0,3/17,2.59%,NOS1AP;AKAP6;ANK3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.39620267653143715,1.013042052381395,0.458955223880597,0.7354075163726794,1.0,11/26,30.14%,NFE2L2;HSPB1;MAPK7;FYN;FBXO7;NOL3;TXN;SOD2;BAG5;HTRA2;PDE8A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.38611293816776016,-1.0129353893938786,0.42105263157894735,0.7327862733263273,1.0,6/11,22.28%,STAT4;STAT3;EBI3;STAT1;IL6ST;IL27RA
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3911105298290804,1.0126358171862901,0.4718826405867971,0.7359847003082541,1.0,9/29,17.95%,SMAD7;NKX2-1;SPRED2;ADIPOR1;EFNA1;SPRED3;BMP5;SFRP1;LDLRAD4
prerank,negative regulation of cholesterol transport (GO:0032375),0.476967882328832,1.012451177652234,0.4571026722925457,0.7360638878233652,1.0,2/10,9.41%,APOA2;NFKB1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.45170141692803534,1.0118450116910205,0.4703389830508475,0.7371630575466649,1.0,4/13,18.45%,SOCS5;CBL;ZGPAT;ERRFI1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.38396935397735693,1.0116485295802131,0.45995145631067963,0.7372467212151393,1.0,17/33,30.09%,RAD50;ANKRD28;ACD;GAR1;DKC1;RFC1;TERT;PPP6C;TERF1;CDK2;PTGES3;HSP90AB1;RAD51;TERF2IP;TERF2;SHQ1;MRE11
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4667072407451134,1.011582067369949,0.46965317919075145,0.737027771555306,1.0,5/12,24.69%,JAG1;YTHDF2;HNRNPU;NOTCH1;N4BP2L2
prerank,cardiac muscle cell action potential (GO:0086001),-0.28858847551831696,-1.0114818771466572,0.42934782608695654,0.7344506880042114,1.0,6/30,8.84%,CACNA2D1;FGF12;DMD;SCN1A;KCND3;CACNA1C
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3975701525999963,1.0114307071688469,0.480440097799511,0.7370267117241336,1.0,13/27,26.23%,NAT8;MSL3;MRGBP;MORF4L2;PHF20L1;KAT7;RUVBL2;BRD8;CREBBP;NAA50;EP300;KAT8;TAF6
prerank,establishment of melanosome localization (GO:0032401),0.4214282919726898,1.0112638913767547,0.47095959595959597,0.7370636242238131,1.0,4/19,18.87%,MYO5A;BLOC1S3;MREG;BBS2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.40270166635413907,-1.0112124895666106,0.4175084175084175,0.7330143708250111,1.0,2/10,8.41%,MTMR9;ABCA3
prerank,cellular response to UV-A (GO:0071492),-0.3865048373367178,-1.0110349880979428,0.4713804713804714,0.7313509197863975,1.0,4/11,23.83%,MME;MMP2;OPN3;MMP1
prerank,regulation of viral transcription (GO:0046782),0.37254134681185946,1.0110247907765533,0.46559633027522934,0.7372825695873668,1.0,6/39,17.30%,MDFIC;POLR2H;GTF2F1;DHX9;POLR2D;UBP1
prerank,regulation of interferon-gamma production (GO:0032649),0.34481652173506355,1.0109389958163995,0.46918918918918917,0.7371173475930792,1.0,15/71,13.73%,SIRPA;CD274;AXL;IL12RB1;IL27;CRTAM;SLC11A1;GAS6;HAVCR2;DDIT3;LILRB1;CEBPG;C1QBP;RIPK3;HSPD1
prerank,cellular response to ATP (GO:0071318),-0.3543507015840319,-1.0105903478931055,0.43006993006993005,0.7304060763431418,1.0,2/14,2.04%,P2RY12;RYR3
prerank,primary neural tube formation (GO:0014020),0.3873407573672611,1.0104721647816275,0.4817432273262662,0.7378612235449479,1.0,11/30,24.28%,PRICKLE1;SKI;LRP6;CELSR1;MTHFR;IFT122;VASP;TGFB1;SCRIB;SEMA4C;MTHFD1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4821594558732229,1.0104038980279875,0.4884393063583815,0.7376610553458844,1.0,1/10,0.80%,NFE2L2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4629456734225752,1.0101299971653193,0.46438746438746437,0.7379867634714513,1.0,2/12,15.25%,SOX9;RBP4
prerank,regulation of cholesterol transport (GO:0032374),0.4225347409600203,1.0096954362599466,0.4641509433962264,0.7386099046470749,1.0,6/20,22.52%,LRP1;APOA2;NFKB1;ARV1;LAMTOR1;NUS1
prerank,regulation of microtubule-based movement (GO:0060632),-0.3920943565535237,-1.009043828336311,0.4186046511627907,0.7324201882043941,1.0,6/11,22.65%,MAP2;NEFH;HAP1;TTC21B;IGBP1;DRC1
prerank,negative regulation of cell motility (GO:2000146),0.3365675760908403,1.0089523490549142,0.47987616099071206,0.7399641777103002,1.0,32/108,21.20%,MITF;MCTP1;ADARB1;RAP2A;CLDN19;DAG1;STK24;CLIC4;SMAD7;JAG1;NKX2-1;ARID2;GTPBP4;CYP1B1;RNF41;ADAM15;NF1;BST2;FLCN;RAP2B;CRK;PIN1;DNAI3;SERPINE1;SFRP1;DUSP3;LDLRAD4;MAPK15;CDH1;AFDN;RNF20;SINHCAF
prerank,regulation of phosphate metabolic process (GO:0019220),-0.3494882330688504,-1.008466032847334,0.43243243243243246,0.7317447691460648,1.0,7/16,19.42%,PSEN1;CD24;SMG6;SMG5;SMG7;RAD17;IGBP1
prerank,B cell homeostasis (GO:0001782),-0.39861195365569924,-1.0083877947951692,0.4176829268292683,0.7298807594266096,1.0,3/10,2.81%,MEF2C;TNFRSF13B;DOCK10
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.33834405125696937,1.007966048271483,0.47564766839378236,0.7419345255235534,1.0,28/95,21.69%,SIRPA;STAP1;CD274;AXL;VIM;TNFRSF1B;GIT1;PABPN1;NFKB1;ACOD1;LILRB1;PLAA;RHOA;TICAM1;CD180;IL6;TNIP2;TNFAIP3;SBNO2;TNIP3;IRGM;SERPINE1;CD68;ZC3H12A;XBP1;SIRT2;TIRAP;IRAK1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4550102040735363,1.0078356508323785,0.4767277856135402,0.7418421648149337,1.0,1/13,0.80%,NFE2L2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4747976556753778,1.0076676029202878,0.4646324549237171,0.741870396162687,1.0,5/12,19.95%,BAX;ERN1;BCL2L11;PTPN1;XBP1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3415812356258682,-1.0073732135009343,0.44976076555023925,0.7304293684335675,1.0,6/17,19.92%,BACH2;IL18;STAT3;EBI3;CD55;MSH2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4476903336973496,1.0063608860968931,0.47419804741980476,0.7445580143433173,1.0,2/14,3.49%,NRP1;VEGFA
prerank,protein homotrimerization (GO:0070207),0.44302431423183697,1.006263452695747,0.461118690313779,0.7440661886066483,1.0,5/14,19.92%,CLYBL;MLKL;ASIC1;DISP1;SLC1A5
prerank,protein trimerization (GO:0070206),0.44302431423183697,1.006263452695747,0.461118690313779,0.7440661886066483,1.0,5/14,19.92%,CLYBL;MLKL;ASIC1;DISP1;SLC1A5
prerank,long-term memory (GO:0007616),0.42305835384576695,1.0060736767733416,0.47416020671834624,0.7441579893976507,1.0,5/19,20.19%,APOE;SGK1;NPAS4;CPEB3;ARC
prerank,modulation by symbiont of entry into host (GO:0052372),0.42662251376336635,1.0055063966969793,0.4616384915474642,0.74512831694288,1.0,3/16,11.34%,TRIM6;CAV1;EXOC2
prerank,embryonic eye morphogenesis (GO:0048048),0.4701917757476607,1.005476990828766,0.46637426900584794,0.7448249588025891,1.0,2/11,7.57%,TH;LRP6
prerank,response to glucocorticoid (GO:0051384),0.3926098979240248,1.0054287623485734,0.48134328358208955,0.7445600617414831,1.0,6/26,19.52%,NR3C1;BCL2L11;IL6;TNF;UBE2L3;HNRNPU
prerank,cellular response to radiation (GO:0071478),0.37040742112545705,1.0051033051351461,0.4716106604866744,0.7449591390323155,1.0,11/40,20.11%,GRB2;TANK;RRH;EEF1D;KDM4D;INO80;RAD51AP1;FIGNL1;RAD9A;BLM;HUS1
prerank,histone modification (GO:0016570),0.33466518095211745,1.0050026933778602,0.46979166666666666,0.7448332138992335,1.0,35/109,22.54%,EYA4;PRKCD;RCOR1;HDAC4;HDAC9;MAP3K12;SUDS3;RCOR3;CARM1;EHMT1;MIER2;PRMT6;PRMT7;BAZ1B;PRMT2;PARP2;USP36;MSL3;HUWE1;MIDEAS;MRGBP;MORF4L2;HDAC1;PHF20L1;UFL1;RUVBL2;USP21;USP16;BRD8;NTMT1;SIRT2;NSD1;MTA3;CREBBP;CDK2
prerank,glycerophospholipid catabolic process (GO:0046475),0.38867365993887903,1.0049934956228723,0.468557336621455,0.7444813100430901,1.0,3/27,5.53%,ABHD12;GDPD3;SMPD4
prerank,glutamate metabolic process (GO:0006536),0.4119312205585173,1.0049852673262751,0.47320261437908495,0.7441394000926581,1.0,4/19,8.10%,GLS2;GLS;FPGS;MTHFS
prerank,cellular zinc ion homeostasis (GO:0006882),0.3966161850956506,1.0049241283252113,0.47277227722772275,0.7439125419734296,1.0,6/26,22.24%,ATP13A2;SLC39A7;SLC39A6;SLC39A13;SLC30A9;MT2A
prerank,kidney development (GO:0001822),-0.23947002974863044,-1.0049223023040996,0.45569620253164556,0.7347323158501196,1.0,13/65,11.36%,SALL1;ROBO2;FGF10;PCSK5;VANGL2;IFT27;ITGA8;GREB1L;MME;CENPF;PAX8;PYGO1;AGT
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3436147875989528,1.0048120485817327,0.47198275862068967,0.7438168018978543,1.0,11/69,12.69%,LPL;PTPRC;HSPB1;CYBA;ARFGEF2;SPHK2;TMEM106A;SYK;HAVCR2;IL6;DHX9
prerank,regulation of intracellular transport (GO:0032386),0.36851888510708974,1.0047963859868223,0.4647058823529412,0.7434889034862495,1.0,5/38,10.36%,LCP1;DYNC1H1;ATP13A2;GRIPAP1;NUMA1
prerank,positive regulation of nervous system process (GO:0031646),0.42027581131468406,1.0046738542929519,0.47214854111405835,0.7433889025296941,1.0,4/18,7.73%,ITGAX;CST7;TNFRSF1B;EGR2
prerank,apoptotic nuclear changes (GO:0030262),0.3985524065340855,1.0043853827291451,0.47642679900744417,0.7437069482613697,1.0,4/24,10.26%,ERN2;DNASE2;DFFB;ACIN1
prerank,transport along microtubule (GO:0010970),0.4508576963133424,1.0039726360728338,0.46839080459770116,0.7443107751152137,1.0,8/13,27.74%,ARHGAP21;BORCS5;BAG3;COPG2;COPG1;CDC42;DYNC1I2;SPG11
prerank,protein localization to membrane (GO:0072657),0.32288355736664043,1.0038803065600599,0.48390342052313884,0.7441528227954611,1.0,37/187,15.76%,SH3PXD2B;RFTN1;FGF13;MYO5A;ANK1;RABEP1;RAB40C;RAP2A;EFR3B;DENND4C;FLNA;RAB32;RAB8B;TTC7B;PACS2;ZDHHC15;TSPAN5;LRP6;NPC1;GAS6;CAV1;PKP2;MYADM;HPS6;AP3D1;RAPGEF6;CACNB3;JUP;TM9SF2;EHD4;BID;GAK;ATP1B3;TNF;FYB1;DLG4;PIP5K1A
prerank,response to amino acid (GO:0043200),0.3834681017434545,1.0038050995593442,0.48390941597139453,0.7439636611425237,1.0,11/31,19.95%,RRAGD;IPO5;CPEB4;CPEB1;LARS1;SESN2;CPEB3;NSMF;LAMTOR3;LAMTOR1;XBP1
prerank,positive regulation of cell division (GO:0051781),0.37238580293359524,1.0036871351540209,0.47330960854092524,0.7438651893504596,1.0,14/38,25.00%,MAP10;PKN2;RHOA;PKP4;GIPC1;CDC25B;HTR2B;SVIL;FGFR2;SIRT2;DRD3;CDC42;CUL3;FGF1
prerank,cellular response to glucose stimulus (GO:0071333),0.3827701146704143,1.0036046614619285,0.47990255785627284,0.7437081906904265,1.0,10/30,23.46%,ADCY8;ERN1;PCK2;GAS6;IGF1R;TRA2B;PDK3;XBP1;RACK1;PTPRN2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41349378646974755,1.0031817271278656,0.46332046332046334,0.7439823295336784,1.0,11/19,35.05%,POLR2H;ACD;POLR2D;TERF1;DAXX;TERF2IP;TERF2;POLR2B;TINF2;POLR2K;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41349378646974755,1.0031817271278656,0.46332046332046334,0.7439823295336784,1.0,11/19,35.05%,POLR2H;ACD;POLR2D;TERF1;DAXX;TERF2IP;TERF2;POLR2B;TINF2;POLR2K;POLR2F
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3670329163042106,1.002868698006517,0.5068027210884354,0.7443235745651566,1.0,16/40,28.22%,PTK2B;FBXW7;CSNK2A2;GNA12;CCDC22;UFL1;LATS1;XPO1;NUB1;RPS7;RPL23;PTEN;DESI1;RAD23A;HIPK2;CDK5RAP3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.47912503895216907,1.002746827688161,0.47474747474747475,0.7442604742479128,1.0,2/10,7.23%,CD274;CRTAM
prerank,negative regulation of viral release from host cell (GO:1902187),0.45090261068914833,1.0021617283350266,0.4897400820793434,0.7452914207168458,1.0,6/13,33.32%,TRIM28;TRIM8;TRIM35;CHMP3;TRIM11;MID2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3326857098763692,1.0021180537034022,0.4942166140904311,0.7450233296024317,1.0,19/95,15.64%,NSMCE2;RAD51B;MCM2;RMI1;AP5Z1;MCM7;RAD50;SLX4;BRCA1;SEM1;PSMD14;ERCC4;KDM4D;INO80;RAD51AP1;MCM8;LIG3;GEN1;YY1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3970638888904646,-1.0020371137999584,0.4437299035369775,0.7400481712007327,1.0,4/10,15.12%,CCR2;WNK1;WNT5A;CCL5
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.31354591346148386,1.0016313925082165,0.507,0.7457698517483551,1.0,62/348,18.39%,IGF1;MITF;HIF1A;FN1;ITGAX;CSF1;NFE2L2;STAP1;FGF2;PIK3CB;POU3F1;VDR;CLDN19;ATP13A2;AGO2;DTNBP1;VEGFA;SOX9;MSN;NAT8;ID2;TRIM28;NKX2-1;CELF1;FGF20;SLC11A1;DLL4;GAS6;BRCA1;STOX1;TREM2;KRAS;DNMT3B;SCYL2;LILRB1;SRPK2;LIMS1;TICAM1;IL6;PID1;MAPK7;VPS35;AGO3;FGF7;SP1;HCFC1;ZBTB7B;TNF;DNMT1;AGO4;FGF18;OLFM1;TFRC;FUBP1;PRKAG1;MAPK3;WFS1;MED1;SLC38A2;VAMP3;PTPN1;TGFBR1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.43547055706627424,1.0014115156103538,0.49416342412451364,0.7458879012354515,1.0,6/16,19.52%,NAPEPLD;ZBTB7B;FLCN;FTO;METRNL;HNRNPU
prerank,thyroid hormone generation (GO:0006590),-0.40278023115441647,-1.0011770390646797,0.4563758389261745,0.740186317322501,1.0,7/10,44.38%,TG;CTSK;SLC5A5;DUOX1;DIO2;FOXE1;CPQ
prerank,pulmonary valve development (GO:0003177),-0.3318819407203658,-1.0010886708922178,0.4152542372881356,0.7382892916551482,1.0,8/18,23.61%,ROBO1;ROBO2;NOTCH2;TGFB2;SLIT2;HEY1;HEY2;NFATC1
prerank,retrograde axonal transport (GO:0008090),0.4302130470185756,1.0010883376442445,0.5088919288645691,0.7462252146672542,1.0,5/16,13.60%,DYNC1H1;MGARP;KIF1A;DST;FBXW11
prerank,sodium ion transmembrane transport (GO:0035725),0.3352334978155147,1.0008536457934385,0.4867162592986185,0.7464047875320401,1.0,16/84,15.17%,SLC9A1;SLC6A6;ASIC3;SLC6A7;SLC24A4;SLC9A7;SLC9A6;SLC6A4;ANO6;SLC8A1;ATP1A1;ATP1A3;ATP1A4;SCN1B;ATP1B3;ASIC1
prerank,cellular response to fluid shear stress (GO:0071498),0.46222649822849515,1.0006649018368132,0.47538677918424754,0.7464861648337905,1.0,4/12,19.03%,NFE2L2;MTSS1;MAPK7;HDAC3
prerank,negative regulation of signal transduction (GO:0009968),0.31805932914449486,1.0004070528850217,0.48144433299899697,0.7467387919180142,1.0,47/249,18.46%,BCL2;LRP1;NIBAN2;PLEK;XDH;FGF2;PIK3CB;PTPRC;PRKCD;SOX30;FSTL3;PTGIR;OTUD4;FBXW7;PRKCB;SIAH2;MDFI;PTPN2;LRPAP1;EGFL7;DLK2;VCP;DLL4;SOCS5;YTHDF2;BRAP;WWP2;SPRY4;CSNK2A2;NCK1;NTN1;PID1;PTPN18;TNFAIP3;UBASH3B;TMBIM1;KCTD21;IFT122;TNF;SUFU;BMP5;WWOX;QARS1;SFRP1;PIP4K2A;PTPN1;DACT1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3556809487069128,1.0003332437326824,0.48734873487348734,0.7465402105469695,1.0,23/50,31.90%,FBXL17;TEDC2;ARMC9;VCP;EVC;KCTD21;IFT122;SUFU;SFRP1;PDCL;FGFR2;TEDC1;CREBBP;RAB34;RACK1;WDR11;MEGF8;GLIS2;BTRC;HERC4;TULP3;MGRN1;UCHL5
prerank,nervous system development (GO:0007399),-0.2313265682519244,-1.0,1.0,0.739200608420414,1.0,104/429,15.34%,NAV3;LSAMP;ROBO1;OPHN1;RAPGEF5;NRXN1;RBFOX1;NLGN1;CHRM2;MEF2C;CRIM1;FGF12;NCKAP1;MBD5;ADGRL3;COX7B;GPM6B;MYT1L;SH3GL2;BTBD3;GDA;ROBO2;SEMA6A;FEZ2;CNTN4;SREBF2;CNTN6;VLDLR;ST8SIA4;MARCKS;SCN8A;SERPINI1;ROGDI;EFNA5;SEMA5A;ADGRG6;VCAN;JARID2;NOTCH2;TMOD2;GFRA1;APC;SOX8;ADAM22;RNF103;APBA2;CDH2;EPHB1;PTS;TBX6;ERBB4;IL1RAPL2;NAB1;DHX30;CRMP1;NFASC;APLP1;VXN;CHRM3;STMN3;STAT3;MARCKSL1;DNER;MBNL1;DPYSL2;TYRO3;DCLK1;FLRT3;FEZ1;ITM2B;DSCAML1;APBA1;SHANK3;ADORA1;SCN2A;PAX8;NLGN3;RAPGEFL1;NBL1;HAP1;RELN;ARHGAP26;ERBB3;ZIC4;RBFOX3;PRKN;NPAS2;ACAN;PAFAH1B3;NRSN2;KIRREL3;IRF2BPL;RPS6KA6;ADGRB2;ECT2;DPF2;FGF11;GPM6A;SPOCK2;EDNRB;DRD2;PRPS1;LGI1;INHBA
prerank,mRNA 3'-end processing (GO:0031124),0.34208030702504894,0.9998863215167568,0.5021459227467812,0.7472081760149251,1.0,20/78,18.29%,DDX39B;GRSF1;SRSF11;PAPOLA;PABPN1;THOC1;SYMPK;THOC2;CHTOP;SRSF2;RPRD1A;CPSF7;UPF3B;POLR2D;SRSF7;PABPC1;THOC6;SRRM1;SSU72;AHCYL1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.45834691390675497,0.9998555720772259,0.5087483176312247,0.7469247722918778,1.0,5/12,25.37%,CAV1;SRI;CALM2;CALM3;CAMK2D
prerank,cGMP biosynthetic process (GO:0006182),0.48060774676450513,0.9995559656144988,0.48306332842415317,0.7472709723784877,1.0,4/10,28.51%,NPPA;NPPC;NPR1;NPR2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3481970396183869,-0.9994642207429404,0.42857142857142855,0.7384766479475936,1.0,9/17,21.16%,CASK;PCSK6;DOK5;TMEM204;XIAP;SLIT2;TWSG1;ZDHHC17;SFRP4
prerank,vasculogenesis (GO:0001570),0.3787770898714836,0.9991552482041979,0.4792408066429419,0.747853411297721,1.0,5/32,10.71%,VEGFA;EGFL7;CAV1;RASA1;TGFBR2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.38748430830438874,0.9991535946650665,0.4675642594859241,0.7474944597054076,1.0,3/28,3.59%,APOE;ADCY8;SQSTM1
prerank,negative regulation of ossification (GO:0030279),0.40593241888545256,0.9990521076738227,0.47880299251870323,0.7473616846486778,1.0,4/23,6.56%,PTK2B;SOX9;LRP4;ECM1
prerank,regulation of heart contraction (GO:0008016),0.3332806428064714,0.9990514510651478,0.5063291139240507,0.7470023161578192,1.0,18/90,18.29%,ASPH;P2RX4;ATP2B1;NPPA;TH;SMAD7;FXYD4;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP2A2;ATP1B3;NPPC;SRI;CALM2;FKBP1B;AHCYL1
prerank,protein insertion into ER membrane (GO:0045048),0.3703492402218066,0.9988696005402921,0.47125140924464487,0.7470484952339421,1.0,9/37,14.77%,UBL4A;HMOX1;ALDH3A2;GET3;VAMP2;EMC9;STX5;EMC4;EMC7
prerank,regulation of Rho protein signal transduction (GO:0035023),0.344391108969148,0.9987241477918726,0.5087527352297593,0.7470481291577948,1.0,13/72,15.91%,MYO9B;ABCA1;APOE;ABL2;NRP1;AKAP13;MYOC;ITGA3;RAF1;GPR65;KCTD10;ARHGEF2;FLCN
prerank,negative regulation of chemokine production (GO:0032682),0.4365123328590108,0.9986676570984473,0.4857916102841678,0.7468083758263884,1.0,1/14,0.63%,SIRPA
prerank,positive regulation of phosphatase activity (GO:0010922),0.4124945493781337,0.9985554584129223,0.4818181818181818,0.7467012275779357,1.0,8/21,25.27%,PLEK;CD300A;PTPA;RIPK3;CALM2;HSP90AB1;PPP1R15B;CALM3
prerank,regulation of primary metabolic process (GO:0080090),0.33107797644403614,0.9977069430699602,0.5020449897750511,0.7482158566370903,1.0,40/126,23.79%,APOE;NFYA;PSMD1;PPARD;PSMD8;ACACA;PSAP;PSMA1;PPARG;AZIN1;ID2;PSMA8;CARM1;ADIPOR1;PSMD14;PSMA5;ACACB;PSMD12;SP1;TM6SF2;PSMB10;PSMD2;ODC1;PSMC4;MED1;HDAC3;TGS1;ABCA7;PSMD6;PSMD3;PSMD5;PSMC2;RXRA;PSME4;CREBBP;PSMB8;PSMA6;LACTB;PSMB7;PSMD4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.45228133295621875,0.9976732419423149,0.481994459833795,0.7479379600784984,1.0,5/14,25.97%,DDX18;WDR12;ZNHIT6;FTSJ3;URB1
prerank,catecholamine biosynthetic process (GO:0042423),0.4600035580639198,0.9973941963409598,0.48746518105849584,0.74820801706306,1.0,3/11,23.83%,TH;MOXD1;DDC
prerank,heart morphogenesis (GO:0003007),0.3572446195053124,0.9972015956438351,0.4769921436588103,0.7483092998149452,1.0,8/50,18.39%,TH;VEGFA;SOX9;CHD7;FLRT2;HTR2B;OLFM1;TGFBR1
prerank,endoplasmic reticulum organization (GO:0007029),0.3414380774092794,0.9971089762649659,0.49840595111583424,0.7481513568395061,1.0,33/72,33.77%,TOR1AIP2;HMOX1;SMPD4;DOP1B;REEP3;ALDH3A2;LPCAT3;VAPB;VAMP2;STX5;GAK;ZBED3;MAPK15;TOR1B;SEC61A1;SEC16A;LMAN2L;STX18;LMAN1;MOSPD3;TRAM1L1;REEP1;SPTSSB;VAPA;ATL3;REEP4;SEC61B;WDR83OS;EMD;LMAN2;MIA3;SHTN1;RNF112
prerank,protein tetramerization (GO:0051262),0.3428430140516932,0.996635339671133,0.48751357220412594,0.7488796575708608,1.0,22/67,26.92%,ACACA;KCNJ2;GNMT;APPL2;GLS;ALDOA;FARSB;FARSA;OSBPL2;HSD17B8;ACACB;APIP;CPSF7;GOLGA2;HOMER1;USP16;TK1;ACOT13;CTH;SOD2;B2M;PKD2L1
prerank,glycogen metabolic process (GO:0005977),0.3889118393345766,0.9966207468696696,0.484375,0.7485578013546305,1.0,7/27,18.97%,GYS1;NHLRC1;GAA;GYG1;PHKB;GBE1;PGM1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3682019387091758,0.996613558484383,0.4839080459770115,0.7482118714743482,1.0,14/37,22.02%,TRIM6;SPHK1;EIF4G1;CAB39;SMAD7;SPRED2;STOX1;SPRED3;CALM2;IRGM;DGKQ;TGFB1;SIRT2;CADM4
prerank,negative regulation of viral process (GO:0048525),0.35112639565863796,0.9957188357070594,0.49393605292171994,0.749913437203737,1.0,13/57,20.35%,SHFL;TNIP1;TRIM6;TRIM28;SRPK1;RNASEL;SRPK2;TNF;BST2;MBL2;UBP1;RSAD2;ZC3HAV1
prerank,steroid metabolic process (GO:0008202),0.3374643310879821,0.9955054809332659,0.5100316789862724,0.7500305129232946,1.0,15/72,21.69%,CYP19A1;CYP27B1;VDR;LIPA;NPC1;CYP1B1;DHRS11;GBA2;SULT2B1;ARV1;SCP2;PIAS4;ABCB11;SRD5A1;CYP2R1
prerank,gene expression (GO:0010467),0.31528612693135194,0.9952518907500464,0.505,0.7502384073357987,1.0,95/348,23.03%,APOBEC1;ADARB1;NUP205;TNIP1;IGHMBP2;AGO2;EIF4G1;MRPL23;HNRNPUL1;POLR2H;RRBP1;DDX39B;RBM39;TSPAN5;SRSF11;PWP1;MRPS15;NUP188;FARSB;PABPN1;THOC1;MRPL52;DRG1;MRPS16;DDX17;RPL10A;RBPMS;RAE1;SYMPK;HNRNPK;RNASEL;EEF1A1;RPL12;RBM15B;THOC2;CHTOP;ATXN1;RPL36;MRPS33;RPS6;ANGPT2;GOLPH3;HNRNPL;MRPL24;EIF4E;NUP42;SRSF2;RPS28;RPL13A;MRPL37;HNRNPA2B1;TPR;HSPD1;FASTKD2;DUSP11;RPS26;MRPL18;UPF3B;MRPL11;DKC1;RPS27A;MRPS12;RPS12;POLR2D;PABPC4;MCM3AP;SRSF7;TASP1;MRPS7;THOC6;SARS1;SRRM1;RPL18;MMS19;NUP54;RPS13;ADAR;HNRNPU;SNRNP40;SMG1;MRPL42;NXF1;RPS2;XRN2;SRSF1;THAP1;NOX4;RPS19;EEF1A2;RANBP2;NUP133;NUP93;WDR33;RPS7;RRAGC
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.28080979291473457,-0.9951231442853448,0.4772727272727273,0.747367497420429,1.0,7/32,6.62%,TWF2;NCKAP1;WASF2;PIK3R1;CARMIL1;ENPP2;AUTS2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.47184235470106806,0.9949297137110283,0.5014450867052023,0.7506055279101695,1.0,2/10,10.07%,FGR;LILRB1
prerank,cation transport (GO:0006812),0.32183560054248483,0.9949178876327013,0.5181818181818182,0.7502698703974213,1.0,23/167,13.17%,FGF13;SGK1;SLC23A1;SLC36A4;SLC6A6;KCNMA1;PIEZO1;SLC3A2;KCNA3;KCNJ2;SLC7A1;PANX1;SLC8B1;TRPM7;ANO6;SLC38A7;SLC7A6;TAF7;SLC7A8;SLC8A1;ATP1A4;KCNN4;KCNA4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.40167456946639485,0.9946869242341813,0.4794871794871795,0.7504297187001621,1.0,5/21,14.28%,ARHGAP25;ARHGAP12;SYNGAP1;SPRY4;MAPKAP1
prerank,response to interferon-alpha (GO:0035455),0.4303594863473257,0.9945232329701479,0.4905149051490515,0.7504584860346196,1.0,7/16,23.59%,AXL;GAS6;TPR;BST2;ADAR;IFNAR2;RO60
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.42463470150421107,0.9942321499267084,0.49523809523809526,0.750745982417084,1.0,3/16,11.50%,NPPA;KLK1;KLK3
prerank,carnitine metabolic process (GO:0009437),0.4590936043231456,0.9940756473511125,0.4896551724137931,0.7507433567591506,1.0,4/12,11.36%,CRAT;ACADL;TMLHE;CPT1A
prerank,negative regulation of cell adhesion (GO:0007162),0.3382777804779706,0.9938406289331551,0.49729144095341277,0.750929415688686,1.0,20/72,22.31%,PLXNC1;PTPRC;MUC1;PLXNA2;GCNT2;JAG1;GTPBP4;FZD4;CYP1B1;RASA1;PLXND1;RHOA;PLXNA1;LPXN;SERPINE1;CDH1;ITGB1BP1;TGFB1;NOTCH1;NF2
prerank,histone exchange (GO:0043486),0.3684115842695406,0.9930919306145746,0.5069444444444444,0.7522839731500713,1.0,20/37,34.31%,CENPO;SRCAP;CENPT;ACTR6;CENPX;CENPA;ANP32E;CENPK;CENPS;DMAP1;VPS72;CENPW;RSF1;CENPU;CENPC;NPM1;MIS18BP1;KNL1;SPTY2D1;ITGB3BP
prerank,tube closure (GO:0060606),0.3793511504587246,0.9929288482922703,0.5052754982415005,0.7523122814975304,1.0,11/31,24.28%,PRICKLE1;SKI;LRP6;CELSR1;MTHFR;IFT122;VASP;TGFB1;SCRIB;SEMA4C;MTHFD1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4704347552210083,0.9925059656454341,0.49635036496350365,0.7528879961775768,1.0,5/10,30.73%,ZNHIT6;PIH1D1;RUVBL2;SHQ1;TAF9
prerank,glutamine family amino acid metabolic process (GO:0009064),0.37063220859523216,0.9924177496603735,0.4928400954653938,0.7527232187595515,1.0,10/33,21.84%,GLS2;GLS;FPGS;MTHFS;CAD;PYCR3;ART4;SIRT4;DDAH1;OAT
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3969636789193981,-0.9924040438994352,0.44554455445544555,0.7522859602680461,1.0,6/10,19.35%,SLC25A12;SLC1A3;PRAF2;SLC1A6;SLC1A1;SLC1A2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3223102795947283,0.9924002161150063,0.5309644670050762,0.752409395831536,1.0,26/149,16.60%,RAB7B;PRKCH;IRAK2;ADAM8;TRAF2;TRIM6;SPHK1;MALT1;PRKCB;UBA52;DHX33;TAB1;CAV1;NFKB1;TICAM1;RIPK3;AIM2;BTK;IL6;DHX9;RIPK4;TNF;RPS27A;UBC;ARHGEF2;TFRC
prerank,fatty acid metabolic process (GO:0006631),0.3256604878562418,0.9921483521501637,0.5118434603501545,0.7526049930656333,1.0,22/115,17.71%,LPL;SLC27A5;PON1;ACSBG2;CEL;PPARD;ACACA;ECHDC3;ABCD2;PPARG;ALKBH7;CRAT;ACSL1;HSD17B8;ADIPOR1;CPT1A;ACOT6;SGPL1;ACSBG1;ACOT1;LPIN3;ACBD5
prerank,regulation of signal transduction (GO:0009966),0.3195474389136947,0.992107885748496,0.535678391959799,0.7523315051155847,1.0,51/190,21.99%,MDFIC;IRAK2;DHRS3;MGLL;FBXL17;RUNX1;DTNBP1;VEPH1;MTCH1;UBTF;RGS3;PTPN2;IGFBP7;GIT1;TREM2;LLGL2;SOCS5;PPP2R1A;BRAP;GLRX2;NCK1;ITGA3;OGT;YWHAG;LLGL1;UBASH3B;FYN;ILK;SOCS2;SNW1;CRK;CDKN2AIP;SHARPIN;POFUT1;PTPN1;PRAG1;RGS11;HOMER1;TIMP1;NCLN;ITGB1BP1;FGFR2;DGKQ;USP33;UGCG;TGFB1;FRMPD1;GDNF;NCK2;IRAK1;CREBBP
prerank,positive regulation of filopodium assembly (GO:0051491),-0.30368489843808383,-0.9912964747874141,0.4519774011299435,0.7531320777202524,1.0,8/24,17.21%,TENM2;NLGN1;PIK3R1;FNBP1L;PLPPR5;RIPOR2;GPM6A;MIEN1
prerank,piRNA metabolic process (GO:0034587),0.41068792391130055,0.991005095899676,0.4941935483870968,0.7544450702891892,1.0,1/19,3.82%,PIWIL2
prerank,microvillus organization (GO:0032528),0.4395584603023743,0.9909784583655216,0.49407114624505927,0.7541542014849195,1.0,4/13,16.57%,RAP2A;RAPGEF6;MINK1;RAP2B
prerank,regulation of wound healing (GO:0061041),0.35891443490146363,0.990648870526762,0.5091954022988506,0.7545541253365325,1.0,8/42,17.51%,PLAU;FGF2;CLDN19;CAV1;TNFAIP3;ARFGEF1;CRK;SERPINE1
prerank,copper ion homeostasis (GO:0055070),0.42256249619130426,0.9902526420611324,0.5178807947019868,0.7550787994475562,1.0,6/17,22.24%,SLC31A2;ATP7A;CCDC22;ATOX1;ATP7B;MT2A
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4240428683752687,0.9901009481111052,0.4899328859060403,0.7550657607679594,1.0,9/16,24.10%,NAA20;NAA16;NAA80;NAA15;CREBBP;AANAT;NAA40;NAA50;EP300
prerank,organophosphate biosynthetic process (GO:0090407),0.3728698530128707,0.9899203614622127,0.493491124260355,0.7551132715758604,1.0,11/37,23.78%,ITPKB;FGF2;GK;LPCAT1;MOCOS;PIP5K1A;MOCS3;AGPAT5;AGPAT3;ITPKC;PNPO
prerank,modulation by host of symbiont process (GO:0051851),0.37712404232733787,0.9897334566479873,0.5024271844660194,0.755186809999555,1.0,13/31,24.10%,CCL4;SMARCB1;JUN;SAP30BP;NAPEPLD;SP1;RRP1B;HDAC1;SNW1;CHD1;SMARCA4;CCL3;EP300
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4263045737426455,0.9895709877015614,0.5236220472440944,0.7551698050005109,1.0,6/17,23.67%,PKP2;SLC8A1;ATP1A1;ATP1A3;FKBP1B;ATP1A2
prerank,regulation of axonogenesis (GO:0050770),0.3495087052887376,0.9891679035079454,0.4983240223463687,0.7557175168629776,1.0,9/51,11.62%,PLXNC1;KIF13B;PLXNA2;GDI1;RUFY3;LRP4;PAK2;PLXND1;RHOA
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4432186035266057,0.9886928585587714,0.5135869565217391,0.7564047125566988,1.0,3/13,13.10%,DCTPP1;ITPA;ENTPD6
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4712078090777318,0.9881742777464478,0.4901129943502825,0.7572336488866519,1.0,5/10,16.74%,RAP2A;MSN;RHOA;MYO9A;SYNE4
prerank,regulation of actin filament polymerization (GO:0030833),0.33601893117466825,0.9880581933608864,0.5288985823336968,0.7571268769666339,1.0,23/69,21.06%,COTL1;PTK2B;PRKCD;WASHC5;NCKAP1L;MYADM;HIP1R;BAIAP2;RASA1;GBA2;NCK1;EVL;HAX1;ARFGEF1;BAIAP2L1;SSH3;LATS1;VASP;BAIAP2L2;PFN1;CDC42EP1;ARF6;NCK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3432381919061318,0.9880257992765104,0.5425764192139738,0.7568377248165293,1.0,18/59,25.37%,CDK5;PRKCD;PDPK1;DYRK2;MAP3K12;CAD;TGFBR2;CSNK2A2;TBK1;TGFBR1;MARK2;DYRK1B;HIPK1;ROCK1;STK39;GSK3B;MAPK1;CAMK2D
prerank,positive regulation of immune effector process (GO:0002699),0.3819072752513577,0.9875837845804818,0.5056179775280899,0.7574784722101032,1.0,9/27,24.64%,PTPRC;IL12RB1;APPL2;LILRB1;IL2;PLA2G5;XBP1;RPS19;MYO18A
prerank,cellular response to virus (GO:0098586),0.38192005844434723,0.9871495677771966,0.48375451263537905,0.7581137129235874,1.0,10/30,19.57%,HIF1A;BAX;IL6;VWCE;RIOK3;RRP1B;EIF5A;LGALS8;IRGM;ZC3H12A
prerank,positive regulation of histone acetylation (GO:0035066),0.39526686832408836,0.9864909126385503,0.49873417721518987,0.7592411379277078,1.0,9/23,20.17%,MUC1;SPHK2;SMARCB1;BRCA1;PIH1D1;KAT7;MAPK3;RUVBL2;GLYR1
prerank,histone mRNA catabolic process (GO:0071044),0.42959454158277505,0.9863542209129396,0.5130548302872062,0.7591767559681345,1.0,9/15,35.68%,EXOSC10;DCP2;EXOSC4;MTPAP;XRN1;TENT4B;SSB;UPF1;TUT1
prerank,protein localization to plasma membrane (GO:0072659),0.32533001618465296,0.9862798631421843,0.5285132382892057,0.7589798119893405,1.0,26/129,15.76%,FGF13;MYO5A;ANK1;RAB40C;RAP2A;EFR3B;DENND4C;FLNA;RAB8B;TTC7B;PACS2;NECTIN3;TSPAN5;LRP6;GAS6;PKP2;MYADM;RAPGEF6;CACNB3;JUP;EHD4;GAK;ATP1B3;TNF;FYB1;PIP5K1A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.42510125942804566,0.9861780278668326,0.5019973368841545,0.7588578941700921,1.0,1/16,0.65%,BCL2L1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.422701524048824,0.9856799067199932,0.5078534031413613,0.7596513522216115,1.0,5/17,14.77%,UBL4A;GET3;EMC9;EMC4;EMC7
prerank,rRNA methylation (GO:0031167),0.39521845609254513,0.9852925461497354,0.5121951219512195,0.760090738573195,1.0,10/22,26.51%,MRM1;MRM3;METTL15;NSUN3;NSUN4;DIMT1;MRM2;FTSJ3;ZCCHC4;FDXACB1
prerank,melanosome localization (GO:0032400),0.4030206615888616,0.9850777875122863,0.5088161209068011,0.7602063498931151,1.0,9/21,32.25%,MYO5A;BLOC1S3;MREG;BBS2;BBS7;RAB11B;VPS33A;RAB11A;SHROOM2
prerank,regulation of mitotic nuclear division (GO:0007088),0.34694500449106425,0.9848257408134375,0.5284280936454849,0.7604229160142278,1.0,11/55,21.81%,IGF1;ANAPC15;CCNB1;CDK13;PIN1;CUL9;FBXO5;PDGFB;DRD3;NME6;PRMT5
prerank,outflow tract septum morphogenesis (GO:0003148),0.39742842282869384,0.984783065983974,0.5088161209068011,0.7601727496001985,1.0,2/24,1.74%,NRP2;NRP1
prerank,protein autoubiquitination (GO:0051865),0.3401852310350397,0.9846878763448438,0.5261984392419174,0.7600306160263776,1.0,12/61,16.81%,CNOT4;TRAF2;NFX1;BRCA1;KLHL24;RNF41;DDB2;WWP2;MDM2;BFAR;RNF185;OBI1
prerank,cartilage development (GO:0051216),0.3496075758912538,0.9846044208023798,0.5177383592017738,0.759879352872737,1.0,7/49,9.55%,FGF2;RUNX1;SOX9;CD44;SNX19;CREB3L2;ATP7A
prerank,iron-sulfur cluster assembly (GO:0016226),0.38789092401191005,0.9844821392745328,0.5224438902743143,0.759800354177782,1.0,6/24,17.57%,HSCB;IBA57;ISCA1;HSPA9;CIAPIN1;MMS19
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.356956789107174,0.9842575791892544,0.503954802259887,0.7599337980685692,1.0,13/46,18.24%,PEAK1;FN1;NRP1;LAMC1;PARVB;RHOA;ATRN;ILK;EFNA1;LPXN;MEGF9;ITGA4;VAMP3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3374134781877594,0.9841397098871826,0.5249457700650759,0.7598597165581125,1.0,10/70,12.31%,PEMT;SLC27A1;APOA2;PON1;PLAAT3;CHKB;LPCAT1;LPCAT3;CSNK2A2;ABHD4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.40325957040959415,0.9834901300117019,0.5031605562579013,0.7609463075956463,1.0,7/20,23.39%,ADAM17;PSEN2;MBTPS2;NFKB1;APH1A;TGFB1;HM13
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3635198938294123,0.9832618277064908,0.5174418604651163,0.7610877810290867,1.0,9/38,16.07%,NLRC3;TNIP1;TANK;TREM2;TNFAIP3;RIOK3;CCDC22;CARD19;TNIP3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3911054851216125,-0.9832313382088199,0.4395973154362416,0.7720819684754234,1.0,5/10,15.59%,CX3CR1;CEACAM1;LGALS9;KLRD1;FCGR2B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.33831558375939574,0.9831045457631997,0.5170893054024256,0.7610959113070042,1.0,19/63,22.54%,CNOT4;MUC1;PLK2;BAX;CCNB1;CNOT10;TRIAP1;CARM1;MDM2;PLK3;CRADD;CNOT6;CHEK2;CNOT9;CCND1;FBXO31;ARID3A;PCBP4;CDK2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.38335597084115414,0.9822222663830458,0.5081761006289308,0.7626731392781682,1.0,6/26,16.81%,FGF2;PTPRC;SLC8B1;ERO1A;HTR2B;CHERP
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4328538323780586,0.9822039960855901,0.5153949129852744,0.7623560621786475,1.0,7/14,27.29%,BCL2L1;TXNDC12;XBP1;HERPUD1;SYVN1;OPA1;CREB3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3157019023613638,0.9819955623136103,0.5503018108651911,0.7624601987735233,1.0,54/166,27.22%,TAF1D;NPPA;VDR;PPARD;E2F3;PPARG;POLR2H;UBTF;TAF4B;HDAC9;HDAC7;GTF2A2;TAF15;MED17;GTF2F1;TAF7;NR3C1;NRBF2;MAML2;POLR1A;TBPL1;MNAT1;POLR2D;GTF2E2;HDAC1;SNW1;NOTCH4;TAF1A;GTF2H1;POLR1G;TAF1C;ERCC2;MAPK3;MED1;RXRB;HDAC3;MED27;POLRMT;TBP;RXRA;NOTCH1;CREBBP;CCNH;NR2C2AP;TEAD1;MAZ;POLR1H;CRCP;NR5A1;TAF6;GTF2A1;RXRG;RSF1;POLR1F
prerank,response to UV-A (GO:0070141),-0.3587579322429581,-0.9814717241858855,0.4642857142857143,0.7744487818843642,1.0,4/14,15.88%,EGFR;MME;MMP2;OPN3
prerank,regulation of Notch signaling pathway (GO:0008593),0.3357670408539215,0.9812145063192336,0.528969957081545,0.7638040747702027,1.0,24/76,23.09%,ZMIZ1;NIBAN2;FBXW7;JAG1;TSPAN5;EGFL7;DLK2;DLL4;LLGL2;NEPRO;YTHDF2;WWP2;MAML2;LLGL1;SNW1;NOTCH4;POFUT1;PRAG1;ITGB1BP1;HIF1AN;NOTCH1;CREBBP;TCIM;METTL3
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3951510447230552,0.9808642942471997,0.4941935483870968,0.7642164016901598,1.0,2/22,5.54%,MDFIC;GDI1
prerank,sensory organ development (GO:0007423),0.35076734962436396,0.9807841209178525,0.5204872646733112,0.764055303237967,1.0,9/51,16.89%,SH3PXD2B;SMG9;BLOC1S3;CHD7;MYO7A;CPAMD8;RBP4;MEIS3;MAFB
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.33699890146162165,0.9806567068790876,0.5207877461706784,0.763976249177914,1.0,23/69,24.54%,DERL3;STT3B;DNAJB14;EDEM1;VCP;RNF121;UBXN4;DNAJC10;UBE4A;RNF185;UBE4B;DNAJB12;WFS1;DERL1;HERPUD1;SYVN1;UBE2J1;HSP90B1;UBQLN1;YOD1;ERLIN2;USP19;UBQLN2
prerank,positive regulation of type I interferon production (GO:0032481),0.3350634217967135,0.9789941448206239,0.5235546038543897,0.7673221222573263,1.0,30/73,28.10%,CTNNB1;LRRFIP1;POLR2H;POLR3D;POLR3E;DHX33;IRF5;NFKB1;DHX9;HSPD1;RIOK3;TBK1;TLR7;G3BP1;POLR3GL;IRAK1;POLR3B;CREBBP;XRCC5;PTPN11;CHUK;EP300;STAT6;CRCP;TLR3;IRF3;PRKDC;DHX36;POLR1C;POLR3A
prerank,response to estradiol (GO:0032355),0.37193247711881033,0.9789435486313844,0.508495145631068,0.7670862118219626,1.0,7/31,20.68%,CTNNB1;CYP19A1;SOCS2;SFRP1;RUVBL2;TGFB1;LCOR
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.34296366132200307,-0.9784955324630848,0.5039370078740157,0.7800439243769949,1.0,6/14,16.85%,RELA;CD226;CD81;NECTIN2;TESPA1;LCK
prerank,membrane lipid catabolic process (GO:0046466),0.47103625939509397,0.9776823078164775,0.5289957567185289,0.7695947173935344,1.0,4/10,16.14%,FUCA1;CYP1B1;PDXDC1;SGPL1
prerank,autophagy of nucleus (GO:0044804),0.4215006997619264,0.9773343471161761,0.5235531628532974,0.7700370449346182,1.0,3/16,11.77%,ATG7;WDR45;ATG2B
prerank,calcium ion homeostasis (GO:0055074),0.32470437992244683,0.977279352834654,0.5321390937829295,0.7698064831383925,1.0,24/95,23.04%,SELENON;ATP2B1;CYP27B1;ATP13A2;SLC24A4;NPTN;TPCN2;SLC8B1;CCL13;CAV1;CCL14;VAPB;SLC8A1;ATP2A2;HTR2B;CHERP;WFS1;STOML2;TMEM165;DRD3;TMCO1;CALR;ATP13A3;CCL3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4387849356966915,0.9771869471598497,0.5028089887640449,0.7696655325753786,1.0,4/13,22.23%,CD2BP2;PRPF6;SART3;SRSF10
prerank,response to molecule of bacterial origin (GO:0002237),0.33579795572413723,0.9769455946078128,0.5361380798274002,0.7698285190136339,1.0,12/69,12.90%,TRIM6;CYP27B1;ADAM17;NOCT;ERBIN;SLC11A1;IRF5;ACOD1;MAPKAPK3;IL6;TNFAIP3;MAPKAPK2
prerank,cellular protein-containing complex assembly (GO:0034622),0.31410258010038006,0.9768697839423119,0.5353535353535354,0.7696196185118473,1.0,50/160,24.89%,NUP205;TRAF2;CYBA;CHMP4B;CHMP4A;HSPA4;SAMM50;DNAJB14;COG4;CCT2;LONP1;NDUFAF1;AHCTF1;HIP1R;COX7A2L;VAMP2;NCK1;BBS10;CENPT;DHX9;TTC12;VAMP4;TPR;HSPD1;PSMG3;CENPA;HIP1;TBCA;DNAJB12;CCDC40;PIK3C2A;COX7A2;VAMP3;HSF1;MID1IP1;TGFB1;SMAD1;DNAJC28;NCK2;HIGD2A;NUP93;PTGES3;PFDN6;SPAG1;HSP90AB1;PSMD4;TBCE;NUP98;CENPW;EIF4B
prerank,regulation of receptor binding (GO:1900120),0.4622119203418292,0.9768440082416391,0.5345080763582967,0.7693134377969475,1.0,2/10,12.30%,ADAM15;ATP2A2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.2903360711122947,-0.9766820830786936,0.5027932960893855,0.7825305409232249,1.0,13/26,27.07%,EPHA5;PPP3CB;EFNA5;LRP5;ADCY5;ADRA2A;GPLD1;BAIAP3;TRPM4;ANO1;KLF7;STXBP4;NR1H4
prerank,protein acetylation (GO:0006473),0.3735628290053553,0.9765606496632322,0.50661853188929,0.7696027293240114,1.0,13/30,24.10%,SPHK1;ING4;NAA16;NAT10;NAA80;NAA15;HAT1;CREBBP;AANAT;FOXO1;NAA40;NAA50;EP300
prerank,monocarboxylic acid transport (GO:0015718),-0.2526714019556705,-0.9762075443721769,0.4956521739130435,0.7817017159861648,1.0,17/51,20.40%,SLCO2B1;SLCO1B1;SLC16A6;SLC6A11;SLC16A7;NCOA1;CEACAM1;NCOA2;SLCO3A1;STARD5;SLCO1C1;ABCB4;SLC16A12;SLC16A4;SLC27A4;CD36;SLC10A1
prerank,vasodilation (GO:0042311),0.43618056476986705,0.9760116439033717,0.5318860244233379,0.7704635214381468,1.0,1/13,1.64%,KCNMA1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.33545308192904943,-0.9758648824301643,0.4530612244897959,0.7804184730969946,1.0,7/17,16.89%,P2RY12;SKAP1;RET;CCL5;TGFB2;RAC3;PODXL
prerank,positive regulation of T cell activation (GO:0050870),0.3310013764805028,0.9753017991309765,0.532972972972973,0.7716434782603151,1.0,6/62,5.80%,ZMIZ1;SIRPA;PTPRC;CD274;SLC7A1;NCKAP1L
prerank,mitotic metaphase plate congression (GO:0007080),0.34299104080750015,0.9749819490805581,0.5254988913525499,0.7719765589792094,1.0,18/51,30.63%,CHMP4B;CHMP4A;EML4;CCNB1;PDCD6IP;VPS4B;BECN1;KIFC1;SPDL1;NUDC;EML3;CHMP7;CUL3;CENPC;DCTN2;CHMP2B;RAB11A;CHMP3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.45223238829603774,0.9748348045606614,0.5035765379113019,0.7719386311292085,1.0,3/10,14.47%,NCKAP1L;TGFBR2;ZBTB7B
prerank,epidermis development (GO:0008544),0.3468548704984913,0.9745560948730235,0.5435267857142857,0.7721875360639845,1.0,11/56,22.46%,FABP5;TGM5;ALDH3A2;ATP2A2;FGF7;HDAC1;GRHL1;FGFR2;FLOT2;UGCG;LAMA3
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4240752627196293,0.9739997863113028,0.5094594594594595,0.7730398407469027,1.0,3/14,20.89%,LRRC52;ATP1B3;ACTN2
prerank,ceramide transport (GO:0035627),0.44171419578639104,0.9730410878249223,0.49714285714285716,0.7747644105749275,1.0,2/12,4.82%,PSAP;GLTP
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3352834128535145,0.9729560927570701,0.5544768069039914,0.7746113738669872,1.0,19/70,19.28%,PEAK1;FN1;UNK;NRP1;LAMC1;RILPL2;RILPL1;PARVB;YTHDF2;RHOA;ATRN;ILK;EFNA1;ACTN1;LPXN;MEGF9;ITGA4;VAMP3;ABI2
prerank,neural tube closure (GO:0001843),0.3673243572557507,0.9728381081627357,0.5326215895610913,0.774514675498512,1.0,11/34,24.28%,PRICKLE1;SKI;LRP6;CELSR1;MTHFR;IFT122;VASP;TGFB1;SCRIB;SEMA4C;MTHFD1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.44038024252221997,0.9726367940850786,0.5255376344086021,0.7745875383217483,1.0,4/13,15.08%,ANAPC15;CCNB1;TPR;GEN1
prerank,ventricular septum morphogenesis (GO:0060412),-0.29354004482716267,-0.972550612141781,0.5212765957446809,0.7871036802267939,1.0,12/27,26.61%,ROBO1;ROBO2;ZFPM1;ZFPM2;TGFB2;SLIT2;TGFBR3;SLIT3;HEY1;HEY2;CITED2;HEYL
prerank,negative regulation of interleukin-1 production (GO:0032692),0.39072102909597894,0.9724692460928204,0.5151133501259446,0.7746099476132845,1.0,3/23,7.99%,IGF1;GIT1;GAS6
prerank,central nervous system neuron development (GO:0021954),0.4251630321219041,0.9722538199888703,0.4986737400530504,0.7747316227294334,1.0,3/15,10.95%,B4GALT5;ATP7A;GBA2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.447278019090833,0.9721477128771628,0.5152777777777777,0.7745942966592884,1.0,1/11,0.66%,P2RX4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.39896470655635835,0.9721254369375897,0.5363984674329502,0.7742936897737456,1.0,3/21,4.30%,NPPA;CACNA1D;FLNA
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4550852613919151,0.9720057363892715,0.5077138849929874,0.7742074649056719,1.0,3/11,19.95%,TMEM106A;TAF7;XBP1
prerank,RNA biosynthetic process (GO:0032774),0.37090641580304823,0.9719307827796938,0.5357142857142857,0.7740159926983287,1.0,18/31,37.95%,TTF1;TAF7;POLA2;TBPL1;TERT;TBP;PRMT5;POLA1;TAF6;RSF1;TAF4;TAF13;SMN1;TAF12;TCEA2;BRF2;TAF10;NAT14
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.36288365164343656,0.97192551781264,0.5299647473560517,0.7736663012029756,1.0,8/38,19.95%,SIRPA;P2RX4;GLA;CAV1;PTGIS;TNF;ZC3H12A;DDAH1
prerank,protein targeting to lysosome (GO:0006622),0.4070574880775103,0.9718834159695889,0.5215736040609137,0.7734111609374152,1.0,4/20,10.47%,GNPTAB;GCC2;RAB7A;LAMP2
prerank,DNA modification (GO:0006304),0.39365540052579484,0.9717215740758941,0.5216836734693877,0.7734101253189142,1.0,13/22,33.64%,NEIL2;ACD;MBD4;PARP2;EXOSC5;TERF1;EXOSC4;PARP1;TERF2IP;TERF2;EXOSC3;TINF2;PARP3
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3997590492430233,0.971627243079182,0.5257731958762887,0.773277196839098,1.0,2/22,1.44%,PLEK;STAP1
prerank,positive regulation of chemokine production (GO:0032722),0.35231434595955735,0.9714940986860393,0.5260115606936416,0.7732203381663044,1.0,11/44,21.44%,LPL;HIF1A;HMOX1;ADAM17;SYK;IL6;TNF;MBP;TLR7;IL17RA;TIRAP
prerank,cellular response to calcium ion (GO:0071277),-0.23716773509597402,-0.9711339585330401,0.5733333333333334,0.7886838063686137,1.0,24/67,21.92%,NLGN1;CAPN3;MEF2C;RYR3;SYT1;SYT10;ALOX5AP;DMTN;KCNH1;LGMN;SYT4;CPNE5;WNT5A;ECT2;GPLD1;SYT7;ADGRV1;MEF2A;SYT2;SYT17;PLCG2;SYT9;CPNE4;CPNE7
prerank,cilium organization (GO:0044782),0.3143127041636024,0.9707454466374681,0.5724346076458753,0.7745218370371596,1.0,63/210,26.79%,ASAP1;ODF2;TEKT2;FOXJ1;ATP6V0D1;PTPN23;IFT43;FLNA;RAB8B;TEKT5;SNX10;ARMC9;RILPL2;IFT88;RILPL1;SPAG16;RTTN;IFT74;RAB1A;EXOC2;MAK;TCTN3;EHD4;WDR35;MARK4;CEP250;CEP41;IFT122;CNGB1;CCDC57;EXOC4;CCP110;CEP83;TMEM107;RILP;ATP6V1D;DNAH5;TRAF3IP1;UNC119B;BBS2;TMEM17;LZTFL1;DYNLT2B;CFAP70;ACTR3;IQCG;NOTCH1;CFAP298;DYNC2I1;PARVA;GSN;WDR19;CPLANE1;KIF3A;TRAPPC14;TMEM216;CYS1;EHD1;ARF4;TTBK2;WDR11;TTLL3;BBS7
prerank,positive regulation of protein transport (GO:0051222),0.3361861957172045,0.9706453192843232,0.5698808234019501,0.7743923980511753,1.0,12/67,15.28%,IGF1;ABCG1;ADAM8;ATP13A2;RUFY3;TREM2;VAMP2;PLK3;GOLPH3;TPR;TNF;ARHGEF5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.31863562494755693,0.9700432308360253,0.5548717948717948,0.7754011918104887,1.0,20/124,12.82%,ERCC6;APOE;PLEK;LRP12;CDK5;ODF2;GPRIN1;ATXN10;DTNBP1;PTPRM;CYFIP1;MYOC;PLEKHA1;TBC1D24;BLOC1S3;CDK16;DOCK7;STX3;IL6;MARK4
prerank,negative regulation of cellular senescence (GO:2000773),0.42822354842775945,0.9692538782829604,0.5428176795580111,0.776707043188311,1.0,6/13,27.92%,CDK6;ZKSCAN3;TERT;FBXO5;RBL1;TERF2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4604945493801858,0.9687109168020076,0.5204513399153737,0.7775127376967361,1.0,6/10,32.83%,PSMC4;PSMC2;PSMC6;PSMC5;TP53;PSMC3
prerank,response to metal ion (GO:0010038),0.33155301834191625,0.9684924933667614,0.5321701199563795,0.7776427195119201,1.0,20/67,27.01%,BCL2;HIF1A;KCNMA1;NDRG1;CAV1;MTF1;CALM2;HVCN1;AHCYL1;HOMER1;SLC25A13;ATP7B;NEDD4;MT2A;TRPV6;CALM3;ALG2;PDCD6;SLC30A5;PLSCR1
prerank,hemidesmosome assembly (GO:0031581),0.44576645753486893,0.9683210417417382,0.5278551532033426,0.7776787862625197,1.0,2/11,7.90%,LAMC1;DST
prerank,protein localization to cilium (GO:0061512),0.37210930801774167,0.9679850689446721,0.5175644028103045,0.7780779327010767,1.0,8/32,18.17%,RABEP1;SNX10;CSNK1D;WDR35;IFT122;TMEM107;MAPK15;ATP6V1D
prerank,protein heterooligomerization (GO:0051291),0.4101575785108471,0.9677069309289931,0.533068783068783,0.7783016614207487,1.0,5/17,14.37%,TMEM120B;FARSB;FARSA;HSD17B8;CPSF7
prerank,placenta development (GO:0001890),-0.36895030631188336,-0.9676739142595164,0.48148148148148145,0.7956246359008312,1.0,3/12,8.11%,ADAM19;PTK2;SOD1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3306933380961432,0.9668739829364545,0.521505376344086,0.7797504577880945,1.0,19/68,24.56%,RAB7B;LPL;CYBA;SPHK2;TMEM106A;SYK;IL6;DHX9;HSPD1;TNF;ARHGEF2;MBP;TLR7;XBP1;IL17RA;TIRAP;PTPN11;SETD4;POU2AF1
prerank,filopodium assembly (GO:0046847),-0.34296461079122464,-0.9666739366204105,0.4860557768924303,0.7960110705439938,1.0,7/16,21.37%,FGD2;EZR;FGD1;DNM3;ARHGEF4;SRGAP2;S1PR2
prerank,cellular senescence (GO:0090398),0.37565480760431447,0.966292252534022,0.5363528009535161,0.7806133719794459,1.0,4/27,9.91%,NSMCE2;PRKCD;ID2;SRF
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.33556566948458866,0.9658954653296863,0.5316315205327414,0.7811220736279878,1.0,15/56,20.43%,NSMCE2;RAD51B;EIF4G1;ADAM17;CCNB1;BRD4;STOX1;VPS4B;CDC25B;KLHL18;CDC25A;CDK4;UBE2C;CCND1;FBXO5
prerank,L-serine metabolic process (GO:0006563),-0.39255165166277384,-0.9655692233123057,0.5033783783783784,0.7967372660866967,1.0,1/10,0.19%,SERINC3
prerank,protein K48-linked deubiquitination (GO:0071108),0.3848133718542336,0.9647315368957685,0.5432098765432098,0.7832479917745047,1.0,10/23,25.25%,OTUD4;USP5;ATXN3;BAP1;TNFAIP3;MINDY2;USP8;USP33;YOD1;OTUD5
prerank,second-messenger-mediated signaling (GO:0019932),0.32832156864447953,0.9646257578718742,0.5633652822151225,0.7831176414697916,1.0,13/82,12.84%,P2RX4;APOE;MCTP1;LAT;SPHK1;PDPK1;TPCN2;RCAN1;DGKD;PPP2R1A;LAT2;BTK;INPP5A
prerank,regulation of microtubule depolymerization (GO:0031114),-0.28595555264549005,-0.9643959478932033,0.4880382775119617,0.7977146949150653,1.0,4/25,5.28%,NAV3;MAP1B;CLASP2;APC
prerank,regulation of smooth muscle contraction (GO:0006940),0.3932862211325371,0.964279535297715,0.5373891001267427,0.7835111224924589,1.0,4/20,9.91%,ATP2B1;SPHK1;CAV1;SRF
prerank,response to ATP (GO:0033198),-0.30906237514508056,-0.964154665826014,0.4798387096774194,0.7962572854565965,1.0,2/18,2.04%,P2RY12;RYR3
prerank,positive regulation of wound healing (GO:0090303),-0.2656315488833404,-0.9641127816413854,0.4768211920529801,0.7942507101619325,1.0,10/36,15.01%,PRKCE;PTK2;KANK1;DMTN;VTN;HRAS;F2R;HBEGF;ADRA2A;THBS1
prerank,mitotic chromosome condensation (GO:0007076),0.37844077675723736,0.9639732783043549,0.5363748458692972,0.7838279037836325,1.0,9/26,23.03%,NCAPG;KMT5A;NCAPG2;CCNB1;CSNK2A2;PHF13;NCAPH;MCPH1;SET
prerank,sprouting angiogenesis (GO:0002040),0.34179508877852544,0.9639141625537571,0.5437219730941704,0.7835984130338404,1.0,5/51,3.49%,FGF2;NRP1;PTK2B;OTULIN;VEGFA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3733691769829264,0.9637565915894604,0.5191846522781774,0.7835742555868309,1.0,9/29,20.19%,APOE;MCTP1;SYNGR1;RAB5A;DLG4;RAB3GAP1;NSMF;CLN3;ARC
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35774028610832126,0.9637247215474383,0.5260047281323877,0.7832712228294999,1.0,8/34,19.95%,PTPRC;TRIM6;SPHK2;IL6;IL2;RBP4;VAMP3;XBP1
prerank,skeletal muscle contraction (GO:0003009),-0.317806265937336,-0.9637231808580382,0.4930875576036866,0.7931820637498942,1.0,6/19,26.77%,RCSD1;STAC;MYH14;TNNI2;TNNT3;CCDC78
prerank,response to hydroxyurea (GO:0072710),0.45100981325574235,0.9635571429894575,0.5445402298850575,0.7832500766086365,1.0,7/11,35.92%,DDI2;KAT7;BLM;FMR1;SPIDR;NSMCE3;RTF2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.42695638039778727,0.9633673179581845,0.5225618631732168,0.7833164690751708,1.0,8/13,31.79%,AXL;GAS6;DHX9;AGPAT1;IL7;AGPAT2;TAF9;MAVS
prerank,regulation of interleukin-4 production (GO:0032673),-0.3074589554868367,-0.9631709331144577,0.4847161572052402,0.7924228842844527,1.0,8/21,16.79%,CD86;RARA;PRKCZ;IRF4;LGALS9;SLC7A5;ZFPM1;LEF1
prerank,glycerolipid metabolic process (GO:0046486),0.4524216643899896,0.9631006046655292,0.5511049723756906,0.7835090551011274,1.0,1/11,0.38%,DGKZ
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.36165170172188665,0.962961383028655,0.5355892648774796,0.7834547441156372,1.0,11/39,22.31%,VEGFA;JAG1;GTPBP4;MYADM;MAPK7;MBP;NOTCH4;CDH1;TGFB1;NOTCH1;NF2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2605824201125959,-0.9624054995340772,0.5147058823529411,0.7924519415024405,1.0,12/36,23.89%,FHIT;OPHN1;PRKCG;CAMLG;NOP53;USP25;UBXN1;N4BP1;ALAD;F8A1;AQP11;RYBP
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.37164902856744936,0.962017279409661,0.5220125786163522,0.7851442250329083,1.0,10/25,25.32%,EAPP;BRD4;WDR43;EAF1;CDK13;RECQL5;LDB1;HNRNPU;NELFA;SUPT4H1
prerank,cell proliferation in forebrain (GO:0021846),-0.3745505468378873,-0.961872256389186,0.4855305466237942,0.7917120268188653,1.0,2/10,3.90%,NUMB;AKNA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.45063251599004306,0.9617983945415873,0.5240875912408759,0.7852870769403494,1.0,2/10,7.36%,DLGAP4;DLGAP3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4670685427049491,0.9616729476403029,0.5365168539325843,0.785224950477042,1.0,6/10,28.94%,ACD;DCLRE1A;DCLRE1C;TERF2IP;TERF2;RIF1
prerank,neuron development (GO:0048666),0.31419654970947253,0.9616562816802618,0.5708502024291497,0.7849048137474028,1.0,24/141,12.58%,B4GALT5;ERCC6;APOE;LRP12;UNK;CDK5;GPRIN1;GRXCR1;ATXN10;RUNX1;DTNBP1;PTPRM;MYOC;TBC1D24;BLOC1S3;HS6ST1;ATP7A;CDK16;SRF;GBA2;THOC2;DOCK7;STX3;IL6
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.456008561508356,0.9614179548187606,0.544179523141655,0.7850650277339579,1.0,6/11,32.24%,IL6;MAP2K2;TGFB1;MAP2K1;DDX5;TP53
prerank,regulation of defense response (GO:0031347),0.3263708972837848,0.9613012239286768,0.5619047619047619,0.7849616076157595,1.0,10/76,8.84%,APOE;FGR;MGLL;PTGES;TRAF3;APPL2;BRD4;CELF1;BCL6;TREM2
prerank,negative regulation of neuron projection development (GO:0010977),0.33548418647185596,0.9605399298713782,0.5673913043478261,0.7862241234391993,1.0,9/56,14.12%,MYLIP;APOE;GDI1;RUFY3;LRP4;RHOA;CBFA2T2;GAK;EFNA1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3843352335266007,0.9601240152728217,0.5257985257985258,0.7867645006955372,1.0,3/22,4.12%,TRAF2;IL12RB1;MALT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.38704842940467843,0.9601068652723482,0.5442708333333334,0.786449569588238,1.0,9/23,25.37%,MYO10;KIF1A;HOOK3;TUBB;HOOK1;TUBA1C;KIF1B;DYNC1I2;KIF5B
prerank,necroptotic process (GO:0070266),0.417421246447224,0.9600292852376039,0.5427069645203679,0.7862464330921934,1.0,4/16,12.27%,TRPM7;TICAM1;RIPK3;MLKL
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.44260823860440046,0.959468577906841,0.5321477428180574,0.7870743508423662,1.0,2/12,7.56%,IL12RB1;SLC11A1
prerank,gas transport (GO:0015669),-0.37953988156800483,-0.9588455688697219,0.4967948717948718,0.7974871184562693,1.0,6/10,39.90%,CA2;CYGB;AQP1;RHAG;IPCEF1;NGB
prerank,ureteric bud development (GO:0001657),-0.3303670158674307,-0.9583641476365016,0.4915254237288136,0.7966516683132324,1.0,6/17,19.79%,SALL1;ROBO2;SLIT2;GPC3;OSR1;BMP2
prerank,atrial septum development (GO:0003283),-0.35215169212195474,-0.9578259797744108,0.4728682170542636,0.795877911037381,1.0,7/13,34.75%,NOTCH2;ZFPM1;TGFB2;HEY2;ISL1;GJA5;MDM4
prerank,positive regulation of protein binding (GO:0032092),0.3319958305613549,0.9577812857829313,0.55,0.790336031339587,1.0,16/56,24.61%,LRP1;APOE;STK3;BAMBI;CAV1;HIP1R;TERT;PIN1;SPPL3;DERL1;DACT1;USP33;NVL;GSK3B;RALB;ABL1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4631531990031772,0.9577554912904298,0.5390173410404624,0.7900327385162912,1.0,6/10,33.47%,TREM2;TICAM1;CD68;ADTRP;MYD88;MIA3
prerank,toxin transport (GO:1901998),0.4571571344299294,0.9575668905759664,0.5613540197461213,0.7900688064685951,1.0,1/10,4.45%,ANTXR2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.36932870782175214,-0.9575149251834433,0.5347222222222222,0.7945826780795062,1.0,3/11,15.01%,LGALS9;ATP6AP2;THBS1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.40491768796461025,0.9573925489313269,0.5673202614379085,0.7900987390904696,1.0,6/20,21.82%,CDK6;PTK2B;HSPA9;MAFB;LDB1;ZBTB16
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.390064234563942,0.9573203554902491,0.530638852672751,0.7898879332700387,1.0,4/20,11.37%,SLC8B1;PMPCA;AFG3L2;PARL
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.404191819235757,0.957306703207459,0.5564102564102564,0.7895628796449651,1.0,5/18,15.91%,ABL2;MYOC;ITGA3;KCTD10;FLCN
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.41889322360388126,0.957292817428387,0.5308641975308642,0.7892339008670229,1.0,4/16,12.19%,PTPRC;IL12RB1;LILRB1;RIPK3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.44860465882269795,0.9571399046788418,0.5414847161572053,0.7892116751158261,1.0,6/11,29.52%,ASAH1;BMP5;DGKQ;EGR1;NR5A1;FGFR4
prerank,cellular response to glucose starvation (GO:0042149),0.35246113908608945,0.9569851757276052,0.557396449704142,0.789181975454886,1.0,22/41,35.71%,CPEB4;SIK1;BECN1;MYBBP1A;SESN2;PRKAG1;ASNS;ZC3H12A;XBP1;BRSK2;SH3GLB1;IMPACT;FOXO3;RRP8;NIM1K;TP53;PICK1;PRKAA2;NUAK2;PRKAA1;PRKAG2;ATF4
prerank,rRNA pseudouridine synthesis (GO:0031118),0.45358173668073565,0.9568635005259192,0.5256975036710719,0.7890797373244259,1.0,3/10,14.98%,GAR1;DKC1;RPUSD1
prerank,ubiquinone metabolic process (GO:0006743),0.41849113591420395,0.9567755881431791,0.5420689655172414,0.788928924515318,1.0,6/15,24.68%,COQ10B;COQ5;AIFM2;COQ8B;COQ3;PDSS2
prerank,cell junction organization (GO:0034330),0.32487176206501933,0.9564965115828906,0.5592315901814301,0.7891454242573903,1.0,10/71,13.40%,APBB2;FBLIM1;TJP2;FLNA;RAB8B;LRP4;LIMS1;RHOA;MYO9A;ILK
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.41083972145398506,0.9564737599168517,0.5332446808510638,0.7888315500030672,1.0,6/15,26.04%,PTPN2;TTLL12;YTHDF2;METTL3;NLRC5;USP18
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.3932978405475019,-0.9562584649535367,0.5031055900621118,0.795673689909874,1.0,4/10,12.45%,APOD;PADI2;LRCH1;RIPOR2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.38321878561565415,-0.9561569611931072,0.49514563106796117,0.793858554863411,1.0,6/10,33.77%,CD74;CD81;FCGR2B;GAPT;CD19;TLR8
prerank,positive regulation of cilium assembly (GO:0045724),0.40399488312803455,0.9559564916024744,0.5357142857142857,0.7895937269226874,1.0,5/18,16.77%,KCTD17;HTT;CEP120;MARK4;CCP110
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3918575609890653,0.9554761493537609,0.5416149068322982,0.7902767426893733,1.0,12/22,32.83%,MED17;SRF;PSMC4;MED1;PSMC2;MED13;MED12;DHX36;PSMC6;PSMC5;TP53;PSMC3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4327906677249522,0.9553762184241859,0.5398351648351648,0.7901416048860893,1.0,4/12,22.34%,DAB2;HDAC1;SFRP1;SMARCA4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.32452344547330336,0.9549379620226625,0.5657202944269191,0.7907010200569883,1.0,22/78,25.21%,CCNY;IPO5;ADAM17;CEBPA;CCNB1;GTPBP4;BCCIP;CCNT2;CDKN3;SERTAD1;CDK5RAP1;MNAT1;CDC25A;GTF2H1;LATS1;BLM;CCND1;PDGFB;CCNH;SPDYA;PTEN;INCA1
prerank,regulation of neuron projection arborization (GO:0150011),0.41044583612706137,0.95493654128974,0.5330520393811533,0.7903484343564774,1.0,4/15,15.34%,MACF1;FZD4;MYO9A;DLG4
prerank,positive regulation of innate immune response (GO:0045089),0.36635263590259104,0.9549256388045554,0.5473554735547356,0.7900148165848064,1.0,12/30,27.01%,ADAM8;TRIM6;POLR3D;DHX9;RIOK3;PLA2G5;IFI35;RPS19;POLR3B;NLRC5;SPI1;PLSCR1
prerank,histone H4-K5 acetylation (GO:0043981),0.4131954525599436,0.9546380947635166,0.5385656292286874,0.7899317232588418,1.0,8/15,25.53%,ING4;OGT;HCFC1;WDR5;KAT7;JADE3;KANSL1;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),0.4131954525599436,0.9546380947635166,0.5385656292286874,0.7899317232588418,1.0,8/15,25.53%,ING4;OGT;HCFC1;WDR5;KAT7;JADE3;KANSL1;KAT8
prerank,bile acid metabolic process (GO:0008206),0.37516613676310706,0.9545763064880022,0.5321782178217822,0.7897025799003552,1.0,7/27,14.88%,SLC27A5;CH25H;NPC1;OSBPL2;OSBP;GBA2;SCP2
prerank,macrophage activation (GO:0042116),0.3643039869308441,0.95439619330099,0.5450236966824644,0.7897328870260971,1.0,11/34,21.51%,FER1L5;TMEM106A;SLC11A1;SYK;TREM2;C5AR1;TNF;SBNO2;ITGB2;CRTC3;IFI35
prerank,mitotic spindle assembly (GO:0090307),0.3443795681853148,0.9543936749397608,0.5546511627906977,0.789388663689876,1.0,11/42,22.07%,MAP10;FLNA;LSM14A;BCCIP;ABRAXAS1;RHOA;CHEK2;GOLGA2;STAG1;TOGARAM2;KIFC1
prerank,protein heterotetramerization (GO:0051290),0.42947266715183646,0.9543020994853476,0.5488826815642458,0.7892358694419168,1.0,4/13,14.37%,FARSB;FARSA;HSD17B8;CPSF7
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.41265048800496446,0.9542777168713685,0.5313751668891856,0.788940517340549,1.0,8/16,28.94%,KMT5B;KDM4D;SETMAR;PNKP;SMCHD1;PARP9;PRKDC;RIF1
prerank,limb morphogenesis (GO:0035108),0.40214578114858807,0.9540162826780065,0.5252918287937743,0.7891392954077827,1.0,3/20,7.57%,FBXW4;SKI;LRP6
prerank,cardiac muscle tissue development (GO:0048738),0.33981674545208457,0.953946583666679,0.5653153153153153,0.7889371287680129,1.0,5/50,5.25%,NPPA;TBX18;SHOX2;AKAP13;SIK1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.39622283046360046,0.9536233000383343,0.5462724935732648,0.7892410991170268,1.0,5/20,14.03%,CHRNB2;GNAQ;GNA11;LY6G6D;GNB1
prerank,regulation of coagulation (GO:0050818),-0.36391847277778727,-0.9535135111901023,0.4983922829581994,0.7986939903687512,1.0,2/11,12.29%,HS3ST5;F2R
prerank,ribosome assembly (GO:0042255),0.3400794240535098,0.9525836484626898,0.5528364849833148,0.7911097747585335,1.0,13/47,22.60%,EIF6;RRP7A;BRIX1;MDN1;PPAN;C1QBP;DHX29;RPS28;EFL1;MRPS7;EIF2A;RPS19;MTERF3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4448129817754678,0.9522600892065812,0.5487977369165488,0.7914176024052091,1.0,2/11,3.06%,SOAT1;AGO2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.450303397821293,0.9522084445608086,0.5386779184247539,0.7911795481733923,1.0,6/10,31.61%,ACAD11;ACADL;GCDH;ACADM;ACADS;ETFA
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3355577857658124,-0.9521124764669019,0.516728624535316,0.8003208230674658,1.0,7/15,20.64%,UBR3;STOX2;RAI2;TGFB2;CELF4;SCEL;CAMSAP3
prerank,homologous chromosome segregation (GO:0045143),-0.3080672387257276,-0.9516638886007049,0.5454545454545454,0.7992717534317945,1.0,7/20,24.01%,PTTG1;FMN2;IHO1;ZCWPW1;SGO1;MAJIN;FANCD2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.45098647078557114,0.9509894732818273,0.5597014925373134,0.7933265678681186,1.0,5/10,28.94%,BRCA1;DNMT3B;DNMT1;KDM1A;RIF1
prerank,cellular response to ionizing radiation (GO:0071479),0.34254904150015913,0.9509054327197282,0.5482406356413166,0.7931582710865962,1.0,16/47,23.94%,GRB2;TANK;MDM2;EEF1D;KDM4D;INO80;RAD51AP1;FIGNL1;MAP3K20;RAD9A;HSF1;BLM;HUS1;XRCC5;KDM1A;RAD51
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3881097793425577,0.950885172353711,0.5361963190184049,0.7928484662681493,1.0,11/23,28.02%,PPARG;PTPN2;IFNGR2;JAK1;IRGM;SUMO1;HSP90AB1;NLRC5;PIAS1;PARP9;TXK
prerank,xenobiotic transport (GO:0042908),-0.32318082273258625,-0.9502050645532485,0.5347826086956522,0.8008216248724198,1.0,11/17,43.40%,ABCA3;SLC7A5;SLC15A2;SLC22A18;ABCC2;SLC22A3;NR1I2;SLC22A2;SLC29A4;SLC47A1;SLC22A4
prerank,cellular response to estrogen stimulus (GO:0071391),-0.34132016614716065,-0.9501367563316369,0.5358490566037736,0.7989539399021529,1.0,7/14,28.10%,RARA;ARID5A;SRA1;NCOA4;BCAS3;AR;SFR1
prerank,cyclooxygenase pathway (GO:0019371),0.455095487160486,0.9496201700334703,0.5469845722300141,0.7951760316504654,1.0,4/10,12.70%,PTGES;TBXAS1;CBR1;PTGIS
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4077944281451829,0.9495887467613462,0.5574866310160428,0.7948942793431334,1.0,4/17,7.77%,ID2;TNFRSF1B;EGR2;SERPINE2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.43233642853342147,0.9488676754036703,0.5614035087719298,0.7960427229893572,1.0,3/12,14.62%,GCNT2;CD44;TNF
prerank,positive regulation of viral life cycle (GO:1903902),0.38342066226296523,0.9487231119227825,0.5460358056265985,0.7959951254243005,1.0,5/22,11.94%,AXL;LGALS1;P4HB;DDB1;KPNA6
prerank,mitotic sister chromatid segregation (GO:0000070),0.3143641095408121,0.9486921561104196,0.5881126173096975,0.7957018371673884,1.0,26/98,25.22%,NCAPG;KMT5A;CHMP4B;CHMP4A;NCAPG2;EML4;CCNB1;PDCD6IP;VPS4B;CSNK2A2;BECN1;INO80;CENPK;TEX14;PHF13;KIFC1;NCAPH;SPDL1;NUDC;MCPH1;SET;EML3;NAA50;CHMP7;CUL3;PDS5A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.32622356317413875,0.9482643182850662,0.5726587728740581,0.7962435612631924,1.0,9/66,12.34%,GPNMB;CDK6;EIF4G1;ADAM17;ID2;APPL2;WEE1;INO80;PRMT2
prerank,receptor-mediated endocytosis (GO:0006898),0.3103362394974731,0.9480703172878884,0.6097308488612836,0.7963223869461902,1.0,17/132,10.07%,COLEC12;CD9;LRP1;APOE;IGF2R;GRB2;DAB2;TPCN2;PIP5K1C;LRP6;DNM2;CAV1;SYK;MASP1;HIP1R;AP4E1;LILRB1
prerank,regulation of neutrophil migration (GO:1902622),0.4456535005724478,0.9475936869407687,0.5444444444444444,0.7969662198454501,1.0,4/10,27.41%,NCKAP1L;RHOG;OLFM4;RAC1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3579392733593908,0.9472548018228804,0.561091340450771,0.7973000936119137,1.0,5/32,6.52%,MCTP1;CPLX4;DTNBP1;VPS18;RAB5A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.33502944244170846,-0.9468514122428153,0.5108695652173914,0.8053535695971616,1.0,10/14,39.99%,ENPEP;AVPR2;ACE;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3069128765615423,0.9461445493624266,0.6238532110091743,0.7993075773280879,1.0,11/138,4.99%,FLT1;CSF1;FGR;STAP1;BLNK;PIK3CB;PTK2B;NPPA;AXL;MTSS1;NEDD9
prerank,calcium-mediated signaling (GO:0019722),0.3139635478546747,0.9461018898431622,0.5828092243186582,0.7990499921081078,1.0,14/93,12.45%,P2RX4;MCTP1;SLC9A1;LAT;PTPRC;SPHK1;PTGFR;PDPK1;TPCN2;RCAN1;LAT2;SLC8A1;ATP2A2;BTK
prerank,pore complex assembly (GO:0046931),0.3964749435907204,0.9459293752844277,0.5552665799739922,0.799055102483767,1.0,7/19,24.02%,NUP205;ANO6;AHCTF1;TPR;AFDN;NUP93;NUP98
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3699996596910583,-0.9458790616493723,0.5374149659863946,0.8058061968136785,1.0,4/11,15.12%,CCR2;WNK1;WNT5A;CCL5
prerank,cellular response to interleukin-4 (GO:0071353),0.447776057471045,0.9456693376452835,0.5552407932011332,0.7992484560848216,1.0,5/10,26.86%,RUFY4;XBP1;TCF7;STAT6;JAK3
prerank,positive regulation of rRNA processing (GO:2000234),0.44481636065933305,0.9456339693798627,0.5398496240601504,0.7989728377279102,1.0,3/10,16.75%,WDR43;RIOK2;DIMT1
prerank,gluconeogenesis (GO:0006094),0.3476163067832018,0.9450627135202805,0.5730994152046783,0.7997698459871566,1.0,9/39,19.91%,SLC25A1;ALDOA;PCK2;ENO2;PGK1;ENO1;RBP4;PGM1;SLC25A13
prerank,glial cell development (GO:0021782),0.37149938996735665,0.9450409147494306,0.5489199491740788,0.799457928424636,1.0,4/25,17.18%,CDK6;NRROS;NF1;EIF2B2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2996568474489778,-0.9449762208781561,0.5370370370370371,0.8059715197938047,1.0,6/20,18.05%,RAPGEF2;PDE4D;ADRB1;ADRA2A;DRD2;GPR101
prerank,regulation of chromatin binding (GO:0035561),0.45312217408642197,0.9447875400269082,0.5662299854439592,0.7995947080583611,1.0,3/10,12.78%,GMNN;KDM4D;WAPL
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.31140900192738796,-0.9446459430809404,0.4935064935064935,0.804738128050082,1.0,7/17,18.97%,LY86;CARD16;SCIMP;CACTIN;NFKBIL1;CD55;CD36
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.35859589833100197,0.9445179721546724,0.562874251497006,0.799794282894163,1.0,7/32,12.03%,CORO1C;MMP12;JAG1;MYOC;RASA1;ADAM15;ARHGAP6
prerank,myelin assembly (GO:0032288),0.449183314897848,0.9442811133443985,0.5565092989985694,0.7999340056987405,1.0,3/10,17.56%,CD9;NCMAP;PMP22
prerank,negative regulation of defense response to virus (GO:0050687),0.44208334636234026,0.9436775019793295,0.5449010654490106,0.8008325216207357,1.0,6/10,29.74%,ILRUN;C1QBP;TRAF3IP1;PCBP2;TSPAN6;PPM1B
prerank,endothelial cell migration (GO:0043542),0.35021992437922994,0.9433292097268348,0.5764705882352941,0.8012083166419302,1.0,13/37,24.61%,NRP1;VEGFA;CYP1B1;PLXND1;RHOA;GIPC1;LGALS8;LPXN;CORO1B;ID1;PIK3CA;FSTL1;ABL1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3737072165538376,0.9429178703612875,0.5608272506082725,0.8016814251331338,1.0,7/25,18.30%,FBXL17;ATXN3;VCP;LONP1;CLPP;RNF185;DERL1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3665453309980944,0.9424789224130413,0.562962962962963,0.8022457610580546,1.0,5/27,12.31%,SLC27A1;PLAAT3;CHKB;NAPEPLD;ABHD4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4122785707773431,0.9424565182964655,0.5466666666666666,0.801937974315539,1.0,2/14,9.49%,UMPS;CAD
prerank,negative regulation of transposition (GO:0010529),0.40198612543918866,0.9423828093854871,0.5561569688768606,0.8017353011476627,1.0,2/16,11.83%,PIWIL2;UBR2
prerank,regulation of protein ubiquitination (GO:0031396),0.31015344305003456,0.9421320354592966,0.5948453608247423,0.801918582111807,1.0,25/108,19.82%,SASH1;PRICKLE1;SPHK1;SQSTM1;FBXW7;MALT1;SMAD7;GTPBP4;BRCA1;CAV1;PRMT3;OGT;TNFAIP3;HUWE1;CENPX;UBE2L3;UFL1;PTTG1IP;WFS1;DERL1;TGFBR1;HDAC3;CENPS;BIRC2;RCHY1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3397483647168848,0.9420421398773201,0.5485714285714286,0.8017348505972006,1.0,13/43,22.40%,GRB2;SH3KBP1;PTPN2;STAM2;SOCS5;RAB7A;MVP;CBL;ZGPAT;DUSP3;ERRFI1;EPN1;CDC42
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3431305638752634,0.9419447914895366,0.5809414466130884,0.8015887730563789,1.0,20/49,28.13%,NLRC3;TREM2;PMEPA1;RAF1;PTGER4;RPL13A;RIOK3;LDLRAD4;PYDC1;DACT1;TRAF3IP1;HSF1;IAPP;CDC42;GSK3B;EP300;ANKRD27;IMPACT;AIDA;PPM1A
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.42455065889568117,0.941831223914497,0.5636114911080712,0.8014633900730053,1.0,6/12,25.17%,CSF1;BST2;MAPK3;IL34;LYN;MAPK1
prerank,regulation of rRNA processing (GO:2000232),0.3975029901587744,0.9418241969027583,0.5578231292517006,0.8011234145319626,1.0,5/16,16.75%,WDR43;YTHDF2;RIOK2;USP36;DIMT1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3158087735959916,0.9417752140397739,0.5993723849372385,0.8008686686984482,1.0,22/91,18.40%,ABL2;FGR;PTPRC;NRP1;CD22;SPHK1;BET1L;RAB8B;RAB5A;SYK;HIP1R;RAB5C;VAMP2;RUFY1;HIP1;SNX17;CPLX2;MAPK3;STON1;MAP2K2;PTPN1;FES
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.397767322269147,0.9416323559454988,0.5626666666666666,0.8008085790442088,1.0,4/17,18.88%,LPGAT1;LPCAT1;SERAC1;PLA2G5
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.34606685980623225,0.9415062992495934,0.5738831615120275,0.8007330310823375,1.0,15/40,30.76%,PRKCD;MCL1;KMT5A;SMYD2;FXR2;CASP9;UBE2V2;SMG1;FBXO5;ABL1;FEM1B;FMR1;PARG;NEK4;FXR1
prerank,positive regulation of phospholipid transport (GO:2001140),0.4582133390627767,0.9413938923215815,0.5636114911080712,0.8006142285347645,1.0,2/10,8.17%,APOE;TRIAP1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.44326256282387355,0.9411113774466399,0.561877667140825,0.8008537976258248,1.0,7/10,30.78%,MAPK3;MAP2K2;LYN;MAPK1;RNF13;MAP2K1;GSTP1
prerank,clathrin coat assembly (GO:0048268),-0.3296961879184107,-0.9408425571892768,0.5572519083969466,0.8124227962656662,1.0,5/15,13.24%,SGIP1;PICALM;AP2S1;NSG2;NSG1
prerank,catecholamine metabolic process (GO:0006584),0.42275262800161784,0.9406053075377001,0.5582655826558266,0.8015150512150877,1.0,3/14,9.55%,TH;RNF180;ATP7A
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4390494730602702,0.9402816197039167,0.5498575498575499,0.8018177714087723,1.0,5/11,20.43%,ZRANB3;GMNN;LIG3;BLM;FBXO5
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.32820643531983335,0.940082007781427,0.5895439377085651,0.8018461892382679,1.0,7/59,10.39%,LPL;SLC27A5;ACACA;CH25H;OSBPL2;HSD17B8;OSBP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4361918650594591,0.9384068358437265,0.5674157303370787,0.8049095005169367,1.0,2/11,14.18%,SLC27A1;CTDNEP1
prerank,mRNA methylation (GO:0080009),0.41563184839314665,0.9383892465617761,0.5635876840696118,0.8045999769461016,1.0,6/15,25.93%,TRMT10C;METTL8;PCIF1;METTL3;NSUN2;CBLL1
prerank,polarized epithelial cell differentiation (GO:0030859),0.42566542207365915,0.9372383376170031,0.5652173913043478,0.8065633258906343,1.0,7/13,23.08%,RAP2A;MSN;RHOA;MYO9A;SYNE4;CDC42;SCRIB
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3853127519926968,0.9369880747750958,0.571969696969697,0.806717303136364,1.0,10/22,27.39%,APOE;AKAP13;GBA2;EFEMP2;PRUNE1;PIK3CA;CAMSAP1;ABL1;AEBP1;MAP1S
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.24389262433059014,-0.9365295153947809,0.5929203539823009,0.821242552383454,1.0,5/46,4.58%,PLCL1;IP6K1;ACVR2B;RBPJ;ADAMTS5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.39880633388072056,0.9364193454172977,0.5546875,0.8075461054911395,1.0,6/18,21.65%,BHLHE41;HDAC4;HDAC1;HDAC3;XBP1;NOTCH1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3236736275928719,-0.9358844726993861,0.5390946502057613,0.8207776133718289,1.0,3/15,12.45%,MAPK14;RAPGEF3;RIPOR2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.37021206037188836,0.9353095120199884,0.5607008760951189,0.8094683548864302,1.0,4/23,13.49%,DNASE2;DNASE1L1;DFFB;SETMAR
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.33652187560361324,-0.9352399121349906,0.5684210526315789,0.8203425179921453,1.0,1/13,0.10%,CYRIB
prerank,female gonad development (GO:0008585),0.38698991829943613,0.9349055122454278,0.5730918499353169,0.8099412513403933,1.0,3/19,9.99%,CYP19A1;VEGFA;COL9A3
prerank,ERAD pathway (GO:0036503),0.3155104915536197,0.9345141685255786,0.5944503735325507,0.8104187236604634,1.0,27/83,25.07%,DERL3;STT3B;DNAJB14;EDEM1;ATXN3;VCP;RNF121;UBXN4;DNAJC10;UBE4A;RNF185;UBE4B;USP13;DNAJB12;WFS1;DERL1;HERPUD1;BRSK2;SYVN1;UBE2J1;HSP90B1;UBQLN1;YOD1;ERLIN2;USP19;UBQLN2;UBXN6
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.30551374256836994,0.9343221545240296,0.6188992731048806,0.8104595902074795,1.0,8/110,3.74%,ABCA1;GNAQ;ADCY8;ADCY3;PTGFR;ADCY7;GNA13;PTGIR
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3912790151619021,0.9336085156877986,0.5612903225806452,0.8115314957407121,1.0,3/18,5.06%,ADCY8;VEGFA;CRTC1
prerank,ganglioside metabolic process (GO:0001573),0.3879462980132551,0.9334075167143877,0.5656167979002624,0.8115736523000826,1.0,4/20,8.85%,HEXA;HEXB;NEU1;ST8SIA6
prerank,cellular response to cadmium ion (GO:0071276),0.3747513501394986,0.9332656278796304,0.5708860759493671,0.8115143395253266,1.0,8/24,25.17%,JUN;MAPK3;HSF1;SUMO1;MT2A;DAXX;CHUK;MAPK1
prerank,transition metal ion homeostasis (GO:0055076),0.36110188046287905,0.933103686932392,0.5635491606714629,0.8114894781221553,1.0,4/28,7.56%,ATP13A2;FTL;HMOX1;SLC11A1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3015201209882115,0.9330733979846304,0.6673387096774194,0.8111990629784072,1.0,43/199,22.46%,GPNMB;CORO1C;ATP2B1;APOA2;PON1;TBX18;PTPN23;SOX9;ADAM17;NPTN;SMAD7;LRP4;LRPAP1;NKX2-1;HDAC9;SLC6A4;SLC11A1;GAS6;SPRED2;DDIT3;SRF;ADIPOR1;DOCK7;EVL;NOVA2;PTGER4;EFNA1;TNF;SPRED3;FLCN;BMP5;SFRP1;LDLRAD4;BBS2;ID1;TIMP1;STK11;TGFB1;ROCK1;NOTCH1;RPS19;CALR;LAMA4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3348795406599713,-0.933028178234317,0.52,0.8237087547814989,1.0,4/13,20.45%,PTS;QDPR;HSP90AA1;PRKG2
prerank,cell-cell junction maintenance (GO:0045217),-0.35960728234102046,-0.9329693844473216,0.5263157894736842,0.8218158065698646,1.0,3/11,12.29%,CSF1R;TJP1;F2R
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4409017163350775,0.9329262070107596,0.5632183908045977,0.811149035890759,1.0,3/10,17.53%,SP7;UFL1;SFRP1
prerank,sister chromatid segregation (GO:0000819),-0.2759933139214624,-0.9328168904623287,0.5838150289017341,0.8202137145978399,1.0,13/31,24.44%,SMC4;TOP2A;NUSAP1;NSL1;CDCA8;WRAP73;CHAMP1;ZW10;SGO1;PLK1;TUBG1;KIF18B;KNSTRN
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.4229460960207179,0.9328070480161221,0.5735694822888283,0.8110231107698154,1.0,6/13,25.37%,CAV1;SLC8A1;SRI;CALM2;CALM3;CAMK2D
prerank,negative regulation of dephosphorylation (GO:0035305),0.39690236188416195,0.9327089635341724,0.5695876288659794,0.8108855476815111,1.0,4/18,19.63%,MFHAS1;PTPA;ZCCHC9;PPP1R8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3191682309399098,0.9326009356163316,0.6008724100327154,0.8107684282652713,1.0,6/63,5.80%,BCL2;CHRNB2;PTPRC;CD274;SLC7A1;NCKAP1L
prerank,positive regulation of chromosome organization (GO:2001252),0.4007167870541154,0.9325321794458437,0.585464333781965,0.8105561563750856,1.0,6/15,30.81%,RAD50;GNL3;PPP1R10;DHX36;MRE11;LIG4
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2432405167192315,-0.9325147823114729,0.6030534351145038,0.8189652498410894,1.0,15/41,21.18%,ITCH;ZFP91;RNF152;TRIM27;RNF168;TRIM56;PRKN;UBE2G1;UBE2B;TRAF1;RNF115;UBE2S;PELI3;UBE2T;UBE2O
prerank,negative regulation of RNA metabolic process (GO:0051253),0.39145496145111275,0.93251111140563,0.5697368421052632,0.810247953791842,1.0,7/18,20.66%,PTBP3;RPS26;TNF;TERT;RPS13;ZC3H12A;TGFB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.35992604476344997,0.932193223236744,0.5690276110444178,0.8105435246120724,1.0,5/28,12.58%,FGR;TRAF3;APPL2;TREM2;ELMOD2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3196749998061317,0.9318015331031898,0.6008676789587852,0.8109925795185162,1.0,11/67,12.55%,MYO10;P2RX4;TBC1D22A;TBC1D2;RAB5A;TBC1D24;CAV1;IFT88;FXR2;TBC1D10A;TBC1D16
prerank,negative regulation of bone mineralization (GO:0030502),0.4164944668352491,0.9317984769436808,0.5681198910081744,0.8106471845768839,1.0,2/13,6.56%,PTK2B;ECM1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3872945725845602,0.9314952923892237,0.5772669220945083,0.8108894924651737,1.0,5/19,19.57%,IGF1;GIT1;TNFAIP3;PYDC1;ZC3H12A
prerank,cell-matrix adhesion (GO:0007160),0.3057731648180194,0.9312471980819746,0.6444906444906445,0.8110451386762502,1.0,22/95,20.89%,PEAK1;FN1;ADAMTS13;OTOA;SIGLEC1;CD44;RHOD;ITGB5;ADAM15;ITGA11;ITGA3;HPSE;ILK;ACTN1;PIP5K1A;ITGA4;ITGB6;PPFIA1;ITGB2;ITGB1BP1;ITGA2;ACTN2
prerank,cranial nerve development (GO:0021545),0.4286653172633941,0.9311263214895167,0.5782792665726375,0.8109117041796831,1.0,2/11,7.93%,CHRNB2;CHD7
prerank,anterograde axonal transport (GO:0008089),0.34092081529239937,0.9309403099370401,0.5958188153310104,0.8109268444564997,1.0,7/37,10.52%,MGARP;DTNBP1;HSPB1;TRAK1;KIF1A;BLOC1S3;AP3D1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3008103447943808,0.9306519994860385,0.6427840327533265,0.8111276896084703,1.0,30/137,20.56%,BCAR3;RGS1;CCL4;ALS2;TBC1D2;PSAP;RIC1;RGP1;CCL13;CCL14;LIMS1;RAPGEF6;RHOA;RIPK3;SNX18;PKP4;LARS1;NF1;DOCK11;FLCN;RAB3GAP1;PIN1;CALM2;MAPK12;SFRP1;ZC3H15;TBC1D20;MMUT;AFDN;RALBP1
prerank,osteoclast differentiation (GO:0030316),0.38185942877107426,0.930459795177271,0.5773584905660377,0.8111521622853661,1.0,4/22,8.84%,CSF1;GAB2;SNX10;TREM2
prerank,electron transport chain (GO:0022900),-0.32481120743462566,-0.9304435086409307,0.5424354243542435,0.8221489449977252,1.0,7/15,23.25%,NDOR1;PPARGC1A;UQCRFS1;NDUFA5;ETFB;CYB561;PDIA5
prerank,sensory perception of chemical stimulus (GO:0007606),0.41268679956931886,0.9303169941475009,0.5727391874180865,0.8110939442801467,1.0,4/15,16.79%,ADCY3;SLC24A4;C5AR1;GNAS
prerank,negative regulation of metabolic process (GO:0009892),-0.22915986420364148,-0.9302805992450787,0.6067415730337079,0.82051206575658,1.0,17/54,24.03%,PLCL1;IP6K1;ACVR2B;RBPJ;ADAMTS5;CCDC3;MAP2K6;IL1B;PCTP;LNPEP;NR1H2;ABHD6;ZDHHC7;NR1H3;IL18R1;TLE3;HOXC10
prerank,ncRNA 3'-end processing (GO:0043628),0.40811063619448146,0.9301585096836791,0.5702917771883289,0.8110627224784044,1.0,7/14,30.68%,INTS6;INTS14;INTS2;TOE1;INTS12;INTS8;SSB
prerank,cellular defense response (GO:0006968),0.3453799073839779,0.9300617231029554,0.5941860465116279,0.810912119944647,1.0,7/40,12.62%,TCIRG1;PTK2B;TRAT1;C5AR1;ZNF148;BECN1;NCF2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.31391997141242295,0.9297946143033854,0.619348054679285,0.8111174725190049,1.0,13/85,14.30%,P2RX4;CHRNB2;MYO1A;GRXCR1;CACNA1D;TPRN;HOMER2;SLC26A4;MYO7A;MYO3B;USP53;ATP6V0A4;CLIC5
prerank,regulation of cytoskeleton organization (GO:0051493),0.30583850387872563,0.9295867521439449,0.6625,0.8111813658057697,1.0,29/108,20.03%,LRP1;IQGAP1;PDGFA;PRKCD;CLIC4;RHOQ;RHOD;CELSR1;HIP1R;BAIAP2;PAK2;RHOG;ARHGAP17;TESK1;RHOA;PHLDB1;SORBS3;RHOF;ARHGEF5;PFDN2;BST2;CRK;MAPK3;CDK2AP2;TRAF3IP1;MARK2;CLN3;TAOK1;RICTOR
prerank,regulation of lipid biosynthetic process (GO:0046890),0.353945909530493,0.9289659264589996,0.5952380952380952,0.8120580060369817,1.0,4/32,10.76%,APOE;EIF6;ASAH1;ADIPOR1
prerank,embryonic digestive tract development (GO:0048566),-0.3096208519299934,-0.9288983665031358,0.5670995670995671,0.8219981673928126,1.0,3/18,5.36%,SALL1;PCSK5;RARB
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.38743759376147713,0.9287058377384568,0.5850785340314136,0.8122307799721726,1.0,4/18,12.58%,PTK2B;ADAM17;SLC8B1;IL6
prerank,collagen fibril organization (GO:0030199),0.3108314273253549,0.9285095619599134,0.619146722164412,0.8122685772136273,1.0,21/88,18.39%,COL10A1;BMP1;COLGALT1;COL20A1;P4HA1;DST;COL12A1;P4HB;ATP7A;CYP1B1;COL9A3;P4HA3;SERPINF2;COL8A2;COL4A1;NF1;PLOD3;COL16A1;LOXL3;ADAMTS2;TGFBR1
prerank,negative regulation of RNA splicing (GO:0033119),0.3878841963531056,0.9281843160950509,0.5708661417322834,0.8125763277862906,1.0,10/19,32.21%,C1QBP;PTBP3;RPS26;SRSF7;RPS13;SRSF10;PCBP4;PTBP1;SAP18;TMBIM6
prerank,protein neddylation (GO:0045116),0.4199519613083817,0.9281238488428459,0.5802968960863698,0.8123404934191916,1.0,7/13,33.55%,DCUN1D4;UBE2F;DCUN1D2;RNF7;DCUN1D3;RBX1;UBA3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.39822857811345685,0.9278287916766045,0.5637319316688568,0.8126000807001426,1.0,8/16,28.01%,PDGFA;NRP1;PIK3C2A;PTPN1;PDGFB;ABL1;PDGFRA;PDGFC
prerank,negative regulation of cell growth (GO:0030308),0.30316388101363834,0.927811239836431,0.6458546571136131,0.8122852925155524,1.0,25/121,22.98%,APBB2;FGF13;CYP27B1;SPHK2;RNF6;DCBLD2;BCL6;SERTAD3;PPP2R1A;ADAM15;ENO1;OSGIN2;SESN2;BST2;FLCN;CDKN2AIP;SFRP1;STK11;TGFB1;FRZB;NME6;NPR1;SMARCA4;PPP1R9B;RACK1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.2714474405272954,-0.9277595080475945,0.5764705882352941,0.8227053276140017,1.0,5/30,8.84%,CACNA2D1;FGF12;SCN1A;SNTA1;CACNA1C
prerank,actin filament capping (GO:0051693),-0.31116085848728414,-0.9276744935834736,0.562753036437247,0.8188499693572379,1.0,4/18,7.69%,TWF2;EPS8;ADD3;ADD2
prerank,barbed-end actin filament capping (GO:0051016),-0.31116085848728414,-0.9276744935834736,0.562753036437247,0.8188499693572379,1.0,4/18,7.69%,TWF2;EPS8;ADD3;ADD2
prerank,chromatin organization (GO:0006325),0.30456422130234156,0.9275118100818637,0.6587628865979381,0.8125268010953097,1.0,53/132,31.32%,NUDT5;FAM47E;SOX9;NPM3;HDAC4;HMGN1;HIRIP3;SMARCB1;BPTF;PHF1;MTF2;CBX3;EHMT1;KDM4D;INO80;BAZ1B;SMARCD2;MYSM1;HCFC1;PIH1D1;SUPV3L1;HDAC1;MCM3AP;RUVBL2;HP1BP3;SAFB;HDAC3;SATB2;CDAN1;GATAD1;HMGN2;CHD1;SMARCA4;DAXX;TOP1;NPM2;SPI1;SUPT4H1;RSF1;ZBTB1;DR1;KDM4B;KDM5C;SMARCC1;SMARCC2;HDAC8;SETDB1;SETD2;HDAC2;BRWD1;LRWD1;NPM1;SMARCE1
prerank,DNA recombination (GO:0006310),0.3447093409381268,0.9274184289496038,0.5880952380952381,0.8123776218759208,1.0,18/37,34.63%,RAD51B;IGHMBP2;ERCC1;RAD50;GEN1;SUPV3L1;RECQL5;BLM;RAD51;MRE11;LIG4;RECQL;MSH3;TSN;DMC1;EXO1;ENDOG;RHNO1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3606524288619478,0.9261296842965688,0.5728643216080402,0.8145708859710327,1.0,7/26,21.06%,FBXW7;ADAM17;SOCS5;CBL;ZGPAT;ERRFI1;NCK2
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3164851963954267,-0.9259632436057768,0.5551470588235294,0.8210606761847109,1.0,5/16,23.53%,TAPT1;LRRK2;BCAP29;UBAC2;PPP1R15A
prerank,regulation of Golgi organization (GO:1903358),0.3946972787769261,0.9257587766674624,0.6021220159151194,0.814961531020734,1.0,6/17,25.17%,MYO5A;STX5;MAPK3;MAP2K2;STX18;MAPK1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3746596549063641,0.9255089399711193,0.5851197982345523,0.8151001851856823,1.0,6/22,14.62%,ABCG1;GSAP;RANBP9;SP1;EFNA1;TNF
prerank,secretion (GO:0046903),0.40272506521095486,0.9254996222326207,0.5652759084791387,0.8147704157978795,1.0,5/14,21.49%,TPD52;VIP;ABCB11;DRD3;NPR1
prerank,RNA 3'-end processing (GO:0031123),0.31856768443383027,0.9254142709334287,0.6266094420600858,0.8145876022957962,1.0,16/69,17.41%,DDX39B;SRSF11;PAPOLA;PABPN1;THOC1;SYMPK;THOC2;CHTOP;SRSF2;RPRD1A;CPSF7;UPF3B;SUPV3L1;SRSF7;THOC6;SRRM1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3430524310083088,0.9251893783194531,0.5807962529274004,0.8146941537110849,1.0,7/36,20.11%,ERCC6;DOT1L;SETMAR;CHEK2;MAP3K20;RAD9A;HUS1
prerank,transport across blood-brain barrier (GO:0150104),0.31358398594646003,0.9245768832853315,0.6422505307855626,0.815567642343186,1.0,22/83,23.67%,LRP1;SLC38A1;SLC6A6;SLC27A1;FABP5;SLC7A1;SLC2A1;SLC7A8;SLC5A3;ATP1A4;SLC19A1;TFRC;SLC38A2;SLC4A4;SLC5A6;SLC1A5;SLC7A3;SLC16A2;SLC7A2;ABCC5;ATP8A1;ATP1A2
prerank,regulation of cellular protein localization (GO:1903827),0.3311474583426159,0.9244194109419214,0.6098104793756968,0.8155325408898848,1.0,15/45,28.57%,LCP1;CTNNB1;ATP13A2;VCP;TRIM67;PIN1;PTPN1;CSNK1E;PARP1;KDM1A;HSP90AB1;RALB;TRIM46;RAB11B;RAB11FIP5
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.3936076124428752,0.9241011633728874,0.5681511470985156,0.815801881403659,1.0,5/16,19.07%,RMI1;SLX4;ERCC4;CENPX;CENPS
prerank,postsynaptic membrane organization (GO:0001941),0.39165829568506505,0.9239842368663916,0.5908496732026144,0.8156741796005352,1.0,3/17,5.71%,APOE;CEL;LRP4
prerank,mitochondrial transcription (GO:0006390),0.44377558947921336,0.9232106637836888,0.5968436154949784,0.8168819153883342,1.0,2/10,7.78%,SLC25A33;TWNK
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3760418894868552,0.9231545480428858,0.571611253196931,0.8166374077829962,1.0,3/20,10.58%,FGF2;NPTN;SPRY4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.4113253961518151,0.9230080985657559,0.5856741573033708,0.8165721560282333,1.0,5/13,30.93%,DLST;PHYH;IDH2;OGDH;GOT1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.28479409253534216,-0.9229193716346584,0.5707547169811321,0.8264833449433954,1.0,10/24,20.16%,IL10RA;KIT;ERBB4;PRLR;F2R;CCL5;GHR;CENPJ;IL10RB;CRLF3
prerank,aminoglycan catabolic process (GO:0006026),0.3558338566453969,0.9224934032829337,0.5987951807228916,0.817254813014761,1.0,6/28,13.02%,GNS;GLB1;GUSB;FUCA1;IDUA;HPSE
prerank,regulation of filopodium assembly (GO:0051489),0.3437889072591482,0.9224683031997413,0.5941176470588235,0.8169545280825697,1.0,6/38,9.58%,MYO10;NRP1;PRKCD;RHOQ;RAB5A;FXR2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.37610374365559907,0.9224162033986018,0.5647208121827412,0.8167068583671482,1.0,5/23,20.66%,SMAD7;ID2;PKP2;FGFR2;TGFB1
prerank,lymphocyte mediated immunity (GO:0002449),0.4269179307487948,0.9223444359841154,0.5667574931880109,0.8165130668956382,1.0,2/12,9.93%,JAG1;BTN3A3
prerank,prostanoid biosynthetic process (GO:0046457),-0.32147028573444786,-0.9223030165175511,0.5435684647302904,0.8260071488448175,1.0,3/15,5.58%,PTGS1;PTGDS;CD74
prerank,negative regulation of growth (GO:0045926),0.30130767527476426,0.9222116239816519,0.6378600823045267,0.8164129845353156,1.0,28/121,24.16%,APBB2;CYP27B1;ING4;SPHK2;DCBLD2;BCL6;SERTAD3;PPP2R1A;ADAM15;ENO1;OSGIN2;SESN2;BST2;FLCN;CDKN2AIP;SFRP1;STK11;TGFB1;FRZB;NME6;NPR1;NOTCH1;MT2A;SMARCA4;PPP1R9B;RACK1;FGFR3;CCDC85B
prerank,regulation of microtubule polymerization (GO:0031113),-0.25083580509568254,-0.922055053674655,0.5971223021582733,0.8245807409330397,1.0,4/40,4.35%,NAV3;TUBB4A;MAP2;ARL2
prerank,negative regulation of cell aging (GO:0090344),0.395386517462004,0.9218215098586988,0.5997322623828648,0.8168084225262034,1.0,6/16,27.92%,CDK6;ZKSCAN3;TERT;FBXO5;RBL1;TERF2
prerank,stem cell differentiation (GO:0048863),0.33979765356725306,0.9218061950852224,0.5959952885747939,0.8164868222722759,1.0,10/39,20.04%,PTPRC;FBXL17;LRP6;MTF2;SP7;PUM1;HTR2B;UFL1;SFRP1;FGFR2
prerank,canonical Wnt signaling pathway (GO:0060070),0.31581682722572846,0.9213441346605895,0.6217105263157895,0.8170457140135158,1.0,9/68,9.77%,CTNNB1;PLPP3;RAB5A;LRP6;FZD4;FZD1;FRAT1;CAV1;SCYL2
prerank,visual perception (GO:0007601),0.30580035658538013,0.9211944396817292,0.6234042553191489,0.8169690316917997,1.0,14/84,18.87%,EYA4;CHRNB2;DHRS3;TH;RDH12;RABGGTB;MYO7A;MYO9A;CEP250;CNGB1;CRYBG3;RDH10;WFS1;BBS2
prerank,peptidyl-threonine modification (GO:0018210),0.31795574667081467,0.9211175085604858,0.6256860592755215,0.8167751822015719,1.0,22/66,27.85%,CDK5;PRKCD;PDPK1;DYRK2;MAP3K12;CAD;TGFBR2;CSNK2A2;GALNT3;TBK1;TGFBR1;MARK2;DYRK1B;HIPK1;ROCK1;STK39;GSK3B;MAPK1;CAMK2D;GALNT1;PRKDC;HIPK2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.339323104669025,-0.9210017450121725,0.5675675675675675,0.8252818967379103,1.0,7/13,29.84%,RNF152;SESN3;SESN1;CASTOR1;DEPDC5;ITFG2;CASTOR2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3588694849456159,0.920799615007284,0.6,0.817041826784297,1.0,7/26,22.56%,B4GALT5;B4GAT1;ST3GAL2;B4GALT1;SLC35D2;CHST1;CHST2
prerank,regulation of double-strand break repair (GO:2000779),0.3389208299592093,0.9206293495506446,0.6002331002331003,0.8170381758649844,1.0,16/39,31.59%,PPP4C;TRIP12;MGMT;RAD51AP1;SLF2;FIGNL1;DEK;PPP4R2;KDM1A;RAD51;TERF2IP;RNF169;ACTR2;SETD2;OTUB1;SPIDR
prerank,positive regulation of intracellular protein transport (GO:0090316),0.29940629306463273,0.9205749263546332,0.6649642492339122,0.8167884334538467,1.0,38/144,21.07%,BCL2;PRKCD;IPO5;FBXW7;FLNA;RUFY3;TRIM28;BAP1;GAS6;PIK3R2;PPP3R1;CSNK2A2;VAMP2;BAG3;PLK3;JUP;YWHAG;SAR1A;BID;USP36;FYN;TPR;HUWE1;SAE1;UBE2L3;PPP3CC;RHOU;RBM22;ITGB2;HDAC3;VPS11;CDH1;ZC3H12A;ITGB1BP1;SEC16A;ATG13;TGFB1;DMAP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3673212131092423,0.9204364387270954,0.5868187579214195,0.8167014249163327,1.0,14/23,36.18%,VCP;DERL1;SEC16A;HERPUD1;SYVN1;LMAN1;HSP90B1;SURF4;TECPR2;AUP1;SEC61B;OS9;SEC13;NPLOC4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3430396210308704,0.9202627461147568,0.5966183574879227,0.8166935091848494,1.0,5/33,9.73%,PLAU;MUC1;NCKAP1L;SYK;CYP1B1
prerank,translesion synthesis (GO:0019985),0.33348155496323184,0.9199130592083825,0.5965909090909091,0.8170306633891598,1.0,8/42,15.77%,UBA52;VCP;UBE2L6;REV1;RFC2;RPS27A;UBC;RFC1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3731790635752904,-0.9195991652032506,0.555921052631579,0.8266997604804103,1.0,4/10,17.14%,CBARP;GNB5;DRD2;CRHR1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2944454721291608,0.9194734717705811,0.6825075834175935,0.817563365518382,1.0,11/152,3.74%,RGS1;ABCA1;GNAQ;ADCY8;ADCY3;PTGFR;ADCY7;CACNA1D;GNA13;PSAP;PTGIR
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3722402233649325,0.9194607301323654,0.5828065739570164,0.8172447123989683,1.0,13/23,32.34%,VCP;KCTD21;IFT122;SUFU;GPR161;RACK1;MEGF8;GLIS2;BTRC;HERC4;TULP3;MGRN1;ENPP1
prerank,regulation of histone acetylation (GO:0035065),0.3456033267944991,0.9193495165609322,0.5765550239234449,0.8171123033034765,1.0,12/33,26.47%,KMT2A;NOC2L;BRCA1;THAP7;TAF7;FLCN;MAPK3;RUVBL2;GLYR1;SET;SPI1;BRD7
prerank,regulation of acrosome reaction (GO:0060046),0.4419113680176289,0.9188270444068479,0.5889046941678521,0.817762347478702,1.0,1/10,2.28%,SERPINA10
prerank,negative regulation of vascular permeability (GO:0043116),-0.348369402940343,-0.9180110085460109,0.5540540540540541,0.8285146149834451,1.0,7/12,24.98%,SH3GL2;PTPRJ;CEACAM1;PDE2A;SLIT2;PDE3A;CLDN5
prerank,extracellular structure organization (GO:0043062),0.29379873755028935,0.9176017908241334,0.7228915662650602,0.8197838765911375,1.0,38/204,18.79%,SPP1;FN1;POSTN;ITGAX;ITGA5;MMP12;PDGFA;FGF2;COL10A1;ADAMTS13;MATN3;DAG1;ADAMTS10;CD44;LAMC1;ITGB5;ATP7A;ADAMTSL5;COL9A3;ADAM15;ITGA11;ITGA3;FURIN;COL8A2;MMP28;COL4A1;ITGA2B;MMP19;MMP17;NF1;TEX14;SERPINE1;COL16A1;ITGA4;ADAMTS2;TGFBR1;ITGB6;ITGB2
prerank,intestinal absorption (GO:0050892),0.4096953782288164,0.9171006041910811,0.5817174515235457,0.8203979039070263,1.0,2/13,4.08%,TJP2;SLC46A1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32437202460067344,0.9170689528104712,0.6095661846496107,0.8201077603839558,1.0,8/54,12.87%,CTNNB1;SQSTM1;SMAD7;GTPBP4;CAV1;PRMT3;OGT;TNFAIP3
prerank,positive regulation of lyase activity (GO:0051349),0.40977126841620587,0.9169548958485301,0.6027777777777777,0.8199902488185709,1.0,3/14,15.65%,CACNA1D;NF1;ORAI1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.32785766326737437,0.9165432156174105,0.6043083900226758,0.8204460402408443,1.0,14/50,23.50%,CCNB1;GTPBP4;BCCIP;STOX1;CCNT2;CDKN3;SERTAD1;MNAT1;CDC25A;GTF2H1;BLM;CCND1;CCNH;HSP90AB1
prerank,cellular response to organic substance (GO:0071310),-0.2026272731469987,-0.9164332567678349,0.8260869565217391,0.8303025247371305,1.0,30/116,17.35%,IL1RAPL1;CSF1R;TWF2;AKAP6;ROBO2;IL18;ACVR2B;NCOA1;BMPR1B;NCOA2;RAMP1;STAT3;LRRK2;PTPN14;IGFBP5;NDOR1;MME;FLT3;RPS6KB1;CCL2;IL1B;ADRA2A;MAPK8;CCL5;NOS1;INPP5K;SLC1A1;SLIT2;LEF1;GHR
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3599993397256359,0.9163065141663574,0.581081081081081,0.8205657537529539,1.0,7/27,18.30%,PRKCD;PRKCB;PTPN2;NCK1;PID1;PIP4K2A;PTPN1
prerank,cellular response to alkaloid (GO:0071312),-0.3116680050486665,-0.916031975365456,0.60546875,0.8292383571547755,1.0,4/17,11.70%,RYR3;TGM2;CASP6;CASP3
prerank,ruffle organization (GO:0031529),0.4009566674351582,0.9159861088905943,0.602921646746348,0.8208439172210068,1.0,6/16,20.45%,PLEK;CYFIP1;PLEKHA1;PIP5K1A;CORO1B;ARF6
prerank,neural crest cell differentiation (GO:0014033),0.3797000791253493,0.9158988366725014,0.5800524934383202,0.8206582456889068,1.0,5/18,15.74%,FBXL17;NOLC1;LRP6;TCOF1;HTR2B
prerank,rRNA 3'-end processing (GO:0031125),0.4430003074778192,0.9143709938889477,0.5913669064748202,0.8232562217381522,1.0,4/10,17.66%,ERI3;EXOSC9;EXOSC10;ERI2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2956865485705659,0.9142755173231057,0.6741344195519349,0.8230946891396456,1.0,24/140,19.84%,CACNA1A;P2RX4;ABL2;ADCY8;BDKRB1;PTGFR;PTGIR;NPTN;C3AR1;CAV1;GLP1R;C5AR1;CACNB3;SLC8A1;PTGER4;EDNRA;GPR65;DLG4;JPH1;SPPL3;TAC4;PTGER3;CD52;IAPP
prerank,negative regulation of macrophage activation (GO:0043031),0.39586982797531467,0.9133685293482394,0.6037735849056604,0.8245533933987215,1.0,2/16,5.63%,PTPRC;CST7
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4323400704717307,0.9129482658282613,0.5954738330975955,0.8250348322616886,1.0,6/11,31.12%,CAV1;ADIPOR1;NF2;SH2B3;LEPROT;VHL
prerank,ion homeostasis (GO:0050801),-0.2671486627687502,-0.9129327768275073,0.5824742268041238,0.8346444581242484,1.0,5/30,6.43%,UNC80;KLHL3;SLC4A10;SLC4A7;WNK1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4160533412030105,0.9125674898879959,0.5799721835883171,0.8254168565442912,1.0,5/12,20.66%,IL6;TNF;TERT;ZC3H12A;TGFB1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.42960008940382255,0.9121054747557565,0.5761973875181422,0.8259610195713329,1.0,2/10,8.64%,GRXCR1;IFT88
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.40360513678290144,0.911960477662317,0.6035182679296346,0.8258967343790155,1.0,10/14,38.20%,MDFI;CCDC22;SUFU;FAF1;PSMD10;NFKBIE;KEAP1;PKD2;PKD1;NFKBIB
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3646074637123006,-0.9118269764860486,0.5365853658536586,0.8353336639173907,1.0,4/10,17.35%,STAT5A;STAT3;PRLR;GHR
prerank,negative regulation of interleukin-17 production (GO:0032700),0.43384148738718187,0.9117721269404356,0.5890207715133531,0.8259064463704323,1.0,2/10,9.15%,NCKAP1L;DDIT3
prerank,regulation of erythrocyte differentiation (GO:0045646),0.34301146717322745,0.9114820767669306,0.6,0.8261195167114416,1.0,8/35,20.64%,HIF1A;CDK6;NCKAP1L;HSPA9;MAFB;MED1;LDB1;BRD1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.34654305753094344,0.9107412686446791,0.6028880866425993,0.8272425805890858,1.0,7/29,17.53%,TRAF2;CAV1;PAK2;BID;TNF;WWOX;SFRP1
prerank,regulation of viral life cycle (GO:1903900),0.36830991278860953,0.9104674338021299,0.5866834170854272,0.8274133950093008,1.0,3/21,11.94%,TRIM6;AXL;KPNA6
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38827650358238336,0.910131935466855,0.5862533692722371,0.8277255868841641,1.0,7/16,28.77%,SART1;PRPF39;RBM22;SRSF1;WBP11;DDX23;PSIP1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.33393957154743387,0.9101253148825311,0.6231721034870641,0.8273882759155383,1.0,9/42,15.77%,UBA52;VCP;UBE2L6;REV1;RFC2;POLE;RPS27A;UBC;RFC1
prerank,eye morphogenesis (GO:0048592),0.3786978551050997,0.9098196439875562,0.5961783439490446,0.8276308236266392,1.0,5/19,14.72%,VEGFA;SKI;AGTPBP1;IFT122;NF1
prerank,negative regulation of hormone secretion (GO:0046888),-0.356423155546637,-0.9097237006868057,0.575,0.8382973900104124,1.0,2/10,13.98%,RAB11FIP3;IL1B
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3063267897525622,-0.9096069361042526,0.5491803278688525,0.836562228952219,1.0,3/18,7.59%,NRIP1;EGFR;KAT5
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4316022121382222,0.909451155498093,0.5834564254062038,0.8279813554361913,1.0,1/10,5.11%,ETFBKMT
prerank,neuron projection development (GO:0031175),0.2924931512389167,0.9093709849559668,0.7062374245472837,0.827788262209777,1.0,23/168,9.74%,ERCC6;APOE;GAS7;LRP12;SGK1;CDK5;GPRIN1;GRXCR1;ATXN10;ALS2;DTNBP1;PTPRM;NCKAP1L;SLC9A6;MYOC;TAOK3;TBC1D24;BLOC1S3;DNM2;IFT88;DIP2A;ATP7A;CDK16
prerank,mitochondrial protein processing (GO:0034982),0.42545822583736775,0.9092130689307502,0.5786435786435786,0.8277404781235714,1.0,6/11,25.98%,PMPCA;AFG3L2;STOML2;SPG7;IMMP1L;OMA1
prerank,neural crest cell development (GO:0014032),-0.23903201745655067,-0.9091225303302686,0.5785123966942148,0.835729322320341,1.0,11/44,13.10%,SEMA6D;SEMA6A;SEMA5A;SOX8;TAPT1;CDH2;ERBB4;PHACTR4;SEMA4B;KBTBD8;SEMA4A
prerank,external encapsulating structure organization (GO:0045229),0.2905101380074673,0.9089666128879043,0.7422266800401204,0.8278661399749668,1.0,30/205,14.72%,SPP1;FN1;POSTN;ITGAX;ITGA5;MMP12;PDGFA;FGF2;COL10A1;ADAMTS13;MATN3;DAG1;ADAMTS10;CD44;LAMC1;ITGB5;ATP7A;ADAMTSL5;COL9A3;ADAM15;ITGA11;ITGA3;FURIN;COL8A2;MMP28;COL4A1;ITGA2B;MMP19;MMP17;NF1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3839494569646111,0.9088446409930447,0.5695538057742782,0.8277395360451487,1.0,7/16,25.37%,SLC8A1;CALM2;FKBP1B;GSTO1;ATP1A2;CALM3;CAMK2D
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3541793785422352,0.9083900745717067,0.6088607594936709,0.8282969370278942,1.0,7/28,17.76%,COTL1;RASA1;GBA2;HAX1;NAA80;LATS1;PFN1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.28325044019486967,-0.908388512399227,0.5911111111111111,0.8355075743094298,1.0,5/24,7.41%,MAPK14;MEF2C;CTNNA2;CDH2;OLFM2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.33418537580195895,-0.9083733984804907,0.5658914728682171,0.8335807337903341,1.0,6/13,15.52%,GLUD1;GAD1;GLUL;PRODH;ALDH4A1;NOS1
prerank,positive regulation of vascular permeability (GO:0043117),0.41545528760462,0.9076845736071789,0.5923392612859097,0.8292816166971057,1.0,2/12,3.75%,VEGFA;TJP2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.4286300303270621,0.9075376901696687,0.6108663729809104,0.8285296750204922,1.0,4/10,19.61%,ERCC1;SLX4;TERF1;BLM
prerank,t-circle formation (GO:0090656),0.4286300303270621,0.9075376901696687,0.6108663729809104,0.8285296750204922,1.0,4/10,19.61%,ERCC1;SLX4;TERF1;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.4286300303270621,0.9075376901696687,0.6108663729809104,0.8285296750204922,1.0,4/10,19.61%,ERCC1;SLX4;TERF1;BLM
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3800201681672088,0.9071366440158095,0.6204188481675392,0.8289326628235656,1.0,2/19,1.59%,XDH;PIK3CB
prerank,microtubule bundle formation (GO:0001578),0.3284427746973025,0.9066051420870437,0.625,0.8295810886602782,1.0,16/42,27.50%,FOXJ1;NAV1;SPAG16;NUMA1;MARK4;CLIP1;CCDC40;NCKAP5L;LRGUK;GAS2L1;CDK5RAP2;NCKAP5;TTLL3;MAP1S;KIF20A;AAAS
prerank,purine nucleotide catabolic process (GO:0006195),0.40886711130712255,0.9057415477602518,0.6091160220994475,0.830887426522044,1.0,2/13,9.05%,XDH;ITPA
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.414828137906742,0.9056662024263183,0.5855728429985856,0.8306845416479552,1.0,6/12,29.79%,BRCA1;ACADL;WDTC1;ERLIN2;ERLIN1;APOC1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.33042163904596,-0.9054784762137134,0.5730337078651685,0.8384139929146573,1.0,3/12,13.90%,TMEFF2;PF4;SELENOS
prerank,heart development (GO:0007507),0.2929554979742697,0.9053823041392406,0.7137055837563452,0.8308816865177575,1.0,24/150,16.23%,SH3PXD2B;FN1;MICAL2;MEF2D;TH;VEGFA;SOX9;AKAP13;ID2;SMG9;HDAC9;CHD7;PKP2;SRF;TGFBR2;FLRT2;ALPK3;DAND5;IFT122;NF1;RBP4;TCF25;HTR2B;BMP5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.30635604693935253,0.9051369816281118,0.6539278131634819,0.8310045369189935,1.0,16/75,18.30%,APOE;PIK3CB;PRKCD;IPO5;CD300A;CEBPA;LRP6;PKIB;SPRY4;TESK1;SLC8A1;NF1;CDK5RAP1;STK38;LATS1;PTPN1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3676589813941989,0.9048047520220085,0.6054931335830213,0.8312611820223678,1.0,9/21,27.37%,DAG1;ADAM17;PSEN2;SPPL3;APH1A;HM13;PRKCQ;SPPL2A;MYH9
prerank,response to sterol (GO:0036314),-0.3476072308502213,-0.9044912259156943,0.5573770491803278,0.8387687032599369,1.0,3/11,7.23%,CCR5;SMAD2;INSIG1
prerank,negative regulation of locomotion (GO:0040013),-0.3391651592609592,-0.9039871877095597,0.5608108108108109,0.8379936326445037,1.0,7/12,23.59%,SPOCK3;FRMD5;CCDC125;FBLN1;WAS;SPINT2;GATA3
prerank,positive regulation of glucose metabolic process (GO:0010907),0.39840232590326347,0.9035935530078679,0.6066024759284732,0.8332207344564153,1.0,3/14,13.96%,PTPN2;DDB1;SLC45A3
prerank,regulation of cellular component biogenesis (GO:0044087),0.33539021338284625,0.9034312003475334,0.6216530849825378,0.833178793859607,1.0,13/39,23.37%,APOE;TRAF2;MSN;BBS10;HCFC1;LATS1;IRGM;GFAP;VPS11;NCLN;ROCK1;NOTCH1;PTPN11
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4104725674116181,0.9033595529385365,0.5954415954415955,0.8326156951536462,1.0,5/12,23.49%,CORO1C;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4104725674116181,0.9033595529385365,0.5954415954415955,0.8326156951536462,1.0,5/12,23.49%,CORO1C;SPRY4;MELTF;ITGB1BP1;ACTN4
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4125674871079255,0.90273783411813,0.604551920341394,0.8334272262801876,1.0,6/12,26.22%,MCM2;MCM7;MCM6;MCM3;CDC7;MCM5
prerank,circulatory system development (GO:0072359),0.29547466448200393,0.9023871065250646,0.6845915201654602,0.8337461905734432,1.0,14/118,11.53%,SH3PXD2B;FN1;MICAL2;TH;SOX9;FBXW7;AKAP13;ID2;SMG9;HDAC9;PKP2;SRF;TGFBR2;ALPK3
prerank,regulation of metal ion transport (GO:0010959),0.3830621815199884,0.9018598728419501,0.6191744340878829,0.8344174503954104,1.0,4/16,16.44%,BCL2;GRIN3B;ORAI1;SRI
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.42592271960810635,0.9016860174570999,0.601123595505618,0.8343885043160228,1.0,3/11,18.29%,PAPOLA;ZC3H3;AHCYL1
prerank,cellular response to hormone stimulus (GO:0032870),0.3068707838932311,0.9011780792853574,0.6518918918918919,0.8349984993717168,1.0,17/69,19.95%,CTSB;MGARP;GCK;CAV1;TFPI;NR3C1;ATP1A1;ATP1A3;SOCS2;UBE2L3;LMO2;SFRP1;MED1;NSMF;CTSL;BRD8;XBP1
prerank,stem cell development (GO:0048864),0.38391696568537603,0.9006501558229572,0.6021798365122616,0.8356593375164028,1.0,3/16,11.82%,PTPRC;NOLC1;TCOF1
prerank,aortic valve development (GO:0003176),0.3368895520811303,0.9004917076218798,0.6278240190249703,0.8355975601632317,1.0,5/34,7.58%,NPPA;SOX9;JAG1;TNFRSF1B;DLL4
prerank,positive regulation of stem cell differentiation (GO:2000738),0.3919919327867619,0.9004404273028049,0.597911227154047,0.8353456917796263,1.0,2/16,10.21%,SOX9;SP7
prerank,positive regulation of macrophage migration (GO:1905523),0.36369170290684094,0.9001574814712483,0.5992217898832685,0.8355457027050897,1.0,2/19,0.73%,P2RX4;CSF1
prerank,cardiac myofibril assembly (GO:0055003),-0.31987746352344254,-0.9001414268186201,0.5916030534351145,0.8452146926577465,1.0,6/15,32.67%,MEF2A;OBSL1;MYL2;FHOD3;NEBL;PROX1
prerank,regulation of small molecule metabolic process (GO:0062012),0.35289004688165465,0.8999389547101854,0.6389228886168911,0.8356072594283538,1.0,7/28,20.09%,APOE;ACADL;ADIPOR1;ARV1;ABCB11;PDK3;DGKQ
prerank,detection of calcium ion (GO:0005513),-0.338752725129729,-0.8997971786755579,0.5813953488372093,0.8440513056671771,1.0,8/13,35.12%,SYT1;KCNMB2;KCNIP2;KCNMB3;STIM1;CASQ2;KCNMB1;RYR2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4061420364079974,0.8996506142251791,0.5891364902506964,0.8357768517727132,1.0,2/13,10.63%,ASPH;TBC1D10A
prerank,regulation of cartilage development (GO:0061035),0.3797592783356347,0.8993568525986416,0.6177215189873417,0.8359859042684241,1.0,2/18,3.85%,BMP1;SOX9
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.4326815717773331,0.8986243291640328,0.6193265007320644,0.837032943447729,1.0,4/10,26.43%,GNMT;OGT;DGKQ;SDHAF3
prerank,miRNA metabolic process (GO:0010586),0.3700742129462262,0.8983425987993157,0.6308290155440415,0.8372447419642765,1.0,3/20,8.55%,AGO2;SND1;DDX17
prerank,amyloid fibril formation (GO:1990000),0.32306787455774844,0.8979620339435326,0.6478405315614618,0.8375844780106128,1.0,13/51,14.97%,NPPA;SIAH2;NAT8;TSPAN5;UBA52;USP9X;UBE2L6;MDM2;RIPK3;FURIN;GGA2;RPS27A;UBC
prerank,protein acylation (GO:0043543),0.33361250048605706,0.8979491254300968,0.6311569301260023,0.8372608560192376,1.0,8/38,15.26%,SPHK1;ING4;ZDHHC18;ZDHHC15;ZDHHC1;NAT10;ZDHHC6;NAA80
prerank,plasma membrane tubulation (GO:0097320),0.403691479181137,0.8977298993315658,0.6142270861833106,0.8373039116657728,1.0,2/13,5.33%,CHMP4A;SNX33
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.29364697225287045,0.8976906754731745,0.7104994903160041,0.8370274759903026,1.0,41/138,26.77%,NPPA;VDR;PPARD;E2F3;PPARG;POLR2H;TAF4B;HDAC9;HDAC7;GTF2A2;TAF15;MED17;GTF2F1;TAF7;NR3C1;NRBF2;MAML2;MNAT1;POLR2D;GTF2E2;HDAC1;SNW1;NOTCH4;GTF2H1;ERCC2;MED1;RXRB;HDAC3;MED27;TBP;RXRA;NOTCH1;CREBBP;CCNH;NR2C2AP;TEAD1;MAZ;NR5A1;TAF6;GTF2A1;RXRG
prerank,regulation of peptide hormone secretion (GO:0090276),0.30795320858382413,0.8967989008345447,0.6605405405405406,0.8383307181769758,1.0,7/67,10.27%,CACNA1A;GCK;CACNA1D;SLC2A1;SLC8B1;CHD7;GLP1R
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.28711932644923804,0.8965423546095576,0.7797797797797797,0.8384706651743716,1.0,66/260,22.48%,ASAP1;SDCBP;RAP2A;NRP1;TEKT2;FGD6;FOXJ1;ATP6V0D1;PTPN23;MTSS1;IFT43;FLNA;RAB8B;TEKT5;SNX10;CYFIP1;ARMC9;RHOD;ANO6;RILPL2;IFT88;RILPL1;SPAG16;PARVB;IFT74;RAB1A;EXOC2;MAK;RAPGEF6;TCTN3;NTN1;EHD4;WDR35;GOLPH3;CEP250;CEP41;IFT122;CNGB1;MINK1;FGD5;PIP5K1A;CCDC57;EXOC4;RAP2B;PMP22;CEP83;TMEM107;RILP;ATP6V1D;DNAH5;TRAF3IP1;UNC119B;BBS2;TMEM17;LZTFL1;DYNLT2B;CFAP70;ACTR3;ARF6;ACTN2;NOTCH1;CFAP298;DYNC2I1;PARVA;PPP1R9B;GSN
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3990031690728091,0.8964157192984021,0.6178861788617886,0.8383583367270744,1.0,5/14,21.65%,CARD10;DLL4;RHOA;ITGB1BP1;NOTCH1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3866000372991981,0.8964037869168825,0.6258503401360545,0.83803948438286,1.0,10/17,36.18%,VCP;DERL1;HERPUD1;SYVN1;HSP90B1;HM13;AUP1;SEC61B;OS9;NPLOC4
prerank,substrate-dependent cell migration (GO:0006929),0.3886895687161598,0.8963953157002782,0.6058091286307054,0.8377106119411021,1.0,5/14,12.33%,SDCBP;PTPRC;NRP1;ITGA11;NTN1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3950612408621957,0.8962297533132532,0.616822429906542,0.8376771177845079,1.0,5/14,19.72%,FLNA;LIMS1;LOXL3;TIMP1;ITGB1BP1
prerank,regulation of neuroblast proliferation (GO:1902692),0.39559001159604223,0.8958884557749057,0.6178082191780822,0.8379531924621868,1.0,2/15,3.49%,CTNNB1;VEGFA
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3788223317440751,0.8953923298706957,0.6371911573472041,0.838545727807591,1.0,8/18,22.98%,PTK2B;RUFY3;LLGL2;LLGL1;ARFGEF1;KRIT1;ROCK1;RACK1
prerank,epithelial cell morphogenesis (GO:0003382),0.37732502774394416,0.894755942785424,0.6023622047244095,0.8393567979320945,1.0,2/17,9.00%,RILPL2;RILPL1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.36478236310832696,0.8940184248986138,0.633112582781457,0.8403767250723877,1.0,2/19,2.77%,PTPRC;PTGFR
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.40062260390801585,0.8938384565716958,0.6268456375838927,0.8403631445291148,1.0,3/13,10.23%,VDAC2;BAX;BCL2L11
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.32168874209856524,0.8933265488806557,0.6335616438356164,0.8409549912704926,1.0,10/44,17.31%,KCNMA1;NPPA;KCNJ2;FLNA;ANO6;KCNN4;ATP1B3;GNB1;KCNJ6;AMIGO1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3702641518728457,-0.8930712748149959,0.6,0.8583829258707826,1.0,5/10,16.89%,SKAP1;WNK1;DPP4;CCL5;PODXL
prerank,endocrine system development (GO:0035270),-0.28115691841833984,-0.8930009456396086,0.6121495327102804,0.8565691260716064,1.0,4/21,13.85%,SALL1;TG;PAX8;DKK3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3562504420101729,-0.8927934886552829,0.5960264900662252,0.855034691506726,1.0,6/10,22.93%,IRS2;IL1B;THBS1;INPP5K;CTTNBP2NL;RSC1A1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.34325844831599833,0.8927254332280375,0.6151990349819059,0.8417509196789812,1.0,12/29,29.31%,GOSR2;NAPA;VTI1A;COPA;COPG2;COPB1;COPG1;COPZ2;GOLGA5;COG8;RAB6A;COG3
prerank,protein hydroxylation (GO:0018126),0.38893658521559415,0.8926968952167607,0.623342175066313,0.8414648545955696,1.0,7/15,23.12%,ASPH;OGFOD1;PLOD3;VIPAS39;EGLN3;HIF1AN;P3H3
prerank,regulation of cilium assembly (GO:1902017),0.3126504532434763,0.8924696712318793,0.6695652173913044,0.841550275207335,1.0,15/62,19.43%,TBC1D22A;KCTD17;TBC1D2;HTT;TBC1D24;IFT88;TBC1D10A;TESK1;CEP120;TBC1D16;MARK4;CCP110;MAPK15;TBC1D20;DYNLT2B
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2730056941345733,-0.8924333437527846,0.6699029126213593,0.8538904912879282,1.0,11/23,23.32%,CD74;DNM1L;DPP4;CAMK1D;RIPOR2;C5AR2;DAPK2;SLIT2;JAM3;BST1;RAC2
prerank,non-motile cilium assembly (GO:1905515),0.3446133841990895,0.891872142901032,0.6200241254523522,0.842308292826464,1.0,10/30,19.18%,TBC1D32;DCTN1;IFT88;CSNK1D;BBS10;CEP250;IFT122;TMEM107;RPGRIP1;TMEM17
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.29963635917599585,0.8917220419112903,0.6694825765575502,0.8422304216311255,1.0,40/84,31.18%,SON;RBM25;NCL;RBM39;CELF1;PUF60;DDX17;SRPK1;HNRNPK;FXR2;RBM15B;SRPK2;NOVA2;C1QBP;HNRNPL;TRA2B;SMU1;SNW1;SRSF7;CIRBP;CELF6;RBFOX2;HNRNPU;MBNL2;SRSF10;PCBP4;NUP98;SF3B4;SF1;PRDX6;SRSF3;PTBP1;FMR1;CWC22;RBM15;DAZAP1;MBNL3;FXR1;DDX5;SAP18
prerank,regulation of BMP signaling pathway (GO:0030510),-0.20878343438248653,-0.8914253411907753,0.7681159420289855,0.8542282286063733,1.0,9/73,5.89%,CRIM1;SORL1;SMURF2;ACVR2B;RBPJ;BMPR1B;BMPER;SMAD2;PCSK6
prerank,negative regulation of organelle assembly (GO:1902116),0.3382679070170113,0.891355462165298,0.6579881656804734,0.8425736980272007,1.0,6/35,11.40%,SMCR8;CHMP4B;CHMP4A;SEC22B;BRCA1;TESK1
prerank,negative regulation of viral transcription (GO:0032897),-0.3158069965809238,-0.8913412695861793,0.5967078189300411,0.8524716339095533,1.0,2/13,8.21%,TRIM27;IFITM3
prerank,ESCRT complex disassembly (GO:1904896),0.41805138197960184,0.890210632471876,0.6330935251798561,0.8439458711473503,1.0,5/10,28.71%,VTA1;VPS4B;CHMP7;IST1;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.41805138197960184,0.890210632471876,0.6330935251798561,0.8439458711473503,1.0,5/10,28.71%,VTA1;VPS4B;CHMP7;IST1;CHMP2B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.34478049720149384,0.8898763007960854,0.6384522370012092,0.8438508011674071,1.0,12/29,36.16%,ACOT9;GLYAT;ACOT6;ACOT1;ACOT13;ACOT4;ACSL6;ACOT7;ACLY;ACOT8;ACSF2;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.34478049720149384,0.8898763007960854,0.6384522370012092,0.8438508011674071,1.0,12/29,36.16%,ACOT9;GLYAT;ACOT6;ACOT1;ACOT13;ACOT4;ACSL6;ACOT7;ACLY;ACOT8;ACSF2;ACAT1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4237508215085348,0.8897777220436692,0.6175182481751825,0.8436887000118146,1.0,6/10,34.41%,DBF4;INO80;STOML2;CDC7;SSBP1;E2F8
prerank,positive regulation of cell killing (GO:0031343),0.4045090360351302,0.8897112540000989,0.6255144032921811,0.8434544564981699,1.0,2/13,8.63%,CYBA;SYK
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.39288018182249007,0.8896254191865413,0.6417112299465241,0.8432582278168704,1.0,4/16,10.76%,PTPN2;CAV1;PPP2R1A;ADIPOR1
prerank,cGMP metabolic process (GO:0046068),0.41169264228318225,0.8891610828215697,0.6299435028248588,0.843767328904169,1.0,3/12,21.49%,NPPA;NPPC;NPR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.313980648258523,0.888984965984926,0.6606741573033708,0.8437617901383587,1.0,11/51,17.75%,CSF1;VEGFA;ADAM17;MOSPD2;ANO6;GAS6;C1QBP;IL6;AKIRIN1;SERPINE1;MAPK3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3604234555564138,0.8887464682260887,0.6150895140664961,0.8438865628709631,1.0,11/21,32.98%,CNOT4;CNOT10;CNOT6;CNOT9;PAN3;PAN2;SAMD4B;CNOT6L;SAMD4A;CNOT3;CNOT7
prerank,myoblast fusion (GO:0007520),0.4053271423943335,0.8887214174533352,0.6271428571428571,0.8435916216212697,1.0,1/12,0.40%,CD9
prerank,regulation of exit from mitosis (GO:0007096),0.3234157537208059,0.888686177798861,0.6372202591283863,0.8433015868893595,1.0,11/38,24.76%,ANAPC15;ANAPC1;UBA52;RPS27A;UBC;CDC26;UBE2C;SIRT2;PPP1R9B;ANAPC7;NPM2
prerank,protein localization to cell surface (GO:0034394),0.3514153598998969,0.8881478136192241,0.6555965559655597,0.8439236668025879,1.0,4/26,13.61%,CTNNB1;FLNA;GGA2;FGF7
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.35675982806490353,-0.8880761467628768,0.5660377358490566,0.8583313765950328,1.0,3/10,6.43%,PDE3B;NEXMIF;WNK1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.32438617609429976,0.8877128237782712,0.6517241379310345,0.8443562417614017,1.0,12/39,22.51%,GRB2;SH3KBP1;PTPN2;STAM2;MVP;PTPN18;CBL;DUSP3;ERRFI1;EPN1;CDC42;PTPN12
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.320109083042191,-0.8874019124870084,0.5905797101449275,0.8579994900975478,1.0,2/14,2.24%,MAPK14;ELAVL4
prerank,positive regulation of keratinocyte migration (GO:0051549),0.4293020279204816,0.8873141564868557,0.6467236467236467,0.8447494933123444,1.0,1/10,0.71%,IQSEC1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3756203239841188,0.8872546082386913,0.631233595800525,0.8445123860466383,1.0,5/18,14.62%,ABCG1;GSAP;SP1;EFNA1;TNF
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3363456429372443,0.8868457240849137,0.6422569027611045,0.8449348794464298,1.0,7/36,14.62%,PTPRC;DOT1L;CAV1;CYP1B1;ADIPOR1;IL6;TNF
prerank,C-terminal protein amino acid modification (GO:0018410),0.4071378958699978,0.8868059046342897,0.6380281690140845,0.8446589679355213,1.0,2/11,11.10%,ATG7;AGTPBP1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3444585634185767,0.88665638142798,0.6376988984088128,0.8445702007445854,1.0,12/29,30.12%,CTNNB1;RBBP5;TERT;HDAC1;CREBBP;SMARCA4;KMT2D;TCF7;EP300;TLE1;BCL9;TRRAP
prerank,negative regulation of JUN kinase activity (GO:0043508),0.42578462942856704,0.8865398842090081,0.6287339971550497,0.8444405019624742,1.0,1/10,2.42%,NPPA
prerank,neuron projection morphogenesis (GO:0048812),0.28757015553688725,0.8861760472203042,0.7125256673511293,0.8447689523365294,1.0,17/137,9.86%,ALCAM;CTNNB1;IQGAP1;GAS7;SGK1;CDK5;ALS2;DTNBP1;LRP4;NCKAP1L;SLC9A6;TAOK3;AFG3L2;DNM2;DIP2A;ATP7A;BAIAP2
prerank,regulation of neurogenesis (GO:0050767),0.3111640788654286,0.8861250675335691,0.6584821428571429,0.8445138322740505,1.0,11/55,16.01%,CTNNB1;BHLHE41;HES7;BHLHE40;APPL2;YTHDF2;DOCK7;HOOK3;IL6;TNF;SNW1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.325383683219169,-0.8859886440062427,0.5942028985507246,0.8572481734802393,1.0,4/13,8.34%,IL15RA;PLCB1;STAT5A;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),-0.325383683219169,-0.8859886440062427,0.5942028985507246,0.8572481734802393,1.0,4/13,8.34%,IL15RA;PLCB1;STAT5A;STAT3
prerank,DNA packaging (GO:0006323),0.37534923939879095,0.8859203727911966,0.6192959582790091,0.8445278646558096,1.0,7/16,32.24%,NOC2L;CHAF1B;HAT1;CDAN1;PRM1;AIFM1;TP53
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3321714567759666,0.8859123001965744,0.6423529411764706,0.8442008828438203,1.0,3/32,8.56%,P2RX4;PDPK1;CAV1
prerank,artery development (GO:0060840),0.35908510949129674,0.8852725000590709,0.632183908045977,0.845063816229036,1.0,7/23,18.39%,NRP1;VEGFA;SMAD7;NF1;HECTD1;EFEMP2;TGFBR1
prerank,positive regulation of cell aging (GO:0090343),-0.3495351981855389,-0.8847520822307041,0.5904059040590406,0.8580349400828814,1.0,5/11,25.64%,ABI3;HMGA2;EEF1E1;ARG2;HMGA1
prerank,regulation of lamellipodium organization (GO:1902743),-0.3173604571857614,-0.8844585922380125,0.569811320754717,0.8568187598630794,1.0,4/14,8.04%,TWF2;CARMIL1;FER;DMTN
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2848629421518983,-0.8838423348752876,0.6106194690265486,0.8563073299729544,1.0,7/20,15.52%,RPS6KA5;RPS6KA4;PPARGC1A;PAXIP1;IL1B;TADA2A;NOS1
prerank,positive regulation of dendritic spine development (GO:0060999),0.36762043670102074,0.8835396108483504,0.623574144486692,0.8479092542792195,1.0,2/20,1.91%,APOE;LLPH
prerank,negative regulation of hydrolase activity (GO:0051346),0.31496780458159834,0.8832016268219776,0.6492622020431328,0.8481621484193403,1.0,11/49,15.36%,APOA2;CPEB2;CST7;ECM1;GMIP;EGLN1;CSTB;ZCCHC9;MAPK7;RRP1B;ARFGEF1
prerank,carnitine shuttle (GO:0006853),0.4150634843157324,0.883021336405758,0.6498559077809798,0.8481536018799343,1.0,5/11,23.83%,ACACA;CPT1A;ACACB;MID1IP1;CPT2
prerank,rRNA modification (GO:0000154),0.35533410872580706,0.8829762157315705,0.6302952503209243,0.8478889874697627,1.0,7/21,17.01%,NSUN3;NSUN4;GAR1;NAT10;DKC1;DIMT1;MRM2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3621720590203832,0.8824433753463927,0.6354300385109114,0.8485112237360777,1.0,3/20,7.33%,P2RX4;C3AR1;ANO6
prerank,mRNA polyadenylation (GO:0006378),0.3472064827113592,0.8817159473358211,0.6413301662707839,0.8491492678475874,1.0,8/26,22.81%,GRSF1;PAPOLA;SYMPK;PABPC1;SSU72;AHCYL1;MTPAP;WDR33
prerank,RNA polyadenylation (GO:0043631),0.3472064827113592,0.8817159473358211,0.6413301662707839,0.8491492678475874,1.0,8/26,22.81%,GRSF1;PAPOLA;SYMPK;PABPC1;SSU72;AHCYL1;MTPAP;WDR33
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3262623942514802,0.8815298089281236,0.6682408500590319,0.8491643062472497,1.0,8/40,17.51%,VEGFA;DAB2;DGKD;HNRNPK;SCYL2;CBL;HIP1;SERPINE1
prerank,regulation of cell-cell adhesion (GO:0022407),0.32638181123409876,0.8813353153704508,0.6424517593643587,0.8491747089114041,1.0,12/39,22.31%,ADAM8;FSTL3;SMAD7;JAG1;MAGI1;GTPBP4;MINK1;CDH1;AFDN;FLOT2;TGFB1;NF2
prerank,myofibril assembly (GO:0030239),-0.2325270515851697,-0.881240906174435,0.6917293233082706,0.8603035907456229,1.0,23/42,43.57%,CAPN3;TMOD2;PGM5;OBSL1;MYL2;FHOD3;TNNT3;TMOD3;LMOD3;MYPN;CSRP1;LMOD1;TNNT2;MYH6;SIX4;MYOM2;TMOD4;SYNPO2L;MYOZ2;TNNT1;CFLAR;PDGFRB;TMOD1
prerank,protein homooligomerization (GO:0051260),0.28908049086356996,0.8811792913248844,0.7243523316062176,0.8491023333277686,1.0,26/114,21.13%,ADCY8;ALS2;ACACA;KCNJ2;GNMT;CLYBL;APPL2;GLS;ALDOA;NINJ1;PDCD6IP;OSBPL2;ACACB;MLKL;EHD4;APIP;ASIC1;DISP1;TRIM72;GOLGA2;USP16;FUS;BLM;SLC1A5;ARC;TK1
prerank,positive regulation of catalytic activity (GO:0043085),0.32947195505575166,0.8810374141871006,0.6504739336492891,0.8490283364709265,1.0,13/37,24.87%,ABL2;PSEN2;CAV1;ATP7A;SLC5A3;CHTOP;MAPK3;APH1A;MID1IP1;XRCC5;STX4;ABL1;B3GAT3
prerank,retinal metabolic process (GO:0042574),0.4034855438784605,0.8802062072256462,0.625,0.8501424646862694,1.0,3/12,17.23%,RDH13;CYP1B1;RDH10
prerank,glycine transport (GO:0015816),-0.3622062268244572,-0.8799161323099154,0.625,0.861254679790437,1.0,3/10,11.28%,SLC6A17;SLC6A9;SLC36A1
prerank,regulation of stress fiber assembly (GO:0051492),0.29951548726625055,0.8798295752090489,0.6915789473684211,0.8504558549578596,1.0,23/74,22.40%,SLC9A1;NRP1;MYOC;LIMK1;PAK2;TESK1;EVL;RHOA;SERPINF2;ARHGAP6;PTGER4;SORBS3;GPR65;ARHGEF5;SFRP1;PFN1;TGFBR1;PPFIA1;ITGB1BP1;ALMS1;ROCK1;NF2;CDC42
prerank,regulation of keratinocyte migration (GO:0051547),0.4049761454560226,0.8794558374503474,0.638268156424581,0.8507715084020996,1.0,1/12,0.71%,IQSEC1
prerank,embryonic limb morphogenesis (GO:0030326),0.33676359814837453,0.8794085198986696,0.6607142857142857,0.8505216880128011,1.0,4/34,7.57%,CTNNB1;FBXW4;SKI;LRP6
prerank,response to estrogen (GO:0043627),0.33306153967860147,0.8793972080151915,0.6566626650660264,0.8502008172270354,1.0,4/31,8.56%,CYP27B1;RBBP5;BRCA1;CAV1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.2700749056386552,-0.879362335231977,0.6703296703296703,0.8606023646444628,1.0,12/25,20.53%,ROBO2;APOD;CLASP2;DUSP22;DMTN;RCC2;ROCK2;IL1B;THBS1;PHLDB2;SRC;SLIT1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.38897982619910865,0.8791366026365278,0.6409214092140921,0.8503628506985779,1.0,4/14,17.55%,LRP1;PRKG1;SERPINE1;CORO1B
prerank,inositol phosphate metabolic process (GO:0043647),0.3199346641162212,0.8782238608792308,0.6700564971751413,0.8516291111050859,1.0,5/46,4.64%,ITPKB;FGF2;PLCB4;INPPL1;PLCB2
prerank,negative regulation of biosynthetic process (GO:0009890),0.3733853178258275,0.878106727092344,0.6313617606602476,0.851495725446403,1.0,3/16,12.58%,ABCD2;TRAP1;IL6
prerank,synaptic vesicle localization (GO:0097479),0.3973396017678381,0.8777547613090967,0.6440217391304348,0.8518202374007326,1.0,3/13,10.44%,CDK5;DNM2;TMEM230
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4151152377087729,0.8773656463204634,0.6288951841359773,0.8521616371774442,1.0,4/10,27.38%,CPEB1;CPEB3;HSF1;DHX36
prerank,cilium movement (GO:0003341),0.31368100039862173,0.8770134065667796,0.6677777777777778,0.8524229010722026,1.0,9/48,20.26%,ODAD2;TEKT2;TEKT5;DNAAF5;CFAP251;DNAI3;CCDC40;DNAH5;CFAP70
prerank,positive regulation of cytokinesis (GO:0032467),0.3324631612086097,0.8769680249391224,0.6674641148325359,0.8521569206624988,1.0,10/32,24.86%,MAP10;PKN2;RHOA;PKP4;GIPC1;CDC25B;SVIL;DRD3;CDC42;CUL3
prerank,mesoderm formation (GO:0001707),-0.3012725773438474,-0.8769570951355776,0.6083333333333333,0.8641995767764227,1.0,5/17,18.24%,SMAD2;ITGA8;ITGB4;HMGA2;KDM6B
prerank,vascular transport (GO:0010232),0.29795866427315376,0.8769450238284028,0.6968085106382979,0.8518585677895623,1.0,21/81,23.67%,LRP1;SLC38A1;SLC6A6;SLC27A1;SLC7A1;SLC2A1;SLC7A8;SLC5A3;ATP1A4;SLC19A1;TFRC;SLC38A2;SLC4A4;SLC5A6;SLC1A5;SLC7A3;SLC16A2;SLC7A2;ABCC5;ATP8A1;ATP1A2
prerank,cilium assembly (GO:0060271),0.2796262805575722,0.8765108037493012,0.8198198198198198,0.852290858983034,1.0,88/297,27.01%,ASAP1;DYNC1H1;ODF2;TEKT2;FOXJ1;ATP6V0D1;PTPN23;HAUS8;IFT43;FLNA;RAB8B;TEKT5;SNX10;NINL;ARMC9;TBC1D32;DCTN1;RILPL2;IFT88;RILPL1;SPAG16;PPP2R1A;IFT74;TNPO1;CSNK1D;RAB1A;BBS10;EXOC2;MAK;TCTN3;YWHAG;EHD4;WDR35;MARK4;CEP250;CEP41;IFT122;CNGB1;CCDC57;EXOC4;CCP110;MAPRE1;TRIP11;CEP83;TUBB;CCDC40;SPATA6;TMEM107;RILP;ATP6V1D;DNAH5;TRAF3IP1;UNC119B;CETN2;RPGRIP1;BBS2;TMEM17;LZTFL1;DYNLT2B;CFAP70;ACTR3;ALMS1;LRGUK;NOTCH1;CFAP298;CSNK1E;DYNC2I1;HAUS2;PARVA;GSN;CEP57;WDR19;CPLANE1;KIF3A;TRAPPC14;TMEM216;CDK5RAP2;SSNA1;DYNC1I2;CYS1;EHD1;CEP97;ARF4;TTBK2;WDR11;TTLL3;BBS7;CCDC39
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3177314614449732,0.8763429101581678,0.6390887290167866,0.8522181122244598,1.0,14/38,21.82%,PTPRC;NEDD9;GAS6;CAV1;MVP;GPRC5B;EFNA1;DLG4;RAP2B;DOK7;PTPN1;PDGFB;NCK2;NOX4
prerank,histone H2B ubiquitination (GO:0033523),-0.34820957062948077,-0.8762905950433909,0.5901639344262295,0.8637527154325997,1.0,5/10,33.57%,DTX3L;CDC73;LEO1;RNF8;RNF40
prerank,mitochondrial genome maintenance (GO:0000002),0.41134924714491095,0.8759987865313182,0.6317280453257791,0.8524663092128862,1.0,3/11,12.35%,SLC25A33;LONP1;SLC25A36
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3279823667666474,0.8755571527036307,0.6612149532710281,0.8528832351819666,1.0,10/34,23.37%,DUSP9;PTPN2;PTPN18;UBASH3B;DUSP3;PTPN1;PTPN6;DUSP6;PTPN12;PTPN11
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.407122412954553,0.8751425611964063,0.6432664756446992,0.8532552131295327,1.0,3/12,11.49%,NINL;DCTN1;HOOK3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4059708405574938,0.8750283009723613,0.6376404494382022,0.8531238474575897,1.0,1/11,1.74%,NRP1
prerank,glycerol metabolic process (GO:0006071),0.41950278286630216,0.8748506522020199,0.641399416909621,0.8530871567310332,1.0,1/10,2.78%,GK
prerank,peroxisomal membrane transport (GO:0015919),0.3451175275316864,0.8745854073449826,0.6745049504950495,0.8532241499951064,1.0,12/27,28.97%,ABCD4;ABCD2;RAB8B;ALDH3A2;PEX14;ACBD5;PXMP2;FIS1;PEX6;PEX1;PEX2;PEX19
prerank,organic anion transport (GO:0015711),0.2945171718513318,0.8744735639339466,0.6945337620578779,0.8530704764672185,1.0,20/76,23.61%,SLC23A1;CYB5R1;CYB5R4;SLC52A2;SLC4A9;SLC4A2;LRRC8D;SLCO5A1;SLC2A6;SLC19A1;SLC35B1;SLCO2A1;MFSD10;SLC2A8;SLC4A4;SLC17A9;SLC16A2;ABCC5;SLC35B4;LRRC8C
prerank,urogenital system development (GO:0001655),0.4092128352776972,0.8743949487868375,0.648876404494382,0.8528678261310391,1.0,1/11,3.85%,SOX9
prerank,negative regulation of viral life cycle (GO:1903901),-0.30684086746011685,-0.874273670494883,0.6627906976744186,0.8663343082874163,1.0,3/15,9.96%,LY6E;IFITM3;CIITA
prerank,peptide biosynthetic process (GO:0043043),0.2819761620674009,0.8739104930988354,0.7527862208713273,0.8534007138853881,1.0,32/153,17.88%,TNIP1;IGHMBP2;AGO2;EIF4G1;MRPL23;RRBP1;MRPS15;FARSB;MRPL52;MRPS16;RPL10A;EEF1A1;RPL12;RPL36;MRPS33;FURIN;RPS6;MRPL24;RPS28;RPL13A;MRPL37;RPS26;MRPL18;MRPL11;RPS27A;MRPS12;RPS12;PABPC4;MRPS7;SARS1;RPL18;RPS13
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2812584573782722,0.8737870863397607,0.7586206896551724,0.8532758425550736,1.0,57/168,28.26%,CNOT4;EIF4G1;DXO;PATL2;PATL1;SMG9;CNOT10;UBA52;DHX34;ETF1;RPL10A;PPP2R1A;RPL12;UPF3A;RPL36;EXOSC9;RPS6;RPS28;CNOT6;RPL13A;EXOSC10;RPS26;UPF3B;RPS27A;RPS12;POLR2D;DCP2;EXOSC5;CNOT9;PABPC1;PYM1;RPL18;RPS13;PAN3;ZC3H12A;SMG1;EXOSC4;RPS2;XRN2;PAN2;RPS19;MTPAP;RPS7;XRN1;CSDE1;SAMD4B;RPL17;RPL23;EIF3E;GSPT1;EIF4A3;TENT4B;PNRC2;RPL4;UPF2;CNOT6L;RPL7A
prerank,negative regulation of blood pressure (GO:0045776),0.39672943800510674,0.8731332137331878,0.6361149110807114,0.8540662287074912,1.0,3/13,21.25%,NPPA;SCPEP1;DRD3
prerank,myelination in peripheral nervous system (GO:0022011),0.3903447431713175,0.8727866253674628,0.6565517241379311,0.8543188222558569,1.0,5/13,20.75%,MYOC;SKI;NCMAP;NF1;SIRT2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3272068389253628,0.8725552658597618,0.6750902527075813,0.8543722991829658,1.0,9/33,24.52%,PAPOLA;PABPN1;SYMPK;CPSF7;SSU72;SNRPF;SNRPD3;WDR33;MAZ
prerank,phosphate ion transport (GO:0006817),0.37226521219902264,0.8725505652157185,0.644474034620506,0.8540355360169666,1.0,5/16,25.24%,SLC37A2;SLC25A3;SLC25A14;SLC37A3;XPR1
prerank,replicative senescence (GO:0090399),0.396683823957979,0.8721080987698764,0.6194444444444445,0.8544741453422731,1.0,7/12,34.00%,CHEK2;TERT;SERPINE1;ATR;ROMO1;TP53;CDKN2A
prerank,regulation of membrane depolarization (GO:0003254),0.3692092174655638,0.8718269756180103,0.6590909090909091,0.8546058876840357,1.0,6/18,25.37%,SMAD7;SCN1B;SCN3B;SCN10A;HCN4;CAMK2D
prerank,ncRNA catabolic process (GO:0034661),0.34178733505114833,0.8705175353880834,0.6456009913258984,0.8565393994573857,1.0,12/28,27.04%,ERN2;SND1;EXOSC9;EXOSC10;ZCCHC8;EXOSC5;TRIR;POP1;EXOSC4;XRN1;DEDD2;TENT4B
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.39654212182940807,0.8701126551728228,0.664796633941094,0.8568865481307165,1.0,2/12,10.48%,CYBA;SLC5A3
prerank,protein import into mitochondrial matrix (GO:0030150),0.36753701925456456,0.8699102727414474,0.6558441558441559,0.8568825292926647,1.0,8/18,25.73%,TIMM44;TOMM40;TIMM23;TIMM21;DNAJC15;PAM16;GRPEL2;TIMM17A
prerank,tRNA metabolic process (GO:0006399),0.37240014433010593,0.8696906769579408,0.6367137355584083,0.8569265502418544,1.0,4/17,18.42%,AARS1;FARS2;SARS1;POP1
prerank,neuron fate commitment (GO:0048663),0.3850735029580663,0.8694577349981757,0.6530054644808743,0.856961015340731,1.0,3/14,18.39%,ID2;DLL4;TGFBR1
prerank,zinc ion transport (GO:0006829),0.36146913738616726,0.8691822354080571,0.6536458333333334,0.8570976560363277,1.0,6/21,21.67%,SLC39A7;SLC39A11;SLC39A6;SLC39A3;SLC39A13;SLC30A9
prerank,neuron projection organization (GO:0106027),0.3692122993994864,0.8689758311326554,0.6423658872077029,0.8571113447170061,1.0,3/15,12.14%,ABCD2;DCTN1;ATP1A3
prerank,T cell homeostasis (GO:0043029),0.4142563602392439,0.8682774994575823,0.6397163120567376,0.857976311272194,1.0,4/10,27.80%,NCKAP1L;RIPK3;JAK3;PPP2R3C
prerank,membrane repolarization (GO:0086009),0.3794649614282545,0.8677618991946262,0.6428571428571429,0.8585508767912391,1.0,3/15,13.63%,KCNJ2;ATP1A1;ATP1B3
prerank,arachidonic acid metabolic process (GO:0019369),0.32756756162872586,0.8677012008406344,0.6619718309859155,0.8583090760219088,1.0,6/35,12.70%,MGLL;PTGES;TBXAS1;CYP1B1;CBR1;PTGIS
prerank,renal absorption (GO:0070293),0.4020313596750591,0.8666422562045094,0.6419213973799127,0.8597849416537031,1.0,1/10,1.39%,SGK1
prerank,protein localization to organelle (GO:0033365),0.2827121176295174,0.8664179454157142,0.7677484787018256,0.8598276664738786,1.0,53/133,32.13%,OPTN;HMOX1;SNX10;ARL1;GCC2;ALDH3A2;LAMP2;VAMP2;CSNK1D;MDM2;XPA;STX5;WDR35;DHX9;CEP250;GAK;VPS35;IFT122;CTDNEP1;MTCH2;FAM83H;DDX1;TOR1B;ATP6V1D;PIKFYVE;CD68;BBS2;ARFRP1;ABCA7;LAMP1;ARF6;CALR;LMNA;DNAJA1;TRAM1L1;EHD1;TSPAN17;TOR1AIP1;PACSIN2;RAB6A;DCP1A;COG3;TOPORS;AUP1;TULP3;RAB11A;SSB;VAPA;GABARAPL2;SEC61B;WDR83OS;ZNF423;EMD
prerank,cellular response to hydroxyurea (GO:0072711),0.4162153187063786,0.8656876015792878,0.652046783625731,0.860767816098555,1.0,6/10,35.92%,DDI2;BLM;FMR1;SPIDR;NSMCE3;RTF2
prerank,transcription preinitiation complex assembly (GO:0070897),0.3908163307931189,0.8654773826945156,0.6440677966101694,0.8607973295226886,1.0,4/12,20.98%,GTF2A2;TAF7;BDP1;TBP
prerank,myeloid cell development (GO:0061515),0.3672493516943301,0.8648949968624507,0.6392811296534018,0.8614238247760968,1.0,4/18,11.16%,NCKAP1L;ALAS1;NRROS;LYAR
prerank,macrophage activation involved in immune response (GO:0002281),0.39420686525566634,0.864472366282468,0.659634317862166,0.8618103728116866,1.0,4/13,15.54%,FER1L5;SYK;TREM2;SBNO2
prerank,histone H2A ubiquitination (GO:0033522),0.3656442715847809,0.8644707638959614,0.6666666666666666,0.8614699007107285,1.0,4/17,11.83%,RNF2;DDB2;DDB1;UBR2
prerank,cellular response to mechanical stimulus (GO:0071260),0.3099805378656254,0.864304494469938,0.6945701357466063,0.8614229043573671,1.0,12/46,23.35%,SLC9A1;PIEZO1;SOX9;NFKB1;PTGER4;CRADD;MAP3K1;MAPK3;TLR7;TNFRSF8;PIEZO2;CASP8AP2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.2745209810158339,-0.8642771180060564,0.6149732620320856,0.8868464083050562,1.0,8/23,19.93%,SMURF2;SMAD2;NREP;LATS2;DKK3;TRIM33;LTBP4;TGFBR3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.2988940198872375,-0.863455586472194,0.6139705882352942,0.8866347862421626,1.0,6/15,23.56%,TMEM170A;ZFYVE27;REEP2;RAB10;ATL1;ARL6IP1
prerank,alpha-amino acid metabolic process (GO:1901605),0.31419090216095713,0.8633793139359114,0.6704936854190585,0.8625890529068522,1.0,15/45,25.32%,GNMT;GLS2;GLS;MTRR;ATP7A;PYCR3;MTHFR;ASNS;MMUT;SLC25A13;DDAH1;NOX4;OAT;MTHFD1;CBS
prerank,histone H2A monoubiquitination (GO:0035518),0.36783612393177784,0.8632450889770215,0.6692307692307692,0.8624795163879936,1.0,7/17,24.62%,RNF2;DDB2;DDB1;PCGF6;PCGF3;BMI1;PCGF2
prerank,regulation of muscle cell differentiation (GO:0051147),0.3273855788115454,0.8631634327994295,0.6748768472906403,0.862277109652318,1.0,11/31,26.01%,CTNNB1;ID2;HDAC9;SPAG9;SRF;BNIP2;MAPK12;FGFR2;CDC42;ABL1;BOC
prerank,negative regulation by host of viral transcription (GO:0043922),0.390802973224206,0.8631426440914644,0.6449375866851595,0.8619712532723298,1.0,5/12,27.06%,CCL4;JUN;HDAC1;CCL3;TARDBP
prerank,protein targeting to ER (GO:0045047),0.28528291616437274,0.8630370738327826,0.7510416666666667,0.8618123623889197,1.0,19/99,15.07%,ZFAND2A;CHMP4B;CHMP4A;EDEM1;UBA52;SPCS3;SRP9;RPL10A;GET3;RPL12;RPL36;SRP14;RPS6;RPS28;RPL13A;SEC63;RPS26;RPS27A;RPS12
prerank,oxoacid metabolic process (GO:0043436),0.33922912796936144,0.8630231730414697,0.6727493917274939,0.8614978945012413,1.0,5/27,17.14%,GNMT;SULT6B1;TPST1;SULT2B1;BPNT2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.36003981587209594,0.8627644278076263,0.6613756613756614,0.8616029626977911,1.0,2/17,8.57%,PLAAT3;LPGAT1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.28589283513509545,0.8620470891278329,0.7484472049689441,0.8624702468046751,1.0,9/101,5.17%,FLT1;PDGFA;CCNY;ADAM8;FGF2;SLC27A1;VEGFA;CAB39;ADAM17
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4093131729338461,0.861900047763248,0.6642651296829971,0.8623581884996774,1.0,2/10,15.91%,DIP2A;FLCN
prerank,plasma membrane invagination (GO:0099024),0.3374153291165489,0.8616566427704909,0.6555142503097894,0.8624090585368362,1.0,6/29,13.91%,ARHGAP25;SNX33;ARHGAP12;RHOA;SNX18;MSR1
prerank,zinc ion homeostasis (GO:0055069),0.33420217575063305,0.861619093050373,0.6682808716707022,0.8621318777716711,1.0,6/28,22.24%,ATP13A2;SLC39A7;SLC39A6;SLC39A13;SLC30A9;MT2A
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.32670040197093625,0.8613947870847203,0.6674528301886793,0.8621692719803465,1.0,19/31,35.40%,TIMM44;TOMM40;PEX14;TIMM23;HSPD1;TIMM21;DNAJC15;PAM16;GRPEL2;PEX6;TIMM17A;PEX1;PEX2;AIFM1;ROMO1;PEX16;DNAJC19;PEX26;TOMM20
prerank,response to prostaglandin E (GO:0034695),0.41229460225609316,0.8613260277223602,0.6714490674318508,0.8619604134941886,1.0,3/10,17.53%,PTGER4;GNB1;SFRP1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.3121814181614316,-0.8613126289340839,0.6792452830188679,0.8892474364046847,1.0,3/15,11.54%,QDPR;KMO;HAAO
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3413842318136314,0.8611050382559935,0.6567901234567901,0.8619957982635353,1.0,1/25,0.22%,FGF13
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.31040507554631735,0.8610356240462886,0.7022988505747126,0.8617695705499676,1.0,8/45,23.08%,CTNNB1;PLK2;BCL6;WEE1;PRCC;TGFB1;NME6;SCRIB
prerank,organic cation transport (GO:0015695),-0.28275996782902313,-0.8606482889719391,0.6958762886597938,0.8886513554855116,1.0,13/20,44.24%,SLC22A5;SEC14L1;SLC25A29;SLC5A7;PDZK1;SLC22A18;SLC22A3;SLC25A42;SLC22A2;SLC29A4;SLC47A1;SLC22A4;SLC25A26
prerank,regulation of adaptive immune response (GO:0002819),0.36345572334437837,0.8605993512373995,0.6536458333333334,0.8621941555873777,1.0,3/18,12.19%,ADCY7;SAMSN1;RIPK3
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4137225372987766,0.8604980911928317,0.6524822695035462,0.8620158861063484,1.0,1/10,0.94%,PLEK
prerank,response to growth factor (GO:0070848),0.31997308291373283,0.8603423602019851,0.6928406466512702,0.8619489729065621,1.0,9/41,22.98%,CTNNB1;SPHK1;TGFBR2;CPNE3;MAPK7;SFRP1;TGFBR1;PDGFB;RACK1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3845618994409201,0.86031239013021,0.6611111111111111,0.8616597689175103,1.0,5/13,26.32%,NAMPT;PTGIS;NAXD;PARP9;PARP16
prerank,positive regulation of cell adhesion (GO:0045785),0.29406069684982133,0.8601166965380627,0.736228813559322,0.8616494299342407,1.0,12/74,11.94%,ADAM8;FSTL3;VEGFA;SMAD7;NCKAP1L;MAGI1;RHOD;SYK;P4HB;LIMS1;C1QBP;STX3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.34058377881642243,0.8596630416985873,0.6611675126903553,0.8620911953511936,1.0,9/24,27.46%,SEC24A;TAPBP;SEC24D;FCER1G;CALR;SEC24B;CANX;B2M;SEC23A
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.31460957637204656,-0.8596450377294335,0.6856060606060606,0.8889205009034046,1.0,5/14,14.36%,PPP1CA;PPP2R2A;PPP2CA;PPP2R2B;PPTC7
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3376276167504434,0.8593131642951491,0.6622114216281896,0.8623501309127442,1.0,9/23,25.27%,TRIM6;SPHK1;CAB39;STOX1;CALM2;IRGM;TGFB1;MAPK1;CALM3
prerank,visual system development (GO:0150063),0.3247125948231512,0.858979445538257,0.699177438307873,0.8625725438128046,1.0,6/37,15.29%,SH3PXD2B;SMG9;BLOC1S3;CPAMD8;RBP4;MEIS3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3123806707983432,0.8584912548956002,0.7089887640449438,0.8630175035325803,1.0,2/43,1.74%,IGF1;NELL1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3523156662554895,0.8583879742494034,0.6579634464751958,0.862844772006542,1.0,6/20,17.85%,NKTR;PPIE;PPIG;PPIL6;PIN1;FKBP1B
prerank,protein import into peroxisome matrix (GO:0016558),-0.32461254855438826,-0.8582781950478435,0.6182432432432432,0.8899916519976862,1.0,4/12,13.46%,PEX13;PEX7;PEX10;PEX12
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.40759976061423986,0.8579790597800289,0.6681222707423581,0.8632077557846413,1.0,1/11,1.15%,PLAUR
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.37654340316256435,0.8577682327300259,0.6689373297002725,0.8632249497447179,1.0,9/15,36.18%,VCP;DERL1;HERPUD1;SYVN1;HSP90B1;AUP1;SEC61B;OS9;NPLOC4
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.32012002972233666,-0.8577263884371775,0.6327868852459017,0.8892220331312003,1.0,3/12,11.18%,TAPT1;INSIG1;INSIG2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3082659963607409,-0.8576221124199572,0.6389891696750902,0.8874880615396946,1.0,4/14,15.01%,CD40;PRKCI;CCL2;THBS1
prerank,regulation of protein polymerization (GO:0032271),-0.24007728222655494,-0.8574151301865458,0.7777777777777778,0.8859735968195339,1.0,13/35,20.96%,FCHSD2;MAP2;ARL2;TPPP;DBN1;MAPT;TPPP3;HSP90AA1;ARHGAP28;CTTN;ESAM;CAMSAP3;ABITRAM
prerank,CENP-A containing chromatin organization (GO:0061641),0.33026118853001774,0.8569761232316115,0.6755126658624849,0.8638610122849385,1.0,14/29,34.31%,CENPO;CENPT;CENPX;CENPA;CENPK;CENPS;CENPW;RSF1;CENPU;CENPC;NPM1;MIS18BP1;KNL1;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.33026118853001774,0.8569761232316115,0.6755126658624849,0.8638610122849385,1.0,14/29,34.31%,CENPO;CENPT;CENPX;CENPA;CENPK;CENPS;CENPW;RSF1;CENPU;CENPC;NPM1;MIS18BP1;KNL1;ITGB3BP
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4067435904125823,0.8569395573714036,0.6497829232995659,0.8635824804743347,1.0,3/10,21.65%,VEGFA;NOTCH4;NOTCH1
prerank,cardiac muscle contraction (GO:0060048),0.3228921153902596,0.856726294759368,0.6754176610978521,0.8636092634532954,1.0,10/34,27.79%,GAA;SLC8A1;SCN1B;MYL4;SCN3B;PIK3CA;GSN;ATP1A2;CAMK2D;TNNI1
prerank,inhibitory synapse assembly (GO:1904862),0.40152127893677525,0.8567027328811686,0.667621776504298,0.8633135636309074,1.0,1/11,0.22%,FGF13
prerank,regulation of striated muscle contraction (GO:0006942),0.33588534162396316,0.8566111291687869,0.6797066014669927,0.8631266247759047,1.0,9/27,27.79%,P2RX4;SMAD7;SRI;CALM2;SCN10A;HCN4;ATP1A2;CALM3;TNNI1
prerank,peptide metabolic process (GO:0006518),0.2917768101110626,0.85650562076044,0.7304812834224599,0.8629711188516935,1.0,16/75,19.84%,ANPEP;ADAMTS13;GSTA2;NAT8;PSEN2;CPD;SPCS3;TPP1;GLRX2;PARL;FURIN;SPPL3;CTNS;GSR;NLN;DNPEP
prerank,chromatin remodeling at centromere (GO:0031055),0.3263604354447965,0.8563300196184387,0.6842105263157895,0.8629314896200841,1.0,15/31,34.31%,CENPO;CENPT;CENPX;CENPA;CENPK;CENPS;CENPW;RSF1;CENPU;CENPC;CENPV;NPM1;MIS18BP1;KNL1;ITGB3BP
prerank,outer dynein arm assembly (GO:0036158),0.3745299065857026,0.8556939429621914,0.6648936170212766,0.8636685659570702,1.0,2/15,9.50%,ODAD2;DNAAF5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.341520378004159,0.8547389029259355,0.6666666666666666,0.8649046531765132,1.0,6/23,19.83%,CADM1;CRTAM;LILRB1;AP1G1;PVR;LAMP1
prerank,cellular response to organic cyclic compound (GO:0071407),0.2769820468403378,0.8546830056957577,0.781985670419652,0.8646671530487346,1.0,40/141,23.94%,SPP1;CTNNB1;P2RX4;ADCY8;ADCY3;MGARP;MSN;LARP1;BRCA1;TFPI;CYP1B1;NR3C1;TIPARP;JUP;P2RY2;ATP1A1;ATP1A3;GOLPH3;RIOK3;GNB1;TNF;UBE2L3;CASP7;SFRP1;MED1;RUVBL2;FES;CDH1;ZC3H12A;BLM;TGFB1;LCOR;PDGFB;AANAT;HCN4;HSP90B1;CCL3;ATP1A2;ARL6IP5;RAD51
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3583057176486044,0.8543740644235164,0.6592689295039165,0.8648313052006528,1.0,7/18,25.96%,MCM7;POLE;LIG3;LIG1;GINS1;MCM3;POLA1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.371617924081757,0.8534859444471934,0.6692708333333334,0.8656397971246399,1.0,4/15,14.04%,DTNBP1;BLOC1S3;AP3D1;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.371617924081757,0.8534859444471934,0.6692708333333334,0.8656397971246399,1.0,4/15,14.04%,DTNBP1;BLOC1S3;AP3D1;AP3S1
prerank,oligodendrocyte differentiation (GO:0048709),0.3520824515241645,0.8530908519564352,0.675392670157068,0.8659427126588928,1.0,2/19,3.85%,CDK5;SOX9
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2241819037346956,-0.8529067978856357,0.7652173913043478,0.8936852127098179,1.0,13/44,16.94%,CYP27A1;CYP7B1;CYP39A1;INSIG1;DHCR7;SC5D;PER2;INSIG2;SLC27A2;OSBPL6;SQLE;OSBPL9;OSBPL7
prerank,cilium-dependent cell motility (GO:0060285),0.35001438546464897,0.8526485202018272,0.6819923371647509,0.86634013533972,1.0,7/22,27.01%,TEKT2;TEKT5;EFHC1;DNAI3;DNAH3;EFHC2;CCDC39
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4034605907931704,0.852112564540049,0.6685878962536023,0.8668878071906573,1.0,2/10,15.81%,ATP7A;KYNU
prerank,response to interleukin-4 (GO:0070670),0.40265408544846837,0.852090446083116,0.6820809248554913,0.8665890915396479,1.0,4/10,26.86%,RUFY4;XBP1;TCF7;JAK3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3279863350878693,0.8520207234544397,0.6706875753920386,0.86637472712166,1.0,12/31,23.08%,ANK1;RAP2A;MSN;ERBIN;PDCD6IP;RHOA;MYO9A;SYNE4;MARK2;WDR1;CDC42;SCRIB
prerank,positive regulation of cell projection organization (GO:0031346),0.27829829348036017,0.8508897733392127,0.7772073921971252,0.8679121728124104,1.0,25/115,19.38%,PLXNC1;APOE;ABL2;PTK2B;CUX1;PLXNA2;ALKAL2;NPTN;SS18L2;FZD4;FZD1;PLXND1;RHOA;CBFA2T2;SCN1B;RETREG3;KIDINS220;PLXNA1;DLG4;CAPRIN1;AMIGO1;SS18L1;FES;MARK2;SCARF1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3854804400169733,0.850779298103815,0.6854256854256854,0.8677604991280532,1.0,4/12,21.00%,SETMAR;CHEK2;HUS1;TOPBP1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.371542564539354,0.8506244449114808,0.6792698826597132,0.8676820570358917,1.0,5/16,19.83%,CADM1;CRTAM;AP1G1;PVR;LAMP1
prerank,acidic amino acid transport (GO:0015800),0.3558901463770431,0.850314564593011,0.6762028608582574,0.8678725961599792,1.0,6/17,23.93%,SLC6A6;LRRC8D;SLC25A18;GIPC1;SLC25A13;ARL6IP5
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.2293597535140247,-0.8502295341814424,0.7905405405405406,0.8973212968165758,1.0,11/38,18.91%,NDUFS3;NDUFV3;NDUFB9;NDUFS4;NDUFS5;NDUFB7;NDUFA10;NDUFB10;NDUFA4;NDUFS2;NDUFA5
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2952787455875179,0.8500339949314285,0.7208008898776418,0.8679830688029229,1.0,17/57,22.54%,FOXN3;FZR1;TAOK3;BRCA1;ABRAXAS1;CHEK2;UIMC1;BABAM2;RAD9A;TAOK1;BLM;BRCC3;HUS1;CCND1;FBXO31;TOPBP1;CDK2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2644833651518471,-0.8499990236415091,0.691304347826087,0.8958575779559681,1.0,9/21,27.66%,GRIN2B;GRIN1;DELE1;BEX3;EPHA7;PSMB9;BIRC3;LTF;MEFV
prerank,regulation of interleukin-2 production (GO:0032663),0.30624082580449274,0.849933734319244,0.7024221453287197,0.8678106232633745,1.0,7/43,8.96%,PTPRC;TRAF2;RUNX1;MALT1;HOMER2;HDAC7;HAVCR2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3399402497757462,-0.8499257503032855,0.6601307189542484,0.8940750425956543,1.0,2/10,5.28%,BICD1;APC
prerank,regulation of chondrocyte differentiation (GO:0032330),0.34533210060031005,0.8492541680285354,0.6964064436183395,0.8686066654549709,1.0,6/24,23.37%,GDF6;SOX9;PKDCC;TGFBR1;ZBTB16;PTPN11
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.39392425590424207,0.8491863230060303,0.6553191489361702,0.8683913770053642,1.0,5/12,26.07%,MBTPS2;LPCAT3;DGKQ;H6PD;CLCN2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2956221980665926,0.8476330589938902,0.7381465517241379,0.8706272957229223,1.0,9/59,12.65%,CD84;PTPRM;CADM1;NPTN;NECTIN3;TRO;NECTIN1;IGSF9;PALLD
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.35028014315608497,0.8463813287203692,0.6814621409921671,0.8723607434166841,1.0,3/18,10.90%,SPG21;C3AR1;C5AR1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.39483852402058184,0.8460154281073843,0.6594827586206896,0.8726226382069244,1.0,1/11,1.44%,STAP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3443332217177835,0.8456241234770303,0.6916129032258065,0.872929412883288,1.0,5/23,15.13%,HTT;DCTN1;NUMA1;FBXW11;CENPA
prerank,membrane repolarization during action potential (GO:0086011),0.38054436653863255,0.845532491711939,0.681881051175657,0.8727362018675765,1.0,2/13,12.14%,KCNJ2;ATP1A1
prerank,tight junction assembly (GO:0120192),-0.21868828676760133,-0.8455121521894331,0.7788461538461539,0.9012047244023568,1.0,14/49,21.87%,F11R;ARL2;APC;MPP7;PARD3;PECAM1;PRKCI;CLDN12;ECT2;CLDN14;ESAM;FRMPD2;OCLN;RAB13
prerank,aorta development (GO:0035904),0.3783749345653606,0.8455100167586103,0.6712707182320442,0.8724285089404799,1.0,2/14,5.85%,LRP1;JAG1
prerank,generation of neurons (GO:0048699),0.2713777184952307,0.8454422310579711,0.8206686930091185,0.8721954360124136,1.0,19/190,11.13%,FGF13;CTNNB1;ERCC6;LRP12;CDK6;NRP1;CDK5;RUNX1;BHLHE41;HES7;NAV1;BHLHE40;USP9X;FZD4;FZD1;CELSR1;YTHDF2;THOC2;DOCK7
prerank,response to cadmium ion (GO:0046686),0.3345729577974686,0.845175356973308,0.6708542713567839,0.8722675898335863,1.0,8/26,25.17%,JUN;MAPK3;HSF1;SUMO1;MT2A;DAXX;CHUK;MAPK1
prerank,positive regulation of transferase activity (GO:0051347),0.2734613787229708,0.8451030719332052,0.7977642276422764,0.8720452054374308,1.0,37/142,25.52%,FLT1;CTNNB1;AXL;FBXW7;RAD50;CCT2;PABPN1;VAC14;TREM2;ACD;IGF1R;PKIB;ARRDC4;DCUN1D4;HNRNPA2B1;RFC2;DKC1;UBE2L3;PNKP;PIN1;DCUN1D2;MAPK3;MAPK15;FGFR2;TGFB1;RPS2;BMI1;NVL;XRCC5;PTGES3;HSP90AB1;FGFR3;EPM2AIP1;PDGFRA;MAPK1;DCUN1D3;DSTYK
prerank,nitric oxide mediated signal transduction (GO:0007263),0.366898032841767,0.8445673618132686,0.6618037135278515,0.872611723407926,1.0,1/16,0.87%,APOE
prerank,N-terminal protein amino acid modification (GO:0031365),0.36992034802654467,0.8444054485230719,0.6716826265389877,0.8725467417509016,1.0,7/14,23.95%,NAA16;NAA15;METAP1D;NTMT1;AANAT;NAA40;NAA50
prerank,amide biosynthetic process (GO:0043604),0.3016073007999871,0.8440064089185502,0.7176339285714286,0.8728537995241006,1.0,17/47,28.89%,SGMS1;CERS6;SMPD4;ASAH1;NANP;FURIN;SAMD8;CLN8;SPTSSA;SGMS2;AANAT;CERS5;ASL;NMRAL1;AGK;SPTSSB;CERS2
prerank,regulation of mitochondrial fission (GO:0090140),-0.2599086817561189,-0.8436340855924573,0.7340425531914894,0.9031670684458017,1.0,6/24,12.85%,CYRIB;SPIRE1;DNM1L;LRRK2;MAPT;PRKN
prerank,development of primary male sexual characteristics (GO:0046546),0.31385381198477497,0.8421864392699152,0.7033997655334114,0.8754899668048197,1.0,5/34,13.07%,LHFPL2;SOX9;COL9A3;KITLG;BIK
prerank,heterocycle biosynthetic process (GO:0018130),-0.3058295597519416,-0.841826581957474,0.6830188679245283,0.9050193158969827,1.0,4/14,13.66%,ALOX5;NFS1;GPHN;NOXRED1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.32575490961720516,0.8417556259723109,0.6908866995073891,0.8758413592714301,1.0,6/27,14.62%,SIRPA;CD44;RHOA;IL6;HSPD1;TNF
prerank,negative regulation of protein secretion (GO:0050709),0.3122049245493813,0.8415048281748174,0.719441210710128,0.8758910654148222,1.0,3/38,4.58%,APOE;RHBDF2;SERGEF
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3500573853486656,0.841067422610594,0.6820580474934037,0.876276488134791,1.0,4/18,9.67%,DERA;STT3B;FUCA1;OGA
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3518689564212396,0.8406126482222916,0.6838624338624338,0.8766752302553813,1.0,5/18,12.87%,PTPRC;HOMER2;HDAC7;HAVCR2;TNFAIP3
prerank,protein oxidation (GO:0018158),0.3908555932330603,0.839738224989773,0.6783216783216783,0.8777542640824938,1.0,1/11,2.39%,APOA2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3929752228188186,0.8391188866440035,0.6685393258426966,0.8784078543795366,1.0,5/11,20.05%,TJP2;RAB1A;RAPGEF6;RAP2B;AFDN
prerank,regulation of centriole replication (GO:0046599),0.3585130836241799,0.8391009794754873,0.7086513994910941,0.8780956345959615,1.0,9/18,31.11%,PLK2;BRCA1;CEP295NL;ALMS1;CEP295;MDM1;CDK5RAP2;TRIM37;NPM1
prerank,response to nutrient levels (GO:0031667),0.3563321745193806,0.8390654610280004,0.6819407008086253,0.8778184461017035,1.0,2/17,5.63%,EIF4G1;SCTR
prerank,negative regulation of cell cycle (GO:0045786),0.2870438015287966,0.8390082310422423,0.7526766595289079,0.8775726507501711,1.0,13/73,16.84%,CDK6;IPO5;NUDT6;CEBPA;GMNN;NUPR2;LILRB1;RNF167;RPS6KA2;CDK5RAP1;NPPC;ZBTB17;LATS1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2733098442830767,-0.8388818939806024,0.7755905511811023,0.905253784900355,1.0,9/20,22.43%,APC;BUB1;CENPF;MAD2L1;KNTC1;ZW10;TTK;PLK1;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2733098442830767,-0.8388818939806024,0.7755905511811023,0.905253784900355,1.0,9/20,22.43%,APC;BUB1;CENPF;MAD2L1;KNTC1;ZW10;TTK;PLK1;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2733098442830767,-0.8388818939806024,0.7755905511811023,0.905253784900355,1.0,9/20,22.43%,APC;BUB1;CENPF;MAD2L1;KNTC1;ZW10;TTK;PLK1;MAD2L2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3143955791370461,0.8387791630345746,0.7163636363636363,0.8776099483245295,1.0,7/33,18.32%,PTGIR;PPARG;HMOX1;VIP;TNFAIP3;PRKG1;EFEMP2
prerank,homeostasis of number of cells (GO:0048872),-0.31564239307799746,-0.8383227643146101,0.6964285714285714,0.9044225481855784,1.0,1/12,0.09%,CX3CR1
prerank,lipid biosynthetic process (GO:0008610),0.2845016157368448,0.8383173733790124,0.7574468085106383,0.8779827359287388,1.0,15/77,22.30%,LPL;CYP19A1;ACACA;ACSL1;LPCAT1;DHRS11;HSD17B8;SCP2;PIP5K1A;CLN8;XBP1;SRD5A1;AGPAT5;MCAT;AGPAT3
prerank,positive regulation of heart contraction (GO:0045823),0.34644074129342994,0.8375282394308742,0.6796875,0.8788359613259116,1.0,5/19,28.24%,NPPA;ATP2A2;SCN3B;ATP1A2;RGS2
prerank,axon guidance (GO:0007411),0.26752936518808523,0.8373473326376532,0.8418932527693856,0.8787877169098841,1.0,30/201,14.12%,PLXNC1;ALCAM;NRP2;PTPRA;NIBAN2;PIK3CB;NRP1;GRB2;PLXNA2;GAB2;DAG1;VEGFA;PTPRM;SH3KBP1;NPTN;CYFIP1;RHOG;PLXND1;RANBP9;EVL;DOK1;IGSF9;NTN1;DOK2;PALLD;LYPLA2;MAPK7;FYN;SCN1B;EFNA1
prerank,tryptophan metabolic process (GO:0006568),0.39257074594794633,0.8371523413607956,0.7113997113997114,0.8787546703370137,1.0,4/11,28.69%,ATP7A;KYNU;IDO2;IL4I1
prerank,quinone biosynthetic process (GO:1901663),0.3712495171849386,0.8369688331979606,0.6886395511921458,0.8787132741345088,1.0,5/14,24.68%,COQ10B;COQ5;COQ8B;COQ3;PDSS2
prerank,Golgi to lysosome transport (GO:0090160),-0.32038027266989844,-0.836798630350334,0.6421052631578947,0.9056328834660545,1.0,4/11,12.67%,ANKFY1;RBSN;SORT1;EHD3
prerank,protein dephosphorylation (GO:0006470),0.27558454876452804,0.836768937383946,0.8038815117466803,0.8786862614986864,1.0,32/135,19.80%,PTPRA;EYA4;PTPRC;PPM1H;DUSP9;PPM1J;PPP2R5C;PTPRM;PTPN2;TAB1;PPP2R1A;PHPT1;PPP2R2D;NCK1;PTPN21;PTPN18;DUSP12;UBASH3B;FBXW11;RPRD1A;DUSP11;CTDNEP1;CTDSP2;PPP3CC;PPP6C;MTMR6;SSU72;DUSP3;PTPN1;PPP1R12A;PTPN6;STK11
prerank,determination of left/right symmetry (GO:0007368),0.3150895408184995,0.8367550161998223,0.7229885057471265,0.8783743380488277,1.0,9/37,27.01%,ODAD2;FOXJ1;DAND5;CCDC40;DNAH5;NOTCH1;MEGF8;BBS7;CCDC39
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3611358887722603,0.8366142975875853,0.6837270341207349,0.8782725861546,1.0,5/17,19.83%,CADM1;CRTAM;AP1G1;PVR;LAMP1
prerank,peroxisome organization (GO:0007031),0.3283369143805855,0.836451676411802,0.7080745341614907,0.8782035648017975,1.0,15/25,34.51%,ABCD4;PLAAT3;ABCD2;PEX14;FIS1;PEX11G;PEX6;PEX1;LONP2;PEX2;PEX19;PEX16;ACOT8;ABCD3;MFF
prerank,epithelial cell migration (GO:0010631),0.3113888872505745,0.8362369512479753,0.7018779342723005,0.8782165940614822,1.0,15/37,25.79%,NRP1;CYP1B1;PKN2;PLXND1;TESK1;RHOA;GIPC1;ZEB2;LPXN;PIK3CA;ROCK1;KANK2;FSTL1;ABL1;NANOS1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2996521068897037,0.8359780153002087,0.7393258426966293,0.8782534869461559,1.0,9/48,18.75%,SELENON;PTK2B;PDPK1;UBASH3B;JPH1;SRI;CALM2;FKBP1B;GSTO1
prerank,cellular response to retinoic acid (GO:0071300),0.3028668199150061,0.8359433428553971,0.735052754982415,0.8779697721738334,1.0,4/42,8.32%,ABL2;PTK2B;SOX9;FZD4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30012010047502,0.8356480382133062,0.7441601779755284,0.8781001647423493,1.0,20/53,28.69%,APOE;FBXW7;TREM2;TMF1;PSMD14;PSME3IP1;GNA12;USP14;UFL1;PSMC2;XPO1;HSP90AB1;USP19;DESI1;RAD23A;BAG2;PSMC6;FMR1;PSME3;PSMC5
prerank,purine-containing compound catabolic process (GO:0072523),0.37786796392214755,0.8351620666583525,0.6947513812154696,0.8785249574699182,1.0,2/13,9.05%,XDH;ITPA
prerank,chemokine-mediated signaling pathway (GO:0070098),0.30513036954787226,0.8344048131519424,0.7400468384074942,0.8793482974677962,1.0,4/42,9.76%,CCL4;PTK2B;CCL13;CCL14
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3921665657033818,0.8343885049082382,0.6734104046242775,0.879039975883302,1.0,3/11,18.30%,VCP;RNF185;DERL1
prerank,positive regulation of heart rate (GO:0010460),0.34849251893096433,0.8342398263677047,0.6941489361702128,0.878946656355899,1.0,3/17,18.59%,NPPA;ATP2A2;SCN3B
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.35049436720056804,0.8341650074470133,0.7030456852791879,0.8787315822486558,1.0,6/19,20.97%,TMEM106A;NFKB1;MAPK7;TNF;WFS1;PDGFB
prerank,cellular amino acid catabolic process (GO:0009063),-0.190793667325428,-0.8337138973035965,0.8253968253968254,0.910050762699265,1.0,23/87,18.17%,HMGCLL1;ASPA;MCCC2;GLUD1;GAD1;GLUL;QDPR;KMO;HNMT;PRODH;BCKDHB;HAAO;ALDH4A1;DDO;CARNMT1;NOS1;IVD;HYKK;ALDH6A1;HAL;BCKDHA;AUH;DBT
prerank,positive regulation of cell death (GO:0010942),0.2895135686394987,0.8331241895975813,0.7582056892778993,0.8800101564190861,1.0,15/59,26.13%,LRP1;SLC6A6;EIF4G1;CELF1;SARM1;MARK4;FYN;TNF;ITGB2;ZC3H12A;EIF2S1;DAXX;GSK3B;EGR1;FAF1
prerank,protein import into peroxisome membrane (GO:0045046),0.3425050268047518,0.8330249766949112,0.7211055276381909,0.8798416298346666,1.0,7/22,21.77%,ABCD2;RAB8B;ALDH3A2;PEX14;ACBD5;PXMP2;FIS1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.39843648442342927,0.8330207318097351,0.7001455604075691,0.8795170614870462,1.0,2/10,15.80%,AGO2;TERT
prerank,phosphate ion transmembrane transport (GO:0035435),0.3723285860421154,0.8329913882834431,0.6831275720164609,0.8792287973643793,1.0,5/12,25.24%,SLC37A2;SLC25A3;SLC25A14;SLC37A3;XPR1
prerank,regulation of microtubule-based process (GO:0032886),0.31514275966152366,0.8328090393287862,0.7053254437869823,0.8791851283015215,1.0,11/36,21.64%,MACF1;MAP10;ATF5;PHLDB1;MEMO1;MARK4;CDK2AP2;TRAF3IP1;MARK2;TAOK1;ROCK1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3610139305639379,0.8318555229323409,0.6771978021978022,0.8803288507228193,1.0,5/15,23.79%,GAS6;BAG3;TPR;RBM22;GSK3B
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.32047904934775673,-0.8317885416741307,0.6727941176470589,0.9120271504400363,1.0,2/11,13.50%,GRK3;GTF2H2
prerank,motor neuron axon guidance (GO:0008045),-0.28832668366969,-0.8316735261814334,0.71900826446281,0.9103268362969303,1.0,7/15,24.25%,EPHA4;TMEFF1;CHN1;SLIT2;SLIT1;RAC2;NTN3
prerank,mitotic spindle organization (GO:0007052),0.26676956296106813,0.8308592908343401,0.8252032520325203,0.881544520839208,1.0,38/153,24.02%,DYNC1H1;FLNA;PLK2;NEK6;EML4;PTPA;LSM14A;CCNB1;VCP;CENPO;BCCIP;DYNC1LI2;ABRAXAS1;AHCTF1;CENPT;RHOA;ERCC6L;CHEK2;DCTN6;EFHC1;CENPA;CLIP1;CENPK;MAPRE1;GOLGA2;CENPS;TAOK1;STAG1;TOGARAM2;XPO1;KIFC1;RANBP2;NUP133;SPDL1;NUDC;EFHC2;TBCE;NUP98
prerank,DNA biosynthetic process (GO:0071897),-0.281438971764537,-0.8306783957427759,0.7112068965517241,0.9104533149952441,1.0,5/16,19.85%,WRN;WRNIP1;CDKN2D;POLD1;POLD2
prerank,synaptic vesicle recycling (GO:0036465),0.32170633540523164,0.8304619192007044,0.7099143206854345,0.8818335220230699,1.0,7/31,11.69%,CDK5;CEL;RAB5A;PIP5K1C;TBC1D24;VAMP2;SYT8
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2371911690850147,-0.8303604159856955,0.7547169811320755,0.9091419278342456,1.0,5/32,12.29%,CAPN3;AKAP6;CEMIP;HAP1;F2R
prerank,apical protein localization (GO:0045176),-0.3389558338821832,-0.8302838455674516,0.678082191780822,0.9073875091803509,1.0,2/10,7.18%,INSC;VANGL2
prerank,regulation of cell killing (GO:0031341),-0.2782058758412927,-0.8294256375567148,0.728744939271255,0.9072292149366834,1.0,6/16,18.46%,NOXO1;WNT5A;MAPK8;TGFB2;NOX1;CD55
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.32796646794802253,0.8288682874437285,0.7197943444730077,0.8840070881335207,1.0,5/24,16.81%,FGF2;PTPRC;ERO1A;HTR2B;CHERP
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3935524763345225,0.8286394973750771,0.7063711911357341,0.8840537881276742,1.0,4/11,23.39%,LPCAT3;VAPB;STX18;MOSPD3
prerank,positive regulation of RNA splicing (GO:0033120),0.31901698587272465,0.8283805221816398,0.7120481927710843,0.884114678392884,1.0,8/29,17.99%,NCL;ERN1;HNRNPLL;TRA2B;SNW1;CIRBP;RBM22;SLC38A2
prerank,substantia nigra development (GO:0021762),0.3127671498624865,0.8283549063066716,0.7323943661971831,0.8838109255132606,1.0,11/37,22.40%,BASP1;SUDS3;ZNF148;RHOA;MAPKAP1;CNP;MBP;CALM2;SEC16A;SIRT2;CDC42
prerank,positive regulation of insulin secretion (GO:0032024),0.30924180692768477,0.8283063440558984,0.7238542890716804,0.8835567618434622,1.0,3/36,2.79%,ADCY8;TRH;GCK
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2639886526522676,-0.8274857001315764,0.7251184834123223,0.9092378572516083,1.0,10/23,22.56%,AGMO;MOGAT3;GPAM;GPAT3;AWAT2;DGAT2;PNPLA3;PLA2G15;PLCE1;PNPLA2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.26542654034507046,-0.8274661906281094,0.7468354430379747,0.907379731252729,1.0,6/20,16.29%,IL18;PRKCE;CCL2;IL1B;CCL5;PTPN22
prerank,positive regulation of vasculogenesis (GO:2001214),-0.33488605672482274,-0.8272991781642381,0.6807017543859649,0.9058387948273371,1.0,3/10,6.66%,RAPGEF2;TMEM100;CEACAM1
prerank,inner mitochondrial membrane organization (GO:0007007),0.2945845352288327,0.8269093297721781,0.7305122494432071,0.8853643718248184,1.0,14/47,26.28%,SAMM50;IMMT;AFG3L2;HSPA9;TMEM11;ATP5MG;GHITM;MTX3;ATP5F1C;ATP5F1B;TIMM9;SPG7;AGK;OPA1
prerank,regulation of lipid kinase activity (GO:0043550),0.37507518172190285,0.8267497226536338,0.6867977528089888,0.8852806554964805,1.0,5/11,25.23%,WDR91;PIK3R2;WDR81;EEF1A2;RBL1
prerank,negative regulation of cellular component movement (GO:0051271),0.36060533582772564,0.826283522442514,0.706989247311828,0.8856600419526145,1.0,4/15,16.76%,CD9;ACTN1;CRK;PIN1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3429643912455338,0.8262742175243128,0.689119170984456,0.8853440568503478,1.0,8/20,27.16%,CCNY;ADAM17;STOX1;CCND1;PDGFB;HSP90AB1;SPDYA;PSMD10
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.31127882448150357,0.8260002286008321,0.7242603550295857,0.885435823377246,1.0,5/33,13.02%,FBXW7;ID2;APPL2;INO80;FAM83D
prerank,metanephric mesenchyme development (GO:0072075),0.38815118553131367,0.8259153119371725,0.6811377245508982,0.8852371703376074,1.0,1/10,4.22%,BASP1
prerank,organic substance transport (GO:0071702),0.2690303624218926,0.8250245804179,0.8213197969543147,0.8862968978040789,1.0,30/121,25.04%,MFSD12;ABCA1;ABCG1;SLC23A1;TOM1;ABCD2;SLC6A4;SLC18A1;RAB7A;VAMP2;RUFY1;ARRDC4;SNX4;ARRDC2;FLVCR1;DISP1;SLC19A1;SLCO2A1;RILP;ABCA7;CLN8;LMAN2L;CHKA;HSP90B1;ATP8A1;SCAMP1;ARL6IP5;KIF3A;SCAMP3;ABCA6
prerank,aortic valve morphogenesis (GO:0003180),0.31549924615184666,0.8248279595057895,0.7222222222222222,0.886257108277237,1.0,8/30,21.65%,NPPA;SOX9;JAG1;DLL4;EFNA1;TGFB1;ROCK1;NOTCH1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.37583495852039345,0.8243028094376842,0.6852861035422343,0.8867218326861948,1.0,1/12,1.29%,UMPS
prerank,cellular response to oxygen-containing compound (GO:1901701),0.26162017528095743,0.8241025976372417,0.8878878878878879,0.8866799452760018,1.0,66/291,23.49%,LPL;SIRPA;P2RX4;RRAGD;ABL2;STAP1;PTK2B;PRKCD;IPO5;CPEB4;CD274;AXL;SOX9;VIM;TNFRSF1B;AGAP3;VCP;GIT1;PABPN1;FZD4;JUN;NFKB1;ACOD1;DAPK1;LILRB1;PLAA;RHOA;P2RY2;TICAM1;CD180;IL6;PID1;TNIP2;TNFAIP3;CPEB1;GNB1;LARS1;SESN2;SBNO2;CPEB3;SNW1;TNIP3;IRGM;SERPINE1;SFRP1;MAPK3;RUVBL2;FES;CD68;NSMF;LAMTOR3;ZC3H12A;PDK3;LAMTOR1;XBP1;LCOR;PDGFB;TIRAP;IRAK1;AANAT;HCN4;CDK2;HSP90B1;RRAGC;FOXO1;CHUK
prerank,bicarbonate transport (GO:0015701),0.32434605591440996,0.8240244581537336,0.7225725094577553,0.8864642888482025,1.0,4/25,10.74%,CYB5R1;CYB5R4;SLC4A9;SLC4A2
prerank,receptor recycling (GO:0001881),0.3936391419278218,0.8240108829138755,0.683982683982684,0.8861524949685997,1.0,2/10,5.24%,REP15;ARFGEF2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3388883116385941,0.8236903142987997,0.7313624678663239,0.8862990779524588,1.0,6/20,25.21%,IPO5;CEBPA;CDK5RAP1;LATS1;PTEN;INCA1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.345665703482094,0.8236355380070555,0.703989703989704,0.8860508185365374,1.0,6/19,21.65%,FGF2;RUNX1;RBP4;TGFBR1;FGFR2;NOTCH1
prerank,negative regulation of JNK cascade (GO:0046329),0.3179829723268879,0.8235117008593743,0.7290167865707434,0.8858891233092854,1.0,3/31,6.73%,SIRPA;NPPA;TAOK3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3169813681943998,0.8227484757962805,0.7191283292978208,0.8867621015421154,1.0,8/29,19.83%,STAP1;IL12RB1;CADM1;CRTAM;AP1G1;STX7;PVR;LAMP1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3629756849514609,0.8224055119564428,0.7069701280227596,0.8869506025821434,1.0,5/13,25.32%,EAPP;RECQL5;HNRNPU;NELFA;SUPT4H1
prerank,cellular respiration (GO:0045333),0.2950881268789235,0.8222429110682143,0.7331042382588774,0.8868609102909196,1.0,15/41,27.50%,COQ10B;NDUFS7;SURF1;COX10;SIRT3;SDHB;SLC25A14;SLC25A13;UQCRH;UQCR10;CYCS;NDUFS8;MTFR1L;SDHC;MTFR1
prerank,regulation of cilium movement (GO:0003352),0.3968463813308473,0.8221135946124839,0.6903703703703704,0.8867273790769402,1.0,4/10,27.01%,ODAD2;CCDC40;CFAP298;CCDC39
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.31131293964137685,-0.8218632074492412,0.6703296703296703,0.9146275754427631,1.0,7/13,28.59%,NR3C2;ABHD2;PLPP1;BMP7;AR;ESR2;PGR
prerank,adherens junction organization (GO:0034332),0.2919325073404235,0.821851186354641,0.7472160356347439,0.8867989002447526,1.0,13/48,20.29%,CTNNB1;CADM1;SMAD7;NECTIN3;PIP5K1C;NECTIN1;PAK2;JUP;PVR;CDH1;AFDN;CDH18;CDH24
prerank,response to ketone (GO:1901654),-0.25014515446026175,-0.8206395866139286,0.7942583732057417,0.9150353965074947,1.0,9/24,22.22%,ABHD2;UBE3A;THBS1;TGFB2;ABCB4;SLIT2;TGFBR3;SLIT3;NR1H3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.34442708555758894,0.8198824922636104,0.7140992167101827,0.8894565582840854,1.0,4/18,21.77%,DDHD1;VPS35;RALBP1;FIS1
prerank,positive regulation of blood coagulation (GO:0030194),0.3424155289934384,0.8192071865922301,0.7014725568942436,0.8901617462200976,1.0,5/17,17.51%,ANO6;SERPINF2;APOH;HPSE;SERPINE1
prerank,neurotransmitter uptake (GO:0001504),0.37189080367379296,0.818918998061862,0.7057220708446866,0.8902530267499972,1.0,1/12,0.83%,SLC38A1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.34716665771121047,0.8177841087448994,0.7169559412550067,0.8916464340831646,1.0,6/17,26.72%,SRD5A3;DPAGT1;ALG13;NUS1;ALG2;MPDU1
prerank,regulation of dopamine secretion (GO:0014059),0.32658343558264546,0.8174730639465306,0.7093596059113301,0.8917742434886495,1.0,4/25,11.69%,CHRNB2;DTNBP1;FGF20;SYT8
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2694429096281256,-0.8173257722146062,0.7536231884057971,0.9194408414336304,1.0,6/20,17.50%,HECW1;PRKCE;HECW2;ADRA2A;NEDD4L;OSR1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3214866172665024,0.8171199944157193,0.7434620174346201,0.8919871921976892,1.0,5/26,23.50%,P2RX4;TMEM106A;TNF;DDAH1;HSP90AB1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.31810654323763277,-0.816992054438678,0.6886446886446886,0.9181509744894724,1.0,3/11,13.62%,UQCRC1;UQCRFS1;UQCC3
prerank,heme biosynthetic process (GO:0006783),0.337546544626134,0.8167707278446512,0.7346437346437347,0.8921698854670015,1.0,5/22,15.26%,ALAS1;COX10;NFE2L1;HMBS;FLVCR1
prerank,peptide cross-linking (GO:0018149),0.3244819312152628,0.8167465427442897,0.752925877763329,0.8918687608220545,1.0,2/25,8.35%,FN1;TGM5
prerank,endothelial cell proliferation (GO:0001935),0.3423376129472771,0.8162302582854603,0.716931216931217,0.8923067791789481,1.0,4/17,21.55%,HMOX1;ERN1;ITGB1BP1;THAP1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.32855050257589224,-0.8156029700630377,0.678125,0.9188239031534083,1.0,3/10,17.19%,SALL1;PAX8;PAX2
prerank,snRNA metabolic process (GO:0016073),0.34305878286245467,0.815584800181809,0.6898817345597897,0.8929525510515859,1.0,7/17,28.15%,INTS6;ZCCHC8;INTS2;INTS3;INTS12;INTS1;INTS8
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2712053482759724,-0.8154216688414326,0.6943231441048034,0.9172871155375197,1.0,5/17,18.05%,RAPGEF2;ADRB1;ADRA2A;DRD2;GPR101
prerank,negative regulation of interleukin-10 production (GO:0032693),0.3466132685524704,0.8150035530556885,0.7263017356475301,0.8934784190718206,1.0,4/16,18.62%,CD274;LILRB1;TRIB2;TNFRSF21
prerank,purine nucleotide metabolic process (GO:0006163),0.3247202831986886,0.8148028390798253,0.731585518102372,0.8934526705643642,1.0,10/24,25.66%,XDH;PRPSAP1;ITPA;GART;PPAT;GUK1;PRPS2;ADSL;MTHFD1;NT5C2
prerank,cardiac muscle cell contraction (GO:0086003),0.33406661015883127,0.814630905458566,0.717948717948718,0.8933941848013599,1.0,8/19,22.48%,CACNA1D;KCNJ2;PKP2;ATP1A1;SCN1B;SCN3B;PIK3CA;GSN
prerank,central nervous system neuron differentiation (GO:0021953),0.3069659202626695,0.8141400740750221,0.7562130177514793,0.8937871467415134,1.0,5/33,11.10%,CTNNB1;LRP6;ATP7A;GBA2;AGTPBP1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.37643186848220894,0.8139075085408809,0.7232796486090776,0.8937920948781595,1.0,5/11,25.24%,STAP1;TICAM1;ITGB2;STX4;SPI1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.37407528970875825,0.8136975635378275,0.7258953168044077,0.893772499520642,1.0,2/12,7.56%,IL12RB1;SLC11A1
prerank,cellular response to osmotic stress (GO:0071470),-0.261985060370691,-0.8136689177181149,0.731404958677686,0.9188271897622823,1.0,4/21,10.38%,CAPN3;RCSD1;SCN2A;WNK3
prerank,tryptophan catabolic process (GO:0006569),-0.32002681434602237,-0.813659337663618,0.6866666666666666,0.916957773462801,1.0,3/11,16.00%,KMO;HAAO;AFMID
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.24554855108115975,-0.8130015164339528,0.7731481481481481,0.9162798539542272,1.0,9/24,21.50%,LEPR;NDUFS4;MRAP2;PPARGC1A;COX15;ACADVL;MTLN;GFPT2;SDHAF4
prerank,cellular response to copper ion (GO:0071280),0.3483465275044878,0.8122531261858917,0.7286501377410468,0.8956487804748366,1.0,3/16,23.20%,HSF1;MT2A;DAXX
prerank,ncRNA metabolic process (GO:0034660),0.302946418504289,0.8121786808334557,0.7497076023391813,0.8954093674242275,1.0,3/37,8.55%,AGO2;PIWIL2;DDX17
prerank,regulation of cell aging (GO:0090342),0.38541792282048304,0.8114839754764912,0.7130681818181818,0.8961206604416345,1.0,4/11,30.61%,NEK6;LMNA;RSL1D1;NEK4
prerank,regulation of cellular senescence (GO:2000772),0.3122953245694715,0.8114086941627371,0.7485101311084624,0.8958956406144639,1.0,11/28,30.61%,CDK6;NEK6;ZKSCAN3;TERT;FBXO5;RBL1;B2M;TERF2;YPEL3;RSL1D1;NEK4
prerank,negative regulation of cell communication (GO:0010648),0.330218916864764,0.8112325139920858,0.7131782945736435,0.8958305821641566,1.0,5/21,23.88%,SOCS5;BRAP;UBASH3B;PTPN1;OPRM1
prerank,ATP transport (GO:0015867),-0.32508971950786647,-0.8111616722801742,0.6970684039087948,0.9178039288189727,1.0,5/10,37.17%,SLC25A17;SLC25A4;ABCC6;SLC25A42;SLC25A41
prerank,reticulophagy (GO:0061709),0.3645771392838054,0.8111325031396489,0.7044817927170869,0.8956454815273411,1.0,5/12,27.43%,RETREG1;ATG2B;UFL1;UFM1;ATG2A
prerank,endoderm development (GO:0007492),0.3622838016747461,0.8108531427538428,0.7197278911564626,0.8957254754606027,1.0,2/13,17.03%,LAMC1;KIF16B
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.30403458650097265,-0.8102066984991796,0.7228070175438597,0.9175928073319405,1.0,3/12,8.81%,PARP8;PARP12;PARP11
prerank,protein localization to centrosome (GO:0071539),0.3467406510915682,0.8097322913314383,0.7265625,0.8970423128050793,1.0,4/17,11.49%,GOLGB1;SNX10;CSNK1D;HOOK3
prerank,regulation of muscle contraction (GO:0006937),-0.2418146742227859,-0.8097188924390885,0.7821229050279329,0.9166501710713988,1.0,9/26,25.48%,CHRM2;KCNB2;KCNA1;PPP1R12B;PLCE1;NMUR2;MYL2;MYBPC3;TNNT3
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.31216083782423126,0.8097147676637064,0.7115151515151515,0.8967261404712096,1.0,6/26,12.87%,NLRC3;ILRUN;ACOD1;LYAR;C1QBP;TNFAIP3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.23246975324788435,-0.8096925668617404,0.8045977011494253,0.9148281412208387,1.0,14/30,24.63%,SMURF2;SMAD2;PCSK6;NREP;LATS2;XIAP;DKK3;TRIM33;TWSG1;LTBP4;TGFBR3;SFRP4;TFAP2B;ENG
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3467097188443842,0.8096416462875451,0.7206851119894598,0.8965041158639773,1.0,5/17,11.28%,COX6A2;COX5B;COX10;COX7A2L;AFG1L
prerank,in utero embryonic development (GO:0001701),0.32259946121792277,0.8093789801948904,0.7456575682382134,0.8965654366168488,1.0,7/25,22.38%,VEGFA;CHD7;FLCN;TGFBR1;ZNF568;FGFR2;EGFL8
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.29616939066515824,-0.8092495831746964,0.7026022304832714,0.9137736543112831,1.0,3/13,6.52%,MEF2C;RBPJ;ERBB4
prerank,cellular biogenic amine metabolic process (GO:0006576),0.36973477439195335,0.8090982719903976,0.7148817802503477,0.8966453245226523,1.0,5/12,28.51%,TRH;ATP7A;ODC1;DDC;AMD1
prerank,regulation of actin filament-based movement (GO:1903115),0.3812362470029033,0.8087306092512461,0.7309859154929578,0.8968364014929957,1.0,2/10,16.44%,PDPN;SRI
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3408384616321074,0.8074682073841994,0.7266839378238342,0.8983300488421145,1.0,2/18,5.31%,PRKCB;SLC2A1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.31885334513928026,0.8074082868006547,0.7316770186335404,0.8980938955852918,1.0,5/24,18.88%,SLC27A1;LPGAT1;LPCAT1;SERAC1;PLA2G5
prerank,covalent chromatin modification (GO:0016569),0.3574185348541693,0.8061102003347854,0.7217514124293786,0.8996490696019229,1.0,4/14,22.18%,PARP2;HDAC1;UFL1;CHD1
prerank,prostaglandin biosynthetic process (GO:0001516),0.34180844829205237,0.8058764166238528,0.7361647361647362,0.8996378618497382,1.0,4/18,12.70%,PTGES;TBXAS1;CBR1;PTGIS
prerank,protein complex oligomerization (GO:0051259),0.27167203393676387,0.8058245614181112,0.8040904198062433,0.8993755623635857,1.0,20/85,21.28%,SLC9A1;ADCY8;ALS2;TMEM120B;TWNK;NINJ1;PDCD6IP;LRRC8D;EHD4;ZNHIT6;CPSF7;TRIM72;HOMER1;FUS;STOML2;ZC3H12A;BLM;NOL3;ARC;CLDN1
prerank,regulation of sodium ion transport (GO:0002028),0.3034460826785081,0.8054793400029363,0.748792270531401,0.899539279970198,1.0,10/34,20.54%,P2RX4;PRSS8;SIK1;PKP2;CNKSR3;ATP1A1;SCN1B;AHCYL1;SCN3B;NEDD4
prerank,cellular modified amino acid catabolic process (GO:0042219),0.34826556859019353,0.8053601688390675,0.7144808743169399,0.8993742531562856,1.0,1/15,1.40%,ABHD12
prerank,protein localization to lysosome (GO:0061462),0.3170365387884768,0.80387222576156,0.7673568818514007,0.9012205408764429,1.0,4/28,9.94%,ATP13A2;RNF128;GCC2;RAB7A
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.36814204984914844,0.8038119365024013,0.7074542897327707,0.9002969748664559,1.0,5/12,29.21%,NSMCE2;ANAPC7;CUL3;ANAPC11;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.36814204984914844,0.8038119365024013,0.7074542897327707,0.9002969748664559,1.0,5/12,29.21%,NSMCE2;ANAPC7;CUL3;ANAPC11;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.36814204984914844,0.8038119365024013,0.7074542897327707,0.9002969748664559,1.0,5/12,29.21%,NSMCE2;ANAPC7;CUL3;ANAPC11;CDC16
prerank,negative regulation of secretion (GO:0051048),-0.32041868004828317,-0.8035651148491519,0.7168458781362007,0.9222239935677331,1.0,3/10,12.62%,CD74;EGF;ERBB3
prerank,cobalamin metabolic process (GO:0009235),0.3434580039257727,0.8034198763694517,0.7337662337662337,0.900551826673216,1.0,2/17,8.75%,ABCD4;MTRR
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.28849817575562414,0.8034012457505014,0.77665544332211,0.9002459923556522,1.0,6/45,12.05%,PRKCD;IRF8;CD44;IRF5;IFNGR2;JAK1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.2995668098069666,0.8031019829652591,0.7737397420867527,0.9003356334335095,1.0,7/36,18.39%,BCL2;SGMS1;CSNK2A2;CRADD;TNF;QARS1;TGFBR1
prerank,mammary gland epithelium development (GO:0061180),-0.2789875811979451,-0.8024352004253636,0.7549407114624506,0.9223157124191618,1.0,2/14,6.52%,CSF1R;ERBB4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.2891044378675159,0.8023980598240558,0.752283105022831,0.9010219064933357,1.0,9/43,18.30%,PRKCD;PRKCB;PTPN2;NCK1;OGT;PID1;ZBTB7B;PIP4K2A;PTPN1
prerank,cytoplasmic translation (GO:0002181),0.26698649824202214,0.8023525579309171,0.8161764705882353,0.9007578531668645,1.0,20/91,18.17%,EIF4A1;UBA52;DRG1;ETF1;RPL10A;RPL12;EIF4A2;RPL36;RPS6;EIF3M;RPS28;RPL13A;RWDD1;RPS26;RPS27A;RPS12;TMA7;RPL18;RPS13;ZC3H15
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.34727309487363284,0.8023030504742088,0.7236315086782377,0.9005090180223717,1.0,4/16,28.35%,KLK6;PDE6G;PRMT5;ACP3
prerank,steroid hormone biosynthetic process (GO:0120178),0.30309875178893025,0.8021838108604604,0.7602905569007264,0.9003547012447248,1.0,7/29,25.16%,CYP19A1;SRD5A3;HSD17B8;MED1;SRD5A1;FDX1;SRD5A2
prerank,ubiquinone biosynthetic process (GO:0006744),0.35008849450161666,0.8019090121128867,0.7276478679504814,0.9004306643122268,1.0,5/15,24.68%,COQ10B;COQ5;COQ8B;COQ3;PDSS2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3233851955222814,0.8016817165338462,0.7571251548946716,0.9004276974743889,1.0,10/24,27.29%,BCL2L1;LPCAT3;WFS1;TXNDC12;XBP1;HERPUD1;SYVN1;RACK1;OPA1;CREB3
prerank,metal ion homeostasis (GO:0055065),0.2995818257703497,0.8011208124614342,0.7790563866513234,0.9008570300616334,1.0,7/40,13.89%,SELENON;CYP27B1;CNNM2;CAV1;SLC7A8;SLC8A1;SLC12A4
prerank,regulation of cellular localization (GO:0060341),-0.21278313171167806,-0.800799859920441,0.8809523809523809,0.9234563471791377,1.0,12/46,15.71%,EPHA5;MAP2;EFNA5;LRP5;FER;ADCY5;LRRK2;WWC1;GOSR1;PRKN;BRSK1;HSP90AA1
prerank,B cell mediated immunity (GO:0019724),-0.3170818618723869,-0.800367006565633,0.6933333333333334,0.9223506250822434,1.0,3/10,19.92%,CD74;FCGR2B;MSH2
prerank,response to ionizing radiation (GO:0010212),0.2743294923724489,0.799650560035049,0.8053763440860215,0.9026151341701,1.0,37/70,35.95%,GRB2;TANK;BRCA1;ABRAXAS1;EEF1D;KDM4D;INO80;RAD51AP1;UIMC1;BABAM2;FIGNL1;RAD9A;BLM;STK11;BRCC3;HUS1;TOPBP1;INTS3;RAD51;DCUN1D3;AEN;USP28;EYA3;IKBIP;LIG4;SPIDR;TP53;NABP2;CLK2;MRNIP;NHEJ1;RHNO1;NET1;PRKAA1;BABAM1;MYC;MEN1
prerank,cytosolic calcium ion transport (GO:0060401),0.3085929185461373,0.798834058946374,0.7773677736777368,0.9034806944555633,1.0,6/28,16.30%,ATP2B1;AFG3L2;CACNB3;SLC8A1;ATP2A2;JPH1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.2660526806518512,-0.7987436808673576,0.7470817120622568,0.9233665439972816,1.0,6/17,14.26%,KAT2B;RBPJ;WWC1;DLGAP5;PBX1;STAT1
prerank,regulation of osteoblast proliferation (GO:0033688),0.33301253738892017,0.7985904833595142,0.7288135593220338,0.9035050307407299,1.0,5/17,20.04%,NELL1;RHOA;HPSE;SFRP1;FGFR2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3176306123825674,0.7985236932592708,0.7842170160295932,0.9032635960300223,1.0,12/25,32.27%,AMPD2;PRPSAP1;GART;PPAT;APRT;PRPS2;ADSL;MTHFD1;SHMT1;ADK;HPRT1;SHMT2
prerank,synaptic vesicle cycle (GO:0099504),0.3085835991171286,0.7983549755841789,0.7661388550548112,0.9031628453042309,1.0,6/30,10.92%,CDK5;CPLX4;DNAJC5;RAB5A;PIP5K1C;VAMP2
prerank,protein O-linked mannosylation (GO:0035269),0.33740789980344277,0.7977317222427022,0.7636122177954847,0.9037222221167894,1.0,2/18,2.56%,LARGE1;B4GAT1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.32707805554985964,0.7976837430946769,0.7297650130548303,0.9034548896282355,1.0,5/20,22.48%,ANO6;IL6;PIAS4;ITGA4;GSN
prerank,gonad development (GO:0008406),0.2906229747755329,0.7970343224187714,0.7717889908256881,0.9040739489415749,1.0,6/41,13.07%,CYP19A1;SOX9;BASP1;COL9A3;KITLG;BIK
prerank,respiratory electron transport chain (GO:0022904),0.3510843847018736,0.7968790204208391,0.739612188365651,0.9039534979453022,1.0,4/14,19.91%,GPD2;SLC25A18;SDHB;SLC25A13
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.294477310819355,-0.7967259142021393,0.7276119402985075,0.9249893260816389,1.0,6/13,23.34%,GLRX3;YAE1;CIAO2A;BOLA2;CISD3;LTO1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.18549777790359778,-0.7963793374699788,0.9122807017543859,0.9237625348711801,1.0,17/87,13.62%,COX16;IMMP2L;NDUFS3;NDUFV3;UQCC2;NDUFB9;ACAD9;NDUFS4;NDUFS5;UQCRFS1;NDUFB7;NDUFA10;NDUFB10;FOXRED1;COX17;COA5;UQCC3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3200402163661198,0.7958874286574842,0.7815656565656566,0.9050267549043622,1.0,8/24,25.37%,SELENON;JPH1;SRI;CALM2;FKBP1B;GSTO1;CALM3;CAMK2D
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28808195015096694,0.7955639042177973,0.770414201183432,0.9051630624301733,1.0,13/41,21.82%,STAP1;FBXW7;NEDD9;ADAM17;GAS6;GPRC5B;FYN;EFNA1;DLG4;DOK7;PTPN1;PDGFB;NOX4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2647163299414246,0.7953716340490871,0.8489583333333334,0.9051139451013802,1.0,23/104,20.41%,SLC27A1;CAB39;CCNB1;HTT;GTPBP4;LRP6;BCCIP;CCNT2;CDKN3;TESK1;RHOA;SLC8A1;TRIB2;SERTAD1;PIH1D1;MNAT1;CDC25A;GTF2H1;CALM2;IRGM;MAP2K2;BLM;CCND1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.35881885821513865,0.7947331193917582,0.7408906882591093,0.9057029245252444,1.0,4/12,23.14%,DHRS3;SNW1;CALR;ASXL1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.2838628821527115,-0.794724173973994,0.7510373443983402,0.9247914043270473,1.0,3/15,7.28%,KCNJ3;KCNN2;KCND3
prerank,positive regulation of JNK cascade (GO:0046330),0.27041546664330507,0.7944403423909654,0.8068669527896996,0.9057802908785502,1.0,8/70,11.97%,SDCBP;MFHAS1;PTK2B;TRAF2;TRAF3;TAOK3;DUSP15;SERPINF2
prerank,muscle tissue morphogenesis (GO:0060415),-0.28421838677187644,-0.7938888535338575,0.7769230769230769,0.9244321711496615,1.0,5/16,24.65%,ZFPM1;BMP2;TGFBR3;HEY2;MYLK
prerank,hippo signaling (GO:0035329),0.3084358469066229,0.7936562072307103,0.76,0.9065307601031974,1.0,7/26,24.28%,TJP2;STK3;FAT4;LATS1;MOB1A;MOB1B;TEAD1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3137885201231025,0.7933608439393733,0.7620221948212084,0.9066268808274836,1.0,2/25,5.80%,HIF1A;NCKAP1L
prerank,positive regulation of ATPase activity (GO:0032781),0.28863318365050866,0.7932701866812595,0.7761363636363636,0.906422525245499,1.0,19/41,33.71%,TOR1AIP2;DNAJC10;CHTOP;DHX9;SETMAR;ATP1B3;MYL4;PFN1;HNRNPU;PLSCR1;TOR1AIP1;VMP1;PFN2;GABARAPL2;MSH3;DYNLL2;ATP1B2;SSBP1;ATP1B1
prerank,regulation of JNK cascade (GO:0046328),0.26360218364346455,0.793139325997511,0.8321167883211679,0.9062775387317057,1.0,17/101,19.31%,SIRPA;SDCBP;RAP2A;MFHAS1;PTK2B;TRAF2;TRAF3;TAOK3;IGF1R;DUSP15;SERPINF2;MINK1;DUSP3;DACT1;MAPK8IP3;HDAC3;TAOK1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.3714089088746548,0.79259660244846,0.7417974322396577,0.9066902528365545,1.0,4/11,23.47%,CAB39;CAV1;ACTN2;STK39
prerank,ceramide biosynthetic process (GO:0046513),0.2892871365607022,0.7925811632917235,0.7946635730858469,0.9063753855861589,1.0,15/40,28.89%,SGMS1;CERS6;SMPD4;ASAH1;ST8SIA6;SAMD8;B3GALT4;CLN8;SPTSSA;SGMS2;CERS5;B4GALNT1;AGK;SPTSSB;CERS2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.31503475515338003,0.7924348682600968,0.7598475222363406,0.9062462235005582,1.0,1/25,0.66%,P2RX4
prerank,pre-miRNA processing (GO:0031054),0.3531114877408447,0.7923413819091053,0.7483176312247645,0.9060469619912862,1.0,4/14,18.46%,AGO2;AGO3;AGO4;ADAR
prerank,energy reserve metabolic process (GO:0006112),-0.266270712465895,-0.7923085513764851,0.7757847533632287,0.9252396407946089,1.0,4/19,10.65%,LEPR;PYGL;MRAP2;UGP2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.26862239572246915,0.7922913989834444,0.8184747583243824,0.9057864495151333,1.0,24/83,26.00%,DYNC1H1;ODF2;HAUS8;NINL;DCTN1;ATF5;PPP2R1A;CSNK1D;YWHAG;CEP250;CEP41;CCP110;MAPRE1;TUBB;CETN2;ALMS1;CSNK1E;HAUS2;CDK2;CEP57;CDK5RAP2;SSNA1;DYNC1I2;NEK10
prerank,response to organonitrogen compound (GO:0010243),0.2915489673300825,0.7917372232813633,0.7757225433526012,0.9062550045526814,1.0,13/38,25.07%,VCP;IRF5;IL6;RNF185;KYNU;KAT7;DNAJB12;DERL1;DRD3;BRSK2;SYVN1;RRAGC;UBXN6
prerank,positive regulation of T cell cytokine production (GO:0002726),0.32467561817596413,0.791681740789382,0.7717250324254216,0.906006039276234,1.0,5/20,19.09%,TRAF2;MALT1;IL6;DENND1B;RSAD2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3212404858737279,0.7916803313269459,0.763681592039801,0.9056757377526197,1.0,11/23,32.88%,NLRC3;HDAC7;ADIPOR1;ZC3H12A;IFI35;SPI1;TSPAN6;PPM1A;PPM1B;ADGRG3;DDX3X
prerank,megakaryocyte differentiation (GO:0030219),-0.3079646287195287,-0.7916265362226034,0.7692307692307693,0.9245952159548063,1.0,2/11,12.77%,KIT;ZFPM1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2918473468368026,0.7911089428268078,0.7819025522041764,0.9061445786363728,1.0,9/39,20.54%,CACNA1D;SPHK2;FXYD4;WWP2;SCN1B;AHCYL1;SCN3B;HOMER1;NEDD4
prerank,cristae formation (GO:0042407),0.30938170137001275,0.7909765003455521,0.7648456057007126,0.9059983233913809,1.0,7/27,23.53%,SAMM50;IMMT;AFG3L2;ATP5MG;ATP5F1C;ATP5F1B;SPG7
prerank,ethanol metabolic process (GO:0006067),-0.3041165740386142,-0.7903590893570402,0.7491525423728813,0.9248388464543348,1.0,2/12,13.51%,ACSS1;ACSS2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3255523298000511,0.7901116890571934,0.7598475222363406,0.9068746099633804,1.0,3/20,8.10%,SLC27A1;FPGS;MTHFS
prerank,striated muscle contraction (GO:0006941),0.28049962479160084,0.7896958265147186,0.8063063063063063,0.9071310079762487,1.0,10/53,20.58%,GAA;ARHGEF11;ALDOA;STAC2;SLC8A1;SCN1B;MYL4;SCN3B;KLHL41;PIK3CA
prerank,regulation of lipid catabolic process (GO:0050994),-0.2546504104525383,-0.789690318517713,0.7946428571428571,0.9240862514884253,1.0,4/19,14.37%,PDE3B;ANGPTL3;IL1B;ADRA2A
prerank,blood circulation (GO:0008015),0.2823578787053661,0.7895920960727995,0.7973124300111982,0.9069495704521855,1.0,11/49,22.35%,MYOF;OLR1;C3AR1;DLL4;SCPEP1;EPO;ITGB1BP1;CYB5R3;NPR1;ROCK1;HCN4
prerank,cardiac atrium morphogenesis (GO:0003209),0.3369770458226904,0.7894286860100576,0.7513157894736842,0.9068556873644648,1.0,2/16,7.58%,SHOX2;DLL4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3461576964514148,0.7893443158909557,0.7686274509803922,0.9066448474040234,1.0,3/15,15.95%,LRP6;ANKRD11;HDAC1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2823895006589747,0.78920765946566,0.7986348122866894,0.9064937928145897,1.0,8/50,12.87%,SQSTM1;SMAD7;LIMK1;GTPBP4;CAV1;PRMT3;OGT;TNFAIP3
prerank,eye development (GO:0001654),0.2826682948300546,0.789109466150691,0.7919911012235817,0.9063022236389409,1.0,8/54,16.57%,SH3PXD2B;SMG9;BLOC1S3;SKI;CPAMD8;RBP4;MEIS3;RAB3GAP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.3331179772456924,0.7879723862937135,0.7622739018087855,0.9075560686025039,1.0,2/18,8.75%,ABCD4;MTRR
prerank,positive regulation of microtubule polymerization (GO:0031116),0.30525872863394615,0.787690736813588,0.7693251533742331,0.9076476606064564,1.0,8/28,18.40%,GIT1;DCTN1;DRG1;NUMA1;SLAIN2;CLIP1;MAPRE1;FES
prerank,positive regulation of neuron migration (GO:2001224),-0.3036131239446175,-0.7872644900317197,0.7319587628865979,0.9263248288882492,1.0,2/11,4.09%,SEMA6A;RAPGEF2
prerank,positive regulation of developmental growth (GO:0048639),0.2836899525812044,0.786921218044778,0.7966850828729282,0.9083858212511775,1.0,8/49,14.53%,MACF1;GOLGA4;ITSN2;RUFY3;LIMK1;PLAA;NTN1;CPNE6
prerank,negative regulation of catabolic process (GO:0009895),0.28343686424625697,0.7867168713856384,0.7954285714285714,0.9083303234207941,1.0,6/47,7.57%,APOA2;FLNA;HDAC4;SF3B3;AZIN1;GIT1
prerank,epithelial tube morphogenesis (GO:0060562),0.2970744790833058,0.7863898362863811,0.7593261131167268,0.9084306274137104,1.0,2/32,3.95%,CTNNB1;MTSS1
prerank,cardiolipin metabolic process (GO:0032048),0.35218045614629984,0.7861882261101535,0.7388268156424581,0.9083827306274439,1.0,4/13,22.93%,SLC27A1;PLA2G5;PTPMT1;TAMM41
prerank,Wnt signaling pathway (GO:0016055),0.26353104947266,0.7853535748932985,0.8476190476190476,0.909218007005108,1.0,21/92,25.12%,CTNNB1;PLPP3;VPS26A;WLS;UBA52;LRP6;FZD4;FZD1;FRAT1;VPS35;RPS27A;UBC;CSNK1G1;SFRP1;CUL1;FRZB;CSNK1E;TCF7;GSK3B;PTEN;CELSR2
prerank,negative regulation of lyase activity (GO:0051350),-0.27271972549535034,-0.7852898550230816,0.7787234042553192,0.9278400957913547,1.0,5/16,16.18%,CCR2;GRM3;EDNRB;DRD2;ADGRV1
prerank,negative regulation of cation channel activity (GO:2001258),0.30773370324042365,0.7850844999908051,0.7722289890377588,0.9092573063474754,1.0,10/26,28.50%,SRI;CALM2;FKBP1B;GSTO1;EPO;DRD3;UBQLN1;KCNAB1;CALM3;FMR1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3122551172654978,-0.7843650800028102,0.7492163009404389,0.9275873564808146,1.0,3/10,20.37%,ENPP2;PNPLA8;PLA2G15
prerank,ncRNA transcription (GO:0098781),0.3488339632069082,0.7843370447732014,0.7524613220815752,0.909975476215438,1.0,3/13,17.05%,SNAPC2;POLR1G;USPL1
prerank,negative regulation of DNA binding (GO:0043392),0.30073393798433457,0.78421970362372,0.7647783251231527,0.9098064111723915,1.0,3/28,8.48%,MDFI;ILRUN;JUN
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3195033389721751,0.7841654182927477,0.7807881773399015,0.9095557887576823,1.0,5/24,15.26%,ALAS1;COX10;NFE2L1;HMBS;FLVCR1
prerank,synaptic vesicle endocytosis (GO:0048488),0.29729988828448084,0.7838981348602552,0.7535885167464115,0.9095967976506253,1.0,8/33,13.03%,CDK5;CEL;ITSN2;PIP5K1C;DNM2;VAMP2;SYT8;GAK
prerank,mitotic nuclear division (GO:0140014),0.2666003878891744,0.7834262267797152,0.8147345612134345,0.9099347870333139,1.0,16/71,22.07%,CHMP4B;FLNA;NCAPG2;LSM14A;BCCIP;ABRAXAS1;PPP2R2D;RHOA;INO80;CHEK2;CENPK;UBE2C;GOLGA2;STAG1;TOGARAM2;KIFC1
prerank,fatty acid biosynthetic process (GO:0006633),0.271081890349541,0.7832565623525307,0.816304347826087,0.9098222662468387,1.0,4/63,4.23%,LPL;ACSBG2;ACACA;HACD2
prerank,protein localization to cell-cell junction (GO:0150105),0.33406345826166023,0.78299762717189,0.7660130718954249,0.9098612452414324,1.0,3/15,12.05%,TJP2;PAK2;JAK1
prerank,cellular response to purine-containing compound (GO:0071415),-0.32068077958262936,-0.7827567779958547,0.7625418060200669,0.9282685730757927,1.0,1/10,2.04%,RYR3
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2703483260354326,0.7827512503877513,0.8032608695652174,0.909881700160046,1.0,10/64,16.91%,AIG1;MGLL;ACSBG2;ACSL1;CYP1B1;ACADL;CPT1A;SCP2;ACSBG1;ACOT1
prerank,protein secretion (GO:0009306),0.2785072396278148,0.7825185251457563,0.8144104803493449,0.9098670489074397,1.0,8/56,14.27%,ABCA1;RAB8B;WLS;SNX19;CYB5R4;VIP;GOLPH3;ARFGAP3
prerank,regulation of gastrulation (GO:0010470),-0.2834508481345882,-0.7823682196675372,0.7977099236641222,0.9271194541510933,1.0,3/14,4.98%,POGLUT1;CLASP2;TENM4
prerank,potassium ion transport (GO:0006813),0.25615248226680315,0.782241324445755,0.8802889576883385,0.9099082321816975,1.0,11/120,6.19%,SLC9A1;KCNK13;KCNMA1;LRRC52;KCNA3;KCNJ2;CCDC51;SLC9A8;SLC24A4;SLC9A7;SLC9A6
prerank,protein destabilization (GO:0031648),0.29636497532230477,0.781914015571964,0.7905325443786982,0.9100278121137888,1.0,14/32,29.20%,HTT;MDM2;FBXW11;IRGM;DERL1;CREBBP;GSN;EP300;CUL3;FBXL3;GGA3;PEX2;RAD23A;BTRC
prerank,negative regulation of response to wounding (GO:1903035),0.32649575795706076,0.7816646485263241,0.7553865652724968,0.9100315924962575,1.0,5/19,17.51%,FGF2;CLDN19;GIT1;CRK;SERPINE1
prerank,type I interferon signaling pathway (GO:0060337),0.2893364292514129,0.781475472252923,0.796037296037296,0.9096301139474133,1.0,13/41,26.60%,IRF8;IRF5;RNASEL;JAK1;BST2;ADAR;RSAD2;IFNAR2;IFI35;IRAK1;PSMB8;EGR1;IRF3
prerank,cellular response to type I interferon (GO:0071357),0.2893364292514129,0.781475472252923,0.796037296037296,0.9096301139474133,1.0,13/41,26.60%,IRF8;IRF5;RNASEL;JAK1;BST2;ADAR;RSAD2;IFNAR2;IFI35;IRAK1;PSMB8;EGR1;IRF3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.35487583402977485,0.7814421278579115,0.7691237830319889,0.9093490217339173,1.0,5/13,27.16%,CD44;MDM2;PTTG1IP;KDM1A;PSMD10
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.26774877616952186,-0.7810875326864172,0.8024193548387096,0.9274206162052442,1.0,5/17,15.12%,CCR2;CCR1;AIF1;LGMN;CCL5
prerank,positive regulation of protein polymerization (GO:0032273),0.2676536198241943,0.7806981903248844,0.8282608695652174,0.9100237282154486,1.0,19/65,21.06%,PTK2B;NCKAP1L;DCTN1;DRG1;BAIAP2;NUMA1;NCK1;EVL;SLAIN2;CLIP1;BAIAP2L1;MAPRE1;VASP;BAIAP2L2;PFN1;FES;CDC42EP1;ARF6;NCK2
prerank,positive regulation of histone modification (GO:0031058),0.2977493390461604,0.7805607416861153,0.7757793764988009,0.9098755063418175,1.0,12/33,26.47%,FAM47E;BRCA1;SAP30BP;CHTOP;ZBTB7B;MAPK3;RUVBL2;SART3;GLYR1;KDM1A;APLNR;BRD7
prerank,phasic smooth muscle contraction (GO:0014821),0.36505097724057595,0.780417627577098,0.7485294117647059,0.9097319051518112,1.0,4/10,26.37%,HTR2B;PTGER3;GDNF;HTR1D
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3540068784262784,0.7801405690781136,0.7848101265822784,0.9097688674784175,1.0,6/12,32.34%,TMEM199;CLN3;TMEM165;VPS33A;PPT1;CCDC115
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.24846269225929385,-0.7799842199179776,0.8078602620087336,0.9274809292885059,1.0,8/18,26.68%,KCNB1;PRKN;REST;ADRA2A;IRS1;CCN3;MIDN;FFAR4
prerank,cellular response to organonitrogen compound (GO:0071417),0.25872898441669184,0.7779212666158132,0.8471204188481676,0.9124188839997929,1.0,25/99,23.03%,CTNNB1;P2RX4;RRAGD;IPO5;CPEB4;SOX9;LARP1;BRCA1;JUP;P2RY2;GOLPH3;CPEB1;LARS1;SESN2;CPEB3;SFRP1;NSMF;LAMTOR3;CDH1;LAMTOR1;XBP1;AANAT;HCN4;HSP90B1;RRAGC
prerank,mismatch repair (GO:0006298),0.3057389498051863,0.7778980937874276,0.7749077490774908,0.9121253703856811,1.0,13/27,34.50%,RNASEH2A;ERCC1;PMS1;LIG1;PMS2;ABL1;MSH5;SETD2;MSH3;MCM9;POLD4;RPA3;EXO1
prerank,serine family amino acid catabolic process (GO:0009071),0.3730953461757084,0.7773079872140034,0.7572674418604651,0.9125782839723109,1.0,6/10,35.73%,AMT;GCSH;CBS;SHMT1;SHMT2;THNSL2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.35968040416976627,0.7772716135203284,0.7442196531791907,0.9122901810116937,1.0,6/11,31.26%,EXOSC10;DKC1;EXOSC5;EXOSC4;TENT4B;EXOSC3
prerank,regulation of establishment of cell polarity (GO:2000114),0.33476698321098974,0.7765169920118752,0.7823218997361477,0.9129378506843234,1.0,7/16,22.98%,PTK2B;RUFY3;ARFGEF1;KRIT1;ROCK1;GSN;RACK1
prerank,phospholipid translocation (GO:0045332),0.2975117215688638,0.7764341878886678,0.7945544554455446,0.9127199774151923,1.0,3/28,7.33%,ABCA1;ATP9B;ANO6
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.32167833155594155,0.776065234050587,0.7739463601532567,0.9128847667271014,1.0,3/20,10.33%,ACACA;SLC25A1;HSD17B8
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.34645936585804266,0.7752806432572558,0.7557803468208093,0.9135873741559496,1.0,4/12,24.12%,EAPP;RECQL5;HNRNPU;NELFA
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37359326808618565,0.7752619126739567,0.7522255192878339,0.9132814399528622,1.0,5/10,29.08%,C1QBP;RIOK3;GPATCH3;TSPAN6;TKFC
prerank,regulation of ion transport (GO:0043269),0.26351431190906915,0.7748610430017187,0.8391534391534392,0.9134840567068646,1.0,10/76,12.14%,P2RX4;CHRNB2;DTNBP1;KCNJ2;SIK1;FGF20;WWP2;VAMP2;SYT8;ATP1A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3631427257395436,0.7745255755645959,0.7657393850658858,0.9135910390170907,1.0,7/11,33.07%,DHX9;PUM1;PUM2;WTIP;FMR1;FXR1;XPO5
prerank,innate immune response in mucosa (GO:0002227),-0.3104607934110544,-0.7738339081085525,0.750788643533123,0.9354414437087525,1.0,3/10,25.57%,RPL39;CAMP;LTF
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3575261738984824,0.773816132309535,0.7699724517906336,0.9142358529394733,1.0,1/11,5.85%,JAG1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2981777983433459,0.7734992927505864,0.7709832134292566,0.914338370481535,1.0,7/31,21.65%,SMAD7;DLL4;PKP2;TGFBR1;FGFR2;TGFB1;NOTCH1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.37094338594995674,0.7734652311147493,0.7693409742120344,0.9140577791401678,1.0,6/10,26.77%,PPARG;SNW1;RXRB;RXRA;ACTN4;RXRG
prerank,bile acid biosynthetic process (GO:0006699),0.30840188947307656,0.7734253748329937,0.77625,0.9137848686970287,1.0,6/24,19.02%,SLC27A5;CH25H;OSBPL2;OSBP;SCP2;ABCB11
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2398694219861517,-0.7726077440789901,0.8055555555555556,0.9354973947777818,1.0,8/23,18.00%,GABPA;TGM2;APLP1;LRRK2;ADCY6;PRKN;PDE4B;GNG2
prerank,endocardial cushion morphogenesis (GO:0003203),0.3273385894827341,0.7721111674221567,0.7870967741935484,0.9151549521374778,1.0,2/18,10.71%,SOX9;TGFBR2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2794107360102654,-0.7719905181535638,0.8093525179856115,0.9346375408961032,1.0,6/13,30.25%,CSTF2T;CPSF6;CPSF4L;NCBP1;CPSF1;CPSF2
prerank,signal peptide processing (GO:0006465),0.36455148954576677,0.771762759620307,0.7332361516034985,0.9152693210751854,1.0,6/11,24.42%,SPCS3;PARL;FURIN;SPPL3;HM13;SEC11A
prerank,mitochondrion localization (GO:0051646),-0.2552528574496485,-0.7716815505729672,0.8008849557522124,0.9332939699844578,1.0,7/19,19.18%,ATCAY;LRRK2;HAP1;NECTIN2;MSTO1;MEF2A;BRAT1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.28775641467030305,0.7705194289751496,0.7892857142857143,0.9165560816164801,1.0,10/34,24.16%,IL6;TRIB2;TNF;FLCN;ANKRD26;TGFB1;SIRT2;ASXL1;FOXO1;CCDC85B
prerank,cellular response to sterol (GO:0036315),-0.2932322534638967,-0.7701532553626556,0.7835820895522388,0.9339276370247498,1.0,7/13,26.64%,INSIG1;INSIG2;GPLD1;OSBPL7;GRAMD1A;SMO;RORA
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.26980827595824386,0.7692239373957469,0.8231441048034934,0.9179498230079294,1.0,7/57,14.62%,IGF1;VEGFA;PTPN2;PPP2R1A;IL6;IL2;TNF
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3242601843245183,0.7688417384739449,0.7776315789473685,0.9181336060786598,1.0,5/18,22.04%,UBA52;RPS27A;UBC;RNF185;SYVN1
prerank,regulation of cell size (GO:0008361),0.30639148826805973,0.7686565758052789,0.7959949937421777,0.9180452560299643,1.0,10/23,27.68%,PLEK;MSN;RHOA;LARS1;VAV1;PTEN;AKT1S1;VAV3;RAC1;MTPN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.30918805330383353,-0.7684882744435757,0.7542087542087542,0.9345410132535062,1.0,4/10,15.35%,EMC2;MMGT1;EMC6;EMC10
prerank,focal adhesion assembly (GO:0048041),0.3112950286863053,0.7684084180432216,0.785622593068036,0.9180214952261129,1.0,4/21,15.76%,PEAK1;RHOD;ACTN1;PIP5K1A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2613378040519892,0.7681848776860498,0.8586723768736617,0.91766392811287,1.0,28/78,28.64%,CTSD;DYNC1H1;SEC24A;DCTN1;DNM2;DYNC1LI2;KLC1;RAB7A;AP1M1;DCTN6;AP1G1;RILP;PIKFYVE;CTSL;SEC24D;CAPZB;LAG3;FCER1G;DCTN5;KIF3A;SEC24B;DYNC1I2;CANX;CLTA;AP2B1;SEC23A;CTSE;DCTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2613378040519892,0.7681848776860498,0.8586723768736617,0.91766392811287,1.0,28/78,28.64%,CTSD;DYNC1H1;SEC24A;DCTN1;DNM2;DYNC1LI2;KLC1;RAB7A;AP1M1;DCTN6;AP1G1;RILP;PIKFYVE;CTSL;SEC24D;CAPZB;LAG3;FCER1G;DCTN5;KIF3A;SEC24B;DYNC1I2;CANX;CLTA;AP2B1;SEC23A;CTSE;DCTN2
prerank,determination of heart left/right asymmetry (GO:0061371),0.2844700673452083,0.7680174136241146,0.8227990970654627,0.9175725207161943,1.0,10/43,27.01%,MICAL2;SRF;TGFBR2;DAND5;CCDC40;NOTCH1;APLNR;MEGF8;BBS7;CCDC39
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.2899890358899562,-0.7663226606505014,0.7816091954022989,0.9360994436833503,1.0,6/13,22.28%,OAS2;STAT3;EBI3;STAT1;IL6ST;IL27RA
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3357667868333878,0.766311783672794,0.780250347705146,0.9194927523685701,1.0,5/14,25.17%,CSF1;AKIRIN1;MAPK3;IL34;MAPK1
prerank,regulation of protein acetylation (GO:1901983),-0.2787126565887677,-0.7662051262096661,0.7947761194029851,0.9344821282756197,1.0,2/12,7.59%,RAPGEF3;KAT5
prerank,ERBB2 signaling pathway (GO:0038128),0.2916044688361379,0.76579869058295,0.8134777376654633,0.9198281665696334,1.0,5/31,12.67%,GRB2;ERBIN;MYOC;CPNE3;PTPN18
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.33503491654722656,0.7657214585003103,0.7742382271468145,0.9195935366834629,1.0,2/15,4.65%,PPARD;PPARG
prerank,regulation of secretion by cell (GO:1903530),0.2728725913966889,0.7656442905657216,0.8325991189427313,0.9193646558856542,1.0,12/54,18.24%,MCTP1;RHBDF2;CPLX4;RIC1;RAB8B;LLGL2;VAMP2;LLGL1;DNAJC1;DISP1;CPLX2;VAMP3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.282201126389778,-0.7655765958688441,0.7992125984251969,0.9335857035779401,1.0,5/14,19.84%,DHX58;DDX60;TLR5;ZCCHC3;TLR9
prerank,regulation of protein localization to cell surface (GO:2000008),0.286517879701598,0.7651284282763321,0.8058479532163743,0.9196912010686314,1.0,11/33,28.57%,CTNNB1;SNX33;STX3;TNF;ABCA7;ACTN2;HSP90AB1;STX4;RAB11B;LEPROT;RAB11FIP5
prerank,ribosomal large subunit assembly (GO:0000027),0.3076425957750298,0.7649001279753257,0.791970802919708,0.9196609781731128,1.0,4/24,13.74%,BRIX1;MDN1;PPAN;FASTKD2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.36755351386158686,0.7643060887938765,0.7421652421652422,0.9197562601366699,1.0,3/10,15.14%,PPP3R1;PPP3CC;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.36755351386158686,0.7643060887938765,0.7421652421652422,0.9197562601366699,1.0,3/10,15.14%,PPP3R1;PPP3CC;NFATC3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.35316296484300647,0.7642929151171829,0.7730496453900709,0.9194423143469864,1.0,3/12,11.84%,CAV1;PKP2;JUP
prerank,apoptotic DNA fragmentation (GO:0006309),0.3299189655008449,0.7642390857200984,0.7816711590296496,0.9191742564637825,1.0,2/16,9.48%,DNASE2;DFFB
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.34293522323829795,0.7641168460514389,0.7783857729138167,0.9190177238665942,1.0,5/13,26.72%,SRD5A3;DPAGT1;ALG13;ALG2;MPDU1
prerank,lung epithelium development (GO:0060428),0.3723661751157452,0.7635482513290742,0.7564102564102564,0.9194181417414644,1.0,1/10,3.44%,FOXJ1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.3486938775721044,0.763372171474894,0.790257104194858,0.919312810583858,1.0,4/13,19.52%,NAPEPLD;ZBTB7B;METRNL;HNRNPU
prerank,negative regulation of ion transport (GO:0043271),-0.23631973513176152,-0.762842694297182,0.8714285714285714,0.93595179267945,1.0,7/24,16.05%,CD33;GPM6B;WNK1;WNK3;ADRA2A;NOS1;INPP5K
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28874956671902274,0.7627140541316755,0.8081048867699643,0.9198032904535188,1.0,8/35,16.29%,MBD4;ADPRS;RFC2;POLE;LIG3;LIG1;RFC1;PNKP
prerank,sensory perception of sound (GO:0007605),0.25665847446269763,0.762423044715614,0.8654048370136698,0.9198494642933902,1.0,12/88,14.30%,CHRNB2;MYO1A;GRXCR1;CACNA1D;TPRN;HOMER2;SLC26A4;MYO7A;MYO3B;USP53;ATP6V0A4;CLIC5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.30927662105933706,-0.7622373797721539,0.7704918032786885,0.9350366989792773,1.0,5/10,25.09%,BIN1;CBARP;ADRA2A;VDAC1;PLN
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.23555164957437216,-0.7620445067550944,0.8341232227488151,0.9335588489644445,1.0,10/22,28.45%,PPM1E;PPP1CA;PPP2CA;PDP1;PPM1G;DUSP1;DUSP7;DUSP5;DUSP8;DUSP2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.29622131422949255,0.7613922234656308,0.7895377128953771,0.9208409882932624,1.0,5/29,21.65%,SMAD7;PKP2;FGFR2;TGFB1;NOTCH1
prerank,positive regulation of cyclase activity (GO:0031281),0.33753149912288477,0.7604518683465425,0.7875507442489851,0.9217658876321396,1.0,4/14,17.75%,CACNA1D;NF1;ORAI1;MAPK3
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.2297941521721366,-0.7598506732918022,0.87,0.934933261022812,1.0,4/25,7.64%,FUT9;B3GALT5;B3GALT1;NDST3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.3095454906531092,0.7597037115232729,0.7967581047381546,0.9223924989209026,1.0,5/22,20.99%,RUNX1;BCL6;IL2;FANCA;LAG3
prerank,protein K11-linked ubiquitination (GO:0070979),0.29591653113257815,0.7596128626788315,0.797979797979798,0.9221756861978022,1.0,6/27,17.94%,FZR1;ANAPC1;UBE2L3;CDC26;UBE2H;UBE2C
prerank,icosanoid metabolic process (GO:0006690),0.28337493177982737,0.7592810104086538,0.8229166666666666,0.9222812277795643,1.0,7/40,12.90%,MGLL;PON1;TBXAS1;CYP1B1;DPEP2;PTGIS;MAPKAPK2
prerank,histone acetylation (GO:0016573),0.25601787984266017,0.7584582039096922,0.8454054054054054,0.9229794628444942,1.0,25/69,26.23%,ING4;ZZZ3;EP400;MSL3;MRGBP;MORF4L2;YEATS2;PHF20L1;WDR5;KAT7;TAF5L;RUVBL2;BRD8;HAT1;BRD1;DMAP1;CREBBP;JADE3;NAA40;NAA50;EP300;TADA1;SPI1;KAT8;TAF6
prerank,protein depolymerization (GO:0051261),0.2958839689190981,0.7583339001533657,0.8174019607843137,0.9228077707006362,1.0,2/27,3.21%,MICAL2;MICAL1
prerank,membrane depolarization during action potential (GO:0086010),0.29656028860237177,0.758146858477551,0.8138686131386861,0.9227045628191435,1.0,8/26,23.67%,CACNA1D;KCNJ2;SLC8A1;SCN1B;SCN3B;SCN10A;HCN4;ATP1A2
prerank,purine ribonucleotide transport (GO:0015868),0.3237037938139356,0.7580331885726808,0.7844474761255116,0.9225201623063279,1.0,5/16,23.61%,LRRC8D;SLC19A1;SLC17A9;ABCC5;LRRC8C
prerank,peptidyl-proline modification (GO:0018208),0.29750634699062695,0.7579935114801735,0.785012285012285,0.9222402547898501,1.0,8/25,19.62%,OGFOD1;NKTR;PPIE;PPIG;PPIL6;PIN1;FKBP1B;NTMT1
prerank,amino sugar metabolic process (GO:0006040),0.35964789342903825,0.7579603674042037,0.7532656023222061,0.9219472580048764,1.0,2/10,14.02%,ST6GAL1;EXTL2
prerank,protein prenylation (GO:0018342),0.3607220947215899,0.7575346500598764,0.7817109144542773,0.9221795529625899,1.0,5/10,31.63%,RABGGTB;PTAR1;PGGT1B;RABGGTA;CHML
prerank,ribosomal small subunit assembly (GO:0000028),0.31858062610838456,0.7573553255728075,0.7703412073490814,0.922060153321643,1.0,8/16,32.88%,RRP7A;RPS28;MRPS7;RPS19;XRCC5;PRKDC;ABT1;RPS27
prerank,establishment of endothelial barrier (GO:0061028),0.29300162518509393,0.7566546348104838,0.8242424242424242,0.9226314788045072,1.0,5/29,11.55%,TJP2;MSN;MYADM;RAB1A;RAPGEF6
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2693363834273812,0.7563372221643415,0.8464961067853171,0.922711049322869,1.0,2/49,3.49%,IGF1;VEGFA
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.33662395746148,0.7562225054013644,0.7789757412398922,0.9225374226071287,1.0,3/14,9.59%,MALT1;NFKBIZ;SOCS5
prerank,response to peptide hormone (GO:0043434),0.27275609044984356,0.7548752508893082,0.8304696449026346,0.9239197943587419,1.0,11/43,25.38%,EIF6;SLC27A1;CAV1;OGT;ZBED3;ZBTB7B;EIF2B2;XBP1;ROCK1;EPM2AIP1;STAT6
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2548853455745236,0.7542528294698444,0.8916929547844374,0.9243482544514443,1.0,27/95,26.12%,DYNC1H1;ODF2;HAUS8;NINL;DCTN1;PPP2R1A;CSNK1D;TCTN3;YWHAG;MARK4;CEP250;CEP41;CCP110;MAPRE1;CEP83;TUBB;CETN2;ALMS1;CSNK1E;HAUS2;CEP57;TMEM216;CDK5RAP2;SSNA1;DYNC1I2;CEP97;TTBK2
prerank,protein targeting to peroxisome (GO:0006625),0.2939449540379142,0.754236805373603,0.8236714975845411,0.9240435629033636,1.0,12/29,28.97%,ABCD2;RAB8B;ALDH3A2;PEX14;ACBD5;PXMP2;FIS1;PEX6;PEX1;LONP2;PEX2;PEX19
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2656215373905951,-0.7540362839311747,0.7448559670781894,0.9415758520333777,1.0,6/15,17.37%,C2CD3;CEP192;CCDC14;STIL;BBS4;CEP131
prerank,dephosphorylation (GO:0016311),0.24562658123017134,0.7534494344925238,0.9061224489795918,0.9247148893937929,1.0,33/147,21.57%,PTPRA;PTPRC;PPM1H;PLPP6;DUSP9;PPM1J;PPP2R5C;PTPRM;PLPP3;TAB1;PPP2R1A;PHPT1;PTPN21;DUSP15;PTPN18;DUSP12;FBXW11;DUSP11;CTDNEP1;CTDSP2;PPP3CC;PNKP;PPP6C;MTMR6;DUSP3;PTPN1;PPP1R12A;PTPN6;STK11;PLPP5;DUSP23;PPP4R2;DUSP6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.30645792434114344,0.7532813374809965,0.8185328185328186,0.9245872048274134,1.0,4/22,16.84%,IPO5;CEBPA;CDK5RAP1;LATS1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3346932630284185,0.7515918655098136,0.7793296089385475,0.9263447488410772,1.0,2/14,10.58%,FGF2;SPRY4
prerank,cell junction assembly (GO:0034329),0.24952886711879546,0.7515890014607777,0.8813025210084033,0.926018830700893,1.0,19/100,20.29%,FBLIM1;FN1;TLN1;CDK5;PCDHB10;FLNA;PKP2;PLXND1;LIMS1;RHOA;MYO9A;ILK;PKP4;FLCN;VASP;FARP1;CDH1;CDH18;CDH24
prerank,regulation of response to external stimulus (GO:0032101),0.24371402900789343,0.7515156842080324,0.9009193054136875,0.9257813262589508,1.0,12/121,8.84%,P2RX4;FGR;MGLL;PTGES;STK24;TRAF3;APPL2;BRD4;CELF1;BCL6;CAV1;TREM2
prerank,protein mannosylation (GO:0035268),0.30297559011611275,0.7510493036148446,0.8256997455470738,0.9260585738462772,1.0,2/22,2.56%,LARGE1;B4GAT1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2548317847471266,0.7506455544355375,0.8764643237486688,0.9262548482014287,1.0,28/79,28.64%,CTSD;DYNC1H1;SEC24A;DCTN1;DNM2;DYNC1LI2;KLC1;RAB7A;AP1M1;DCTN6;AP1G1;RILP;PIKFYVE;CTSL;SEC24D;CAPZB;LAG3;FCER1G;DCTN5;KIF3A;SEC24B;DYNC1I2;CANX;CLTA;AP2B1;SEC23A;CTSE;DCTN2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.345279678011145,0.7504829531334077,0.7828492392807745,0.9261184477502423,1.0,3/12,15.02%,PTK2B;IL6;DOCK11
prerank,regulation of catecholamine secretion (GO:0050433),0.29402337032795073,0.74999946317133,0.8090575275397797,0.926407022616604,1.0,4/29,11.69%,CHRNB2;DTNBP1;FGF20;SYT8
prerank,cellular response to nitrogen compound (GO:1901699),0.31341500102325254,0.7499270788092017,0.796078431372549,0.9261870395682308,1.0,8/20,33.05%,DDI2;RIOK3;HSF1;BLM;DAXX;FMR1;SPIDR;NSMCE3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.22824392883082162,-0.7496046244198094,0.8636363636363636,0.946071969016091,1.0,6/23,16.25%,MTMR9;MTMR7;PIP4P1;INPP5J;INPP5K;SACM1L
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3076242045163111,-0.7494767264907216,0.780952380952381,0.9444777719354596,1.0,3/10,9.43%,CST3;DPP4;FAP
prerank,regulation of insulin secretion (GO:0050796),0.24855251966830696,0.7491979289870841,0.8817427385892116,0.9267287396522731,1.0,15/101,17.53%,CACNA1A;TRH;GCK;CACNA1D;SLC2A1;SLC8B1;CDK16;GLP1R;IL6;TNF;AACS;RBP4;SIRT4;GIPR;SFRP1
prerank,isotype switching (GO:0045190),-0.3072582569976002,-0.7491073146180245,0.7830508474576271,0.9431867249396778,1.0,4/10,20.33%,RNF168;CCR6;MSH2;MSH6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3137386790775244,0.74861792790488,0.7974193548387096,0.9271161190109003,1.0,3/19,6.15%,FOXJ1;CLIC4;ERBIN
prerank,cardiac muscle cell development (GO:0055013),0.30809779982613733,0.748560060709848,0.821882951653944,0.9268572813978627,1.0,3/20,12.09%,VEGFA;ALPK3;SLC8A1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3084228787043474,0.7475721323117549,0.7803921568627451,0.9277314662224515,1.0,8/19,30.93%,PIPOX;DLST;SLC25A21;PHYKPL;GCDH;AASS;OGDH;GOT1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2974300640360401,-0.7475144738014792,0.7674418604651163,0.9435435960463026,1.0,4/11,25.56%,TIMM10B;TOMM70;TIMM29;TIMM10
prerank,ear morphogenesis (GO:0042471),-0.24457239823506158,-0.7474700777612102,0.8623853211009175,0.9418380859846257,1.0,10/20,38.17%,MYO6;PAX8;PAX2;OSR1;TWIST1;ZIC1;TMIE;TBX1;TFAP2A;ATP6V1B1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2550924385108624,0.7467633994923224,0.8700322234156821,0.928416476638641,1.0,23/76,28.13%,SASH1;NLRC3;TRIM6;SPHK1;HDAC7;ADIPOR1;LIMS1;RHOA;ILK;TNF;TLR7;ZC3H12A;IFI35;IRAK1;TCIM;ACTN4;EP300;SPI1;TLR3;TERF2IP;TSPAN6;TRADD;PPM1A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2617337868618339,-0.7464831260057072,0.84251968503937,0.9414788238451044,1.0,7/15,24.01%,TIPIN;NEK11;RAD9B;MUS81;RAD17;EME1;FANCD2
prerank,tRNA 5'-leader removal (GO:0001682),0.3366110520523464,0.7464217373222566,0.7953615279672579,0.9285175985247907,1.0,5/13,30.68%,PRORP;RPP38;POP1;RPP25L;SSB
prerank,synaptonemal complex organization (GO:0070193),0.32712835179359834,0.746096115302539,0.7902374670184696,0.9282679366050549,1.0,5/15,29.38%,TRIP13;SYCP2;SYCE2;TEX11;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.32712835179359834,0.746096115302539,0.7902374670184696,0.9282679366050549,1.0,5/15,29.38%,TRIP13;SYCP2;SYCE2;TEX11;P3H4
prerank,triglyceride biosynthetic process (GO:0019432),0.3153207472222023,0.7460368224828021,0.7896825396825397,0.9280143590961187,1.0,5/18,19.77%,GK;PCK2;LPGAT1;LPIN3;DGAT1
prerank,negative regulation of mRNA processing (GO:0050686),0.3257242036488841,0.7459718212706354,0.7906666666666666,0.9277671736471761,1.0,8/15,35.19%,C1QBP;SRSF7;SRSF10;PCBP4;PTBP1;SAP18;BARD1;SFSWAP
prerank,granulocyte differentiation (GO:0030851),0.3091347123654772,0.7459285270288387,0.7986842105263158,0.9274953182872011,1.0,7/18,25.24%,CEBPA;CDK4;DEK;RXRA;CDK2;EP300;SPI1
prerank,regulation of actin nucleation (GO:0051125),0.3430223198634761,0.7458544884766694,0.7900709219858156,0.9272601771790742,1.0,3/12,22.48%,WASHC5;CORO1B;GSN
prerank,purine ribonucleotide catabolic process (GO:0009154),0.30511524680909685,0.7452504081178711,0.8072916666666666,0.927645503306341,1.0,1/21,1.27%,XDH
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24068045626256607,-0.7449371928005949,0.8838174273858921,0.9417249177591799,1.0,9/21,22.43%,APC;BUB1;CENPF;MAD2L1;KNTC1;ZW10;TTK;PLK1;MAD2L2
prerank,adenine nucleotide transport (GO:0051503),0.3162586108272185,0.7448854358748219,0.8092643051771117,0.9277539112014515,1.0,5/17,23.61%,LRRC8D;SLC19A1;SLC17A9;ABCC5;LRRC8C
prerank,T cell migration (GO:0072678),0.3338481241325565,0.7445924470869738,0.8051771117166212,0.9277823425947365,1.0,6/13,30.09%,MSN;CCL3;CXCL16;S1PR1;GPR183;PIK3CG
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2740572105700195,0.7429533651130599,0.8482352941176471,0.9293812066644662,1.0,5/39,15.25%,TRH;GCK;CRH;AACS;RBP4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3196829058181309,0.7427266539157829,0.8160315374507228,0.9293193579153414,1.0,2/17,5.17%,CCNY;ADAM17
prerank,regulation of chromatin organization (GO:1902275),0.3292391763300305,0.7427090781259524,0.7861035422343324,0.9290140959358545,1.0,6/14,33.34%,TLK1;HPF1;HNRNPU;PARG;SETD1A;CDK9
prerank,embryonic organ development (GO:0048568),0.26116734028694377,0.7426045663936061,0.8621064060803475,0.9288208972693927,1.0,13/61,20.90%,KMT2A;PDGFA;NES;TGFBR2;KITLG;PKDCC;IFT122;TNF;RBP4;TBC1D23;FGFR2;TGFB1;GDNF
prerank,sensory perception of light stimulus (GO:0050953),0.24575131563961997,0.7418102935897115,0.888771186440678,0.9294516548988624,1.0,13/87,18.87%,EYA4;CHRNB2;DHRS3;TH;RDH12;RABGGTB;MYO7A;MYO9A;CNGB1;CRYBG3;RDH10;WFS1;BBS2
prerank,glucan catabolic process (GO:0009251),0.32316585138593673,0.7414998271850367,0.810958904109589,0.9294903522102193,1.0,3/15,13.14%,GAA;PHKB;MGAM
prerank,positive regulation of peptidase activity (GO:0010952),0.3046150389817608,0.7395907326580444,0.821656050955414,0.9314779440614368,1.0,4/20,18.03%,TANK;VCP;MAPK12;APH1A
prerank,neuromuscular synaptic transmission (GO:0007274),0.31305755252782386,0.7392348087881632,0.8158940397350993,0.9315759327103353,1.0,2/18,7.04%,CHRNB2;TBC1D24
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3178424834096134,0.7382060611255848,0.7984084880636605,0.9324506920821107,1.0,10/16,34.34%,NCL;TRA2B;SNW1;CIRBP;NUP98;SF3B4;PRDX6;DAZAP1;THRAP3;RBM3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.30614553705599834,0.7380791846106488,0.8133848133848134,0.9322719641827423,1.0,3/19,11.75%,NCKAP1L;MOSPD2;C1QBP
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2297637617001002,-0.7377297932597764,0.8865979381443299,0.9494880083961339,1.0,9/24,20.27%,AGBL4;TTLL7;NAA10;TTLL11;CFAP20;TTLL5;TPGS1;TTLL9;VKORC1L1
prerank,Notch signaling involved in heart development (GO:0061314),0.3440381239139191,0.7376078815585185,0.7945791726105563,0.9324738768668175,1.0,2/11,7.58%,JAG1;DLL4
prerank,positive regulation of interleukin-10 production (GO:0032733),0.28027960780307204,0.737196119071364,0.8261964735516373,0.9326404072791395,1.0,4/30,13.73%,CD274;SYK;IL6;HSPD1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2821586777761022,0.7360062072501908,0.8267813267813268,0.9334007933422779,1.0,7/31,18.10%,POLR2H;GTF2F1;MNAT1;POLR2D;GTF2H1;ERCC2;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.2821586777761022,0.7360062072501908,0.8267813267813268,0.9334007933422779,1.0,7/31,18.10%,POLR2H;GTF2F1;MNAT1;POLR2D;GTF2H1;ERCC2;RNMT
prerank,nucleoside catabolic process (GO:0009164),0.34669115793482913,0.7357494409788116,0.7955182072829131,0.9333755628832535,1.0,1/11,4.15%,DERA
prerank,negative regulation of TOR signaling (GO:0032007),0.27620986427615346,0.7356999448793659,0.8227699530516432,0.9331025591781201,1.0,11/36,26.08%,NPRL3;UBR2;FNIP1;SESN2;FLCN;STK11;NPRL2;AKT1S1;TMEM127;PDCD6;MINAR1
prerank,regulation of nuclear division (GO:0051783),0.3024002793686191,0.7355810080667887,0.8133669609079445,0.9329367344263404,1.0,11/20,37.35%,CDK13;PIN1;CUL9;FBXO5;PRMT5;BORA;PKMYT1;RCC1;CUL7;CAV2;KIF20B
prerank,regulation of cytoplasmic transport (GO:1903649),0.3388084491071368,0.7346828116707743,0.8121468926553672,0.933666146867972,1.0,7/11,34.16%,MAPK3;MAP2K2;MAPK1;MAP2K1;CHMP3;ATP9A;USP7
prerank,potassium ion transmembrane transport (GO:0071805),0.2388562739582296,0.7341261924148034,0.9344262295081968,0.9339978399152966,1.0,18/135,13.89%,SLC9A1;KCNK13;LRRC52;KCNA3;KCNJ2;CCDC51;SLC9A8;SLC24A4;SLC9A7;SLC9A6;KCNH8;ATP1A1;ATP1A3;ATP1A4;KCNN4;KCNA4;ATP1B3;SLC12A4
prerank,axonemal dynein complex assembly (GO:0070286),0.28852825653145364,0.734030844601087,0.8322903629536921,0.9337851406336481,1.0,6/28,18.48%,ODAD2;DNAAF5;TTC12;DNAI3;CCDC40;DNAH5
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.311887418552633,0.7336054529471232,0.8185430463576159,0.9339669865818657,1.0,2/16,8.85%,LARGE1;ST8SIA6
prerank,zinc ion transmembrane transport (GO:0071577),0.3035455097574782,0.7333412658035547,0.8282442748091603,0.933937999673792,1.0,5/22,20.46%,SLC39A7;SLC39A11;SLC39A6;SLC39A3;SLC39A13
prerank,regulation of DNA metabolic process (GO:0051052),0.2611677778985956,0.7326262669189375,0.8531791907514451,0.9344479186201978,1.0,23/44,36.69%,PDGFA;THOC1;STOX1;UBE2V2;KAT7;WDR70;SMG1;MPHOSPH8;XRCC5;TERF2IP;TERF2;KPNA2;PARG;HDAC8;SMARCAD1;MPV17;CDK9;HNRNPD;WDR18;UPF1;MYC;KPNA1;UBE2N
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.34002177016666507,0.7318716740581093,0.7859154929577464,0.935020793936639,1.0,3/11,22.99%,P4HB;FYN;UBQLN1
prerank,muscle cell migration (GO:0014812),0.349392993852519,0.7316851389037357,0.8066378066378066,0.9349263711417977,1.0,3/10,21.64%,AAMP;ITGB1BP1;ROCK1
prerank,regulation of astrocyte differentiation (GO:0048710),0.336970294063933,0.7316098980479439,0.8536585365853658,0.9346855935979809,1.0,3/12,12.58%,ID2;SERPINE2;IL6
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3012340830357856,0.7313687093974514,0.8210116731517509,0.9346444802556797,1.0,1/21,0.22%,FGF13
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.30433865471059984,0.7311063805762064,0.8007761966364813,0.9346207370311813,1.0,7/18,25.37%,CAB39;CAV1;EPO;SLC43A2;STK39;ATP1A2;CAMK2D
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.24975348474931924,0.7309631150520608,0.8920335429769392,0.9344561601049237,1.0,7/79,7.38%,NIBAN2;FGF2;FSTL3;PPARG;SMAD7;BAMBI;SKI
prerank,regulation of chemotaxis (GO:0050920),0.2773381544133865,0.730896035938619,0.8397129186602871,0.9342054119702903,1.0,9/30,20.97%,P2RX4;PTPN2;ZSWIM8;TREM2;STX3;USP14;DUSP3;TGFB1;PDGFB
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3040949808102217,0.7307631165837868,0.8450704225352113,0.9340508386441859,1.0,4/19,15.14%,PPP3R1;INPP5A;PPP3CC;NFATC3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.26717968504459777,0.730732195376731,0.8388571428571429,0.9337621637436434,1.0,5/41,10.71%,SMAD7;JAG1;DLL4;PKP2;TGFBR2
prerank,negative regulation of DNA recombination (GO:0045910),0.26407115844450363,0.7305873804050166,0.8589595375722543,0.9335999178708979,1.0,18/43,35.47%,POLR2H;ZRANB3;ACD;POLR2D;TERF1;BLM;DAXX;SMCHD1;TERF2IP;TERF2;RIF1;MSH3;POLR2B;TINF2;PARP3;POLR2K;POLR2F;SHLD1
prerank,apoptotic cell clearance (GO:0043277),0.28030414500610734,0.7304651606244076,0.8262910798122066,0.9334136295969729,1.0,4/30,10.24%,LRP1;GAS6;TREM2;RHOG
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.33037613370262187,0.7301706212817342,0.8077455048409405,0.9334213666235915,1.0,5/13,21.69%,RHOA;IL6;TNF;ITGB2;IRAK1
prerank,cellular response to interleukin-7 (GO:0098761),-0.24917976396687502,-0.7298979730852395,0.8702290076335878,0.9560825743556298,1.0,4/17,8.87%,STAT5A;IL7R;STAT3;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.24917976396687502,-0.7298979730852395,0.8702290076335878,0.9560825743556298,1.0,4/17,8.87%,STAT5A;IL7R;STAT3;IRS2
prerank,chondrocyte differentiation (GO:0002062),0.275875332544866,0.7298570767946321,0.851508120649652,0.9334705299840215,1.0,4/32,7.60%,RUNX1;SOX9;SNX19;CREB3L2
prerank,positive regulation of coagulation (GO:0050820),0.34912817854817424,0.7298379993430304,0.8224163027656477,0.9328490633088046,1.0,3/10,17.51%,APOH;HPSE;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),0.34912817854817424,0.7298379993430304,0.8224163027656477,0.9328490633088046,1.0,3/10,17.51%,APOH;HPSE;SERPINE1
prerank,protein processing (GO:0016485),0.23986036267842073,0.7290291834510061,0.9111570247933884,0.933447942195046,1.0,21/102,19.55%,ADAMTS13;KLK1;KLK6;ADAM17;DDI2;PSEN2;CPD;SPCS3;AFG3L2;KLKB1;PITRM1;PARL;KLK3;OGT;FURIN;F9;SPPL3;APH1A;CTSL;CLN3;STOML2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.34442415315569985,0.7287777341982347,0.8201754385964912,0.9334114014913479,1.0,2/10,8.06%,DDX39B;THOC1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.23855769444506725,0.7281993627620066,0.9192546583850931,0.933776615994037,1.0,29/125,24.02%,DYNC1H1;PLK2;NEK6;EML4;PTPA;CCNB1;CENPO;BCCIP;DYNC1LI2;TACC3;AHCTF1;CENPT;ERCC6L;DCTN6;EFHC1;CENPA;CLIP1;CENPK;MAPRE1;CENPS;TAOK1;XPO1;RANBP2;NUP133;SPDL1;NUDC;EFHC2;TBCE;NUP98
prerank,regulation of tube diameter (GO:0035296),0.32505616438426005,0.7279486489651401,0.8268156424581006,0.9334190962470658,1.0,4/13,21.64%,SCPEP1;ITGB1BP1;NPR1;ROCK1
prerank,vascular process in circulatory system (GO:0003018),0.32505616438426005,0.7279486489651401,0.8268156424581006,0.9334190962470658,1.0,4/13,21.64%,SCPEP1;ITGB1BP1;NPR1;ROCK1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.28606403013182674,-0.7260704358019358,0.8178694158075601,0.9589607476365648,1.0,11/11,71.42%,TPK1;NT5C3A;ENPP3;SLC19A3;THTPA;CTPS2;DCTD;DCK;SLC25A19;SLC19A2;ERH
prerank,negative regulation of cellular protein localization (GO:1903828),0.2720748858078204,0.7260310380734067,0.8574766355140186,0.935288579246971,1.0,13/34,28.02%,MFHAS1;SNX33;ILRUN;FLCN;LATS1;ANKRD13A;LZTFL1;ACTN2;GSK3B;DNAJA1;SPI1;TTBK2;LEPROT
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.31682142583012596,0.7249599953311662,0.8269230769230769,0.9361489855126887,1.0,2/14,7.99%,PTPN2;GAS6
prerank,maintenance of protein location in nucleus (GO:0051457),-0.22947288003736752,-0.7241870842946315,0.8636363636363636,0.9593721146325499,1.0,6/20,19.55%,MORC3;ARL2;SUPT7L;BCL3;BBS4;SUN2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.27139377266157266,0.7237411937866297,0.8467836257309942,0.9371940540857701,1.0,12/35,27.41%,PIK3CB;LRPAP1;HNRNPK;HIP1R;CBL;HIP1;SERPINE1;ARF6;RSPO1;B2M;LDLRAP1;RAC1
prerank,intracellular protein transmembrane transport (GO:0065002),0.2645828441150774,0.7236009970913273,0.8747152619589977,0.9370224338078549,1.0,23/42,35.40%,TIMM44;TOMM40;PEX14;TIMM23;HSPD1;SEC63;TIMM21;SEC61A1;DNAJC15;PAM16;GRPEL2;PEX6;TIMM17A;PEX1;PEX2;AIFM1;SEC61B;ROMO1;PEX16;AKT2;DNAJC19;PEX26;TOMM20
prerank,protein localization to cell junction (GO:1902414),0.2934803189568255,0.7234177815734537,0.8535031847133758,0.9368979324260107,1.0,6/22,19.56%,TJP2;NECTIN1;PAK2;JAK1;DLG4;NPHS1
prerank,iron ion transmembrane transport (GO:0034755),0.3412368827006831,0.7233289350309714,0.8229461756373938,0.9366788322468161,1.0,2/10,22.06%,SLC25A37;ABCC5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.3061602880679099,0.7233211401699128,0.8034076015727392,0.9363652314357475,1.0,3/17,11.75%,NCKAP1L;MOSPD2;C1QBP
prerank,mitotic cytokinesis (GO:0000281),0.25993187447760596,0.7232606463235494,0.8867713004484304,0.9361102678582,1.0,14/47,23.56%,SON;CHMP4B;SNX33;PDCD6IP;RASA1;JTB;SNX18;EFHC1;CENPA;STAMBP;USP8;ROCK1;TTC19;EFHC2
prerank,regulation of lipid metabolic process (GO:0019216),0.2453870483373317,0.723255620963013,0.9081419624217119,0.9357917061296086,1.0,18/88,19.55%,NFYA;PPARD;ACACA;PSAP;PPARG;ID2;CAV1;NPC2;CARM1;ADIPOR1;ACACB;SP1;TM6SF2;MED1;HDAC3;TGS1;MID1IP1;ABCA7
prerank,signal transduction by p53 class mediator (GO:0072331),-0.20865689789398711,-0.7223247457451194,0.9213483146067416,0.9597710413501414,1.0,9/30,21.98%,FHIT;MYO6;PAXIP1;BCL3;ACER2;GREM1;PDK2;PMAIP1;E2F7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.29404324423384104,0.7221681877536067,0.830379746835443,0.9363757866155928,1.0,9/22,30.68%,ZDHHC18;ZDHHC15;ZDHHC1;ZDHHC6;GOLGA7;ZDHHC4;ZDHHC21;ZDHHC8;ZDHHC9
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.29404324423384104,0.7221681877536067,0.830379746835443,0.9363757866155928,1.0,9/22,30.68%,ZDHHC18;ZDHHC15;ZDHHC1;ZDHHC6;GOLGA7;ZDHHC4;ZDHHC21;ZDHHC8;ZDHHC9
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2929617986367976,0.7211505196604315,0.8284993694829761,0.9371612640339086,1.0,4/23,18.88%,PLAAT3;LPCAT3;ABHD4;PLA2G5
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3180335470533606,0.7193334978236116,0.8091397849462365,0.9388800272359386,1.0,6/14,31.18%,C1QBP;SRSF7;SRSF10;PCBP4;PTBP1;SAP18
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.2807013544575337,-0.7192396525468475,0.8280254777070064,0.9597798230473003,1.0,2/10,9.65%,APC;CDC42EP4
prerank,regulation of pseudopodium assembly (GO:0031272),-0.2807013544575337,-0.7192396525468475,0.8280254777070064,0.9597798230473003,1.0,2/10,9.65%,APC;CDC42EP4
prerank,UV protection (GO:0009650),0.3481122928732724,0.7190959148775738,0.8161434977578476,0.9388253738656946,1.0,3/10,17.70%,CAT;XPA;ERCC2
prerank,regulation of superoxide anion generation (GO:0032928),0.3195894951396546,0.7187307013560357,0.8051771117166212,0.9388891044999294,1.0,4/14,20.66%,PRKCD;SYK;ITGB2;TGFB1
prerank,metanephros development (GO:0001656),0.2832270543757718,0.7183251729307312,0.8617683686176837,0.9390149819836177,1.0,2/26,4.22%,GDF6;BASP1
prerank,positive regulation of neuron projection development (GO:0010976),0.24383092595430028,0.7182310945009338,0.8995771670190275,0.9387977692981201,1.0,16/85,19.38%,APOE;ABL2;PTK2B;ALKAL2;NPTN;ZDHHC15;FZD1;CBFA2T2;SCN1B;RETREG3;KIDINS220;BMP5;CAPRIN1;FES;MARK2;SCARF1
prerank,mitochondrial fission (GO:0000266),0.31128313870861085,0.716753277904255,0.8271092669432918,0.9400590415276642,1.0,6/16,27.50%,DNM2;MTFP1;FIS1;OPA1;MTFR1L;MTFR1
prerank,brain morphogenesis (GO:0048854),-0.27492109925953323,-0.7166255327185971,0.8506944444444444,0.9609791672982724,1.0,5/12,17.19%,CTNNA2;SHANK3;PAFAH1B1;BBS4;PAX2
prerank,lipid translocation (GO:0034204),0.2934529534642324,0.7165998773292165,0.8597640891218873,0.9399026742264,1.0,2/21,5.35%,ABCA1;ATP9B
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.23383841789967277,0.71619237183369,0.9265010351966874,0.9400237461866776,1.0,35/110,28.82%,EIF4G1;SMG9;UBA52;DHX34;ETF1;RPL10A;PPP2R1A;RPL12;UPF3A;RPL36;RPS6;RPS28;RPL13A;RPS26;UPF3B;RPS27A;RPS12;PABPC1;PYM1;RPL18;RPS13;SMG1;RPS2;RPS19;RPS7;RPL17;RPL23;EIF3E;GSPT1;EIF4A3;PNRC2;RPL4;UPF2;RPL7A;DCP1A
prerank,ureteric bud morphogenesis (GO:0060675),0.30333325276096557,0.7160324413538279,0.8328912466843501,0.9398760619665114,1.0,1/16,1.55%,FGF2
prerank,kinetochore organization (GO:0051383),-0.2572164681543526,-0.7159137486836613,0.8534798534798534,0.9600052687150845,1.0,6/13,22.91%,CENPF;DLGAP5;CENPE;CENPH;CDT1;NUF2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.18159143961232857,-0.7152392567276508,0.989247311827957,0.9572553339582012,1.0,10/56,12.40%,NDUFS3;NDUFV3;NDUFB9;ACAD9;NDUFS4;NDUFS5;NDUFB7;NDUFA10;NDUFB10;FOXRED1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.18159143961232857,-0.7152392567276508,0.989247311827957,0.9572553339582012,1.0,10/56,12.40%,NDUFS3;NDUFV3;NDUFB9;ACAD9;NDUFS4;NDUFS5;NDUFB7;NDUFA10;NDUFB10;FOXRED1
prerank,presynaptic endocytosis (GO:0140238),0.28843101947419947,0.7150398716136906,0.83729662077597,0.9406376578302135,1.0,5/24,11.69%,CDK5;CEL;PIP5K1C;VAMP2;SYT8
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.33026212977869085,0.7137080488207523,0.8333333333333334,0.9417702628888429,1.0,1/12,1.93%,ADCY8
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3232961831481196,0.7127370571578148,0.8205841446453408,0.9424868420620495,1.0,4/13,20.66%,PRKCD;SYK;ITGB2;TGFB1
prerank,potassium ion import across plasma membrane (GO:1990573),0.26197022551243127,0.7126255396872382,0.8627450980392157,0.9422740216173385,1.0,7/41,16.59%,KCNJ2;ATP1A1;ATP1A3;ATP1A4;ATP1B3;SLC12A4;KCNJ6
prerank,C4-dicarboxylate transport (GO:0015740),0.317041940839513,0.7124013594881938,0.8434065934065934,0.942182808284908,1.0,5/14,19.91%,LRRC8D;SLC25A18;SLC13A5;SLC25A14;SLC25A13
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.2871748843943115,0.7117493793072524,0.8429951690821256,0.9425673641987707,1.0,2/24,3.49%,NRP1;VEGFA
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.3303937930672832,0.7117299098671055,0.8222849083215797,0.9422629014093665,1.0,1/11,1.59%,PIK3CB
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3306312064822257,0.7113792294514,0.8293706293706293,0.9423265689804424,1.0,2/11,12.14%,KCNJ2;ATP1A1
prerank,histone H3-K36 demethylation (GO:0070544),0.3427483945232135,0.7112262785963175,0.8161764705882353,0.9421596984620931,1.0,3/10,16.98%,RIOX1;RIOX2;KDM2A
prerank,regulation of macrophage cytokine production (GO:0010935),-0.260672265579898,-0.7111071085886247,0.8413284132841329,0.9601163385552063,1.0,7/13,25.90%,CD74;IRAK3;WNT5A;TGFB2;PLCG2;SEMA7A;TGFB3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.2483744231505015,-0.7109152090111674,0.854251012145749,0.9585902053519111,1.0,6/15,21.16%,TIAM1;DAAM2;WNT5B;RSPO3;GPC3;SFRP4
prerank,cellular response to BMP stimulus (GO:0071773),0.24333273235968345,0.7104702547800077,0.8951271186440678,0.9426340517274727,1.0,5/66,7.94%,BMP8B;GDF6;SOX9;SMAD7;USP9X
prerank,protein insertion into membrane (GO:0051205),0.2695705164650792,0.7103066441541425,0.8782201405152225,0.9425016695679143,1.0,5/32,14.55%,HMOX1;ALDH3A2;VAMP2;STX5;GRIN3B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.3159220677769349,0.7098429937853513,0.8306010928961749,0.942683494667451,1.0,1/13,2.56%,B4GAT1
prerank,apical junction assembly (GO:0043297),0.24991558457488292,0.709427885977244,0.8994475138121547,0.9427952180595964,1.0,10/53,22.01%,CLDN19;CLDN18;PDCD6IP;PKN2;PAK2;RHOA;PARD6A;AFDN;CLDN1;WDR1
prerank,cellular response to drug (GO:0035690),0.28017170039024397,0.7086498995744835,0.8566084788029925,0.9433336854093428,1.0,5/25,17.60%,RAP2A;GAS6;AIM2;TFRC;RBM22
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2805314509828575,0.7082871366593195,0.8553459119496856,0.9433702108711666,1.0,4/23,14.62%,MGAT5;CYP1B1;IL6;TNF
prerank,regulation of tau-protein kinase activity (GO:1902947),0.33705629267943654,0.7082656070734236,0.8231098430813124,0.9430699598078954,1.0,4/10,25.09%,C5AR1;NAB2;HSP90AB1;EGR1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.24608078189895188,-0.7080076055106296,0.8910505836575876,0.9599427428409143,1.0,8/16,34.94%,FOXK2;PRKN;PDK1;PDK2;RORA;PDK4;SCARB2;RORC
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.28978773784831346,0.7079586515852015,0.8613989637305699,0.9430668210597019,1.0,1/19,0.73%,CSF1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.31160874156410107,0.7072882311933203,0.8552097428958051,0.9434299924649932,1.0,6/15,26.20%,ERN1;DDX1;TSEN15;TSEN2;RTCB;FAM98B
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3061196729573893,0.7072265306561702,0.823915900131406,0.943167958878173,1.0,5/16,21.69%,RHOA;IL6;TNF;ITGB2;IRAK1
prerank,cellular response to chemokine (GO:1990869),0.2529599539030121,0.7072151802798465,0.8755707762557078,0.9428557848366581,1.0,5/46,11.62%,CCL4;PTK2B;CCL13;CCL14;RHOA
prerank,indolalkylamine catabolic process (GO:0046218),-0.2873203525133687,-0.7069404174268157,0.8442367601246106,0.9593228046098345,1.0,2/10,11.54%,KMO;HAAO
prerank,positive regulation of leukocyte activation (GO:0002696),0.2934014454507375,0.7063657204465313,0.8383311603650587,0.9434450169252057,1.0,3/18,13.73%,CEBPA;TNIP2;HSPD1
prerank,myelin maintenance (GO:0043217),-0.2800855266842221,-0.7060991650507444,0.8491803278688524,0.9584789142700818,1.0,3/10,9.24%,DEGS1;SOD1;EPB41L3
prerank,retina homeostasis (GO:0001895),0.2828144265434468,0.705873937877938,0.8531645569620253,0.9436390010257594,1.0,3/23,14.35%,HSPB1;PRDX1;CNGB1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.2611784470637544,0.7056140683947717,0.8774341351660939,0.9435772642880952,1.0,11/39,21.99%,ZMIZ1;JAG1;TSPAN5;DLL4;NEPRO;MAML2;SNW1;NOTCH4;ITGB1BP1;NOTCH1;CREBBP
prerank,negative regulation of cilium assembly (GO:1902018),0.3263226986397249,0.7055126401444178,0.842391304347826,0.9433775566603584,1.0,5/12,31.08%,TESK1;CCP110;CEP97;MAP4;TBC1D7
prerank,neuromuscular process (GO:0050905),0.3037195034408885,0.704571624011778,0.8504672897196262,0.9440485858226672,1.0,3/16,11.10%,DCTN1;TPP1;AGTPBP1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2642984647921322,0.7031391239112494,0.8951707891637221,0.9452252132654929,1.0,11/37,24.04%,IFT43;IFT88;IFT74;TNPO1;WDR35;IFT122;TRIP11;TRAF3IP1;DYNC2I1;WDR19;KIF3A
prerank,nerve growth factor signaling pathway (GO:0038180),-0.27415401199569717,-0.7024105939150295,0.8493589743589743,0.9608205359776713,1.0,1/10,4.09%,RAPGEF2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3339638559449746,0.7023157216810584,0.8340425531914893,0.9457721304345216,1.0,1/10,2.48%,DERL3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.301317434782683,0.7018750716947968,0.847167325428195,0.9459228700386615,1.0,3/17,9.69%,NEIL2;ACD;MBD4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.238807671968834,0.700986058633088,0.9152542372881356,0.9464956723511488,1.0,10/75,13.89%,SLC9A1;KCNJ2;SLC9A7;SLC9A6;SLC8A1;ATP1A1;ATP1A3;ATP1A4;ATP1B3;SLC12A4
prerank,regulation of hormone secretion (GO:0046883),-0.24189950942718474,-0.70029578810355,0.8935361216730038,0.9612988374562317,1.0,1/15,2.27%,SCG5
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.26834395034365754,0.6979048145563894,0.8783132530120482,0.9492512957840614,1.0,9/31,26.26%,CYP19A1;DHRS11;PYCR3;MOCOS;SCP2;MOCS3;SRD5A1;SRD5A2;MOCS1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.26704053393346466,0.6978465747146407,0.8746928746928747,0.9489904686617796,1.0,15/32,32.24%,DYRK2;CDIP1;MYBBP1A;SNW1;STK11;HIPK1;EP300;AEN;TMEM109;PHLDA3;USP28;HIPK2;DDX5;RRP8;TP53
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3159236719257319,0.6967711936876868,0.8613861386138614,0.9497560979596051,1.0,1/12,2.56%,B4GAT1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.2628059197603792,-0.6963607486599335,0.8552631578947368,0.9635858723645943,1.0,7/12,38.60%,ABCC9;CACNA1H;TRPM4;P2RX3;RHAG;KCNJ8;ATP1B4
prerank,histone mRNA metabolic process (GO:0008334),0.27164485835948826,0.6962260807190478,0.8717026378896883,0.9499704921948207,1.0,12/27,36.13%,EXOSC10;DCP2;SNRPF;EXOSC4;SNRPD3;MTPAP;XRN1;TENT4B;SSB;UPF1;TUT1;NCBP2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.24676962588500354,0.6960473223331797,0.9093997734994338,0.9498352390913226,1.0,14/52,20.13%,RBM25;CELF1;PUF60;DDX17;FXR2;RBM15B;NOVA2;HNRNPL;TRA2B;SMU1;CELF6;RBFOX2;HNRNPU;MBNL2
prerank,purine-containing compound salvage (GO:0043101),0.3187040146680777,0.6959619287673692,0.8573388203017832,0.9495999522163604,1.0,2/12,14.65%,AMPD2;APRT
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3140044767975131,0.6957730276369781,0.8439620081411127,0.9494694987455956,1.0,1/13,1.75%,EIF6
prerank,positive regulation of receptor internalization (GO:0002092),0.2822281558842631,0.6940067831645369,0.850253807106599,0.950918213795425,1.0,2/22,9.77%,VEGFA;SCYL2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.24323744912238043,0.6937258835050101,0.9190687361419069,0.9508743935035063,1.0,11/62,17.70%,POLR2H;GTF2F1;ELOF1;CCNT2;EAF1;CDK13;ELOB;MNAT1;POLR2D;GTF2H1;ERCC2
prerank,cellular response to metal ion (GO:0071248),0.2262895143675971,0.6936608784895418,0.9512448132780082,0.9506172445921149,1.0,7/123,4.97%,IQGAP1;P2RX4;ITPKB;ADCY8;ADCY7;ATP13A2;CLIC4
prerank,polyol metabolic process (GO:0019751),0.251912221839787,0.6934317651994714,0.902027027027027,0.9505214666202201,1.0,4/46,4.64%,ITPKB;PLCB4;INPPL1;PLCB2
prerank,DNA strand elongation (GO:0022616),0.29591040935560026,0.6927098346101273,0.8350785340314136,0.9509260666368594,1.0,6/18,25.96%,MCM7;RAD50;TERT;GINS1;MCM3;POLA1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.2396860282574568,-0.692620304089009,0.9117647058823529,0.9657447927865702,1.0,16/16,76.06%,SGO1;DSCC1;REC8;CDCA5;PDS5B;RAD21L1;RAD21;HASPIN;BOD1;NIPBL;SMC1A;POGZ;RB1;MAU2;PDS5A;NAA50
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.29217567898674707,0.6925686607986596,0.8605577689243028,0.9507479468283851,1.0,1/16,1.55%,FGF2
prerank,negative regulation of cell projection organization (GO:0031345),0.24790352135271645,0.6922279179154462,0.9103291713961408,0.9507643820157845,1.0,2/48,0.87%,MYLIP;APOE
prerank,activin receptor signaling pathway (GO:0032924),0.30149454887299226,0.6920765042223046,0.8554216867469879,0.9505941703857315,1.0,1/15,2.35%,GDF6
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2827992590745945,0.691319468287273,0.8788659793814433,0.9510069811583619,1.0,4/21,10.98%,SMAD7;CAV1;CNKSR3;NCK1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.24894270070249275,0.6906312888499394,0.8961325966850828,0.9513380241501982,1.0,5/51,7.38%,FSTL3;PPARG;SMAD7;BAMBI;SKI
prerank,stabilization of membrane potential (GO:0030322),0.293774380689774,0.6895871006779793,0.8588235294117647,0.9520354146563024,1.0,2/16,12.42%,KCNK13;KCNN4
prerank,establishment of mitotic spindle localization (GO:0040001),0.27087212317718573,0.6891349695702134,0.8851851851851852,0.9521366798818922,1.0,5/28,15.13%,HTT;DCTN1;NUMA1;FBXW11;CENPA
prerank,response to copper ion (GO:0046688),0.28144713481763023,0.6884953357291208,0.8821192052980132,0.952449460011267,1.0,4/20,23.20%,HSF1;ATP7B;MT2A;DAXX
prerank,negative regulation of protein depolymerization (GO:1901880),0.2750114199765821,0.6877471137288661,0.8863920099875156,0.9528700643554296,1.0,1/24,0.22%,FGF13
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.2950560721551282,0.6876621950550326,0.8827404479578392,0.9526336217671029,1.0,5/17,24.40%,VEGFA;TNF;PPP1R12A;ROCK1;S1PR3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.28443614628546765,0.6873251690564716,0.8530150753768844,0.9526160690069715,1.0,3/19,15.80%,AMPD2;APRT;TERT
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.296674006297022,0.6872993565880013,0.8509485094850948,0.9523189007782936,1.0,4/16,18.83%,DDX17;PPARGC1B;RBFOX2;SAFB
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3059056358056731,0.6872475360755205,0.8571428571428571,0.9520485555816658,1.0,4/13,20.71%,HACD2;HACD1;ELOVL2;TECR
prerank,organic hydroxy compound transport (GO:0015850),0.2570084742670977,0.6868023188717877,0.8933177022274326,0.9521404723799345,1.0,8/36,21.56%,SLC27A5;NPC2;OSBP;SLC5A3;RBP4;ABCB11;RALBP1;RXRA
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2672777390950428,0.686540980189686,0.8954869358669834,0.9520765525423002,1.0,13/29,33.29%,TSR1;KRI1;UTP20;UTP4;RPS19;NOP14;BMS1;DCAF13;DHX37;ABT1;TBL3;NGDN;NOP9
prerank,nucleotide biosynthetic process (GO:0009165),0.2885448807741739,0.686312701760843,0.8850726552179656,0.9519867805274266,1.0,8/18,24.28%,PRPSAP1;GART;PPAT;RRM1;NMNAT3;PRPS2;ADSL;MTHFD1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.24683111972403804,-0.6862733649877016,0.8975265017667845,0.9701027918113531,1.0,4/13,19.84%,CCL2;SELENOS;NOD2;TLR9
prerank,calcium import into the mitochondrion (GO:0036444),0.3273984570219783,0.6859706324872407,0.8602620087336245,0.95200201477381,1.0,1/10,7.39%,AFG3L2
prerank,thymus development (GO:0048538),-0.254184405377117,-0.6855996301318134,0.8969465648854962,0.9689885861787823,1.0,2/13,8.11%,FGF10;SOD1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.25650988515217904,-0.6855454835424316,0.8677966101694915,0.9672912872339793,1.0,3/12,10.76%,UHMK1;PTPN14;KHDRBS1
prerank,synaptic vesicle membrane organization (GO:0048499),0.29024900063003833,0.6852410010601246,0.8866666666666667,0.9524019096908356,1.0,3/17,11.94%,SYNGR1;AP3D1;STX3
prerank,fatty acid elongation (GO:0030497),0.30487946503894825,0.6852177457717441,0.849507735583685,0.9520960765300128,1.0,4/13,20.71%,HACD2;HACD1;ELOVL2;TECR
prerank,regulation of endocytic recycling (GO:2001135),-0.2680136099047133,-0.6843321227055383,0.8819672131147541,0.9667284450804422,1.0,1/11,1.12%,SORL1
prerank,regulation of interleukin-8 production (GO:0032677),0.2336285354839486,0.682978358532633,0.9257265877287406,0.9539071594478695,1.0,10/69,18.91%,PTPRC;ANXA4;APOA2;SYK;DDIT3;RAB1A;IL6;TNF;SERPINE1;TLR7
prerank,negative regulation of neuron differentiation (GO:0045665),0.2807146862502139,0.682387365634684,0.8590852904820766,0.9541386705667876,1.0,7/22,26.88%,SOX9;NEPRO;MED1;CALR;GSK3B;EIF2AK4;B2M
prerank,NAD biosynthetic process (GO:0009435),0.27613049131115913,0.6816619608347073,0.8844155844155844,0.9545125113449863,1.0,7/20,26.32%,NAMPT;PTGIS;KYNU;NMNAT3;NAXD;PARP9;PARP16
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3159447583176397,0.6813114644020565,0.847009735744089,0.9545142960739346,1.0,11/11,68.43%,PKD2L1;PKD1L3;RTP3;PIGR;GNAT2;TAS1R2;GNAT3;RTP4;TAS1R3;RTP2;LPO
prerank,positive regulation of mRNA processing (GO:0050685),0.27660231632725607,0.6811692200644853,0.8650990099009901,0.9543223877104932,1.0,9/21,29.55%,NCL;TRA2B;SNW1;CIRBP;NUP98;SF3B4;PRDX6;DHX36;DAZAP1
prerank,dendritic spine organization (GO:0097061),0.2658157489979675,0.6809582967100731,0.88125,0.9541965462746231,1.0,9/26,24.98%,TREM2;DIP2A;IGF1R;ITGA3;FYN;DLG4;ARC;CDC42;PTEN
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.2770087935104383,-0.6807079469539841,0.8533333333333334,0.9682865105324764,1.0,4/10,19.55%,CORO2B;NDFIP1;MAPT;NDFIP2
prerank,positive regulation of protein acetylation (GO:1901985),0.3096475324931576,0.6800085456019631,0.8624641833810889,0.9547787713946689,1.0,7/12,35.24%,DIP2A;TAOK1;CEP295;TERF2IP;DDX3X;PRKAA2;PRKAA1
prerank,regulation of kinase activity (GO:0043549),0.2273009631420156,0.6796095357782925,0.9357894736842105,0.9548313659290769,1.0,8/89,10.09%,FLT1;FGR;AXL;RAD50;VAC14;TREM2;IGF1R;EEF1A1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.30917959292758757,0.6795674701192974,0.8581460674157303,0.9545517807656407,1.0,7/12,32.24%,PLK3;CCND1;FBXO31;CDK2;PRKDC;SDE2;TP53
prerank,regulation of isotype switching (GO:0045191),0.2994543358459506,0.6793584205589989,0.860632183908046,0.9544319543549179,1.0,2/14,16.60%,KMT5B;TFRC
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.23707047696479058,0.6793499217780832,0.9271523178807947,0.9541192553807682,1.0,11/64,17.70%,POLR2H;GTF2F1;ELOF1;CCNT2;EAF1;CDK13;ELOB;MNAT1;POLR2D;GTF2H1;ERCC2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2550977666200995,0.6792392278143158,0.9024676850763808,0.9539070405334915,1.0,7/36,19.03%,SIRPA;TAOK3;TREM2;QARS1;DUSP3;DACT1;HDAC3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.26419773217897224,0.6780131851176251,0.8853658536585366,0.9546991122792369,1.0,9/26,28.50%,SRI;CALM2;FKBP1B;GSTO1;DRD3;UBQLN1;ATP1A2;CALM3;FMR1
prerank,skeletal system morphogenesis (GO:0048705),0.2491242515156334,0.677859497621544,0.9128919860627178,0.9545258145414413,1.0,11/42,26.68%,HOXA4;SKI;LRP6;ANKRD11;WWOX;TGFBR1;FGFR2;DYNC2I1;FGFR3;PDGFRA;MEGF8
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.23283566192836316,-0.6771861918993582,0.8835341365461847,0.9698014926321196,1.0,9/17,37.66%,SNTA1;NEDD4L;KCNH2;KCNQ1;KCNE3;KCNE4;RYR2;KCNJ8;KCNE2
prerank,heart looping (GO:0001947),0.25261824416065976,0.6767033821209008,0.9058553386911596,0.9552427128722225,1.0,3/40,10.71%,MICAL2;SRF;TGFBR2
prerank,arachidonic acid secretion (GO:0050482),-0.2765820889297428,-0.6765223266407934,0.8742138364779874,0.9669651695551625,1.0,5/10,30.54%,DRD2;PNPLA8;NMUR2;BDKRB2;ACE
prerank,arachidonate transport (GO:1903963),-0.2765820889297428,-0.6765223266407934,0.8742138364779874,0.9669651695551625,1.0,5/10,30.54%,DRD2;PNPLA8;NMUR2;BDKRB2;ACE
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.28588025922658533,0.6763211845560353,0.8779472954230236,0.955291185855233,1.0,5/17,26.70%,PPARG;PRKG1;EFEMP2;PTEN;SOD2
prerank,early endosome to Golgi transport (GO:0034498),0.31562498899787805,0.6761019555453541,0.8625180897250362,0.9551821680608592,1.0,6/11,28.64%,SNX8;STX5;SNX1;LMAN1;SURF4;RAB6A
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.2658910222303461,0.6759610931463854,0.8967193195625759,0.9549849650978918,1.0,7/26,18.40%,DCTN1;DRG1;NUMA1;SLAIN2;CLIP1;MAPRE1;FES
prerank,positive regulation of protein deacetylation (GO:0090312),0.2997424686298409,0.6758705729349592,0.8523676880222841,0.9547451693945138,1.0,3/14,24.51%,SAP30BP;ZBTB7B;APLNR
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3225083022122691,0.6747835254609943,0.8609550561797753,0.9554062766217551,1.0,2/10,9.75%,PTPN2;PPP2R1A
prerank,protein localization to condensed chromosome (GO:1903083),-0.25230727963591926,-0.6744101323922743,0.8526315789473684,0.9671261078370056,1.0,5/12,21.24%,CDK1;CHAMP1;AURKB;ZW10;TTK
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.24550770415095247,-0.6743393230045956,0.9073359073359073,0.965481453723342,1.0,3/14,11.30%,ZBTB8OS;RTRAF;CLP1
prerank,embryonic digit morphogenesis (GO:0042733),-0.22637468711170466,-0.6737429839841065,0.9497716894977168,0.9643112961530487,1.0,1/18,0.61%,SALL1
prerank,positive regulation of potassium ion transport (GO:0043268),0.2502269316015011,0.6733758912480057,0.9135071090047393,0.9563606082590158,1.0,7/38,17.31%,KCNMA1;KCNJ2;FLNA;KCNN4;GNB1;KCNJ6;AMIGO1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.2964717300618282,0.6729593486484963,0.8604026845637583,0.9564193668733899,1.0,3/14,11.99%,LILRB1;GPRC5B;TICAM1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.23688478403868923,0.6721988895088339,0.9359823399558499,0.9567719037002487,1.0,15/56,23.56%,SON;CHMP4B;SNX33;PDCD6IP;RASA1;JTB;RHOA;SNX18;EFHC1;CENPA;STAMBP;USP8;ROCK1;TTC19;EFHC2
prerank,negative regulation of cartilage development (GO:0061037),0.3069063770359144,0.6715826785920472,0.8823529411764706,0.9570205186240064,1.0,3/13,23.37%,SOX9;TGFBR1;PTPN11
prerank,regulation of catabolic process (GO:0009894),0.2840096030256705,0.6714868787884133,0.88296488946684,0.9567836432687676,1.0,6/18,21.18%,MDM2;FURIN;FAM83D;CHEK2;ODC1;CENATAC
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.2375912385603228,0.6708068532999225,0.9151785714285714,0.9570667424341199,1.0,15/50,27.84%,SASH1;SPHK1;LIMS1;RHOA;ILK;TNF;TLR7;IFI35;IRAK1;TCIM;ACTN4;EP300;TLR3;TERF2IP;TRADD
prerank,mesenchymal cell development (GO:0014031),-0.2214726769095487,-0.6706317881068703,0.9027237354085603,0.9652112695818853,1.0,4/18,11.84%,SOX8;TAPT1;CDH2;KBTBD8
prerank,regulation of endopeptidase activity (GO:0052548),0.23467939135065938,0.6694743180729796,0.9269102990033222,0.9579261089902232,1.0,12/59,20.59%,SERPINA10;ATP13A2;SERPINE2;TIMP2;SERPINF2;FURIN;HDAC1;SERPINE1;APH1A;BIRC2;TIMP1;SERPIND1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.23846781189273392,0.6694562058008214,0.9252232142857143,0.9576185207416361,1.0,9/49,21.44%,APOA2;SYK;DDIT3;RAB1A;IL6;TNF;SERPINE1;TLR7;TIRAP
prerank,regulation of interleukin-10 production (GO:0032653),0.2378060889903655,0.6652763327375752,0.9213872832369943,0.9609967495971679,1.0,6/44,14.03%,CD274;SYK;LILRB1;IL6;HSPD1;TRIB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.2858211705923619,0.663824297626603,0.8847184986595175,0.9615726831804555,1.0,1/16,0.64%,CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.2858211705923619,0.663824297626603,0.8847184986595175,0.9615726831804555,1.0,1/16,0.64%,CORO1C
prerank,B cell activation involved in immune response (GO:0002312),-0.2436921762110159,-0.6625860687374581,0.8893280632411067,0.9701987053988732,1.0,7/13,32.34%,RNF168;FCGR2B;MSH2;MSH6;RNF8;GAPT;CD19
prerank,dendrite self-avoidance (GO:0070593),0.28266074051589674,0.6621197314207043,0.897503285151117,0.9627261979524177,1.0,3/16,12.65%,NPTN;IGSF9;PALLD
prerank,transcription by RNA polymerase III (GO:0006383),0.25657052621876203,0.6613892003758289,0.9127086007702182,0.9630522909518966,1.0,9/27,26.78%,SNAPC1;SNAPC2;SNAPC4;POLR3GL;GTF3C4;TBP;RO60;CRCP;ICE1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.27783962716756083,0.6613497055310703,0.8894806924101198,0.9627653828264259,1.0,1/18,1.78%,CDK5
prerank,ameboidal-type cell migration (GO:0001667),-0.17276741838867807,-0.6602996851014468,0.9797979797979798,0.9702489435213887,1.0,14/51,19.39%,SEMA6D;SEMA6A;SEMA5A;SOX8;ERBB4;PHACTR4;AMOT;SEMA4B;ITGB7;SEMA4A;SEMA6C;GPC3;SEMA3B;CCN3
prerank,Notch signaling pathway (GO:0007219),0.22961633707324444,0.6584856542529791,0.9319429198682766,0.9648602281704426,1.0,12/59,18.03%,ADAM17;JAG1;PSEN2;DLL4;DTX3;DTX4;MAML2;PLXND1;SNW1;NOTCH4;POFUT1;APH1A
prerank,negative regulation of nervous system development (GO:0051961),0.28066742056813526,0.6581899147859878,0.8903566710700133,0.9647621821577509,1.0,8/17,29.97%,APPL2;HOOK3;IL6;TNF;NOTCH1;B2M;WNT7A;PCM1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.24193458116133734,0.6581587215435019,0.9263873159682899,0.9644701573254603,1.0,9/44,27.01%,MICAL2;SRF;TGFBR2;CCDC40;NOTCH1;APLNR;MEGF8;BBS7;CCDC39
prerank,regulation of glycogen metabolic process (GO:0070873),-0.24638346929694493,-0.6578210602298296,0.9142857142857143,0.9705398293456027,1.0,3/12,18.87%,KHK;INPP5K;PPP1R3E
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.24263750649290525,0.6572490430123964,0.9380733944954128,0.9649055776146195,1.0,12/37,31.90%,SDCBP;CSNK2A2;OGT;GIPC1;RPS7;HSP90AB1;RPL23;BAG5;HIPK2;TAF9;CCAR2;UCHL5
prerank,regulation of T cell mediated immunity (GO:0002709),0.31100699040508223,0.6565334141704854,0.8771428571428571,0.9651930290093828,1.0,2/10,12.19%,TNFRSF1B;RIPK3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.28033257441236115,0.6563985400994089,0.8929032258064517,0.9649825557180787,1.0,4/17,21.65%,JAG1;DLL4;TGFB1;NOTCH1
prerank,negative regulation of angiogenesis (GO:0016525),0.22398373523037074,0.6560444955550454,0.9576271186440678,0.9649439402444685,1.0,13/84,18.04%,CTNNB1;NIBAN2;PIK3CB;PTPRM;PPARG;PGK1;CCN6;KLK3;APOH;TNF;SARS1;SERPINE1;KRIT1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.22689718097240846,0.6552489662908803,0.956989247311828,0.9652834865224854,1.0,8/75,12.73%,CTNNB1;NIBAN2;PTPRM;PPARG;PGK1;CCN6;KLK3;APOH
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2768111839969756,0.6550576388050647,0.8866666666666667,0.9651276375906495,1.0,4/18,13.44%,CEBPA;JAK1;IL6;CBL
prerank,regulation of adenylate cyclase activity (GO:0045761),0.26300188062833035,0.6543273525583785,0.9095477386934674,0.9654121262368346,1.0,4/22,15.65%,CACNA1D;CAP1;NF1;ORAI1
prerank,steroid biosynthetic process (GO:0006694),0.22917032795808323,0.6534932969291818,0.9358108108108109,0.9657776940111681,1.0,6/56,10.39%,SLC27A5;CYP19A1;CH25H;DHRS11;OSBPL2;OSBP
prerank,protein maturation (GO:0051604),0.21790105055506304,0.6532894860651328,0.9667359667359667,0.9656256228894516,1.0,19/95,19.18%,ADAMTS13;ADAM17;DDI2;PSEN2;CPD;TSPAN5;AFG3L2;ISCA1;PITRM1;OGT;FURIN;GCSH;NAA16;HSPD1;TASP1;MMS19;NAA15;APH1A;CLN3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.2752419714968404,0.6504614543980813,0.8808900523560209,0.9676000192960341,1.0,7/18,29.77%,NCKAP1L;CRTAM;METTL3;ABL1;PRKDC;IL4I1;PRELID1
prerank,response to gamma radiation (GO:0010332),0.2574913990274026,0.649533289222826,0.8966376089663761,0.9680343317154884,1.0,13/24,35.95%,MDM2;MAP3K20;HSF1;XRCC5;KDM1A;DCUN1D3;TMEM109;LIG4;ATR;TP53;PRKAA1;MYC;MEN1
prerank,spinal cord development (GO:0021510),0.2994492115397033,0.6492260013695519,0.9004207573632539,0.9679683259363215,1.0,2/12,18.14%,NF1;LOXL3
prerank,response to progesterone (GO:0032570),0.27348045186743186,0.6483914701497159,0.8938401048492791,0.9683087184335644,1.0,6/18,26.24%,CAV1;ACOD1;TGFB1;CATSPER2;WBP2;CATSPERD
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.22047527866517042,0.6476273755609607,0.9493534482758621,0.9686107376655609,1.0,14/75,22.37%,PLEK;MGLL;KLK6;RGS3;GIT1;CNGB1;PDE6G;RGS11;DGKQ;USP33;SAG;FRMPD1;ROCK1;PPP1R9B
prerank,negative regulation of B cell proliferation (GO:0030889),0.3022919401730657,0.6469570163359866,0.8890449438202247,0.9688139556470253,1.0,1/11,3.27%,CD300A
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3011624171195939,0.6466289291827306,0.9077340569877883,0.9681148046140358,1.0,8/11,36.16%,PPCS;COASY;DCAKD;ACOT7;PANK2;SLC25A16;PANK3;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.3011624171195939,0.6466289291827306,0.9077340569877883,0.9681148046140358,1.0,8/11,36.16%,PPCS;COASY;DCAKD;ACOT7;PANK2;SLC25A16;PANK3;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3011624171195939,0.6466289291827306,0.9077340569877883,0.9681148046140358,1.0,8/11,36.16%,PPCS;COASY;DCAKD;ACOT7;PANK2;SLC25A16;PANK3;ACAT1
prerank,phosphate ion homeostasis (GO:0055062),-0.2525265206201745,-0.6462963326975345,0.922077922077922,0.977460667900643,1.0,10/10,74.77%,SFRP4;TFAP2B;FGF23;SLC34A2;SLC34A1;GCM2;SLC34A3;ENPP1;FGFR4;XPR1
prerank,bone morphogenesis (GO:0060349),0.28720729817662205,0.645893574338945,0.9097035040431267,0.9683549727788939,1.0,2/14,7.57%,SKI;LRP6
prerank,secondary palate development (GO:0062009),0.2776973479558132,0.6452114247305966,0.9014285714285715,0.9685479924769473,1.0,2/14,10.71%,CHD7;TGFBR2
prerank,ephrin receptor signaling pathway (GO:0048013),0.21714905909133655,0.6451919070126664,0.9616204690831557,0.9682420002733924,1.0,26/82,28.08%,SDCBP;ARPC3;ARPC2;ARPC5;PSEN2;GIT1;YES1;ARPC1B;RASA1;RHOA;FYN;EFNA1;CRK;APH1A;ACTR3;NCK2;ROCK1;CDC42;PTPN11;NGEF;LYN;VAV3;AP2B1;RAC1;ARHGEF7;ANKS1B
prerank,negative regulation of phosphatase activity (GO:0010923),0.25578382428148455,0.6438233413367653,0.9168704156479217,0.9690100849025339,1.0,4/25,17.85%,PTPA;BOD1L1;ZCCHC9;FKBP1B
prerank,regulation of cellular respiration (GO:0043457),0.2735535488627263,0.6435352918071632,0.913563829787234,0.968905277239293,1.0,2/17,8.28%,VCP;TRAP1
prerank,proteasome assembly (GO:0043248),-0.24326567148494238,-0.6428137020097454,0.9119718309859155,0.9781987529362371,1.0,3/11,22.26%,PSMG1;ADRM1;POMP
prerank,icosanoid secretion (GO:0032309),-0.24213792250280478,-0.6422811249084539,0.9383561643835616,0.9768472701847624,1.0,5/12,30.54%,DRD2;PNPLA8;NMUR2;BDKRB2;ACE
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2390497591968312,0.6414185138550693,0.9327354260089686,0.9702035655241401,1.0,7/39,22.10%,ABCA1;RAB8B;GOLPH3;ARFGAP3;COPG2;STEAP3;COPG1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3081537624427013,0.6408476737034972,0.901018922852984,0.9703021743075638,1.0,3/10,23.89%,CAV1;SUMO1;KCNAB1
prerank,SNARE complex assembly (GO:0035493),0.3074611753478802,0.6402726270466937,0.9035971223021583,0.9704010602692548,1.0,3/10,18.24%,VAMP2;VAMP4;VAMP3
prerank,positive regulation of tissue remodeling (GO:0034105),0.3042748148483604,0.6391526303527256,0.9012875536480687,0.970962530678333,1.0,3/10,21.64%,TMBIM1;IL2;ROCK1
prerank,protein localization to kinetochore (GO:0034501),-0.2336557711446796,-0.6390679169519681,0.9198473282442748,0.9773637793473964,1.0,6/14,21.24%,RCC2;CDK1;CHAMP1;AURKB;ZW10;TTK
prerank,regulation of phosphatase activity (GO:0010921),0.2560841968176783,0.6383967387144629,0.9165613147914032,0.9712126764718053,1.0,4/24,12.99%,PTPA;HTT;RIPK3;ZCCHC9
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.30083983380805346,0.6382610934089223,0.8903903903903904,0.9709975769793887,1.0,3/10,15.74%,DGKH;DGKD;HTR2B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2421606495247275,0.638122719068204,0.9462759462759462,0.9707713380602232,1.0,5/32,21.85%,CCL13;RNASE7;RNASE3;HMGN2;RPS19
prerank,protein localization to mitochondrion (GO:0070585),0.298762730089873,0.6367389071351128,0.907624633431085,0.9714843642883733,1.0,3/11,24.85%,MTCH2;HK1;DNAJA1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.28642919483937707,0.6366014408619477,0.902158273381295,0.9712615303870492,1.0,1/12,4.63%,ABCD2
prerank,nuclear body organization (GO:0030575),0.28972188756666306,0.6364628294463966,0.9124293785310734,0.9710497719701836,1.0,5/12,32.38%,SRPK2;USPL1;HIPK2;USP50;DYRK3
prerank,epithelial cell-cell adhesion (GO:0090136),0.29481290400010235,0.6341291839181439,0.8846153846153846,0.9723594651508519,1.0,2/11,11.84%,ITGB5;JUP
prerank,regulation of protein localization to membrane (GO:1905475),0.24801176446810932,0.6335255435918729,0.9291819291819292,0.9724799061396348,1.0,7/28,22.48%,CDK5;CRIPT;SLC5A3;FYN;STX7;CLN3;GSN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2156669580081798,-0.6330840062814649,0.9307359307359307,0.9794749063194242,1.0,6/17,21.24%,CTCF;CDK1;CHAMP1;AURKB;ZW10;TTK
prerank,heart trabecula morphogenesis (GO:0061384),0.267317173823465,0.6322933838145488,0.9150823827629911,0.9730598410765022,1.0,5/18,21.65%,DLL4;RBP4;BMP5;TGFBR1;NOTCH1
prerank,negative regulation of heart contraction (GO:0045822),0.29207872223726294,0.6313265679109922,0.9244505494505495,0.973430659183377,1.0,5/11,30.09%,SRI;FKBP1B;ZC3H12A;ATP1A2;PIK3CG
prerank,cell junction maintenance (GO:0034331),0.27884700849025845,0.6291959691262023,0.9174825174825175,0.974606917893561,1.0,4/14,21.28%,DCTN1;MYADM;PARD6A;CLDN1
prerank,mRNA splice site selection (GO:0006376),0.24310863949914263,0.628742532393774,0.9424019607843137,0.9745942130748873,1.0,8/30,22.23%,LUC7L2;CELF1;PUF60;PRPF39;CELF6;NOL3;SRSF1;SRSF10
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.2625995039987624,0.6283303699655927,0.9298013245033112,0.9745501690650545,1.0,5/19,21.65%,VEGFA;SERPINF2;NOTCH4;AFDN;NOTCH1
prerank,axoneme assembly (GO:0035082),0.2409622747826918,0.628098908106165,0.9485570890840652,0.9743981767649886,1.0,9/31,27.01%,FOXJ1;DNAJB13;SPAG16;TTC12;CCDC40;LRGUK;SPAG1;TTLL3;CCDC39
prerank,linoleic acid metabolic process (GO:0043651),-0.20527359183356989,-0.6257299908043773,0.9618320610687023,0.9822775665337949,1.0,1/17,1.51%,ALOX5
prerank,amyloid-beta metabolic process (GO:0050435),0.2650184174569417,0.6255655496798591,0.907258064516129,0.9757979897761134,1.0,4/16,19.55%,NAT8;PSEN2;APH1A;ABCA7
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.2103279948948849,-0.6254279570169808,0.9457364341085271,0.9807707552497849,1.0,7/17,22.15%,PDCD10;SCIMP;MID1;TGFB2;KLHDC10;NOD2;INAVA
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.25448644600530684,0.6229847116321515,0.9257861635220126,0.9772346676006918,1.0,9/22,32.06%,SPRED2;SPRED3;EIF5A;RPS7;RPL23;CDK5RAP3;DDX5;ATR;RPS20
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.24433994813022913,0.6193975929196757,0.9425427872860636,0.9792740707520713,1.0,3/26,8.84%,OTUD4;APPL2;TREM2
prerank,genitalia development (GO:0048806),0.28262773934569874,0.6191080367029719,0.9251412429378532,0.9791414783149813,1.0,1/12,7.93%,CHD7
prerank,basement membrane organization (GO:0071711),-0.22185891780995742,-0.6188325297633428,0.9256198347107438,0.9828839713752228,1.0,2/14,4.99%,CTSS;NTNG1
prerank,negative regulation of ATPase activity (GO:0032780),-0.21557299843014127,-0.6187025067603913,0.9485294117647058,0.9812562321659246,1.0,16/16,78.47%,TLR9;PXK;PLN;PPIF;LTF;VCPKMT;TNNT2;IFIT1;SIRT1;TSC1;TNNI3;OXA1L;THADA;TP53;ATP5IF1;PAM16
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.2627963582350887,0.6184878309464817,0.906801007556675,0.979224233037312,1.0,4/16,22.36%,ATP5MG;ATP5F1C;STOML2;ATP5F1B
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2813252455243332,0.6178323846530791,0.9276410998552822,0.9793314100136581,1.0,3/12,19.61%,GMNN;KAT7;BLM
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2210519019603171,0.6174181539468269,0.9629629629629629,0.9792838893070969,1.0,12/47,25.17%,RAP2A;TAOK3;IGF1R;QARS1;MAPK3;MAP2K2;MAPK8IP3;TAOK1;FOXO1;ARL6IP5;SEMA4C;MAPK1
prerank,ovarian follicle development (GO:0001541),0.27673575255797433,0.6167138799462628,0.914364640883978,0.9794290261281254,1.0,1/13,3.49%,VEGFA
prerank,response to nitric oxide (GO:0071731),0.2792682658490725,0.6163307248662315,0.9159891598915989,0.9793580709534913,1.0,4/13,26.65%,EGLN1;CDK2;FOXO1;TXN
prerank,dorsal/ventral pattern formation (GO:0009953),-0.19539225643471164,-0.6156185434340761,0.9669811320754716,0.9812850008206707,1.0,8/20,31.50%,BMPR1B;DSCAML1;NBL1;GREM1;FBXL15;SHH;GLI2;WNT8B
prerank,positive regulation of translational initiation (GO:0045948),0.25953464705726553,0.6145777990610336,0.9389416553595658,0.9801417001346062,1.0,3/18,15.24%,LARP1;YTHDF2;POLR2D
prerank,response to calcium ion (GO:0051592),0.20345091554720887,0.6142477494247669,0.9810725552050473,0.9800454428144856,1.0,5/102,4.97%,IQGAP1;ITPKB;KCNMA1;ADCY8;CLIC4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.23835098298872595,0.6139219826564661,0.9366459627329192,0.9799285521718331,1.0,11/28,28.69%,FBXW7;TREM2;CCDC22;PSMC2;PTEN;ATP5IF1;CDK5RAP3;BAG2;PSMC6;FMR1;PSMC5
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.27042576994989154,0.6119717433544217,0.930327868852459,0.9808217958773853,1.0,2/14,14.37%,ERN1;CPSF7
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.25268107893970904,0.6118124652370489,0.9181818181818182,0.9806009746949831,1.0,6/19,27.38%,CEBPA;NAB2;MAF1;PRDX5;ICE1;DHX36
prerank,endocardial cushion development (GO:0003197),0.2508603406146241,0.6115407440421959,0.9330808080808081,0.9804538503868581,1.0,3/21,21.65%,SOX9;CRELD1;NOTCH1
prerank,cellular response to gamma radiation (GO:0071480),0.2592891766522607,0.6108824516498614,0.93048128342246,0.9805189364782537,1.0,8/17,32.24%,MDM2;MAP3K20;HSF1;XRCC5;KDM1A;TMEM109;ATR;TP53
prerank,insulin secretion (GO:0030073),0.24742391978484884,0.6099342549120771,0.9346153846153846,0.9807960249197585,1.0,2/19,7.21%,SNX19;CYB5R4
prerank,negative regulation of developmental process (GO:0051093),0.2086927956202029,0.6098492581117382,0.9749182115594329,0.9805338505561662,1.0,20/69,29.16%,CDK6;FOXJ1;SOX9;GAS6;VAT1;HUWE1;NOTCH4;TFRC;SFRP1;TGFB1;SINHCAF;ROCK1;NOTCH1;FGFR3;SPI1;OMA1;WDR77;BNIP3;RC3H1;FOXC1
prerank,regulation of glucose metabolic process (GO:0010906),0.23059658529714872,0.6097937928030789,0.9588377723970944,0.9802430742046918,1.0,6/34,20.09%,GNMT;ADIPOR1;OGT;SLC45A3;PDK3;DGKQ
prerank,defense response to tumor cell (GO:0002357),-0.2464994734081773,-0.609595762021028,0.9404388714733543,0.9827964837500937,1.0,2/10,11.52%,ABI3;RBMS3
prerank,replication fork processing (GO:0031297),0.22856762765800293,0.6090652013191504,0.9494584837545126,0.9803612726138724,1.0,16/38,31.96%,ZRANB3;THOC1;BOD1L1;SETMAR;CENPX;GEN1;CENPS;BLM;ZGRF1;RAD51;SMARCAL1;MRE11;MMS22L;EME2;DNA2;ATR
prerank,V(D)J recombination (GO:0033151),0.2804932776240028,0.6089156825071097,0.9072463768115943,0.9801353553297786,1.0,4/11,30.81%,LIG3;LIG1;PRKDC;LIG4
prerank,BMP signaling pathway (GO:0030509),0.21068952383514827,0.6088302481951874,0.9838882921589689,0.9798656224168869,1.0,4/62,7.94%,BMP8B;GDF6;SMAD7;USP9X
prerank,atrioventricular valve morphogenesis (GO:0003181),0.25018674413023256,0.6085270760421192,0.9193758127438232,0.9797299399790396,1.0,4/19,21.65%,TGFBR2;EFNA1;OLFM1;NOTCH1
prerank,Golgi inheritance (GO:0048313),0.2897977622305723,0.6071098080514492,0.9199438202247191,0.980238153633841,1.0,3/11,18.47%,PLK3;STX5;GOLGA2
prerank,histone monoubiquitination (GO:0010390),0.2412138953732481,0.6066513218949581,0.9344660194174758,0.9801811564784568,1.0,3/24,10.55%,RNF2;DDB2;DDB1
prerank,histone ubiquitination (GO:0016574),-0.19161104301837523,-0.6062796180753462,0.9757281553398058,0.9828963032912185,1.0,10/21,33.90%,DTX3L;ATXN7L3;UBE2B;UHRF1;CDC73;LEO1;RNF8;PHC1;RNF40;UBE2U
prerank,alpha-amino acid catabolic process (GO:1901606),0.23135489991668587,0.6059925975574604,0.964329643296433,0.9802393646180081,1.0,9/29,31.11%,MTRR;BLMH;KYNU;HOGA1;IDO2;SARDH;CBS;IL4I1;GSTZ1
prerank,centromere complex assembly (GO:0034508),0.2278082795875952,0.6058172764777091,0.9487776484284052,0.9800230444910564,1.0,15/36,34.31%,CENPO;CENPT;CENPX;CENPA;CENPK;CENPS;CENPW;RSF1;CENPU;CENPC;CENPV;NPM1;MIS18BP1;KNL1;ITGB3BP
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.2579096832860589,0.6053618568390876,0.9140625,0.9799654980272674,1.0,6/17,27.16%,CD44;MDM2;PTTG1IP;KDM1A;RNF34;PSMD10
prerank,cotranslational protein targeting to membrane (GO:0006613),0.2007855223227427,0.603016949523067,0.9885057471264368,0.9810035485601134,1.0,22/91,24.94%,UBA52;SRP9;RPL10A;RPL12;SIL1;RPL36;SRP14;RPS6;RPS28;RPL13A;SEC63;RPS26;RPS27A;RPS12;RPL18;RPS13;SEC61A1;RPS2;RPS19;RPS7;RPL17;RPL23
prerank,regulation of ion transmembrane transport (GO:0034765),0.22858199948436053,0.6017557360543283,0.9633136094674556,0.9814111901946013,1.0,7/33,22.06%,KCNJ2;ANO6;WWP2;KCNJ6;AHCYL1;NEDD4;SCN10A
prerank,renal system development (GO:0072001),0.21323841061521046,0.6013961555669917,0.9724366041896362,0.9813036818016421,1.0,8/52,18.53%,TBX18;VEGFA;LRP4;IFT88;RBP4;WFS1;TGFBR1;TRAF3IP1
prerank,microtubule-based transport (GO:0099111),-0.22114926810333604,-0.6013291028698349,0.9256505576208178,0.9836761412647801,1.0,1/13,1.18%,DYNC1I1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.2772135029286501,0.5998630788662602,0.9388038942976356,0.9818535444881221,1.0,4/12,23.08%,CELSR1;TRAF3IP1;LAMA3;SCRIB
prerank,cardiac ventricle development (GO:0003231),-0.19708443913036275,-0.5993179558005648,0.975,0.9829391776509887,1.0,8/20,26.61%,SALL1;PDE2A;HEY1;HEY2;GATA3;ENG;MATR3;HEYL
prerank,regulation of protein export from nucleus (GO:0046825),0.23702054000944608,0.5960457282064692,0.9491740787801779,0.9836275911231652,1.0,9/23,33.68%,GAS6;BAG3;TPR;RBM22;GSK3B;IFI27;EMD;TP53;BARD1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.2087683474827578,-0.5960213697784791,0.9438202247191011,0.9828957244972724,1.0,7/15,29.37%,EZH2;ATAD5;PLCG2;CDC73;CRNN;STXBP4;PHB2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.22299081131862097,0.5958897253613169,0.9532163742690059,0.9833891030271943,1.0,4/30,16.19%,SDCBP;OGT;GIPC1;USP14
prerank,antibacterial humoral response (GO:0019731),0.26025410566632573,0.595587304845931,0.921302578018996,0.9832167726943166,1.0,3/16,20.73%,RNASE7;RNASE3;DMBT1
prerank,protein palmitoylation (GO:0018345),0.23080673168425825,0.5941873372070161,0.9481927710843373,0.9836353568167514,1.0,11/30,30.83%,ZDHHC18;ZDHHC15;ZDHHC1;ZDHHC6;GOLGA7;ZDHHC4;ZDHHC21;ZDHHC8;HHAT;ZDHHC9;SELENOK
prerank,response to retinoic acid (GO:0032526),0.20475893997106634,0.593659047685218,0.9801762114537445,0.9836128144228957,1.0,3/59,3.85%,ABL2;PTK2B;SOX9
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.26519758355048956,0.5936050479439395,0.9391891891891891,0.9833184584262179,1.0,3/14,23.37%,SOX9;TGFBR1;PTPN11
prerank,cellular biogenic amine catabolic process (GO:0042402),0.27681632745872453,0.5935072039187018,0.9138972809667674,0.9830454810971876,1.0,1/10,6.81%,SMOX
prerank,ATP synthesis coupled proton transport (GO:0015986),0.24969952095638492,0.5926365128369903,0.9283018867924528,0.9832050377078071,1.0,4/17,22.36%,ATP5MG;ATP5F1C;STOML2;ATP5F1B
prerank,regulation of vasoconstriction (GO:0019229),0.23134700146631076,0.5923601728703132,0.9443099273607748,0.9830404963960847,1.0,2/27,8.56%,ATP2B1;CAV1
prerank,exit from mitosis (GO:0010458),0.2707354055207123,0.5902895772165734,0.9472934472934473,0.9838218591983752,1.0,3/12,17.94%,CHMP4B;PPP2R2D;UBE2C
prerank,acute inflammatory response (GO:0002526),0.23698076165447646,0.5886705777491626,0.9523809523809523,0.984338381190516,1.0,3/23,16.10%,ANO6;IL6;MBL2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.22821094941898495,0.5875643065757853,0.9669926650366748,0.9845846117069114,1.0,3/29,9.40%,PLAAT3;LPCAT1;LPCAT3
prerank,regulation of RNA export from nucleus (GO:0046831),0.2756929239303758,0.587563626784588,0.9416909620991254,0.9842661051983793,1.0,4/11,30.27%,DHX9;TPR;NSUN2;SETD2
prerank,dopamine metabolic process (GO:0042417),0.24994249888511727,0.5873223595198798,0.9506493506493506,0.9840618918447527,1.0,2/18,9.55%,TH;ATP7A
prerank,coenzyme A metabolic process (GO:0015936),0.2620287887147804,0.58636378770545,0.9364864864864865,0.9842267960066547,1.0,10/14,37.20%,PPCS;COASY;DCAKD;ACOT7;ACLY;PANK2;SLC25A16;PANK3;ACAT1;NUDT7
prerank,glutathione metabolic process (GO:0006749),0.2154159682300879,0.5859664419436081,0.9782608695652174,0.9841152793283203,1.0,12/38,32.44%,GSTA2;NAT8;GLRX2;CTNS;GSR;GSTK1;OPLAH;GSTT1;HPGDS;GSTP1;GSTZ1;CNDP2
prerank,positive regulation of isotype switching (GO:0045830),0.2547088049956687,0.5857253062882735,0.9491059147180193,0.9839200287215558,1.0,3/15,20.66%,KMT5B;TFRC;TGFB1
prerank,mitochondrion morphogenesis (GO:0070584),-0.22473257055654217,-0.5850588275327873,0.9297124600638977,0.9860686669832619,1.0,3/11,11.51%,DNM1L;SLIRP;MYH14
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22773576199593754,0.5847541649005368,0.958179581795818,0.9841009043648447,1.0,7/29,29.38%,PRDM9;TRIP13;SYCP2;SYCE2;MEI4;TEX11;P3H4
prerank,regulation of viral release from host cell (GO:1902186),0.23672903475804655,0.5843184063332768,0.9475,0.9840029368061246,1.0,8/21,33.32%,TRIM28;DDB1;TRIM8;CHMP2B;TRIM35;CHMP3;TRIM11;MID2
prerank,bicellular tight junction assembly (GO:0070830),0.20906019252769303,0.5841799756307327,0.9832214765100671,0.9837543278654998,1.0,4/46,9.97%,CLDN19;CLDN18;PDCD6IP;PAK2
prerank,positive regulation of cellular respiration (GO:1901857),0.27499519985257176,0.5835768012947318,0.9392655367231638,0.9837067542071849,1.0,1/11,7.30%,VCP
prerank,mesenchyme morphogenesis (GO:0072132),0.24798073064323695,0.5819223347946196,0.9510309278350515,0.9841685988509749,1.0,1/17,3.85%,SOX9
prerank,smooth muscle tissue development (GO:0048745),0.2820794779357891,0.5813306335514583,0.9304347826086956,0.9841282828331562,1.0,2/10,18.32%,NF1;EFEMP2
prerank,contractile actin filament bundle assembly (GO:0030038),0.25205735730669165,0.5778542809893463,0.9346049046321526,0.9851347304201907,1.0,2/15,11.62%,ITGB5;RHOA
prerank,stress fiber assembly (GO:0043149),0.25205735730669165,0.5778542809893463,0.9346049046321526,0.9851347304201907,1.0,2/15,11.62%,ITGB5;RHOA
prerank,respiratory chain complex IV assembly (GO:0008535),0.2380980578387048,0.5777919406364878,0.962772785622593,0.9848538151474424,1.0,7/21,28.48%,SURF1;COX10;TIMM21;BCS1L;PET100;SMIM20;FASTKD3
prerank,nucleic acid-templated transcription (GO:0097659),0.21165118579294748,0.5767616028925577,0.9772985244040863,0.9850184943749392,1.0,17/42,35.05%,POLR2H;PWP1;DRG1;POLR2D;TERT;MMS19;THAP1;RRAGC;SCX;FUBP3;POLR3A;TOPORS;EPC1;POLR2B;NR4A2;POLR2K;POLR2F
prerank,pancreas development (GO:0031016),-0.21855197642757768,-0.5765650432562542,0.9568345323741008,0.9878377442803057,1.0,1/12,5.10%,SELENOT
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.19268446678875772,0.576289674110776,0.9936842105263158,0.9849024773146288,1.0,21/87,24.94%,UBA52;SRP9;RPL10A;RPL12;RPL36;SRP14;RPS6;RPS28;RPL13A;SEC63;RPS26;RPS27A;RPS12;RPL18;RPS13;SEC61A1;RPS2;RPS19;RPS7;RPL17;RPL23
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.21622270206693844,0.5761523364200499,0.9758745476477684,0.9846459512045291,1.0,9/40,19.61%,ZRANB3;THOC1;BOD1L1;SETMAR;CENPX;POLE;GEN1;CENPS;BLM
prerank,cell part morphogenesis (GO:0032990),0.26170266620099025,0.576051095640088,0.946058091286307,0.9843732331129701,1.0,8/13,34.51%,PID1;SUPV3L1;FIS1;PACSIN2;NUBPL;CSPG5;WASF1;MFF
prerank,negative regulation of nuclear division (GO:0051784),-0.22484543929889508,-0.5759902546561245,0.9595959595959596,0.9863611233158697,1.0,4/11,30.78%,TOM1L2;CHEK1;BMP7;TOM1L1
prerank,rRNA transcription (GO:0009303),-0.1958189452981829,-0.5734082441272951,0.9666666666666667,0.9855986912426206,1.0,5/17,20.82%,TAF1B;GTF3C1;GTF3C6;BRF1;GTF3C2
prerank,odontogenesis (GO:0042476),0.2145939182723876,0.5723163145881568,0.9744186046511628,0.9857068525098438,1.0,5/35,20.04%,LRP6;ANKRD11;TUFT1;HDAC1;FGFR2
prerank,positive regulation of dendrite development (GO:1900006),0.27535484828467943,0.5720381363718279,0.9416785206258891,0.9855130330990884,1.0,2/10,16.23%,ZDHHC15;BMP5
prerank,smoothened signaling pathway (GO:0007224),0.21660534656275085,0.5719222229310623,0.9640287769784173,0.9852499707217595,1.0,8/32,27.85%,PTCHD1;DYRK2;TCTN3;TMEM17;HIPK1;TTBK2;PKD2L1;HIPK2
prerank,response to X-ray (GO:0010165),0.2513218130191505,0.5714518765990557,0.9534246575342465,0.9851484389301868,1.0,5/14,30.81%,BLM;BRCC3;XRCC5;IKBIP;LIG4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.2693732305874022,0.5708709351764636,0.9495091164095372,0.9850729685873867,1.0,1/10,9.46%,NAMPT
prerank,male gonad development (GO:0008584),0.21327100340141092,0.5707559503871903,0.9660023446658851,0.9848139662867554,1.0,4/34,13.07%,SOX9;COL9A3;KITLG;BIK
prerank,cellular glucan metabolic process (GO:0006073),0.2621744277082224,0.5691298207612884,0.9415121255349501,0.9851849655185265,1.0,3/11,23.79%,PHKB;GBE1;GSK3B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.26779639048402165,0.5687343472904588,0.958981612446959,0.9847030036113836,1.0,4/11,24.98%,INPP5A;SYNJ1;SYNJ2;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.26779639048402165,0.5687343472904588,0.958981612446959,0.9847030036113836,1.0,4/11,24.98%,INPP5A;SYNJ1;SYNJ2;PTEN
prerank,negative regulation of centrosome duplication (GO:0010826),0.2682879116663824,0.567159346441321,0.946927374301676,0.9850620349450395,1.0,6/11,31.11%,BRCA1;CENATAC;MDM1;CDK5RAP2;TRIM37;NPM1
prerank,magnesium ion transport (GO:0015693),0.25880117639470296,0.5666737428712532,0.952513966480447,0.9849518102130275,1.0,5/12,29.68%,MAGT1;NIPAL4;TUSC3;MRS2;NIPA2
prerank,mesenchyme development (GO:0060485),0.2450023474820124,0.5654657172895841,0.9529569892473119,0.9851026966254688,1.0,3/15,20.04%,TGFBR1;CRELD1;FGFR2
prerank,regulation of chromosome organization (GO:0033044),0.22430110273824988,0.56523677249154,0.9625935162094763,0.9848755145762584,1.0,12/22,35.76%,WAPL;SETMAR;SMG1;XRCC5;TERF2IP;TERF2;HDAC8;CENPV;LIG4;HNRNPD;UPF1;MYC
prerank,response to cholesterol (GO:0070723),0.24120186758659928,0.5649630095875833,0.9506666666666667,0.984679716502669,1.0,6/17,24.82%,LRP6;TGFBR2;TGFBR1;TGFB1;CCL3;MLC1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.26839475849912003,0.5649373049898347,0.949438202247191,0.9843730838565868,1.0,3/10,22.40%,CCNB1;SIRT2;CDC42
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.21501704599573057,0.5639418424776426,0.9679715302491103,0.98448211653539,1.0,8/31,26.68%,HOXA4;TGFBR2;TGFBR1;FGFR2;DYNC2I1;PDGFRA;EIF4A3;MEGF8
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.2564495361158108,0.5632037529364663,0.9388888888888889,0.9844459940560293,1.0,2/13,13.81%,NRROS;DAND5
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.26667167664710706,0.5581990661078585,0.9705056179775281,0.9860700419490462,1.0,2/10,19.01%,ATP5MG;ATP5F1C
prerank,phospholipid dephosphorylation (GO:0046839),0.20597704590137597,0.55654278890463,0.9801401869158879,0.9864123389885563,1.0,9/37,24.98%,PLPP6;PLPP3;MTMR12;MTMR6;MTMR10;SYNJ1;PLPP5;SYNJ2;PTEN
prerank,histone deubiquitination (GO:0016578),0.2347375369481865,0.5531520826588917,0.9633507853403142,0.9873617308659993,1.0,5/18,19.88%,USP36;UIMC1;USP21;USP16;BRCC3
prerank,epithelial cell development (GO:0002064),0.2286823741235534,0.552694965468613,0.9572538860103627,0.9872090126453908,1.0,2/20,9.00%,RILPL2;RILPL1
prerank,cellular response to inorganic substance (GO:0071241),0.227885214520955,0.5526824352799266,0.9697732997481109,0.986900600199366,1.0,7/21,33.05%,DDI2;BLM;CDK2;FOXO1;FMR1;SPIDR;NSMCE3
prerank,inositol phosphate catabolic process (GO:0071545),0.2546265654781522,0.5512675066053583,0.9568245125348189,0.9870838009688604,1.0,4/12,24.98%,INPP5A;SYNJ1;SYNJ2;PTEN
prerank,regulation of water loss via skin (GO:0033561),0.23628612910924474,0.5511552474745031,0.9645293315143247,0.9864981134976324,1.0,3/15,21.28%,HRNR;UGCG;CLDN1
prerank,establishment of skin barrier (GO:0061436),0.23628612910924474,0.5511552474745031,0.9645293315143247,0.9864981134976324,1.0,3/15,21.28%,HRNR;UGCG;CLDN1
prerank,regulation of chromosome segregation (GO:0051983),0.23659152520747617,0.5503738130554571,0.9641909814323607,0.9864594646769081,1.0,4/16,22.28%,NUMA1;CSNK2A2;PUM1;PUM2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.2414506601708516,0.5501549075561342,0.956338028169014,0.9862159868420223,1.0,2/14,11.75%,LILRB1;C1QBP
prerank,protein K48-linked ubiquitination (GO:0070936),0.19195023383107404,0.549714069528643,0.9842873176206509,0.9860593438159635,1.0,19/54,32.36%,RNF6;TTC3;UBE2R2;BFAR;TNFAIP3;UBE2H;UBE2C;SYVN1;RNF34;CUL3;CDC34;RNF216;SKP2;ARIH2;UBE2K;TOPORS;UBE2A;IFI27;RBX1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.23146508118352863,0.549534211962743,0.967741935483871,0.9858052348820484,1.0,6/18,28.48%,SURF1;TIMM21;BCS1L;PET100;SMIM20;FASTKD3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.2494651218716884,0.5479833388441159,0.9730458221024259,0.9860267286370995,1.0,3/13,17.86%,MBTPS2;LPCAT3;WFS1
prerank,positive regulation of vasoconstriction (GO:0045907),0.2471931089623759,0.5475731239141322,0.9683195592286501,0.9858507950813942,1.0,1/13,8.56%,CAV1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.24037416471099243,0.5470456134175712,0.9635343618513323,0.9857222231060611,1.0,2/14,16.60%,KMT5B;TFRC
prerank,positive regulation of interferon-beta production (GO:0032728),0.20514488567254335,0.5426470795326936,0.9905437352245863,0.9868753365933554,1.0,11/33,28.10%,POLR3D;IRF5;DHX9;RIOK3;TBK1;TLR7;POLR3B;PTPN11;TLR3;IRF3;POLR3A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.2434679961797857,0.5402614943910107,0.9673295454545454,0.9873190955416014,1.0,4/13,25.63%,ECHDC3;ZBTB7B;PTPN11;SNX5
prerank,extracellular transport (GO:0006858),0.24318037368989712,0.5397172483589069,0.970310391363023,0.9871819262992169,1.0,2/13,17.70%,WWP2;CCDC40
prerank,negative regulation of cell division (GO:0051782),-0.21302252171968034,-0.5394516148047445,0.9664429530201343,0.9946662498601722,1.0,4/11,21.98%,TXNIP;AURKB;CHMP4C;E2F7
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.1771134279613114,-0.5388608212274301,0.9823008849557522,0.9931242974474778,1.0,19/19,82.32%,ODAD4;CFAP53;ADCY10;OFD1;SPAG17;DNAAF2;DNAAF1;RFX3;DNAAF4;ROPN1L;CCDC103;CABYR;NPHP3;SPA17;SPEF2;AQP4;CCDC39;NEK10;CCDC40
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.22466227955001628,0.5387305346564647,0.9748677248677249,0.9871738723266011,1.0,5/18,25.85%,C1QBP;PUM1;BIRC2;PUM2;GPATCH3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2366012834049361,0.5379357046102631,0.9693593314763231,0.9871057835597078,1.0,1/14,4.63%,ABCD2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.2408307668542144,0.5349548034733428,0.9700272479564033,0.9876610312320152,1.0,2/13,15.15%,SPRED2;SPRED3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.19776267571261258,0.5344313849690512,0.9953434225844005,0.9875113999138009,1.0,6/41,19.53%,MGLL;ACSL1;CYP1B1;SCP2;FADS3;ELOVL2
prerank,extracellular matrix assembly (GO:0085029),0.2153351375097745,0.5338978731543976,0.9759797724399494,0.9873473624508439,1.0,10/23,33.76%,GAS6;ATP7A;EFEMP2;TGFB1;EMILIN1;TNXB;LAMB2;PXDN;QSOX1;HAS3
prerank,peptidyl-arginine modification (GO:0018195),0.2330981749554935,0.5325351203829529,0.9550408719346049,0.9874285551261427,1.0,2/15,11.88%,PRMT7;ART4
prerank,epithelial structure maintenance (GO:0010669),-0.2011416694707529,-0.5251134485841592,0.9905660377358491,0.9945307948760389,1.0,5/11,38.65%,NOD2;TLR9;CXADR;PIWIL4;MUC6
prerank,blood vessel diameter maintenance (GO:0097746),0.1961686701653788,0.5236350530660429,0.9878787878787879,0.9895372704771189,1.0,7/34,21.64%,SERPINF2;SCPEP1;EDNRA;HTR2B;ITGB1BP1;NPR1;ROCK1
prerank,endothelial cell differentiation (GO:0045446),0.23650058003164012,0.5230347878125197,0.9792243767313019,0.9893888795822935,1.0,1/12,5.85%,JAG1
prerank,regulation of axon regeneration (GO:0048679),0.23938523655576993,0.5229323551617476,0.9675675675675676,0.9891023372649478,1.0,4/12,28.89%,STK24;SCARF1;KLK8;CERS2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.23477502544180334,0.5198892853123892,0.9682320441988951,0.9895645698616361,1.0,7/13,35.01%,ZC3H12A;ZC3HAV1;PRR5L;RC3H1;CNOT7;KHSRP;UPF1
prerank,neural tube development (GO:0021915),-0.18472937335175185,-0.5079108595781638,0.9916317991631799,0.9960177572567628,1.0,15/15,81.55%,STIL;ARL13B;GRHL2;PROX1;ALDH1A2;HES5;DVL1;PTCH1;SOX11;SOX4;PKD1;PKD2;TRIM71;TGFB1;DACT1
prerank,motile cilium assembly (GO:0044458),0.23582303023326373,0.502961788750912,0.9748603351955307,0.9930761807184626,1.0,3/12,27.01%,CCDC40;SPATA6;CCDC39
prerank,modulation by host of viral genome replication (GO:0044827),0.22492307175732124,0.500003037732786,0.9798387096774194,0.9933375803821054,1.0,6/13,31.64%,TBC1D20;ZC3H12A;EIF2AK4;FMR1;VAPA;IFI27
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2244553399178812,0.4895283248129303,0.9831223628691983,0.9949459857390505,1.0,1/14,6.99%,SLC6A4
prerank,muscle filament sliding (GO:0030049),0.1817011750417414,0.48823995330565984,0.9954954954954955,0.9945215922109236,1.0,7/38,28.47%,VIM;TPM4;MYL4;ACTN2;MYL1;TNNI1;NEB
prerank,actin-myosin filament sliding (GO:0033275),0.1817011750417414,0.48823995330565984,0.9954954954954955,0.9945215922109236,1.0,7/38,28.47%,VIM;TPM4;MYL4;ACTN2;MYL1;TNNI1;NEB
prerank,I-kappaB phosphorylation (GO:0007252),0.23260397720099743,0.4857025013121175,0.9856938483547926,0.9946196315692838,1.0,3/10,26.55%,TLR7;CHUK;TLR3
prerank,heterochromatin assembly (GO:0031507),0.20298655569300708,0.48303401713297117,0.9858429858429858,0.9947182654629637,1.0,8/20,34.00%,HDAC1;BAHD1;SIRT2;SMCHD1;H3-3A;CENPV;RRP8;CDKN2A
prerank,regulation of stem cell population maintenance (GO:2000036),-0.16350314342516245,-0.4803760734512906,0.996078431372549,0.997888177310395,1.0,7/18,31.67%,CNOT2;HMGA2;REST;ESRRB;CNOT1;PTN;KAT2A
prerank,nitric oxide metabolic process (GO:0046209),0.2127661213695432,0.47408193351714906,0.9835841313269493,0.9956455880731879,1.0,2/14,19.74%,CYP1B1;CYB5R3
prerank,embryonic organ morphogenesis (GO:0048562),0.17148737198657338,0.4713083736644383,0.9965870307167235,0.9956956019326012,1.0,2/42,5.88%,HOXA4;ID2
prerank,spermatid development (GO:0007286),0.17939584494131733,0.468922913211205,1.0,0.9956842461635063,1.0,6/32,28.34%,SOX30;SYCP3;IQCG;CEP57;CDYL;CIB1
prerank,nitric oxide biosynthetic process (GO:0006809),0.2127785186213567,0.46830938922284865,0.9793388429752066,0.9954532000306561,1.0,2/13,19.74%,CYP1B1;CYB5R3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.20586311909550564,0.44958431959750955,0.9850136239782016,0.9971071677857599,1.0,4/12,28.85%,EXTL2;GFUS;GALT;PARG
prerank,negative regulation by host of viral process (GO:0044793),0.21661108788694627,0.4464358422038708,0.9926900584795322,0.9970773530431084,1.0,4/10,32.83%,ZC3H12A;EIF2AK4;VAPA;PSMC3
prerank,heterochromatin organization (GO:0070828),0.18880177691972141,0.42583073156037754,0.9985915492957746,0.9983009389786511,1.0,4/14,29.58%,BAHD1;HP1BP3;SMCHD1;SETDB1
prerank,embryonic heart tube development (GO:0035050),-0.14089282350725185,-0.39881692351141157,1.0,0.9998145865208646,1.0,14/14,85.93%,NDRG4;CITED2;TBX2;RYR2;PITX2;SOX17;APELA;FGF8;SOX18;TBX20;ACVR1;HES1;MEGF8;IFT122
prerank,pharyngeal system development (GO:0060037),0.16709190339794947,0.3783988900767983,0.9974059662775616,0.9997814882136082,1.0,2/15,18.39%,BMP5;TGFBR1
prerank,atrioventricular valve development (GO:0003171),0.16639487630978556,0.37309946890815016,0.9986282578875172,0.999573739609903,1.0,3/14,24.51%,TGFBR2;NOTCH1;APLNR
